Citrus Sinensis ID: 023430
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 282 | 2.2.26 [Sep-21-2011] | |||||||
| Q39030 | 471 | Serine/threonine-protein | yes | no | 0.797 | 0.477 | 0.541 | 2e-69 | |
| P42818 | 465 | Serine/threonine-protein | no | no | 0.804 | 0.488 | 0.507 | 3e-65 | |
| P28178 | 479 | Protein kinase 2 OS=Dicty | yes | no | 0.492 | 0.290 | 0.597 | 4e-47 | |
| P54644 | 444 | RAC family serine/threoni | no | no | 0.531 | 0.337 | 0.503 | 1e-42 | |
| Q8MYF1 | 456 | Probable serine/threonine | no | no | 0.510 | 0.315 | 0.543 | 5e-42 | |
| P11792 | 824 | Serine/threonine-protein | yes | no | 0.517 | 0.177 | 0.512 | 2e-41 | |
| Q9UBS0 | 482 | Ribosomal protein S6 kina | yes | no | 0.581 | 0.340 | 0.508 | 3e-41 | |
| P51812 | 740 | Ribosomal protein S6 kina | no | no | 0.531 | 0.202 | 0.522 | 2e-40 | |
| P18654 | 740 | Ribosomal protein S6 kina | yes | no | 0.531 | 0.202 | 0.522 | 2e-40 | |
| Q9Z1M4 | 485 | Ribosomal protein S6 kina | no | no | 0.581 | 0.338 | 0.502 | 4e-40 |
| >sp|Q39030|KPK2_ARATH Serine/threonine-protein kinase AtPK2/AtPK19 OS=Arabidopsis thaliana GN=ATPK2 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 262 bits (670), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 144/266 (54%), Positives = 179/266 (67%), Gaps = 41/266 (15%)
Query: 20 LTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSP 76
L+I+PP + D F++VFGP+ S + + +P V+++RSHS VGPS
Sbjct: 24 LSISPPKSVLGDNLELQFSDVFGPMPEA----NSEEACDVAYDEPAVVYSRSHSLVGPS- 78
Query: 77 RYALSSSLP---LQIQELE--------------HEND---AELEAESERK-------IGP 109
+S SL L ++E E END + +SE+ +G
Sbjct: 79 -LVVSHSLKMNKLTLRETEDSVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGI 137
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DFE+ +VVGQGAFGKV+QV+KK D+ IYAMKVMRKD I++KNH +YMKAERDIL
Sbjct: 138 EDFEVLKVVGQGAFGKVYQVRKK-----DTSEIYAMKVMRKDKIVEKNHAEYMKAERDIL 192
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
TK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVS
Sbjct: 193 TKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVS 252
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM 255
HLH+ GI+HRDLKPENILMD DGHVM
Sbjct: 253 HLHEKGIMHRDLKPENILMDVDGHVM 278
|
Downstream effector of TOR signaling pathway. May be involved in adaptation of plant to cold or high-salt conditions. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P42818|KPK1_ARATH Serine/threonine-protein kinase AtPK1/AtPK6 OS=Arabidopsis thaliana GN=ATPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 3e-65, Method: Compositional matrix adjust.
Identities = 138/272 (50%), Positives = 180/272 (66%), Gaps = 45/272 (16%)
Query: 16 KLKKLTITPPSASSPD---FDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
K + L+I+P ++ D +F++VFGPL P N+ + +P V+++RSHS V
Sbjct: 14 KQQYLSISPSNSVLKDDVELEFSDVFGPL-PEEAND-------IAYDEPAVVYSRSHSLV 65
Query: 73 GPSPRYALSSSLP----------------LQIQELEHENDAELEAESERK---------- 106
GP + S L L+ + L+ +D +S+ +
Sbjct: 66 GPCSLDSHSLKLTKLTLLETEDSIDLVECLEGESLKENDDFSGNDDSDNEKALEGDLVKV 125
Query: 107 ---IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
+G DFE+ +VVG+GAFGKV+QV+KK ++ IYAMKVMRKD I++KNH +YMK
Sbjct: 126 SGVVGIDDFEVMKVVGKGAFGKVYQVRKK-----ETSEIYAMKVMRKDHIMEKNHAEYMK 180
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
AERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY QG+FRED AR YTAE
Sbjct: 181 AERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYHQGLFREDLARVYTAE 240
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
IVSAVSHLH+ GI+HRDLKPENILMD+DGHVM
Sbjct: 241 IVSAVSHLHEKGIMHRDLKPENILMDTDGHVM 272
|
Downstream effector of TOR signaling pathway involved in osmotic stress response. Could be involved in the control of plant growth and development. Phosphorylates the ribosomal proteins P14, P16 and S6. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28178|PK2_DICDI Protein kinase 2 OS=Dictyostelium discoideum GN=pkgB PE=1 SV=2 | Back alignment and function description |
|---|
Score = 188 bits (478), Expect = 4e-47, Method: Compositional matrix adjust.
Identities = 86/144 (59%), Positives = 112/144 (77%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE+ V+G+G+FGKV QVKKKG D I+AMKV+RKD II + V++ K+E+ IL
Sbjct: 152 DFELLNVIGKGSFGKVMQVKKKG-----EDKIFAMKVLRKDAIIARKQVNHTKSEKTILQ 206
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
++HPFIV L Y+FQT+ KLY++LDF+NGG LFFHL R+G F E + + Y AEIVSA+ H
Sbjct: 207 CISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREGRFSEPRVKIYAAEIVSALDH 266
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LHK IV+RDLKPENIL+DS+GH+
Sbjct: 267 LHKQDIVYRDLKPENILLDSEGHI 290
|
Required for morphogenesis during multicellular development. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P54644|KRAC_DICDI RAC family serine/threonine-protein kinase homolog OS=Dictyostelium discoideum GN=pkbA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (438), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 78/155 (50%), Positives = 112/155 (72%), Gaps = 5/155 (3%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
+ + K+G DFE+ +VG+G+FGKV QV+KK D+ +YAMKV+ K I++ N V
Sbjct: 108 QPKKSEKVGVADFELLNLVGKGSFGKVIQVRKK-----DTGEVYAMKVLSKKHIVEHNEV 162
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
++ +ER+IL K+ HPF+V L YSFQT KLY ILD++NGG LF+HL + F ED+ R+
Sbjct: 163 EHTLSERNILQKINHPFLVNLNYSFQTEDKLYFILDYVNGGELFYHLQKDKKFTEDRVRY 222
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
Y AEIV A+ HLH G+++RDLKPEN+L+ ++GH+
Sbjct: 223 YGAEIVLALEHLHLSGVIYRDLKPENLLLTNEGHI 257
|
Predominantly involved during the aggregation to control cell polarity and chemotaxis. Phosphorylates talB, gefN, gefS, PI4P 5-kinase and gacQ. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8MYF1|Y2070_DICDI Probable serine/threonine-protein kinase DDB_G0277449 OS=Dictyostelium discoideum GN=DDB_G0277449 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 5e-42, Method: Compositional matrix adjust.
Identities = 81/149 (54%), Positives = 105/149 (70%), Gaps = 5/149 (3%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I +F I +VG+G FGKVFQV D+ +YA+KV++K+ II K V AE+
Sbjct: 123 INLSNFIIKHLVGKGGFGKVFQVV-----HVDTQKVYALKVIKKNHIIAKKSVVNTLAEK 177
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
DIL K++HPFIV L Y+FQ KLYL++DF+NGG LF+HL ++ IF EDQ RFY AE++
Sbjct: 178 DILKKISHPFIVNLHYAFQNEKKLYLVMDFVNGGQLFYHLQKEAIFSEDQVRFYMAELIL 237
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVM 255
A+ HLH IVHRDLKPENIL+DS GH +
Sbjct: 238 ALEHLHDSNIVHRDLKPENILLDSQGHCI 266
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P11792|SCH9_YEAST Serine/threonine-protein kinase SCH9 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SCH9 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 169 bits (428), Expect = 2e-41, Method: Compositional matrix adjust.
Identities = 79/154 (51%), Positives = 113/154 (73%), Gaps = 8/154 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
+R GP DFE+ R++G+G FG+V+QVKKK D+ IYAMKV+ K I+KKN + +
Sbjct: 404 KRHYGPQDFEVLRLLGKGTFGQVYQVKKK-----DTQRIYAMKVLSKKVIVKKNEIAHTI 458
Query: 164 AERDILTKV---THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
ER+IL + PFIV L++SFQT + LYL+ D+++GG LF+HL ++G F ED+A+FY
Sbjct: 459 GERNILVTTASKSSPFIVGLKFSFQTPTDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY 518
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
AE+V A+ HLH IV+RDLKPENIL+D++G++
Sbjct: 519 IAELVLALEHLHDNDIVYRDLKPENILLDANGNI 552
|
Protein kinase that is part of growth control pathway which is at least partially redundant with the cAMP pathway. Regulates both BCY1 phosphorylation and MPK1 activity. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9UBS0|KS6B2_HUMAN Ribosomal protein S6 kinase beta-2 OS=Homo sapiens GN=RPS6KB2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 168 bits (426), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 88/173 (50%), Positives = 118/173 (68%), Gaps = 9/173 (5%)
Query: 88 IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKK-KGVDDGDSDGI 142
++ + H + EL S +IGP FE+ RV+G+G +GKVFQV+K +G + G I
Sbjct: 39 LEPVGHYEEVELTETSVNVGPERIGPHCFELLRVLGKGGYGKVFQVRKVQGTNLGK---I 95
Query: 143 YAMKVMRKDTIIKK-NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
YAMKV+RK I++ + +AER+IL V HPFIV+L Y+FQT KLYLIL+ ++GG
Sbjct: 96 YAMKVLRKAKIVRNAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGE 155
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
LF HL R+GIF ED A FY AEI A+ HLH GI++RDLKPENI++ S GH+
Sbjct: 156 LFTHLEREGIFLEDTACFYLAEITLALGHLHSQGIIYRDLKPENIMLSSQGHI 208
|
Phosphorylates specifically ribosomal protein S6. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51812|KS6A3_HUMAN Ribosomal protein S6 kinase alpha-3 OS=Homo sapiens GN=RPS6KA3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (420), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 80/153 (52%), Positives = 108/153 (70%), Gaps = 3/153 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
E K P FE+ +V+GQG+FGKVF VKK + D+ +YAMKV++K T+ ++ V
Sbjct: 58 EGHEKADPSQFELLKVLGQGSFGKVFLVKK--ISGSDARQLYAMKVLKKATLKVRDRV-R 114
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
K ERDIL +V HPFIV+L Y+FQT KLYLILDF+ GG LF L ++ +F E+ +FY
Sbjct: 115 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 174
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
AE+ A+ HLH GI++RDLKPENIL+D +GH+
Sbjct: 175 AELALALDHLHSLGIIYRDLKPENILLDEEGHI 207
|
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Thr-529 by FGFR3. Phosphorylates DAPK1. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18654|KS6A3_MOUSE Ribosomal protein S6 kinase alpha-3 OS=Mus musculus GN=Rps6ka3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 166 bits (419), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 80/153 (52%), Positives = 108/153 (70%), Gaps = 3/153 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
E K P FE+ +V+GQG+FGKVF VKK + D+ +YAMKV++K T+ ++ V
Sbjct: 58 EGHEKADPSQFELLKVLGQGSFGKVFLVKK--ISGSDARQLYAMKVLKKATLKVRDRV-R 114
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
K ERDIL +V HPFIV+L Y+FQT KLYLILDF+ GG LF L ++ +F E+ +FY
Sbjct: 115 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 174
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
AE+ A+ HLH GI++RDLKPENIL+D +GH+
Sbjct: 175 AELALALDHLHSLGIIYRDLKPENILLDEEGHI 207
|
Serine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of the transcription factors CREB1, ETV1/ER81 and NR4A1/NUR77, regulates translation through RPS6 and EIF4B phosphorylation, and mediates cellular proliferation, survival, and differentiation by modulating mTOR signaling and repressing pro-apoptotic function of BAD and DAPK1. In fibroblast, is required for EGF-stimulated phosphorylation of CREB1 and histone H3 at 'Ser-10', which results in the subsequent transcriptional activation of several immediate-early genes. In response to mitogenic stimulation (EGF and PMA), phosphorylates and activates NR4A1/NUR77 and ETV1/ER81 transcription factors and the cofactor CREBBP. Upon insulin-derived signal, acts indirectly on the transcription regulation of several genes by phosphorylating GSK3B at 'Ser-9' and inhibiting its activity. Phosphorylates RPS6 in response to serum or EGF via an mTOR-independent mechanism and promotes translation initiation by facilitating assembly of the preinitiation complex. In response to insulin, phosphorylates EIF4B, enhancing EIF4B affinity for the EIF3 complex and stimulating cap-dependent translation. Is involved in the mTOR nutrient-sensing pathway by directly phosphorylating TSC2 at 'Ser-1798', which potently inhibits TSC2 ability to suppress mTOR signaling, and mediates phosphorylation of RPTOR, which regulates mTORC1 activity and may promote rapamycin-sensitive signaling independently of the PI3K/AKT pathway. Mediates cell survival by phosphorylating the pro-apoptotic proteins BAD and DAPK1 and suppressing their pro-apoptotic function. Promotes the survival of hepatic stellate cells by phosphorylating CEBPB in response to the hepatotoxin carbon tetrachloride (CCl4). Is involved in cell cycle regulation by phosphorylating the CDK inhibitor CDKN1B, which promotes CDKN1B association with 14-3-3 proteins and prevents its translocation to the nucleus and inhibition of G1 progression. In LPS-stimulated dendritic cells, is involved in TLR4-induced macropinocytosis, and in myeloma cells, acts as effector of FGFR3-mediated transformation signaling, after direct phosphorylation at Thr-529 by FGFR3. Phosphorylates DAPK1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z1M4|KS6B2_MOUSE Ribosomal protein S6 kinase beta-2 OS=Mus musculus GN=Rps6kb2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 4e-40, Method: Compositional matrix adjust.
Identities = 87/173 (50%), Positives = 116/173 (67%), Gaps = 9/173 (5%)
Query: 88 IQELEHENDAELEAES----ERKIGPGDFEIFRVVGQGAFGKVFQVKK-KGVDDGDSDGI 142
++ + H + EL S +IGP FE+ V+G+G +GKVFQV+K +G + G I
Sbjct: 39 LETVGHYEEVELTESSVNLGPERIGPHCFELLSVLGKGGYGKVFQVRKVQGTNLGK---I 95
Query: 143 YAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
YAMKV+RK I+ + +AER+IL V HPFIV+L Y+FQT KLYLIL+ ++GG
Sbjct: 96 YAMKVLRKAKIVCSAKDTAHTRAERNILESVKHPFIVELAYAFQTGGKLYLILECLSGGE 155
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
LF HL R+GIF ED A FY AEI A+ HLH GI++RDLKPENI++ S GH+
Sbjct: 156 LFTHLEREGIFLEDTACFYLAEITLALGHLHSHGIIYRDLKPENIMLSSQGHI 208
|
Phosphorylates specifically ribosomal protein S6. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 282 | ||||||
| 225457176 | 452 | PREDICTED: serine/threonine-protein kina | 0.875 | 0.546 | 0.673 | 5e-90 | |
| 224119194 | 470 | predicted protein [Populus trichocarpa] | 0.886 | 0.531 | 0.665 | 5e-89 | |
| 147817142 | 463 | hypothetical protein VITISV_040765 [Viti | 0.875 | 0.533 | 0.669 | 5e-89 | |
| 449440730 | 483 | PREDICTED: serine/threonine-protein kina | 0.868 | 0.507 | 0.614 | 3e-85 | |
| 449527582 | 486 | PREDICTED: serine/threonine-protein kina | 0.868 | 0.504 | 0.608 | 8e-85 | |
| 62183960 | 466 | putative ribosomal-protein S6 kinase-lik | 0.872 | 0.527 | 0.6 | 3e-77 | |
| 358248554 | 415 | uncharacterized protein LOC100798259 [Gl | 0.680 | 0.462 | 0.775 | 4e-75 | |
| 168036479 | 470 | predicted protein [Physcomitrella patens | 0.790 | 0.474 | 0.569 | 1e-71 | |
| 167999486 | 452 | predicted protein [Physcomitrella patens | 0.780 | 0.486 | 0.558 | 3e-71 | |
| 302807666 | 456 | hypothetical protein SELMODRAFT_181752 [ | 0.812 | 0.502 | 0.547 | 3e-70 |
| >gi|225457176|ref|XP_002280523.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 337 bits (863), Expect = 5e-90, Method: Compositional matrix adjust.
Identities = 177/263 (67%), Positives = 205/263 (77%), Gaps = 16/263 (6%)
Query: 6 QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
+K LHS+L +KLK +T PS SSPD DF++VFGPLTP H + S +S +L
Sbjct: 8 KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64
Query: 59 GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
GDPQVIHNRSHS +GPSPR+A+++ L P + + ++ E E ++GPGDFEI
Sbjct: 65 GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124
Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
RVVG+GAFGKVFQV+KKG + GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184
Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
HPFIV LR SFQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCSFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244
Query: 233 KCGIVHRDLKPENILMDSDGHVM 255
K GIVHRDLKPENILMD+DGHVM
Sbjct: 245 KSGIVHRDLKPENILMDADGHVM 267
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119194|ref|XP_002318010.1| predicted protein [Populus trichocarpa] gi|222858683|gb|EEE96230.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 333 bits (854), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 189/284 (66%), Positives = 213/284 (75%), Gaps = 34/284 (11%)
Query: 1 MVSTSQK-NLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPL-TPCRHNNQSPASTSASL 58
+VSTSQK L SLL+ LKKLTITPP+ D +F++VFGP TP N+ STS+S+
Sbjct: 6 LVSTSQKKTLLSLLSINLKKLTITPPN----DLEFSDVFGPSSTPHDPNHSHSPSTSSSV 61
Query: 59 GDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAES--------------- 103
DP VIHNRSHSFVGPSPRY L SS PL ++ +++A +E ES
Sbjct: 62 LDPPVIHNRSHSFVGPSPRYPLPSS-PLPFHHIQEDDEAVIENESCDNEKGKSEDDEGQV 120
Query: 104 -----ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKD 151
KIGP DFEI RVVG+GAFGKVFQV+KK D + G IYAMKVMRKD
Sbjct: 121 GSCGNNNKIGPADFEILRVVGKGAFGKVFQVRKKTGDGKEKGGGGGSGDGIYAMKVMRKD 180
Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
TIIKK HVDYMKAERDILTKV HPFIVQLRYSFQT+SKLYLILDF+NGGHLFFHLYRQGI
Sbjct: 181 TIIKKKHVDYMKAERDILTKVVHPFIVQLRYSFQTKSKLYLILDFMNGGHLFFHLYRQGI 240
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
F EDQARFYTAEIVSAV+HLHKCGIVHRDLKPENIL+D+DGHV+
Sbjct: 241 FSEDQARFYTAEIVSAVAHLHKCGIVHRDLKPENILLDADGHVL 284
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147817142|emb|CAN77683.1| hypothetical protein VITISV_040765 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 333 bits (854), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 176/263 (66%), Positives = 204/263 (77%), Gaps = 16/263 (6%)
Query: 6 QKNLHSLLTTKLKKLTITPPSASSPD-FDFTEVFGPLTPCRHN------NQSPASTSASL 58
+K LHS+L +KLK +T PS SSPD DF++VFGPLTP H + S +S +L
Sbjct: 8 KKTLHSILASKLK---LTIPSPSSPDSLDFSDVFGPLTPHHHKASPSSSSPSSSSPCVAL 64
Query: 59 GDPQVIHNRSHSFVGPSPRYALSSSL-PLQIQELEHENDAELEAE---SERKIGPGDFEI 114
GDPQVIHNRSHS +GPSPR+A+++ L P + + ++ E E ++GPGDFEI
Sbjct: 65 GDPQVIHNRSHSLLGPSPRFAVTAPLLPFKEDMVFQSEGSDKEGGDEVGEGRVGPGDFEI 124
Query: 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
RVVG+GAFGKVFQV+KKG + GDSDGI+AMKVMRKDTII KNH+DYMKAERDIL KV
Sbjct: 125 MRVVGKGAFGKVFQVRKKGGPEISGDSDGIFAMKVMRKDTIISKNHMDYMKAERDILIKV 184
Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
HPFIV LR FQT SKLYLI+DF+NGGHLFFHLYRQGIF EDQAR Y AEIVSAVSHLH
Sbjct: 185 EHPFIVSLRCFFQTNSKLYLIMDFVNGGHLFFHLYRQGIFSEDQARVYIAEIVSAVSHLH 244
Query: 233 KCGIVHRDLKPENILMDSDGHVM 255
K GIVHRDLKPENILMD+DGHVM
Sbjct: 245 KSGIVHRDLKPENILMDADGHVM 267
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449440730|ref|XP_004138137.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 320 bits (821), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 188/306 (61%), Positives = 208/306 (67%), Gaps = 61/306 (19%)
Query: 1 MVSTS-QKNLHSLLTTKLKKLTITPPSASSP---------DFDFTEVFGPLTPCRHNNQS 50
MVS S QKN+HSLL L KLTI S+SS DFDF +VFGP P
Sbjct: 1 MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAVHDFDFNDVFGPTNP------- 53
Query: 51 PASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE-------- 94
S S+ GDPQ VIHNRSHSFVGPSPR +SLP +E++ +
Sbjct: 54 --SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEEEEE 110
Query: 95 --NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQVKKK 132
ND E+ + E +R KIG GDF+I RVVG+GAFGKVF V+KK
Sbjct: 111 EENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLVRKK 170
Query: 133 GVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
G G D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT+SK
Sbjct: 171 GNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQTKSK 230
Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
LYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENILMD
Sbjct: 231 LYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENILMD 290
Query: 250 SDGHVM 255
+DGHV+
Sbjct: 291 ADGHVV 296
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449527582|ref|XP_004170789.1| PREDICTED: serine/threonine-protein kinase AtPK2/AtPK19-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 319 bits (818), Expect = 8e-85, Method: Compositional matrix adjust.
Identities = 188/309 (60%), Positives = 208/309 (67%), Gaps = 64/309 (20%)
Query: 1 MVSTS-QKNLHSLLTTKLKKLTITPPSASSP------------DFDFTEVFGPLTPCRHN 47
MVS S QKN+HSLL L KLTI S+SS DFDF +VFGP P
Sbjct: 1 MVSASIQKNMHSLLVANLTKLTIPSSSSSSSPSASAAAAAAVHDFDFNDVFGPTNP---- 56
Query: 48 NQSPASTSASLGDPQ--------VIHNRSHSFVGPSPRYALSSSLPLQIQELEHE----- 94
S S+ GDPQ VIHNRSHSFVGPSPR +SLP +E++ +
Sbjct: 57 -----SPSSFHGDPQHHEQQQPVVIHNRSHSFVGPSPRLTPPASLPF-FREVDSQSEGEE 110
Query: 95 -----NDAEL------EAESER--------------KIGPGDFEIFRVVGQGAFGKVFQV 129
ND E+ + E +R KIG GDF+I RVVG+GAFGKVF V
Sbjct: 111 EEEEENDLEISTRDGAQEEEKRVGETENCSGENVQGKIGVGDFDILRVVGKGAFGKVFLV 170
Query: 130 KKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186
+KKG G D+D IYAMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQLRYSFQT
Sbjct: 171 RKKGNCKGNGSDNDEIYAMKVMRKDTIIKKNHVDYMKAERDILTKVAHPFIVQLRYSFQT 230
Query: 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246
+SKLYLILDFINGGHLF+HLYRQGIF EDQAR Y AEIVSAVSHLH CGIVHRDLKPENI
Sbjct: 231 KSKLYLILDFINGGHLFYHLYRQGIFSEDQARVYAAEIVSAVSHLHNCGIVHRDLKPENI 290
Query: 247 LMDSDGHVM 255
LMD+DGHV+
Sbjct: 291 LMDADGHVV 299
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62183960|gb|AAX73301.1| putative ribosomal-protein S6 kinase-like protein [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 294 bits (753), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 171/285 (60%), Positives = 200/285 (70%), Gaps = 39/285 (13%)
Query: 2 VSTSQKNLHSLLTTKLKKLTITPPSASSPD------FDFTEVFGPLTPCRHNNQSPASTS 55
+ +K +HS+L KL L I S+SS FDF++VFG T SP+S+S
Sbjct: 4 AAQQKKAIHSMLANKLTHLKIPDSSSSSSPPPTDPDFDFSDVFGAPT-------SPSSSS 56
Query: 56 ASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAEL---------------- 99
+ L DPQ+IH+RSHSFVGPSPR LS LP QE++ E +++
Sbjct: 57 SFLTDPQIIHSRSHSFVGPSPRITLSKPLPFH-QEVDSEGESDSDKVNTHVGTHQTECSD 115
Query: 100 --------EAESERKIGPGDFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMRK 150
E + K GPGDFEI R++G+G+FGKVFQVK K +G+ DGI AMKVMRK
Sbjct: 116 GIEEISGDEGSAVTKFGPGDFEILRMIGKGSFGKVFQVKMKGYGGEGEGDGILAMKVMRK 175
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
DT+IK NHVDYM+AERDILTKV HPFIVQLRYSFQT+SKLYLILDFINGGHLF+HLYRQG
Sbjct: 176 DTVIKNNHVDYMRAERDILTKVEHPFIVQLRYSFQTKSKLYLILDFINGGHLFYHLYRQG 235
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
IF EDQAR Y AEIVSAVSHLH+ GIVHRDLKPENILMD DGHVM
Sbjct: 236 IFSEDQARIYAAEIVSAVSHLHQRGIVHRDLKPENILMDGDGHVM 280
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248554|ref|NP_001239901.1| uncharacterized protein LOC100798259 [Glycine max] gi|255634893|gb|ACU17805.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 287 bits (734), Expect = 4e-75, Method: Compositional matrix adjust.
Identities = 152/196 (77%), Positives = 163/196 (83%), Gaps = 4/196 (2%)
Query: 63 VIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE---AESERKIGPGDFEIFRVVG 119
VI +RSHSFVGPSPR+ + SS PL E E E + E E KIGP DF I RVVG
Sbjct: 32 VIFSRSHSFVGPSPRF-VPSSTPLFFLEEEEEEEEEEELPFGPDPPKIGPSDFHILRVVG 90
Query: 120 QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
QGAFGKVF V+KKG D+DG++AMKVMRKDTIIKKNHVDYMKAERDILTKV HPFIVQ
Sbjct: 91 QGAFGKVFLVRKKGDCFDDADGVFAMKVMRKDTIIKKNHVDYMKAERDILTKVLHPFIVQ 150
Query: 180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHR 239
LRYSFQT+SKLYL+LDFINGGHLFF LYRQGIF EDQAR YTAEIVSAVSHLHK GIVHR
Sbjct: 151 LRYSFQTKSKLYLVLDFINGGHLFFQLYRQGIFSEDQARLYTAEIVSAVSHLHKNGIVHR 210
Query: 240 DLKPENILMDSDGHVM 255
DLKPENILMD+DGHVM
Sbjct: 211 DLKPENILMDADGHVM 226
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168036479|ref|XP_001770734.1| predicted protein [Physcomitrella patens subsp. patens] gi|162677952|gb|EDQ64416.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 275 bits (704), Expect = 1e-71, Method: Compositional matrix adjust.
Identities = 148/260 (56%), Positives = 178/260 (68%), Gaps = 37/260 (14%)
Query: 25 PSASSPDFDFTEVFGPLTPCRHNNQSPASTSAS-----------LGDPQVIHNRSHSFVG 73
P + ++DF++VFG + P +N P A L DP V+++RSHS VG
Sbjct: 28 PDQLNEEYDFSDVFGHVQP---HNTPPLLVVAEDVDTIEWGPELLQDPVVVYSRSHSLVG 84
Query: 74 PSPRYAL-------------SSSLPLQIQELEHENDAELEAESER-----KIGPGDFEIF 115
PSP+ +L SSS + E E D L E E+ K+GP DFE+
Sbjct: 85 PSPKLSLTRSHNKSACDEQGSSSAIEEAISFERECDEHLPKELEKGNGVEKLGPQDFELL 144
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
RVVGQGAFGKVFQV+KKG + IYAMKVMRK+ II++NH DYMKAERDILTKV HP
Sbjct: 145 RVVGQGAFGKVFQVQKKGTSE-----IYAMKVMRKEKIIERNHGDYMKAERDILTKVVHP 199
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
FIVQL+YSFQT+SKLYL+LDFINGGHLFF L+RQG F ED AR YTAEIV AV+HLH+ G
Sbjct: 200 FIVQLQYSFQTKSKLYLVLDFINGGHLFFQLFRQGTFNEDLARMYTAEIVLAVAHLHENG 259
Query: 236 IVHRDLKPENILMDSDGHVM 255
I+HRDLKPENIL+D+DGHVM
Sbjct: 260 IIHRDLKPENILLDADGHVM 279
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|167999486|ref|XP_001752448.1| predicted protein [Physcomitrella patens subsp. patens] gi|162696348|gb|EDQ82687.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 274 bits (701), Expect = 3e-71, Method: Compositional matrix adjust.
Identities = 148/265 (55%), Positives = 179/265 (67%), Gaps = 45/265 (16%)
Query: 25 PSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLG-----------DPQVIHNRSHSFVG 73
P + +FDF++VFGP+ P + SP A G DP V+++RSHS VG
Sbjct: 8 PDQCNEEFDFSDVFGPVPP---HPTSPLPAVAEDGETIDWSLELRQDPVVVYSRSHSLVG 64
Query: 74 PSPRYALSSSLPLQIQELEHENDA-----------------ELEAE------SERKIGPG 110
PSP+ +L+ LQ + + E D+ EL ++ K+GP
Sbjct: 65 PSPKPSLTR---LQSKPVWDEQDSLSLVRVASDSPTVHEVGELTSKDFVNGIGTEKLGPQ 121
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE+ RVVGQGAFGKVFQV+KKG + IYAMKVMRK+ II++NH DYMKAERDILT
Sbjct: 122 DFELLRVVGQGAFGKVFQVQKKGTSE-----IYAMKVMRKEKIIERNHGDYMKAERDILT 176
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
KV HPFIVQL+YSFQT+SKLYL+LDFINGGHLFF LYRQG F ED AR YTAEIV AV+H
Sbjct: 177 KVVHPFIVQLQYSFQTQSKLYLVLDFINGGHLFFQLYRQGTFNEDLARMYTAEIVLAVAH 236
Query: 231 LHKCGIVHRDLKPENILMDSDGHVM 255
LHK GI+HRDLKPENIL+D DG+VM
Sbjct: 237 LHKNGIIHRDLKPENILLDGDGYVM 261
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302807666|ref|XP_002985527.1| hypothetical protein SELMODRAFT_181752 [Selaginella moellendorffii] gi|302810705|ref|XP_002987043.1| hypothetical protein SELMODRAFT_271894 [Selaginella moellendorffii] gi|300145208|gb|EFJ11886.1| hypothetical protein SELMODRAFT_271894 [Selaginella moellendorffii] gi|300146733|gb|EFJ13401.1| hypothetical protein SELMODRAFT_181752 [Selaginella moellendorffii] | Back alignment and taxonomy information |
|---|
Score = 271 bits (692), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 145/265 (54%), Positives = 178/265 (67%), Gaps = 36/265 (13%)
Query: 13 LTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQ--------VI 64
L ++ +L + + +FDF++VFG L + +A G P+ VI
Sbjct: 14 LPSRPPRLDAVVAADDAGEFDFSDVFGQLPSVKEGE------AADWGQPELHYVADTLVI 67
Query: 65 HNRSHSFVGPSPRYALSSSLPLQIQELEHENDA----------ELEAESE-----RKIGP 109
+RSHS VGPSPR +L PL+ E +DA ++E + E RK+GP
Sbjct: 68 CSRSHSLVGPSPRPSLRVGCPLE--ECAAGDDAGEDSDFSDAVDVEQQQEFDDTTRKLGP 125
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
GDFE+ +VGQGAFGKVFQV+ KG D IYAMKVMRKD +++KN+VDYMKAERDI+
Sbjct: 126 GDFELLNLVGQGAFGKVFQVRLKGSSD-----IYAMKVMRKDKVLEKNYVDYMKAERDIM 180
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
TK+ HPFIVQLR SFQT++KLYLILDFINGGHLFF LYRQG F ED R Y AEIVSAV+
Sbjct: 181 TKIVHPFIVQLRCSFQTKTKLYLILDFINGGHLFFQLYRQGTFSEDLCRVYAAEIVSAVA 240
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
HLH GIVHRDLKPENIL+D+DGHV
Sbjct: 241 HLHSKGIVHRDLKPENILLDADGHV 265
|
Source: Selaginella moellendorffii Species: Selaginella moellendorffii Genus: Selaginella Family: Selaginellaceae Order: Selaginellales Class: Isoetopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 282 | ||||||
| TAIR|locus:2077873 | 465 | PK1 "protein-serine kinase 1" | 0.563 | 0.341 | 0.634 | 6.1e-58 | |
| TAIR|locus:2077843 | 471 | S6K2 "serine/threonine protein | 0.780 | 0.467 | 0.516 | 4.4e-52 | |
| UNIPROTKB|E1BZK5 | 364 | SGK2 "Uncharacterized protein" | 0.503 | 0.390 | 0.493 | 1.7e-38 | |
| DICTYBASE|DDB_G0290157 | 479 | pkgB "SGK family protein kinas | 0.560 | 0.329 | 0.481 | 1.9e-37 | |
| MGI|MGI:1351318 | 367 | Sgk2 "serum/glucocorticoid reg | 0.503 | 0.386 | 0.479 | 6.4e-37 | |
| RGD|620232 | 367 | Sgk2 "serum/glucocorticoid reg | 0.503 | 0.386 | 0.479 | 8.2e-37 | |
| UNIPROTKB|Q8R4U9 | 367 | Sgk2 "Serine/threonine-protein | 0.503 | 0.386 | 0.479 | 8.2e-37 | |
| UNIPROTKB|F2Z3C8 | 285 | SGK2 "Serine/threonine-protein | 0.503 | 0.498 | 0.479 | 8.2e-37 | |
| UNIPROTKB|Q9HBY8 | 427 | SGK2 "Serine/threonine-protein | 0.503 | 0.332 | 0.479 | 8.2e-37 | |
| UNIPROTKB|I3LUF0 | 371 | SGK2 "Uncharacterized protein" | 0.503 | 0.382 | 0.479 | 2.7e-36 |
| TAIR|locus:2077873 PK1 "protein-serine kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 6.1e-58, Sum P(2) = 6.1e-58
Identities = 106/167 (63%), Positives = 127/167 (76%)
Query: 92 EHENDAELEAESERK---IGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVM 148
+ +N+ LE + + +G DFE+ +VVG+GAF IYAMKVM
Sbjct: 111 DSDNEKALEGDLVKVSGVVGIDDFEVMKVVGKGAFGKVYQVRKKETSE-----IYAMKVM 165
Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
RKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +LYL+LDFINGGHLFF LY
Sbjct: 166 RKDHIMEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYRLYLVLDFINGGHLFFQLYH 225
Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD+DGHVM
Sbjct: 226 QGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMDTDGHVM 272
|
|
| TAIR|locus:2077843 S6K2 "serine/threonine protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 4.4e-52, P = 4.4e-52
Identities = 127/246 (51%), Positives = 154/246 (62%)
Query: 31 DFDFTEVFGPLTP------CRHNNQSPA---STSASLGDPQVIHNRSHSFVGPSPRYALS 81
+ F++VFGP+ C PA S S SL P ++ + S + R
Sbjct: 38 ELQFSDVFGPMPEANSEEACDVAYDEPAVVYSRSHSLVGPSLVVSHSLKMNKLTLRETED 97
Query: 82 SSLPLQIQELEH--END---AELEAESERK-------IGPGDFEIFRVVGQGAFXXXXXX 129
S ++ E E END + +SE+ +G DFE+ +VVGQGAF
Sbjct: 98 SVDLVECVEGESIKENDEFSGNDDTDSEKSPEEVSGVVGIEDFEVLKVVGQGAFGKVYQV 157
Query: 130 XXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
IYAMKVMRKD I++KNH +YMKAERDILTK+ HPFIVQL+YSFQT+ +
Sbjct: 158 RKKDTSE-----IYAMKVMRKDKIVEKNHAEYMKAERDILTKIDHPFIVQLKYSFQTKYR 212
Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
LYL+LDFINGGHLFF LY QG+FRED AR YTAEIVSAVSHLH+ GI+HRDLKPENILMD
Sbjct: 213 LYLVLDFINGGHLFFQLYHQGLFREDLARVYTAEIVSAVSHLHEKGIMHRDLKPENILMD 272
Query: 250 SDGHVM 255
DGHVM
Sbjct: 273 VDGHVM 278
|
|
| UNIPROTKB|E1BZK5 SGK2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 384 (140.2 bits), Expect = 1.7e-38, Sum P(2) = 1.7e-38
Identities = 73/148 (49%), Positives = 99/148 (66%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P DF+ +V+G+G+F YA+KV+ K TI+KK +++ AER++
Sbjct: 32 PTDFDFLKVIGKGSFGKVLLAKRKSDGT-----FYAVKVLHKKTILKKKEQNHIMAERNV 86
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L K V HPF+V L YSFQT KLY +LD++NGG LFFHL R+ FRE +ARFY AE+ SA
Sbjct: 87 LLKNVKHPFLVGLHYSFQTSEKLYFVLDYVNGGELFFHLQRERCFREPRARFYAAEVASA 146
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +LH I++RDLKPENIL+D GHV+
Sbjct: 147 IGYLHSLNIIYRDLKPENILLDCQGHVV 174
|
|
| DICTYBASE|DDB_G0290157 pkgB "SGK family protein kinase PkgB" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 402 (146.6 bits), Expect = 1.9e-37, P = 1.9e-37
Identities = 79/164 (48%), Positives = 111/164 (67%)
Query: 92 EHENDAE-LEAESERKIGPGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRK 150
E E E + +++++ DFE+ V+G+G+F I+AMKV+RK
Sbjct: 132 EDEGPEEVIFSKNKQSATKDDFELLNVIGKGSFGKVMQVKKKGEDK-----IFAMKVLRK 186
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
D II + V++ K+E+ IL ++HPFIV L Y+FQT+ KLY++LDF+NGG LFFHL R+G
Sbjct: 187 DAIIARKQVNHTKSEKTILQCISHPFIVNLHYAFQTKDKLYMVLDFVNGGELFFHLKREG 246
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
F E + + Y AEIVSA+ HLHK IV+RDLKPENIL+DS+GH+
Sbjct: 247 RFSEPRVKIYAAEIVSALDHLHKQDIVYRDLKPENILLDSEGHI 290
|
|
| MGI|MGI:1351318 Sgk2 "serum/glucocorticoid regulated kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 370 (135.3 bits), Expect = 6.4e-37, Sum P(2) = 6.4e-37
Identities = 71/148 (47%), Positives = 99/148 (66%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P DF+ +V+G+G + YA+KV++K +I+K +++ AER++
Sbjct: 32 PTDFDFLKVIGKGNYGKVLLAKRKSDGA-----FYAVKVLQKKSILKNKEQNHIMAERNV 86
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L K V HPF+V LRYSFQT KLY +LD++NGG LFFHL R+ F E +ARFYTAE+ SA
Sbjct: 87 LLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQRERRFLEPRARFYTAEVASA 146
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +LH I++RDLKPENIL+D GHV+
Sbjct: 147 IGYLHSLNIIYRDLKPENILLDCQGHVV 174
|
|
| RGD|620232 Sgk2 "serum/glucocorticoid regulated kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 369 (135.0 bits), Expect = 8.2e-37, Sum P(2) = 8.2e-37
Identities = 71/148 (47%), Positives = 98/148 (66%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P DF+ +V+G+G + YA+KV++K +I+K ++ AER++
Sbjct: 32 PTDFDFLKVIGKGNYGKVLLAKRKSDGA-----FYAVKVLQKKSILKNKEQSHIMAERNV 86
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L K V HPF+V LRYSFQT KLY +LD++NGG LFFHL R+ F E +ARFYTAE+ SA
Sbjct: 87 LLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQREHRFLEPRARFYTAEVASA 146
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +LH I++RDLKPENIL+D GHV+
Sbjct: 147 IGYLHSLNIIYRDLKPENILLDCQGHVV 174
|
|
| UNIPROTKB|Q8R4U9 Sgk2 "Serine/threonine-protein kinase Sgk2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 369 (135.0 bits), Expect = 8.2e-37, Sum P(2) = 8.2e-37
Identities = 71/148 (47%), Positives = 98/148 (66%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P DF+ +V+G+G + YA+KV++K +I+K ++ AER++
Sbjct: 32 PTDFDFLKVIGKGNYGKVLLAKRKSDGA-----FYAVKVLQKKSILKNKEQSHIMAERNV 86
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L K V HPF+V LRYSFQT KLY +LD++NGG LFFHL R+ F E +ARFYTAE+ SA
Sbjct: 87 LLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQREHRFLEPRARFYTAEVASA 146
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +LH I++RDLKPENIL+D GHV+
Sbjct: 147 IGYLHSLNIIYRDLKPENILLDCQGHVV 174
|
|
| UNIPROTKB|F2Z3C8 SGK2 "Serine/threonine-protein kinase Sgk2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 368 (134.6 bits), Expect = 8.2e-37, Sum P(2) = 8.2e-37
Identities = 71/148 (47%), Positives = 97/148 (65%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P DF+ +V+G+G + YA+KV++K +I+KK ++ AER +
Sbjct: 32 PTDFDFLKVIGKGNYGKVLLAKRKSDGA-----FYAVKVLQKKSILKKKEQSHIMAERSV 86
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L K V HPF+V LRYSFQT KLY +LD++NGG LFFHL R+ F E +ARFY AE+ SA
Sbjct: 87 LLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQRERRFLEPRARFYAAEVASA 146
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +LH I++RDLKPENIL+D GHV+
Sbjct: 147 IGYLHSLNIIYRDLKPENILLDCQGHVV 174
|
|
| UNIPROTKB|Q9HBY8 SGK2 "Serine/threonine-protein kinase Sgk2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 368 (134.6 bits), Expect = 8.2e-37, Sum P(2) = 8.2e-37
Identities = 71/148 (47%), Positives = 97/148 (65%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P DF+ +V+G+G + YA+KV++K +I+KK ++ AER +
Sbjct: 92 PTDFDFLKVIGKGNYGKVLLAKRKSDGA-----FYAVKVLQKKSILKKKEQSHIMAERSV 146
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L K V HPF+V LRYSFQT KLY +LD++NGG LFFHL R+ F E +ARFY AE+ SA
Sbjct: 147 LLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQRERRFLEPRARFYAAEVASA 206
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +LH I++RDLKPENIL+D GHV+
Sbjct: 207 IGYLHSLNIIYRDLKPENILLDCQGHVV 234
|
|
| UNIPROTKB|I3LUF0 SGK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 364 (133.2 bits), Expect = 2.7e-36, Sum P(2) = 2.7e-36
Identities = 71/148 (47%), Positives = 97/148 (65%)
Query: 109 PGDFEIFRVVGQGAFXXXXXXXXXXXXXXXXXXIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P DF+ +V+G+G + YA+KV++K +I+KK ++ AER +
Sbjct: 38 PTDFDFLKVIGKGNYGKVLLAKHKSDGM-----FYAVKVLQKKSILKKKEQGHIMAERSV 92
Query: 169 LTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L K V HPF+V LRYSFQT KLY +LD++NGG LFFHL R+ F E +ARFY AE+ SA
Sbjct: 93 LLKNVRHPFLVGLRYSFQTPEKLYFVLDYVNGGELFFHLQRERRFLEPRARFYAAEVASA 152
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +LH I++RDLKPENIL+D GHV+
Sbjct: 153 IGYLHSLHIIYRDLKPENILLDCQGHVV 180
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 282 | |||
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-76 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-58 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-56 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-56 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-54 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-54 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-54 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-53 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-52 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-50 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-49 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-49 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-49 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-48 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-47 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-47 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-46 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-45 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-45 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-45 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-44 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-44 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-43 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-43 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-42 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-42 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-41 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-41 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-40 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-39 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-39 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-38 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-38 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-38 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-38 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-38 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-38 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-37 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-37 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-37 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-37 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-35 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-35 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-35 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-34 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-34 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-34 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-34 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-33 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-32 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-32 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-32 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-32 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-32 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-31 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-30 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-30 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-30 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-29 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-29 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-29 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-29 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-27 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-27 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-15 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-14 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-09 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-06 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 8e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-04 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 5e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.001 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.001 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.001 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.001 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 0.002 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.002 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.002 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.003 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.003 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.003 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 2e-76
Identities = 74/138 (53%), Positives = 105/138 (76%), Gaps = 5/138 (3%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G+FGKV V+KK D+ +YAMKV++K IIK+ V++ ER+IL+++ HPFI
Sbjct: 1 LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
V+L Y+FQT KLYL+L++ GG LF HL ++G F E++ARFY AEIV A+ +LH GI+
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 238 HRDLKPENILMDSDGHVM 255
+RDLKPENIL+D+DGH+
Sbjct: 116 YRDLKPENILLDADGHIK 133
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-58
Identities = 65/144 (45%), Positives = 95/144 (65%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE + +G G+FG+V V+ K S YA+K++ K I+K V+++ E+ IL
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ HPF+V L SFQ S LYL+++++ GG LF HL + G F E ARFY A++V A+ +
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LH IV+RDLKPEN+L+DSDG++
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYI 140
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 2e-56
Identities = 70/145 (48%), Positives = 105/145 (72%), Gaps = 5/145 (3%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DFE+ +V+G+GAFG+V+ V+ K D+ +YAMKV+RK +IK+N + +++AERDIL
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL 55
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
P+IV+L YSFQ LYL+++++ GG L L R+ +F E+ ARFY AE+V A+
Sbjct: 56 ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALD 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
+HK G +HRD+KP+NIL+D+DGH+
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHI 140
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-56
Identities = 81/141 (57%), Positives = 107/141 (75%), Gaps = 5/141 (3%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDILTKVT 173
+V+G+G +GKVFQV+K V D+ I+AMKV++K TI++ N D + KAER+IL V
Sbjct: 2 KVLGKGGYGKVFQVRK--VTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVK 58
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
HPFIV L Y+FQT KLYLIL++++GG LF HL R+GIF ED A FY +EI A+ HLH+
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 234 CGIVHRDLKPENILMDSDGHV 254
GI++RDLKPENIL+D+ GHV
Sbjct: 119 QGIIYRDLKPENILLDAQGHV 139
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 9e-56
Identities = 64/144 (44%), Positives = 92/144 (63%), Gaps = 7/144 (4%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+EI +G+G+FGKV+ + K + + A+KV++K I K + + E IL K
Sbjct: 1 YEILEKLGEGSFGKVYLARDK-----KTGKLVAIKVIKKKKIKKD--RERILREIKILKK 53
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP IV+L F+ KLYL++++ GG LF L ++G ED+ARFY +I+SA+ +L
Sbjct: 54 LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113
Query: 232 HKCGIVHRDLKPENILMDSDGHVM 255
H GIVHRDLKPENIL+D DGHV
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVK 137
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-54
Identities = 75/140 (53%), Positives = 98/140 (70%), Gaps = 6/140 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
+V+G+G+FGKV K K YA+KV++K I+KK ++ AER++L K V H
Sbjct: 1 KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+V L YSFQT KLY +LD++NGG LFFHL R+ F E +ARFY AEI SA+ +LH
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 235 GIVHRDLKPENILMDSDGHV 254
I++RDLKPENIL+DS GHV
Sbjct: 116 NIIYRDLKPENILLDSQGHV 135
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 6e-54
Identities = 58/146 (39%), Positives = 94/146 (64%), Gaps = 6/146 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF+ +++G+G+F V K+K +++ YA+K++ K +IK+ V Y+K E+++LT
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56
Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
++ HP I++L Y+FQ LY +L++ G L ++ + G E RFY AEI+ A+
Sbjct: 57 RLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM 255
+LH GI+HRDLKPENIL+D D H+
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIK 142
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 8e-54
Identities = 66/143 (46%), Positives = 96/143 (67%), Gaps = 5/143 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
FE+ RV+G+GAFGKV V+K+ D+ ++AMK M K ++K V + ER IL +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HPF+V L YSFQ +YL++D + GG L +HL ++ F E+Q +F+ EIV A+ +L
Sbjct: 57 LNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H GI+HRD+KP+NIL+D GHV
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHV 139
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 3e-53
Identities = 76/146 (52%), Positives = 107/146 (73%), Gaps = 4/146 (2%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV-DYMKAERDIL 169
+FE+ RV+G GA+GKVF V+K G D+ +YAMKV++K TI++K ++ + ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVG--GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVL 58
Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
V PF+V L Y+FQT +KL+LILD++NGG LF HLY++ F E + R Y AEIV A+
Sbjct: 59 EAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
HLH+ GI++RD+K ENIL+DS+GHV
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHV 144
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-52
Identities = 67/137 (48%), Positives = 95/137 (69%), Gaps = 5/137 (3%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+ +GA+G+VF KKK D IYA+KV++K +I+KN VD + ERDIL++ P++
Sbjct: 1 ISKGAYGRVFLAKKKSTGD-----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
V+L YSFQ + LYL+++++ GG L L G ED AR Y AEIV A+ +LH GI+
Sbjct: 56 VKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 238 HRDLKPENILMDSDGHV 254
HRDLKP+NIL+DS+GH+
Sbjct: 116 HRDLKPDNILIDSNGHL 132
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 5e-50
Identities = 74/139 (53%), Positives = 102/139 (73%), Gaps = 3/139 (2%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+V+GQG+FGKVF V+K + D+ +YAMKV++K T+ ++ V K ERDIL +V HP
Sbjct: 2 KVLGQGSFGKVFLVRK--ITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHP 58
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
FIV+L Y+FQT KLYLILDF+ GG LF L ++ +F E+ +FY AE+ A+ HLH G
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 236 IVHRDLKPENILMDSDGHV 254
I++RDLKPENIL+D +GH+
Sbjct: 119 IIYRDLKPENILLDEEGHI 137
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-49
Identities = 71/137 (51%), Positives = 100/137 (72%), Gaps = 5/137 (3%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G+FGKV QV+K+ D+ IYA+K +RK I+ ++ V + AER +L +V PFI
Sbjct: 1 IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI 55
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
V L++SFQ+ KLYL+L FINGG LF HL R+G F +ARFYTAE++ A+ +LHK ++
Sbjct: 56 VPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 238 HRDLKPENILMDSDGHV 254
+RDLKPENIL+D GH+
Sbjct: 116 YRDLKPENILLDYQGHI 132
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 3e-49
Identities = 64/144 (44%), Positives = 102/144 (70%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE +V+G+GAFG+V V+KK D+ IYAMK +RK +++K V +++AERDIL
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ +P++V+L YSFQ + LYLI++++ GG + L ++ F E++ RFY AE + A+
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
+HK G +HRD+KP+N+L+D+ GH+
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHI 140
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 4e-49
Identities = 77/142 (54%), Positives = 105/142 (73%), Gaps = 8/142 (5%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTK-VT 173
+V+G+G+FGKV K+K SDG YA+KV++K TI+KK +++ AER++L K +
Sbjct: 1 KVIGKGSFGKVLLAKRK------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK 54
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
HPF+V L YSFQT KLY +LD++NGG LFFHL R+ F E +ARFY AE+ SA+ +LH
Sbjct: 55 HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 234 CGIVHRDLKPENILMDSDGHVM 255
I++RDLKPENIL+DS GHV+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVV 136
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 5e-48
Identities = 74/147 (50%), Positives = 111/147 (75%), Gaps = 4/147 (2%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
+FE+ +V+G GA+GKVF V+K V D+ +YAMKV++K +++K V++ + ER++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRK--VTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
V PF+V L Y+FQT +KL+LILD+++GG +F HLY++ F ED+ RFY+ EI+ A+
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVM 255
HLHK GIV+RD+K ENIL+DS+GHV+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVV 145
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 1e-47
Identities = 73/140 (52%), Positives = 101/140 (72%), Gaps = 8/140 (5%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--- 174
+G+G FG+V+QV+KK D+ IYAMKV+ K I+ K V + ER+IL +
Sbjct: 1 IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PFIV L++SFQT S LYL+ D+++GG LF+HL ++G F ED+A+FY AE+V A+ HLHK
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 235 GIVHRDLKPENILMDSDGHV 254
IV+RDLKPENIL+D+ GH+
Sbjct: 116 DIVYRDLKPENILLDATGHI 135
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-47
Identities = 65/139 (46%), Positives = 97/139 (69%), Gaps = 5/139 (3%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+++G+G FGKV V++K + YAMK+++K+ II K+ V + E +L HP
Sbjct: 1 KLLGKGTFGKVILVREKA-----TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
F+ L+YSFQT +L ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH C
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 236 IVHRDLKPENILMDSDGHV 254
+V+RDLK EN+++D DGH+
Sbjct: 116 VVYRDLKLENLMLDKDGHI 134
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-47
Identities = 65/145 (44%), Positives = 89/145 (61%), Gaps = 5/145 (3%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DF+I VGQG +G+VF KKK D+ I A+K M+K + K N V ++ ERDIL
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDIL 55
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
T ++V+L Y+FQ LYL ++++ GG L G+ ED ARFY AE+ AV
Sbjct: 56 TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
LH+ G +HRDLKPEN L+D+ GH+
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHI 140
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-46
Identities = 55/143 (38%), Positives = 88/143 (61%), Gaps = 6/143 (4%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+E+ R +G G+FG V++ K KG I A+K+++K + K + E IL +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGK-----IVAVKILKKRSEKSKKDQ-TARREIRILRR 54
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
++HP IV+L +F+ + LYL++++ GG LF +L R G ED+A+ +I+ + +L
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H GI+HRDLKPENIL+D +G V
Sbjct: 115 HSNGIIHRDLKPENILLDENGVV 137
|
Length = 260 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 65/143 (45%), Positives = 96/143 (67%), Gaps = 5/143 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F + +G GAFG+V V+K D++ +YAMK +RK ++ +N ++KAERDIL +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ ++V+L YSFQ + LY ++D+I GG + L R GIF ED ARFY AE+ A+ +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV 117
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
HK G +HRD+KP+NIL+D DGH+
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHI 140
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 2e-45
Identities = 74/147 (50%), Positives = 108/147 (73%), Gaps = 4/147 (2%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVDYMKAERDIL 169
+FE+ +V+G GA+GKVF V+K V DS +YAMKV++K TI++K ++ + ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRK--VSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58
Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
+ PF+V L Y+FQT +KL+LILD+INGG LF HL ++ F+E + + Y+ EIV A+
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVM 255
HLHK GI++RD+K ENIL+DS+GHV+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVV 145
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 3e-45
Identities = 76/141 (53%), Positives = 101/141 (71%), Gaps = 6/141 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
+V+G+G+FGKV K+K DG YA+KV++K ++ + ++ AER++L K V H
Sbjct: 1 KVIGKGSFGKVLLAKRK--LDGK---CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+V L YSFQT KLY +LDF+NGG LFFHL R+ F E +ARFY AEI SA+ +LH
Sbjct: 56 PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 235 GIVHRDLKPENILMDSDGHVM 255
IV+RDLKPENIL+DS GHV+
Sbjct: 116 NIVYRDLKPENILLDSQGHVV 136
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-44
Identities = 72/141 (51%), Positives = 100/141 (70%), Gaps = 6/141 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTH 174
+V+G+G+FGKV + K + YA+KV++K I+KK ++ +ER++L K V H
Sbjct: 1 KVIGKGSFGKVLLARHKA-----EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+V L +SFQT KLY +LD+INGG LF+HL R+ F E +ARFY AEI SA+ +LH
Sbjct: 56 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 115
Query: 235 GIVHRDLKPENILMDSDGHVM 255
IV+RDLKPENIL+DS GH++
Sbjct: 116 NIVYRDLKPENILLDSQGHIV 136
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 5e-44
Identities = 61/140 (43%), Positives = 97/140 (69%), Gaps = 6/140 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
+V+G+G+FGKV + KG D+ +YA+KV++KD I++ + V+ E+ +L H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDE-----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+ QL FQT+ +L+ +++++NGG L FH+ R G F E +ARFY AEIV + LH+
Sbjct: 56 PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 235 GIVHRDLKPENILMDSDGHV 254
GI++RDLK +N+L+DS+GH+
Sbjct: 116 GIIYRDLKLDNVLLDSEGHI 135
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-43
Identities = 63/147 (42%), Positives = 94/147 (63%), Gaps = 7/147 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
F+ +++G+G G+VF V+ KG + ++A+KV+ K +IK+N V + E++IL
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILA 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAV 228
+ HPF+ L SFQT + L L++D+ GG LF L RQ E+ ARFY AE++ A+
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVM 255
+LH GIV+RDLKPENIL+ GH+M
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIM 143
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-43
Identities = 68/144 (47%), Positives = 94/144 (65%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF +V+G+GAFG+V V+KK D G IYAMK + K + KK+ + ++KAERD+L
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKK--DTGK---IYAMKTLLKSEMFKKDQLAHVKAERDVLA 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ P++V L YSFQ LYLI++F+ GG L L + F ED RFY AE V A+
Sbjct: 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
+HK G +HRD+KP+NIL+D GH+
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHI 140
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-42
Identities = 63/144 (43%), Positives = 94/144 (65%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE+ +G G+FG+V K KG + YA+K ++K I+K V ++ E+ IL
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGE-----YYAIKCLKKREILKMKQVQHVAQEKSILM 73
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+++HPFIV + SFQ +++Y +L+F+ GG LF HL + G F D A+FY AE+V A +
Sbjct: 74 ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LH I++RDLKPEN+L+D+ GHV
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHV 157
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 5e-42
Identities = 62/139 (44%), Positives = 96/139 (69%), Gaps = 5/139 (3%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+++G+G FGKV V++K + YAMK++RK+ II K+ V + E +L HP
Sbjct: 1 KLLGKGTFGKVILVREKA-----TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
F+ L+Y+FQT +L ++++ NGG LFFHL R+ +F E++ARFY AEIVSA+ +LH
Sbjct: 56 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 236 IVHRDLKPENILMDSDGHV 254
+V+RD+K EN+++D DGH+
Sbjct: 116 VVYRDIKLENLMLDKDGHI 134
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-41
Identities = 64/145 (44%), Positives = 96/145 (66%), Gaps = 6/145 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF++ +VG+G FG+V V++K D IYAMKVM+K ++ + V + + ERDIL+
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGD-----IYAMKVMKKSVLLAQETVSFFEEERDILS 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
P+I QL+Y+FQ + LYL++++ GG L L R + F ED A+FY AE+V A+
Sbjct: 57 ISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
+H+ G VHRD+KPEN+L+D GH+
Sbjct: 117 SVHQMGYVHRDIKPENVLIDRTGHI 141
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 6e-41
Identities = 65/139 (46%), Positives = 97/139 (69%), Gaps = 5/139 (3%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+++G+G FGKV V++K S YAMK+++K+ II K+ V + E +L HP
Sbjct: 1 KLLGKGTFGKVILVREKA-----SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
F+ L+YSFQT+ +L +++++NGG LFFHL R+ +F ED+ RFY AEIVSA+ +LH
Sbjct: 56 FLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 236 IVHRDLKPENILMDSDGHV 254
IV+RDLK EN+++D DGH+
Sbjct: 116 IVYRDLKLENLMLDKDGHI 134
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 66/143 (46%), Positives = 95/143 (66%), Gaps = 5/143 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F + +G GAFG+V +K D+ +YAMK +RK ++ +N V ++KAERDIL +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE 57
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ ++V+L YSFQ + LY ++D+I GG + L R GIF ED ARFY AE+ AV +
Sbjct: 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESV 117
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
HK G +HRD+KP+NIL+D DGH+
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHI 140
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-39
Identities = 58/143 (40%), Positives = 94/143 (65%), Gaps = 6/143 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTH 174
+V+G+G+FGKV + KG D+ +YA+KV++KD I++ + VD E+ IL H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDE-----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+ L FQT+ +L+ +++++NGG L F + R F E ++RFY AE+ A+ LH+
Sbjct: 56 PFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 235 GIVHRDLKPENILMDSDGHVMAA 257
G+++RDLK +NIL+D++GH A
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLA 138
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 55/144 (38%), Positives = 88/144 (61%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D E + VG G FG+V V+ + S+ YA+KVM +I+ ++ E+ +L
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRI-----SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+V+HPFI++L ++ + LY++++++ GG LF +L G F FY +EIV A+ +
Sbjct: 57 EVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEY 116
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LH IV+RDLKPENIL+D +GH+
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHI 140
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 53/137 (38%), Positives = 90/137 (65%), Gaps = 5/137 (3%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G G FG+V VK K + +A+K ++K I++ +++ +E++IL + HPFI
Sbjct: 1 LGVGGFGRVELVKVKS-----KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI 55
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
V+L +F+ + +Y+++++ GG L+ L +G+F E ARFY A +V A +LH GI+
Sbjct: 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 238 HRDLKPENILMDSDGHV 254
+RDLKPEN+L+DS+G+V
Sbjct: 116 YRDLKPENLLLDSNGYV 132
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-38
Identities = 61/139 (43%), Positives = 93/139 (66%), Gaps = 6/139 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
RV+G+G+FGKV + K +S +YA+KV++KD I++ + V+ E+ IL+ H
Sbjct: 1 RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+ QL FQT +L+ +++F+NGG L FH+ + F E +ARFY AEI SA+ LH
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 235 GIVHRDLKPENILMDSDGH 253
GI++RDLK +N+L+D +GH
Sbjct: 116 GIIYRDLKLDNVLLDHEGH 134
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-38
Identities = 64/140 (45%), Positives = 97/140 (69%), Gaps = 6/140 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+++G+G FGKV VK+K + YAMK+++K+ I+ K+ V + E +L HP
Sbjct: 1 KLLGKGTFGKVILVKEKA-----TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KC 234
F+ L+YSFQT +L ++++ NGG LFFHL R+ +F ED+ARFY AEIVSA+ +LH +
Sbjct: 56 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 235 GIVHRDLKPENILMDSDGHV 254
+V+RDLK EN+++D DGH+
Sbjct: 116 NVVYRDLKLENLMLDKDGHI 135
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 2e-38
Identities = 55/139 (39%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G FG+V + K + +YA K + K + K+ E+ IL KV+ FI
Sbjct: 1 LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG 235
V L Y+F+T+ L L++ +NGG L +H+Y G F E +A FY A+I+ + HLH+
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 236 IVHRDLKPENILMDSDGHV 254
IV+RDLKPEN+L+D G+V
Sbjct: 116 IVYRDLKPENVLLDDHGNV 134
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-38
Identities = 62/144 (43%), Positives = 99/144 (68%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE +V+G+GAFG+V V+KK D+ IYAMK++RK +++K V +++AERDIL
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILV 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ ++V++ YSFQ + LYLI++F+ GG + L ++ E+ +FY AE V A+
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
+H+ G +HRD+KP+N+L+D+ GHV
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHV 140
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 62/144 (43%), Positives = 100/144 (69%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE +V+G+GAFG+V V+KK D+ +YAMK++RK +++K V +++AERDIL
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILV 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ ++V++ YSFQ + LYLI++F+ GG + L ++ E++ +FY AE V A+
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
+H+ G +HRD+KP+N+L+DS GHV
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHV 140
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 62/143 (43%), Positives = 92/143 (64%), Gaps = 5/143 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F + +G GAFG+V K D+ +YAMK +RK ++ +N V ++KAERDIL +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE 57
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ ++V+L YSFQ + LY ++D+I GG + L R +F E ARFY AE+ A+ +
Sbjct: 58 ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESV 117
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
HK G +HRD+KP+NIL+D DGH+
Sbjct: 118 HKMGFIHRDIKPDNILIDLDGHI 140
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 58/148 (39%), Positives = 95/148 (64%), Gaps = 6/148 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF V+G+G+FGKV ++KG +D +YA+K+++KD II+ + V+ E+ +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
P F+ QL FQT +LY +++++NGG L +H+ + G F+E A FY AEI +
Sbjct: 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
LH GI++RDLK +N+++D++GH+ A
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDAEGHIKIA 143
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 59/146 (40%), Positives = 97/146 (66%), Gaps = 9/146 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+F I + + +GAFGKV+ +KK ++ +YA+KV++K +I KN V ++AERD L
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALA 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
PFIV L YS Q+ + +YL+++++ GG + H+Y G F E+ A Y +E+ A+
Sbjct: 60 LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALAL 117
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
+LH+ GI+HRDLKP+N+L+ ++GH+
Sbjct: 118 DYLHRHGIIHRDLKPDNMLISNEGHI 143
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 9e-37
Identities = 58/140 (41%), Positives = 96/140 (68%), Gaps = 6/140 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTH 174
RV+G+G++ KV V+ K + IYAMKV++K+ + +D+++ E+ + T H
Sbjct: 1 RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+V L FQT S+L+ +++F++GG L FH+ RQ E+ ARFY+AEI A++ LH+
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 235 GIVHRDLKPENILMDSDGHV 254
GI++RDLK +N+L+D++GH+
Sbjct: 116 GIIYRDLKLDNVLLDAEGHI 135
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 4e-36
Identities = 61/148 (41%), Positives = 91/148 (61%), Gaps = 6/148 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFEI +V+G+GAFG+V VK K +YAMK++ K ++K+ + ERD+L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQ-----VYAMKILNKWEMLKRAETACFREERDVLV 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
+I L Y+FQ + LYL++D+ GG L L + + ED ARFY AE+V A+
Sbjct: 57 NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
+H+ G VHRD+KP+N+L+D +GH+ A
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLA 144
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-35
Identities = 58/140 (41%), Positives = 99/140 (70%), Gaps = 6/140 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
RV+G+G++ KV V+ K ++ IYAMKV++K+ + +D+++ E+ + + + H
Sbjct: 1 RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+V L FQT S+L+ +++++NGG L FH+ RQ E+ ARFY+AEI A+++LH+
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 235 GIVHRDLKPENILMDSDGHV 254
GI++RDLK +N+L+DS+GH+
Sbjct: 116 GIIYRDLKLDNVLLDSEGHI 135
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 59/147 (40%), Positives = 92/147 (62%), Gaps = 6/147 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF++ +V+G+GAFG+V V+ K S +YAMK++ K +IK++ + ERDI+
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+IVQL Y+FQ LY++++++ GG L + I E ARFYTAE+V A+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDA 157
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMAA 257
+H G +HRD+KP+N+L+D GH+ A
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLA 184
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 59/140 (42%), Positives = 98/140 (70%), Gaps = 6/140 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
RV+G+G++ KV V+ K +D IYAMKV++K+ + +D+++ E+ + + ++
Sbjct: 1 RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+V L FQT S+L+L+++++NGG L FH+ RQ E+ ARFY AEI A++ LH+
Sbjct: 56 PFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 235 GIVHRDLKPENILMDSDGHV 254
GI++RDLK +N+L+D+DGH+
Sbjct: 116 GIIYRDLKLDNVLLDADGHI 135
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-35
Identities = 57/143 (39%), Positives = 93/143 (65%), Gaps = 6/143 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
+V+G+G+FGKV + KG ++ +A+K ++KD +++ + V+ ER +L H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNE-----FFAIKALKKDVVLEDDDVECTMVERRVLALAWEH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+ L +FQT+ L+ +++++NGG L FH+ G F E +ARFY AEI+ + LHK
Sbjct: 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 235 GIVHRDLKPENILMDSDGHVMAA 257
GI++RDLK +N+L+D DGH+ A
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIA 138
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-34
Identities = 57/138 (41%), Positives = 88/138 (63%), Gaps = 6/138 (4%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPF 176
+ +GAFG V+ KK+ D +A+KV++K +I KN V +KAER I+ + P+
Sbjct: 4 ISKGAFGSVYLAKKRSTGD-----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPY 58
Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
+ +L YSFQ++ LYL+++++NGG + G ED A+ Y AE+V V LH+ GI
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 237 VHRDLKPENILMDSDGHV 254
+HRD+KPEN+L+D GH+
Sbjct: 119 IHRDIKPENLLIDQTGHL 136
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-34
Identities = 59/148 (39%), Positives = 97/148 (65%), Gaps = 6/148 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF V+G+G+FGKV ++KG D+ +YA+K+++KD +I+ + V+ E+ +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
P F+ QL FQT +LY +++++NGG L +H+ + G F+E QA FY AEI +
Sbjct: 56 LQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
LH+ GI++RDLK +N+++DS+GH+ A
Sbjct: 116 FLHRRGIIYRDLKLDNVMLDSEGHIKIA 143
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 6e-34
Identities = 57/148 (38%), Positives = 94/148 (63%), Gaps = 6/148 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF V+G+G+FGKV ++KG D+ +YA+K+++KD +I+ + V+ E+ +L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDVVIQDDDVECTMVEKRVLA 55
Query: 171 -KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
PF+ QL FQT +LY +++++NGG L + + + G F+E A FY AEI +
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
LH GI++RDLK +N+++DS+GH+ A
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIA 143
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-34
Identities = 64/148 (43%), Positives = 88/148 (59%), Gaps = 13/148 (8%)
Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-ERDI 168
F +RV+G+G FG+V QV+ G +YA K + K I KK + M E+ I
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRI-KKRKGEAMALNEKQI 53
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVS 226
L KV F+V L Y+++T+ L L+L +NGG L FH+Y G F E++A FY AEI
Sbjct: 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ LH+ IV+RDLKPENIL+D GH+
Sbjct: 114 GLEDLHRERIVYRDLKPENILLDDYGHI 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 9e-34
Identities = 49/149 (32%), Positives = 87/149 (58%), Gaps = 12/149 (8%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+EI + +G+G+FGKV+ V++K SDG +Y +K + + +K D + E IL
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRK------SDGKLYVLKEIDLSNMSEKEREDALN-EVKIL 53
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI----FREDQARFYTAEIV 225
K+ HP I++ SF+ + KL +++++ +GG L + +Q F E+Q + ++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
A+ +LH I+HRD+KP+NI + S+G V
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLV 142
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-33
Identities = 47/135 (34%), Positives = 77/135 (57%), Gaps = 8/135 (5%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G FG V+ + D + A+K+++K+ + ++ + E +IL K+ HP I
Sbjct: 1 LGEGGFGTVYLAR-----DKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNI 53
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGI 236
V+L F+ + LYL++++ GG L L G ED+ +I+ + +LH GI
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113
Query: 237 VHRDLKPENILMDSD 251
+HRDLKPENIL+DSD
Sbjct: 114 IHRDLKPENILLDSD 128
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 60/141 (42%), Positives = 85/141 (60%), Gaps = 8/141 (5%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
++G+G FG+V+ +K D+ +YAMK + K I K ER +L+ V+
Sbjct: 1 IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55
Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
PFIV + Y+F T KL ILD +NGG L +HL + G+F E + RFY AEI+ + H+H
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 234 CGIVHRDLKPENILMDSDGHV 254
+V+RDLKP NIL+D GHV
Sbjct: 116 RFVVYRDLKPANILLDEHGHV 136
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-32
Identities = 56/145 (38%), Positives = 87/145 (60%), Gaps = 5/145 (3%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DFE +++ GA+G V+ V+ K ++ +AMK + K +I +N + + ERDIL
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDIL 55
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
T +PF+V + SF+T+ L ++++++ GG L G D AR Y AE V A+
Sbjct: 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
+LH GIVHRDLKP+N+L+ S GH+
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHI 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 61/147 (41%), Positives = 86/147 (58%), Gaps = 11/147 (7%)
Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
F +RV+G+G FG+V QV+ G +YA K + K I K+ E+ IL
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATG-------KMYACKRLEKKRIKKRKGESMALNEKQIL 54
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
KV F+V L Y+++T+ L L+L +NGG L FH+Y G F E++A FY AEI+
Sbjct: 55 EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
+ LH+ V+RDLKPENIL+D GH+
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHI 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-32
Identities = 47/141 (33%), Positives = 80/141 (56%), Gaps = 8/141 (5%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
++G+G+FG V+ +D D+ + A+K + ++ ++ ++ E IL+ + HP
Sbjct: 6 ELLGRGSFGSVYL----ALDK-DTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHP 59
Query: 176 FIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
IV+ S + K L + L++++GG L L + G E R YT +I+ +++LH
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 234 CGIVHRDLKPENILMDSDGHV 254
GIVHRD+K NIL+DSDG V
Sbjct: 120 NGIVHRDIKGANILVDSDGVV 140
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 62/148 (41%), Positives = 94/148 (63%), Gaps = 6/148 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFEI +V+G+GAFG+V VK K ++D ++AMK++ K ++K+ + ERD+L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLV 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
+ +I L Y+FQ + LYL++D+ GG L L + + ED ARFY AE+V A+
Sbjct: 57 NGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
+H+ VHRD+KP+NILMD +GH+ A
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGHIRLA 144
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 51/149 (34%), Positives = 84/149 (56%), Gaps = 9/149 (6%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-- 169
F V+G+G FGKV + K + +YA+K ++K II ++ V+ + E+ I
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKK-----TGELYAIKALKKGDIIARDEVESLMCEKRIFET 55
Query: 170 -TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
HPF+V L FQT + ++++ GG L H++ +F E +A FY A +V +
Sbjct: 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGL 114
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+LH+ IV+RDLK +N+L+D++G V A
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIA 143
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-31
Identities = 62/147 (42%), Positives = 85/147 (57%), Gaps = 11/147 (7%)
Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
F +RV+G+G FG+V QV+ G +YA K + K I K+ E+ IL
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGESMALNEKQIL 54
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
KV F+V L Y+++T+ L L+L +NGG L FH+Y G F E +A FY AEI
Sbjct: 55 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
+ LH+ IV+RDLKPENIL+D GH+
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHI 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 60/148 (40%), Positives = 92/148 (62%), Gaps = 6/148 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFEI +V+G+GAFG+V VK K ++ IYAMK++ K ++K+ + ER++L
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLV 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVS 229
+I L Y+FQ + LYL++D+ GG L L + + ED ARFY AE+V A+
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
+H+ VHRD+KP+N+L+D +GH+ A
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLA 144
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 64/161 (39%), Positives = 91/161 (56%), Gaps = 4/161 (2%)
Query: 94 ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
++D+ E + + K+ DF R +G G+FG+V K + D + A+K K I
Sbjct: 14 DSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYK---NEDFPPV-AIKRFEKSKI 69
Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
IK+ VD++ +ER IL + HPF V L SF+ S LYL+L+F+ GG F L R F
Sbjct: 70 IKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP 129
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
D FY A+IV +L IV+RDLKPEN+L+D DG +
Sbjct: 130 NDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170
|
Length = 340 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-30
Identities = 56/141 (39%), Positives = 87/141 (61%), Gaps = 9/141 (6%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G FG+V + + + +YA K + K + K+ + E+ IL KV FI
Sbjct: 1 LGKGGFGEVSACQMRA-----TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI 55
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHK 233
V L Y+FQT++ L L++ +NGG L +H+Y F E +A FYTA+I+S + HLH+
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 234 CGIVHRDLKPENILMDSDGHV 254
I++RDLKPEN+L+D+DG+V
Sbjct: 116 RRIIYRDLKPENVLLDNDGNV 136
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 9e-30
Identities = 59/141 (41%), Positives = 84/141 (59%), Gaps = 8/141 (5%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-- 174
++G+G FG+V+ +K D+ +YAMK + K I K ER +L+ V+
Sbjct: 1 IIGRGGFGEVYGCRK-----ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 55
Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
PFIV + Y+F T KL ILD +NGG L +HL + G+F E + RFY EI+ + H+H
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 234 CGIVHRDLKPENILMDSDGHV 254
+V+RDLKP NIL+D GHV
Sbjct: 116 RFVVYRDLKPANILLDEHGHV 136
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 58/147 (39%), Positives = 93/147 (63%), Gaps = 6/147 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D+E+ +V+G+GAFG+V V+ K + +YAMK++ K +IK++ + ERDI+
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKS-----TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
P++VQL Y+FQ LY++++++ GG L +L E ARFYTAE+V A+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDA 157
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMAA 257
+H G +HRD+KP+N+L+D GH+ A
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLA 184
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 54/143 (37%), Positives = 91/143 (63%), Gaps = 6/143 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
+++G+G+FGKVF + KG ++ +A+K ++KD ++ + V+ E+ +L+ H
Sbjct: 1 KMLGKGSFGKVFLAELKG-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+ L +FQT+ L+ +++++NGG L FH+ F +A FY AEI+ + LH
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 235 GIVHRDLKPENILMDSDGHVMAA 257
GIV+RDLK +NIL+D+DGH+ A
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIA 138
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 56/147 (38%), Positives = 93/147 (63%), Gaps = 6/147 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D+++ +V+G+GAFG+V V+ K S +YAMK++ K +IK++ + ERDI+
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKS-----SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
P++VQL +FQ LY++++++ GG L +L E A+FYTAE+V A+
Sbjct: 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLALDA 157
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMAA 257
+H G++HRD+KP+N+L+D GH+ A
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLA 184
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 6e-29
Identities = 60/147 (40%), Positives = 84/147 (57%), Gaps = 11/147 (7%)
Query: 112 FEIFRVVGQGAFGKVF--QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
F +RV+G+G FG+V QV+ G +YA K + K I K+ E+ IL
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATG-------KMYACKKLEKKRIKKRKGEAMALNEKRIL 54
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSA 227
KV F+V L Y+++T+ L L+L +NGG L FH+Y G F E +A FY AE+
Sbjct: 55 EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
+ L + IV+RDLKPENIL+D GH+
Sbjct: 115 LEDLQRERIVYRDLKPENILLDDRGHI 141
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 53/143 (37%), Positives = 89/143 (62%), Gaps = 6/143 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-TH 174
+V+G+G+FGKV + KG + +A+K ++KD ++ + V+ E+ +L +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGE-----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
PF+ L +FQT+ L+ +++F+NGG L FH+ +G F +A FY AEIV + LH
Sbjct: 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115
Query: 235 GIVHRDLKPENILMDSDGHVMAA 257
GI++RDLK +N+++D DGH+ A
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIA 138
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-27
Identities = 54/140 (38%), Positives = 82/140 (58%), Gaps = 11/140 (7%)
Query: 118 VGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+G+G FG+V QVK G +YA K + K + KK+ E++IL KV P
Sbjct: 1 LGKGGFGEVCAVQVKNTG-------KMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP 53
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR--FYTAEIVSAVSHLHK 233
FIV L Y+F++++ L L++ +NGG L +H+Y G + R Y+A+I + HLH
Sbjct: 54 FIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 234 CGIVHRDLKPENILMDSDGH 253
IV+RD+KPEN+L+D G+
Sbjct: 114 MDIVYRDMKPENVLLDDQGN 133
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 5e-27
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 21/151 (13%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
FEI +G+G FG+V++ + K G A+KV++ ++ KK + E IL
Sbjct: 1 LFEILEKIGKGGFGEVYKARHK------RTGKEVAIKVIKLESKEKKEKI---INEIQIL 51
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAE 223
K HP IV+ S+ + +L+++++F +GG L + E Q + E
Sbjct: 52 KKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL-----KDLLKSTNQTLTESQIAYVCKE 106
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + +LH GI+HRD+K NIL+ SDG V
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGEV 137
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 106 bits (264), Expect = 2e-26
Identities = 55/148 (37%), Positives = 85/148 (57%), Gaps = 12/148 (8%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ I R +G+G+FG+V+ + + + A+KV+ K K V+ E IL
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK--------LVALKVLAKKLESKSKEVERFLREIQILA 52
Query: 171 KVTHP-FIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVS 226
+ HP IV+L FQ LYL++++++GG L + R+G E +A F A+I+S
Sbjct: 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHV 254
A+ +LH GI+HRD+KPENIL+D DG V
Sbjct: 113 ALEYLHSKGIIHRDIKPENILLDRDGRV 140
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 44/144 (30%), Positives = 80/144 (55%), Gaps = 6/144 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++++ ++G+GAFG V+ KG++ ++ A+K + + I ++ M E D+L
Sbjct: 1 NYQLGDLIGRGAFGVVY----KGLN-LETGDFVAIKQISLEKIKEEALKSIM-QEIDLLK 54
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ HP IV+ S +T LY+IL++ G L + + G F E Y +++ +++
Sbjct: 55 NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LH+ G++HRD+K NIL DG V
Sbjct: 115 LHEQGVIHRDIKAANILTTKDGVV 138
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-21
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 26/172 (15%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
+E+ VVG+GA+G V + + K G+ I K D +KK A R++ L
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKFKESEDDEDVKK------TALREVKVL 54
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVS 226
++ H IV L+ +F+ + +LYL+ +++ L G+ D R Y +++
Sbjct: 55 RQLRHENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGL-PPDAVRSYIWQLLQ 111
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCCFFFFLFLGGG 278
A+++ H I+HRD+KPENIL+ G + +LC F F L
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVL----------KLCDFGFARALRAR 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-21
Identities = 47/144 (32%), Positives = 77/144 (53%), Gaps = 7/144 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
++G G+FG V++ G++ D +A+K + D + V ++ E +L+K+
Sbjct: 6 ELLGSGSFGSVYE----GLN-LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
HP IVQ + + LY+ L+ + GG L L + G F E R YT +I+ + +LH
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 234 CGIVHRDLKPENILMDSDGHVMAA 257
VHRD+K NIL+D++G V A
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLA 144
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 6e-20
Identities = 43/136 (31%), Positives = 71/136 (52%), Gaps = 8/136 (5%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G G FGKV+ + D+ + A+K +R K + E +L + HP +
Sbjct: 8 IGGGTFGKVYTAV-----NLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNL 61
Query: 178 VQLRYSFQT-RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI 236
V+ Y + R K+Y+ +++ +GG L L I E R YT +++ +++LH GI
Sbjct: 62 VKY-YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120
Query: 237 VHRDLKPENILMDSDG 252
VHRD+KP NI +D +G
Sbjct: 121 VHRDIKPANIFLDHNG 136
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 42/145 (28%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D E +V+GQG+ G V++V+ K G IYA+K + D + + E L
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKP--TGK---IYALKKIHVDGDEEFRKQ--LLRELKTLR 54
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
P++V+ +F ++ ++L++++GG L L + G E + +I+ + +
Sbjct: 55 SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDY 114
Query: 231 LHKC-GIVHRDLKPENILMDSDGHV 254
LH I+HRD+KP N+L++S G V
Sbjct: 115 LHTKRHIIHRDIKPSNLLINSKGEV 139
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-19
Identities = 47/147 (31%), Positives = 81/147 (55%), Gaps = 11/147 (7%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH-VDYMKAERDIL 169
+ + RVVG+G+FG+ V+ +SD YAMK +R + K + V+ + E +L
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIR---LPKSSSAVEDSRKEAVLL 52
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSA 227
K+ HP IV + SF+ LY+++++ +GG L L R +F ED + ++
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
V H+H+ ++HRD+K +NI + +G V
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKV 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-19
Identities = 45/139 (32%), Positives = 76/139 (54%), Gaps = 8/139 (5%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G+FGK VK K +DG I + + + + + + E +L+ + HP I
Sbjct: 8 IGEGSFGKAILVKSK--EDGKQYVIKEINISK----MSPKEREESRKEVAVLSNMKHPNI 61
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GI-FREDQARFYTAEIVSAVSHLHKCG 235
VQ + SF+ LY+++D+ GG L+ + Q G+ F EDQ + +I A+ H+H
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 236 IVHRDLKPENILMDSDGHV 254
I+HRD+K +NI + DG +
Sbjct: 122 ILHRDIKSQNIFLTKDGTI 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-19
Identities = 38/143 (26%), Positives = 75/143 (52%), Gaps = 10/143 (6%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
++ +G+G +G V++ + D + I A+K ++ ++ A R+I L
Sbjct: 1 YQKLGKIGEGTYGVVYKAR-----DKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLL 52
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
++ HP I++L F+ + LYL+ +F++ RQ E + Y +++ ++
Sbjct: 53 KELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 230 HLHKCGIVHRDLKPENILMDSDG 252
H GI+HRDLKPEN+L++++G
Sbjct: 113 FCHSHGILHRDLKPENLLINTEG 135
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 4e-19
Identities = 36/160 (22%), Positives = 77/160 (48%), Gaps = 38/160 (23%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
+E +G+G +G+V++ + K + + A+K +R + E++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGE-----LVALKKIRMEN------------EKEGFPI 43
Query: 168 -------ILTKVTHPFIVQLR--YSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFRE 214
+L K+ HP IV+L+ + + + +Y++ +++ G + F E
Sbjct: 44 TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG----LLDSPEVKFTE 99
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
Q + Y +++ + +LH GI+HRD+K NIL+++DG +
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVL 139
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 42/164 (25%), Positives = 83/164 (50%), Gaps = 14/164 (8%)
Query: 96 DAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
+ EL+A + + GD ++ +G+GA G+V++ + G A+K MR
Sbjct: 1 EEELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRA--TGKE---VAIKKMR-- 53
Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QG 210
++K + + + E I+ HP IV S+ +L++++++++GG L + +
Sbjct: 54 --LRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV 111
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
E Q + E++ + +LH ++HRD+K +NIL+ DG V
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSV 155
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-19
Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 3/146 (2%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P ++ +++GQGAFG+V+ VD G + + K V+ ++ E +
Sbjct: 1 PTNWRRGKLLGQGAFGRVYLCYD--VDTGRELAVKQVPFDPDSPETK-KEVNALECEIQL 57
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
L + H IVQ + L + ++++ GG + L G E R YT +I+ V
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
+LH IVHRD+K NIL DS G+V
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNV 143
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-18
Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 8/145 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+EI + +G+G+FGK++ K K DS+ ++ +K+ K E +L K
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKS----DSEHCVIKEIDLTKMPVKEKEAS--KKEVILLAK 55
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
+ HP IV SFQ +L++++++ +GG L + RQ +F EDQ + +I +
Sbjct: 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
H+H I+HRD+K +NI + +G V
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMV 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-18
Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 17/149 (11%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
+++ + +G G FG V+ + K ++ + A+K M+K + + M R++ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKF---YSWEECMN-LREVKSL 51
Query: 170 TKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIV 225
K+ HP IV+L+ F+ +LY + +++ G + L + F E R +I+
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRKGKPFSESVIRSIIYQIL 109
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++H+HK G HRDLKPEN+L+ V
Sbjct: 110 QGLAHIHKHGFFHRDLKPENLLVSGPEVV 138
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-18
Identities = 48/167 (28%), Positives = 85/167 (50%), Gaps = 21/167 (12%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
DFEI +G+G+FG VF+V +K D +YAMK + + + ++ +D E
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRK--ADKR---VYAMKQIDLSKMNRREREEAID----EAR 51
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQA-RFYTAEI 224
+L K+ +I++ SF + KL +++++ G H + R EDQ RF+ +I
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QI 110
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVM-----AAHSLNSHNQL 266
+ ++HLH I+HRD+K N+ +D+ +V A L+ +
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 14/158 (8%)
Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
R + P + +EI +G GAFGKV++ K K ++ + A KV+ +T ++ DYM
Sbjct: 5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVI--ETKSEEELEDYM 57
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQARF 219
E +IL HP+IV+L +F KL+++++F GG + L R E Q +
Sbjct: 58 -VEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQV 114
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+++ A+ +LH I+HRDLK N+L+ DG + A
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLA 152
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 40/143 (27%), Positives = 77/143 (53%), Gaps = 8/143 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F + +G+G+FG+V+ K +D + + A+KV+ + ++ ++ ++ E L++
Sbjct: 3 FTLLECIGKGSFGEVY----KAIDKRTNQ-VVAIKVIDLEE--AEDEIEDIQQEIQFLSQ 55
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
P+I + SF SKL++I+++ GG L + G E F E++ + +L
Sbjct: 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVLLGLEYL 114
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H+ G +HRD+K NIL+ +G V
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDV 137
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 1e-17
Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 32/154 (20%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
+E +G+G +G V++ + K + I A+K +R D T ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDNEEEGIPSTALR-------- 47
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQAR 218
E +L ++ HP IV+L T KLYL+ ++ + L R G + +
Sbjct: 48 -EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-----MDLKKYLDKRPGPLSPNLIK 101
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+++ +++ H I+HRDLKP+NIL++ DG
Sbjct: 102 SIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG 135
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-17
Identities = 45/145 (31%), Positives = 77/145 (53%), Gaps = 8/145 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ RV+G+GAFG+ ++ + D + K + + +K D + E IL+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRLSEKERRDALN-EIVILSL 55
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVS 229
+ HP I+ F + L + +++ NGG L+ + RQ +F E+ +Y +IVSAVS
Sbjct: 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
++HK GI+HRD+K NI + G +
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLI 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 50/151 (33%), Positives = 82/151 (54%), Gaps = 10/151 (6%)
Query: 109 PGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
P D EI +G GAFGKV++ + K ++ A K++ ++ D+M E D
Sbjct: 3 PNDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKII--QIESEEELEDFM-VEID 54
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVS 226
IL++ HP IV L ++ +KL+++++F +GG L L + E Q R+ +++
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
A++ LH ++HRDLK NIL+ DG V A
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTLDGDVKLA 145
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 54/155 (34%), Positives = 83/155 (53%), Gaps = 14/155 (9%)
Query: 107 IGPGDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
+ P +F EI +G GAFGKV++ + K ++ + A KV+ DT ++ DYM E
Sbjct: 1 LNPEEFWEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVI--DTKSEEELEDYM-VE 52
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQGIFREDQARFYTA 222
DIL HP IV+L +F + L+++++F GG + L R E Q R
Sbjct: 53 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCK 110
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ + A+++LH+ I+HRDLK NIL DG + A
Sbjct: 111 QTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLA 145
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 17/156 (10%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK-------VMRKDTIIKKNHVDYMKA 164
+ + +G GAFG V++V+KK + + A+K KD + + + +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVS 57
Query: 165 ERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARF 219
E I+ + + HP IV+ +F +LY+++D I G L H ++ F E++
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 220 YTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHV 254
++V A+ +LHK IVHRDL P NI++ D V
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKV 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 41/151 (27%), Positives = 70/151 (46%), Gaps = 17/151 (11%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAER 166
D E +G G G V +V + + I A+K +R + I K+ + E
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRP-----TGKIMAVKTIRLEINEAIQKQ-----ILREL 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
DIL K P+IV +F + + +++++GG L + I E +
Sbjct: 51 DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI-PERILGKIAVAV 109
Query: 225 VSAVSHLH-KCGIVHRDLKPENILMDSDGHV 254
+ +++LH K I+HRD+KP NIL++S G +
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVNSRGQI 140
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-16
Identities = 40/140 (28%), Positives = 76/140 (54%), Gaps = 6/140 (4%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR----KDTIIKKNHVDYMKAERDILTKV 172
++G+G +G+V+ V G+ + +++ + +K+ V +++E + L +
Sbjct: 8 LIGKGTYGRVYLALN--VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
H IVQ T L + L+++ GG + L G F E RF+T +++ +++LH
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 233 KCGIVHRDLKPENILMDSDG 252
GI+HRDLK +N+L+D+DG
Sbjct: 126 SKGILHRDLKADNLLVDADG 145
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 40/149 (26%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DF++ + +G+G++G V++VK+ SD YA+K + ++ +K D + R IL
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKR------LSDNQFYALKEVDLGSMSQKEREDAVNEIR-IL 53
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
V HP I+ + +F +KL +++++ G L + ++ + E + +++
Sbjct: 54 ASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ LH+ I+HRDLK NIL+ ++ V
Sbjct: 114 RGLQALHEQKILHRDLKSANILLVANDLV 142
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-16
Identities = 46/148 (31%), Positives = 77/148 (52%), Gaps = 24/148 (16%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM-KAER---- 166
+E RVVG+GAFG V ++K D +K IIK+ V+ M K ER
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRK--AD------------QKLVIIKQIPVEQMTKDERLAAQ 47
Query: 167 ---DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
+L ++HP I++ +F L +++++ GG L ++ ++ + ED +
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMD 249
+I+ A+ H+H I+HRDLK +NIL+D
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLD 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 30/145 (20%), Positives = 71/145 (48%), Gaps = 11/145 (7%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
F+I +G+G++G V++ K ++ + A+KV+ + +++ + E IL
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEEDLQE-----IIKEISILK 53
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVS 229
+ P+IV+ S+ + L++++++ G + + E++ + + +
Sbjct: 54 QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
+LH +HRD+K NIL++ +G
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQA 138
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 42/157 (26%), Positives = 83/157 (52%), Gaps = 20/157 (12%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
G FE+ V+G+G +GKV++ + K + + A+K+M I ++ + +K E +I
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMD----IIEDEEEEIKEEYNI 55
Query: 169 LTKVT-HPFIVQLRYSFQTRS------KLYLILDFINGG---HLFFHLYRQG-IFREDQA 217
L K + HP I +F ++ +L+L+++ GG L L ++G +E+
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWI 115
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ E + +++LH+ ++HRD+K +NIL+ + V
Sbjct: 116 AYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEV 152
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 26/155 (16%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDIL 169
D+E+ V+G GA V+ A+ + + + IK+ ++ + D L
Sbjct: 2 DYELIEVIGVGATAVVYA---------------AICLPNNEKVAIKRIDLEKCQTSVDEL 46
Query: 170 TK-------VTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARF 219
K HP +V+ SF +L+L++ +++GG + Y +G E
Sbjct: 47 RKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT 106
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
E++ + +LH G +HRD+K NIL+ DG V
Sbjct: 107 VLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSV 141
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 22/152 (14%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK---VMRKDTIIKKNHVDYMKAERD 167
++I +G+GA G VF+ K + + A+K + R + I + +KA
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRE-----TGETVALKKVALRRLEGGIPNQALREIKA--- 52
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-----RQGIFREDQARFYTA 222
L HP++V+L F S L+++++ L + E Q + Y
Sbjct: 53 -LQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMR 106
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ V+++H GI+HRDLKP N+L+ +DG +
Sbjct: 107 MLLKGVAYMHANGIMHRDLKPANLLISADGVL 138
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 41/146 (28%), Positives = 79/146 (54%), Gaps = 11/146 (7%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D+E+ + +G G +G V++ + D + + A+KV++ + + + ++ E +L
Sbjct: 4 DYELIQRIGSGTYGDVYKAR-----DIATGELVAIKVIKLE---PGDDFEIIQQEISMLK 55
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
+ HP IV S+ R KL++++++ GG L + + R G E Q + E + +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGL 114
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
++LH+ G +HRD+K NIL+ DG V
Sbjct: 115 AYLHETGKIHRDIKGANILLTEDGDV 140
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-15
Identities = 37/112 (33%), Positives = 57/112 (50%), Gaps = 2/112 (1%)
Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHL 202
M + T I K + R+ LT + H P +V L + ++L+L GG L
Sbjct: 13 MDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ H+ + E+ + + AE+V A+ LH+ GIV RDL P NIL+D GH+
Sbjct: 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHI 124
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 41/156 (26%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
D+E+ +G+G+FG V +V++K SDG I K + + +K + +E +IL
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRK------SDGKILVWKEIDYGNMTEKEK-QQLVSEVNIL 53
Query: 170 TKVTHPFIVQL--RYSFQTRSKLYLILDFINGGHL--FFHLYRQ--GIFREDQARFYTAE 223
++ HP IV+ R ++ LY+++++ GG L ++ E+ +
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHV 254
++ A+ H ++HRDLKP NI +D++ +V
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-14
Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 17/150 (11%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+ +G+GAFG+V++ K KG D ++ A+K +++D ++ D++K E ++ K+ HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEV--AVKTLKEDASEEE-RKDFLK-EARVMKKLGHP 56
Query: 176 FIVQLR-YSFQTRSKLYLILDFINGGHL----------FFHLYRQGIFREDQARFYTAEI 224
+V+L LYL+L+++ GG L F + + +D F +I
Sbjct: 57 NVVRLLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF-AIQI 114
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +L VHRDL N L+ D V
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVV 144
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (173), Expect = 3e-14
Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 4/140 (2%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+ +G+GAFG+V++ KG +G + A+K +++ ++ ++++ E I+ K++HP
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGT-ETKVAVKTLKEGAS-EEEREEFLE-EASIMKKLSHP 61
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKC 234
IV+L LY++ +++ GG L L + G +I + +L
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 235 GIVHRDLKPENILMDSDGHV 254
VHRDL N L+ + V
Sbjct: 122 NFVHRDLAARNCLVTENLVV 141
|
Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 6e-14
Identities = 59/222 (26%), Positives = 96/222 (43%), Gaps = 27/222 (12%)
Query: 48 NQSPASTSASLGDPQVIHNRSH-----SFVGPSPRYALSSSLPLQIQELEHENDAELEAE 102
Q P +R + P +L+ LPL + + A
Sbjct: 4 IQPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSAS 63
Query: 103 SERKIGPGDF-EIFRV--VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
E+ RV +G GA G V++V + + +YA+KV I NH
Sbjct: 64 GSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRP-----TGRLYALKV------IYGNHE 112
Query: 160 DYMK----AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED 215
D ++ E +IL V HP +V+ F ++ ++L+F++GG L F D
Sbjct: 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD 172
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
AR +I+S +++LH+ IVHRD+KP N+L++S +V A
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIA 210
|
Length = 353 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 7e-14
Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 11/144 (7%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
+ +G+GAFG+V+ KG G DG A+K +++D + ++ E I+ K+
Sbjct: 5 KKLGEGAFGEVY----KGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58
Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSH 230
HP IV+L L ++++++ GG L + R + +I + +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
L +HRDL N L+ + V
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVV 142
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-14
Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE+ + +G G +G V+ K + V+ G+ + A+KV++ + ++ E ++
Sbjct: 10 DFELIQRIGSGTYGDVY--KARNVNTGE---LAAIKVIKLE---PGEDFAVVQQEIIMMK 61
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
H IV S+ R KL++ ++F GG L + G E Q + + E + + +
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMAA 257
LH G +HRD+K NIL+ +GHV A
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLA 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 1e-13
Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
+E + +G+G + V++ + D ++ I A+K ++ + A R+I L
Sbjct: 2 YEKGKKLGEGTYAVVYKAR-----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLL 56
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS--- 226
++ HP I+ L F +S + L+ +F+ L + + ++ A+I S
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFM-ETDL------EKVIKDKSIVLTPADIKSYML 109
Query: 227 ----AVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +LH I+HRDLKP N+L+ SDG +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVL 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 42/140 (30%), Positives = 73/140 (52%), Gaps = 6/140 (4%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
FE+ VVG+GA+G V + + K ++ I A+K KD+ + + E +L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKF-KDSEENEEVKETTLRELKMLRT 56
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ IV+L+ +F+ R KLYL+ +++ L ++ R Y +++ A+
Sbjct: 57 LKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWC 116
Query: 232 HKCGIVHRDLKPENILMDSD 251
HK IVHRD+KPEN+L+ +
Sbjct: 117 HKNDIVHRDIKPENLLISHN 136
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-13
Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 9/150 (6%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAER 166
P ++ + +++G+GAFG+V+ D D+ A+K + D ++ V+ ++ E
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVPFDPDSQETSKEVNALECEI 55
Query: 167 DILTKVTHPFIVQLRYSFQ--TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
+L + H IVQ + KL + ++++ GG + L G E+ R YT +I
Sbjct: 56 QLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI 115
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ VS+LH IVHRD+K NIL DS G+V
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNV 145
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-13
Identities = 42/159 (26%), Positives = 82/159 (51%), Gaps = 16/159 (10%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
++ ++G+GA+G V+ + K V G + A+K++ DT + V ++ E +L++
Sbjct: 3 YQRLELIGRGAYGAVY--RGKHVPTGR---VVALKIINLDT--PDDDVSDIQREVALLSQ 55
Query: 172 VTH---PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
+ P I + S+ +L++I+++ GG + L + G E E++ A+
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVAL 114
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVM-----AAHSLNS 262
++HK G++HRD+K NIL+ + G+V A LN
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 40/140 (28%), Positives = 78/140 (55%), Gaps = 8/140 (5%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G+FG+VF KG+D+ + + A+K++ D ++ ++ ++ E +L++ P++
Sbjct: 12 IGKGSFGEVF----KGIDN-RTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
+ S+ +KL++I++++ GG L R G F E Q EI+ + +LH +
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 238 HRDLKPENILMDSDGHVMAA 257
HRD+K N+L+ G V A
Sbjct: 124 HRDIKAANVLLSEQGDVKLA 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 11/151 (7%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAER 166
P ++ + +++GQGAFG+V+ D D+ A+K ++ ++ V+ ++ E
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCY-----DADTGRELAVKQVQFDPESPETSKEVNALECEI 55
Query: 167 DILTKVTHPFIVQLRYSF---QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
+L + H IVQ Y L + ++ + GG + L G E+ R YT +
Sbjct: 56 QLLKNLLHERIVQY-YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ 114
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
I+ VS+LH IVHRD+K NIL DS G+V
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANILRDSVGNV 145
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 21/149 (14%)
Query: 117 VVGQGAFGKVF-----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
++G G+FG V+ VK+ + + KD K++ +D + E
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASS--------KDR--KRSMLDALARE 56
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+L ++ H IVQ S L + L+++ GG + L G F E R + +I+
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL 116
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++LH GI+HRD+K NIL+D+ G +
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILVDNKGGI 145
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 37/151 (24%), Positives = 78/151 (51%), Gaps = 2/151 (1%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+ +G GAF +Q + V G + + +R + ++ V+ ++ E ++ ++ HP
Sbjct: 6 QQLGTGAFSSCYQARD--VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
I+++ + S L ++++ GG + L + G F+E YT +++ +S+LH+
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 236 IVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266
I+HRD+K N+L+DS G + + +L
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 34/143 (23%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERDILTKV 172
+ +G+GAFG+V+ KG G A+K +++D + ++ E I+ K+
Sbjct: 5 KKLGEGAFGEVY----KGKLKGKGGKKKVEVAVKTLKEDASEQ--QIEEFLREARIMRKL 58
Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHL 231
HP +V+L LY++++++ GG L +L + + +I + +L
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
+HRDL N L+ + V
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVV 141
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 37/147 (25%), Positives = 75/147 (51%), Gaps = 7/147 (4%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F+ +G+G +G V++ + K + + A+K +R DT + ++ E +L +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLKE 55
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ HP IV+L T +KLYL+ +F++ F + Y +++ ++
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMAA 257
H ++HRDLKP+N+L++++G + A
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLA 142
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-12
Identities = 44/171 (25%), Positives = 82/171 (47%), Gaps = 26/171 (15%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK-DTIIKKNHVDYMKAERDI 168
G+F+I + +G+G F V++ + A+K ++ + + K D +K E D+
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLK-EIDL 55
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQG-IFREDQARFYTAEI 224
L ++ HP +++ SF ++L ++L+ + G + H +Q + E Y ++
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV---------------MAAHSL 260
SA+ H+H I+HRD+KP N+ + + G V AAHSL
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 39/146 (26%), Positives = 77/146 (52%), Gaps = 8/146 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F +G+G+FG+VF KG+D+ + + A+K++ D ++ ++ ++ E +L++
Sbjct: 6 FTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQ 58
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
P++ + S+ +KL++I++++ GG L G E Q EI+ + +L
Sbjct: 59 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYL 117
Query: 232 HKCGIVHRDLKPENILMDSDGHVMAA 257
H +HRD+K N+L+ G V A
Sbjct: 118 HSEKKIHRDIKAANVLLSEHGEVKLA 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-11
Identities = 45/143 (31%), Positives = 74/143 (51%), Gaps = 9/143 (6%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT 173
+++GQGAFG+V+ D D+ A K ++ ++ V ++ E +L +
Sbjct: 8 KLLGQGAFGRVYLCY-----DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 174 HPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
H IVQ + R++ L + ++++ GG + L G E R YT +I+ +S+L
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H IVHRD+K NIL DS G+V
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNV 145
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 36/145 (24%), Positives = 71/145 (48%), Gaps = 25/145 (17%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMKAERDIL 169
+G+G +G V++ + K + I A+K +R + T I+ E +L
Sbjct: 7 IGEGTYGVVYKARDKLTGE-----IVALKKIRLETEDEGVPSTAIR---------EISLL 52
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSA 227
++ HP IV+L + +KLYL+ +F++ G+ + Y +++
Sbjct: 53 KELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP-PLIKSYLYQLLQG 111
Query: 228 VSHLHKCGIVHRDLKPENILMDSDG 252
+++ H ++HRDLKP+N+L+D +G
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREG 136
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 42/138 (30%), Positives = 77/138 (55%), Gaps = 13/138 (9%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--ILTKVT 173
RVVG+G++G+V V+ + +DG V++K + + + AE++ +L+++
Sbjct: 6 RVVGKGSYGEVSLVRHR------TDG--KQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 174 HPFIVQLRYSFQTRS-KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSH 230
HP IV R S++ LY+++ F GG L+ L Q + E+Q + +I A+ +
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 231 LHKCGIVHRDLKPENILM 248
LH+ I+HRDLK +N+ +
Sbjct: 118 LHEKHILHRDLKTQNVFL 135
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 39/159 (24%), Positives = 67/159 (42%), Gaps = 29/159 (18%)
Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
+E +G+GA+G V++ + KK +GI + +R+ ++K+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI-PLSTLREIALLKQ----- 54
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRS-----KLYLILDFINGG-HLFFHLYRQGIFRED 215
L HP IV+L KL L+ + ++ + + +
Sbjct: 55 -------LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPE 107
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +++ V LH IVHRDLKP+NIL+ SDG V
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV 146
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 42/136 (30%), Positives = 61/136 (44%), Gaps = 26/136 (19%)
Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN------HV-DYMKAERDILTKVT 173
G FGKV +K K K+ + I KN V MK
Sbjct: 27 GKFGKVSVLKHKPTQ----------KLFVQKIIKAKNFNAIEPMVHQLMK---------D 67
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
+P ++L YS T LI+D+I G LF L ++G E + + ++V A++ LHK
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 234 CGIVHRDLKPENILMD 249
I+H D+K EN+L D
Sbjct: 128 HNIIHNDIKLENVLYD 143
|
Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 42/154 (27%), Positives = 79/154 (51%), Gaps = 18/154 (11%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
G FE+ VVG G +G+V+ K + V G + A+KVM + ++ + +K E ++L
Sbjct: 16 GIFELVEVVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTEDEEEEIKLEINML 66
Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
K +H + Y +F +S +L+L+++F G + + +ED +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
EI+ ++HLH ++HRD+K +N+L+ + V
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEV 160
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 37/137 (27%), Positives = 67/137 (48%), Gaps = 11/137 (8%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHP 175
+G+G+FG V+ VK K + +KV+++ + + N E +L+K+ HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQG--IFREDQARFYTAEIVSAVSHL 231
IV+ SF R +I ++ G L L + E+Q + +++ V ++
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 232 HKCGIVHRDLKPENILM 248
H+ I+HRDLK +NI +
Sbjct: 123 HQRRILHRDLKAKNIFL 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-11
Identities = 51/173 (29%), Positives = 82/173 (47%), Gaps = 28/173 (16%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI 168
+E +VG+G++G V + K K ++ I A+K D ++KK A R+I
Sbjct: 3 YENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDDKMVKK------IAMREI 51
Query: 169 --LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIV 225
L ++ H +V L F+ + +LYL+ +F++ L Y G+ E + R Y +I+
Sbjct: 52 RMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGL-DESRVRKYLFQIL 110
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCCFFFFLFLGGG 278
+ H I+HRD+KPENIL+ G V +LC F F L
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVSQSGVV----------KLCDFGFARTLAAP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 7e-11
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 29/155 (18%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK------NHVDYMKAE 165
+EI + +G+GA+G V+ K +D + ++ +KK N D +
Sbjct: 9 YEILQKLGKGAYGIVW----KAID----------RRTKEVVALKKIFDAFRNATDAQRTF 54
Query: 166 RDI--LTKVT-HPFIVQLR--YSFQTRSKLYLILDFINGGHLFFH-LYRQGIFREDQARF 219
R+I L ++ HP IV+L + +YL+ +++ H + R I + R+
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETD---LHAVIRANILEDVHKRY 111
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++ A+ ++H ++HRDLKP NIL++SD V
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRV 146
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD--YMKAERDI- 168
+EI +G+G +G+V++ K+K +G YA+K + D K A R+I
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRK---NGKDGKEYAIKKFKGD----KEQYTGISQSACREIA 54
Query: 169 -LTKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHL---YRQGIFREDQARFY-- 220
L ++ H +V L F + +YL+ D+ H + + +RQ
Sbjct: 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--HDLWQIIKFHRQAKRVSIPPSMVKS 112
Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+I++ V +LH ++HRDLKP NIL+ +G
Sbjct: 113 LLWQILNGVHYLHSNWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-11
Identities = 37/140 (26%), Positives = 76/140 (54%), Gaps = 8/140 (5%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G+FG+V+ KG+D+ + + A+K++ D ++ ++ ++ E +L++ P+I
Sbjct: 12 IGKGSFGEVY----KGIDN-RTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYI 64
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
+ S+ +KL++I++++ GG L + G E EI+ + +LH +
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 238 HRDLKPENILMDSDGHVMAA 257
HRD+K N+L+ G V A
Sbjct: 124 HRDIKAANVLLSEQGDVKLA 143
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 29/159 (18%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ER 166
+G+GA G V + + K + I+A+K TI + D K E
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALK-----TITTDPNPDLQKQILREL 50
Query: 167 DILTKVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE- 223
+I P+IV+ +F ++ S + + +++ GG L +Y++ ++ R E
Sbjct: 51 EINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-SIYKK--VKKRGGR--IGEK 105
Query: 224 --------IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ +S+LH I+HRD+KP NIL+ G V
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV 144
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 25/154 (16%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-----AMKVMRKDTIIKKNHVDY 161
I + ++ +G+G FG V G Y A+K ++ D+
Sbjct: 3 INSKELKLGATIGKGEFGDVML------------GDYRGQKVAVKCLKDDS----TAAQA 46
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY---RQGIFREDQAR 218
AE ++T + HP +VQL + LY++ +++ G L +L R I Q
Sbjct: 47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLG 106
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
F ++ + +L + VHRDL N+L+ D
Sbjct: 107 F-ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL 139
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 40/158 (25%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
+ R+ D+E+ + VG G +G V++ + + G+ + +K+ D D+
Sbjct: 1 DILRRNPQHDYELIQRVGSGTYGDVYKARN--LHTGELAAVKIIKLEPGD--------DF 50
Query: 162 MKAERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
+++I + + H IV S+ +R KL++ +++ GG L + G E Q +
Sbjct: 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
E + +++LH G +HRD+K NIL+ +G V A
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLA 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 39/147 (26%), Positives = 68/147 (46%), Gaps = 32/147 (21%)
Query: 119 GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVT-HP 175
G+G F +V K + G YA+K M+K ++ + R+I L +++ HP
Sbjct: 8 GEGTFSEVL--KAQSRKTGKY---YAIKCMKK----HFKSLEQVNNLREIQALRRLSPHP 58
Query: 176 FIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGI----------FREDQARFYTAEI 224
I++L + ++ D G L F L + E + + Y ++
Sbjct: 59 NILRL---------IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQL 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD 251
+ ++ H+H+ GI HRD+KPENIL+ D
Sbjct: 110 LKSLDHMHRNGIFHRDIKPENILIKDD 136
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 32/169 (18%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDI--LTKV 172
+G+G++G VF+ + + ++ I A+K D +IKK A R+I L ++
Sbjct: 9 IGEGSYGVVFKCRNR-----ETGQIVAIKKFVESEDDPVIKK------IALREIRMLKQL 57
Query: 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVS 229
HP +V L F+ + KL+L+ ++ + H + +G+ E + + + AV+
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCD--HTVLNELEKNPRGV-PEHLIKKIIWQTLQAVN 114
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCCFFFFLFLGGG 278
HK +HRD+KPENIL+ G + +LC F F L G
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQI----------KLCDFGFARILTGP 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 7e-10
Identities = 33/149 (22%), Positives = 68/149 (45%), Gaps = 20/149 (13%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--L 169
+E+ + +G GA+G V D + A+K + + + +D + R+I L
Sbjct: 2 YELLKPIGSGAYGVVCSAV-----DKRTGRKVAIKKISN---VFDDLIDAKRILREIKLL 53
Query: 170 TKVTHPFIVQLRYSFQTRSK-----LYLILDFINGGHLFFH--LYRQGIFREDQARFYTA 222
+ H I+ L + S +Y++ + + H + +D +++
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM---ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+I+ + +LH ++HRDLKP NIL++S+
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSN 139
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-10
Identities = 38/148 (25%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ E+ +G+G +G V++V + + AMK +R + + ++ + + E DIL
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLE--LDESKFNQIIMELDILH 54
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
K P+IV +F +Y+ +++++ G L+ ED R T +V
Sbjct: 55 KAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKG 114
Query: 228 VSHL-HKCGIVHRDLKPENILMDSDGHV 254
+ L + I+HRD+KP N+L++ +G V
Sbjct: 115 LKFLKEEHNIIHRDVKPTNVLVNGNGQV 142
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 1/110 (0%)
Query: 144 AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-SKLYLILDFINGGHL 202
A+K++R D +++ + E + ++ HP IV L S + L+ + +++ G L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
L G + +++ A++ H GIVHRDLKP+NI++ G
Sbjct: 67 REVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 29/158 (18%)
Query: 107 IGPGDFEIFRVVGQGAFGKV--------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
I P + + +G G FG V +V K +++G M ++ I+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG---------AMSEEDFIE--- 48
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
E ++ K++HP +VQL Y T+ K LY++ +F+ G L +L RQG +D
Sbjct: 49 ------EAKVMMKLSHPKLVQL-YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM 101
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + +L + +HRDL N L+ S G V
Sbjct: 102 LLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV 139
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 39/149 (26%), Positives = 77/149 (51%), Gaps = 9/149 (6%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+F I + +G+G F +V+ + + DG + +++ D + K D +K E D+L
Sbjct: 2 ANFRIEKKIGRGQFSEVY--RATCLLDGVPVALKKVQIF--DLMDAKARADCIK-EIDLL 56
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIV 225
++ HP +++ SF ++L ++L+ + G L H +Q + E Y ++
Sbjct: 57 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC 116
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
SA+ H+H ++HRD+KP N+ + + G V
Sbjct: 117 SALEHMHSRRVMHRDIKPANVFITATGVV 145
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 36/164 (21%)
Query: 112 FEIFRVVGQGAFGKVFQVK----------KKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
+E +G+G +GKV++ + KK + D +GI T ++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGI-------PPTALR------ 49
Query: 162 MKAERDILTKVTH-PFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFR- 213
E +L ++ +IV+L K LYL+ ++++ F +G R
Sbjct: 50 ---EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP 106
Query: 214 --EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ + +++ V+H HK G++HRDLKP+N+L+D ++
Sbjct: 107 LPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL 150
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 23/146 (15%)
Query: 117 VVGQGAFGKVF----------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
V+G+GA+G V+ VK+ +D + A K K ++ E
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLA--AEKEYEK-----------LQEEV 53
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
D+L + H IVQ + + + + ++F+ GG + L R G E YT +I+
Sbjct: 54 DLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD 113
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDG 252
V++LH +VHRD+K N+++ +G
Sbjct: 114 GVAYLHNNCVVHRDIKGNNVMLMPNG 139
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 41/166 (24%), Positives = 78/166 (46%), Gaps = 36/166 (21%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
F+I +G+G +G+V++ + D D+ + A+K +R D T I+
Sbjct: 9 FDIIGQIGEGTYGQVYKAR-----DKDTGELVALKKVRLDNEKEGFPITAIR-------- 55
Query: 164 AERDILTKVTHPFIVQLR---------YSFQTRSK-LYLILDFINGGHLFFHLYRQGI-- 211
E IL ++ H IV L+ F+ YL+ ++++ H L G+
Sbjct: 56 -EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD--HDLMGLLESGLVH 112
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
F ED + + +++ +++ HK +HRD+K NIL+++ G + A
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 44/167 (26%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYM 162
D+ +G+G +G V++ + K + I AMK +R + T I+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESEEEGVPSTAIR------- 48
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN------------GGHLFFHLYRQG 210
E +L ++ HP IV L+ S+LYLI +F++ G ++ L +
Sbjct: 49 --EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKS- 105
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
Y +I+ + H ++HRDLKP+N+L+D+ G + A
Sbjct: 106 ---------YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLA 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 3e-09
Identities = 40/154 (25%), Positives = 79/154 (51%), Gaps = 18/154 (11%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
G FE+ +VG G +G+V+ K + V G + A+KVM + + + +K E ++L
Sbjct: 6 GIFELVELVGNGTYGQVY--KGRHVKTGQ---LAAIKVMD----VTGDEEEEIKQEINML 56
Query: 170 TKVTHPFIVQLRY-SFQTRS------KLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
K +H + Y +F ++ +L+L+++F G + + +E+ +
Sbjct: 57 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 116
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
EI+ +SHLH+ ++HRD+K +N+L+ + V
Sbjct: 117 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 150
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 25/158 (15%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+EI +G+G +GKV++V K DG + A+K++ D I + + ++AE +IL
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNK--KDGS---LAAVKIL--DPI--SDVDEEIEAEYNIL 72
Query: 170 TKVT-HPFIVQLRYSFQTRSK-----LYLILDFINGG---HLFFHLYRQGIFREDQAR-- 218
+ HP +V+ F K L+L+L+ NGG L L G R D+A
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMIS 131
Query: 219 --FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
Y A + + HLH I+HRD+K NIL+ ++G V
Sbjct: 132 YILYGALL--GLQHLHNNRIIHRDVKGNNILLTTEGGV 167
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 39/146 (26%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
+ F +G+G+ G V K + A+K M + K+ + + E I
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKM---DLRKQQRRELLFNEVVI 69
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
+ HP IV++ S+ +L+++++F+ GG L + E+Q ++ A+
Sbjct: 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIATVCLAVLKAL 128
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
S LH G++HRD+K ++IL+ SDG V
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRV 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-09
Identities = 38/150 (25%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I P + + +G G FG V K +G D A+K++R+ + + D+++ E
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKID------VAIKMIREGAM---SEDDFIE-EA 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEI 224
++ K++HP +VQL Y T+ + ++++ +++ G L +L + G + +++
Sbjct: 51 KVMMKLSHPNLVQL-YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV 109
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
A+ +L G +HRDL N L+ D V
Sbjct: 110 CEAMEYLESNGFIHRDLAARNCLVGEDNVV 139
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 39/148 (26%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+F+I + +G+G F +V+ + D + KV + + K D +K E D+L
Sbjct: 3 NFQIEKKIGRGQFSEVY----RATCLLDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLK 57
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHL---FFHLYRQG-IFREDQARFYTAEIVS 226
++ HP +++ SF ++L ++L+ + G L + +Q + E Y ++ S
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHV 254
AV H+H ++HRD+KP N+ + + G V
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVV 145
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-09
Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 8/143 (5%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+ +G+G FGKV + + D + + A+K + ++ H + E +IL + H
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQV-AVKSLNHSG--EEQHRSDFEREIEILRTLDHE 66
Query: 176 FIVQLRY--SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
IV+ + L LI++++ G L +L R + + R ++++I + +L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYL 125
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
+HRDL NIL++S+ V
Sbjct: 126 GSQRYIHRDLAARNILVESEDLV 148
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 30/151 (19%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
VG+G +G V++ K+K DG D YA+K + I M A R+I L ++ HP
Sbjct: 9 VGRGTYGHVYKAKRK---DGKDDRDYALKQIEGTGI-------SMSACREIALLRELKHP 58
Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
++ L+ F + + K++L+ D+ H +H+ + R +A +
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPVQLPRGMVKSLL 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+I+ + +LH ++HRDLKP NIL+ +G
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 109 PGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD 167
P D +EI +G+G +GKVF+V K +G A+K++ I + ++AE +
Sbjct: 16 PSDTWEIIETIGKGTYGKVFKVLNK--KNGSKA---AVKILDPIHDIDEE----IEAEYN 66
Query: 168 ILTKVT-HPFIVQL-----RYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQA 217
IL ++ HP +V+ + + +L+L+L+ NGG + L R E
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ E + + HLH +HRD+K NIL+ ++G V
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 14/155 (9%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ R +GQG+FG V++ KGV G+ + A+K + ++ +++ +A ++
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA--SVMK 64
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY---------- 220
+ +V+L T ++++ + G L +L R +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKFIQ 123
Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
AEI +++L VHRDL N ++ D V
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 30/149 (20%), Positives = 62/149 (41%), Gaps = 17/149 (11%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK---DTIIKKNHVDYMKAERDI 168
++ +G GA+G V +D + K+ T+ K+ E I
Sbjct: 7 YKPIENIGSGAYGVVC----SAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-----RELKI 57
Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
L H I+ +R + Y+++D + L ++ E+ R++ ++
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+ + ++H ++HRDLKP N+L++ D
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLVNEDCE 145
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 39/152 (25%), Positives = 76/152 (50%), Gaps = 13/152 (8%)
Query: 107 IGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ GD E + +G+G+ G V ++K S A+K+M + K+ + +
Sbjct: 14 VDQGDPRSLLENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMM---DLRKQQRRELL 65
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
E I+ H +V++ S+ +L+++++F+ GG L + Q E+Q
Sbjct: 66 FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQTRLNEEQIATVCE 124
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ A+ +LH G++HRD+K ++IL+ DG V
Sbjct: 125 SVLQALCYLHSQGVIHRDIKSDSILLTLDGRV 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 38/151 (25%), Positives = 63/151 (41%), Gaps = 18/151 (11%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
R +G+GAFGKVF + ++ + + A+K + K+T D+ + E ++LT H
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASNDARKDFER-EAELLTNFQHE 68
Query: 176 FIVQLRYSFQTR-SKLYLILDFINGGHLFFHLYRQG-----IFREDQARF---------Y 220
IV+ Y T ++ +++ G L L G + D
Sbjct: 69 NIVKF-YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+I S + +L VHRDL N L+ D
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYD 158
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 37/178 (20%)
Query: 96 DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
D E +K + I RV+G GA G V K+ V DG+ +A+KV+ + +
Sbjct: 23 DEATAKEQAKK-----YWISRVLGSGATGTVLCAKR--VSDGEP---FAVKVVDMEGM-- 70
Query: 156 KNHVDYMKA--ERDILTKVTHPFIVQLRYSFQTR--------SKLYLILDFINGGHLFFH 205
+ D +A E L IV+ F + + L+LD+ N G L
Sbjct: 71 -SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL--- 126
Query: 206 LYRQGI---------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
RQ I FRE +A +++ AV H+H ++HRD+K NIL+ S+G V
Sbjct: 127 --RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV 182
|
Length = 496 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 23/155 (14%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAER 166
+ E +V+G GAFG V+ KGV +G+ I A+KV+R++T K + + + E
Sbjct: 7 TELEKIKVLGSGAFGTVY----KGVWIPEGEKVKIPVAIKVLREETS-PKANKEILD-EA 60
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF------- 219
++ V HP +V+L S++ LI + G L ++ R +
Sbjct: 61 YVMASVDHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYV------RNHKDNIGSQYLLN 113
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +I +S+L + +VHRDL N+L+ + HV
Sbjct: 114 WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHV 148
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 15/149 (10%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--DYMKAERDILTKVTH 174
+G+G FG+VF K KG+++ + + +K ++K K ++ ++ + E D+ K++H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRR-ELDMFRKLSH 67
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV---- 228
+V+L + Y+IL++ + G L F + + T + V+
Sbjct: 68 KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 229 ---SHLHKCGIVHRDLKPENILMDSDGHV 254
HL VHRDL N L+ S V
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREV 156
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 41/143 (28%), Positives = 67/143 (46%), Gaps = 15/143 (10%)
Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
F +GQGA G V+ V G I M + +K+ II N + M+ +
Sbjct: 24 FEKIGQGASGTVYTAID--VATGQEVAIKQMNLQQQPKKELII--NEILVMRENK----- 74
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
HP IV S+ +L+++++++ GG L + + E Q E + A+ L
Sbjct: 75 --HPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 131
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H ++HRD+K +NIL+ DG V
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSV 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 42/168 (25%), Positives = 81/168 (48%), Gaps = 16/168 (9%)
Query: 91 LEHENDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
+ HE + A + + PGD + F +G+G+ G V +K + A+K
Sbjct: 2 VSHE---QFRAALQLVVSPGDPREYLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVK 53
Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
M + K+ + + E I+ H +V + S+ +L+++++F+ GG L +
Sbjct: 54 KM---DLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT-DI 109
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
E+Q ++ A+S+LH G++HRD+K ++IL+ SDG +
Sbjct: 110 VTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI 157
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-08
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 30/151 (19%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
VG+G +G V++ K+K DG + YA+K + I M A R+I L ++ HP
Sbjct: 9 VGRGTYGHVYKAKRK---DGKDEKEYALKQIEGTGI-------SMSACREIALLRELKHP 58
Query: 176 FIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQA------------RFYT 221
++ L+ F + S K++L+ D+ H +H+ + R +A +
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAE--HDLWHIIK--FHRASKANKKPMQLPRSMVKSLL 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+I+ + +LH ++HRDLKP NIL+ +G
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEG 145
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 34/162 (20%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
+FE +G+G +G V++ + D S I A+K +R M ERD
Sbjct: 8 EFEKLNRIGEGTYGIVYRAR-----DTTSGEIVALKKVR------------MDNERDGIP 50
Query: 168 --------ILTKVTHPFIVQLRYSFQTRS--KLYLILDFING--GHLFFHLYRQGIFRED 215
+L + HP IV+L+ + ++L++++ L ++ F E
Sbjct: 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSES 108
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
Q + +++ + +LH+ I+HRDLK N+L+ G + A
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIA 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 32/145 (22%), Positives = 71/145 (48%), Gaps = 25/145 (17%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
+G+G + V++ + + + I A+K + D T I+ E ++
Sbjct: 8 LGEGTYATVYKGRNRTTGE-----IVALKEIHLDAEEGTPSTAIR---------EISLMK 53
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGIFREDQARFYTAEIVSA 227
++ H IV+L T +KL L+ ++++ ++ H R G + + +T +++
Sbjct: 54 ELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVR-GALDPNTVKSFTYQLLKG 112
Query: 228 VSHLHKCGIVHRDLKPENILMDSDG 252
++ H+ ++HRDLKP+N+L++ G
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRG 137
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 37/155 (23%), Positives = 73/155 (47%), Gaps = 23/155 (14%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I P D + +G G FG V K +G D A+K++++ ++ + ++ E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSEDEFIE----EA 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
++ K++H +VQL + +Y++ ++++ G L +L RE RF ++++
Sbjct: 51 KVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLE 104
Query: 227 -------AVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++L +HRDL N L+D G V
Sbjct: 105 MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCV 139
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 39/138 (28%), Positives = 71/138 (51%), Gaps = 6/138 (4%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
RV+G+G FGKV +DG + + A+K ++++ + + K E +IL + H
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGE-MVAVKTLKREC--GQQNTSGWKKEINILKTLYHE 66
Query: 176 FIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
IV+ + S Q L LI++++ G L +L + + Q + +I +++LH
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL-NLAQLLLFAQQICEGMAYLHS 125
Query: 234 CGIVHRDLKPENILMDSD 251
+HRDL N+L+D+D
Sbjct: 126 QHYIHRDLAARNVLLDND 143
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 15/143 (10%)
Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
F +GQGA G V+ V G I M + +K+ II N + M+ ++
Sbjct: 25 FEKIGQGASGTVYTAMD--VATGQEVAIRQMNLQQQPKKELII--NEILVMRENKN---- 76
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
P IV S+ +L+++++++ GG L + + E Q E + A+ L
Sbjct: 77 ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H ++HRD+K +NIL+ DG V
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSV 155
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 19/147 (12%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
+V+G GAFG V+ K + DG++ I A+KV+R++T K N + E ++ V
Sbjct: 13 KVLGSGAFGTVY--KGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGS 68
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------YTAEIVSA 227
P++ +L S + L+ + G L ++ RE++ R + +I
Sbjct: 69 PYVCRL-LGICLTSTVQLVTQLMPYGCLLDYV------RENKDRIGSQDLLNWCVQIAKG 121
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
+S+L + +VHRDL N+L+ S HV
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNHV 148
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 15/155 (9%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
D E +G G G+V++++ K + + A+K MR+ ++N M
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGNKEENKRILM-- 62
Query: 165 ERDILTKVTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFY 220
+ D++ K +H P+IV+ F T S +++ ++ + L + QG ED
Sbjct: 63 DLDVVLK-SHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKM 119
Query: 221 TAEIVSAVSHL-HKCGIVHRDLKPENILMDSDGHV 254
T IV A+ +L K G++HRD+KP NIL+D+ G+V
Sbjct: 120 TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV 154
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-07
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 28/158 (17%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
D + V+G+G FG+V + + K DG+ A+K M K+ K +H D+ E +
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIK------KDGLRMDAAIKRM-KEYASKDDHRDF-AGELE 59
Query: 168 ILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED----------- 215
+L K+ HP I+ L + + R LYL +++ G+L L + + D
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 216 -----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
Q + A++ + +L + +HRDL NIL+
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 40/163 (24%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 98 ELEAESERKIGPGD----FEIFRVVGQGAFGKV--FQVKKKGVDDGDSDGIYAMKVMRKD 151
+ A + + PGD + F +G+G+ G V VK G + ++K
Sbjct: 4 QFRAALQMVVDPGDPRTYLDNFIKIGEGSTGIVCIATVKSSG----------KLVAVKKM 53
Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
+ K+ + + E I+ H +V++ S+ +L+++++F+ GG L +
Sbjct: 54 DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIVTHTR 112
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
E+Q ++ A+S LH G++HRD+K ++IL+ DG V
Sbjct: 113 MNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 36/155 (23%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
++ + R +G GAFG+V++ +G D + A+K + + +++ D++ E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLM-E 59
Query: 166 RDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR---- 218
I++K H IV+L SF+ + +++L+ + GG L F R R
Sbjct: 60 ALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118
Query: 219 -FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
F ++ +L + +HRD+ N L+ G
Sbjct: 119 LFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG 153
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 35/133 (26%), Positives = 68/133 (51%), Gaps = 13/133 (9%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+GQG FG+V+ G +G + A+K ++ T+ + + E ++ K+ H +
Sbjct: 14 LGQGCFGEVW----MGTWNGTTR--VAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKL 63
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCG 235
VQL Y+ + +Y++ ++++ G L L + R Q A+I S ++++ +
Sbjct: 64 VQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN 122
Query: 236 IVHRDLKPENILM 248
VHRDL+ NIL+
Sbjct: 123 YVHRDLRAANILV 135
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 36/154 (23%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+GQG FG+VF+ + K I A+K + + + + ++ E IL + H +
Sbjct: 20 IGQGTFGEVFKARHKKTKQ-----IVALKKVLMENEKEGFPITALR-EIKILQLLKHENV 73
Query: 178 VQL------------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI- 224
V L RY + YL+ +F H G+ +F +EI
Sbjct: 74 VNLIEICRTKATPYNRY----KGSFYLVFEFCE--HDL-----AGLLSNKNVKFTLSEIK 122
Query: 225 ------VSAVSHLHKCGIVHRDLKPENILMDSDG 252
++ + ++H+ I+HRD+K NIL+ DG
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-07
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 15/143 (10%)
Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM---RKDTIIKKNHVDYMKAERDILTK 171
F +GQGA G V+ + G I M + +K+ II N + M+ ++
Sbjct: 24 FEKIGQGASGTVYTAID--IATGQEVAIKQMNLQQQPKKELII--NEILVMRENKN---- 75
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
P IV S+ +L+++++++ GG L + + E Q E + A+ L
Sbjct: 76 ---PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALDFL 131
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H ++HRD+K +NIL+ DG V
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSV 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-07
Identities = 34/148 (22%), Positives = 73/148 (49%), Gaps = 11/148 (7%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--IL 169
+E +G+G++ V++ K K + + A+KV+R +++ A R+ +L
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKV-----NGKLVALKVIR----LQEEEGTPFTAIREASLL 57
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
+ H IV L T+ L L+ ++++ + G + + + +++ +S
Sbjct: 58 KGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
++H+ I+HRDLKP+N+L+ G + A
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLA 145
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 46/215 (21%)
Query: 65 HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFR-------- 116
H + G + L +E H N+A + + E+ I D +I R
Sbjct: 18 HKANKGGSGKFEM----NDKKLDEEERSHNNNAGEDEDEEKMI---DNDINRSPNKSYKL 70
Query: 117 --VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
++G G+FG V++ + S+ + KV++ Y E I+ + H
Sbjct: 71 GNIIGNGSFGVVYE----AICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNH 118
Query: 175 PFIVQLRYSFQTRSK--------LYLILDFINGGHLFFHLYRQGIFREDQA------RFY 220
I+ L+ + T L ++++FI H Y + R + A + Y
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQT---VHKYMKHYARNNHALPLFLVKLY 175
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ ++ A++++H I HRDLKP+N+L+D + H +
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTL 210
|
Length = 440 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 34/152 (22%), Positives = 62/152 (40%), Gaps = 22/152 (14%)
Query: 116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
+G GAFG+V++ + G A+K +RK ++ +++K E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLK-EAHLMSNFNH 58
Query: 175 PFIV-QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA----------- 222
P IV L Y+I++ + GG L +L + RF
Sbjct: 59 PNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARV-----ERFGPPLLTLKELLDIC 112
Query: 223 -EIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
++ +L + +HRDL N L+ G+
Sbjct: 113 LDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY 144
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 22/156 (14%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-- 164
+ D E +G G G V +VK I VM K + H+ +
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKH----------IPTGTVMAKKVV----HIGAKSSVR 47
Query: 165 -----ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
E I+ + P+IV +F + + + ++F++ G L + G +
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK 107
Query: 220 YTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHV 254
+V +++L+ I+HRD+KP NIL++S G +
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI 143
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-07
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I +I +V+G G FG+V + K G + A+K + K +K D++ +E
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLK--LPGKREIPVAIKTL-KAGYTEKQRRDFL-SEA 56
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
I+ + HP I+ L T+SK + ++ +++ G L R+ +F ++V
Sbjct: 57 SIMGQFDHPNIIHLE-GVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLV 109
Query: 226 -------SAVSHLHKCGIVHRDLKPENILMDSD 251
S + +L G VHRDL NIL++S+
Sbjct: 110 GMLRGIASGMKYLSDMGYVHRDLAARNILVNSN 142
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE +G G G VF+V K S I A K++ + IK + + E +L
Sbjct: 6 DFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ P+IV +F + ++ + ++ ++GG L L + G E + ++ +++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 118
Query: 231 L-HKCGIVHRDLKPENILMDSDGHV 254
L K I+HRD+KP NIL++S G +
Sbjct: 119 LREKHKIMHRDVKPSNILVNSRGEI 143
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 23/155 (14%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
I P I +V+G G FG+V + +K G + D A+K K K +D++
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEID----VAIK-TLKAGSSDKQRLDFL-T 54
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
E I+ + HP I++L T+S+ + +I +++ G L L RE+ +F +
Sbjct: 55 EASIMGQFDHPNIIRL-EGVVTKSRPVMIITEYMENGSLDKFL------RENDGKFTVGQ 107
Query: 224 IV-------SAVSHLHKCGIVHRDLKPENILMDSD 251
+V S + +L + VHRDL NIL++S+
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN 142
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 43/176 (24%), Positives = 66/176 (37%), Gaps = 37/176 (21%)
Query: 92 EHENDAE----LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
E E+DA+ L AE+ I F I GA G F
Sbjct: 70 EDESDADASLALCAEARAGIEKAGFSILETFTPGAEGFAFACIDNKT------------- 116
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
+ +IK E IL + HP I+QL+ +F LIL Y
Sbjct: 117 -CEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP----------RY 165
Query: 208 RQGIF--REDQARFYTAEIVS-------AVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ ++ + +I++ A+ +LH+ I+HRD+K ENI ++ G V
Sbjct: 166 KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221
|
Length = 391 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 32/140 (22%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
++ + +G G FG+V+ G +G++ A+K ++ T+ ++ ++ E I+ K
Sbjct: 8 LQLIKKLGNGQFGEVWM----GTWNGNTK--VAVKTLKPGTMSPESFLE----EAQIMKK 57
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAV 228
+ H +VQL Y+ + +Y++ ++++ G L L + G R A++ + +
Sbjct: 58 LRHDKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGM 115
Query: 229 SHLHKCGIVHRDLKPENILM 248
+++ + +HRDL+ NIL+
Sbjct: 116 AYIERMNYIHRDLRSANILV 135
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 39/141 (27%), Positives = 66/141 (46%), Gaps = 11/141 (7%)
Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDS-DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
+ +GQGA G VF + I K +K+ II N + MK ++
Sbjct: 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII--NEILVMK-------ELK 74
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
+P IV SF +L+++++++ GG L + + E Q E + A+ LH
Sbjct: 75 NPNIVNFLDSFLVGDELFVVMEYLAGGSLT-DVVTETCMDEAQIAAVCRECLQALEFLHA 133
Query: 234 CGIVHRDLKPENILMDSDGHV 254
++HRD+K +N+L+ DG V
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSV 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 26/162 (16%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM--KAERD 167
D+EI +G+G FG+V++ ++ + + A+K I+ N D A R+
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQI-----KTGRVVALK-----KILMHNEKDGFPITALRE 57
Query: 168 I--LTKVTHPFIVQL------RYSFQTRSK--LYLILDFINGGH-LFFHLYRQGI-FRED 215
I L K+ HP +V L R R + +Y++ +++ H L L + E
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPSVKLTES 115
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
Q + Y +++ +++LH+ I+HRD+K NIL+D+ G + A
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIA 157
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 34/142 (23%), Positives = 70/142 (49%), Gaps = 10/142 (7%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
+G+G +G VF+ K + ++ I A+K +R D + A R+I L ++ H
Sbjct: 8 IGEGTYGTVFKAKNR-----ETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHK 59
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
IV+L + KL L+ ++ + + G + + + +++ ++ H
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 236 IVHRDLKPENILMDSDGHVMAA 257
++HRDLKP+N+L++ +G + A
Sbjct: 120 VLHRDLKPQNLLINKNGELKLA 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 24/161 (14%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDI 168
++I R++G+G G+V+ D S + A+K +R+D +++ E I
Sbjct: 2 QRYDIIRLIGKGGMGEVYL----AYDPVCSRRV-ALKKIREDLSENPLLKKRFLR-EAKI 55
Query: 169 LTKVTHPFIVQLRYSFQTRSKL-YLILDFING---GHLFFHLYRQGIFREDQAR------ 218
+ HP IV + YS + Y + +I G L ++++ ++ A
Sbjct: 56 AADLIHPGIVPV-YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 219 ----FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
F+ I + + ++H G++HRDLKP+NIL+ G V+
Sbjct: 115 FLSIFHK--ICATIEYVHSKGVLHRDLKPDNILLGLFGEVV 153
|
Length = 932 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 39/143 (27%), Positives = 70/143 (48%), Gaps = 18/143 (12%)
Query: 118 VGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
+G G +G+V++ V KK A+K +++DT+ V+ E ++ ++ HP
Sbjct: 14 LGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPN 63
Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ---ARFYTA-EIVSAVSHLH 232
+VQL Y+I +F+ G+L +L R++ Y A +I SA+ +L
Sbjct: 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE 121
Query: 233 KCGIVHRDLKPENILMDSDGHVM 255
K +HRDL N L+ + H++
Sbjct: 122 KKNFIHRDLAARNCLV-GENHLV 143
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 33/113 (29%), Positives = 62/113 (54%), Gaps = 6/113 (5%)
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
I A+KV+ D ++ + +E +IL K P+I+ +F +++ + +F++GG
Sbjct: 28 ILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
L +YR+ I R A +V +++L I+HRD+KP N+L+++ G V
Sbjct: 86 L--DVYRK-IPEHVLGRIAVA-VVKGLTYLWSLKILHRDVKPSNMLVNTRGQV 134
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 33/144 (22%), Positives = 67/144 (46%), Gaps = 15/144 (10%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ ++ + +G+G FG V +G A+K ++ D + AE ++T
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQA-----FLAEASVMT 54
Query: 171 KVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSA 227
++ H +VQL + + LY++ +++ G L +L +G + D ++ ++ A
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 228 VSHLHKCGIVHRDLKPENILMDSD 251
+ +L VHRDL N+L+ D
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSED 138
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 23/154 (14%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI---YAMKVMRKDTIIKKNHVDYMKAERD 167
+F+ +V+G GAFG V+ KG+ + + + A+K +R+ T K N + E
Sbjct: 8 EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAY 61
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
++ V +P + +L S + LI + G L ++ RE + +
Sbjct: 62 VMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYV------REHKDNIGSQYLLNW 114
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I +++L + +VHRDL N+L+ + HV
Sbjct: 115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHV 148
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 37/152 (24%), Positives = 64/152 (42%), Gaps = 20/152 (13%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRK--DTIIKKNHVDYMKAE 165
P ++ VG GA+G+V G A+K + + + I H E
Sbjct: 14 PDRYQNLSPVGSGAYGQVCSAFDTKT------GRKVAIKKLSRPFQSAI---HAKRTYRE 64
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLYRQGIFREDQARF 219
+L + H ++ L F S L YL+ + G ++ + +D +F
Sbjct: 65 LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQF 122
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+I+ + ++H GI+HRDLKP NI ++ D
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 154
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 37/153 (24%), Positives = 76/153 (49%), Gaps = 19/153 (12%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++E+ + +G G FG+VF VK K + + K + +K+ + E +++
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQE-----FFCWKAISYRG-LKEREKSQLVIEVNVMR 67
Query: 171 KVTHPFIVQL--RYSFQTRSKLYLILDFINGGHLFFHL---YRQ-GIFREDQARFYTAEI 224
++ H IV+ R+ + KLY++++F + G L ++ Y+ G E T ++
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 225 VSAVSHLHKCG-------IVHRDLKPENILMDS 250
+ A+++ H ++HRDLKP+NI + +
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160
|
Length = 1021 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 5e-06
Identities = 36/151 (23%), Positives = 75/151 (49%), Gaps = 22/151 (14%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++E + +G +G V++ + K + I A+K ++ + + + ++ E +IL
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEKEGFPITSLR-EINILL 59
Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI---- 224
K+ HP IV ++ K+Y++++++ H + + Q F +E+
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEYVE------HDLKSLMETMKQ-PFLQSEVKCLM 112
Query: 225 ---VSAVSHLHKCGIVHRDLKPENILMDSDG 252
+S V+HLH I+HRDLK N+L+++ G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRG 143
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 6e-06
Identities = 31/104 (29%), Positives = 58/104 (55%), Gaps = 6/104 (5%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
E DIL ++H I+ L ++++ +S + +++ LF ++ R G +QA +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRL 194
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVM-----AAHSLNSH 263
+ A+++LH GI+HRD+K ENI +D + + AA L++H
Sbjct: 195 LEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
|
Length = 392 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 36/151 (23%), Positives = 64/151 (42%), Gaps = 17/151 (11%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA-----------ER 166
+G+G +GKV + D + I A+K ++ I D E
Sbjct: 17 LGEGTYGKVEKAY-----DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVS 226
I+ ++ H I+ L + + L++D + L + R+ E Q + +I++
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILN 130
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
++ LHK +HRDL P NI ++S G A
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIA 161
|
Length = 335 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 33/138 (23%), Positives = 64/138 (46%), Gaps = 15/138 (10%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
++G+G FG V Q + G A+K ++ D + E ++TK+ H
Sbjct: 13 IIGEGEFGAVLQGEYTGQK-------VAVKNIKCDVTAQA-----FLEETAVMTKLHHKN 60
Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKC 234
+V+L + LY++++ ++ G+L L +G + ++ ++ + +L
Sbjct: 61 LVRL-LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 235 GIVHRDLKPENILMDSDG 252
+VHRDL NIL+ DG
Sbjct: 120 KLVHRDLAARNILVSEDG 137
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 8e-06
Identities = 36/141 (25%), Positives = 70/141 (49%), Gaps = 25/141 (17%)
Query: 118 VGQGAFG----KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT 173
+G G FG V++++KK +D A+KV++ + +K+ D M E +I+ ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID-------VAIKVLKNEN--EKSVRDEMMREAEIMHQLD 53
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIFREDQARFYTAEIVSAVS-- 229
+P+IV++ + + L L+++ +GG + F + I + E++ VS
Sbjct: 54 NPYIVRMIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSN-----VVELMHQVSMG 107
Query: 230 --HLHKCGIVHRDLKPENILM 248
+L VHRDL N+L+
Sbjct: 108 MKYLEGKNFVHRDLAARNVLL 128
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 41/143 (28%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
R +G+G FGKV + +GD+ G A+K ++ ++ NH+ +K E +IL + H
Sbjct: 10 RDLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYH 65
Query: 175 PFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHL 231
IV+ + + + + LI++F+ G L +L R + Q Y +I + +L
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
VHRDL N+L++S+ V
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQV 148
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 36/147 (24%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 107 IGPGDFEIFRVVGQGAFGKVF----QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
I P + + + +G G FG V+ K+K A+K +R+ + +++
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRK----------VAIKTIREGAMSEED----F 46
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYT 221
E ++ K++HP +VQL RS + L+ +F+ G L +L Q G F ++
Sbjct: 47 IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILM 248
++ +++L ++HRDL N L+
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLV 133
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 15/93 (16%)
Query: 168 ILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE-DQAR-- 218
++ V H I+ L + S + +YL+++ ++ Q I + D R
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD------ANLCQVIQMDLDHERMS 121
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+ +++ + HLH GI+HRDLKP NI++ SD
Sbjct: 122 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 154
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-05
Identities = 34/148 (22%), Positives = 74/148 (50%), Gaps = 25/148 (16%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD--------TIIKKNHVDYMK 163
+E +G+G +G V++ + + ++ A+K +R + T I+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTAIR-------- 50
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ--ARFYT 221
E +L ++ H IV+L+ + +LYL+ ++++ L H+ F ++ + Y
Sbjct: 51 -EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYL 108
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMD 249
+I+ +++ H ++HRDLKP+N+L+D
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLID 136
|
Length = 294 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 34/148 (22%), Positives = 70/148 (47%), Gaps = 27/148 (18%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
R +G G FG+V+ G +G + A+K ++ T+ + +++ E I+ K+ H
Sbjct: 12 RKLGAGQFGEVW----MGTWNGTTK--VAVKTLKPGTMSPE---AFLQ-EAQIMKKLRHD 61
Query: 176 FIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARF--------YTAEIVS 226
+VQL Y+ + + +Y++ ++++ G L L + + + A+I
Sbjct: 62 KLVQL-YAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAE 114
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++L +HRDL NIL+ + V
Sbjct: 115 GMAYLESRNYIHRDLAARNILV-GENLV 141
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 33/156 (21%), Positives = 70/156 (44%), Gaps = 29/156 (18%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDY- 161
+GP ++ +G+GA+G V +KV IKK H +
Sbjct: 3 VGP-RYQNLSYIGEGAYGMVCSAT---------HKPTGVKVA-----IKKISPFEHQTFC 47
Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
+ R+I L + H I+ + SF++ + +Y++ + + + L +
Sbjct: 48 QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD--LYKLIKTQHLSN 105
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
D +++ +I+ + ++H ++HRDLKP N+L+++
Sbjct: 106 DHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 33/150 (22%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDI 168
F R +G G+FG V+ + D ++ + A+K M K + K D +K E
Sbjct: 17 FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQ--DIIK-EVRF 68
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
L ++ HP ++ + + +L++++ + ++++ + +E + +
Sbjct: 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPL-QEVEIAAICHGALQG 127
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+++LH +HRD+K NIL+ G V A
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTVKLA 157
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 35/149 (23%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D E+ +G+GA+G V +++ + I A+K +R ++ M + DI
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNSQEQKRLLM--DLDISM 54
Query: 171 KVTH-PFIVQLRYSFQTRSKLYLILDFINGG--HLFFHLYRQGIF-REDQARFYTAEIVS 226
+ P+ V + +++ ++ ++ + +Y +G+ ED IV
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114
Query: 227 AVSHLH-KCGIVHRDLKPENILMDSDGHV 254
A+ +LH K ++HRD+KP N+L++ +G V
Sbjct: 115 ALEYLHSKLSVIHRDVKPSNVLINRNGQV 143
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 31/137 (22%), Positives = 63/137 (45%), Gaps = 12/137 (8%)
Query: 147 VMRKDTIIKKNHVDYMKAERDILT--KVTHPFIVQLRYSFQTRSKLYLILDFINGGH--- 201
++K + + D +++I+T ++ HP I+ SF S+LY++ + G
Sbjct: 29 AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM-----A 256
L + +G E F ++++A+ ++H G +HR +K +IL+ DG V+
Sbjct: 89 LLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147
Query: 257 AHSLNSHNQ-LCCFFFF 272
+ S+ H + F
Sbjct: 148 SVSMIKHGKRQRVVHDF 164
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 32/143 (22%), Positives = 64/143 (44%), Gaps = 14/143 (9%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ + + + G+ G+VF K G D + +K+ +K T + E +L
Sbjct: 68 YTVIKTLTPGSEGRVFVATK----PGQPDPV-VLKIGQKGTTL---------IEAMLLQN 113
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
V HP +++++ + + + ++L + + R DQA +I+ + +L
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H I+HRD+K ENI ++ V
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQV 196
|
Length = 357 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
+G+G FG V + + D+ G + A+K ++ T H+ + E +IL + H
Sbjct: 12 LGKGNFGSVELCRYDPL--QDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDN 66
Query: 177 IVQLR---YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHL 231
IV+ + YS R L L+++++ G L +L + R D + Y ++I + +L
Sbjct: 67 IVKYKGVCYS-AGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL 124
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
VHRDL NIL++S+ V
Sbjct: 125 GSKRYVHRDLATRNILVESENRV 147
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 41/177 (23%), Positives = 70/177 (39%), Gaps = 24/177 (13%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+ E R +GQGAFG+VFQ + G+ + + A+K M K+ D+ + E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALM 62
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYT- 221
+ HP IV+L + L+ +++ G L L AR
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 222 --------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264
++ + +++L + VHRDL N L+ + V A S N
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 37/157 (23%), Positives = 72/157 (45%), Gaps = 26/157 (16%)
Query: 111 DFEIFRVVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
D + V+G+G FG+V + +KK D + A M K+ + +H D+ E ++
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKK------DGLKMNAAIKMLKEFASENDHRDF-AGELEV 55
Query: 169 LTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED------------ 215
L K+ HP I+ L + + R LY+ +++ G+L L + + D
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 216 ----QARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
Q + +++ + + +L + +HRDL N+L+
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 3e-05
Identities = 54/264 (20%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 18 KKLTITPPSASSPDFDFTEV-----FGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFV 72
+K++I P + P + G L R N AS + F
Sbjct: 64 EKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHLDFD 123
Query: 73 GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVG---QGAFGKVF-- 127
P A +PL +L+H+++ FRV+ GAFGK+F
Sbjct: 124 EAPPDAA--GPVPLAQAKLKHDDEF--------------LAHFRVIDDLPAGAFGKIFIC 167
Query: 128 --------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
++GV+ + +++ K ++ E L ++ H I++
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227
Query: 180 LRYSFQTRSKLYLI---LDFINGGHLFFHLYRQGIFRED-----QARFYTAEIVSAVSHL 231
+ ++ + Y+I DF L+ +Y + +D Q R +++ AV ++
Sbjct: 228 IEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYI 283
Query: 232 HKCGIVHRDLKPENILMDSDGHVM 255
H ++HRD+K ENI ++ DG ++
Sbjct: 284 HDKKLIHRDIKLENIFLNCDGKIV 307
|
Length = 501 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 14/27 (51%), Positives = 20/27 (74%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMD 249
+I+ A+ LH GIVHRD+KP+NI+
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFS 289
|
Length = 566 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 9/142 (6%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI-YAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
+V+G GAFG V+ K V +G++ I A+K++ + T K N V++M E I+ + H
Sbjct: 13 KVLGSGAFGTVY--KGIWVPEGETVKIPVAIKILNETTGPKAN-VEFMD-EALIMASMDH 68
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
P +V+L + L+ + G L + H ++ I + + +I + +L
Sbjct: 69 PHLVRL-LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMYLE 126
Query: 233 KCGIVHRDLKPENILMDSDGHV 254
+ +VHRDL N+L+ S HV
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHV 148
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 41/159 (25%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F + R++G+G FG V + + K +DG + A+K+++ D + ++++ E + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLK-SEDGSFQKV-AVKMLKADIFSSSDIEEFLR-EAACMKE 57
Query: 172 VTHPFIVQL-RYSFQTRSKLYL-----ILDFINGG--HLFFHLYRQG-----IFREDQAR 218
HP +++L S ++R+K L IL F+ G H F + R G + + R
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
F +I S + +L +HRDL N +++ + V A
Sbjct: 118 FMI-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 40/152 (26%), Positives = 69/152 (45%), Gaps = 28/152 (18%)
Query: 117 VVGQGAFGKVFQ--VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
V+G+G FG+V + +KK G+ + A K+ K +H D+ E ++L K+ H
Sbjct: 2 VIGEGNFGQVLKARIKKDGLR------MDAAIKRMKEYASKDDHRDF-AGELEVLCKLGH 54
Query: 175 -PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA---------------- 217
P I+ L + + R LYL +++ G+L L + + D A
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 218 -RFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
F A++ + +L + +HRDL NIL+
Sbjct: 115 LHF-AADVARGMDYLSQKQFIHRDLAARNILV 145
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 39/162 (24%), Positives = 69/162 (42%), Gaps = 38/162 (23%)
Query: 115 FRVVGQGAFGKVFQ-----------VKKKGVDDGDS--DGIYAMKVMRK---DTIIKKNH 158
R +G G+ G VF VKK + D S + +K++R+ D I+K
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 159 VDYMKAERD-----ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR 213
V LT++ +IVQ Y+ D N + QG
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQE----------YMETDLAN-------VLEQGPLS 112
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
E+ AR + +++ + ++H ++HRDLKP N+ ++++ V+
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 39/155 (25%), Positives = 62/155 (40%), Gaps = 26/155 (16%)
Query: 106 KIGPGDFEIFRVVGQGAF----GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
K+G G F VV +G + GKV V A+K ++ D + D+
Sbjct: 2 KLGDGSF---GVVRRGEWSTSGGKVIPV--------------AVKCLKSDKL-SDIMDDF 43
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARF 219
+K E I+ + H +++L Y L ++ + G L G F
Sbjct: 44 LK-EAAIMHSLDHENLIRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
Y +I + + +L +HRDL NIL+ SD V
Sbjct: 102 YAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 27/105 (25%), Positives = 51/105 (48%), Gaps = 13/105 (12%)
Query: 156 KNHVDYMKAERDI--LTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHL-FFHL 206
+N +A R++ L V H I+ L + S + +YL+++ ++ H+
Sbjct: 59 QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM 118
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
++ + +++ + HLH GI+HRDLKP NI++ SD
Sbjct: 119 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 159
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 7e-05
Identities = 39/147 (26%), Positives = 72/147 (48%), Gaps = 19/147 (12%)
Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
+I V+G G FG+V + + K G + A+K + K +K D++ +E I+ +
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLP--GKREIFVAIKTL-KSGYTEKQRRDFL-SEASIMGQF 62
Query: 173 THPFIVQLRYSFQTRSKLYLIL-DFINGGHLFFHLYRQGIFREDQARFYTAEIV------ 225
HP I+ L T+S+ +I+ +F+ G L R++ +F ++V
Sbjct: 63 DHPNIIHLE-GVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGI 115
Query: 226 -SAVSHLHKCGIVHRDLKPENILMDSD 251
+ + +L + VHRDL NIL++S+
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVNSN 142
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-05
Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 5/147 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
+I P +V+G G FG+VF+ K G + A+K + K +K D++ +E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILK--MPGRKEVAVAIKTL-KPGYTEKQRQDFL-SE 56
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEI 224
I+ + +H I++L +I +++ G L +L G F Q I
Sbjct: 57 ASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSD 251
+ + +L VHRDL NIL++S+
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSN 143
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 7e-05
Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 35/168 (20%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIKKNHVDYMK--AERDILTK 171
+ +G+G FGKV VK G A+K+++++ + + +E ++L +
Sbjct: 6 KTLGEGEFGKV--VKATAFRLKGRAGYTTVAVKMLKENA----SSSELRDLLSEFNLLKQ 59
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQ--------GIFREDQARF-- 219
V HP +++L + L LI+++ G L F R+ R
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 220 ------------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +I + +L + +VHRDL N+L+ ++G M
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKM 166
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 8e-05
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 17/119 (14%)
Query: 147 VMRKDTIIKK------NHVDYMKAERD-ILTK-VTHPFIVQLRYSFQTRSKL------YL 192
V+ ++ IKK N +A R+ +L K V H I+ L F + L YL
Sbjct: 40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL 99
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+++ ++ Q ++ + +++ + HLH GI+HRDLKP NI++ SD
Sbjct: 100 VMELMDAN---LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 16/32 (50%), Positives = 25/32 (78%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++++ + LH+ GIVHRD+KPEN+L+ DG V
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
|
Length = 507 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 28/147 (19%), Positives = 65/147 (44%), Gaps = 12/147 (8%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
++ +G FG++F G + ++ V + I+ V + E +L ++H
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ---VTLLLQESCLLYGLSHQN 69
Query: 177 IVQ-LRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA--------EIVSA 227
I+ L + +++ ++N G+L L + + + + + +I
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
+S+LHK G++H+D+ N ++D + V
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQV 156
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 9e-05
Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 15/134 (11%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+GQG FG+V+ G +G + A+K ++ T++ + + E I+ K+ H +
Sbjct: 14 LGQGCFGEVWM----GTWNGTTK--VAIKTLKPGTMMPEAFLQ----EAQIMKKLRHDKL 63
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKC 234
V L Y+ + +Y++ +F+ G L L ++G + Q A+I ++++ +
Sbjct: 64 VPL-YAVVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 235 GIVHRDLKPENILM 248
+HRDL+ NIL+
Sbjct: 122 NYIHRDLRAANILV 135
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 39/145 (26%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE +G G G V +V + S I A K++ + IK + + E +L
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLE--IKPAIRNQIIRELKVLH 54
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ P+IV +F + ++ + ++ ++GG L L + G E+ + ++ +++
Sbjct: 55 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114
Query: 231 LH-KCGIVHRDLKPENILMDSDGHV 254
L K I+HRD+KP NIL++S G +
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEI 139
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 32/150 (21%), Positives = 65/150 (43%), Gaps = 25/150 (16%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+F + R +G G FG+V++ K A+K+++ D D+ K E L
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSDD--LLKQQDFQK-EVQALK 57
Query: 171 KVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT-------- 221
++ H ++ L ++ + + +Y+I + + G L L R + +
Sbjct: 58 RLRHKHLISL-FAVCSVGEPVYIITELMEKGSLLAFL------RSPEGQVLPVASLIDMA 110
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
++ +++L + +HRDL NIL+ D
Sbjct: 111 CQVAEGMAYLEEQNSIHRDLAARNILVGED 140
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 37/153 (24%), Positives = 67/153 (43%), Gaps = 22/153 (14%)
Query: 109 PGDFEIFRVVGQGAFGKV---------FQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
P ++ VG GA+G V +V K + I+A + R+ ++K
Sbjct: 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK---- 71
Query: 160 DYMKAERDI-LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
+MK E I L V P S + + +YL+ + G ++ + +D +
Sbjct: 72 -HMKHENVIGLLDVFTP-----ARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ 123
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
F +I+ + ++H I+HRDLKP N+ ++ D
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 156
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 31/140 (22%), Positives = 59/140 (42%), Gaps = 11/140 (7%)
Query: 118 VGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
+G G FG V KGV G + A+K ++++ I E ++ ++ H
Sbjct: 3 LGHGNFGSV----VKGVYLMKSGKEVEV-AVKTLKQEHI--AAGKKEFLREASVMAQLDH 55
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
P IV+L + L L+++ G L +L ++ + ++ +++L
Sbjct: 56 PCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 235 GIVHRDLKPENILMDSDGHV 254
VHRDL N+L+ +
Sbjct: 115 HFVHRDLAARNVLLVNRHQA 134
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 33/143 (23%), Positives = 60/143 (41%), Gaps = 5/143 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F R +G G+FG V+ + D + + A+K M + E L K
Sbjct: 17 FSDLREIGHGSFGAVYFAR-----DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP +Q R + +L++++ G + +E + T + +++L
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H ++HRD+K NIL+ G V
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLV 154
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 34/139 (24%), Positives = 69/139 (49%), Gaps = 16/139 (11%)
Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
++ R +G G FG+V++ G+ + + A+K ++ T+ K+ + AE I+ K+
Sbjct: 9 QLLRKLGAGQFGEVWE----GLWNNTTP--VAVKTLKPGTMDPKDFL----AEAQIMKKL 58
Query: 173 THPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAV 228
HP ++QL Y+ T + +Y++ + + G L +L + A++ S +
Sbjct: 59 RHPKLIQL-YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM-AAQVASGM 116
Query: 229 SHLHKCGIVHRDLKPENIL 247
++L +HRDL N+L
Sbjct: 117 AYLEAQNYIHRDLAARNVL 135
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 1e-04
Identities = 22/93 (23%), Positives = 45/93 (48%)
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
E +L + H IV L T+ L + ++++ + + G R + ++
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL 112
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ ++++H I+HRDLKP+N+L+ G + A
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLISYLGELKLA 145
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 33/150 (22%), Positives = 60/150 (40%), Gaps = 35/150 (23%)
Query: 118 VGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
VG GA+G V +V K + I+A + R+ T++K + + D+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYRQGIFREDQARFYT 221
T S YL++ + I G ED+ ++
Sbjct: 83 FTSAV---------SGDEFQDFYLVMPYMQTDLQKIMGHP----------LSEDKVQYLV 123
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+++ + ++H GI+HRDLKP N+ ++ D
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 59/261 (22%), Positives = 106/261 (40%), Gaps = 33/261 (12%)
Query: 2 VSTSQKNLHSLLTTKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDP 61
S K +S T + + S D + +++ A+T + P
Sbjct: 28 SGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTP 87
Query: 62 QVIHNRSHSFVGPSP-RYALSSSLPLQIQELEHEN---DAELEAESERKIGPGDFEIFRV 117
++ V P P + ++ +LP Q +E H +++ ++R F+I +
Sbjct: 88 T-----TNVEVAPPPKKKKVTYALPNQSREEGHFYVVLGEDIDVSTQR------FKILSL 136
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR---KDTIIKKNHVDYMKAERDILTKVTH 174
+G+G FGKV + D A+K++R K T K + +M+ R
Sbjct: 137 LGEGTFGKVVEAW-----DRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRF 191
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV----SAVSH 230
P + RY FQ + I+ G L + + G F + A+I+ A+ +
Sbjct: 192 PLMKIQRY-FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHR----HLAQIIFQTGVALDY 246
Query: 231 LH-KCGIVHRDLKPENILMDS 250
H + ++H DLKPENILM++
Sbjct: 247 FHTELHLMHTDLKPENILMET 267
|
Length = 467 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 42/148 (28%), Positives = 64/148 (43%), Gaps = 27/148 (18%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
+VG+ F V +G D + + A VM D + Y ++E L H
Sbjct: 74 LVGRNPTTAAF-VATRGSDP--KEKVVAKFVMLND----ERQAAYARSELHCLAACDHFG 126
Query: 177 IVQLRYSFQTRSKLYLILDFINGG------------HLFFHLYRQGIFREDQARFYTAEI 224
IV+ F++ KL LI+++ +GG HL F Y G+ FY +I
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL------FY--QI 178
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDG 252
V A+ +H ++HRDLK NI + G
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTG 206
|
Length = 478 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 15/29 (51%), Positives = 22/29 (75%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+++ + HLH GI+HRDLKP NI++ SD
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSD 162
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 30/137 (21%), Positives = 67/137 (48%), Gaps = 13/137 (9%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+ +G G FG+V+ + A+K M+ ++ V+ AE +++ + H
Sbjct: 12 KKLGAGQFGEVWMATY------NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHD 61
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHK 233
+V+L ++ T+ +Y+I +F+ G L L ++ + ++A+I ++ + +
Sbjct: 62 KLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 234 CGIVHRDLKPENILMDS 250
+HRDL+ NIL+ +
Sbjct: 121 RNYIHRDLRAANILVSA 137
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 31/146 (21%), Positives = 62/146 (42%), Gaps = 5/146 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F R +G G+FG V+ + D ++ + A+K M + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFAR-----DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP ++ + + +L++++ G + +E + T + +++L
Sbjct: 82 IKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 232 HKCGIVHRDLKPENILMDSDGHVMAA 257
H ++HRD+K NIL+ G V A
Sbjct: 142 HSHNMIHRDIKAGNILLTEPGQVKLA 167
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 15/39 (38%), Positives = 27/39 (69%), Gaps = 1/39 (2%)
Query: 214 EDQ-ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
E Q +++ +I+ + ++H G+VHRDLKP NIL++ +
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 35/157 (22%), Positives = 70/157 (44%), Gaps = 30/157 (19%)
Query: 109 PGDFEIFRVVGQGAFGKVF---------QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
P ++ VG GA+G V +V K + I+A + R+ ++K
Sbjct: 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK---- 69
Query: 160 DYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE 214
+MK E D+ T T S + +++YL+ + + G ++ + +
Sbjct: 70 -HMKHENVIGLLDVFTPAT---------SIENFNEVYLVTNLM--GADLNNIVKCQKLSD 117
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+ +F +++ + ++H GI+HRDLKP N+ ++ D
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 154
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 32/133 (24%), Positives = 65/133 (48%), Gaps = 9/133 (6%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176
++G+G FG+VF K + D A+K ++D + ++ + ++ R IL + HP
Sbjct: 2 LLGKGNFGEVF---KGTLKDKTP---VAVKTCKED-LPQELKIKFLSEAR-ILKQYDHPN 53
Query: 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCG 235
IV+L R +Y++++ + GG L + + + Q + + + +++L
Sbjct: 54 IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 236 IVHRDLKPENILM 248
+HRDL N L+
Sbjct: 114 CIHRDLAARNCLV 126
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 31/144 (21%), Positives = 60/144 (41%), Gaps = 17/144 (11%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA----ERDILTK 171
+G+G FG V++ KG + A+K R +K E +IL +
Sbjct: 1 EKIGKGNFGDVYKGVLKG------NTEVAVKTCRSTL------PPDLKRKFLQEAEILKQ 48
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSH 230
HP IV+L + +Y++++ + GG L L ++ + + + + + +
Sbjct: 49 YDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY 108
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
L +HRDL N L+ + +
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVL 132
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 3e-04
Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE +G G G V +V+ K S I A K++ + IK + + E +L
Sbjct: 6 DFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLE--IKPAIRNQIIRELQVLH 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ P+IV +F + ++ + ++ ++GG L L E+ + ++ +++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 118
Query: 231 L-HKCGIVHRDLKPENILMDSDGHV 254
L K I+HRD+KP NIL++S G +
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEI 143
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 14/37 (37%), Positives = 26/37 (70%)
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
D + + +I+ + +LH GI+HRD+KP N+L++S+
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 4e-04
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGI-YAMKVMRKDTIIKKNH--V 159
R + + +++G G FG V KG+ +GDS I A+K ++ + +
Sbjct: 2 RILKETELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEIT 57
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQAR 218
D+M A + + H +IV+L + L L+ G L H+ + +
Sbjct: 58 DHMLA----MGSLDHAYIVRL-LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ +I + +L + +VHR+L NIL+ SD V A
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIA 151
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 2/62 (3%)
Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
YL++ F+ G L + ED+ +F +++ + ++H GI+HRDLKP N+ ++
Sbjct: 95 FYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN 152
Query: 250 SD 251
D
Sbjct: 153 ED 154
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 5e-04
Identities = 25/63 (39%), Positives = 31/63 (49%), Gaps = 8/63 (12%)
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDS 250
L+ + G L HL R D A F +A A+ LH+ GI H DL KP+N LM
Sbjct: 95 LVRGWTEGVPL--HLARP---HGDPAWFRSAH--RALRDLHRAGITHNDLAKPQNWLMGP 147
Query: 251 DGH 253
DG
Sbjct: 148 DGE 150
|
Length = 365 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 23/153 (15%)
Query: 118 VGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
+G+G FG+V + +G+ + + A+K++R D + K D++K E I
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLK-EIKI 70
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRE------------DQ 216
++++ +P I++L + L +I +++ G L L ++ I
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
+ +I S + +L VHRDL N L+
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 6e-04
Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 32/157 (20%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+E+ + +GQGA+G V + + ++ I +K T + IL K
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAI------KKITNVFSK---------KILAK 46
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDF-------INGGHLFFHLYR---QGIFREDQA---- 217
+ LR+ F+ + + D N +L+ L I R Q
Sbjct: 47 RALRELKLLRH-FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105
Query: 218 --RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+ + +I+ + ++H ++HRDLKP N+L+++D
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC 142
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 6e-04
Identities = 15/53 (28%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHV 254
+ + + + E+ V A+++L + I+HRD+KP NIL+D +G++
Sbjct: 95 YVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNI 147
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 32/147 (21%), Positives = 67/147 (45%), Gaps = 21/147 (14%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
+G+G + VF+ + K ++ + A+K +R + T I+ E +L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ H IV L T L L+ ++++ + I + + +I+ +++
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMAA 257
H+ ++HRDLKP+N+L++ G + A
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLA 146
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 18/35 (51%), Positives = 22/35 (62%)
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ + + LH IVHRDLKPENIL+ S G V A
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLA 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 38/154 (24%), Positives = 68/154 (44%), Gaps = 26/154 (16%)
Query: 118 VGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+G+G FG+V + +G++ G+ + A+K++R+D K D++K E
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLK-EI 70
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA--------- 217
I++++ P I++L T L +I +++ G L L R +E
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE-PQEAAEKADVVTISY 129
Query: 218 ---RFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
F +I S + +L VHRDL N L+
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 15/38 (39%), Positives = 25/38 (65%)
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
E FYT +I+ + +LH IVHRD+K +N+L+++
Sbjct: 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 33/147 (22%), Positives = 67/147 (45%), Gaps = 21/147 (14%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
+G+G + VF+ + K ++ + A+K +R + T I+ E +L
Sbjct: 13 LGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 58
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ H IV L T L L+ ++++ + + + + +++ +S+
Sbjct: 59 NLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 231 LHKCGIVHRDLKPENILMDSDGHVMAA 257
HK I+HRDLKP+N+L++ G + A
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLA 145
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 34/145 (23%), Positives = 64/145 (44%), Gaps = 12/145 (8%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV 172
+ +G GAFGKV + G+ D+ MKV M K T + + + +E I++ +
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDA----VMKVAVKMLKPT-AHSSEREALMSELKIMSHL 95
Query: 173 -THPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAVS 229
H IV L + + +I ++ G L F R+ + ++ ++ ++
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
L +HRDL N+L+ + G +
Sbjct: 156 FLASKNCIHRDLAARNVLL-THGKI 179
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 39/154 (25%), Positives = 65/154 (42%), Gaps = 19/154 (12%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D + R +G+GAFGKVF + + + A+K ++ T+ + D+ + E ++LT
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQR-EAELLT 62
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE--- 223
+ H IV+ L ++ +++ G L L G I + Q R E
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 224 ---------IVSAVSHLHKCGIVHRDLKPENILM 248
I S + +L VHRDL N L+
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 9/115 (7%)
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFRED 215
V +++ E + HP IV R +F ++L+++ F+ G L + G+ E
Sbjct: 43 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM-SEL 101
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA-----HSLNSHNQ 265
+ ++ A+ ++H G VHR +K +IL+ DG V + S+ +H Q
Sbjct: 102 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 31/138 (22%), Positives = 61/138 (44%), Gaps = 20/138 (14%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177
+G+G FG+VF + + + A+K R +T+ +++ R IL + +HP I
Sbjct: 3 IGRGNFGEVFSGRLRA-----DNTPVAVKSCR-ETLPPDLKAKFLQEAR-ILKQYSHPNI 55
Query: 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV-------SAVSH 230
V+L + +Y++++ + GG R + R E++ + + +
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDF------LTFLRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 231 LHKCGIVHRDLKPENILM 248
L +HRDL N L+
Sbjct: 110 LESKHCIHRDLAARNCLV 127
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 20/156 (12%)
Query: 118 VGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THP 175
+G+G FG+V + G+D D + + M KD +K+ D + +E +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGKHK 81
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHL---------YRQGIFR--EDQARFY---- 220
I+ L + LY+I+++ + G+L +L Y I R ++Q F
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 221 -TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
T ++ + +L +HRDL N+L+ ++ +VM
Sbjct: 142 CTYQVARGMEYLASQKCIHRDLAARNVLV-TENNVM 176
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.002
Identities = 10/38 (26%), Positives = 27/38 (71%)
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+D +++ +++ + ++H ++HRDLKP N+L++++
Sbjct: 107 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN 144
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 33/138 (23%), Positives = 74/138 (53%), Gaps = 13/138 (9%)
Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
++ + +G G FG+V+ G +G + A+K +++ ++ + AE +++ ++
Sbjct: 9 KLVKKLGAGQFGEVWM----GYYNGHTK--VAIKSLKQGSM----SPEAFLAEANLMKQL 58
Query: 173 THPFIVQLRYSFQTRSKLYLILDFI-NGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSH 230
HP +V+L Y+ T+ +Y+I +++ NG + F +GI ++ A+I ++
Sbjct: 59 QHPRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 231 LHKCGIVHRDLKPENILM 248
+ + +HRDL+ NIL+
Sbjct: 118 IERKNYIHRDLRAANILV 135
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 13/37 (35%), Positives = 26/37 (70%)
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+ +F+ +++ A+ ++H + HRDLKP+NIL ++D
Sbjct: 103 EHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD 139
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 33/148 (22%), Positives = 69/148 (46%), Gaps = 23/148 (15%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMKAERDILT 170
+G+G + V++ + K D+ + A+K +R + T I+ E +L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIR---------EVSLLK 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
+ H IV L T L L+ ++++ L +L G + + +++ ++
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ H+ ++HRDLKP+N+L++ G + A
Sbjct: 119 YCHRRKVLHRDLKPQNLLINERGELKLA 146
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 34/143 (23%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQ-VKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
D + R +G+G FG V+Q V ++ + + K ++ +K E I+
Sbjct: 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-----FLQEAYIM 61
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF--YTAEIVSA 227
+ HP IV+L T + ++++++ G L +L + + D A Y+ ++ +A
Sbjct: 62 RQFDHPHIVKL-IGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTA 119
Query: 228 VSHLHKCGIVHRDLKPENILMDS 250
+++L VHRD+ N+L+ S
Sbjct: 120 LAYLESKRFVHRDIAARNVLVSS 142
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 282 | |||
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.98 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.96 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.95 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.94 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.91 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.88 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.86 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.85 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.8 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.78 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.63 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.62 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.62 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.6 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.55 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.5 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.37 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.23 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.2 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.09 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.85 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.69 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.69 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.65 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.62 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.58 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.52 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.4 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.37 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.11 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.04 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.02 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.01 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.95 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.85 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.84 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.82 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.69 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.44 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.39 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.32 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.31 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.29 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.26 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.01 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.85 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 96.71 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 96.68 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.65 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.61 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.6 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.59 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.41 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.12 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.05 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.84 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.78 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.69 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.3 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.29 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.86 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.76 |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=306.10 Aligned_cols=170 Identities=54% Similarity=0.887 Sum_probs=160.2
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
...+++|+++++||+|+||+||+++.+ .++++||+|++++.........+....|..||..++||.||.++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~-----dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKK-----DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEc-----ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 345679999999999999999999987 578899999999998888878888999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+...+|+|+||+.||.|+.++.+++.|++..++.++.+|+.||.|||++|||||||||+|||||.+|+++|+|||+|+..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999865
Q ss_pred ccc-------hhheeeccCccc
Q 023430 266 LCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~-------~~~~~~~ape~~ 280 (282)
..+ .||+.|||||++
T Consensus 176 ~~~~~~t~tfcGT~eYmAPEil 197 (357)
T KOG0598|consen 176 LKDGDATRTFCGTPEYMAPEIL 197 (357)
T ss_pred ccCCCccccccCCccccChHHH
Confidence 555 789999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=305.17 Aligned_cols=167 Identities=31% Similarity=0.470 Sum_probs=150.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||+||+|+++ ..+..||||.+.+... .+..++.+..|+.+|+.++|||||+++++....+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~-----~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK-----KSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEec-----cCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 468999999999999999999998 4567899999987754 3455667889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC------CcEEEEecCcc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------GHVMAAHSLNS 262 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~------~~v~l~Dfg~s 262 (282)
.+|||||||.||+|..++.+++.+++..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999875 34899999999
Q ss_pred cccccc------hhheeeccCcccc
Q 023430 263 HNQLCC------FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~~------~~~~~~~ape~~~ 281 (282)
+..-.. .|++.|||||++.
T Consensus 163 R~L~~~~~a~tlcGSplYMAPEV~~ 187 (429)
T KOG0595|consen 163 RFLQPGSMAETLCGSPLYMAPEVIM 187 (429)
T ss_pred hhCCchhHHHHhhCCccccCHHHHH
Confidence 742211 8999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=292.64 Aligned_cols=167 Identities=28% Similarity=0.422 Sum_probs=149.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh----hhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----KNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.+.|.+.+.||+|+||.|-+|..+ .+++.||||++.+..... ......+.+|+++|++|+|||||+++++|
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~-----~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEK-----KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEc-----ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 457889999999999999999977 578899999998866433 22333467999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEEecCc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAAHSLN 261 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~Dfg~ 261 (282)
...+..||||||++||+|++++..++.+.+...+.++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999999999999999999999999999999999999999999999999999866 7799999999
Q ss_pred ccccccc------hhheeeccCccc
Q 023430 262 SHNQLCC------FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~~------~~~~~~~ape~~ 280 (282)
|+..-.. .||+.|.|||++
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl 350 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVL 350 (475)
T ss_pred hhccccceehhhhcCCccccChhhe
Confidence 9876332 889999999997
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=284.83 Aligned_cols=168 Identities=27% Similarity=0.390 Sum_probs=151.1
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++.+.+..||+|+.|+||+++++ .+++++|+|++..+ .+....+++.+|+++++.++||+||.+|++|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk-----~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHK-----PTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEc-----CCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 44567888899999999999999998 56789999999544 245556778999999999999999999999999
Q ss_pred CC-EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RS-KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
++ .+.|+||||++|+|..++...+.++|.....++.++++||.|||+ ++||||||||+|||++..|+|||||||.|+.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 98 599999999999999999888999999999999999999999995 8999999999999999999999999999975
Q ss_pred ccc---c--hhheeeccCcccc
Q 023430 265 QLC---C--FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~---~--~~~~~~~ape~~~ 281 (282)
.+. + .||..|||||.++
T Consensus 229 lvnS~a~tfvGT~~YMsPERi~ 250 (364)
T KOG0581|consen 229 LVNSIANTFVGTSAYMSPERIS 250 (364)
T ss_pred hhhhhcccccccccccChhhhc
Confidence 443 3 6799999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=298.17 Aligned_cols=167 Identities=25% Similarity=0.404 Sum_probs=157.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
..|+..+.||+|+|+.||.++.. .++..||+|++.+.........+.+.+||+|.+.|+|||||+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-----~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-----DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-----CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 36999999999999999999976 4678899999999888888888999999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
+|||+|+|..++|..++++.+.++|.+++.+++||+.||.|||+++|||||||..|+||+++.+|||+|||+|.....+
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999999865533
Q ss_pred ------hhheeeccCcccc
Q 023430 269 ------FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ------~~~~~~~ape~~~ 281 (282)
.|||-|+|||+++
T Consensus 173 Erk~TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLN 191 (592)
T ss_pred cccceecCCCcccChhHhc
Confidence 8999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=270.16 Aligned_cols=170 Identities=37% Similarity=0.634 Sum_probs=159.3
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
...++|++++.||.|+||.|.+++.+ .++..||+|++.+.....-.+++...+|..+|+.+.||.++++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k-----~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREK-----HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEc-----cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 56789999999999999999999987 5678899999999888777888889999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+.+||||||.+||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+...
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999997544
Q ss_pred cc----hhheeeccCcccc
Q 023430 267 CC----FFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~~----~~~~~~~ape~~~ 281 (282)
.. .|||-|+|||++.
T Consensus 196 ~rT~TlCGTPeYLAPEii~ 214 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQ 214 (355)
T ss_pred CcEEEecCCccccChHHhh
Confidence 43 8899999999873
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=288.02 Aligned_cols=154 Identities=44% Similarity=0.820 Sum_probs=147.7
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.++..++|+++.+||+|+||.||+|+.+ .++.+||+|++++.......+++.++.|..+|...++++||+||..|
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk-----~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKK-----DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEc-----cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 3577899999999999999999999987 57889999999999988999999999999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.+...+||||||++||++..+|.+.+.|++.+++.++.+++.|++.||..|+|||||||+|+|||..|++||+|||||.
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=283.78 Aligned_cols=171 Identities=37% Similarity=0.641 Sum_probs=157.6
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 184 (282)
...+.+|..++.||+|+|++|++|+.+ .+++.||||++.+.-+..+..++.+.+|-.+|..| .||.|++||..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~-----~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREK-----ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeec-----CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 456789999999999999999999977 47788999999998888888888999999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.++..+|+|+||+++|+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||||.+|+++|+|||.++.
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998741
Q ss_pred ----cc---------------cc-hhheeeccCcccc
Q 023430 265 ----QL---------------CC-FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ----~~---------------~~-~~~~~~~ape~~~ 281 (282)
+. +. .||+.|.+||.|+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~ 260 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN 260 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence 11 11 6799999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=282.69 Aligned_cols=170 Identities=25% Similarity=0.425 Sum_probs=149.2
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+.+...++.+.+.||+|+||+||++.|+++ ..||||++......... .+.|.+|+.+|.+++|||||+++|++
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~------~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~ 108 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWRGT------DVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGAC 108 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeCCc------eeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 344455667777899999999999999843 22999999876654444 67899999999999999999999999
Q ss_pred EeCC-EEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-CEeeccCCCceEEcCCC-cEEEEec
Q 023430 185 QTRS-KLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPENILMDSDG-HVMAAHS 259 (282)
Q Consensus 185 ~~~~-~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~-iiHrDlKp~NILl~~~~-~v~l~Df 259 (282)
.... .++|||||+++|+|..++.+ +..++...++.|+.||++||.|||+++ |||||||++|||++.++ ++||+||
T Consensus 109 ~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 109 TSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred cCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 9887 79999999999999999987 577999999999999999999999999 99999999999999998 9999999
Q ss_pred Cccccccc-------chhheeeccCcccc
Q 023430 260 LNSHNQLC-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 260 g~s~~~~~-------~~~~~~~~ape~~~ 281 (282)
|+++.... -.||..|||||+|.
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~ 217 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLR 217 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhc
Confidence 99975443 27799999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=278.34 Aligned_cols=170 Identities=33% Similarity=0.517 Sum_probs=150.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh--hHHHHHHHHHHHHHhcC-CCCeeeeeEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--NHVDYMKAERDILTKVT-HPFIVQLRYS 183 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 183 (282)
...+.|.+.+.||+|+||+|+.|.+. .++..||+|++.+...... ...+.+.+|+.+++.+. ||||++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~-----~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHR-----LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeec-----cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 34578999999999999999999987 4557899998776532211 23456778999999999 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-CcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-~~v~l~Dfg~s 262 (282)
+.....+|+|||||.||+|++++...+.+.|.+++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||+|
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999999999999998999999999999999999999999999999999999999999 99999999999
Q ss_pred ccc-ccc------hhheeeccCcccc
Q 023430 263 HNQ-LCC------FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~-~~~------~~~~~~~ape~~~ 281 (282)
... ..+ .|++.|+|||+|.
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~ 194 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLS 194 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhC
Confidence 854 121 7899999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=275.14 Aligned_cols=167 Identities=31% Similarity=0.481 Sum_probs=155.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
.+|++.+.||+|+||+|-+|... ..++.||||.++++.+.++..+-.+++||+||..|+||||+.+|.+|+..+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~-----~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEH-----KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhc-----cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 47999999999999999998854 5788999999999988888888889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc-----
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN----- 264 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~----- 264 (282)
+.|||||..+|.|++|+.+.+.+++.+++.+++||+.|+.|||.++++|||||.+|||||.++++||+|||+|--
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999942
Q ss_pred cccc-hhheeeccCcccc
Q 023430 265 QLCC-FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~~-~~~~~~~ape~~~ 281 (282)
-+.. .|++.|..||++|
T Consensus 208 fLqTFCGSPLYASPEIvN 225 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVN 225 (668)
T ss_pred HHHHhcCCcccCCccccC
Confidence 2222 6799999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=270.61 Aligned_cols=170 Identities=28% Similarity=0.448 Sum_probs=142.3
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-----------hhHHHHHHHHHHHHHhcCC
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------KNHVDYMKAERDILTKVTH 174 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h 174 (282)
....++|++++.||+|.||+|-+|+.. ..++.||||++.+..... ....+.+++||.+|++|.|
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~-----~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H 167 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDE-----VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH 167 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeec-----CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence 345689999999999999999999865 567899999998654322 1224578899999999999
Q ss_pred CCeeeeeEEEEeC--CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 175 PFIVQLRYSFQTR--SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 175 ~nIv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
+|||+|+.+..+. +.+|||+|||..|.+...-.....+.+.+++.|+++++.||+|||.+|||||||||+|+||+++|
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 9999999998764 58999999999988744332223389999999999999999999999999999999999999999
Q ss_pred cEEEEecCcccc-------ccc-----chhheeeccCccc
Q 023430 253 HVMAAHSLNSHN-------QLC-----CFFFFLFLGGGVF 280 (282)
Q Consensus 253 ~v~l~Dfg~s~~-------~~~-----~~~~~~~~ape~~ 280 (282)
.|||+|||.|-. ... ..|||+|||||.+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c 287 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELC 287 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhh
Confidence 999999998851 111 1789999999975
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=278.24 Aligned_cols=170 Identities=35% Similarity=0.654 Sum_probs=155.4
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 183 (282)
..+..++|.++++||+|+||+|+++..++ +++.||||+++++.+..++.++....|..|+.... ||.++.++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~-----~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKG-----TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcC-----CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc
Confidence 46778899999999999999999999884 56689999999999999999999999999998876 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
|.+..++|+||||+.||++. ++...+.|++..++.|++.|+.||+|||++|||+||||.+|||||.+|++||+|||+|+
T Consensus 438 fQT~~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 438 FQTKEHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred cccCCeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999999999943 33345779999999999999999999999999999999999999999999999999998
Q ss_pred ccccc-------hhheeeccCccc
Q 023430 264 NQLCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~~-------~~~~~~~ape~~ 280 (282)
..... .||+-|||||++
T Consensus 517 e~m~~g~~TsTfCGTpey~aPEil 540 (694)
T KOG0694|consen 517 EGMGQGDRTSTFCGTPEFLAPEVL 540 (694)
T ss_pred ccCCCCCccccccCChhhcChhhh
Confidence 76632 789999999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=272.70 Aligned_cols=169 Identities=24% Similarity=0.301 Sum_probs=150.8
Q ss_pred hhhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeee
Q 023430 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR 181 (282)
Q Consensus 102 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 181 (282)
..+|.+..+++.+.+.||+|.||+||+|+|.+ .||||+++.+.. ..+.++.|++|+.++++-+|.||+-+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFM 454 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFM 454 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeee
Confidence 35677888899999999999999999999985 399999988764 445889999999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
|++..... .||+.||+|.+|+.+++-. ..|.....+.|++||++||.|||.++|||||||..||+|.++++|||.|||
T Consensus 455 G~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 455 GACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred hhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccc
Confidence 99988776 9999999999999999754 458889999999999999999999999999999999999999999999999
Q ss_pred ccc---------ccccchhheeeccCccc
Q 023430 261 NSH---------NQLCCFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~---------~~~~~~~~~~~~ape~~ 280 (282)
++. ....-.|...|||||++
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvI 562 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVI 562 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHH
Confidence 984 23334889999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=260.06 Aligned_cols=165 Identities=22% Similarity=0.357 Sum_probs=143.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE-EEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY-SFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~ 188 (282)
.+|+++++||+|+||.||++.+. .++..+|.|.+.-.. .+....+.+..|+.+|++|+|||||++++ .|..++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~-----~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCL-----LDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeec-----cCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 47999999999999999999987 467889999998544 45566777889999999999999999998 565555
Q ss_pred E-EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--CEeeccCCCceEEcCCCcEEEEec
Q 023430 189 K-LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK--CG--IVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 189 ~-~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~--~~--iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
. ++||||||.+|+|.+++.. ++.+++..++.++.|++.||..+|. .+ |+||||||.||+|+.+|.|||.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 9999999999999988864 3568999999999999999999998 44 999999999999999999999999
Q ss_pred Ccccccccc-------hhheeeccCccc
Q 023430 260 LNSHNQLCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~~-------~~~~~~~ape~~ 280 (282)
|+++..-.+ .|||-||+||.+
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i 200 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERI 200 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHH
Confidence 999743222 789999999986
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=259.07 Aligned_cols=170 Identities=27% Similarity=0.403 Sum_probs=151.0
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+....++|++.++||.|..++||+|++.. .+..||||++..+.... .++.+++|+..|+.++||||++++..
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEE
Confidence 345567799999999999999999999884 45789999998876543 37889999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
|..+..+|+||.||.+|++.+++... ..+.|..+..+++++++||.|||.+|-||||||+.||||+.+|.|+|+|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 99999999999999999999999764 3489999999999999999999999999999999999999999999999997
Q ss_pred ccc-------cccc----hhheeeccCccc
Q 023430 262 SHN-------QLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~-------~~~~----~~~~~~~ape~~ 280 (282)
+.. +..+ .|++.|||||++
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl 202 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVL 202 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHh
Confidence 742 2222 679999999984
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=266.96 Aligned_cols=165 Identities=24% Similarity=0.401 Sum_probs=142.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.+.|+.+++||+|+||.||+|++. .++++||+|+++.+.. +........+||.||++|+||||++|.+.....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~-----~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDL-----ETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeec-----ccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 356899999999999999999976 5788999999987653 344556678999999999999999999988776
Q ss_pred -CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 -SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 -~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+.+|||+|||+. +|.-++... -.|++.++..++.||+.||+|||.+||+|||||.+|||||.+|.+||+|||+|+..
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999987 676666553 35999999999999999999999999999999999999999999999999999722
Q ss_pred ccc--------hhheeeccCccc
Q 023430 266 LCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~--------~~~~~~~ape~~ 280 (282)
..+ .-|.-|-+||.|
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELL 291 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELL 291 (560)
T ss_pred cCCCCcccccceEEeeccChHHh
Confidence 211 448889999976
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=265.76 Aligned_cols=149 Identities=42% Similarity=0.779 Sum_probs=137.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||+||+|+++ .+++.||+|++.+.........+.+.+|+.+++.++|+||+++++.+.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 47999999999999999999876 4567899999987655455556678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+|+||||+++|+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.++|+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~ 149 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=271.83 Aligned_cols=164 Identities=27% Similarity=0.474 Sum_probs=149.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|.+.+.||+|+||.||+|+.+ .+.+.||+|.+.+.... ...++.+++|++|++.++|||||.++++|++..+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK-----~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRK-----YTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccc-----cceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence 47888999999999999999987 45678999999877643 3446678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
+|+|.|||.| +|+.++...+.++|+.++.++.+++.||.|||+.+|+|||+||.|||++..|.+|+||||+++..-..
T Consensus 76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9999999988 99999999999999999999999999999999999999999999999999999999999999753333
Q ss_pred ------hhheeeccCccc
Q 023430 269 ------FFFFLFLGGGVF 280 (282)
Q Consensus 269 ------~~~~~~~ape~~ 280 (282)
-|||.|||||.+
T Consensus 155 ~vltsikGtPlYmAPElv 172 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELV 172 (808)
T ss_pred eeeeeccCcccccCHHHH
Confidence 789999999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=273.41 Aligned_cols=167 Identities=26% Similarity=0.418 Sum_probs=154.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.+-|++++.||.|+-|.|.+|++. .+|+.+|||++.+...........+.+||.+|+.+.||||+++|++|.+..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~-----~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHA-----ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcc-----cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence 467999999999999999999987 567889999998875455555677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC 268 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~ 268 (282)
++|+|.||++||.|++++.+++.+++.++..+++||+.|+.|||..+|+||||||+|+|||.++++||+|||.|..+..+
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999866655
Q ss_pred ------hhheeeccCccc
Q 023430 269 ------FFFFLFLGGGVF 280 (282)
Q Consensus 269 ------~~~~~~~ape~~ 280 (282)
+|.++|++||++
T Consensus 166 klLeTSCGSPHYA~PEIV 183 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIV 183 (786)
T ss_pred ccccccCCCcccCCchhh
Confidence 899999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=256.81 Aligned_cols=164 Identities=27% Similarity=0.416 Sum_probs=142.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS- 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 188 (282)
.+|...+.||+|+||.||++... .++..+|||.+..... ...+.+.+|+.+|+.++|||||+++|......
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~-----~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK-----KTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred chhhhhccccCccceEEEEEEec-----CCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 45777889999999999999977 3467899999876521 11567889999999999999999999754444
Q ss_pred -EEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCccccc
Q 023430 189 -KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 -~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~~~ 265 (282)
.++++|||+++|+|.+++.+.+ .+++..++.+.+||++||.|||++|||||||||+|||++. ++.+||+|||+++..
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 6999999999999999999876 7999999999999999999999999999999999999999 799999999988743
Q ss_pred cc----------chhheeeccCcccc
Q 023430 266 LC----------CFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~----------~~~~~~~~ape~~~ 281 (282)
.. --||+.|||||++.
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred ccccccccccccccCCccccCchhhc
Confidence 31 16799999999874
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=246.39 Aligned_cols=172 Identities=31% Similarity=0.447 Sum_probs=156.0
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.+.||+|.||.||+|+.+ .+.-+||+|++.+..+......+.+++|++|-..|+||||+++|++|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarek-----ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREK-----KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeec-----cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence 3456789999999999999999999977 67889999999988776666667899999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+...+|+++||...|+++..+. +...+++..+..++.|++.||.|+|.++||||||||+|+|++.+|.+||+|||.|
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 99999999999999999999998 5567999999999999999999999999999999999999999999999999988
Q ss_pred cccccc-----hhheeeccCcccc
Q 023430 263 HNQLCC-----FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~~-----~~~~~~~ape~~~ 281 (282)
-..-+. .||.-|.+||..+
T Consensus 172 V~~p~~kR~tlcgt~dyl~pEmv~ 195 (281)
T KOG0580|consen 172 VHAPSNKRKTLCGTLDYLPPEMVE 195 (281)
T ss_pred eecCCCCceeeecccccCCHhhcC
Confidence 543333 8999999999763
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.90 Aligned_cols=149 Identities=46% Similarity=0.773 Sum_probs=136.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++++.||+|+||.||++.++ ..++.||||++.+.........+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-----DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 37999999999999999999876 4567899999977654455566778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+|+||||+++|+|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~ 149 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=263.69 Aligned_cols=149 Identities=43% Similarity=0.807 Sum_probs=137.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|+++ ..++.||||++.............+.+|+.+|+.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 47999999999999999999977 3567899999987654445556678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+|+||||+++|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 149 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccce
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=263.95 Aligned_cols=148 Identities=42% Similarity=0.738 Sum_probs=136.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++++.||+|+||+||+|+++ .++..||+|++.+.........+.+.+|+.+++.++|+||+++++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence 6899999999999999999976 45678999999876655556667789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~ 149 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=259.42 Aligned_cols=170 Identities=38% Similarity=0.611 Sum_probs=151.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||+|+++ ..++.||+|++.+.........+.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHK-----GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 44578999999999999999999987 3567899999987654444556678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+..|+||||+.+|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987432
Q ss_pred c----chhheeeccCcccc
Q 023430 267 C----CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~----~~~~~~~~ape~~~ 281 (282)
. -.|++.|||||++.
T Consensus 170 ~~~~~~~gt~~y~aPE~~~ 188 (329)
T PTZ00263 170 DRTFTLCGTPEYLAPEVIQ 188 (329)
T ss_pred CCcceecCChhhcCHHHHc
Confidence 2 25799999999873
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=256.58 Aligned_cols=174 Identities=40% Similarity=0.707 Sum_probs=162.8
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY 182 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 182 (282)
...++..++|+.+++||+|+||+|.+|+.+ .+++.||+|+++++.+..++.+..-..|-++|+.++||.+..+..
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEK-----at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY 235 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREK-----ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY 235 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeec-----ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh
Confidence 345567789999999999999999999976 678899999999999888888888888999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.|++.+.+|+||||..||.|+.++.+...+++..++.+...|+.||.|||+++||.||||.+|+|+|.+|++||+|||+|
T Consensus 236 sFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLC 315 (516)
T KOG0690|consen 236 SFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLC 315 (516)
T ss_pred hhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccc
Confidence 99999999999999999999999999889999999999999999999999999999999999999999999999999999
Q ss_pred cccccc-------hhheeeccCcccc
Q 023430 263 HNQLCC-------FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~~-------~~~~~~~ape~~~ 281 (282)
+..+.+ .|||.|+|||+++
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred hhcccccceeccccCChhhcCchhhc
Confidence 987766 7899999999983
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=250.31 Aligned_cols=165 Identities=22% Similarity=0.310 Sum_probs=139.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
+.|+.+.++|+|+||+||+|+++ .++++||||++.... .++...+-..+||++|++++|+|+|.++++|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk-----~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNK-----DTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccC-----CcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 46888999999999999999988 578899999986543 223333445689999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
+++|+|||+..-|.++-.-...++...+..++.|++.|+.|||++++|||||||+||||..+|.+||||||+|+...+
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999999998755544333345589999999999999999999999999999999999999999999999999986542
Q ss_pred ---chh--heeeccCccc
Q 023430 268 ---CFF--FFLFLGGGVF 280 (282)
Q Consensus 268 ---~~~--~~~~~ape~~ 280 (282)
.+| |.-|-|||.+
T Consensus 156 d~YTDYVATRWYRaPELL 173 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELL 173 (396)
T ss_pred chhhhhhhhhhccChhhh
Confidence 233 8899999976
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=262.11 Aligned_cols=149 Identities=44% Similarity=0.793 Sum_probs=136.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++++.||+|+||.||+|+.+ ..++.||+|++.+.........+.+.+|+.+|+.++|+||+++++.+..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-----CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 37999999999999999999977 4577899999976654444555678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+|+||||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+|.
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=262.59 Aligned_cols=148 Identities=45% Similarity=0.790 Sum_probs=136.3
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|+++++||+|+||.||+|+.+ ..++.||+|++.+.........+.+.+|+.+++.++|+||+++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence 5899999999999999999976 45678999999876554555667788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
|+|||||++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~ 149 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=259.11 Aligned_cols=173 Identities=35% Similarity=0.512 Sum_probs=151.9
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
...+..++|++.+.||+|+||.||+|.++.. ....||+|++.+.........+.+.+|+.+++.++||||++++++
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 99 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNE----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGS 99 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECC----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEE
Confidence 3445667899999999999999999987632 235799999977654445556678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+...+.+|+||||+++|+|..++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 100 ~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 100 FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 99999999999999999999999888889999999999999999999999999999999999999999999999999986
Q ss_pred ccc----cchhheeeccCccc
Q 023430 264 NQL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~----~~~~~~~~~ape~~ 280 (282)
... ...|++.|||||++
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~ 200 (340)
T PTZ00426 180 VVDTRTYTLCGTPEYIAPEIL 200 (340)
T ss_pred ecCCCcceecCChhhcCHHHH
Confidence 422 22579999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=255.52 Aligned_cols=161 Identities=42% Similarity=0.744 Sum_probs=143.2
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+.||+|+||.||+|+++ ..++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREK-----ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 36999999999999976 4567899999987654445555667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------c
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-------C 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-------~ 268 (282)
|+++++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 999999999998888899999999999999999999999999999999999999999999999999874321 1
Q ss_pred hhheeeccCcccc
Q 023430 269 FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ~~~~~~~ape~~~ 281 (282)
.|++.|||||.+.
T Consensus 156 ~gt~~y~aPE~~~ 168 (323)
T cd05571 156 CGTPEYLAPEVLE 168 (323)
T ss_pred ecCccccChhhhc
Confidence 4799999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=258.68 Aligned_cols=149 Identities=42% Similarity=0.782 Sum_probs=137.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+++++ ..+..||+|++...........+.+.+|+.++..++|+||+++++.+...+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 47999999999999999999977 4567899999987655455566778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+|+||||+++|+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~ 149 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=240.81 Aligned_cols=164 Identities=22% Similarity=0.351 Sum_probs=141.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
.+|..+++||+|.||.||+|++. .+++.||||+++.....+..... ..+||.+|+.++|+||+.++++|...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~-----~t~~~VAIKKIkl~~~kdGi~~t-alREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDT-----ETGKRVAIKKIKLGNAKDGINRT-ALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEec-----CCCcEEEEEEeeccccccCccHH-HHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 46888899999999999999976 57788999999876543333333 5579999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc----
Q 023430 190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN---- 264 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~---- 264 (282)
+.||+||++. +|...++... .+...++..|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+++.
T Consensus 76 l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 76 LSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9999999976 7887776543 488999999999999999999999999999999999999999999999999963
Q ss_pred ---cccchhheeeccCccc
Q 023430 265 ---QLCCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ---~~~~~~~~~~~ape~~ 280 (282)
+..+..|.-|-|||.|
T Consensus 155 ~~~~~~~V~TRWYRAPELL 173 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELL 173 (318)
T ss_pred CcccccceeeeeccChHHh
Confidence 3334568889999965
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=253.53 Aligned_cols=167 Identities=34% Similarity=0.568 Sum_probs=148.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ ..++.||+|++...........+.+.+|+.+++.++||||+++++.+.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR-----ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence 37999999999999999999976 3567899999976544333445668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999874332
Q ss_pred --chhheeeccCcccc
Q 023430 268 --CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 --~~~~~~~~ape~~~ 281 (282)
..|++.|+|||.+.
T Consensus 156 ~~~~gt~~y~aPE~~~ 171 (291)
T cd05612 156 WTLCGTPEYLAPEVIQ 171 (291)
T ss_pred ccccCChhhcCHHHHc
Confidence 25799999999863
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.02 Aligned_cols=167 Identities=40% Similarity=0.642 Sum_probs=149.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|+++ ..+..||+|++.+.........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 47999999999999999999976 3567899999987654444455678889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
.|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~ 155 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA 155 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999974322
Q ss_pred --chhheeeccCcccc
Q 023430 268 --CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 --~~~~~~~~ape~~~ 281 (282)
..|++.|||||++.
T Consensus 156 ~~~~gt~~y~aPE~~~ 171 (333)
T cd05600 156 NSVVGSPDYMAPEVLR 171 (333)
T ss_pred CCcccCccccChhHhc
Confidence 36799999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=258.34 Aligned_cols=171 Identities=33% Similarity=0.585 Sum_probs=149.1
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
......++|++.+.||+|+||.||+++++ ..++.+|+|++.+.........+.+.+|+.+++.++||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHK-----SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34556678999999999999999999987 4567899999976544344445567889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+..+..+|+||||+++|+|..++... .+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|.
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999999999988654 58999999999999999999999999999999999999999999999999986
Q ss_pred ccc--------cchhheeeccCccc
Q 023430 264 NQL--------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~--------~~~~~~~~~ape~~ 280 (282)
... ...|++.|||||++
T Consensus 191 ~~~~~~~~~~~~~~gt~~Y~aPE~~ 215 (370)
T cd05621 191 KMDETGMVRCDTAVGTPDYISPEVL 215 (370)
T ss_pred ecccCCceecccCCCCcccCCHHHH
Confidence 421 12579999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=262.11 Aligned_cols=166 Identities=22% Similarity=0.323 Sum_probs=143.4
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+....+.+++.||+|.||.||.|.+++. ..||+|.++...... +.|.+|+++|++|+|+|||++++++..
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~------~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~ 272 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGS------TKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK 272 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCC------CcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence 3344566678999999999999999853 248899887653322 347789999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
+..+|||||||+.|+|.+++.. ...+...+.+.++.|||+||+||+++++|||||..+||||++++.|||+|||+++.
T Consensus 273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 8899999999999999999986 45688999999999999999999999999999999999999999999999999995
Q ss_pred cccchh--------heeeccCccccC
Q 023430 265 QLCCFF--------FFLFLGGGVFNF 282 (282)
Q Consensus 265 ~~~~~~--------~~~~~ape~~~~ 282 (282)
...+-| -..|.|||+|+|
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~ 378 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNY 378 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhh
Confidence 444422 568999999976
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=252.71 Aligned_cols=166 Identities=37% Similarity=0.670 Sum_probs=146.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+++.+ ..++.||+|++.+.........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-----NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 47999999999999999999977 4567899999986554445556678889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
+|+||||+++|+|..++.+ ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999999999976 45689999999999999999999999999999999999999999999999999853211
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..|++.|||||++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~ 175 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEIL 175 (331)
T ss_pred CCccccceeccccccCHHHH
Confidence 2579999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=251.97 Aligned_cols=167 Identities=36% Similarity=0.620 Sum_probs=146.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+++++ ..++.||+|++.+.........+.+.+|+.++..++|+||+++++++...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 47999999999999999999876 4567899999976544444455667889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.|+||||++||+|..++.+ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999976 46789999999999999999999999999999999999999999999999999853221
Q ss_pred -------chhheeeccCcccc
Q 023430 268 -------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 -------~~~~~~~~ape~~~ 281 (282)
..|++.|||||+++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQ 176 (331)
T ss_pred CceeeccccCCcccCCHHHHh
Confidence 25799999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=260.44 Aligned_cols=164 Identities=26% Similarity=0.439 Sum_probs=142.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 187 (282)
.++|.++++||.|+||.||+|+.+ ..+..||||.+++.... +++.- -.||+..|++|+ |||||++.+++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~-----~~~~~VAIK~MK~Kf~s-~ee~~-nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSK-----ETGELVAIKKMKKKFYS-WEECM-NLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeec-----CCCceeeHHHHHhhhcc-HHHHH-HHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 467999999999999999999977 46677999999876543 33222 246999999999 99999999999988
Q ss_pred C-EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 S-KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 ~-~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+ .+|+|||||+. +|+++++.+ ..|++..++.|+.||++||+|+|.+|+.|||+||+|||+.....|||+|||+|+..
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 8 99999999975 789888764 55999999999999999999999999999999999999999999999999999854
Q ss_pred ccc------hhheeeccCccc
Q 023430 266 LCC------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~------~~~~~~~ape~~ 280 (282)
... ..|.-|-|||+|
T Consensus 161 ~SkpPYTeYVSTRWYRAPEvL 181 (538)
T KOG0661|consen 161 RSKPPYTEYVSTRWYRAPEVL 181 (538)
T ss_pred ccCCCcchhhhcccccchHHh
Confidence 433 349999999987
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=251.80 Aligned_cols=161 Identities=40% Similarity=0.712 Sum_probs=142.7
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+.||+|+||.||+++.+ ..+..||+|++.............+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 36999999999999976 4567899999987654444555667789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------c
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-------C 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-------~ 268 (282)
|+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... -
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999864322 1
Q ss_pred hhheeeccCcccc
Q 023430 269 FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ~~~~~~~ape~~~ 281 (282)
.|++.|||||.+.
T Consensus 156 ~gt~~y~aPE~~~ 168 (323)
T cd05595 156 CGTPEYLAPEVLE 168 (323)
T ss_pred cCCcCcCCccccc
Confidence 5789999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=251.82 Aligned_cols=160 Identities=42% Similarity=0.723 Sum_probs=142.7
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++||+|+||.||+++.+ ..+..||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREK-----ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 36899999999999976 4567899999987655445556678889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-------
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------- 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------- 268 (282)
|+++|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....+
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998643221
Q ss_pred hhheeeccCccc
Q 023430 269 FFFFLFLGGGVF 280 (282)
Q Consensus 269 ~~~~~~~ape~~ 280 (282)
.|++.|||||.+
T Consensus 156 ~gt~~y~aPE~~ 167 (328)
T cd05593 156 CGTPEYLAPEVL 167 (328)
T ss_pred cCCcCccChhhh
Confidence 478999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=254.13 Aligned_cols=174 Identities=33% Similarity=0.592 Sum_probs=150.2
Q ss_pred hhhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeee
Q 023430 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR 181 (282)
Q Consensus 102 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 181 (282)
.....+..++|++.+.||+|+||.||+|+++ .+++.+|+|++.+.........+.+.+|+.+++.++||||++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3345566789999999999999999999987 45678999999765444444455678899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+.+.....+|+||||+++|+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999999999888654 589999999999999999999999999999999999999999999999999
Q ss_pred ccccc--------cchhheeeccCcccc
Q 023430 262 SHNQL--------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~~--------~~~~~~~~~ape~~~ 281 (282)
+.... ...|++.|||||.+.
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~ 216 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLK 216 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHh
Confidence 86321 125799999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=255.99 Aligned_cols=163 Identities=21% Similarity=0.255 Sum_probs=141.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS- 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 188 (282)
++|.-..+||+|+||.||+|... .+..||||.+....... .+.|.+|+.++.+++|||+|+|+|+|.+.+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~------~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS------DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC------CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 57777789999999999999865 23689999876543221 344999999999999999999999999888
Q ss_pred EEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+||+|||++|+|.+++.... .++|.....|+.++++||+|||... |||||||++|||||++...||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 5999999999999999998754 7899999999999999999999753 9999999999999999999999999996
Q ss_pred cccc---c-----hhheeeccCcccc
Q 023430 264 NQLC---C-----FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~---~-----~~~~~~~ape~~~ 281 (282)
..-. . .||.+|+|||++.
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~ 251 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYAS 251 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhc
Confidence 4432 1 6899999999874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=260.31 Aligned_cols=164 Identities=24% Similarity=0.351 Sum_probs=145.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
...|....+||+|+.|.||.++.. ..+..||||.+...... ..+.+.+|+.+|+..+|+|||.+++.|...+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~-----~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d 343 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKI-----STKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGD 343 (550)
T ss_pred hhhhcchhhhccccccceeeeeec-----cCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence 346888899999999999999976 45667999999876533 3355789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC 268 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~ 268 (282)
.+|+|||||+||+|.+.+.. -.++|.++..++++++.||+|||.+||||||||.+|||++.+|.|||+|||+|....+.
T Consensus 344 eLWVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eeEEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 99999999999999888754 45899999999999999999999999999999999999999999999999999865444
Q ss_pred -------hhheeeccCcccc
Q 023430 269 -------FFFFLFLGGGVFN 281 (282)
Q Consensus 269 -------~~~~~~~ape~~~ 281 (282)
+||+-|||||+.+
T Consensus 423 ~~KR~TmVGTPYWMAPEVvt 442 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVT 442 (550)
T ss_pred cCccccccCCCCccchhhhh
Confidence 8999999999863
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=254.37 Aligned_cols=150 Identities=47% Similarity=0.881 Sum_probs=137.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|++. ..++.||+|++.+.........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 47999999999999999999976 3577899999987655454566778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
+|+||||+++++|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=254.27 Aligned_cols=172 Identities=34% Similarity=0.606 Sum_probs=149.4
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY 182 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 182 (282)
....+..++|++.+.||+|+||.||+++++ ..+..||+|++.+.........+.+.+|+.+++.++||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 344566789999999999999999999977 456789999997655444445556788999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
++..++.+|+||||+++|+|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 99999999999999999999988865 45889999999999999999999999999999999999999999999999998
Q ss_pred cccc--------cchhheeeccCccc
Q 023430 263 HNQL--------CCFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~--------~~~~~~~~~ape~~ 280 (282)
.... ...|++.|||||.+
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 215 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVL 215 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHh
Confidence 6422 12579999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=253.24 Aligned_cols=167 Identities=30% Similarity=0.466 Sum_probs=149.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 187 (282)
...|++.+.||+|.||.||+|+.+. +++.+|+|++.+.........+.+.+|+.+|+.+. |||||.+++.|++.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~-----tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKS-----TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecC-----CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 3579999999999999999999884 47789999998877655555677899999999998 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC----CcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~----~~v~l~Dfg~s~ 263 (282)
..+++|||+|.||.|++.+.+. .+++..+..++.|++.++.|||++||+||||||+|+|+... +.++++|||+|.
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 9999999999999999999876 49999999999999999999999999999999999999644 479999999996
Q ss_pred cccc------chhheeeccCcccc
Q 023430 264 NQLC------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~------~~~~~~~~ape~~~ 281 (282)
...- -.|++.|+|||++.
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~ 211 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLG 211 (382)
T ss_pred EccCCceEeeecCCccccCchhhc
Confidence 4332 18899999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=248.79 Aligned_cols=159 Identities=45% Similarity=0.752 Sum_probs=141.3
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||+|+||.||+|+++ .+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 699999999999976 356789999998655444555667788999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------chh
Q 023430 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-------CFF 270 (282)
Q Consensus 198 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-------~~~ 270 (282)
++|+|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.... ..|
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 9999999998888899999999999999999999999999999999999999999999999999864221 157
Q ss_pred heeeccCcccc
Q 023430 271 FFLFLGGGVFN 281 (282)
Q Consensus 271 ~~~~~ape~~~ 281 (282)
++.|||||.+.
T Consensus 156 t~~y~aPE~~~ 166 (312)
T cd05585 156 TPEYLAPELLL 166 (312)
T ss_pred CcccCCHHHHc
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=249.73 Aligned_cols=167 Identities=39% Similarity=0.676 Sum_probs=148.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+++.+ ..++.||+|+++..........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-----ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 37999999999999999999876 4567899999987655445566778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.|+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+++|+||||||+|||++.+|.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999999999876 6799999999999999999999999999999999999999999999999999864221
Q ss_pred -------chhheeeccCcccc
Q 023430 268 -------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 -------~~~~~~~~ape~~~ 281 (282)
..|++.|||||.+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~ 176 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLT 176 (330)
T ss_pred CceeeecccCCccccCHHHhc
Confidence 25789999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=249.25 Aligned_cols=160 Identities=41% Similarity=0.710 Sum_probs=141.5
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+.||+|+||.||+++++ ..+..||+|++.+...........+.+|+++++.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 36999999999999876 4567899999987654444555667789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
|+++|+|..++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 99999999999888889999999999999999999997 7999999999999999999999999999864221
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
..|++.|||||.+
T Consensus 156 ~~gt~~y~aPE~~ 168 (325)
T cd05594 156 FCGTPEYLAPEVL 168 (325)
T ss_pred ccCCcccCCHHHH
Confidence 1579999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=251.35 Aligned_cols=174 Identities=20% Similarity=0.287 Sum_probs=143.1
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
|.+..++|++.++||+|+||.||+|.+.+......+..||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 455667899999999999999999987654444556789999986532 223345688899999999 89999999998
Q ss_pred EEeC-CEEEEEEeccCCCchHHHHHhc-----------------------------------------------------
Q 023430 184 FQTR-SKLYLILDFINGGHLFFHLYRQ----------------------------------------------------- 209 (282)
Q Consensus 184 ~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 209 (282)
+... ..++++|||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 8754 4689999999999999888642
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc---------hhh
Q 023430 210 ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC---------FFF 271 (282)
Q Consensus 210 ---------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~---------~~~ 271 (282)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++....+ .++
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 23677888899999999999999999999999999999999999999999999743211 234
Q ss_pred eeeccCccc
Q 023430 272 FLFLGGGVF 280 (282)
Q Consensus 272 ~~~~ape~~ 280 (282)
..|||||.+
T Consensus 240 ~~y~aPE~~ 248 (338)
T cd05102 240 LKWMAPESI 248 (338)
T ss_pred ccccCcHHh
Confidence 689999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=247.50 Aligned_cols=166 Identities=34% Similarity=0.670 Sum_probs=145.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC-CeeeeeEEEEeCCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTRSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~ 189 (282)
+|++++.||+|+||.||+|+++ ..++.||+|++.+.........+.+..|+.++..+.|+ +|+.+++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 5899999999999999999976 35678999999876544445556678899999999765 68889999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
+|+||||+++|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999864221
Q ss_pred -----chhheeeccCcccc
Q 023430 268 -----CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 -----~~~~~~~~ape~~~ 281 (282)
..|++.|||||++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~ 174 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIA 174 (324)
T ss_pred CceeeecCCccccChhhhc
Confidence 15799999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=255.34 Aligned_cols=177 Identities=21% Similarity=0.265 Sum_probs=150.2
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.|.+.-++..+.++||+|+||.||+|+.+..... ....||||..+......+.....+.+|+++|+.++|||||++||+
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCc-eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445555666778999999999999998743221 122289999876444566778889999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
......++||||+|.||+|.+++.+.+. ++..+...++.+.+.||+|||++++|||||-.+|+|++.++.+||+|||+|
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 9999999999999999999999998764 999999999999999999999999999999999999999999999999999
Q ss_pred cccc-cc--h-h---heeeccCcccc
Q 023430 263 HNQL-CC--F-F---FFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~-~~--~-~---~~~~~ape~~~ 281 (282)
+... .. . . -.+|+|||.++
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~ 335 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLN 335 (474)
T ss_pred cCCcceeeccccccCcceecChhhhc
Confidence 7643 11 1 2 38999999985
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=247.95 Aligned_cols=166 Identities=37% Similarity=0.648 Sum_probs=146.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.++||+|+||.||+++++ ..++.+|+|++.+.........+.+.+|+.++..++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 37999999999999999999977 3567899999976544444455668889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
+|+||||+++|+|.+++.+ ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999999999976 45689999999999999999999999999999999999999999999999999853211
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..|++.|||||++
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~ 175 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEIL 175 (332)
T ss_pred CcceecccccCccccCHHHH
Confidence 2579999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=241.26 Aligned_cols=166 Identities=35% Similarity=0.570 Sum_probs=143.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++.+.||+|+||.||++.++ .++..||+|++.+...........+.+|+.+++.++|+||+++++.+...+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEe-----cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence 3788999999999999999977 35678999998766543333445577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
++||||+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++....
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999999998777543 358899999999999999999999999999999999999999999999999986421
Q ss_pred ----cchhheeeccCcccc
Q 023430 267 ----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ----~~~~~~~~~ape~~~ 281 (282)
...|+..|||||.+.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVIN 174 (285)
T ss_pred CeecCCCCCCCccCHhhhc
Confidence 225799999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=277.56 Aligned_cols=173 Identities=39% Similarity=0.638 Sum_probs=158.7
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.-.+..++|+++++||+|+||.|..++++ .++++||+|++.+-....+.....|+.|..+|...+.+.|++++.+
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k-----~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHK-----STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEee-----ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 34566789999999999999999999988 4678999999998777777777889999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
|.++.++|+||||++||+|..++.+.+.+++..+++|...|+.||+-||+.|+|||||||+|||||..|++||+|||.|-
T Consensus 144 FQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 144 FQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred hcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999999999998899999999999999999999999999999999999999999999999999985
Q ss_pred ccccc--------hhheeeccCcccc
Q 023430 264 NQLCC--------FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~~--------~~~~~~~ape~~~ 281 (282)
.-..| .|||-|++||+|.
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLq 249 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQ 249 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHH
Confidence 43322 8999999999973
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=248.11 Aligned_cols=160 Identities=36% Similarity=0.691 Sum_probs=142.1
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
++||+|+||.||+++++ ..++.||+|++++.........+.+.+|+.+++.+ +||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 36899999999999977 45678999999876554555566788899999988 6999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9999999999988888899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
-.|+..|||||.+
T Consensus 156 ~~gt~~y~aPE~~ 168 (329)
T cd05588 156 FCGTPNYIAPEIL 168 (329)
T ss_pred ccCCccccCHHHH
Confidence 1578999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=246.37 Aligned_cols=168 Identities=44% Similarity=0.774 Sum_probs=144.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
+|++.+.||+|+||.||+++.... ...++.||+|++.+..... ....+.+..|+.+++.++ |+||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEccc--CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 589999999999999999986531 2467889999997654322 233456778999999995 999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.+++||||+++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999999998888899999999999999999999999999999999999999999999999999864211
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
-.|++.|||||.+
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~ 178 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEII 178 (332)
T ss_pred CCCccccccCCccccCHHHh
Confidence 1479999999986
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=246.29 Aligned_cols=162 Identities=27% Similarity=0.392 Sum_probs=138.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|+.++.||+|+||.||+++++ ..++.||||++.... .....+.+.+|+++++.++|+||+++++++...+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHR-----PTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEEC-----CCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 457888899999999999999876 356789999986542 2233456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.+++||||+++++|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999999999988542 335677888999999999999999999999999999999999999999999986321
Q ss_pred -----cchhheeeccCcccc
Q 023430 267 -----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -----~~~~~~~~~ape~~~ 281 (282)
...|+..|||||.++
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERIN 241 (353)
T ss_pred cccccccccCccccCccccc
Confidence 226799999999873
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=240.28 Aligned_cols=165 Identities=22% Similarity=0.358 Sum_probs=139.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|+.+..|++|+||.||+|+++ .++.+||+|.++.+.....--+. -.+||.+|.+++|||||.+..+....
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk-----~t~eIVALKr~kmekek~GFPIt-sLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDK-----KTDEIVALKRLKMEKEKEGFPIT-SLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccC-----CcceeEEeeecccccccCCCcch-hHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 457999999999999999999977 67889999999876532222222 35799999999999999998887643
Q ss_pred -CEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 -SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+.+|||||||+. +|..++...+ .|...++..++.|+++||+|||.+.|+|||||++|+|+...|.+||+|||+|+..
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 579999999987 7888887654 7999999999999999999999999999999999999999999999999999743
Q ss_pred ccc-------hhheeeccCccc
Q 023430 266 LCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~-------~~~~~~~ape~~ 280 (282)
-.- .-|.-|-|||.|
T Consensus 228 gsp~k~~T~lVVTLWYRaPELL 249 (419)
T KOG0663|consen 228 GSPLKPYTPLVVTLWYRAPELL 249 (419)
T ss_pred cCCcccCcceEEEeeecCHHHh
Confidence 322 347888899875
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=245.46 Aligned_cols=166 Identities=34% Similarity=0.662 Sum_probs=144.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 189 (282)
+|++.+.||+|+||.||+|+++ ..+..||+|++.+.........+.+..|..++..+ .|++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 5889999999999999999976 35678999999876544444455567788888777 48999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
+|+||||+++|+|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987432
Q ss_pred ----cchhheeeccCcccc
Q 023430 267 ----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ----~~~~~~~~~ape~~~ 281 (282)
...|++.|||||.+.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIA 174 (323)
T ss_pred CccccCCCChhhcCHHHhc
Confidence 125799999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=245.89 Aligned_cols=161 Identities=39% Similarity=0.691 Sum_probs=140.8
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+|+++ ..++.||+|++.+.........+.+..|+.++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEc-----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 36999999999999976 45678999999876544445556677788888776 6999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++|+|..++.+...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864321
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|++.|||||.+.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (320)
T cd05590 156 FCGTPDYIAPEILQ 169 (320)
T ss_pred cccCccccCHHHHc
Confidence 15799999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=245.09 Aligned_cols=164 Identities=48% Similarity=0.785 Sum_probs=140.9
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+++.... ...++.||+|++.+.... .......+.+|+.+|+.++||||+++++++..++..|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTG--ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEccc--CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 5799999999999986421 245678999999765432 2233445778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++++|.+++.+.+.+.+..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863221
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|++.|||||.+.
T Consensus 160 ~~gt~~y~aPE~~~ 173 (323)
T cd05584 160 FCGTIEYMAPEILM 173 (323)
T ss_pred cCCCccccChhhcc
Confidence 15789999999873
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=252.33 Aligned_cols=165 Identities=21% Similarity=0.374 Sum_probs=148.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
..|..++.||+|+||.||+|.+. .+++.||+|++..+. .+...+.+++|+.+|.+++++||.++|+.|..+..
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~-----~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDN-----KTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred cccccchhccccccceeeeeeec-----cccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 35888899999999999999976 577889999998765 34556778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
+|++||||.||++.+.+.....+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.||++|||.+...-.+
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 9999999999999999988777799999999999999999999999999999999999999999999999998532222
Q ss_pred ------hhheeeccCcccc
Q 023430 269 ------FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ------~~~~~~~ape~~~ 281 (282)
+||+-|||||+++
T Consensus 166 ~rr~tfvGTPfwMAPEVI~ 184 (467)
T KOG0201|consen 166 KRRKTFVGTPFWMAPEVIK 184 (467)
T ss_pred hccccccccccccchhhhc
Confidence 7899999999974
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=244.88 Aligned_cols=166 Identities=35% Similarity=0.681 Sum_probs=144.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 189 (282)
+|+..+.||+|+||.||+|+++ .+++.||+|++.+.........+.+..|+.+++.+. |++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 4788899999999999999976 456789999998765444445566778888998886 5778889999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
+|+||||+++|+|..++.+.+.+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999864221
Q ss_pred -----chhheeeccCcccc
Q 023430 268 -----CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 -----~~~~~~~~ape~~~ 281 (282)
..|++.|||||++.
T Consensus 156 ~~~~~~~gt~~y~aPE~~~ 174 (323)
T cd05615 156 VTTRTFCGTPDYIAPEIIA 174 (323)
T ss_pred ccccCccCCccccCHHHHc
Confidence 14799999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=244.96 Aligned_cols=164 Identities=33% Similarity=0.568 Sum_probs=141.0
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH---HhcCCCCeeeeeEEEEeCC
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL---TKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~ 188 (282)
|++++.||+|+||.||+|.++ .++..||||++++.........+.+.+|+.++ +.++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-----KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 678999999999999999977 45678999999876544445556677777665 4567999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
..|+||||+++++|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999999999887754 5689999999999999999999999999999999999999999999999999864221
Q ss_pred ------chhheeeccCcccc
Q 023430 268 ------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ------~~~~~~~~ape~~~ 281 (282)
-.|++.|||||.+.
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~ 174 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLT 174 (324)
T ss_pred CCcccccccCccccCHhHhc
Confidence 25799999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=245.32 Aligned_cols=161 Identities=37% Similarity=0.704 Sum_probs=141.5
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+++++ ..+..||+|++.+.........+.+.+|+.++..+ +||||+++++++...+..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 46999999999999977 45678999999876544455566678899888776 7999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-------c
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-------C 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-------~ 267 (282)
||+++|+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 999999999988888889999999999999999999999999999999999999999999999999986422 1
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|+..|||||.+.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (329)
T cd05618 156 FCGTPNYIAPEILR 169 (329)
T ss_pred ccCCccccCHHHHc
Confidence 25799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=244.96 Aligned_cols=160 Identities=36% Similarity=0.686 Sum_probs=140.2
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
++||+|+||.||+|+++ ..+..||+|++.+.........+.+..|.++++.+ +||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-----GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence 36899999999999976 35678999999876544445556677888888866 7999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
..|++.|||||.+
T Consensus 156 ~~gt~~y~aPE~~ 168 (321)
T cd05591 156 FCGTPDYIAPEIL 168 (321)
T ss_pred cccCccccCHHHH
Confidence 1478999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=244.26 Aligned_cols=161 Identities=35% Similarity=0.683 Sum_probs=138.5
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
++||+|+||.||+|+++ .++..||+|+++..........+.+..|..++.. .+||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-----GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999976 3567899999987654444444555667777765 47999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++|+|..++...+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++.....
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999964321
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|++.|||||.+.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (316)
T cd05592 156 FCGTPDYIAPEILK 169 (316)
T ss_pred ccCCccccCHHHHc
Confidence 15799999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=244.02 Aligned_cols=160 Identities=47% Similarity=0.769 Sum_probs=137.1
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHH-HHHHhcCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER-DILTKVTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
++||+|+||.||+|+++ ..+..||+|++.+...........+..|+ .+++.++||||+++++.+...+..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-----SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999976 45678999999865543333344455555 4678899999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++++|...+.+...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 9999999999888878899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
..|++.|||||.+
T Consensus 156 ~~gt~~y~aPE~~ 168 (321)
T cd05603 156 FCGTPEYLAPEVL 168 (321)
T ss_pred ccCCcccCCHHHh
Confidence 1468999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=244.11 Aligned_cols=161 Identities=47% Similarity=0.765 Sum_probs=137.6
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHH-HHHhcCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||+||+|+++ ..++.||+|++.+.........+.+..|.. +++.++||||+++++.+...+..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 36999999999999976 456789999998764433333444555544 567899999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|++.|||||.+.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (323)
T cd05575 156 FCGTPEYLAPEVLR 169 (323)
T ss_pred ccCChhhcChhhhc
Confidence 14789999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=244.41 Aligned_cols=161 Identities=47% Similarity=0.758 Sum_probs=137.7
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHH-HHHhcCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+|+++ ..+..||+|++.+...........+..|.. +++.++||||+++++.+...+..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-----LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence 36899999999999976 456789999998764433334444555554 577899999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|+..|||||.+.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (325)
T cd05604 156 FCGTPEYLAPEVIR 169 (325)
T ss_pred ccCChhhCCHHHHc
Confidence 14789999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=238.14 Aligned_cols=154 Identities=38% Similarity=0.651 Sum_probs=143.1
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
...++.++|++++.||.|.-|+||+|+.++ +...+|+|++.+.....+....+.+.|.+||+.++||.+++||..
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~ 145 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS 145 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence 345677889999999999999999999874 458899999999988888888889999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
|+.....|+|||||+||+|..+++++ +.|++..++.++.+++.||+|||..|||.|||||+||||.++|+|+|+||-+
T Consensus 146 fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDL 225 (459)
T KOG0610|consen 146 FETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDL 225 (459)
T ss_pred eeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccc
Confidence 99999999999999999999988876 4699999999999999999999999999999999999999999999999976
Q ss_pred c
Q 023430 262 S 262 (282)
Q Consensus 262 s 262 (282)
|
T Consensus 226 S 226 (459)
T KOG0610|consen 226 S 226 (459)
T ss_pred c
Confidence 6
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=243.61 Aligned_cols=160 Identities=38% Similarity=0.710 Sum_probs=142.3
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+|+.+ ..++.||+|++.+.........+.+.+|+.++..+ +|+||+.+++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 36999999999999976 45678999999877655555667788899999888 5999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9999999999988888899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
-.|++.|||||.+
T Consensus 156 ~~gt~~y~aPE~~ 168 (327)
T cd05617 156 FCGTPNYIAPEIL 168 (327)
T ss_pred ccCCcccCCHHHH
Confidence 1579999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=249.39 Aligned_cols=167 Identities=32% Similarity=0.437 Sum_probs=150.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.+.|.+...||+|.|+.|.++++. .++..||||++.+.... ...++.+.+|+++|+.++|||||+++.+...+.
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~-----~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHI-----LTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEec-----CCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 468999999999999999999987 45677999999887643 344455889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc----
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN---- 264 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~---- 264 (282)
.+|+||||+.+|.+++++.+++.+.+..++.++.|++.+++|||+++|||||||.+||||+.+.++||+|||+|..
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999953
Q ss_pred -cccc-hhheeeccCcccc
Q 023430 265 -QLCC-FFFFLFLGGGVFN 281 (282)
Q Consensus 265 -~~~~-~~~~~~~ape~~~ 281 (282)
.+.+ .|++.|+|||.|+
T Consensus 209 ~~lqt~cgsppyAaPEl~~ 227 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFN 227 (596)
T ss_pred ccccccCCCCCccChHhhc
Confidence 2222 7799999999985
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=243.25 Aligned_cols=160 Identities=46% Similarity=0.754 Sum_probs=135.8
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHH-HHHHhcCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER-DILTKVTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+|+++ ..++.||+|++.+...........+..|. .+++.++|+||+++++++...+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-----AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 36999999999999976 35678999999865433333333344444 4578899999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++++|..++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
-.|++.|||||++
T Consensus 156 ~~gt~~y~aPE~~ 168 (325)
T cd05602 156 FCGTPEYLAPEVL 168 (325)
T ss_pred ccCCccccCHHHH
Confidence 1479999999986
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=241.94 Aligned_cols=161 Identities=32% Similarity=0.623 Sum_probs=139.0
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
++||+|+||.||+|+++ .++..||+|++++.........+.+..|..++.. ++|+||+++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-----GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 46999999999999987 3567899999987654333444556678888775 48999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-------c
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-------C 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-------~ 267 (282)
||+.+|+|..++...+.+++.++..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.... .
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 999999999999888889999999999999999999999999999999999999999999999999986421 1
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|++.|||||++.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (316)
T cd05620 156 FCGTPDYIAPEILQ 169 (316)
T ss_pred cCCCcCccCHHHHc
Confidence 15799999999873
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=245.88 Aligned_cols=172 Identities=38% Similarity=0.667 Sum_probs=153.6
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+.+..+.|...++||+|+||.||-|+.+ .+++.||+|.+.+..+..+.......+|..+|.+++.+.||.+-.+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvr-----aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVR-----ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEe-----cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 4466778999999999999999999877 57889999999887765555555567899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
++.+.+++||..|.||+|..+|...+ .|++.+++.++.+|+.||++||+.+||.|||||+|||||+.|+|.|+|+|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 99999999999999999998888766 6999999999999999999999999999999999999999999999999999
Q ss_pred cc-----ccc-chhheeeccCcccc
Q 023430 263 HN-----QLC-CFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~-----~~~-~~~~~~~~ape~~~ 281 (282)
-. -+. ..||.+|||||+++
T Consensus 335 vei~~g~~~~~rvGT~GYMAPEvl~ 359 (591)
T KOG0986|consen 335 VEIPEGKPIRGRVGTVGYMAPEVLQ 359 (591)
T ss_pred EecCCCCccccccCcccccCHHHHc
Confidence 42 222 28999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=249.61 Aligned_cols=152 Identities=44% Similarity=0.793 Sum_probs=143.8
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
++...-|..++.||-|+||+|.+++.. .+..+||+|.+++.....+.++..++.|..||...+++.||+||..|.
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~Kv-----DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKV-----DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeec-----chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 455677999999999999999999865 357789999999998888888899999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+.+.+|+||+|++||++..+|.+.+.|.|..+++++.++..|+++.|..|+|||||||+|||||.+|++||.|||||
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=236.18 Aligned_cols=164 Identities=24% Similarity=0.368 Sum_probs=138.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~ 188 (282)
..|+.+++||+|+||+||+|+.+ .++..||+|+++..... +.......+|+.+|+.++|+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~-----~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~ 84 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSK-----RTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN 84 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEe-----cCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence 35777788999999999999988 45688999999876432 122233567999999999999 999999998877
Q ss_pred ------EEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 189 ------KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 189 ------~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
.+++|+||+.. +|..++.... .++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|
T Consensus 85 ~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 85 NHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred cccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeec
Confidence 89999999965 8888887644 477789999999999999999999999999999999999999999999
Q ss_pred cCccccc-------ccchhheeeccCccc
Q 023430 259 SLNSHNQ-------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~-------~~~~~~~~~~ape~~ 280 (282)
||+|+.. ....+|.-|=|||++
T Consensus 164 FGlAra~~ip~~~yt~evvTlWYRaPEvL 192 (323)
T KOG0594|consen 164 FGLARAFSIPMRTYTPEVVTLWYRAPEVL 192 (323)
T ss_pred cchHHHhcCCcccccccEEEeeccCHHHh
Confidence 9999732 222568889999975
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=242.91 Aligned_cols=160 Identities=19% Similarity=0.329 Sum_probs=144.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
-|.++++||+|+||.||++.++ .++.++|||.+..+ ..++.+..|+.+|++++.++||++||.|.....+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~-----EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL 103 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHR-----ESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL 103 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHh-----ccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence 4677889999999999999988 57889999998654 3456788899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
|||||||..|++.+.+.. ++.+.+.++..+++..++||+|||...-||||||..|||++.+|..||+|||.+.+....
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999999999998864 567999999999999999999999999999999999999999999999999999654433
Q ss_pred ------hhheeeccCccc
Q 023430 269 ------FFFFLFLGGGVF 280 (282)
Q Consensus 269 ------~~~~~~~ape~~ 280 (282)
.||+.|||||++
T Consensus 184 AKRNTVIGTPFWMAPEVI 201 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVI 201 (502)
T ss_pred HhhCccccCcccccHHHH
Confidence 789999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=237.56 Aligned_cols=164 Identities=21% Similarity=0.338 Sum_probs=140.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.++||+|+||.||+|..+ .++..||+|+++.... ......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSK-----LTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTER 76 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEEC-----CCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 467999999999999999999876 3567899999865431 122345678999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
..++||||+.+ +|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 77 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 77 CLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred eEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 99999999985 8888886544 47899999999999999999999999999999999999999999999999986321
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...+++.|||||.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~ 175 (288)
T cd07871 156 PTKTYSNEVVTLWYRPPDVL 175 (288)
T ss_pred CCccccCceecccccChHHh
Confidence 22568999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=238.25 Aligned_cols=171 Identities=22% Similarity=0.280 Sum_probs=141.5
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCC-----------CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF 176 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n 176 (282)
..++|++.++||+|+||.||+|.+....+ ...+..||+|++.... .......+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45689999999999999999998653221 1234579999987543 2334556889999999999999
Q ss_pred eeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCE
Q 023430 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------IFREDQARFYTAEIVSAVSHLHKCGIV 237 (282)
Q Consensus 177 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~gL~ylH~~~ii 237 (282)
|+++++++...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999886532 356778899999999999999999999
Q ss_pred eeccCCCceEEcCCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 238 HRDLKPENILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 238 HrDlKp~NILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
||||||+|||++.++.+||+|||+++.... ..++..|||||.+
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence 999999999999999999999999864211 1236789999976
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=247.97 Aligned_cols=175 Identities=17% Similarity=0.244 Sum_probs=146.6
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
.|.+..++|++.+.||+|+||.||+|.+..++.......||+|++..... ....+.+.+|+.+++.+ +|+||+++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 34556678999999999999999999987665555667899999975432 23345688899999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhc-----------------------------------------------------
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQ----------------------------------------------------- 209 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 209 (282)
++...+.+++|||||++|+|.+++...
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 999999999999999999999888542
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc----
Q 023430 210 -----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC---- 268 (282)
Q Consensus 210 -----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~---- 268 (282)
..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 13677888999999999999999999999999999999999999999999998643221
Q ss_pred -----hhheeeccCccc
Q 023430 269 -----FFFFLFLGGGVF 280 (282)
Q Consensus 269 -----~~~~~~~ape~~ 280 (282)
.++..|||||++
T Consensus 270 ~~~~~~~~~~y~aPE~~ 286 (374)
T cd05106 270 VKGNARLPVKWMAPESI 286 (374)
T ss_pred eccCCCCccceeCHHHh
Confidence 124579999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=239.67 Aligned_cols=167 Identities=23% Similarity=0.296 Sum_probs=146.8
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+++++ ..+..+|+|++.... .....+.+.+|+++|+.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEEC-----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 4578999999999999999999977 456789999987542 223445688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
+.+++||||+++++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999999999998878899999999999999999999986 59999999999999999999999999986432
Q ss_pred c-----chhheeeccCcccc
Q 023430 267 C-----CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~-----~~~~~~~~ape~~~ 281 (282)
. ..|++.|+|||.+.
T Consensus 156 ~~~~~~~~g~~~y~aPE~~~ 175 (331)
T cd06649 156 DSMANSFVGTRSYMSPERLQ 175 (331)
T ss_pred ccccccCCCCcCcCCHhHhc
Confidence 2 15789999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=245.31 Aligned_cols=161 Identities=22% Similarity=0.236 Sum_probs=140.9
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+...+|++++.||+|+||.||+|... .+++.||+|.... +.+.+|+++|+.++||||++++++|.
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~-----~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~ 153 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDN-----KTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFT 153 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEEC-----CCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence 355678999999999999999999976 4567899996532 23567999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.....++|||++. ++|..++.....+++..++.++.|++.||.|||++|||||||||+|||++.++.++|+|||++...
T Consensus 154 ~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 154 YNKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred ECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 9999999999995 688888887778999999999999999999999999999999999999999999999999998532
Q ss_pred c--------cchhheeeccCcccc
Q 023430 266 L--------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~--------~~~~~~~~~ape~~~ 281 (282)
. ...||+.|||||++.
T Consensus 233 ~~~~~~~~~~~~gt~~y~aPE~~~ 256 (391)
T PHA03212 233 VDINANKYYGWAGTIATNAPELLA 256 (391)
T ss_pred ccccccccccccCccCCCChhhhc
Confidence 1 125799999999873
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=241.49 Aligned_cols=158 Identities=49% Similarity=0.806 Sum_probs=135.8
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCCeeeeeEEEEeCCEEEEEE
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
||+|+||+||+|+++ ..+..||+|++.+...........+..|..++..+ .||||+++++.+......|+||
T Consensus 1 lG~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEEC-----CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 699999999999976 45678999999765443333344455577776655 6999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864221
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
..|+..|||||.+
T Consensus 156 ~~gt~~y~aPE~~ 168 (330)
T cd05586 156 FCGTTEYLAPEVL 168 (330)
T ss_pred ccCCccccCHHHH
Confidence 2578999999986
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=239.13 Aligned_cols=164 Identities=21% Similarity=0.364 Sum_probs=139.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+.+ ..++.||+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK-----VNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC-----CCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 468999999999999999999976 3567899999875432 122234667999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
..++||||+. ++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9999999996 5677766553 568899999999999999999999999999999999999999999999999986321
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...+++.|||||++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~ 175 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVL 175 (303)
T ss_pred CCccCCCCcccCCCCChHHH
Confidence 12468899999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=239.75 Aligned_cols=161 Identities=33% Similarity=0.634 Sum_probs=138.4
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+|+++ ..+..||+|+++..........+....|..+++. ++||||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-----GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence 36999999999999976 3567899999987643333344556667778776 48999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-------c
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-------C 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-------~ 267 (282)
||+++|+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 999999999999877789999999999999999999999999999999999999999999999999986422 1
Q ss_pred chhheeeccCcccc
Q 023430 268 CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~~~~~~~~ape~~~ 281 (282)
..|++.|||||.+.
T Consensus 156 ~~gt~~y~aPE~~~ 169 (316)
T cd05619 156 FCGTPDYIAPEILL 169 (316)
T ss_pred ecCCccccCHHHHc
Confidence 15789999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=240.24 Aligned_cols=163 Identities=47% Similarity=0.755 Sum_probs=140.5
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+.||+|+||.||+++... ....+..||+|++.+.... ......+.+|+++++.++||||+++++++...+.+|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKIT--GPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEec--cCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence 579999999999987642 1245778999999865432 2233456789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-------
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------- 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------- 268 (282)
|+++|+|..++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998643222
Q ss_pred hhheeeccCcccc
Q 023430 269 FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ~~~~~~~ape~~~ 281 (282)
.|++.|||||.+.
T Consensus 159 ~g~~~y~aPE~~~ 171 (318)
T cd05582 159 CGTVEYMAPEVVN 171 (318)
T ss_pred cCChhhcCHHHHc
Confidence 4689999999863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=237.07 Aligned_cols=166 Identities=29% Similarity=0.412 Sum_probs=144.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.+.|++.++||+|.|+.||++.++ .++..+|+|++........ ..+.+.+|+.|.+.|+|||||++.+.+...+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~-----~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~ 83 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEES 83 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhc-----cchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccc
Confidence 467899999999999999999877 4566789998876655443 4567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEEecCccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~Dfg~s~~~ 265 (282)
..|||+|++.|++|..-+.....+++..+..+++||+.+|.|+|.++|||||+||+|+|+... .-|||+|||++...
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred eeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999999999997777666778999999999999999999999999999999999999754 34999999999643
Q ss_pred ccc------hhheeeccCccc
Q 023430 266 LCC------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~------~~~~~~~ape~~ 280 (282)
-.. .|+|.|||||++
T Consensus 164 ~~g~~~~G~~GtP~fmaPEvv 184 (355)
T KOG0033|consen 164 NDGEAWHGFAGTPGYLSPEVL 184 (355)
T ss_pred CCccccccccCCCcccCHHHh
Confidence 311 679999999987
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=240.28 Aligned_cols=161 Identities=38% Similarity=0.717 Sum_probs=141.4
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+++++ ..+..||+|++.+.........+.+.+|+.+++.+ +||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-----GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 36999999999999976 35678999999876544455566677899999888 6999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------ 268 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------ 268 (282)
||+++|+|..++.+.+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++......
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998642221
Q ss_pred -hhheeeccCcccc
Q 023430 269 -FFFFLFLGGGVFN 281 (282)
Q Consensus 269 -~~~~~~~ape~~~ 281 (282)
.|++.|||||.+.
T Consensus 156 ~~g~~~y~aPE~~~ 169 (318)
T cd05570 156 FCGTPDYIAPEILS 169 (318)
T ss_pred eecCccccCHHHhc
Confidence 4789999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=253.43 Aligned_cols=163 Identities=20% Similarity=0.269 Sum_probs=143.1
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|.-++.||.|+||.||.|++. .+..+||||++........+..+.+..|+..|++++|||+|.+.|+|..+...|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~-----~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeecc-----CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 556788999999999999976 567789999998777666677778899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc---cc
Q 023430 192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ---LC 267 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~---~~ 267 (282)
||||||-| +-.+++.- ++++.+.++..|+.+.+.||.|||+.+.||||||..|||+.+.|.|||+|||.+... ..
T Consensus 103 LVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred HHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 99999976 55566543 456899999999999999999999999999999999999999999999999988632 22
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
=.|||-|||||++
T Consensus 182 FvGTPywMAPEVI 194 (948)
T KOG0577|consen 182 FVGTPYWMAPEVI 194 (948)
T ss_pred ccCCccccchhHh
Confidence 2789999999986
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=233.43 Aligned_cols=165 Identities=36% Similarity=0.580 Sum_probs=142.7
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++.++||+|+||.||++.+. .++..||+|++.............+.+|+.+++.++|+||+++++.+..++.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-----CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence 4889999999999999999876 35678999999765443333345567899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
++||||+++|+|..++... ..+++..+..++.|++.||.|||+.+|+||||||+||++++++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999998887653 358999999999999999999999999999999999999999999999999986421
Q ss_pred ----cchhheeeccCccc
Q 023430 267 ----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ----~~~~~~~~~ape~~ 280 (282)
...|+..|||||.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~ 173 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVV 173 (285)
T ss_pred CccccccCCCCccCcHHh
Confidence 12568999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=231.45 Aligned_cols=168 Identities=24% Similarity=0.365 Sum_probs=145.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----hhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
...|+-.+.||+|..++|.+|.++ .+++.+|+|++..... .....++.-.+|+.||+++ .||+|+++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k-----~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHK-----ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhc-----ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 346777889999999999998877 4566789998864321 1223345567899999997 5999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+|+++..+++|+|+|+.|.|++++...-.+++.+.+.+++|++.|+.|||.++||||||||+|||+|++.+++|+|||+|
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecccee
Confidence 99999999999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred cc-----cccc-hhheeeccCcccc
Q 023430 263 HN-----QLCC-FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~-----~~~~-~~~~~~~ape~~~ 281 (282)
.. .+.+ .|||+|+|||.+.
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIK 195 (411)
T ss_pred eccCCchhHHHhcCCCcccChhhee
Confidence 63 2222 8999999999873
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=238.71 Aligned_cols=167 Identities=24% Similarity=0.332 Sum_probs=145.9
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||++.++ ..+..+|+|++.... .....+.+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEEC-----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC
Confidence 4578999999999999999999976 356679999886542 223345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
+.+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999999999998878899999999999999999999975 79999999999999999999999999986432
Q ss_pred c-----chhheeeccCcccc
Q 023430 267 C-----CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~-----~~~~~~~~ape~~~ 281 (282)
. ..|+..|+|||.+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~ 175 (333)
T cd06650 156 DSMANSFVGTRSYMSPERLQ 175 (333)
T ss_pred hhccccCCCCccccCHHHhc
Confidence 2 15789999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=245.07 Aligned_cols=175 Identities=18% Similarity=0.227 Sum_probs=144.4
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
.+.+..++|++.+.||+|+||.||+|++.+......+..||+|+++.... ....+.+.+|+.+|+.+ +||||+++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 34455668999999999999999999865443445667899999865432 22345678899999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcC----------------------------------------------------
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQG---------------------------------------------------- 210 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------- 210 (282)
++...+..++|||||++|+|..++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999998886421
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 211 -----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 211 -----------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
.+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 367788899999999999999999999999999999999999999999999864322
Q ss_pred c---------hhheeeccCccc
Q 023430 268 C---------FFFFLFLGGGVF 280 (282)
Q Consensus 268 ~---------~~~~~~~ape~~ 280 (282)
. .++..|||||.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~ 288 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESI 288 (375)
T ss_pred cccccccCCCCCCcceeChhHh
Confidence 1 124579999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=244.35 Aligned_cols=176 Identities=20% Similarity=0.261 Sum_probs=146.9
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeee
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLR 181 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~ 181 (282)
..+.+..++|+++++||+|+||.||+|.+...........||||++.... .....+.+.+|+.+|+.+. ||||++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~ 107 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLL 107 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEE
Confidence 34556677899999999999999999998655444455679999986543 2233456889999999996 99999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhc----------------------------------------------------
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQ---------------------------------------------------- 209 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------- 209 (282)
+++...+..|||||||++|+|.+++...
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 108 GACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 9999999999999999999998887542
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 210 --------------------------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 210 --------------------------------------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 136777888999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
||++.++.+||+|||++.....+ .++..|||||.+
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~ 311 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI 311 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence 99999999999999998643221 346789999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=234.75 Aligned_cols=165 Identities=25% Similarity=0.405 Sum_probs=141.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|+++ .++..||+|++..... .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-----CCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 47999999999999999999987 3567899999876432 22334567789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
.|+||||++++.+..+......+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99999999998776555445668999999999999999999999999999999999999999999999999986421
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|+..|+|||++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~ 173 (287)
T cd07848 155 NANYTEYVATRWYRSPELL 173 (287)
T ss_pred cccccccccccccCCcHHH
Confidence 12578899999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=245.89 Aligned_cols=166 Identities=27% Similarity=0.431 Sum_probs=147.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|+.++++|+|+||.++.++++. ....|++|.+.......+. .+....|+.+++++.|||||.+++.|..++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~-----~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~ 76 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS-----DDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDG 76 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc-----CCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCC
Confidence 3689999999999999999999873 4568999999877654444 335677999999999999999999999988
Q ss_pred E-EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 189 K-LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~-~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
. ++|||+||+||+|.+.+.+++ .+++..+..|+.|++.|+.|||+++|+|||||+.||++..++.|+|.|||+|+..
T Consensus 77 ~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l 156 (426)
T KOG0589|consen 77 QLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKIL 156 (426)
T ss_pred ceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhc
Confidence 8 999999999999999998754 5899999999999999999999999999999999999999999999999999854
Q ss_pred ccc-------hhheeeccCccc
Q 023430 266 LCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~-------~~~~~~~ape~~ 280 (282)
..+ .||+-||.||.|
T Consensus 157 ~~~~~~a~tvvGTp~YmcPEil 178 (426)
T KOG0589|consen 157 NPEDSLASTVVGTPYYMCPEIL 178 (426)
T ss_pred CCchhhhheecCCCcccCHHHh
Confidence 444 679999999987
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=239.04 Aligned_cols=163 Identities=18% Similarity=0.324 Sum_probs=138.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC---
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--- 187 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 187 (282)
+|++.++||+|+||.||+|+++ .++..||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-----CCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 5899999999999999999976 4567899999864322 222334577899999999999999999887543
Q ss_pred --CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+|+|||||. ++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 75 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 75 EFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 25899999995 689888888778999999999999999999999999999999999999999999999999998643
Q ss_pred cc----------chhheeeccCccc
Q 023430 266 LC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~----------~~~~~~~~ape~~ 280 (282)
.. ..|++.|||||++
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~ 178 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELC 178 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHH
Confidence 21 2578999999976
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=232.82 Aligned_cols=159 Identities=36% Similarity=0.577 Sum_probs=137.0
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||+|+||+||++.++ .+++.||+|++.+.........+.+..|+.+++.++|+||+++.+++......|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMR-----ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEc-----cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 699999999999876 456789999997665444444566778999999999999999999999999999999999
Q ss_pred CCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc------
Q 023430 198 NGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------ 267 (282)
Q Consensus 198 ~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------ 267 (282)
++|+|..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 99999877743 34589999999999999999999999999999999999999999999999999853211
Q ss_pred -chhheeeccCcccc
Q 023430 268 -CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 -~~~~~~~~ape~~~ 281 (282)
..|++.|||||.+.
T Consensus 156 ~~~g~~~y~aPE~~~ 170 (280)
T cd05608 156 GYAGTPGFMAPELLQ 170 (280)
T ss_pred ccCCCcCccCHHHhc
Confidence 15689999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=246.52 Aligned_cols=165 Identities=21% Similarity=0.257 Sum_probs=139.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
..|.+.+.||+|+||.||+|..... .+..||+|.+.... ......+.+|+.+|+.++||||+++++++...+.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~----~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD----PKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC----CCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence 3599999999999999999986532 24568888764432 2334567789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+||||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 9999999999999887753 345889999999999999999999999999999999999999999999999999642
Q ss_pred cc---------chhheeeccCcccc
Q 023430 266 LC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~---------~~~~~~~~ape~~~ 281 (282)
.. ..|++.|||||++.
T Consensus 220 ~~~~~~~~~~~~~gt~~y~aPE~~~ 244 (478)
T PTZ00267 220 SDSVSLDVASSFCGTPYYLAPELWE 244 (478)
T ss_pred CCccccccccccCCCccccCHhHhC
Confidence 11 14799999999863
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=253.14 Aligned_cols=168 Identities=36% Similarity=0.562 Sum_probs=149.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.++||+|+||.||+|.+. ..++.||||+++............+..|+.+++.++|+||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 468999999999999999999976 356789999998765444555667889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.+||||||+.+++|..++...+.+++..++.++.||+.||.|||.++||||||||+||||+.++.++|+|||+++...
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 999999999999999999887889999999999999999999999999999999999999999999999999997433
Q ss_pred -----cchhheeeccCcccc
Q 023430 267 -----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -----~~~~~~~~~ape~~~ 281 (282)
...+++.|++||...
T Consensus 158 ~~~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 158 ELNMMDILTTPSMAKPKNDY 177 (669)
T ss_pred cccccccccCccccCccccc
Confidence 236699999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=222.20 Aligned_cols=167 Identities=25% Similarity=0.349 Sum_probs=139.7
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 185 (282)
..+++.+++..||.|+.|.||+++++ .++.+.|||.+++.. ..++.+++...+.++... ++|+||+.+|+|.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~r-----s~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFR-----STGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEc-----ccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 44567778889999999999999988 467899999998765 455667787788776555 4999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.+..++|.||.|.. -+..++.+ ++.++|..+-.+...++.||.||.+ ++|||||+||+|||+|+.|++|+||||+|.
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsG 240 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISG 240 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccc
Confidence 99999999999853 23333333 5678999889999999999999985 589999999999999999999999999997
Q ss_pred ccccc------hhheeeccCcccc
Q 023430 264 NQLCC------FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~~------~~~~~~~ape~~~ 281 (282)
..+.. .||+.|||||.++
T Consensus 241 rlvdSkAhtrsAGC~~YMaPERid 264 (391)
T KOG0983|consen 241 RLVDSKAHTRSAGCAAYMAPERID 264 (391)
T ss_pred eeecccccccccCCccccCccccC
Confidence 55444 8999999999985
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=232.43 Aligned_cols=157 Identities=27% Similarity=0.482 Sum_probs=131.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-- 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 188 (282)
.|+-.+++|.|+||.||+|.... +++.+|||++-.+.. .-.+|.++|+.++|||||++..+|....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 58888999999999999999874 467899998865432 1346999999999999999988775432
Q ss_pred ---EEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-CcEEEEecC
Q 023430 189 ---KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMAAHSL 260 (282)
Q Consensus 189 ---~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-~~v~l~Dfg 260 (282)
.+.+||||++. +|...++. +..++...++.+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||
T Consensus 93 d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 93 DEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred chhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 35689999976 78887764 4678999999999999999999999999999999999999976 999999999
Q ss_pred cccccccc----hh--heeeccCccc
Q 023430 261 NSHNQLCC----FF--FFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~~----~~--~~~~~ape~~ 280 (282)
.|+..+.. .| +.-|=|||.+
T Consensus 172 SAK~L~~~epniSYicSRyYRaPELi 197 (364)
T KOG0658|consen 172 SAKVLVKGEPNISYICSRYYRAPELI 197 (364)
T ss_pred cceeeccCCCceeEEEeccccCHHHH
Confidence 99865544 33 7778899865
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=228.63 Aligned_cols=166 Identities=40% Similarity=0.652 Sum_probs=148.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||++.+. ..++.+|+|++...........+.+.+|+++++.++||||+++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 37999999999999999999976 3567899999977654444556678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
.|+||||+++++|.+++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999998753322
Q ss_pred ---hhheeeccCccc
Q 023430 269 ---FFFFLFLGGGVF 280 (282)
Q Consensus 269 ---~~~~~~~ape~~ 280 (282)
.+++.|+|||.+
T Consensus 156 ~~~~~~~~y~aPE~~ 170 (290)
T cd05580 156 YTLCGTPEYLAPEII 170 (290)
T ss_pred CCCCCCccccChhhh
Confidence 568899999976
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=226.85 Aligned_cols=169 Identities=18% Similarity=0.202 Sum_probs=143.4
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
...+|++.+.||+|+||.||+|.++.. ......||+|.++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~--~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLP--SKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRG 78 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecC--CCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence 346799999999999999999986532 23456799999876432 23345688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+++++||||||+|||++.++.++++|||.+....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999999988764 468999999999999999999999999999999999999999999999999875432
Q ss_pred cc--------hhheeeccCccc
Q 023430 267 CC--------FFFFLFLGGGVF 280 (282)
Q Consensus 267 ~~--------~~~~~~~ape~~ 280 (282)
.. .++..|+|||.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~ 180 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAI 180 (266)
T ss_pred ccchhcccCCCCceeecCHHHH
Confidence 21 235789999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=228.71 Aligned_cols=158 Identities=28% Similarity=0.401 Sum_probs=139.2
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+|+.|-.|... .++..||||++.+.. ...+.++.+|++++..++ |+||++|+++|+++..+||||
T Consensus 84 e~LGeGAyasVqtcv~i-----~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSI-----QTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHhcCccceeeeeeeee-----ccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 57999999999988766 467789999998763 455667889999999986 999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc---EEEEecCcccccc-----
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMAAHSLNSHNQL----- 266 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~---v~l~Dfg~s~~~~----- 266 (282)
|-|.||.|..+|.++..|++.++..++.+|+.||+|||.+||.||||||+|||....++ ||||||-+.....
T Consensus 156 EKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred ecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999999999999999999999999999999999999999999999999999976654 7999997764322
Q ss_pred --------cc-hhheeeccCcccc
Q 023430 267 --------CC-FFFFLFLGGGVFN 281 (282)
Q Consensus 267 --------~~-~~~~~~~ape~~~ 281 (282)
.. .|+..|||||+.+
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCCCCccccCcccchhhcchhHHh
Confidence 11 7899999999864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=252.00 Aligned_cols=175 Identities=21% Similarity=0.328 Sum_probs=153.0
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+...+.+..+.||+|.||+||+|+..+.........||||.++... +....+.|++|+++|..++|||||+|+|++.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 35566778889999999999999998877766788889999998764 3446678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ----------G----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~----------~----~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~ 251 (282)
.++.+++|+|||..|+|.++|... . .++..+.+.|+.||+.||+||-++.+|||||.++|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 999999999999999999998642 1 27788999999999999999999999999999999999999
Q ss_pred CcEEEEecCcccccccchh---------heeeccCccccC
Q 023430 252 GHVMAAHSLNSHNQLCCFF---------FFLFLGGGVFNF 282 (282)
Q Consensus 252 ~~v~l~Dfg~s~~~~~~~~---------~~~~~ape~~~~ 282 (282)
..|||+|||+|+.....+| -.+||+||.+-|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly 679 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY 679 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc
Confidence 9999999999986544422 568999998743
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=227.32 Aligned_cols=173 Identities=35% Similarity=0.692 Sum_probs=160.4
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
..+.++..+|.++++||+|+|++|.+++++ .+.++||+|+++++...+.+..++.+.|-.+.... +||.+|-+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~-----~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh 317 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH 317 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehc-----ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence 456678899999999999999999999987 56789999999999888888888899898888776 599999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
.+|.++..+++|.||++||+|..++.++..+++..++.+...|+.||.|||++|||.||||.+|+|+|.+|++|+.|+|.
T Consensus 318 scfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 318 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred hhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-------hhheeeccCccc
Q 023430 262 SHNQLCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~~-------~~~~~~~ape~~ 280 (282)
|+..+.+ .||+-|+|||++
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeil 423 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEIL 423 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhh
Confidence 9876655 679999999987
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=253.13 Aligned_cols=166 Identities=21% Similarity=0.241 Sum_probs=142.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.++||+|+||.||+|.+. ..++.||+|++...........+++.+|+.+++.++||||+++++++...+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-----~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-----VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-----CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence 68999999999999999999876 3567899999976543334445678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 190 LYLILDFINGGHLFFHLYRQ-----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
.|++|||++|++|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.+|.++|+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999999999888641 2245567788999999999999999999999999999999999999999
Q ss_pred cCcccccc-------------------------cchhheeeccCccc
Q 023430 259 SLNSHNQL-------------------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~-------------------------~~~~~~~~~ape~~ 280 (282)
||++.... .-.|++.|||||.+
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l 203 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL 203 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh
Confidence 99986431 01479999999976
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=227.32 Aligned_cols=166 Identities=36% Similarity=0.587 Sum_probs=143.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++.+.||+|+||.||++.++ .+++.||+|.+...........+.+.+|+.+++.++|+||+.+++.+...+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEc-----CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence 3778899999999999999987 45678999998765443333345567899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ--- 265 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~--- 265 (282)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++...
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999999998888543 34889999999999999999999999999999999999999999999999998532
Q ss_pred ---ccchhheeeccCcccc
Q 023430 266 ---LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ---~~~~~~~~~~ape~~~ 281 (282)
....|+..|||||.++
T Consensus 156 ~~~~~~~g~~~y~aPE~~~ 174 (285)
T cd05630 156 QTIKGRVGTVGYMAPEVVK 174 (285)
T ss_pred ccccCCCCCccccChHHHc
Confidence 1236789999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=236.28 Aligned_cols=159 Identities=29% Similarity=0.392 Sum_probs=138.7
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++||.|.||+||-|+++ .+++-||||++.+.+...+.. ..+++|+.||+.+.||.||.+...|++.+.+++|||
T Consensus 570 evLGSGQFG~VYgg~hR-----ktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME 643 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHR-----KTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME 643 (888)
T ss_pred hhccCCcceeeecceec-----ccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence 68999999999999988 577889999998877655443 679999999999999999999999999999999999
Q ss_pred ccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEEecCcccccccc---
Q 023430 196 FINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAAHSLNSHNQLCC--- 268 (282)
Q Consensus 196 ~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~Dfg~s~~~~~~--- 268 (282)
.+.|.-|.-.+. +.+++++.....++.||+.||.|||.++|+|+||||+|||+.+. -.|||||||.++..-..
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 997655544443 35789999999999999999999999999999999999999765 35999999999743332
Q ss_pred ---hhheeeccCccc
Q 023430 269 ---FFFFLFLGGGVF 280 (282)
Q Consensus 269 ---~~~~~~~ape~~ 280 (282)
.||++|+|||+|
T Consensus 724 rsVVGTPAYLaPEVL 738 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVL 738 (888)
T ss_pred hhhcCCccccCHHHH
Confidence 889999999997
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=226.47 Aligned_cols=165 Identities=35% Similarity=0.584 Sum_probs=142.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|+..+.||+|+||+||++.+. ..++.+|+|++.............+.+|+++++.++|+||+.+++.+..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVR-----ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence 3778899999999999999876 35678999998765443333445577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
+++|||+++++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999999998887653 358999999999999999999999999999999999999999999999999885321
Q ss_pred ----cchhheeeccCccc
Q 023430 267 ----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ----~~~~~~~~~ape~~ 280 (282)
...|+..|||||.+
T Consensus 156 ~~~~~~~g~~~~~aPE~~ 173 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVL 173 (285)
T ss_pred CcccCCCCCcCccChHHh
Confidence 12678999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-33 Score=250.84 Aligned_cols=163 Identities=28% Similarity=0.453 Sum_probs=141.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
+.|+|+..||.|+||.||+|..+. ++...|.|++... ..+.++.+.-||+||..|+||+||+|++.|..++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke-----t~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE-----TKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc-----chhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 457788899999999999998773 4455677777543 35566778889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~ 268 (282)
+||+.|||.||-....+.. ...+.+.++..+++|++.||.|||+++|||||||..|||+.-+|.|+|+|||.|......
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999999999988766654 456999999999999999999999999999999999999999999999999999754433
Q ss_pred -------hhheeeccCccc
Q 023430 269 -------FFFFLFLGGGVF 280 (282)
Q Consensus 269 -------~~~~~~~ape~~ 280 (282)
.|||-|||||+.
T Consensus 184 ~qkRDsFIGTPYWMAPEVv 202 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVV 202 (1187)
T ss_pred HhhhccccCCcccccchhe
Confidence 679999999985
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=238.12 Aligned_cols=163 Identities=21% Similarity=0.327 Sum_probs=132.6
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC------CCeeeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQLR 181 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~ 181 (282)
..++|+++++||+|+||+||+|.+. ..++.||||+++... ...+.+..|+.+++.++| .+|++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDR-----KRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEc-----CCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 3578999999999999999999876 356789999986432 112334557777766654 4588888
Q ss_pred EEEEeC-CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCC-------
Q 023430 182 YSFQTR-SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDG------- 252 (282)
Q Consensus 182 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~------- 252 (282)
++|... ..+|+|||++ +++|.+++.+.+.+++..+..++.||+.||.|||. .|||||||||+|||++.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 888754 5789999988 67888888888889999999999999999999998 5999999999999998766
Q ss_pred ---------cEEEEecCcccccc----cchhheeeccCccc
Q 023430 253 ---------HVMAAHSLNSHNQL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 253 ---------~v~l~Dfg~s~~~~----~~~~~~~~~ape~~ 280 (282)
.+||+|||++.... ...||+.|||||++
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~ 317 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVV 317 (467)
T ss_pred ccccCCCCceEEECCCCccccCccccccccCCccccCcHHh
Confidence 49999999885422 23679999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=242.43 Aligned_cols=162 Identities=23% Similarity=0.253 Sum_probs=143.2
Q ss_pred hhhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeee
Q 023430 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR 181 (282)
Q Consensus 102 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 181 (282)
...|.+..+...-++.||.|+-|.||+++.+ ++.||||+++.- -..+|+-|++|+|+||+.|.
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-------netVAVKKV~el----------kETdIKHLRkLkH~NII~Fk 178 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH-------NETVAVKKVREL----------KETDIKHLRKLKHPNIITFK 178 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeecc-------CceehhHHHhhh----------hhhhHHHHHhccCcceeeEe
Confidence 3456676667777889999999999999865 456999987432 12478899999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
|+|.....+|||||||..|.|+..|+....+.......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.
T Consensus 179 GVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 179 GVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred eeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999999999999888899999999999999999999999999999999999999999999999999
Q ss_pred ccccccc------hhheeeccCccc
Q 023430 262 SHNQLCC------FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~~------~~~~~~~ape~~ 280 (282)
|+....- .||..|||||++
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvI 283 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVI 283 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHh
Confidence 9854332 679999999987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-33 Score=236.90 Aligned_cols=171 Identities=36% Similarity=0.674 Sum_probs=154.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 185 (282)
+...+|..+.+||+|+||+|.++..++ +..+||||+++++.+...+.++.-..|-++|.... -|.+++++.+|.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred eeecccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 445689999999999999999999875 56789999999988777777776677888887764 678999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+-+.+|+||||+.||+|.-.+..-+.+.+..+..++..|+.||-|||++|||.||||.+|||||.+|+|||+|||+|+..
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999999977
Q ss_pred ccc-------hhheeeccCccccC
Q 023430 266 LCC-------FFFFLFLGGGVFNF 282 (282)
Q Consensus 266 ~~~-------~~~~~~~ape~~~~ 282 (282)
+-+ .||+-|||||++.|
T Consensus 501 i~~~~TTkTFCGTPdYiAPEIi~Y 524 (683)
T KOG0696|consen 501 IFDGVTTKTFCGTPDYIAPEIIAY 524 (683)
T ss_pred ccCCcceeeecCCCcccccceEEe
Confidence 665 78999999999865
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=224.98 Aligned_cols=158 Identities=32% Similarity=0.566 Sum_probs=135.2
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||+|+||.||+++.+ ..++.||+|.+.............+..|+++++.++||||+++++.+......|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVK-----NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEc-----cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 699999999999877 457789999987654333333344567999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc------ccch
Q 023430 198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ------LCCF 269 (282)
Q Consensus 198 ~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~------~~~~ 269 (282)
++++|..++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++... ....
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 9999988876543 4788899999999999999999999999999999999999999999999988632 1236
Q ss_pred hheeeccCccc
Q 023430 270 FFFLFLGGGVF 280 (282)
Q Consensus 270 ~~~~~~ape~~ 280 (282)
|+..|+|||++
T Consensus 156 ~~~~y~aPE~~ 166 (277)
T cd05607 156 GTNGYMAPEIL 166 (277)
T ss_pred CCCCccCHHHH
Confidence 78999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=242.47 Aligned_cols=168 Identities=26% Similarity=0.344 Sum_probs=141.4
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|.+.+.||+|+||.||+|++. ..+..||||++..... .......+.+|+.++..++|+||++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRV-----SDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEc-----CCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3468999999999999999999876 4567899999876543 233455678899999999999999998776533
Q ss_pred C--------EEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEE
Q 023430 188 S--------KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 188 ~--------~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~ 255 (282)
. .+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 378999999999999988642 4588999999999999999999999999999999999999999999
Q ss_pred EEecCccccccc---------chhheeeccCcccc
Q 023430 256 AAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 256 l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
|+|||+++.... -.|++.|||||.+.
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 218 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR 218 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhC
Confidence 999999863211 14789999999874
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=259.27 Aligned_cols=166 Identities=25% Similarity=0.386 Sum_probs=139.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|+.++.||+|+||.||+++++ -.++.||||+++... .......+.+|+.+|.+|+|||||++|..|....
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNK-----lDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNK-----LDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeec-----ccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 357888899999999999999988 567889999998765 3344556889999999999999999987773221
Q ss_pred E-------------------------------------------------------------------------------
Q 023430 189 K------------------------------------------------------------------------------- 189 (282)
Q Consensus 189 ~------------------------------------------------------------------------------- 189 (282)
.
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 0
Q ss_pred ----------------------------------------EEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHH
Q 023430 190 ----------------------------------------LYLILDFINGGHLFFHLYRQGIF-REDQARFYTAEIVSAV 228 (282)
Q Consensus 190 ----------------------------------------~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~i~~qi~~gL 228 (282)
+||-||||+.-.|.+++.++... ....+.++++||+.||
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHH
Confidence 79999999998888877765443 4788899999999999
Q ss_pred HHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-------------------------cchhheeeccCcccc
Q 023430 229 SHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-------------------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 229 ~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-------------------------~~~~~~~~~ape~~~ 281 (282)
.|+|++|||||||||.||++++++.|||.|||++.... ...||..|+|||.|.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999999999999999999999999999999996511 117899999999874
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=225.27 Aligned_cols=173 Identities=17% Similarity=0.208 Sum_probs=142.9
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||++.+++......+..||+|++.... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4456899999999999999999987754333456779999885432 12233457889999999999999999999998
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEE
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMA 256 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l 256 (282)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|||+++++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 899999999999999999886532 2467788899999999999999999999999999999999999999
Q ss_pred EecCccccccc---------chhheeeccCcccc
Q 023430 257 AHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 257 ~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
+|||++..... ..++..|||||.+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 194 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 194 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhh
Confidence 99999864321 13366899999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=245.67 Aligned_cols=170 Identities=22% Similarity=0.351 Sum_probs=144.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 183 (282)
..++..++++.+.|.+|+|+.||.|+... .+..||+|++-.. ++..++.+.+||.+|+.|+ |+|||.|++.
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~-----~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVK-----GGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecC-----CCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 34556678999999999999999999763 3377999988654 5667788999999999997 9999999993
Q ss_pred -EEe------CCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcCCC
Q 023430 184 -FQT------RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG 252 (282)
Q Consensus 184 -~~~------~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~~~ 252 (282)
... .-.++|+||||.||.|.+++.. +..|.+.+++.|+.|+++|+.+||.+. |||||||.+||||..+|
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g 183 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG 183 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC
Confidence 221 1268899999999999999874 456999999999999999999999997 99999999999999999
Q ss_pred cEEEEecCcccccccc----------------hhheeeccCccccC
Q 023430 253 HVMAAHSLNSHNQLCC----------------FFFFLFLGGGVFNF 282 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~~----------------~~~~~~~ape~~~~ 282 (282)
+.||||||.+...+.. +-|+.|=|||.+|+
T Consensus 184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl 229 (738)
T KOG1989|consen 184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL 229 (738)
T ss_pred CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh
Confidence 9999999988533222 44999999999874
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=243.24 Aligned_cols=166 Identities=19% Similarity=0.282 Sum_probs=138.6
Q ss_pred CCe-EEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechh-hhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 110 GDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
++| +...+||+|+|-+||+|.+. ..+..||--.++... ......+++|..|+.+|+.|+|+||+++|++|.+.
T Consensus 39 gRy~k~~evLGrGafKtVYka~De-----~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDE-----EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred Cceeehhhhcccccceeeeecccc-----ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 444 34478999999999999864 344445544333322 23345568899999999999999999999999876
Q ss_pred CE--EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcC-CCcEEEEecCcc
Q 023430 188 SK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMAAHSLNS 262 (282)
Q Consensus 188 ~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~-~~~v~l~Dfg~s 262 (282)
.. +.+|+|++..|+|..|+.+.+.+....++.|++||++||.|||++. |||||||.+||+|+. .|.|||.|+|||
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence 54 8899999999999999999999999999999999999999999986 999999999999985 599999999999
Q ss_pred cc-----cccchhheeeccCccc
Q 023430 263 HN-----QLCCFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~-----~~~~~~~~~~~ape~~ 280 (282)
+. ...-.|||.|||||.+
T Consensus 194 tl~r~s~aksvIGTPEFMAPEmY 216 (632)
T KOG0584|consen 194 TLLRKSHAKSVIGTPEFMAPEMY 216 (632)
T ss_pred HHhhccccceeccCccccChHHH
Confidence 63 2223899999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=226.57 Aligned_cols=164 Identities=20% Similarity=0.311 Sum_probs=141.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe---
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--- 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 186 (282)
..|..++.||+|+||.|+.+.++ .++..||||++.... ......++..+|+.+|+.++|+||+.+++.+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~-----~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDK-----RTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEc-----CCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 45666899999999999999987 456789999986433 344556677889999999999999999999876
Q ss_pred --CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
-..+|+|+|+| +-+|...++.+..+.+..++.++.|+++||+|+|+.+|+||||||.|+|++.++.+||+|||+|+.
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence 24799999999 458888888777799999999999999999999999999999999999999999999999999986
Q ss_pred cc----cc-----hhheeeccCccc
Q 023430 265 QL----CC-----FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~----~~-----~~~~~~~ape~~ 280 (282)
.- .. .-|.-|=|||.+
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPEll 199 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELL 199 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHH
Confidence 52 22 228899999976
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=233.82 Aligned_cols=157 Identities=20% Similarity=0.173 Sum_probs=135.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
...|.+.+.||+|+||.||++.+.. .+..||||.... ..+.+|+++|+.++|+|||++++++...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-----~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~ 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGG 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-----CCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 4579999999999999999999773 456799996422 22567999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
..++|||++. ++|..++... ..+++.+++.++.|++.||.|||++|||||||||+|||++.++.++|+|||+++...
T Consensus 234 ~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 234 LTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 9999999995 5787777653 468999999999999999999999999999999999999999999999999986321
Q ss_pred --------cchhheeeccCccc
Q 023430 267 --------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 --------~~~~~~~~~ape~~ 280 (282)
...|+..|||||.+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~ 334 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVL 334 (461)
T ss_pred ccccccccccCCCcCCcCHHHH
Confidence 12479999999986
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=228.09 Aligned_cols=164 Identities=20% Similarity=0.318 Sum_probs=139.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||.||+|+.+ ..+..||+|.+..... ......+.+|+.+++.++|+||+++++++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 77 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSK-----LTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK 77 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEec-----CCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC
Confidence 467999999999999999999876 3566899999875432 122234667999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
..++||||+++ +|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 78 SLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred eEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 99999999986 777777654 447899999999999999999999999999999999999999999999999986421
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...+++.|+|||.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~ 176 (309)
T cd07872 157 PTKTYSNEVVTLWYRPPDVL 176 (309)
T ss_pred CccccccccccccccCCHHH
Confidence 12458899999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=236.70 Aligned_cols=176 Identities=19% Similarity=0.269 Sum_probs=146.4
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~ 182 (282)
.+.+..++|.+.+.||+|+||.||+|++++.........||+|++..... ....+.+.+|+.+|..+. |+||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 45566678999999999999999999987654445567899999975432 223456788999999997 999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcC----------------------------------------------------
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQG---------------------------------------------------- 210 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------------------------------------- 210 (282)
++...+.+++||||+.+|+|.+++.+.+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999886531
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCC
Q 023430 211 ----------------------------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244 (282)
Q Consensus 211 ----------------------------------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~ 244 (282)
.+++..++.++.|++.||.|||+++|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2456678889999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCccccccc---------chhheeeccCcccc
Q 023430 245 NILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 245 NILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
|||++.++.++|+|||+++.... ..++..|||||.+.
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 314 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIF 314 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhc
Confidence 99999999999999999864221 13467899999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=228.65 Aligned_cols=170 Identities=19% Similarity=0.207 Sum_probs=140.5
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+...+|++.+.||+|+||.||+|++...+. .....||+|++.... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~ 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCC-ccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence 456789999999999999999999764322 223458999986432 22344568889999999999999999998876
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
. ..++++||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||++...
T Consensus 81 ~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 81 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred C-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 4 578999999999999998764 45888999999999999999999999999999999999999999999999999743
Q ss_pred ccc---------hhheeeccCccc
Q 023430 266 LCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~---------~~~~~~~ape~~ 280 (282)
..+ .++..|||||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~ 183 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESI 183 (316)
T ss_pred cCCCcceeccCCccceeecChHHh
Confidence 211 225679999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=224.54 Aligned_cols=166 Identities=36% Similarity=0.572 Sum_probs=145.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||++.++ ..++.|++|.+...........+.+.+|+.+++.++|+||+++++.+..++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC-----CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence 37999999999999999999977 3567899999876654344455678889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
+++||||++|++|..++...+.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999886311
Q ss_pred -------------------cchhheeeccCccc
Q 023430 267 -------------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -------------------~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhc
Confidence 11357789999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=232.24 Aligned_cols=163 Identities=21% Similarity=0.312 Sum_probs=136.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++.+. ..+..||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDT-----VLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEc-----CCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 468999999999999999999876 4567899999865432 2233455778999999999999999999886543
Q ss_pred ------EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+|+||||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999976 4555553 34788999999999999999999999999999999999999999999999999
Q ss_pred ccccc------chhheeeccCccc
Q 023430 263 HNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~------~~~~~~~~ape~~ 280 (282)
..... ..|++.|||||.+
T Consensus 171 ~~~~~~~~~~~~~~t~~y~aPE~~ 194 (359)
T cd07876 171 RTACTNFMMTPYVVTRYYRAPEVI 194 (359)
T ss_pred cccccCccCCCCcccCCCCCchhc
Confidence 64322 2568899999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=236.07 Aligned_cols=163 Identities=20% Similarity=0.276 Sum_probs=138.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-- 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 188 (282)
+|++.+.||+|+||.||++... ..++.||+|++..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-----RDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-----CCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 4788899999999999999875 4567899998864321 2223456788999999999999999999998776
Q ss_pred ---EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+|+||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7999999997 578888877778999999999999999999999999999999999999999999999999998643
Q ss_pred cc--------chhheeeccCccc
Q 023430 266 LC--------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~--------~~~~~~~~ape~~ 280 (282)
.. ..++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~ 176 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEIL 176 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHH
Confidence 22 1457889999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=231.69 Aligned_cols=158 Identities=20% Similarity=0.280 Sum_probs=135.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|++.+.||+|+||.||+|++. ..+..||+|+..... ...|+.+++.++|+||+++++++....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKP-----GQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEEC-----CCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 457999999999999999999976 345679999754322 345899999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..++|||++. ++|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred eeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9999999996 477777754 45689999999999999999999999999999999999999999999999999964221
Q ss_pred ------chhheeeccCcccc
Q 023430 268 ------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ------~~~~~~~~ape~~~ 281 (282)
..|+..|||||.+.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~ 229 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLA 229 (357)
T ss_pred CcccccccccccccCCeecC
Confidence 25789999999873
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=221.64 Aligned_cols=164 Identities=30% Similarity=0.457 Sum_probs=143.6
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|++.+.||+|+||+||+++.. ..+..||+|++......... .....+|+.+++.++|+||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-----KNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-----TTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-----CCCeEEEEEEeccccccccc-cchhhhhhhcccccccccccccccccccccccc
Confidence 789999999999999999987 45668999999876543322 233455999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc---c---
Q 023430 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN---Q--- 265 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~---~--- 265 (282)
+|||++++++|.+++.....+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+.. .
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~ 154 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN 154 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999998778899999999999999999999999999999999999999999999999999852 1
Q ss_pred -ccchhheeeccCcccc
Q 023430 266 -LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 -~~~~~~~~~~ape~~~ 281 (282)
....++..|+|||.++
T Consensus 155 ~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp BSSSSSSGGGSCHHHHT
T ss_pred ccccccccccccccccc
Confidence 1225688999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=225.10 Aligned_cols=171 Identities=19% Similarity=0.276 Sum_probs=144.7
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|.............+++|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 345799999999999999999987755434455679999886543 233445688999999999999999999999988
Q ss_pred CEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~ 251 (282)
...|++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 8999999999999999998764 347788999999999999999999999999999999999999
Q ss_pred CcEEEEecCcccccc---------cchhheeeccCccc
Q 023430 252 GHVMAAHSLNSHNQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 252 ~~v~l~Dfg~s~~~~---------~~~~~~~~~ape~~ 280 (282)
+.++|+|||++.... ...+++.|||||.+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI 198 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHh
Confidence 999999999986321 11346789999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=238.11 Aligned_cols=160 Identities=21% Similarity=0.339 Sum_probs=131.1
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
...+|++.++||+|+||.||+|.+. ..+..||||++.... ....+|+.+|+.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICI-----DTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 4568999999999999999999976 356789999885432 1234699999999999999998876432
Q ss_pred --------CEEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cE
Q 023430 188 --------SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HV 254 (282)
Q Consensus 188 --------~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v 254 (282)
..+++||||+++ +|..++. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCce
Confidence 247799999986 5655553 245689999999999999999999999999999999999999665 69
Q ss_pred EEEecCcccccc------cchhheeeccCccc
Q 023430 255 MAAHSLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 255 ~l~Dfg~s~~~~------~~~~~~~~~ape~~ 280 (282)
||+|||+|+... ...|++.|||||.+
T Consensus 211 kL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~ 242 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQRSVSYICSRFYRAPELM 242 (440)
T ss_pred eeeccccchhccCCCCcccCCCCcCccCHHHh
Confidence 999999997432 22568899999975
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=225.39 Aligned_cols=164 Identities=23% Similarity=0.319 Sum_probs=143.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||++.+. .++..+|+|.+.... .....+.+.+|+++++.++||||+++++.+..++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 73 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE 73 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc-----CCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE
Confidence 36999999999999999999876 345679999886542 23344567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
+++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++.....
T Consensus 74 ~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 74 ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred EEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999999999999888889999999999999999999997 6899999999999999999999999999864321
Q ss_pred ----chhheeeccCccc
Q 023430 268 ----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----~~~~~~~~ape~~ 280 (282)
-.++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~aPE~~ 170 (308)
T cd06615 154 MANSFVGTRSYMSPERL 170 (308)
T ss_pred ccccCCCCcCccChhHh
Confidence 1468899999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=220.77 Aligned_cols=166 Identities=20% Similarity=0.319 Sum_probs=143.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|+++ ..+..||||.+.............+.+|+.+++.++||||+++++.+...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-----LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-----CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 57999999999999999999976 3567899998865443344455668889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+++|||+++++|..++.. ...+++..+..++.|++.||.|||+++++|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999999887753 344788999999999999999999999999999999999999999999999988632
Q ss_pred c-------cchhheeeccCccc
Q 023430 266 L-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~-------~~~~~~~~~ape~~ 280 (282)
. ...++..|||||.+
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~ 178 (267)
T cd08228 157 SSKTTAAHSLVGTPYYMSPERI 178 (267)
T ss_pred cchhHHHhcCCCCccccChhhh
Confidence 1 12568899999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=232.26 Aligned_cols=174 Identities=19% Similarity=0.259 Sum_probs=143.5
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
|.+..++|++.+.||+|+||.||+|.+.++....+++.||+|+++... .....+.+..|+.+++.+ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 445567899999999999999999987766555667889999986532 122345577899999999 79999999998
Q ss_pred EEe-CCEEEEEEeccCCCchHHHHHhc-----------------------------------------------------
Q 023430 184 FQT-RSKLYLILDFINGGHLFFHLYRQ----------------------------------------------------- 209 (282)
Q Consensus 184 ~~~-~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 209 (282)
+.. +..++++|||+++++|..++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 764 45789999999999999888542
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc---------hhhe
Q 023430 210 --------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC---------FFFF 272 (282)
Q Consensus 210 --------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~---------~~~~ 272 (282)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... .++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 25788889999999999999999999999999999999999999999999999753211 2356
Q ss_pred eeccCccc
Q 023430 273 LFLGGGVF 280 (282)
Q Consensus 273 ~~~ape~~ 280 (282)
.|||||.+
T Consensus 240 ~y~aPE~~ 247 (337)
T cd05054 240 KWMAPESI 247 (337)
T ss_pred cccCcHHh
Confidence 79999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=226.42 Aligned_cols=170 Identities=24% Similarity=0.319 Sum_probs=140.1
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 185 (282)
+..++|++.+.||+|+||.||+|.++.. .....+++|.+.... .....+.+.+|+.++.++ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~---~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~ 78 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACE 78 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccC---CceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence 4567899999999999999999997632 122345777665322 233445688899999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~ 249 (282)
..+..|+||||+++++|.+++.+.+ .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~ 158 (303)
T cd05088 79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158 (303)
T ss_pred CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec
Confidence 9999999999999999999987542 468889999999999999999999999999999999999
Q ss_pred CCCcEEEEecCccccccc------chhheeeccCcccc
Q 023430 250 SDGHVMAAHSLNSHNQLC------CFFFFLFLGGGVFN 281 (282)
Q Consensus 250 ~~~~v~l~Dfg~s~~~~~------~~~~~~~~ape~~~ 281 (282)
.++.++|+|||++..... ..++..|||||.+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (303)
T cd05088 159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 196 (303)
T ss_pred CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHh
Confidence 999999999999964221 12256799999763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=234.45 Aligned_cols=161 Identities=22% Similarity=0.273 Sum_probs=139.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|++++.||+|+||.||+|...+. ..+..|++|.+.... ...+|+.+|+.++|+||+++++++....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~---~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGD---EQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCC---ccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 45799999999999999999986532 345678999875431 2457999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|++||++. ++|..++.....+++.+++.++.||+.||.|||++|||||||||+|||++.++.++|+|||++....
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 5788888777789999999999999999999999999999999999999999999999999985321
Q ss_pred -------cchhheeeccCcccc
Q 023430 267 -------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -------~~~~~~~~~ape~~~ 281 (282)
...|++.|||||.+.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~ 260 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLA 260 (392)
T ss_pred cccccccccccccCccCHhHhc
Confidence 125799999999874
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=236.17 Aligned_cols=167 Identities=26% Similarity=0.373 Sum_probs=146.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHH-----HHHHHHHHHHhcC---CCCeeee
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD-----YMKAERDILTKVT---HPFIVQL 180 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~nIv~l 180 (282)
..+|..++.+|+|+||.|++|.++ .....|+||.+.+.+.....+++ .+-.||+||..++ |+||+++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K-----~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHK-----ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred cccceeeeeccccccceEEEeeec-----ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 457999999999999999999988 45778999999887654433322 2457999999998 9999999
Q ss_pred eEEEEeCCEEEEEEecc-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 181 RYSFQTRSKLYLILDFI-NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
+++|++++.+||+||-. +|.+|++++..+..+.|.++..|++|++.|+++||++||||||||-+|++++.+|-|||+||
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 99999999999999975 45699999999999999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-----hhheeeccCccc
Q 023430 260 LNSHNQLCC-----FFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~~-----~~~~~~~ape~~ 280 (282)
|.|.--..- .||..|+|||+|
T Consensus 715 gsaa~~ksgpfd~f~gtv~~aapevl 740 (772)
T KOG1152|consen 715 GSAAYTKSGPFDVFVGTVDYAAPEVL 740 (772)
T ss_pred cchhhhcCCCcceeeeeccccchhhh
Confidence 998633322 569999999987
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=220.90 Aligned_cols=164 Identities=23% Similarity=0.369 Sum_probs=143.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+.+ ..+..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~ 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL-----HTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC-----CCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence 457999999999999999999976 356789999986542 223345778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+||||+++++|.+++...+.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++....
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 999999999999999998877789999999999999999999999999999999999999999999999999986422
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 160 ~~~~~~~~~~~~y~~PE~~ 178 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred ccccCccccCccccCHhHc
Confidence 12467899999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=223.14 Aligned_cols=173 Identities=17% Similarity=0.215 Sum_probs=142.4
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.++||+|+||.||+|..+....+.....||+|.+..... ......+.+|+.+++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 455678999999999999999999876543334566799998764431 122334678999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEE
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~ 255 (282)
.....++||||+++|+|.+++...+ .+....+..++.|++.||.|||+++|+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999986532 235677888999999999999999999999999999999999999
Q ss_pred EEecCccccccc---------chhheeeccCccc
Q 023430 256 AAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 256 l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
|+|||+++.... ..++..|||||.+
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 193 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHh
Confidence 999999864221 1335679999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=230.66 Aligned_cols=174 Identities=18% Similarity=0.275 Sum_probs=142.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
|.+..++|++.+.||+|+||.||+|.+.+......++.||||+++... .....+.+.+|+.++..+ +|+||++++++
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 345567899999999999999999997765555567889999987543 223345677899999999 58999999988
Q ss_pred EEe-CCEEEEEEeccCCCchHHHHHhc-----------------------------------------------------
Q 023430 184 FQT-RSKLYLILDFINGGHLFFHLYRQ----------------------------------------------------- 209 (282)
Q Consensus 184 ~~~-~~~~~lv~e~~~~g~L~~~l~~~----------------------------------------------------- 209 (282)
+.. ...++++|||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 765 45689999999999999888642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-------
Q 023430 210 --------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------- 268 (282)
Q Consensus 210 --------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------- 268 (282)
..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++.....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 13567788889999999999999999999999999999999999999999998643211
Q ss_pred --hhheeeccCccc
Q 023430 269 --FFFFLFLGGGVF 280 (282)
Q Consensus 269 --~~~~~~~ape~~ 280 (282)
.++..|||||.+
T Consensus 240 ~~~~~~~y~aPE~~ 253 (343)
T cd05103 240 DARLPLKWMAPETI 253 (343)
T ss_pred CCCCCcceECcHHh
Confidence 235679999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=242.40 Aligned_cols=163 Identities=28% Similarity=0.368 Sum_probs=137.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-- 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 188 (282)
.|...+.||+|+||.||+++++ .+|+.||||.++... ....++.+.+|+++|++++|+|||++++.-++..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnk-----etG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNK-----ETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeeccc-----ccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 4666788999999999999987 577889999998754 2344566888999999999999999988765433
Q ss_pred ----EEEEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc--CCCc--EEEE
Q 023430 189 ----KLYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGH--VMAA 257 (282)
Q Consensus 189 ----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~--~~~~--v~l~ 257 (282)
...+|||||.||+|+..+.+. ..+++.+++.++.+++.||.|||++|||||||||.||++- .+|. -||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 568999999999999999763 3489999999999999999999999999999999999984 3344 6999
Q ss_pred ecCcccccccc------hhheeeccCccc
Q 023430 258 HSLNSHNQLCC------FFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~~~------~~~~~~~ape~~ 280 (282)
|||.|+..-.+ .||..|++||.+
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~ 195 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELY 195 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHH
Confidence 99999854433 779999999976
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=221.86 Aligned_cols=171 Identities=18% Similarity=0.249 Sum_probs=142.0
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|.+...+. ..+..+++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 79 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGM-DHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE 79 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCC-CCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence 34679999999999999999998643221 345679999986532 233345688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~ 250 (282)
...|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999999999988532 23678889999999999999999999999999999999999
Q ss_pred CCcEEEEecCccccccc---------chhheeeccCcccc
Q 023430 251 DGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 251 ~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
++.++|+|||+++.... ..++..|+|||.+.
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 199 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIM 199 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhc
Confidence 99999999999964321 13356799999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=232.15 Aligned_cols=167 Identities=23% Similarity=0.292 Sum_probs=144.6
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
++..+...+.++||+|-||.|.+|... ....||||+++... ..+.++.|..|+++|.+|+||||++++++|.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve------g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE------GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec------CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 455567888999999999999999854 24679999998765 3455678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.++.+++++||+++|+|.+++.++.. ........++.||+.||+||.+.++|||||.+.|+|++.++++||+|||.|+
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 99999999999999999999988733 3445667799999999999999999999999999999999999999999998
Q ss_pred ccccchh---------heeeccCccc
Q 023430 264 NQLCCFF---------FFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~~~~---------~~~~~ape~~ 280 (282)
+.....+ -.+|||+|.+
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsi 711 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESI 711 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHH
Confidence 6544422 4799999975
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=219.57 Aligned_cols=163 Identities=24% Similarity=0.374 Sum_probs=138.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++.++. ...+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA------QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK 72 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc------CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence 4579999999999999999998752 34689998764432 1245778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..++||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.....
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence 999999999999999988653 4588999999999999999999999999999999999999999999999998864321
Q ss_pred -----c---hhheeeccCcccc
Q 023430 268 -----C---FFFFLFLGGGVFN 281 (282)
Q Consensus 268 -----~---~~~~~~~ape~~~ 281 (282)
. .+...|+|||.+.
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFN 174 (256)
T ss_pred CceeccCCCCCchhhCChhhcc
Confidence 1 2345799999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=217.75 Aligned_cols=166 Identities=28% Similarity=0.371 Sum_probs=143.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
++|++.+.||+|+||.||++... ..+..+|+|.+...... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-----DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-----CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence 47899999999999999999865 35678999988654321 122345688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
...++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 9999999999999999999888889999999999999999999999999999999999999999999999999985321
Q ss_pred ---------cchhheeeccCccc
Q 023430 267 ---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ---------~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~ 179 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVI 179 (263)
T ss_pred cccccccccCCCcCccccCccee
Confidence 12457789999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=224.09 Aligned_cols=158 Identities=11% Similarity=0.086 Sum_probs=137.9
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe----CCEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLY 191 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~ 191 (282)
..||+|++|.||+|++. ++.||||.+...........+.+.+|+.+|++++||||+++++++.+ ...++
T Consensus 26 ~~i~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEEC-------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 57899999999999864 56799999976544344445678899999999999999999999876 35789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCcccc----cc
Q 023430 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHN----QL 266 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~----~~ 266 (282)
+||||+++|+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++. ..
T Consensus 99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~ 178 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178 (283)
T ss_pred EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc
Confidence 999999999999999887889999999999999999999998 4899999999999999999999999999864 22
Q ss_pred cchhheeeccCccc
Q 023430 267 CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~~~~~~~~~ape~~ 280 (282)
...++..|||||.+
T Consensus 179 ~~~~~~~y~aPE~~ 192 (283)
T PHA02988 179 KNVNFMVYFSYKML 192 (283)
T ss_pred cccCcccccCHHHh
Confidence 34678999999987
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=220.89 Aligned_cols=170 Identities=23% Similarity=0.360 Sum_probs=146.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|++.+.||+|+||.||+|+.+...+....+.+++|.+.... .....+.+.+|++++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 35799999999999999999998765554566789999876532 2234566889999999999999999999999888
Q ss_pred EEEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 189 KLYLILDFINGGHLFFHLYRQG---------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6899999999999999999999999999999999999999999999999
Q ss_pred Cccccccc--------chhheeeccCccc
Q 023430 260 LNSHNQLC--------CFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~--------~~~~~~~~ape~~ 280 (282)
|++..... ..++..|++||.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 190 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAV 190 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhh
Confidence 99864321 1446779999975
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=222.01 Aligned_cols=171 Identities=20% Similarity=0.275 Sum_probs=143.9
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
...+|.+.+.||+|+||.||++.............+|+|.+.... ....+.+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 456899999999999999999986543333455678999886532 23345688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcE
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG-------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v 254 (282)
+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999987543 38899999999999999999999999999999999999999999
Q ss_pred EEEecCccccccc---------chhheeeccCcccc
Q 023430 255 MAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 255 ~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
+|+|||++..... ..++..|+|||.+.
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 195 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 195 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhc
Confidence 9999999863221 12366899999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=218.07 Aligned_cols=166 Identities=28% Similarity=0.374 Sum_probs=142.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
.+|++.+.||+|+||.||++.+. .++..||+|.+..... ......+.+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-----DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-----CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 57999999999999999999876 3567899998864321 1223456788999999999999999999988763
Q ss_pred --CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..++++|||+++++|.+++.+.+.+++..++.++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 568899999999999999988777899999999999999999999999999999999999999999999999988632
Q ss_pred c----------cchhheeeccCccc
Q 023430 266 L----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~----------~~~~~~~~~ape~~ 280 (282)
. ...++..|+|||.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVI 181 (265)
T ss_pred ccccccccccccCCCCccccChhhh
Confidence 1 12468899999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=222.72 Aligned_cols=164 Identities=24% Similarity=0.332 Sum_probs=132.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCCeeeeeEEEE--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ-- 185 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~-- 185 (282)
+|++.+.||+|+||.||+|++.. ..+..||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcC----CCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 69999999999999999998752 235679999887543222 2223355677777665 6999999999875
Q ss_pred ---eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 186 ---TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 186 ---~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
....+++||||+. ++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 2456899999997 5888888653 348899999999999999999999999999999999999999999999999
Q ss_pred cccccc------cchhheeeccCccc
Q 023430 261 NSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~------~~~~~~~~~ape~~ 280 (282)
++.... ...|++.|||||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (290)
T cd07862 156 LARIYSFQMALTSVVVTLWYRAPEVL 181 (290)
T ss_pred ceEeccCCcccccccccccccChHHH
Confidence 986322 22568999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=232.02 Aligned_cols=165 Identities=30% Similarity=0.383 Sum_probs=145.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
+=|.+.+.||+|.|++|-+|++. .++..||||++.+.....- ....+.+|+++|+.++|||||+||.+..++..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHV-----FTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhh-----cccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 45888899999999999999887 5778899999988765433 33446679999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCccc----
Q 023430 190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSH---- 263 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~---- 263 (282)
+|||+|+-.+|+|+++|.++. .+.+..++.++.||+.|+.|||...+|||||||+|+.+.+ -|-|||.|||++-
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999999998764 4899999999999999999999999999999999998765 5899999999994
Q ss_pred --ccccchhheeeccCccc
Q 023430 264 --NQLCCFFFFLFLGGGVF 280 (282)
Q Consensus 264 --~~~~~~~~~~~~ape~~ 280 (282)
......|..+|-|||+|
T Consensus 172 G~kL~TsCGSLAYSAPEIL 190 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEIL 190 (864)
T ss_pred cchhhcccchhhccCchhh
Confidence 22333889999999987
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=220.36 Aligned_cols=173 Identities=18% Similarity=0.230 Sum_probs=145.2
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||++.++....+.....||+|.+..... ......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 355678999999999999999999987654445567899999865431 223345778999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEE
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~ 255 (282)
.....++||||+++++|.+++.... .+.+..+..++.|++.||.|||+.+|+||||||+|||++.++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999886432 357788999999999999999999999999999999999999999
Q ss_pred EEecCccccccc---------chhheeeccCccc
Q 023430 256 AAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 256 l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
|+|||+++.... ..++..|+|||.+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHH
Confidence 999999863221 2346789999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=222.34 Aligned_cols=170 Identities=22% Similarity=0.325 Sum_probs=144.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCC-----------CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDD-----------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI 177 (282)
.++|++.+.||+|+||.||++....... ......||+|.+..... ....+.+.+|+++++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 4689999999999999999998764321 12345689999875532 2445678899999999999999
Q ss_pred eeeeEEEEeCCEEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCce
Q 023430 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246 (282)
Q Consensus 178 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NI 246 (282)
+++++++..++..+++|||+++++|..++.... .+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999987755 688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 247 LMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 247 Ll~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
+++.++.++|+|||++...... .++..|||||.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 9999999999999998742211 235689999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=230.12 Aligned_cols=163 Identities=21% Similarity=0.327 Sum_probs=135.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++.+.||+|+||.||++.+. ..++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEec-----CCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 468999999999999999999865 4567799999865432 223345577899999999999999999988643
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
...|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 90 SLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999976 56565543 4788999999999999999999999999999999999999999999999999
Q ss_pred ccccc------chhheeeccCccc
Q 023430 263 HNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~------~~~~~~~~ape~~ 280 (282)
+.... ..|+..|||||.+
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~~ 190 (355)
T cd07874 167 RTAGTSFMMTPYVVTRYYRAPEVI 190 (355)
T ss_pred ccCCCccccCCccccCCccCHHHH
Confidence 74322 2578999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=221.76 Aligned_cols=164 Identities=26% Similarity=0.403 Sum_probs=143.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|++. ..+..||+|+++... ......+.+|+.+++.++||||+++++.+...+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNV-----NTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEc-----CCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 347888899999999999999876 356789999986543 122345778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+||||+++++|.+++...+.+++.+++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999985321
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|+..|||||.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~ 178 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVA 178 (267)
T ss_pred ccccccccCcccccChhhh
Confidence 12578999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=222.00 Aligned_cols=171 Identities=20% Similarity=0.256 Sum_probs=144.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||.||+|.+...........||+|++.... .....+.+.+|+++++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 45788999999999999999987654333456789999986543 2223467889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcE
Q 023430 189 KLYLILDFINGGHLFFHLYRQG--------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~--------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v 254 (282)
..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999987542 36788999999999999999999999999999999999999999
Q ss_pred EEEecCccccccc---------chhheeeccCcccc
Q 023430 255 MAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 255 ~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
+|+|||++..... ..++..|+|||.+.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIM 197 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhc
Confidence 9999999864211 12357899999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=217.76 Aligned_cols=169 Identities=22% Similarity=0.240 Sum_probs=143.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.++... .....||+|++.... .......+.+|+.+++.++|+||+++++.+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence 467999999999999999999986431 234579999886543 2333456788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..+++|||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999999998764 4689999999999999999999999999999999999999999999999999875431
Q ss_pred ---------chhheeeccCcccc
Q 023430 268 ---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ---------~~~~~~~~ape~~~ 281 (282)
..++..|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~ 181 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIA 181 (266)
T ss_pred cccceeccCCCCCccccChhhhc
Confidence 12346799999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=219.17 Aligned_cols=159 Identities=22% Similarity=0.322 Sum_probs=138.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.++||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHL-----LTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI 74 (279)
T ss_pred cchheeeeccCCCeEEEEEEEc-----CCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence 6888999999999999999876 456789999986542 223345688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
++||||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccc
Confidence 999999999988544 3478889999999999999999999999999999999999999999999999964222
Q ss_pred --chhheeeccCccc
Q 023430 268 --CFFFFLFLGGGVF 280 (282)
Q Consensus 268 --~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 151 ~~~~~~~~y~aPE~~ 165 (279)
T cd06619 151 KTYVGTNAYMAPERI 165 (279)
T ss_pred cCCCCChhhcCceee
Confidence 2568999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=225.58 Aligned_cols=158 Identities=23% Similarity=0.319 Sum_probs=133.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~ 187 (282)
.+..+.+.||+|.||.||+|+|++ ..||||++.... + +.+.+|.+|.+. |+|+||+.++++=...
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~srd-----E-~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRG-------EDVAVKIFSSRD-----E-RSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred heeEEEEEecCccccceeeccccC-------CceEEEEecccc-----h-hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 468899999999999999999984 459999986432 2 345568888775 6899999998765433
Q ss_pred C----EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEeeccCCCceEEcCCCcEE
Q 023430 188 S----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 188 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~--------~iiHrDlKp~NILl~~~~~v~ 255 (282)
. ++|||++|.+.|+|+++|.+ ..++....+.++..++.||.+||.. .|.|||||..|||+..+|...
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 2 79999999999999999987 5688999999999999999999953 399999999999999999999
Q ss_pred EEecCcccc--cc---------cchhheeeccCcccc
Q 023430 256 AAHSLNSHN--QL---------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 256 l~Dfg~s~~--~~---------~~~~~~~~~ape~~~ 281 (282)
|+|+|+|-. +. ...||.+|||||+||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd 393 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD 393 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence 999999932 11 128899999999986
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=222.84 Aligned_cols=171 Identities=20% Similarity=0.295 Sum_probs=140.9
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCC---------CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDD---------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV 178 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 178 (282)
..++|++.+.||+|+||.||+|++.+..+ ......||+|.+.... .....+.+.+|+++++.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 34689999999999999999988654321 1223458999987542 233445688999999999999999
Q ss_pred eeeEEEEeCCEEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCce
Q 023430 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246 (282)
Q Consensus 179 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NI 246 (282)
++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999886432 367888899999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 247 LMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 247 Ll~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
|++.++.++|+|||++...... .++..|+|||.+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 203 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI 203 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence 9999999999999998642111 225689999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=228.99 Aligned_cols=164 Identities=19% Similarity=0.299 Sum_probs=137.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++++.||+|+||.||+|.+. ..+..||||++..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDT-----RLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEEC-----CCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 468999999999999999999876 3567899999875432 223344567899999999999999999887543
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
...|++||++ +++|..++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3578999988 678877664 456899999999999999999999999999999999999999999999999999
Q ss_pred cccccc----hhheeeccCccc
Q 023430 263 HNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~----~~~~~~~ape~~ 280 (282)
...... .|++.|+|||.+
T Consensus 166 ~~~~~~~~~~~~t~~y~aPE~~ 187 (343)
T cd07878 166 RQADDEMTGYVATRWYRAPEIM 187 (343)
T ss_pred eecCCCcCCccccccccCchHh
Confidence 753322 568999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=219.94 Aligned_cols=159 Identities=20% Similarity=0.198 Sum_probs=131.2
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEec
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF 196 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 196 (282)
.||+|+||.||+|..... .....+++|.+.... .......+.+|+.+++.++|+||+++++.+......|+||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG---MSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecC---CCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence 589999999999975422 345568888775432 223345577899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc---
Q 023430 197 INGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC--- 268 (282)
Q Consensus 197 ~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~--- 268 (282)
+++|+|.+++.... ..++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999999987643 2457788899999999999999999999999999999999999999999998643211
Q ss_pred ------hhheeeccCccc
Q 023430 269 ------FFFFLFLGGGVF 280 (282)
Q Consensus 269 ------~~~~~~~ape~~ 280 (282)
.++..|+|||++
T Consensus 157 ~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05042 157 ITKDCHAVPLRWLAPELV 174 (269)
T ss_pred eccCCCCCcccccCHHHH
Confidence 235679999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=222.64 Aligned_cols=174 Identities=17% Similarity=0.256 Sum_probs=143.0
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
+.+..++|.+.+.||+|+||.||++++.+.... .....+|+|.+.... .......+.+|+.+++.+ +|+||++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 344457899999999999999999987643221 234569999987542 123345577899999999 799999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
+++...+..|+||||+++|+|.+++..+. .+++.+++.++.|++.||+|||++|++||||||+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997642 37888999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
||++.++.++|+|||++..... ..++..|||||.+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 214 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence 9999999999999999864221 1224689999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=222.67 Aligned_cols=174 Identities=17% Similarity=0.262 Sum_probs=143.1
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCC--CCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVD--DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
+.+..++|.+.+.||+|+||.||+|++.... .......+|+|.+.... .....+.+.+|+.+++.+ +|+||++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 4455678999999999999999999865322 12234579999886542 223345688899999999 799999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
+.+......|++|||+++++|..++.+. ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 9999999999999999999999998753 236778889999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
||++.++.++|+|||+++.... ..++..|||||++
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence 9999999999999999864321 1235679999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=220.81 Aligned_cols=174 Identities=17% Similarity=0.306 Sum_probs=145.2
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
+.+..++|++.+.||+|+||.||++.++..........+|+|.+..... ......+.+|+.+++.+ +|+||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4455678999999999999999999987554334556799998875432 22345578899999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceE
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NIL 247 (282)
+...+.++++|||+++|+|..++... ..+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999998642 35788899999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCccccccc-------c--hhheeeccCccc
Q 023430 248 MDSDGHVMAAHSLNSHNQLC-------C--FFFFLFLGGGVF 280 (282)
Q Consensus 248 l~~~~~v~l~Dfg~s~~~~~-------~--~~~~~~~ape~~ 280 (282)
++.++.++|+|||+++.... . .++..|+|||++
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 206 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL 206 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh
Confidence 99999999999999864221 1 234679999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=222.37 Aligned_cols=150 Identities=42% Similarity=0.702 Sum_probs=134.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
.+|++.+.||+|+||.||+|... ..+..||+|.+...........+.+.+|+++++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLK-----GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEc-----CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 36999999999999999999876 3567899999987654443456678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.|++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 152 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence 99999999999999988754 4689999999999999999999999999999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=219.90 Aligned_cols=170 Identities=22% Similarity=0.280 Sum_probs=143.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|.+.+.||+|+||.||++++...........+++|.+.... ....+.+.+|+.+++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 45799999999999999999987654444556678999876443 223356888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 189 KLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
..++||||+++++|.+++..+. .+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999987542 378899999999999999999999999999999999999999
Q ss_pred cEEEEecCccccccc---------chhheeeccCcccc
Q 023430 253 HVMAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
.++|+|||++..... ..++..|||||.+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 198 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 198 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhc
Confidence 999999999864321 23467899999763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=222.32 Aligned_cols=174 Identities=17% Similarity=0.268 Sum_probs=145.6
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
+.+..++|.+.+.||+|+||.||++.+...........+|+|+++... .....+.+.+|+.+++++ +|+||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 445567899999999999999999986543333456679999886543 223345688999999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+...+..|++|||+.+|+|..++.... .+++.++..++.|++.||.|||+++|+|+||||+|||++.++.++++|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999987543 389999999999999999999999999999999999999999999999999
Q ss_pred ccccccc---------hhheeeccCccc
Q 023430 262 SHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~~---------~~~~~~~ape~~ 280 (282)
+...... .++..|||||.+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 215 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESI 215 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhh
Confidence 8643211 235679999976
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=245.34 Aligned_cols=168 Identities=23% Similarity=0.402 Sum_probs=140.7
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
...++|++++.||+|+||.||+|+++ ..+..+|+|++..... .......+..|+.+|+.++|||||+++++|..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk-----~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHK-----RTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEEC-----CCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34578999999999999999999987 4567899999875543 23344668889999999999999999998864
Q ss_pred --CCEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CCEeeccCCCceEEcC---
Q 023430 187 --RSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-------GIVHRDLKPENILMDS--- 250 (282)
Q Consensus 187 --~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~-------~iiHrDlKp~NILl~~--- 250 (282)
...+||||||+++++|..++.. .+.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 3579999999999999988865 25689999999999999999999984 4999999999999964
Q ss_pred --------------CCcEEEEecCcccccc------cchhheeeccCccc
Q 023430 251 --------------DGHVMAAHSLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 251 --------------~~~v~l~Dfg~s~~~~------~~~~~~~~~ape~~ 280 (282)
.+.++|+|||++.... ...|++.|||||++
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL 213 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL 213 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHH
Confidence 2348999999986432 22679999999986
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=216.72 Aligned_cols=166 Identities=19% Similarity=0.276 Sum_probs=141.4
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.++||+|+||.||+|... .+..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN------NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec------CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456779999999999999999999854 23468999876532 22456888999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+..+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 999999999999999999988653 457888999999999999999999999999999999999999999999999996
Q ss_pred cccc--------chhheeeccCcccc
Q 023430 264 NQLC--------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~--------~~~~~~~~ape~~~ 281 (282)
.... ..++..|||||.++
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAIN 177 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhc
Confidence 4321 13356799999763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=218.00 Aligned_cols=166 Identities=40% Similarity=0.687 Sum_probs=147.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||+|.+. .++..||+|++.+.........+.+.+|+++++.++||||+++++.+......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-----cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence 5899999999999999999876 35677999999876544445567788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc----
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL---- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~---- 266 (282)
++||||+.+++|..++.....+++..+..++.|++.||.|||+++++|+||||+||++++++.++|+|||++....
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 9999999999999999877789999999999999999999999999999999999999999999999999886422
Q ss_pred --cchhheeeccCcccc
Q 023430 267 --CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 --~~~~~~~~~ape~~~ 281 (282)
...++..|++||.+.
T Consensus 156 ~~~~~~~~~y~~PE~~~ 172 (258)
T cd05578 156 TTSTSGTPGYMAPEVLC 172 (258)
T ss_pred ccccCCChhhcCHHHHc
Confidence 235688999999863
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=228.20 Aligned_cols=163 Identities=20% Similarity=0.316 Sum_probs=136.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++.+.||+|+||.||++.+. ..++.||||++..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDA-----ILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEEC-----CCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 468999999999999999999876 3567799999875432 223345577899999999999999999887543
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999976 56666643 4788899999999999999999999999999999999999999999999999
Q ss_pred ccccc------chhheeeccCccc
Q 023430 263 HNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~------~~~~~~~~ape~~ 280 (282)
+.... ..++..|+|||.+
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~ 197 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVI 197 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHH
Confidence 74322 2568999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=216.97 Aligned_cols=169 Identities=21% Similarity=0.235 Sum_probs=142.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.++..+ .....+|+|.+.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457999999999999999999876332 234579999886543 1233456888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..|+||||+++++|.+++.+. +.+++.++..++.|++.||.|||+++++||||||+|||++.++.++++|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999999998764 4579999999999999999999999999999999999999999999999999864221
Q ss_pred c----------hhheeeccCcccc
Q 023430 268 C----------FFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~----------~~~~~~~ape~~~ 281 (282)
. .++..|++||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~ 182 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIA 182 (267)
T ss_pred ccceeeecCCCccceeecCHhHhc
Confidence 1 1245799999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=222.53 Aligned_cols=170 Identities=17% Similarity=0.247 Sum_probs=142.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|++.+.||+|+||.||+|.+...........||+|++.... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 34678889999999999999987755444456789999987543 2233456888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 189 KLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
..++++||+.+++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999888531 2477888999999999999999999999999999999999999
Q ss_pred cEEEEecCccccccc---------chhheeeccCccc
Q 023430 253 HVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
.+||+|||+++.... ..+++.|||||.+
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI 198 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHH
Confidence 999999998863221 1336789999976
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=213.48 Aligned_cols=163 Identities=28% Similarity=0.515 Sum_probs=140.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||++++. ..+..+|+|.++.... ....+.+.+|+.+++.++|+||+++++.+...+.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-----CCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 5889999999999999999976 3567799998865432 23345677899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
|++|||+++++|..++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||++.....
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999999998888653 3478999999999999999999999999999999999999999999999999863321
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|||||.+
T Consensus 154 ~~~~~~~~~~~~~~aPE~~ 172 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIW 172 (255)
T ss_pred ccccccccCCccccCHHHH
Confidence 2468889999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=205.62 Aligned_cols=164 Identities=24% Similarity=0.336 Sum_probs=135.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~ 188 (282)
++...+..||+|++|.|-+.++. .++.+.|+|.++.... ....+++.+|+.+..+ ..+|.+|.+||.+..+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~-----~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHI-----QSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred hhhhhhhhhcCCccchhhheeec-----cCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 45555678999999999888877 6788999999876532 2334556678876554 46999999999999999
Q ss_pred EEEEEEeccCCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 189 KLYLILDFINGGHLFFH----LYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.+||.||.|.- +|..+ +.+.+.++|..+-+++..+..||.|||++ .|||||+||+|||++.+|+||+||||+|.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999964 55333 33456799999999999999999999977 79999999999999999999999999996
Q ss_pred cccc------chhheeeccCcccc
Q 023430 264 NQLC------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~------~~~~~~~~ape~~~ 281 (282)
-... |.||..|||||.+|
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~ 221 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERIN 221 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcC
Confidence 3322 58999999999985
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=214.52 Aligned_cols=166 Identities=21% Similarity=0.333 Sum_probs=143.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|... .++..||+|.++..........+.+.+|+++++.++|+||+++++.+...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-----CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 57999999999999999999976 3567899998875443444446678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.++||||+++++|..++.. ...+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999999988864 234789999999999999999999999999999999999999999999999988532
Q ss_pred c-------cchhheeeccCccc
Q 023430 266 L-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~-------~~~~~~~~~ape~~ 280 (282)
. ...++..|+|||.+
T Consensus 157 ~~~~~~~~~~~~~~~y~apE~~ 178 (267)
T cd08224 157 SSKTTAAHSLVGTPYYMSPERI 178 (267)
T ss_pred cCCCcccceecCCccccCHHHh
Confidence 1 12568889999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=218.20 Aligned_cols=166 Identities=20% Similarity=0.315 Sum_probs=143.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||++.++ ..+..++||.+...........+.+.+|+.+++.++|+||+++++++...+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-----CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence 57888999999999999999976 3567899998876443344455678889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+++|||+++++|..++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999999888763 345889999999999999999999999999999999999999999999999987532
Q ss_pred c-------cchhheeeccCccc
Q 023430 266 L-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~-------~~~~~~~~~ape~~ 280 (282)
. ...++..|+|||.+
T Consensus 157 ~~~~~~~~~~~~~~~~~ape~~ 178 (267)
T cd08229 157 SSKTTAAHSLVGTPYYMSPERI 178 (267)
T ss_pred ccCCcccccccCCcCccCHHHh
Confidence 1 12568899999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=219.21 Aligned_cols=163 Identities=26% Similarity=0.360 Sum_probs=132.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCCeeeeeEEEEe-
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT- 186 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~- 186 (282)
+|++.+.||+|+||.||+|+++ .+++.||+|.+....... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-----HSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 4889999999999999999977 456789999987543211 1122345677776655 69999999998764
Q ss_pred ----CCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 187 ----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
....+++|||+.+ +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 3468999999985 788877653 348999999999999999999999999999999999999999999999999
Q ss_pred ccccccc------chhheeeccCccc
Q 023430 261 NSHNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~------~~~~~~~~ape~~ 280 (282)
++....+ ..++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVL 179 (288)
T ss_pred ccccccCcccCCCccccccccCchHh
Confidence 9864322 2568899999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=234.70 Aligned_cols=164 Identities=23% Similarity=0.418 Sum_probs=141.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEe-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~- 186 (282)
.+-|++.++||.|.+|.||+++.+ ..+...|+|++..+. +..+++..|..+|+... |||++.+|++|..
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~-----~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHV-----KTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeee-----ecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 457999999999999999999987 456778999887653 23345777888988874 9999999999863
Q ss_pred ----CCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 187 ----RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 187 ----~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
++++|||||||.||+.-++++. ...+.|..+..|++.++.||.+||...+||||||-.|||++.+|.||++|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 4689999999999999998865 4568999999999999999999999999999999999999999999999999
Q ss_pred ccccc-------ccchhheeeccCcccc
Q 023430 261 NSHNQ-------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~-------~~~~~~~~~~ape~~~ 281 (282)
+|++. ....||+.|||||++.
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEVia 196 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIA 196 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeee
Confidence 99643 2337899999999873
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=215.74 Aligned_cols=167 Identities=23% Similarity=0.277 Sum_probs=142.5
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+...+|.+.+.||+|+||.||+|.++ ..+..+|+|++..+. .....+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEe-----cCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 345567999999999999999999976 356779999886542 22355788999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+.++++|||+++++|.+++... ..+++..++.++.|++.||.|||+++++||||||+|||+++++.++|+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 999999999999999999988653 357889999999999999999999999999999999999999999999999986
Q ss_pred ccccc--------hhheeeccCcccc
Q 023430 264 NQLCC--------FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~~--------~~~~~~~ape~~~ 281 (282)
..... .++..|+|||.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 178 (263)
T cd05052 153 LMTGDTYTAHAGAKFPIKWTAPESLA 178 (263)
T ss_pred ccccceeeccCCCCCccccCCHHHhc
Confidence 43222 2356799999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=214.23 Aligned_cols=159 Identities=19% Similarity=0.299 Sum_probs=134.8
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+.||+|+||.||+|.++ ..++.+|+|.+.... .......+.+|+++++.++|+||+++++++......|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-----ADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEe-----cCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 36899999999999876 356779999876432 23344568889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc------
Q 023430 196 FINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------ 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------ 268 (282)
|+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999999999987643 5889999999999999999999999999999999999999999999999998642211
Q ss_pred ---hhheeeccCcccc
Q 023430 269 ---FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ---~~~~~~~ape~~~ 281 (282)
.....|+|||.++
T Consensus 154 ~~~~~~~~y~aPE~~~ 169 (252)
T cd05084 154 GMKQIPVKWTAPEALN 169 (252)
T ss_pred CCCCCceeecCchhhc
Confidence 1135699999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=217.56 Aligned_cols=163 Identities=25% Similarity=0.388 Sum_probs=138.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||+|+.+ ..+..||+|++..... .....+.+.+|+.+++.++|+||+++++++..++..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-----CCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence 5889999999999999999876 3567899999865432 222335577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.+|.++|+|||++....
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 99999997 5787777542 458999999999999999999999999999999999999999999999999986321
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...+++.|+|||.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~ 173 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVL 173 (285)
T ss_pred CcccccCCcccccccChHHh
Confidence 22558899999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=217.23 Aligned_cols=165 Identities=21% Similarity=0.289 Sum_probs=142.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+++++ ..++.||+|++..... .....+.+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-----ETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-----CCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 47999999999999999999876 3567899998865432 12223457789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
.++||||++++.|..++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999999998888777666679999999999999999999999999999999999999999999999999986422
Q ss_pred ----cchhheeeccCccc
Q 023430 267 ----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ----~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 155 ~~~~~~~~~~~~~aPE~~ 172 (286)
T cd07847 155 DDYTDYVATRWYRAPELL 172 (286)
T ss_pred ccccCcccccccCCHHHH
Confidence 12467889999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=229.58 Aligned_cols=160 Identities=24% Similarity=0.402 Sum_probs=136.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-C-----CCeeeeeEEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H-----PFIVQLRYSF 184 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~ 184 (282)
+|++++.||+|+||.|.+|.+. .+++.||||+++... ...++-..|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-----~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-----KTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEec-----CCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 5889999999999999999977 567889999998654 33344566999999987 4 3999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC--CcEEEEecC
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMAAHSL 260 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~--~~v~l~Dfg 260 (282)
...+++|||+|++.. +|+++++..+ .++...++.++.||+.||.+||+.+|||+||||+||||.+- ..|||+|||
T Consensus 258 ~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 999999999999854 8999998653 48899999999999999999999999999999999999764 469999999
Q ss_pred cccccccc--hh--heeeccCccc
Q 023430 261 NSHNQLCC--FF--FFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~~--~~--~~~~~ape~~ 280 (282)
.|...-.. .| +.-|=|||+|
T Consensus 337 SSc~~~q~vytYiQSRfYRAPEVI 360 (586)
T KOG0667|consen 337 SSCFESQRVYTYIQSRFYRAPEVI 360 (586)
T ss_pred cccccCCcceeeeeccccccchhh
Confidence 99643222 44 8999999987
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-29 Score=211.78 Aligned_cols=164 Identities=26% Similarity=0.434 Sum_probs=143.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.+. ..+..+++|++.... ....+.+.+|+.+++.++||||+++++.+....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDI-----ATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEec-----CCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 368999999999999999999876 345679999987543 224567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
.+|++|||+++++|..++... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++....
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 999999999999999988765 679999999999999999999999999999999999999999999999999886321
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~ 173 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVA 173 (262)
T ss_pred hhhccccccCCccccCchhh
Confidence 11457789999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=222.97 Aligned_cols=174 Identities=16% Similarity=0.267 Sum_probs=142.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
+.+...+|++.+.||+|+||.||+|++.+.... .....+|+|.+.... .....+.+.+|+.+++++ +|+||++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLL 84 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence 445556899999999999999999987643321 123468999876432 223446688899999999 799999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
+++...+..+++|||+++|+|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 164 (334)
T cd05100 85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARN 164 (334)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence 99999999999999999999999987532 36778888999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
||++.++.++|+|||+++.... ..++..|||||++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence 9999999999999999864221 1224679999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=214.17 Aligned_cols=165 Identities=20% Similarity=0.241 Sum_probs=140.5
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||+|.+. .+..||+|.++.... ..+.+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN------NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec------CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence 44568999999999999999999864 235699999865432 23457789999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 999999999999999999987644 589999999999999999999999999999999999999999999999998864
Q ss_pred ccc-----chh---heeeccCcccc
Q 023430 265 QLC-----CFF---FFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~-----~~~---~~~~~ape~~~ 281 (282)
... ..+ ...|||||.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~ 177 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAAL 177 (261)
T ss_pred ccCCcccccCCCcCceeccCccccc
Confidence 321 122 35799999763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=215.96 Aligned_cols=160 Identities=21% Similarity=0.213 Sum_probs=132.3
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+.||+|+||.||+|.+.. ......+|+|.++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcC---CCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEE
Confidence 358999999999998653 23456799998865432 2223457789999999999999999999998889999999
Q ss_pred ccCCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 196 FINGGHLFFHLYRQG-----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
|+++|+|.+++.... ..++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999999886532 345677888999999999999999999999999999999999999999999864222
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|||||.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~ 174 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELV 174 (269)
T ss_pred eecCCCcCCcccccCHhHh
Confidence 1346789999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=212.09 Aligned_cols=164 Identities=27% Similarity=0.410 Sum_probs=142.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|+.++.||+|+||.||.++.. ..+..+++|.+...... ....+.+.+|+++++.++|+||+++++++...+.+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-----CCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence 5899999999999999998866 45677999988654422 23445678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999999998764 4588999999999999999999999999999999999999999999999998864322
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 155 ~~~~~~~~~~~~y~ape~~ 173 (256)
T cd08221 155 YSMAETVVGTPYYMSPELC 173 (256)
T ss_pred cccccccCCCccccCHhhc
Confidence 2468999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=243.92 Aligned_cols=173 Identities=21% Similarity=0.278 Sum_probs=148.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+.....++.+.||+|+||.||.|.............||||.+++.. +......|.+|..+|+.++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 3456788899999999999999998865443335568999887653 45566778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
....+|++|||+||+|..+|.+. ..+...+.+.++.||++|+.||+++++|||||..+|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999864 24788999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc-----hh----heeeccCcccc
Q 023430 260 LNSHNQLCC-----FF----FFLFLGGGVFN 281 (282)
Q Consensus 260 g~s~~~~~~-----~~----~~~~~ape~~~ 281 (282)
|+|+..... .+ -.+|||||.|.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHh
Confidence 999833222 22 36899999983
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=219.58 Aligned_cols=164 Identities=18% Similarity=0.309 Sum_probs=139.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+++ .++..||+|.+..... ......+.+|+.+++.++|+||+++++++...+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSK-----LTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEc-----CCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 468999999999999999999876 3567899999865432 222334667999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
..++||||+. ++|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++....
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 9999999997 4888877653 458899999999999999999999999999999999999999999999999986422
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...+++.|+|||.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~ 176 (301)
T cd07873 157 PTKTYSNEVVTLWYRPPDIL 176 (301)
T ss_pred CCCcccccceeecccCcHHH
Confidence 22458899999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=214.51 Aligned_cols=169 Identities=21% Similarity=0.218 Sum_probs=142.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.++..+ .....||+|.+.... .....+.+..|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCC--CCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence 457999999999999999999977432 234579999986542 2334566889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..++||||+++++|..++... +.+++.+++.++.|++.||.|||++|++||||||+|||++.++.++++|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999999888753 4589999999999999999999999999999999999999999999999998853221
Q ss_pred c---------hh---heeeccCcccc
Q 023430 268 C---------FF---FFLFLGGGVFN 281 (282)
Q Consensus 268 ~---------~~---~~~~~ape~~~ 281 (282)
. .+ ...|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIA 184 (269)
T ss_pred CccccccccccCCCcceeecCHhHhc
Confidence 1 11 35799999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=216.95 Aligned_cols=159 Identities=37% Similarity=0.638 Sum_probs=132.1
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH---hcCCCCeeeeeEEEEeCCEEEEE
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT---KVTHPFIVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~~~~~lv 193 (282)
.||+|+||.||++... ..+..+|+|.+.+.............+|..+++ ..+|+||+.+++.+...+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEEC-----CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence 4899999999999876 356789999987654322222223344444433 34799999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc-----ccc
Q 023430 194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ-----LCC 268 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~-----~~~ 268 (282)
|||+++++|..++..++.+++..+..++.|++.||.|||+++|+||||||+|||++.++.++++|||++... ...
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCc
Confidence 999999999999988888999999999999999999999999999999999999999999999999998532 122
Q ss_pred hhheeeccCccc
Q 023430 269 FFFFLFLGGGVF 280 (282)
Q Consensus 269 ~~~~~~~ape~~ 280 (282)
.|+..|||||.+
T Consensus 156 ~~~~~y~aPE~~ 167 (279)
T cd05633 156 VGTHGYMAPEVL 167 (279)
T ss_pred CCCcCccCHHHh
Confidence 579999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=216.81 Aligned_cols=164 Identities=28% Similarity=0.446 Sum_probs=142.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.+.|+++++||+|+||.||+++.. ..+..+++|++.... ....+.+.+|+.+++.++|+||+++++.+..++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~-----~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEEC-----CCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 356999999999999999999876 356789999986542 334566788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..|+||||+++++|..++.+ ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999999999999877754 35689999999999999999999999999999999999999999999999998864221
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~ 182 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVV 182 (292)
T ss_pred cccccceecCCccccCceee
Confidence 1467899999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-29 Score=215.32 Aligned_cols=167 Identities=20% Similarity=0.294 Sum_probs=139.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--C
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 187 (282)
.+|++.+.||+|+||.||++..+... ...+..||+|.+.... ....+.+.+|+++++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 47999999999999999999865332 2456789999986542 2334668899999999999999999987653 3
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
..+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 4689999999999999998764 458999999999999999999999999999999999999999999999999987422
Q ss_pred cc----------hhheeeccCccc
Q 023430 267 CC----------FFFFLFLGGGVF 280 (282)
Q Consensus 267 ~~----------~~~~~~~ape~~ 280 (282)
.. .+...|+|||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~ 183 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESL 183 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHh
Confidence 11 224569999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=231.53 Aligned_cols=172 Identities=17% Similarity=0.243 Sum_probs=129.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCC----------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCee
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGD----------SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV 178 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv 178 (282)
.++|++++.||+|+||+||+|..+...... .+...+.+.+.+...........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998765321100 0011111111111111223345678999999999999999
Q ss_pred eeeEEEEeCCEEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc
Q 023430 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253 (282)
Q Consensus 179 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~ 253 (282)
++++++...+..|+|+|++.+ +|..++... ......+++.++.||+.||.|||++|||||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999854 666666432 22345678889999999999999999999999999999999999
Q ss_pred EEEEecCcccccc--------cchhheeeccCcccc
Q 023430 254 VMAAHSLNSHNQL--------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 254 v~l~Dfg~s~~~~--------~~~~~~~~~ape~~~ 281 (282)
+||+|||++.... ...|+..|||||.+.
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 341 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILA 341 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhc
Confidence 9999999996321 125799999999874
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=215.96 Aligned_cols=170 Identities=20% Similarity=0.236 Sum_probs=139.9
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+...+|++.+.||+|+||.||+|++...+. .....||+|++.... .....+.+.+|+.+++.+.|+||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGE-NVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCC-ccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 345689999999999999999999774332 123358999986543 22334568889999999999999999998865
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
...+++|||+++|+|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 4578999999999999998764 46899999999999999999999999999999999999999999999999998632
Q ss_pred cc---------chhheeeccCccc
Q 023430 266 LC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~---------~~~~~~~~ape~~ 280 (282)
.. ..+...||+||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESI 183 (279)
T ss_pred ccccceeecCCCccchhhCCHHHh
Confidence 21 1235679999986
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=215.12 Aligned_cols=163 Identities=23% Similarity=0.326 Sum_probs=138.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|++++.||+|+||.||++++.+ ...+|+|.+..... ..+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4579999999999999999998652 23499998865432 1245788999999999999999999999888
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..+++|||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+|||++.++.++|+|||.++....
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999999999999998764 4689999999999999999999999999999999999999999999999998863322
Q ss_pred c--------hhheeeccCcccc
Q 023430 268 C--------FFFFLFLGGGVFN 281 (282)
Q Consensus 268 ~--------~~~~~~~ape~~~ 281 (282)
. .++..|++||.+.
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~ 174 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLL 174 (256)
T ss_pred CceeecCCCccChhhCCHHHHh
Confidence 1 2346799999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=216.54 Aligned_cols=171 Identities=20% Similarity=0.261 Sum_probs=143.0
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
...+|.+.++||+|+||.||++..........+..+++|.+.... ....+.+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 345788999999999999999986543333456678999876432 23345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG---------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
...+++|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999987643 378899999999999999999999999999999999999999
Q ss_pred cEEEEecCccccccc---------chhheeeccCcccc
Q 023430 253 HVMAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
.++|+|||++..... ..++..|+|||.+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 197 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhc
Confidence 999999999863221 12357899999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=211.34 Aligned_cols=164 Identities=27% Similarity=0.420 Sum_probs=142.3
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|.+.+.||+|+||.||++.++ ..+..|++|.+...... ....+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-----ADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-----CCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence 5888999999999999999976 35678999998754332 33455688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999999998764 568899999999999999999999999999999999999999999999999876321
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...++..|+|||++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~ 173 (256)
T cd08529 155 TNFANTIVGTPYYLSPELC 173 (256)
T ss_pred cchhhccccCccccCHHHh
Confidence 12567889999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=220.05 Aligned_cols=174 Identities=17% Similarity=0.261 Sum_probs=142.4
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
+.+..++|.+.+.||+|+||.||++++.+... ......+|+|.+.... .......+..|+.+++.+ +|+||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34455789999999999999999998654321 1244568999886542 223345678899999999 599999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
+++...+..|++|||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999889999999999999999998653 237888899999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCccccccc-------c--hhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQLC-------C--FFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~~-------~--~~~~~~~ape~~ 280 (282)
||++.++.++|+|||+++.... . .++..|||||.+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 208 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL 208 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH
Confidence 9999999999999999964321 1 223579999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=215.34 Aligned_cols=161 Identities=22% Similarity=0.331 Sum_probs=137.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
.+|++.+.||+|+||.||++.++ ....+|+|++...... ...+.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR------GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP 73 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec------CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 46889999999999999999865 2346899988654321 2346779999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~ 268 (282)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999999999998753 46889999999999999999999999999999999999999999999999998643321
Q ss_pred --------hhheeeccCccc
Q 023430 269 --------FFFFLFLGGGVF 280 (282)
Q Consensus 269 --------~~~~~~~ape~~ 280 (282)
.++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~ 173 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVF 173 (256)
T ss_pred cccccCCCCCCccccCHHHh
Confidence 223579999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=218.85 Aligned_cols=164 Identities=24% Similarity=0.402 Sum_probs=141.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++++.||+|+||.||++++. ..+..||+|.+.... .....+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA 73 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-----CCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe
Confidence 36889999999999999999876 356789999886532 22334568889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.|+||||+++++|..++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++...
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 74 VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999999999998888653 368999999999999999999997 59999999999999999999999999998642
Q ss_pred cc-----chhheeeccCccc
Q 023430 266 LC-----CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~-----~~~~~~~~ape~~ 280 (282)
.. ..++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~ 173 (286)
T cd06622 154 VASLAKTNIGCQSYMAPERI 173 (286)
T ss_pred cCCccccCCCccCccCcchh
Confidence 11 2467899999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=217.91 Aligned_cols=168 Identities=18% Similarity=0.266 Sum_probs=139.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||+|.............+++|.+..... ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4788899999999999999876443333446688888865432 23345688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCce
Q 023430 191 YLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NI 246 (282)
+++|||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999887642 2367888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 247 LMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 247 Ll~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
|+++++.++|+|||++..... ..++..|||||.+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 999999999999999864211 1236789999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=221.62 Aligned_cols=157 Identities=24% Similarity=0.361 Sum_probs=127.1
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYL 192 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l 192 (282)
.++||+|+||.||+|+++.. ..+..||+|.+..... ...+.+|+.+|+.++||||+++++++.. ...+|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~---~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l 77 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG---KDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 77 (317)
T ss_pred ccccccCCCeEEEEEEEccC---CCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEE
Confidence 35799999999999987632 3557799998865421 2336679999999999999999998854 457899
Q ss_pred EEeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE----cCCCcEEEEec
Q 023430 193 ILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMAAHS 259 (282)
Q Consensus 193 v~e~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl----~~~~~v~l~Df 259 (282)
+|||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 78 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred EEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 9999865 777766432 247899999999999999999999999999999999999 45678999999
Q ss_pred Ccccccc----------cchhheeeccCccc
Q 023430 260 LNSHNQL----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~----------~~~~~~~~~ape~~ 280 (282)
|+++... ...+++.|||||++
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHH
Confidence 9985321 12568899999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=252.83 Aligned_cols=164 Identities=26% Similarity=0.404 Sum_probs=143.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+++-...||.|.||.||.|... .++...|+|.++..... ......+.+|..+|..++|||+|++||+-...+.+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~-----~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNL-----DTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred eeccccccCCcceeeeEEeecC-----CccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 3555668999999999999876 46678999988765433 34445678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc--
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC-- 268 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~-- 268 (282)
+|.||||++|+|.+.+...+..++...+.+..|++.|+.|||++|||||||||+||||+.+|-+|+.|||.|......
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999999999988878888888999999999999999999999999999999999999999999998532222
Q ss_pred ---------hhheeeccCccc
Q 023430 269 ---------FFFFLFLGGGVF 280 (282)
Q Consensus 269 ---------~~~~~~~ape~~ 280 (282)
.||+.|||||++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhh
Confidence 789999999987
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=212.40 Aligned_cols=163 Identities=20% Similarity=0.304 Sum_probs=142.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+...+|++.+.||+|+||.||+|... +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-------~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-------GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-------CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 44568999999999999999999854 46799999876532 34668889999999999999999999998
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||.++.
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 899999999999999999987665 689999999999999999999999999999999999999999999999999975
Q ss_pred cccc----hhheeeccCccc
Q 023430 265 QLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~~----~~~~~~~ape~~ 280 (282)
.... .+...|+|||.+
T Consensus 152 ~~~~~~~~~~~~~~~ape~~ 171 (256)
T cd05039 152 ASQGQDSGKLPVKWTAPEAL 171 (256)
T ss_pred cccccccCCCcccccCchhh
Confidence 4221 335679999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=221.53 Aligned_cols=161 Identities=19% Similarity=0.334 Sum_probs=136.1
Q ss_pred EEeeeCcC--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 114 IFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 114 ~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
++++||+| +|++||++..+ .++..||+|++..... .....+.+.+|+.+++.++||||+++++++..++..|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-----PTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeec-----ccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence 45789999 78999999877 4677899999876532 2334556888999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 192 LILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.++++||+......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999999988653 458999999999999999999999999999999999999999999999998543211
Q ss_pred -----------cchhheeeccCccc
Q 023430 267 -----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----------~~~~~~~~~ape~~ 280 (282)
...++..|||||++
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~ 180 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVL 180 (327)
T ss_pred ccccccccccccccceecccChHHh
Confidence 11346779999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-29 Score=213.08 Aligned_cols=167 Identities=28% Similarity=0.359 Sum_probs=141.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQT- 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~- 186 (282)
.+|+..+.||+|+||.||++... ..+..|++|++...... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV-----DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc-----CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 47899999999999999999876 35678999988654311 22344568889999999999999999998875
Q ss_pred -CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
...++++|||+++++|.+++...+.+++.....++.|++.||.|||+++|+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 3678999999999999999988778899999999999999999999999999999999999999999999999998632
Q ss_pred c----------cchhheeeccCcccc
Q 023430 266 L----------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~----------~~~~~~~~~ape~~~ 281 (282)
. ...++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVIS 182 (266)
T ss_pred ccccccCCccccCCccccccCHHHhC
Confidence 1 124688899999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-29 Score=214.49 Aligned_cols=165 Identities=22% Similarity=0.286 Sum_probs=136.6
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--SK 189 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 189 (282)
|++.+.||+|+||+||++.+.... ...+..||+|.+.... .......+.+|+++++.++||||+++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPAN-DGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred ceeceecccCCCcEEEEeeEcccc-CCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 488999999999999987755322 2456789999987542 122345677899999999999999999987653 46
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
++++|||+++++|.+++... .+++.++..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 89999999999999988654 589999999999999999999999999999999999999999999999999863211
Q ss_pred --------chhheeeccCccc
Q 023430 268 --------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 --------~~~~~~~~ape~~ 280 (282)
..++..|++||.+
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECL 182 (283)
T ss_pred hhhccCCCCCCCceeeCHhHh
Confidence 1345679999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=218.29 Aligned_cols=164 Identities=22% Similarity=0.318 Sum_probs=141.3
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
+|++.+.||+|+||.||+|.+. ..+..||+|.+...... .......+..|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-----ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-----CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence 4888999999999999999976 34678999999765432 1222345678999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..++||||+ +++|..++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999999999 889999997765 789999999999999999999999999999999999999999999999999864322
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~ 174 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELL 174 (298)
T ss_pred CCccccccccceeeeCHHHH
Confidence 2457889999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=200.19 Aligned_cols=146 Identities=23% Similarity=0.430 Sum_probs=128.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|...++||+|+||+||+++.+ .++++||+|.++.+.. ++.......+||-+|+.++|.|||++++....+..+
T Consensus 3 ~ydkmekigegtygtvfkarn~-----~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccC-----CccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence 4666789999999999999977 5678999999987653 223334567899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
-+|+|||.. +|..+... ++.++...++.++.|+++||.|+|+++++||||||.|+||+.+|++|++|||+++
T Consensus 77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglar 149 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLAR 149 (292)
T ss_pred EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhh
Confidence 999999964 67666654 5678999999999999999999999999999999999999999999999999996
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=216.21 Aligned_cols=161 Identities=16% Similarity=0.188 Sum_probs=131.7
Q ss_pred eeCcCCCeEEEEEEEcCCC-------------------CCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe
Q 023430 117 VVGQGAFGKVFQVKKKGVD-------------------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI 177 (282)
.||+|+||.||++.+...+ .......|++|++.... ......+.+|+.+++.++|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 5899999999999754221 11223458889886542 2233457789999999999999
Q ss_pred eeeeEEEEeCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC----
Q 023430 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---- 252 (282)
Q Consensus 178 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~---- 252 (282)
+++++++......++||||+++|+|..++.+ .+.+++..+..++.|++.||.|||+++|+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999888865 45689999999999999999999999999999999999998654
Q ss_pred ---cEEEEecCccccccc---chhheeeccCccc
Q 023430 253 ---HVMAAHSLNSHNQLC---CFFFFLFLGGGVF 280 (282)
Q Consensus 253 ---~v~l~Dfg~s~~~~~---~~~~~~~~ape~~ 280 (282)
.++++|||++..... ..++..|||||.+
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~ 192 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSREERVERIPWIAPECV 192 (274)
T ss_pred ccceeeecCCccccccccccccccCCcccCchhh
Confidence 389999998864332 2568889999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=225.59 Aligned_cols=159 Identities=19% Similarity=0.286 Sum_probs=135.5
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCCeeeeeEEEE
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQ 185 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~ 185 (282)
.....+++++||+|.||.||+|+.. ++.||||+++.. ..+.|..|.+|.+. ++|+||++++++-.
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~-------~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ek 274 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD-------NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEK 274 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc-------CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhc
Confidence 3456788899999999999999865 478999998643 34567788888765 57999999998876
Q ss_pred eCC----EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCEeeccCCCceEEcCCC
Q 023430 186 TRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILMDSDG 252 (282)
Q Consensus 186 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~---------~iiHrDlKp~NILl~~~~ 252 (282)
... .+|||+||.+.|+|.+++..+ .+++....+++..+++||+|||+- .|+|||||..||||.+|+
T Consensus 275 r~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl 353 (534)
T KOG3653|consen 275 RGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL 353 (534)
T ss_pred cCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence 554 899999999999999999754 579999999999999999999963 499999999999999999
Q ss_pred cEEEEecCcccc---------cccchhheeeccCccc
Q 023430 253 HVMAAHSLNSHN---------QLCCFFFFLFLGGGVF 280 (282)
Q Consensus 253 ~v~l~Dfg~s~~---------~~~~~~~~~~~ape~~ 280 (282)
...|+|||+|.. .....||.+|||||+|
T Consensus 354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvL 390 (534)
T KOG3653|consen 354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVL 390 (534)
T ss_pred cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHH
Confidence 999999999942 2223889999999987
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=214.43 Aligned_cols=166 Identities=28% Similarity=0.422 Sum_probs=138.0
Q ss_pred EEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Q 023430 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192 (282)
Q Consensus 113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 192 (282)
++.+.||.|.||.||+|.+.. .....+..|+||.+.... .....+.+.+|++.+++++||||+++++++...+..++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEecccc--ccccceeeeecccccccccccccccccccccccccccc
Confidence 567899999999999999884 233456779999995432 23345678889999999999999999999998888999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc----
Q 023430 193 ILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL---- 266 (282)
Q Consensus 193 v~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~---- 266 (282)
||||+++|+|.+++... ..+++.....|+.|++.||.|||+++|+|+||+++|||++.++.+||+|||++....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999876 668999999999999999999999999999999999999999999999999987541
Q ss_pred -----cchhheeeccCcccc
Q 023430 267 -----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -----~~~~~~~~~ape~~~ 281 (282)
.......|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~ 178 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLK 178 (259)
T ss_dssp EEESTTSESGGGGS-HHHHH
T ss_pred cccccccccccccccccccc
Confidence 124478999999863
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=215.91 Aligned_cols=163 Identities=19% Similarity=0.301 Sum_probs=136.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|.+.+.||+|+||.||+|..+ ..+..||+|++..... ......+.+|+.+++.++|+||+++++++..+..
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 77 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISR-----INGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKET 77 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEc-----CCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence 57999999999999999999876 3466899999865432 1222346679999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.|+||||+. ++|..++.. ...+.+..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++....
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 999999996 566666544 3457888899999999999999999999999999999999999999999999886321
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~ 175 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVL 175 (291)
T ss_pred CCCCCCccccccccCCcee
Confidence 12468899999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=217.44 Aligned_cols=163 Identities=29% Similarity=0.452 Sum_probs=142.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||++.+. ..+..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+..+..
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENK 76 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEc-----CCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence 57999999999999999999876 346779999986442 3344567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.|+||||+++++|..++.+. ..+++..++.++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999999988764 4689999999999999999999999999999999999999999999999998853222
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|++||.+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~ 175 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVV 175 (280)
T ss_pred ccccceeecchhhcCHHHH
Confidence 1568899999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=217.70 Aligned_cols=172 Identities=21% Similarity=0.289 Sum_probs=143.3
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||++.+.+...+.....+|+|++.... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 346899999999999999999987643333466789999986543 223345688899999999999999999999998
Q ss_pred CEEEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
...+++|||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999986432 36778889999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCcccccccc---------hhheeeccCcccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVFN 281 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~~ 281 (282)
||++.++.++|+|||++.....+ .....|+|||.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 99999999999999998642211 2356799999753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=214.38 Aligned_cols=165 Identities=23% Similarity=0.389 Sum_probs=141.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh---hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
+|+..+.||+|+||.||++... .++..+|+|++...... .....+.+.+|+.+++.++|+||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDV-----KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEc-----CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence 4778899999999999999865 45677999998653311 122356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~~~ 266 (282)
+..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||.+....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999999999999998878899999999999999999999999999999999999998776 59999999985322
Q ss_pred c-----------chhheeeccCccc
Q 023430 267 C-----------CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~-----------~~~~~~~~ape~~ 280 (282)
. ..++..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~ 180 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVL 180 (268)
T ss_pred cccccCCccccccccccceeCHhHh
Confidence 1 1457899999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=216.19 Aligned_cols=171 Identities=18% Similarity=0.193 Sum_probs=138.1
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||+|.+...+. .....+++|.+.... .......+..|+.+++.++|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~-~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~- 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGD-SIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP- 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCC-ceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence 445689999999999999999999864322 122347788775321 2233456777888999999999999999875
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
....++++||+++|+|.+++... +.+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 80 GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 45678999999999999999764 56899999999999999999999999999999999999999999999999999643
Q ss_pred ccc---------hhheeeccCcccc
Q 023430 266 LCC---------FFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~~---------~~~~~~~ape~~~ 281 (282)
..+ .++..||+||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~ 184 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESIL 184 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhc
Confidence 211 2356899999863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=211.92 Aligned_cols=167 Identities=28% Similarity=0.380 Sum_probs=142.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechh--hhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
.+|++.+.||+|+||.||++.++ .++..||+|.+.... .........+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-----DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-----CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 47999999999999999999876 356789999875432 11233456788999999999999999999998764
Q ss_pred --CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..++++|||+++++|.+++...+.+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 468999999999999999987777899999999999999999999999999999999999999999999999999642
Q ss_pred cc----------chhheeeccCcccc
Q 023430 266 LC----------CFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~----------~~~~~~~~ape~~~ 281 (282)
.. ..++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 182 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVIS 182 (264)
T ss_pred ccccccCccccccCCcccccCHhhhc
Confidence 11 14688999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=216.80 Aligned_cols=169 Identities=21% Similarity=0.317 Sum_probs=136.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHH-HHhcCCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~ 183 (282)
+.+..++.+-+..||.|+||+|++..++ .+++..|||.++.... ....+++..|.+. ++.-+.||||++||+
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk-----~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHK-----PSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcC-----ccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 3344556666788999999999999988 5788999999987653 2333456667664 555579999999999
Q ss_pred EEeCCEEEEEEeccCCCchHH---HHH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEE
Q 023430 184 FQTRSKLYLILDFINGGHLFF---HLY--RQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~---~l~--~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
...++..||.||+|.- +|.. ++. .+..++|.-+-.+....+.||.||.. ..|||||+||+|||++..|.||||
T Consensus 132 ~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLC 210 (361)
T KOG1006|consen 132 LFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLC 210 (361)
T ss_pred hhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeee
Confidence 9999999999999964 4432 222 24568888888888899999999984 579999999999999999999999
Q ss_pred ecCcccccc------cchhheeeccCcccc
Q 023430 258 HSLNSHNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 258 Dfg~s~~~~------~~~~~~~~~ape~~~ 281 (282)
|||+|.... .|.||..|||||.++
T Consensus 211 DFGIcGqLv~SiAkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 211 DFGICGQLVDSIAKTVDAGCRPYMAPERID 240 (361)
T ss_pred cccchHhHHHHHHhhhccCCccccChhccC
Confidence 999997443 448999999999874
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=214.89 Aligned_cols=161 Identities=29% Similarity=0.444 Sum_probs=139.1
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|++.+.||+|+||.||++.+. ..+..+++|.+.... ....+.+.+|+++++.++|+||+++++.+...+..|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-----CCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence 677889999999999999876 345678999885432 233456788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
+||||+++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++++|||++.....
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99999999999887754 45689999999999999999999999999999999999999999999999999864321
Q ss_pred ----chhheeeccCccc
Q 023430 268 ----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----~~~~~~~~ape~~ 280 (282)
..++..|||||.+
T Consensus 159 ~~~~~~~~~~y~aPE~~ 175 (282)
T cd06643 159 RRDSFIGTPYWMAPEVV 175 (282)
T ss_pred ccccccccccccCHhhc
Confidence 1468899999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=212.84 Aligned_cols=165 Identities=24% Similarity=0.336 Sum_probs=141.7
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh---hhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI---IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
+|++.+.||+|+||.||+|... .+..+|+|.+..... ......+.+.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 4778899999999999999743 456799998864321 1233345688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
+..+++|||+++++|.+++.+...+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999999999999887788999999999999999999999999999999999999999999999999886321
Q ss_pred ------------cchhheeeccCcccc
Q 023430 267 ------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ------------~~~~~~~~~ape~~~ 281 (282)
...++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~ 181 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVIN 181 (265)
T ss_pred ccccccccccccccCCCccccChhhhc
Confidence 124678899999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=216.43 Aligned_cols=166 Identities=20% Similarity=0.296 Sum_probs=136.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 188 (282)
++|++.+.||+|+||.||+|..+..+ ....+++|.++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG---LKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC---CcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC
Confidence 58999999999999999999876321 22346788775321 222345678899999999 6999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 189 KLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
..|++|||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 9999999999999999986532 477889999999999999999999999999999999999999
Q ss_pred cEEEEecCcccccccc----hh--heeeccCccc
Q 023430 253 HVMAAHSLNSHNQLCC----FF--FFLFLGGGVF 280 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~~----~~--~~~~~ape~~ 280 (282)
.++|+|||++...... .+ +..|||||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (297)
T cd05089 157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESL 190 (297)
T ss_pred eEEECCcCCCccccceeccCCCCcCccccCchhh
Confidence 9999999998643211 12 4569999976
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=213.06 Aligned_cols=165 Identities=25% Similarity=0.375 Sum_probs=141.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh------hhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------KKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+|.+.+.||+|+||.||+|.+. ..+..+|+|.+...... .....+.+.+|+.+++.++|+||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNA-----SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEec-----CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 3677889999999999999865 34567999988654321 122345688899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
...+..+++|||+++++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+..
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999998864
Q ss_pred cccc-------------hhheeeccCccc
Q 023430 265 QLCC-------------FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~~-------------~~~~~~~ape~~ 280 (282)
...+ .|+..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~ 184 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVV 184 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHh
Confidence 3311 357889999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=214.50 Aligned_cols=168 Identities=43% Similarity=0.728 Sum_probs=143.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 188 (282)
+|++.+.||+|+||.||+++.... ...+..||+|++....... ....+.+.+|+.+++.+ +|+||+.+++++..+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~--~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSG--HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccC--CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 488999999999999999986521 1356789999987643322 22345678899999999 5999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
..++||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999999998878899999999999999999999999999999999999999999999999999864322
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..|+..|+|||.+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~ 178 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIV 178 (290)
T ss_pred cccccccccCCcccCChhhc
Confidence 1468899999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=215.64 Aligned_cols=163 Identities=21% Similarity=0.308 Sum_probs=142.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|++.+.||+|+||.||++..+ ..+..+++|.+..... ...+.+.+|+.+++.+.|+||+++++.+..+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEEC-----CCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 458999999999999999999865 3567899998876432 22355788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+||||+++++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999999998854 457899999999999999999999999999999999999999999999999886422
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...+++.|+|||.+
T Consensus 170 ~~~~~~~~~~~~y~aPE~~ 188 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVV 188 (296)
T ss_pred ccccCcccCCccccCHHHH
Confidence 23678899999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=215.40 Aligned_cols=166 Identities=19% Similarity=0.245 Sum_probs=140.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
...|++.+.||+|+||.||++... ..+..||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDV-----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEc-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC
Confidence 346899999999999999999876 356789999986544333444566888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..|+||||+.+ ++.+.+.. .+.+++..+..++.|++.||.|||+++|+||||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 89 TAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred eEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99999999975 66565543 45689999999999999999999999999999999999999999999999999864322
Q ss_pred ---chhheeeccCccc
Q 023430 268 ---CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ---~~~~~~~~ape~~ 280 (282)
..++..|||||.+
T Consensus 168 ~~~~~~~~~y~aPE~~ 183 (307)
T cd06607 168 ANSFVGTPYWMAPEVI 183 (307)
T ss_pred CCCccCCccccCceee
Confidence 2568899999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=216.61 Aligned_cols=165 Identities=24% Similarity=0.347 Sum_probs=141.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ ..++.||+|++...... ....+.+.+|+++++.++|+||+++++++..++.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-----CCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence 36999999999999999999976 34678999987654322 2334567789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
.|+||||++++.|..+......+++..+..++.|++.||.|||+++|+|+||+|+||++++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999999998887776666689999999999999999999999999999999999999999999999998863211
Q ss_pred -----chhheeeccCccc
Q 023430 268 -----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -----~~~~~~~~ape~~ 280 (282)
..++..|+|||++
T Consensus 155 ~~~~~~~~~~~y~aPE~~ 172 (286)
T cd07846 155 EVYTDYVATRWYRAPELL 172 (286)
T ss_pred cccCcccceeeccCcHHh
Confidence 1468899999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=216.27 Aligned_cols=170 Identities=23% Similarity=0.344 Sum_probs=139.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCC-----------CCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI 177 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI 177 (282)
.++|++.+.||+|+||.||++.+.... .......+|+|++.... .....+.+.+|+.+++.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 457999999999999999998754321 11234568999986542 23344568899999999999999
Q ss_pred eeeeEEEEeCCEEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCce
Q 023430 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-----------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENI 246 (282)
Q Consensus 178 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NI 246 (282)
+++++++...+..+++|||+++++|..++.... .+++..+..++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999887542 356778999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 247 LMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 247 Ll~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
|++.++.++|+|||++...... .++..||+||.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 204 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESI 204 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHH
Confidence 9999999999999998742211 225689999964
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=213.48 Aligned_cols=169 Identities=21% Similarity=0.235 Sum_probs=141.1
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|.++.++. .....+|+|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGE-KVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCC-CcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 34689999999999999999999775432 2344689998765532 3344568889999999999999999999887
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999998764 458999999999999999999999999999999999999999999999999986322
Q ss_pred cc---------hhheeeccCccc
Q 023430 267 CC---------FFFFLFLGGGVF 280 (282)
Q Consensus 267 ~~---------~~~~~~~ape~~ 280 (282)
.. .++..|||||.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~ 183 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESI 183 (279)
T ss_pred CcccceecCCCcccccccCHHHh
Confidence 11 124679999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=214.54 Aligned_cols=167 Identities=23% Similarity=0.278 Sum_probs=139.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--C
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~ 188 (282)
-|++++.||+|+||.||++++.... ...+..||+|.++... .....+.+.+|+.+++.++|+||+++++++... .
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCC-CCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4788999999999999999865321 2456789999986543 233445688999999999999999999988765 5
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 789999999999999998664 3589999999999999999999999999999999999999999999999999863211
Q ss_pred ----------chhheeeccCccc
Q 023430 268 ----------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~ 184 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECL 184 (284)
T ss_pred CccceeecCCCCCCccccCHHHh
Confidence 1335679999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=212.02 Aligned_cols=161 Identities=16% Similarity=0.176 Sum_probs=133.7
Q ss_pred eeeCcCCCeEEEEEEEcCCCC-----CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDD-----GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+.||+|+||.||++.+..... ......+++|.+..... . ...+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---h-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 368999999999999875431 11223577787654321 1 4567889999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-------cEEEEecCcc
Q 023430 191 YLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-------HVMAAHSLNS 262 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-------~v~l~Dfg~s 262 (282)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 689999999999999999999999999999999999999888 7999999998
Q ss_pred ccccc---chhheeeccCcccc
Q 023430 263 HNQLC---CFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~---~~~~~~~~ape~~~ 281 (282)
..... ..+...|+|||.+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~ 177 (259)
T cd05037 156 ITVLSREERVERIPWIAPECIR 177 (259)
T ss_pred cccccccccccCCCccChhhhc
Confidence 75332 24578899999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=217.46 Aligned_cols=163 Identities=21% Similarity=0.364 Sum_probs=138.3
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||+|+++ ..+..+|+|.+..... .......+.+|+.+++.++|+||+++++++.+....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-----~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-----CCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence 4889999999999999999977 3567899999875432 222234567799999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
|+++||+.+ +|..++.. .+.+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 75 TLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 999999975 67776654 4668999999999999999999999999999999999999999999999999886321
Q ss_pred ----cchhheeeccCccc
Q 023430 267 ----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ----~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 154 ~~~~~~~~~~~y~aPE~~ 171 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVL 171 (284)
T ss_pred CCcCCCccccCCcChHHH
Confidence 12457899999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=214.45 Aligned_cols=164 Identities=19% Similarity=0.311 Sum_probs=139.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++..+ ..+..||+|.+...... .....+.+|+.+++.++|+||+++++++...+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSK-----LTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKK 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEc-----CCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCC
Confidence 468999999999999999999876 35678999998754321 12234567999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..++||||+.+ +|..++.+. ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||++.....
T Consensus 77 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 77 TLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred eEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 99999999985 898888654 4578999999999999999999999999999999999999999999999999864211
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~aPE~~ 175 (291)
T cd07844 156 PSKTYSNEVVTLWYRPPDVL 175 (291)
T ss_pred CCccccccccccccCCcHHh
Confidence 1357889999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=210.92 Aligned_cols=159 Identities=21% Similarity=0.235 Sum_probs=132.1
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEec
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF 196 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 196 (282)
.||+|+||.||+|.++.. ..+..||+|++.... .....+.+.+|+.+++.++|+||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~---~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecC---CCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEe
Confidence 389999999999987632 234569999886542 2334456889999999999999999999875 4578999999
Q ss_pred cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-------
Q 023430 197 INGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------- 268 (282)
Q Consensus 197 ~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------- 268 (282)
+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....+
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999999998875 456899999999999999999999999999999999999999999999999998632221
Q ss_pred ---hhheeeccCcccc
Q 023430 269 ---FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ---~~~~~~~ape~~~ 281 (282)
.++..|||||.++
T Consensus 156 ~~~~~~~~y~aPE~~~ 171 (257)
T cd05115 156 SAGKWPLKWYAPECIN 171 (257)
T ss_pred CCCCCCcccCCHHHHc
Confidence 2246899999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=208.48 Aligned_cols=164 Identities=24% Similarity=0.425 Sum_probs=139.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 189 (282)
+|++.+.||+|+||.||++.++ ..++.+|+|.+..... .....+.+.+|+.+++.++|+||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-----TDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-----CCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence 4899999999999999999976 3456799999865432 22334567889999999999999999988764 446
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
+|++|||+++++|.+++... ..+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 89999999999999888753 458999999999999999999999999999999999999999999999999986322
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...+++.|||||.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~ 174 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELF 174 (257)
T ss_pred cCCccccccCCcCccChhHh
Confidence 12568899999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=231.21 Aligned_cols=157 Identities=24% Similarity=0.400 Sum_probs=136.8
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEec
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF 196 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 196 (282)
+||+|+||+||.|+++ .+....|||.+.... ....+-+..||.+-+.|+|.|||+++|++..++.+-|.||-
T Consensus 582 VLGKGTYG~VYA~RD~-----~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-----DTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeeccc-----cceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 7999999999999976 456678999986543 34456688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCccccc----ccc
Q 023430 197 INGGHLFFHLYR-QGIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSHNQ----LCC 268 (282)
Q Consensus 197 ~~~g~L~~~l~~-~~~~--~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~~~----~~~ 268 (282)
++||+|..++.. .+++ .+..+-++.+||++||.|||++.|||||||-+|+|++. .|-+||+|||.|+.. =|.
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 999999998865 4666 78889999999999999999999999999999999974 689999999988632 222
Q ss_pred ---hhheeeccCcccc
Q 023430 269 ---FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ---~~~~~~~ape~~~ 281 (282)
.||.-|||||+++
T Consensus 734 ETFTGTLQYMAPEvID 749 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVID 749 (1226)
T ss_pred cccccchhhhChHhhc
Confidence 7799999999986
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=211.21 Aligned_cols=160 Identities=19% Similarity=0.234 Sum_probs=134.4
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEec
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF 196 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 196 (282)
.||+|+||.||+|.++.. ..+..+|+|++.... ......+.+.+|+.+++.++|+||+++++++. ....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~---~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMK---KSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecC---CCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence 589999999999976533 345679999986543 22334566888999999999999999999875 4567999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc--------
Q 023430 197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC-------- 268 (282)
Q Consensus 197 ~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~-------- 268 (282)
+++++|..++.....+++..+..++.|++.||.|||++||+||||||.|||++.++.++|+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999999999987778999999999999999999999999999999999999999999999999998642211
Q ss_pred --hhheeeccCcccc
Q 023430 269 --FFFFLFLGGGVFN 281 (282)
Q Consensus 269 --~~~~~~~ape~~~ 281 (282)
.++..|||||.++
T Consensus 157 ~~~~~~~y~aPE~~~ 171 (257)
T cd05116 157 HGKWPVKWYAPECMN 171 (257)
T ss_pred CCCCCccccCHhHhc
Confidence 2246899999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=212.37 Aligned_cols=159 Identities=19% Similarity=0.187 Sum_probs=130.6
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEec
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDF 196 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 196 (282)
.||+|+||.||+++.... .....+++|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~---~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTD---TGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcC---CCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEec
Confidence 589999999999975422 2344567777654321 22345688899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc----
Q 023430 197 INGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC---- 268 (282)
Q Consensus 197 ~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~---- 268 (282)
+++|+|..++.+. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999988753 23566778899999999999999999999999999999999999999999998642211
Q ss_pred -----hhheeeccCccc
Q 023430 269 -----FFFFLFLGGGVF 280 (282)
Q Consensus 269 -----~~~~~~~ape~~ 280 (282)
.++..|+|||++
T Consensus 157 ~~~~~~~~~~y~aPE~~ 173 (268)
T cd05086 157 TEDDKCVPLRWLAPELV 173 (268)
T ss_pred cccCCcCcccccCchhc
Confidence 346789999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=211.00 Aligned_cols=163 Identities=20% Similarity=0.343 Sum_probs=137.4
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE-
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ- 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~- 185 (282)
+...+|++.+.||+|+||.||++... +..+++|.+.... ..+.+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc-------CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence 44568999999999999999999754 4568999875432 2345788999999999999999998754
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+..+++|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred CCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence 4567999999999999999987643 37889999999999999999999999999999999999999999999999987
Q ss_pred ccccc----hhheeeccCcccc
Q 023430 264 NQLCC----FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~~----~~~~~~~ape~~~ 281 (282)
..... .++..|||||++.
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~ 172 (256)
T cd05082 151 EASSTQDTGKLPVKWTAPEALR 172 (256)
T ss_pred eccccCCCCccceeecCHHHHc
Confidence 43222 3366899999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-29 Score=210.01 Aligned_cols=165 Identities=25% Similarity=0.385 Sum_probs=145.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||++... ..+..|++|.+...... ....+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-----DTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-----CCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence 4889999999999999999865 35678999998765432 34567789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
++|+||+++++|.+++.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999999998777789999999999999999999999999999999999999999999999998864321
Q ss_pred --------chhheeeccCcccc
Q 023430 268 --------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 --------~~~~~~~~ape~~~ 281 (282)
..++..|++||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~ 176 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVIT 176 (264)
T ss_pred cccccccCCcCCcCccChhhcc
Confidence 24578999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=213.04 Aligned_cols=170 Identities=20% Similarity=0.306 Sum_probs=140.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||.||+|.+...........|++|.+.... .......+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45799999999999999999998743222356678999876432 1222345778999999999999999999999888
Q ss_pred EEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC---cEEEEe
Q 023430 189 KLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMAAH 258 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~---~v~l~D 258 (282)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++++||||||+|||++.++ .++|+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999987643 478899999999999999999999999999999999998765 589999
Q ss_pred cCcccccccc---------hhheeeccCccc
Q 023430 259 SLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
||+++..... .....|||||++
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAF 193 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHH
Confidence 9998743211 224579999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=219.17 Aligned_cols=158 Identities=20% Similarity=0.142 Sum_probs=122.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCCeee-eeEEEE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQ 185 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~ 185 (282)
.++|.+.++||+|+||+||+|.++.. .+..+|||++..... ......+.+.+|+++|+.++|+||+. +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGD----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCC----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 46799999999999999999987631 345589998753311 12234566899999999999999985 4432
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecc-CCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDl-Kp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
+..|+||||++|++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 45899999999999963 21 111 1467889999999999999999999 99999999999999999999961
Q ss_pred c--------------ccc-hhheeeccCcccc
Q 023430 265 Q--------------LCC-FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~--------------~~~-~~~~~~~ape~~~ 281 (282)
. ++. .+++.|+|||.++
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 1 111 4577899999864
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=212.08 Aligned_cols=166 Identities=19% Similarity=0.235 Sum_probs=136.4
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE--
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-- 189 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-- 189 (282)
|++.+.||+|+||.||+|..... ......||+|++..... .....+.+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 77 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQD--DGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ 77 (273)
T ss_pred CccccccCcCCCceEEEEEEecC--CCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence 56788999999999999987632 12456799999875432 23345568889999999999999999998765443
Q ss_pred ----EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 190 ----LYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 190 ----~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
.+++|||+++++|..++... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+||
T Consensus 78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCc
Confidence 79999999999998887542 35789999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc---------hhheeeccCccc
Q 023430 260 LNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~~---------~~~~~~~ape~~ 280 (282)
|+++..... ..+..|+|||.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESL 187 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhc
Confidence 998743211 235689999976
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=216.14 Aligned_cols=165 Identities=22% Similarity=0.295 Sum_probs=144.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++.+. ..+..||+|++.... .....+.+.+|+++++.++|+||+++++.+...+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 76 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHI-----PTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN 76 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEc-----CCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC
Confidence 457889999999999999999876 356789999886542 2334466889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
.+++||||+++++|..++.+.+.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999999999998887789999999999999999999996 6899999999999999999999999999864221
Q ss_pred -----chhheeeccCccc
Q 023430 268 -----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -----~~~~~~~~ape~~ 280 (282)
-.++..|+|||.+
T Consensus 157 ~~~~~~~~~~~~~aPE~~ 174 (284)
T cd06620 157 SIADTFVGTSTYMSPERI 174 (284)
T ss_pred hccCccccCcccCCHHHH
Confidence 2568999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=213.27 Aligned_cols=165 Identities=25% Similarity=0.380 Sum_probs=137.5
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEE-
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ- 185 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~- 185 (282)
..++|++.+.||+|+||.||++... ..+..+|+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNK-----KNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEEC-----CCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 3568999999999999999999876 346679999875432 1124477899999999 6999999999874
Q ss_pred ----eCCEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEE
Q 023430 186 ----TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 186 ----~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
.++..++||||+++++|..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 34579999999999999887753 2458889999999999999999999999999999999999999999999
Q ss_pred ecCcccccc-------cchhheeeccCcccc
Q 023430 258 HSLNSHNQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 258 Dfg~s~~~~-------~~~~~~~~~ape~~~ 281 (282)
|||++.... ...|+..|+|||++.
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhc
Confidence 999986321 125788999999873
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=211.20 Aligned_cols=165 Identities=26% Similarity=0.394 Sum_probs=141.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-------hhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-------KKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
+|.+.+.||+|+||.||+|... ..+..+|+|.+...... .....+.+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-----TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeec-----CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 5788899999999999999865 34668999987642211 11123567889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+...+..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+++++||||||+||+++.++.++++|||++.
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 99999999999999999999999887889999999999999999999999999999999999999999999999999986
Q ss_pred cccc---------chhheeeccCccc
Q 023430 264 NQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~---------~~~~~~~~ape~~ 280 (282)
.... -.++..|+|||.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~ 182 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVI 182 (272)
T ss_pred cccccccccccccccCCccccCHHHh
Confidence 4221 1457889999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=210.46 Aligned_cols=170 Identities=21% Similarity=0.215 Sum_probs=142.1
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|+..+.||+|+||.||+|..+..+ .....+++|.+.... .....+.+..|+.+++.++|+||+++.+++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPG--RKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF 78 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCC--CCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence 4568999999999999999999876422 234579999886542 223345688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
+..++||||+++++|..++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999999988764 568999999999999999999999999999999999999999999999999986332
Q ss_pred cc----------hhheeeccCcccc
Q 023430 267 CC----------FFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~~----------~~~~~~~ape~~~ 281 (282)
.. .....|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~ 183 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIA 183 (268)
T ss_pred cccccceeccCCCcCceecCHHHhh
Confidence 11 1134699999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=211.07 Aligned_cols=162 Identities=17% Similarity=0.209 Sum_probs=132.4
Q ss_pred eeeCcCCCeEEEEEEEcCCCC-------CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 116 RVVGQGAFGKVFQVKKKGVDD-------GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
+.||+|+||.||+|++....+ ......+++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999998642211 1123357888875532 233446778999999999999999999999988
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc-------EEEEecC
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-------VMAAHSL 260 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~-------v~l~Dfg 260 (282)
..+++|||+++++|..++..+ ..+++..+..++.|++.||.|||+++|+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998888654 56899999999999999999999999999999999999987664 8999999
Q ss_pred ccccccc---chhheeeccCccc
Q 023430 261 NSHNQLC---CFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~---~~~~~~~~ape~~ 280 (282)
++..... ..++..|||||.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~ 180 (262)
T cd05077 158 IPITVLSRQECVERIPWIAPECV 180 (262)
T ss_pred CCccccCcccccccccccChhhh
Confidence 9864332 2568889999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=214.44 Aligned_cols=162 Identities=22% Similarity=0.310 Sum_probs=141.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
.+|++.+.||+|+||.||++... ..+..||+|.+..... ...+.+.+|+.+++.++|+||+++++.+...+.
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDI-----ATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEEC-----CCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 57999999999999999999865 3567899999865432 223557889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
.|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999999998864 457899999999999999999999999999999999999999999999999886321
Q ss_pred ----cchhheeeccCccc
Q 023430 267 ----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ----~~~~~~~~~ape~~ 280 (282)
...+++.|+|||.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~ 187 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVV 187 (297)
T ss_pred cCcCcccCCccccCHHHH
Confidence 12568899999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=212.62 Aligned_cols=158 Identities=35% Similarity=0.578 Sum_probs=136.6
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||+|+||.||+|..+ ..++.||+|++...........+.+.+|+++++.++||||+++++.+...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEc-----CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 699999999999876 356789999987654333334455678999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc------cch
Q 023430 198 NGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL------CCF 269 (282)
Q Consensus 198 ~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~------~~~ 269 (282)
++++|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.... ...
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 9999999987755 68999999999999999999999999999999999999999999999999885321 225
Q ss_pred hheeeccCccc
Q 023430 270 FFFLFLGGGVF 280 (282)
Q Consensus 270 ~~~~~~ape~~ 280 (282)
++..|++||.+
T Consensus 156 ~~~~y~~PE~~ 166 (277)
T cd05577 156 GTPGYMAPEVL 166 (277)
T ss_pred CCCCcCCHHHh
Confidence 57889999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=212.69 Aligned_cols=159 Identities=37% Similarity=0.642 Sum_probs=131.8
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHH---HHHHhcCCCCeeeeeEEEEeCCEEEEE
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---DILTKVTHPFIVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~nIv~l~~~~~~~~~~~lv 193 (282)
.||+|+||.||++.+. ..++.||+|++.+...........+..|. .+++...|+||+++++.+...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEe-----cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence 4899999999999876 35678999998765432222222233343 344556799999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc-----ccc
Q 023430 194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ-----LCC 268 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~-----~~~ 268 (282)
|||+.|++|..++...+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||++... ...
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCc
Confidence 999999999999988888999999999999999999999999999999999999999999999999988532 123
Q ss_pred hhheeeccCccc
Q 023430 269 FFFFLFLGGGVF 280 (282)
Q Consensus 269 ~~~~~~~ape~~ 280 (282)
.|+..|||||.+
T Consensus 156 ~~~~~y~aPE~~ 167 (278)
T cd05606 156 VGTHGYMAPEVL 167 (278)
T ss_pred CCCcCCcCcHHh
Confidence 679999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=211.03 Aligned_cols=163 Identities=22% Similarity=0.285 Sum_probs=136.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.++||+|+||.||+|++.. ...||+|++..... ..+.+.+|+++++.++|+||+++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~- 71 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS- 71 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecC------CceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-
Confidence 445689999999999999999998652 23589999875332 2245788999999999999999998874
Q ss_pred CCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
....++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||.+..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 45689999999999999998753 3478899999999999999999999999999999999999999999999999853
Q ss_pred cc--------cchhheeeccCccc
Q 023430 265 QL--------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~--------~~~~~~~~~ape~~ 280 (282)
.. ...++..||+||..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~ 175 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAA 175 (262)
T ss_pred ccccccccccCCcccceecCHhHh
Confidence 21 11335679999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-29 Score=209.25 Aligned_cols=166 Identities=28% Similarity=0.401 Sum_probs=143.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
+|+..+.||+|+||.||+|... ..+..|++|.+..... ..+...+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNL-----DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEc-----CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence 3677789999999999999875 3567799998865331 12334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.++++|||+++++|.+++.+...+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999999999999887778999999999999999999999999999999999999999999999999886422
Q ss_pred ----cchhheeeccCcccc
Q 023430 267 ----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ----~~~~~~~~~ape~~~ 281 (282)
...++..|++||.+.
T Consensus 156 ~~~~~~~~~~~y~~pe~~~ 174 (258)
T cd06632 156 SFAKSFKGSPYWMAPEVIA 174 (258)
T ss_pred ccccccCCCcceeCHHHhc
Confidence 235688899999763
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=209.82 Aligned_cols=158 Identities=34% Similarity=0.570 Sum_probs=140.2
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||.|+||.||+++.. ..+..+++|++.+.........+.+.+|+.+++.++|+||+++++.+..+...+++|||+
T Consensus 1 lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVK-----SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEEC-----CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 699999999999976 356789999998765444455567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc------chhh
Q 023430 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------CFFF 271 (282)
Q Consensus 198 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------~~~~ 271 (282)
++++|.+++.+...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..... ..++
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 9999999998877889999999999999999999999999999999999999999999999999864322 2468
Q ss_pred eeeccCccc
Q 023430 272 FLFLGGGVF 280 (282)
Q Consensus 272 ~~~~ape~~ 280 (282)
..||+||.+
T Consensus 156 ~~~~~PE~~ 164 (262)
T cd05572 156 PEYVAPEII 164 (262)
T ss_pred cCccChhHh
Confidence 899999986
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=209.91 Aligned_cols=162 Identities=24% Similarity=0.345 Sum_probs=139.8
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+.||+|+||.||+|...... ..+..+++|++....... ..+.+.+|+.+++.++|+||+++++++......+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE
Confidence 46899999999999976321 236779999987654322 45678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 196 FINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 196 ~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
|+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||.+....
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999999875 678999999999999999999999999999999999999999999999999996433
Q ss_pred c---------chhheeeccCcccc
Q 023430 267 C---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~---------~~~~~~~~ape~~~ 281 (282)
. ..++..|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~ 180 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLK 180 (262)
T ss_pred cccccccccCCCcCccccCHHHhc
Confidence 2 24578999999763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=212.50 Aligned_cols=165 Identities=24% Similarity=0.414 Sum_probs=141.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ ..+..|++|+++.... .....+.+.+|+++++.++|+||+++++.+...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-----ATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-----CCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence 37999999999999999999876 3467899998865432 23344668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
.+++|||++++.+..+..+...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999999999877776666666789999999999999999999999999999999999999999999999998863222
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|||||++
T Consensus 155 ~~~~~~~~~~~~~~~PE~~ 173 (288)
T cd07833 155 ASPLTDYVATRWYRAPELL 173 (288)
T ss_pred cccccCcccccCCcCCchh
Confidence 1447889999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=211.34 Aligned_cols=163 Identities=24% Similarity=0.358 Sum_probs=141.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||+|.+. ..+..|++|++...... ....+.+.+|+.+++.++|+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-----ETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-----CCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence 5899999999999999999976 34678999998765422 23345688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
++||||+ +++|..++.. ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9999999 9999998865 3568999999999999999999999999999999999999999999999999886422
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~ 172 (286)
T cd07832 154 PRLYSHQVATRWYRAPELL 172 (286)
T ss_pred CCccccccCcccccCceee
Confidence 23568899999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=225.81 Aligned_cols=168 Identities=21% Similarity=0.284 Sum_probs=143.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
...+.+.||+|-||.||+|.+..... ...-.||||..+.+.. .+..+.|..|..+|+.++|||||+++|.+... ..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~k-ge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEK-GERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred hccHHHhhcCCcccceeeeEeccccc-CcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 34455789999999999999876532 2334589998877653 33467788999999999999999999998764 59
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccch
Q 023430 191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCCF 269 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~~ 269 (282)
|||||+++-|.|..++... ..++......++.||+.||.|||+.++|||||..+|||+....-||++|||+|+....+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999999999765 458888889999999999999999999999999999999999999999999998655553
Q ss_pred h--------heeeccCccccC
Q 023430 270 F--------FFLFLGGGVFNF 282 (282)
Q Consensus 270 ~--------~~~~~ape~~~~ 282 (282)
+ -..|||||-+||
T Consensus 546 yYkaS~~kLPIKWmaPESINf 566 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINF 566 (974)
T ss_pred hhhccccccceeecCccccch
Confidence 2 568999999998
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=210.39 Aligned_cols=165 Identities=18% Similarity=0.288 Sum_probs=138.7
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.++||+|+||.||+|..+ .+..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 455678999999999999999999854 345699998875432 2345788999999999999999998864
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.+..+++|||+.+++|.+++... ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 45789999999999999988653 357889999999999999999999999999999999999999999999999986
Q ss_pred cccc--------chhheeeccCcccc
Q 023430 264 NQLC--------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~--------~~~~~~~~ape~~~ 281 (282)
.... ..++..|+|||.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~ 176 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhc
Confidence 4321 13356899999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=209.07 Aligned_cols=165 Identities=21% Similarity=0.246 Sum_probs=140.9
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.++||+|+||.||++... ....+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~------~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN------GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc------CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 356678999999999999999999865 235689998875432 2345788999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.....+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++++|||++.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 888999999999999999998764 358899999999999999999999999999999999999999999999999986
Q ss_pred ccccc--------hhheeeccCccc
Q 023430 264 NQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~~--------~~~~~~~ape~~ 280 (282)
....+ ..+..|+|||.+
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~ 176 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAA 176 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHh
Confidence 43211 224679999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=214.20 Aligned_cols=164 Identities=21% Similarity=0.364 Sum_probs=139.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
++|++.+.||+|+||.||+|.++ ..+..+++|.++..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC-----CCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 57899999999999999999976 34667999998755432 22233466799999999999999999998877
Q ss_pred CEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
+..|+||||+.+ +|..++.... .+++..++.++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 899999999975 8888876643 48999999999999999999999999999999999999999999999999886322
Q ss_pred c-------chhheeeccCccc
Q 023430 267 C-------CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~-------~~~~~~~~ape~~ 280 (282)
. ..+++.|||||.+
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~ 178 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELL 178 (293)
T ss_pred CCccccccccccccccCchhh
Confidence 1 2568889999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=210.77 Aligned_cols=158 Identities=44% Similarity=0.707 Sum_probs=139.9
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||+|+||.||++++. ..+..+++|++...........+.+.+|+++++.++|+||+++++.+......|++|||+
T Consensus 1 lg~g~~~~vy~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKK-----STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEEC-----CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 689999999999976 346789999997665444455677889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc---------
Q 023430 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC--------- 268 (282)
Q Consensus 198 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~--------- 268 (282)
++++|..++.+.+.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99999999988778999999999999999999999999999999999999999999999999988643322
Q ss_pred ------hhheeeccCccc
Q 023430 269 ------FFFFLFLGGGVF 280 (282)
Q Consensus 269 ------~~~~~~~ape~~ 280 (282)
.++..|++||.+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~ 173 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVI 173 (265)
T ss_pred ccccCcccCccccCHHHh
Confidence 457889999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=208.24 Aligned_cols=164 Identities=25% Similarity=0.365 Sum_probs=142.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||.|+||.||++.+. ..+..+++|++....... ..+.+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-----PNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-----CCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 47999999999999999999876 345679999986543222 45668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.|++||++++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++....
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 99999999999999998764 458999999999999999999999999999999999999999999999999885322
Q ss_pred c-----------chhheeeccCccc
Q 023430 267 C-----------CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~-----------~~~~~~~~ape~~ 280 (282)
. ..++..|++||.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~ 178 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVM 178 (267)
T ss_pred cCccccccccccccCChhhcChHHH
Confidence 2 1467889999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=210.24 Aligned_cols=163 Identities=21% Similarity=0.326 Sum_probs=141.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|++.+.||.|+||.||++... ..+..|++|.+.... ....+.+.+|+.+++.++|+||+++++.+....
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDV-----ATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEc-----CCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 356999999999999999999865 456789999886543 223456788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+|+||+++++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999999999988864 458999999999999999999999999999999999999999999999999886321
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...++..|||||.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~ 187 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVV 187 (296)
T ss_pred cccCCCcCCCccccCcchh
Confidence 12568899999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=230.29 Aligned_cols=179 Identities=22% Similarity=0.252 Sum_probs=155.2
Q ss_pred HHhhhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeee
Q 023430 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179 (282)
Q Consensus 100 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 179 (282)
..+..+++......+.++||.|.||.||+|+.+... +....||||.++... .+.++..|..|+.||.+++||||++
T Consensus 619 vreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 619 VREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred HHHhhhhcChhheEEEEEEecccccceecccccCCC--CcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEE
Confidence 334456677888999999999999999999987543 566779999997653 3445566889999999999999999
Q ss_pred eeEEEEeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 180 LRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 180 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
|.|+......+.||.|||++|+|..+|..+ +.|...++.-+++.|+.||+||-+.+.|||||..+|||++.+..+|++|
T Consensus 695 LEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsD 774 (996)
T KOG0196|consen 695 LEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSD 774 (996)
T ss_pred EEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecc
Confidence 999999999999999999999999999764 5688999999999999999999999999999999999999999999999
Q ss_pred cCcccccccch---h-------heeeccCccccC
Q 023430 259 SLNSHNQLCCF---F-------FFLFLGGGVFNF 282 (282)
Q Consensus 259 fg~s~~~~~~~---~-------~~~~~ape~~~~ 282 (282)
||+|+....|. + -.+|.|||++.|
T Consensus 775 FGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~ 808 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY 808 (996)
T ss_pred ccceeecccCCCccccccCCccceeecChhHhhh
Confidence 99999655552 1 368999999865
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=215.04 Aligned_cols=156 Identities=24% Similarity=0.372 Sum_probs=126.1
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RSKLYLI 193 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 193 (282)
.+||+|+||.||+|+.+.. ..+..||+|.+..... ...+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~---~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 78 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG---KDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78 (317)
T ss_pred eEeccCCCeeEEEEEecCC---CccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEE
Confidence 5799999999999987632 3457799998865421 2346789999999999999999998853 5678999
Q ss_pred EeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE----cCCCcEEEEecC
Q 023430 194 LDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMAAHSL 260 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl----~~~~~v~l~Dfg 260 (282)
|||+.+ +|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 79 FDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 999875 666665421 247888999999999999999999999999999999999 566789999999
Q ss_pred cccccc----------cchhheeeccCccc
Q 023430 261 NSHNQL----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~----------~~~~~~~~~ape~~ 280 (282)
+++... ...+++.|||||.+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 187 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELL 187 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHh
Confidence 986321 11568899999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=208.56 Aligned_cols=161 Identities=21% Similarity=0.246 Sum_probs=137.1
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++||+|+||.||++.+... ......+|+|.+...... ...+.+.+|+.++++++|+||+++++.+.. ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEE
Confidence 4689999999999998642 123446999998776532 455678899999999999999999999988 88999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc------
Q 023430 196 FINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------ 267 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------ 267 (282)
|+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++.....
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999999987654 588999999999999999999999999999999999999999999999998864322
Q ss_pred ----chhheeeccCcccc
Q 023430 268 ----CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ----~~~~~~~~ape~~~ 281 (282)
..++..|++||.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~ 173 (257)
T cd05040 156 MEEHLKVPFAWCAPESLR 173 (257)
T ss_pred cccCCCCCceecCHHHhc
Confidence 23567899999763
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=236.25 Aligned_cols=165 Identities=27% Similarity=0.398 Sum_probs=148.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
-..++|+++.++|.|+||.||+++++ .+++..|+|+++.... ....-++.|+-+++.++|+|||.+++.+..
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~-----~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDK-----RSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccchhhhccc-----ccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhh
Confidence 34578999999999999999999977 5778899999876542 334557789999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+.+|++||||.||+|.+.-+--+.+++.++.+.++..++||+|||++|-+|||||-.|||+.+.|.||++|||.+....
T Consensus 84 ~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999999998888777889999999999999999999999999999999999999999999999999997544
Q ss_pred cc-------hhheeeccCcc
Q 023430 267 CC-------FFFFLFLGGGV 279 (282)
Q Consensus 267 ~~-------~~~~~~~ape~ 279 (282)
+. .||+-|||||+
T Consensus 164 ati~KrksfiGtpywmapEv 183 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEV 183 (829)
T ss_pred hhhhhhhcccCCccccchhH
Confidence 43 78999999996
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=209.88 Aligned_cols=164 Identities=18% Similarity=0.268 Sum_probs=136.9
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|... .+..+|+|.+..... ..+.+.+|+.++++++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN------GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec------CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence 345568999999999999999999764 234589998875432 2245788999999999999999998875
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
....+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 72 -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred -CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 45689999999999999988753 348899999999999999999999999999999999999999999999999986
Q ss_pred ccccc--------hhheeeccCccc
Q 023430 264 NQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~~--------~~~~~~~ape~~ 280 (282)
..... .+...|||||.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~ 175 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAA 175 (260)
T ss_pred eccCcccccccCCCCCccccChHHH
Confidence 42211 234579999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=209.55 Aligned_cols=163 Identities=20% Similarity=0.292 Sum_probs=134.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHH-HHHhcCCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~ 188 (282)
++|++.+.||+|+||.||+++++ .+++.||+|++...... .... .+..|+. .++.++|+||+++++++...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNS-QEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-----CCCcEEEEEEEecCCCc-HHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 47999999999999999999977 45788999998764321 2222 3444555 467778999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..|++|||++ ++|..++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999997 577666643 24589999999999999999999997 99999999999999999999999999986
Q ss_pred ccc------cchhheeeccCccc
Q 023430 264 NQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~------~~~~~~~~~ape~~ 280 (282)
... ...++..|+|||.+
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~ 175 (283)
T cd06617 153 YLVDSVAKTIDAGCKPYMAPERI 175 (283)
T ss_pred ccccccccccccCCccccChhhc
Confidence 422 13568899999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=210.90 Aligned_cols=162 Identities=24% Similarity=0.407 Sum_probs=137.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~- 187 (282)
+.|++.+.||+|+||.||+|.++ ..+..+|+|++.... .....+.+|+.+++.+ +|+||+++++.+...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEc-----CCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 46888899999999999999876 356789999986542 2234577899999998 699999999998753
Q ss_pred -----CEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
...|++|||+.+++|..++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCC
Confidence 4689999999999999988763 358899999999999999999999999999999999999999999999999
Q ss_pred ccccccc-------chhheeeccCccc
Q 023430 261 NSHNQLC-------CFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~-------~~~~~~~~ape~~ 280 (282)
++..... ..|+..|+|||++
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~ 183 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVI 183 (272)
T ss_pred CceecccccccCCcccccccccCHhHh
Confidence 9864221 2568899999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=212.04 Aligned_cols=162 Identities=15% Similarity=0.188 Sum_probs=134.0
Q ss_pred eeeCcCCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 193 (282)
+.||+|+||.||+|.++...+. .....+++|.+.... ....+.+.+|+.+++.+.||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 3689999999999987643321 233457888775432 23345677899999999999999999999998999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc--------EEEEecCcccc
Q 023430 194 LDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------VMAAHSLNSHN 264 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~--------v~l~Dfg~s~~ 264 (282)
|||+++|+|..++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999987644 5899999999999999999999999999999999999987765 69999999864
Q ss_pred ccc---chhheeeccCccc
Q 023430 265 QLC---CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~---~~~~~~~~ape~~ 280 (282)
... ..++..|||||.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~ 176 (258)
T cd05078 158 VLPKEILLERIPWVPPECI 176 (258)
T ss_pred cCCchhccccCCccCchhc
Confidence 332 2568899999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=207.10 Aligned_cols=162 Identities=20% Similarity=0.350 Sum_probs=142.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++.++ ..+..+++|.+..... .+.+.+|+.+++.++|+||+++++.+....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEc-----CCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 367999999999999999999976 3457899999865432 456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..|+++||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999999999865 34689999999999999999999999999999999999999999999999999864222
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..++..|++||.+
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~ 171 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVI 171 (256)
T ss_pred CccccccccCCccccCHHHH
Confidence 2468899999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=211.70 Aligned_cols=166 Identities=35% Similarity=0.622 Sum_probs=145.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
++|.+.+.||+|+||.||++..+ ..+..||+|++.+.........+.+.+|+.+++.++ |+||+++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-----CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 37999999999999999999876 356789999987654433444566888999999998 999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC 268 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~ 268 (282)
..++||||+++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999988632211
Q ss_pred ---------------------------hhheeeccCccc
Q 023430 269 ---------------------------FFFFLFLGGGVF 280 (282)
Q Consensus 269 ---------------------------~~~~~~~ape~~ 280 (282)
.++..|++||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~ 194 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL 194 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHh
Confidence 357889999975
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=211.55 Aligned_cols=162 Identities=19% Similarity=0.246 Sum_probs=140.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
.+|++.++||+|+||.||+|.++. +..+++|++..... ...+.+.+|+.+++.++|+||+++++++.....
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 76 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN------RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP 76 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC------CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence 468999999999999999998762 56799999875432 234457889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 77 VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999999999753 3578999999999999999999999999999999999999999999999999864322
Q ss_pred c-------hhheeeccCccc
Q 023430 268 C-------FFFFLFLGGGVF 280 (282)
Q Consensus 268 ~-------~~~~~~~ape~~ 280 (282)
+ .++..|++||.+
T Consensus 157 ~~~~~~~~~~~~~~~~PE~~ 176 (261)
T cd05148 157 DVYLSSDKKIPYKWTAPEAA 176 (261)
T ss_pred ccccccCCCCceEecCHHHH
Confidence 2 335689999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=207.33 Aligned_cols=160 Identities=38% Similarity=0.621 Sum_probs=134.6
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH-HhcCCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+|... ..++.||+|++.+...........+..|..++ ...+|+||+++++++...+..|++|
T Consensus 2 ~~l~~g~~~~v~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-----STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEec-----CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 56899999999999876 35678999998765433333333344455444 4558999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---chhh
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC---CFFF 271 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~---~~~~ 271 (282)
||+++++|..++...+.+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..... ..++
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGT 156 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCC
Confidence 9999999999998878899999999999999999999999999999999999999999999999999875332 2568
Q ss_pred eeeccCccc
Q 023430 272 FLFLGGGVF 280 (282)
Q Consensus 272 ~~~~ape~~ 280 (282)
..|++||.+
T Consensus 157 ~~y~~pe~~ 165 (260)
T cd05611 157 PDYLAPETI 165 (260)
T ss_pred cCccChhhh
Confidence 899999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=205.27 Aligned_cols=164 Identities=27% Similarity=0.492 Sum_probs=141.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||+++.. ..++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-----EDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-----CCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence 5899999999999999999876 35678999998754332 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
|+||||+.+++|..++.... .+++..++.++.|++.||.|||+++++|+||+|+|||++.++.++++|||++.....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999999999886543 478999999999999999999999999999999999999999999999999864322
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~~pe~~ 173 (256)
T cd08218 155 VELARTCIGTPYYLSPEIC 173 (256)
T ss_pred hhhhhhccCCccccCHHHh
Confidence 2467889999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=208.83 Aligned_cols=161 Identities=24% Similarity=0.334 Sum_probs=131.5
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
+.||+|+||.||+++.+.++ ....+++|.+.... .....+.+.+|+.+++++ +||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~---~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC---CeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEE
Confidence 36899999999999876321 12346888776422 223345678899999999 7999999999999999999999
Q ss_pred eccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 195 DFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
||+++|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+|||++.++.++++|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 9999999999987542 367889999999999999999999999999999999999999999999
Q ss_pred cCcccccccc------hhheeeccCcccc
Q 023430 259 SLNSHNQLCC------FFFFLFLGGGVFN 281 (282)
Q Consensus 259 fg~s~~~~~~------~~~~~~~ape~~~ 281 (282)
||++...... ..+..|+|||.+.
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~ 184 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLN 184 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHc
Confidence 9998632211 2255799999863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=209.47 Aligned_cols=162 Identities=20% Similarity=0.375 Sum_probs=138.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|++|.||+|++. .++..||+|++..... ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-----TTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-----CCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 5899999999999999999976 3567899999876432 22234567899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 191 YLILDFINGGHLFFHLYRQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
++||||+++ +|..++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++++|||++....
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 999999985 787777653 358999999999999999999999999999999999999999999999999986321
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...++..|++||.+
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~ 172 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVL 172 (284)
T ss_pred CccccccccccccccChHHh
Confidence 22457889999976
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=206.93 Aligned_cols=161 Identities=18% Similarity=0.223 Sum_probs=134.5
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++||+|+||.||+|.+.... .....+|+|.+...... ...+.+.+|+.+++.++|+||+++++++. ....++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~--~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS--GKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccC--CCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEE
Confidence 46999999999999876432 13467999998765432 33456888999999999999999999876 456899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-------
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------- 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------- 268 (282)
|+++++|.+++.....+++..+..++.|++.||.|||.++++||||||+|||++.++.++|+|||++......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 76 LAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred eCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 9999999999988778999999999999999999999999999999999999999999999999998632111
Q ss_pred ---hhheeeccCcccc
Q 023430 269 ---FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ---~~~~~~~ape~~~ 281 (282)
.++..|+|||.+.
T Consensus 156 ~~~~~~~~y~aPE~~~ 171 (257)
T cd05060 156 TAGRWPLKWYAPECIN 171 (257)
T ss_pred cCccccccccCHHHhc
Confidence 1235799999763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=206.06 Aligned_cols=158 Identities=21% Similarity=0.321 Sum_probs=133.2
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++||+|+||.||++... .+..+|+|++.... .......+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK------DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEec------CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 36899999999999753 35679999876543 22233457889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc------
Q 023430 196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC------ 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~------ 268 (282)
|+++++|..++... ..+.+..+..++.|++.||.|||++|++||||||+||+++.++.++++|||++......
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99999999988653 45789999999999999999999999999999999999999999999999998642221
Q ss_pred --hhheeeccCcccc
Q 023430 269 --FFFFLFLGGGVFN 281 (282)
Q Consensus 269 --~~~~~~~ape~~~ 281 (282)
.++..|+|||.++
T Consensus 153 ~~~~~~~y~aPE~~~ 167 (250)
T cd05085 153 LKQIPIKWTAPEALN 167 (250)
T ss_pred CCCCcccccCHHHhc
Confidence 2256799999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=209.40 Aligned_cols=168 Identities=20% Similarity=0.261 Sum_probs=141.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--C
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 187 (282)
.+|++.+.||+|+||.||++.+.... ...+..+|+|++...... ...+.+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 46888899999999999999876432 235678999998765432 345678899999999999999999998877 5
Q ss_pred CEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
...+++|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 57999999999999999987654 58999999999999999999999999999999999999999999999999997543
Q ss_pred c----------chhheeeccCccc
Q 023430 267 C----------CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~----------~~~~~~~~ape~~ 280 (282)
. ..+...|++||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~ 184 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECL 184 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHH
Confidence 1 1335569999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=210.42 Aligned_cols=164 Identities=24% Similarity=0.346 Sum_probs=143.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||++.++ ..+..+++|.+..... ....+.+.+|+++++.++|+||+++++.+...+.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 73 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR-----PTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD 73 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc-----CCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE
Confidence 36788899999999999999976 4567899998876532 2344567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.+.....
T Consensus 74 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 74 ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 99999999999999999775 678999999999999999999999 9999999999999999999999999999864322
Q ss_pred -----chhheeeccCccc
Q 023430 268 -----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -----~~~~~~~~ape~~ 280 (282)
..++..|++||.+
T Consensus 154 ~~~~~~~~~~~y~~PE~~ 171 (265)
T cd06605 154 SLAKTFVGTSSYMAPERI 171 (265)
T ss_pred HHhhcccCChhccCHHHH
Confidence 3568899999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-28 Score=206.55 Aligned_cols=163 Identities=23% Similarity=0.314 Sum_probs=136.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
+++.....||+|+||.||++.++ ..+..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++.
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDL-----STQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ccCCceEEEecCCceEEEEeEec-----CCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 34444568999999999999876 346679999876543 2234568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIF--REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~--~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~~~ 265 (282)
.++++||+++++|..++... ..+ ++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999999988764 445 78888999999999999999999999999999999986 679999999988532
Q ss_pred c-------cchhheeeccCccc
Q 023430 266 L-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~-------~~~~~~~~~ape~~ 280 (282)
. ...++..|+|||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~ 181 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVI 181 (268)
T ss_pred ccCCCccccCCCCccccChhhh
Confidence 1 12468899999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=207.81 Aligned_cols=169 Identities=20% Similarity=0.237 Sum_probs=139.2
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
...+|.+.+.||+|+||.||+|.+.... .....+++|...... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 3457999999999999999999876331 234468999876543 13344568889999999999999999998875
Q ss_pred CEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
...|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|||++.++.++++|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 45789999999999999997643 58999999999999999999999999999999999999999999999999886322
Q ss_pred cc--------hhheeeccCcccc
Q 023430 267 CC--------FFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~~--------~~~~~~~ape~~~ 281 (282)
.. .+...|+|||.+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~ 181 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESIN 181 (270)
T ss_pred cccceecCCCCccccccChhhhc
Confidence 11 1245799999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=205.99 Aligned_cols=165 Identities=20% Similarity=0.296 Sum_probs=138.1
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||++... ....+++|.+.... ...+.+.+|+.+++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec------CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 455678999999999999999999754 23458999876432 23456788999999999999999999987
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
. ...+++|||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence 7 7789999999999999998763 346788899999999999999999999999999999999999999999999885
Q ss_pred ccc-----c---chhheeeccCcccc
Q 023430 264 NQL-----C---CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~-----~---~~~~~~~~ape~~~ 281 (282)
... + ..++..|+|||.+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAIN 176 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhc
Confidence 321 1 13356799999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=209.22 Aligned_cols=165 Identities=19% Similarity=0.227 Sum_probs=132.4
Q ss_pred EEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----
Q 023430 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR----- 187 (282)
Q Consensus 113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 187 (282)
.+.++||+|+||.||+|.+... .....+|+|.++... ......+.+.+|+.+++.++|+||+++++.+...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~---~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQD---DSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred ccccccCcccCceEEEeEEccC---CCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 4668899999999999987632 122358999886543 2334456788899999999999999999876432
Q ss_pred -CEEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 188 -SKLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 188 -~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
...+++|||+.+|+|..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCC
Confidence 257899999999999887742 1347899999999999999999999999999999999999999999999999
Q ss_pred ccccccc-------c--hhheeeccCcccc
Q 023430 261 NSHNQLC-------C--FFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~~~-------~--~~~~~~~ape~~~ 281 (282)
++..... . .+++.|++||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 187 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLA 187 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHcc
Confidence 9864221 1 2366899999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=204.29 Aligned_cols=165 Identities=25% Similarity=0.384 Sum_probs=141.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||++... ..+..+|+|.+..... .....+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-----ADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-----CCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence 5899999999999999999876 3567899999876543 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecCcccccc-
Q 023430 191 YLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSLNSHNQL- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~~~- 266 (282)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++++|||.+....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999999998764 3488999999999999999999999999999999999998654 57999999986332
Q ss_pred -----cchhheeeccCcccc
Q 023430 267 -----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -----~~~~~~~~~ape~~~ 281 (282)
...++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08220 155 KSKAYTVVGTPCYISPELCE 174 (256)
T ss_pred CccccccccCCcccCchhcc
Confidence 125688999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=208.52 Aligned_cols=163 Identities=25% Similarity=0.436 Sum_probs=142.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||.|+||.||++.+. ..+..+|+|++.... .......+.+|+.+++.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-----RTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-----CCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 36888899999999999999976 356789999986543 22334567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
+|+|+||+++++|.+++... .+++..+..++.|++.||.|||+++++||||+|+||++++++.++|+|||++....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999999999988755 78999999999999999999999999999999999999999999999999885321
Q ss_pred ----cchhheeeccCccc
Q 023430 267 ----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ----~~~~~~~~~ape~~ 280 (282)
...++..|++||.+
T Consensus 153 ~~~~~~~~~~~y~~PE~~ 170 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVI 170 (274)
T ss_pred cccccccCCccccChhhh
Confidence 22567889999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=210.83 Aligned_cols=165 Identities=19% Similarity=0.277 Sum_probs=140.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
..|+..+.||+|+||.||++++. ..+..+|+|++.............+.+|+++++.++|+|++++++++.....
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-----CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 35788899999999999999876 3467899999875433333445568889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.|+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++.....
T Consensus 100 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 100 AWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9999999975 66666643 45689999999999999999999999999999999999999999999999998864332
Q ss_pred --chhheeeccCccc
Q 023430 268 --CFFFFLFLGGGVF 280 (282)
Q Consensus 268 --~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 179 ~~~~~~~~y~aPE~~ 193 (317)
T cd06635 179 NSFVGTPYWMAPEVI 193 (317)
T ss_pred ccccCCccccChhhh
Confidence 2578899999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=213.01 Aligned_cols=166 Identities=22% Similarity=0.319 Sum_probs=136.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--C
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~ 188 (282)
.|++.+.||+|+||.||+|..+.. ..+..||+|.+...........+.+.+|+.+++.++||||+++++++... .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 488999999999999999997631 15678999998764322233345577899999999999999999999988 7
Q ss_pred EEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC----CCcEEEEec
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS----DGHVMAAHS 259 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~----~~~v~l~Df 259 (282)
.+|+||||+++ +|...+... ..+++..+..++.|++.||.|||+++|+||||||+|||++. ++.+||+||
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 89999999976 565555422 25789999999999999999999999999999999999999 899999999
Q ss_pred Cccccccc----------chhheeeccCccc
Q 023430 260 LNSHNQLC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~----------~~~~~~~~ape~~ 280 (282)
|++..... ..++..|+|||.+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 187 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELL 187 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHH
Confidence 99864221 1457889999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=212.41 Aligned_cols=171 Identities=18% Similarity=0.199 Sum_probs=138.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+...+|+..+.||+|+||.||++.+...+.. ....+|+|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~ 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGET-VKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLS 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCc-ceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence 3456899999999999999999987643321 223578898765432 2223457789999999999999999998865
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
. ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 81 P-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred C-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 4 5779999999999999987643 5889999999999999999999999999999999999999999999999999632
Q ss_pred cc---------chhheeeccCcccc
Q 023430 266 LC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~---------~~~~~~~~ape~~~ 281 (282)
.. ..++..|||||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~ 184 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIH 184 (303)
T ss_pred cCcccccccCCCccccccCCHHHhc
Confidence 21 12356899999763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=205.02 Aligned_cols=164 Identities=26% Similarity=0.407 Sum_probs=144.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|++|.||+|..+ ..++.|++|++...... ...+.+.+|+..+..++|+||+++++.+.....
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK-----PTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe
Confidence 36899999999999999999977 35678999998765321 345668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.+++|||+++++|.+++.....+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||.+.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 74 ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 99999999999999999877889999999999999999999999 9999999999999999999999999998863221
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~ 172 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERI 172 (264)
T ss_pred CCcccceeecccccCHhhh
Confidence 2457899999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=206.06 Aligned_cols=163 Identities=21% Similarity=0.270 Sum_probs=135.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||++.+.. ...+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNG------TTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS- 71 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcC------CceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence 344679999999999999999998652 23589998765432 2345778999999999999999998875
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+..+++|||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++..
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 456899999999999999987542 478899999999999999999999999999999999999999999999999863
Q ss_pred ccc--------chhheeeccCccc
Q 023430 265 QLC--------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~--------~~~~~~~~ape~~ 280 (282)
... ..++..|+|||.+
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~ 175 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAA 175 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHh
Confidence 211 1235679999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=204.76 Aligned_cols=163 Identities=23% Similarity=0.335 Sum_probs=138.9
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
.+.+|++.+.||+|+||.||++.+. .+..+|+|++...... ...+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL------EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTER 71 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe------CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccC
Confidence 3468999999999999999999865 2456899988654321 23477899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
...++||||+++++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++....
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 151 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL 151 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecc
Confidence 9999999999999999988754 458899999999999999999999999999999999999999999999999886432
Q ss_pred c--------chhheeeccCccc
Q 023430 267 C--------CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~--------~~~~~~~~ape~~ 280 (282)
. ..++..|+|||.+
T Consensus 152 ~~~~~~~~~~~~~~~~~aPe~~ 173 (256)
T cd05112 152 DDQYTSSTGTKFPVKWSSPEVF 173 (256)
T ss_pred cCcccccCCCccchhhcCHhHh
Confidence 1 1235689999976
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-28 Score=204.46 Aligned_cols=164 Identities=22% Similarity=0.382 Sum_probs=139.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~ 188 (282)
+|++.+.||.|+||.||++.+. ..+..+|+|++..... .....+.+..|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-----SDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-----CCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 5889999999999999999876 3567799998875443 23345668889999999999999999987754 45
Q ss_pred EEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLH-----KCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH-----~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
..|++|||+++++|..++.. ...+++..++.++.|++.||.||| +.+++|+||||+||+++.++.++++||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 78999999999999988865 356899999999999999999999 889999999999999999999999999
Q ss_pred Cccccccc-------chhheeeccCccc
Q 023430 260 LNSHNQLC-------CFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~-------~~~~~~~~ape~~ 280 (282)
|++..... ..+++.|++||.+
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~pE~~ 182 (265)
T cd08217 155 GLAKILGHDSSFAKTYVGTPYYMSPEQL 182 (265)
T ss_pred cccccccCCcccccccccCCCccChhhh
Confidence 98864221 2468899999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=208.44 Aligned_cols=162 Identities=23% Similarity=0.396 Sum_probs=139.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCCeeeeeEEEEeC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTR 187 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 187 (282)
.|++.+.||+|+||.||+|.+. ..+..||+|.+.... .....+.+.+|+.+++.++ |+||+++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-----PTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-----CCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 4778899999999999999976 356789999886542 2234456788999999986 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
...|+||||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999999999988855 4789999999999999999999999999999999999999999999999998853221
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..|+..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~ 173 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVI 173 (277)
T ss_pred CccccccccCCcceeCHHHh
Confidence 2568889999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=208.39 Aligned_cols=168 Identities=46% Similarity=0.770 Sum_probs=142.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 188 (282)
+|++.+.||+|+||.||+++..... ..+..||||++++..... ....+.+.+|+.++..+ +|+||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4889999999999999999865322 356779999987543222 22345677899999999 5999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC 268 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~ 268 (282)
..++||||+.+++|..++.....+++..++.++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 99999999999999999887777899999999999999999999999999999999999999999999999988642211
Q ss_pred --------hhheeeccCccc
Q 023430 269 --------FFFFLFLGGGVF 280 (282)
Q Consensus 269 --------~~~~~~~ape~~ 280 (282)
.++..|+|||.+
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~ 178 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVI 178 (288)
T ss_pred cccccccccCCccccCHHHh
Confidence 368899999976
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=213.43 Aligned_cols=161 Identities=22% Similarity=0.335 Sum_probs=137.3
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|.....||+|+||.||++... ..+..||||.+.... ....+.+.+|+.+++.++|+||+++++.+...+..
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC-----CCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 3444567999999999999865 356789999886532 23345578899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc----
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL---- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~---- 266 (282)
|+||||+++++|..++.. +.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 999999999999887754 468999999999999999999999999999999999999999999999999885321
Q ss_pred ---cchhheeeccCccc
Q 023430 267 ---CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ---~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 174 ~~~~~~~~~~y~aPE~~ 190 (292)
T cd06658 174 KRKSLVGTPYWMAPEVI 190 (292)
T ss_pred cCceeecCccccCHHHH
Confidence 12568899999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-28 Score=215.35 Aligned_cols=163 Identities=20% Similarity=0.326 Sum_probs=135.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++.+.||+|+||.||+|... ..+..||+|++.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT-----VTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC-----CCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 467999999999999999999876 3567899999865322 223334567899999999999999999988643
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
...|+||||+.+ +|...+... +++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 89 SLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999965 777777543 889999999999999999999999999999999999999999999999999
Q ss_pred ccccc------chhheeeccCccc
Q 023430 263 HNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~------~~~~~~~~ape~~ 280 (282)
..... ..++..|+|||.+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~ 189 (353)
T cd07850 166 RTAGTSFMMTPYVVTRYYRAPEVI 189 (353)
T ss_pred eeCCCCCCCCCCcccccccCHHHH
Confidence 74321 2467889999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=205.82 Aligned_cols=161 Identities=20% Similarity=0.303 Sum_probs=135.5
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
...+|++.+.||+|+||.||++.. .++.||+|++.... ..+.+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~-------~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY-------TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc-------CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 346799999999999999998763 35569999886532 234578899999999999999999988654
Q ss_pred CEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+++|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++...
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceec
Confidence 5799999999999999987643 4788999999999999999999999999999999999999999999999998743
Q ss_pred ccc----hhheeeccCcccc
Q 023430 266 LCC----FFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~~----~~~~~~~ape~~~ 281 (282)
... .....|+|||.+.
T Consensus 151 ~~~~~~~~~~~~y~~pe~~~ 170 (254)
T cd05083 151 SMGVDNSKLPVKWTAPEALK 170 (254)
T ss_pred cccCCCCCCCceecCHHHhc
Confidence 221 2356799999763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=206.59 Aligned_cols=163 Identities=25% Similarity=0.403 Sum_probs=139.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 187 (282)
.++|++.+.||+|+||.||+|.++ ..+..+++|++..... ..+.+.+|+.+++++ +|+||+++++++...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEEC-----CCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 478999999999999999999976 3456799998875432 235588899999998 699999999999764
Q ss_pred C------EEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEE
Q 023430 188 S------KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 188 ~------~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
. .+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEEC
Confidence 4 58999999999999888764 3468999999999999999999999999999999999999999999999
Q ss_pred ecCcccccc-------cchhheeeccCccc
Q 023430 258 HSLNSHNQL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~-------~~~~~~~~~ape~~ 280 (282)
|||.+.... ...++..|+|||.+
T Consensus 156 d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (275)
T cd06608 156 DFGVSAQLDSTLGRRNTFIGTPYWMAPEVI 185 (275)
T ss_pred CCccceecccchhhhcCccccccccCHhHh
Confidence 999885321 22568889999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=226.72 Aligned_cols=171 Identities=27% Similarity=0.468 Sum_probs=154.2
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+...+++++..||-|+||.|-+++.+. ....+|+|++++..+.+..+.+.+..|..||..++.+.||++|..|
T Consensus 415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~-----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf 489 (732)
T KOG0614|consen 415 AQVKLSDLKRIATLGVGGFGRVELVKVNS-----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF 489 (732)
T ss_pred cccchhhhhhhhhcccCccceEEEEEecc-----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh
Confidence 34556788889999999999999988763 2235899999988777777778888999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+...+|++||-|-||.|...+.+++.|.+..++.++..+++|++|||++|||.|||||+|+|+|.+|.+||.|||+++.
T Consensus 490 rd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk 569 (732)
T KOG0614|consen 490 RDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKK 569 (732)
T ss_pred ccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999975
Q ss_pred cccc------hhheeeccCccc
Q 023430 265 QLCC------FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~~------~~~~~~~ape~~ 280 (282)
.... .||+.|.|||++
T Consensus 570 i~~g~KTwTFcGTpEYVAPEII 591 (732)
T KOG0614|consen 570 IGSGRKTWTFCGTPEYVAPEII 591 (732)
T ss_pred hccCCceeeecCCcccccchhh
Confidence 4333 789999999986
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=206.82 Aligned_cols=163 Identities=25% Similarity=0.412 Sum_probs=137.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 187 (282)
.++|++.+.||+|+||.||++..+ ..++.+|+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~-----~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNK-----KDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEEC-----CCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 468999999999999999999876 356789999886432 1234567899999998 799999999988753
Q ss_pred -----CEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 188 -----SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
+..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.++|+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEee
Confidence 368999999999999888753 35689999999999999999999999999999999999999999999999
Q ss_pred cCcccccc-------cchhheeeccCccc
Q 023430 259 SLNSHNQL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~-------~~~~~~~~~ape~~ 280 (282)
||++.... ...++..|+|||.+
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 200 (291)
T cd06639 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200 (291)
T ss_pred cccchhcccccccccCccCCccccChhhh
Confidence 99886422 22568899999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=202.11 Aligned_cols=165 Identities=26% Similarity=0.423 Sum_probs=145.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|++|.||++.+. ..+..|++|.+...... ....+.+.+|+++++.++|+||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-----ETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-----CCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence 4888999999999999999876 35567999998766432 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
+++|||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999998864322
Q ss_pred ----chhheeeccCcccc
Q 023430 268 ----CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ----~~~~~~~~ape~~~ 281 (282)
..++..|+|||.++
T Consensus 155 ~~~~~~~~~~y~~pe~~~ 172 (254)
T cd06627 155 DDASVVGTPYWMAPEVIE 172 (254)
T ss_pred cccccccchhhcCHhhhc
Confidence 25688899999763
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=205.27 Aligned_cols=166 Identities=20% Similarity=0.326 Sum_probs=140.5
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
+++.+.||+|+||.||++.+..... .....+|+|++..... ....+.+..|+.+++.++|+||+++++.+...+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 3567889999999999999874321 2347799999865432 224567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 192 LILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
++|||+++++|.+++..... +++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999999876544 899999999999999999999999999999999999999999999999999643221
Q ss_pred -------hhheeeccCccc
Q 023430 269 -------FFFFLFLGGGVF 280 (282)
Q Consensus 269 -------~~~~~~~ape~~ 280 (282)
.++..|+|||.+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~ 176 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESL 176 (258)
T ss_pred ccccccCCCcccccChHHh
Confidence 246789999976
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=209.97 Aligned_cols=169 Identities=23% Similarity=0.345 Sum_probs=136.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe-C
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-R 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~ 187 (282)
...|+++..||+|+||.||+|..+.+.+. ..+.+|||.++........ -....+|+.+++.++|+||+.+..+|.. +
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~k-r~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDK-RTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcc-cchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 35799999999999999999976655432 2457999998765322222 2335679999999999999999988877 7
Q ss_pred CEEEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC----CcEEEEe
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMAAH 258 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~----~~v~l~D 258 (282)
..+|+++||.+. +|...++-+ +.++...+..++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 799999999987 777777532 358889999999999999999999999999999999999888 9999999
Q ss_pred cCcccc------cccc----hhheeeccCccc
Q 023430 259 SLNSHN------QLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~------~~~~----~~~~~~~ape~~ 280 (282)
||+++. -+.+ .-|.-|-|||.|
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELL 211 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELL 211 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHh
Confidence 999962 1212 238899999975
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-28 Score=206.77 Aligned_cols=171 Identities=16% Similarity=0.235 Sum_probs=141.4
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||+|.+.... ......|++|.+.... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 34568999999999999999999987432 1235678999876432 33445668889999999999999999998765
Q ss_pred -CCEEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEE
Q 023430 187 -RSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 187 -~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
....++++||+++++|..++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 56789999999999999988653 347899999999999999999999999999999999999999999999
Q ss_pred ecCccccccc---------chhheeeccCccc
Q 023430 258 HSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
|||+++.-.. ..++..|||||.+
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 9999864221 1346679999976
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=208.74 Aligned_cols=163 Identities=23% Similarity=0.388 Sum_probs=138.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||.|+||.||+|+++ .++..||||++..... .....+.+.+|+++++.++||||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-----CCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence 4889999999999999999876 3567899998865432 222334678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc---
Q 023430 191 YLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ--- 265 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~--- 265 (282)
++||||+. ++|..++.. ...+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999996 578887765 345889999999999999999999999999999999999999999999999988532
Q ss_pred ----ccchhheeeccCccc
Q 023430 266 ----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ----~~~~~~~~~~ape~~ 280 (282)
....++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~ 172 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEIL 172 (284)
T ss_pred ccccccccccccccCCeEE
Confidence 122457889999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=207.22 Aligned_cols=164 Identities=20% Similarity=0.335 Sum_probs=135.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|.||.||+++++ ..+..||+|.+..... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-----VTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-----CCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence 57999999999999999999876 3567899998865432 12233557789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~~~~ 266 (282)
.|+||||+++ +|..++..... +++..+..++.||+.||.|||+++|+||||||+||+++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 76 LYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9999999964 77777755433 578888899999999999999999999999999999985 5679999999996432
Q ss_pred -------cchhheeeccCccc
Q 023430 267 -------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -------~~~~~~~~~ape~~ 280 (282)
...+++.|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~ 175 (294)
T PLN00009 155 IPVRTFTHEVVTLWYRAPEIL 175 (294)
T ss_pred CCccccccCceeecccCHHHH
Confidence 12457889999975
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=207.91 Aligned_cols=164 Identities=23% Similarity=0.396 Sum_probs=135.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
++|++.+.||+|+||.||+|.+. ..+..||+|++..... .......+.+|+.+++.+. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-----NTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-----CCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 46999999999999999999976 3567899998865432 2223345778999999995 699999999988766
Q ss_pred E-----EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEE
Q 023430 189 K-----LYLILDFINGGHLFFHLYRQ-----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAA 257 (282)
Q Consensus 189 ~-----~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~ 257 (282)
. .|++|||+++ +|..++... ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++.++|+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 5 8999999986 787777542 34789999999999999999999999999999999999998 8999999
Q ss_pred ecCccccccc-------chhheeeccCccc
Q 023430 258 HSLNSHNQLC-------CFFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~~-------~~~~~~~~ape~~ 280 (282)
|||++..... ..+++.|+|||.+
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~ 183 (295)
T cd07837 154 DLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183 (295)
T ss_pred ecccceecCCCccccCCcccccCCCChHHh
Confidence 9999864321 2457889999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=208.67 Aligned_cols=163 Identities=19% Similarity=0.282 Sum_probs=138.7
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|...+.||+|+||.||+|+.. ..+..|++|++...........+.+.+|+.+++.++|+||+++++++......|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS-----HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC-----CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 666788999999999999875 356789999987654333444556788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
+||||+.+ +|...+.. ...+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~ 176 (313)
T cd06633 98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176 (313)
T ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence 99999965 66666654 45689999999999999999999999999999999999999999999999999864322
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
..|+..|+|||.+
T Consensus 177 ~~~~~~y~aPE~~ 189 (313)
T cd06633 177 FVGTPYWMAPEVI 189 (313)
T ss_pred ccccccccChhhc
Confidence 2568899999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=210.96 Aligned_cols=163 Identities=21% Similarity=0.388 Sum_probs=139.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|+..+.||+|+||.||+|.+. ..+..||+|.+..... ....+.+.+|+.+++.++|+||+++++.+......
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN-----RTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL 77 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc-----CCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence 3666778999999999999875 3466799998865431 23446788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc--
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC-- 268 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~-- 268 (282)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++++|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999999999888754 56889999999999999999999999999999999999999999999999998642221
Q ss_pred -----hhheeeccCcccc
Q 023430 269 -----FFFFLFLGGGVFN 281 (282)
Q Consensus 269 -----~~~~~~~ape~~~ 281 (282)
.++..|+|||.++
T Consensus 157 ~~~~~~~~~~y~aPE~~~ 174 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIK 174 (277)
T ss_pred hhhcccCcccccCHHHhC
Confidence 4678899999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=204.83 Aligned_cols=161 Identities=19% Similarity=0.210 Sum_probs=130.8
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCCEEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSKLYLIL 194 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~ 194 (282)
+.||+|+||.||+|.+.... .....+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSD--GQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCC--CceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEE
Confidence 36899999999999875321 244679999875422 2234456788999999999999999999765 455689999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc------
Q 023430 195 DFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------ 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------ 267 (282)
||+.+++|.+++.+. ....+..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||+++....
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999999998764 3467778889999999999999999999999999999999999999999999864221
Q ss_pred -----chhheeeccCccc
Q 023430 268 -----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -----~~~~~~~~ape~~ 280 (282)
..++..|||||.+
T Consensus 157 ~~~~~~~~~~~y~aPE~~ 174 (262)
T cd05058 157 HNHTGAKLPVKWMALESL 174 (262)
T ss_pred cccccCcCCccccChhHh
Confidence 1336689999976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=213.16 Aligned_cols=164 Identities=21% Similarity=0.335 Sum_probs=137.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++... ..+..||||++.... ......+.+.+|+.+|+.++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR-----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC-----CCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 568999999999999999999866 456789999886532 12223345778999999999999999999887543
Q ss_pred ------EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..++||||+ +++|..++. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 468999998 678877775 456899999999999999999999999999999999999999999999999999
Q ss_pred cccccc----hhheeeccCccc
Q 023430 263 HNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~----~~~~~~~ape~~ 280 (282)
...... .+++.|||||.+
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~ 187 (343)
T cd07880 166 RQTDSEMTGYVVTRWYRAPEVI 187 (343)
T ss_pred cccccCccccccCCcccCHHHH
Confidence 743322 458899999975
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-27 Score=205.08 Aligned_cols=164 Identities=23% Similarity=0.311 Sum_probs=138.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
++|+..+.||.|++|.||++... ..+..+|+|.+..... ......+.+|+++++.++|+||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK-----NTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC-----CCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 47899999999999999999976 3567899999875432 23345688899999999999999999988653
Q ss_pred CEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 478999999999999887653 3457899999999999999999999999999999999999999999999999986
Q ss_pred ccc-----cchhheeeccCccc
Q 023430 264 NQL-----CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~-----~~~~~~~~~ape~~ 280 (282)
... ...++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~ 175 (287)
T cd06621 154 ELVNSLAGTFTGTSFYMAPERI 175 (287)
T ss_pred cccccccccccCCccccCHHHh
Confidence 322 12458889999976
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-28 Score=206.07 Aligned_cols=162 Identities=23% Similarity=0.402 Sum_probs=140.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|+..+.||.|+||.||+|.+. ..+..+|+|++..... ....+.+.+|+.+++.++|+||+++++.+......
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL 77 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEc-----cCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 5778889999999999999876 3467899998875432 23346688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++++|||++.....
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999999999998864 5688999999999999999999999999999999999999999999999999854221
Q ss_pred ----chhheeeccCccc
Q 023430 268 ----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 157 ~~~~~~~~~~y~apE~~ 173 (277)
T cd06640 157 KRNTFVGTPFWMAPEVI 173 (277)
T ss_pred ccccccCcccccCHhHh
Confidence 1457789999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=205.22 Aligned_cols=162 Identities=22% Similarity=0.398 Sum_probs=139.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
-|++.+.||+|+||.||++.+. ..+..+|+|++..... ....+.+.+|+.+++.++|+||+++++.+..+...
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-----RTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-----CCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence 3777889999999999999865 3567899998764322 23345688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
|+||||+++++|..++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999999999988854 4688999999999999999999999999999999999999999999999998853211
Q ss_pred ----chhheeeccCccc
Q 023430 268 ----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----~~~~~~~~ape~~ 280 (282)
..++..|++||.+
T Consensus 157 ~~~~~~~~~~y~~PE~~ 173 (277)
T cd06641 157 KRNTFVGTPFWMAPEVI 173 (277)
T ss_pred hhccccCCccccChhhh
Confidence 1457889999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-27 Score=204.67 Aligned_cols=158 Identities=25% Similarity=0.353 Sum_probs=131.5
Q ss_pred CeEEEeee--CcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC
Q 023430 111 DFEIFRVV--GQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187 (282)
Q Consensus 111 ~y~~~~~l--G~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 187 (282)
+|++.+.+ |+|+||.||++..+ ..+..+|+|++....... .|+.....+ +|+||+++++.+...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHK-----PTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEc-----CCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 55665555 99999999999876 356779999986543211 122222222 699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~~~ 266 (282)
+..|+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999998877899999999999999999999999999999999999999998 99999999986543
Q ss_pred cc---hhheeeccCcccc
Q 023430 267 CC---FFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~~---~~~~~~~ape~~~ 281 (282)
.. .++..|||||.+.
T Consensus 162 ~~~~~~~~~~y~aPE~~~ 179 (267)
T PHA03390 162 TPSCYDGTLDYFSPEKIK 179 (267)
T ss_pred CCccCCCCCcccChhhhc
Confidence 33 5689999999873
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=211.51 Aligned_cols=161 Identities=22% Similarity=0.326 Sum_probs=137.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|+....||+|+||.||++... ..+..||+|++..... ...+.+.+|+.+++.++||||+++++.+..++..
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEc-----CCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3555567999999999999865 3567899999865432 2335577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc----
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL---- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~---- 266 (282)
|++|||+++++|..++.. ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++....
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 999999999999887754 568999999999999999999999999999999999999999999999999985321
Q ss_pred ---cchhheeeccCccc
Q 023430 267 ---CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ---~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 173 ~~~~~~~~~~y~aPE~~ 189 (297)
T cd06659 173 KRKSLVGTPYWMAPEVI 189 (297)
T ss_pred cccceecCccccCHHHH
Confidence 12468899999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=208.79 Aligned_cols=165 Identities=22% Similarity=0.306 Sum_probs=135.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+.+ .++..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHK-----KTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEEC-----CCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 468999999999999999999976 35678999988654321 222234567999999999999999999876543
Q ss_pred --------EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 189 --------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 189 --------~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
..++||||+.+ +|...+... ..+++.++..++.|++.||.|||++|++|+||||+|||++.++.++|+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999975 777776554 36899999999999999999999999999999999999999999999999
Q ss_pred Ccccccc-----------cchhheeeccCccc
Q 023430 260 LNSHNQL-----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~-----------~~~~~~~~~ape~~ 280 (282)
|++.... ...++..|+|||.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELL 195 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHh
Confidence 9885321 12457789999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=213.38 Aligned_cols=164 Identities=14% Similarity=0.320 Sum_probs=139.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
.+|.+.+.||+|+||.||+++.. .++..||||.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNS-----ETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEec-----CCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 57999999999999999999876 4577899998865422 222334567899999999999999999887644
Q ss_pred ---CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 188 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
...|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 35899999996 68888888778899999999999999999999999999999999999999999999999999975
Q ss_pred cccc-------hhheeeccCccc
Q 023430 265 QLCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~~-------~~~~~~~ape~~ 280 (282)
.... .++..|+|||.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~ 180 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELL 180 (337)
T ss_pred cCCCcccccccccccCccChHHH
Confidence 3322 467889999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=206.94 Aligned_cols=163 Identities=23% Similarity=0.326 Sum_probs=139.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++... ..+..|++|.+.... ....+.+.+|+.+++.++||||+++++.+...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV-----ATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc-----CCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 358999999999999999999865 345679999885432 223356788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999999999988653 57889999999999999999999999999999999999999999999999875321
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...++..|++||.+
T Consensus 169 ~~~~~~~~~~~~y~~PE~~ 187 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVV 187 (293)
T ss_pred ccccccccCChhhcCchhh
Confidence 12467789999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=212.81 Aligned_cols=162 Identities=16% Similarity=0.298 Sum_probs=135.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
++|++.+.||+|+||.||+|.++ .++..||+|++.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHK-----PTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSF 77 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEc-----CCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccc
Confidence 58999999999999999999876 356789999886422 223345577899999999999999999876543
Q ss_pred ---CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 188 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
...|++|||+.+ +|..++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 78 ~~~~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 78 ESFNDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cccceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 358999999975 7777664 45689999999999999999999999999999999999999999999999999864
Q ss_pred ccc----------chhheeeccCccc
Q 023430 265 QLC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~----------~~~~~~~~ape~~ 280 (282)
... ..++..|||||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 181 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIM 181 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHh
Confidence 321 2467889999974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=209.16 Aligned_cols=166 Identities=22% Similarity=0.335 Sum_probs=137.6
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|.++ .++..||+|++....... .....+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-----TSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-----CCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 3568999999999999999999976 356789999987543221 2222355799999999999999999998754
Q ss_pred --CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 188 --SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 188 --~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
+.+++||||+.+ +|..++.. ...+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 79 HLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 568999999975 77777765 35689999999999999999999999999999999999999999999999999864
Q ss_pred ccc-------chhheeeccCccc
Q 023430 265 QLC-------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~-------~~~~~~~~ape~~ 280 (282)
... ..++..|+|||.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~ 180 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELL 180 (309)
T ss_pred cCCccCCCCcccccccccChhhh
Confidence 322 1347789999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=214.06 Aligned_cols=164 Identities=18% Similarity=0.310 Sum_probs=139.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe---
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--- 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 186 (282)
++|++.+.||+|+||.||++..+ .++..||+|++..... .....+.+.+|+.+|+.++|+||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT-----RSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 58999999999999999999876 4567899999875432 22334567789999999999999999988753
Q ss_pred -CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
...+++||||+. ++|..++...+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++...
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 357899999996 588888877777999999999999999999999999999999999999999999999999998542
Q ss_pred cc-----------chhheeeccCccc
Q 023430 266 LC-----------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~-----------~~~~~~~~ape~~ 280 (282)
.. ..++..|+|||.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~ 183 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELL 183 (334)
T ss_pred cccCcCCCcccccccccccccChHHh
Confidence 21 2567889999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=205.16 Aligned_cols=163 Identities=25% Similarity=0.401 Sum_probs=137.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEe-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~- 186 (282)
.+.|++.+.||+|+||.||++.++ ..+..+|+|++.... .....+..|+.+++.+ +|+||+++++++..
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEc-----CCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 457999999999999999999976 356689999886542 2234577899999988 69999999998853
Q ss_pred -----CCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 187 -----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 187 -----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
....|++|||+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 45789999999999999888653 34788889999999999999999999999999999999999999999999
Q ss_pred Ccccccc-------cchhheeeccCccc
Q 023430 260 LNSHNQL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~-------~~~~~~~~~ape~~ 280 (282)
|++.... ...++..|+|||.+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l 193 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVI 193 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhc
Confidence 9986321 12568899999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=205.76 Aligned_cols=162 Identities=22% Similarity=0.373 Sum_probs=138.5
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|++.+.||+|++|.||+|.++ ..+..||+|++..... .....+.+.+|+.+++.++|+||+++++++...+..|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-----LTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-----CCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence 567889999999999999976 3567899999875532 2223345778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc----
Q 023430 192 LILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ---- 265 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~---- 265 (282)
++|||++ ++|..++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++...
T Consensus 75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 9999995 58988887655 6899999999999999999999999999999999999999999999999998632
Q ss_pred ---ccchhheeeccCccc
Q 023430 266 ---LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ---~~~~~~~~~~ape~~ 280 (282)
....++..|||||.+
T Consensus 154 ~~~~~~~~~~~~~aPE~~ 171 (283)
T cd07835 154 RTYTHEVVTLWYRAPEIL 171 (283)
T ss_pred cccCccccccCCCCCcee
Confidence 122457889999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=204.47 Aligned_cols=162 Identities=24% Similarity=0.427 Sum_probs=138.4
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--CE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--SK 189 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 189 (282)
|++.+.||+|+||.||+|.+. ..+..+|+|.+.... ......+.+.+|+.+++.++|+||+++++++... +.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-----KTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-----CCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999976 346789999998654 2233345577899999999999999999999887 89
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.++||||+++ +|..++... ..+++..+..++.|++.||.|||++|++|+||||+||++++++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9999999975 888877654 5689999999999999999999999999999999999999999999999998864322
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~ 173 (287)
T cd07840 154 NSADYTNRVITLWYRPPELL 173 (287)
T ss_pred CcccccccccccccCCceee
Confidence 2447789999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=196.62 Aligned_cols=168 Identities=24% Similarity=0.333 Sum_probs=141.9
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+...+|.+.+.||+|+|+-||+++.. .+++.||+|++.... .+..+...+|++..++++||||++++++..
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~-----s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGL-----STGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeeccc-----Ccccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 455678999999999999999999865 467789999987653 344566788999999999999999977653
Q ss_pred e-----CCEEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcCCCcE
Q 023430 186 T-----RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHV 254 (282)
Q Consensus 186 ~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~~~~v 254 (282)
. ....||++.|...|+|.+.+.+. ..+++.+++.|+.++++||++||+.. ..||||||.|||+.+++..
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCce
Confidence 3 33599999999999999888652 35899999999999999999999998 9999999999999999999
Q ss_pred EEEecCcccc------------cccc----hhheeeccCcccc
Q 023430 255 MAAHSLNSHN------------QLCC----FFFFLFLGGGVFN 281 (282)
Q Consensus 255 ~l~Dfg~s~~------------~~~~----~~~~~~~ape~~~ 281 (282)
++.|||.+.. .+.+ .-|..|-|||.||
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~ 211 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFN 211 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchhee
Confidence 9999998741 1122 3399999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=199.27 Aligned_cols=164 Identities=28% Similarity=0.476 Sum_probs=142.7
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||++.+. ..+..+++|++..... .....+.+.+|+++++.++|+|++++.+.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-----SDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-----CCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence 5889999999999999999976 3567899999876542 234455688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 191 YLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
++++||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 9999999999999988764 668999999999999999999999999999999999999999999999999886422
Q ss_pred cc-------hhheeeccCccc
Q 023430 267 CC-------FFFFLFLGGGVF 280 (282)
Q Consensus 267 ~~-------~~~~~~~ape~~ 280 (282)
.. .+++.|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~ 175 (258)
T cd08215 155 STVDLAKTVVGTPYYLSPELC 175 (258)
T ss_pred cCcceecceeeeecccChhHh
Confidence 21 468889999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=208.07 Aligned_cols=165 Identities=23% Similarity=0.389 Sum_probs=137.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.++ ..+..||+|+++.... .......+.+|+.+++.++||||+++++++....
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDK-----DTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEEC-----CCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 468999999999999999999987 3456899999875432 1222345678999999999999999999887654
Q ss_pred ----------EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEE
Q 023430 189 ----------KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 189 ----------~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
.+++|+||+++ ++...+... ..+++..++.++.|++.||.|||+.||+||||||+||++++++.++|+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 79999999987 666666543 468999999999999999999999999999999999999999999999
Q ss_pred ecCcccccccc--------hhheeeccCccc
Q 023430 258 HSLNSHNQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~~~--------~~~~~~~ape~~ 280 (282)
|||++...... .++..|+|||.+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~ 189 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELL 189 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHh
Confidence 99998743321 347789999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=201.46 Aligned_cols=164 Identities=27% Similarity=0.473 Sum_probs=139.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||++..+ ..+..+|+|.+...... ....+.+.+|+.+++.++|+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-----SDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-----CCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence 5889999999999999999976 34567999998765332 22345678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc-EEEEecCccccccc
Q 023430 191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-VMAAHSLNSHNQLC 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~-v~l~Dfg~s~~~~~ 267 (282)
++++||+++++|.+++.+.. .+++..+..++.|++.||.|||+++++|+||||+||++++++. ++++|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999999999887643 4789999999999999999999999999999999999998865 69999998853211
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..|+..|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~~ape~~ 174 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEIC 174 (257)
T ss_pred CcccccccCCCccccCHHHH
Confidence 2468889999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=200.03 Aligned_cols=158 Identities=20% Similarity=0.288 Sum_probs=134.2
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++||+|+||.||++... . ++.|++|++...... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~-----~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-----G-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEe-----C-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 36899999999999865 2 667999988765322 344568889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-----c-
Q 023430 196 FINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-----C- 268 (282)
Q Consensus 196 ~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-----~- 268 (282)
|+.+++|.+++... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++..... .
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99999999988653 4578899999999999999999999999999999999999999999999999864321 1
Q ss_pred ---hhheeeccCcccc
Q 023430 269 ---FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ---~~~~~~~ape~~~ 281 (282)
.++..|+|||.+.
T Consensus 153 ~~~~~~~~y~~PE~~~ 168 (251)
T cd05041 153 GLKQIPIKWTAPEALN 168 (251)
T ss_pred ccCcceeccCChHhhc
Confidence 1245699999763
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=209.51 Aligned_cols=164 Identities=20% Similarity=0.290 Sum_probs=136.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++.+.||+|+||.||++... .++..||+|++.+... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEc-----CCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 478999999999999999999865 3567899999875422 222345577899999999999999999887643
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
...|++++++ +++|..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3478888887 6788777654 46899999999999999999999999999999999999999999999999998
Q ss_pred cccccc----hhheeeccCccc
Q 023430 263 HNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~----~~~~~~~ape~~ 280 (282)
...... .++..|+|||.+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~ 189 (345)
T cd07877 168 RHTDDEMTGYVATRWYRAPEIM 189 (345)
T ss_pred ccccccccccccCCCccCHHHH
Confidence 743322 568889999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=200.03 Aligned_cols=158 Identities=48% Similarity=0.805 Sum_probs=140.3
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||+|+||.||++.+. ..+..+++|++.+...........+..|+.+++.++|+||+++++.+..+...+++|||+
T Consensus 1 lg~G~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEEC-----CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 699999999999876 346789999988765544445667889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-------cchh
Q 023430 198 NGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-------CCFF 270 (282)
Q Consensus 198 ~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-------~~~~ 270 (282)
++++|.+++.....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||.+.... ...+
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 999999999887788999999999999999999999999999999999999999999999999986432 2256
Q ss_pred heeeccCccc
Q 023430 271 FFLFLGGGVF 280 (282)
Q Consensus 271 ~~~~~ape~~ 280 (282)
+..|++||.+
T Consensus 156 ~~~~~~Pe~~ 165 (250)
T cd05123 156 TPEYLAPEVL 165 (250)
T ss_pred CccccChHHh
Confidence 8899999975
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=210.54 Aligned_cols=159 Identities=18% Similarity=0.241 Sum_probs=132.7
Q ss_pred eeeCcC--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Q 023430 116 RVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 116 ~~lG~G--~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 193 (282)
..||+| +||+||++++. ..+..||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v 77 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHT-----PTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77 (328)
T ss_pred HHhCCcccCceeEEEEEEc-----CCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence 346666 99999999876 46778999998754322 23456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc----
Q 023430 194 LDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC---- 267 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~---- 267 (282)
|||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++++||+.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999999888764 3488999999999999999999999999999999999999999999999975432111
Q ss_pred -----c-----hhheeeccCccc
Q 023430 268 -----C-----FFFFLFLGGGVF 280 (282)
Q Consensus 268 -----~-----~~~~~~~ape~~ 280 (282)
+ .++..|||||++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~ 180 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELL 180 (328)
T ss_pred ccccccccccccCccCccChhhh
Confidence 1 224569999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=197.06 Aligned_cols=163 Identities=29% Similarity=0.462 Sum_probs=143.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|++|.||++.+. ..+..+++|++..... ...+.+.+|+.+++.++|+||+++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK-----RTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC-----CCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 4888999999999999999976 3567799999876542 3456688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
++++||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999999988775 578999999999999999999999999999999999999999999999999886432
Q ss_pred ---cchhheeeccCcccc
Q 023430 267 ---CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ---~~~~~~~~~ape~~~ 281 (282)
...++..|++||.+.
T Consensus 153 ~~~~~~~~~~~~~PE~~~ 170 (253)
T cd05122 153 ARNTMVGTPYWMAPEVIN 170 (253)
T ss_pred cccceecCCcccCHHHHc
Confidence 235688999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=197.67 Aligned_cols=165 Identities=29% Similarity=0.407 Sum_probs=144.7
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--C
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--S 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~ 188 (282)
+|.+.+.||+|++|.||+|..+ ..+..+++|++...... ....+.+.+|+.++++++|+||+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK-----DTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC-----CCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4788899999999999999876 35678999998765422 34566788999999999999999999999988 8
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc---
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ--- 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~--- 265 (282)
..+++|||+++++|.+++.....+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||.+...
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999999999988778999999999999999999999999999999999999999999999999988532
Q ss_pred ------ccchhheeeccCcccc
Q 023430 266 ------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ------~~~~~~~~~~ape~~~ 281 (282)
....++..|++||.+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~ 176 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIR 176 (260)
T ss_pred cccccccCCCCCccccCHhhhc
Confidence 2235689999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=199.56 Aligned_cols=159 Identities=28% Similarity=0.421 Sum_probs=132.4
Q ss_pred CCCeEEE-eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEe
Q 023430 109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT 186 (282)
Q Consensus 109 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 186 (282)
.++|.+. ++||-|-.|.|..|.++ .++..+|+|++.... ..++|+++--.. .|||||.++++|..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k-----~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHK-----RTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hhhheehhhhhccccCCceEEEEec-----cchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 4567765 68999999999999988 456679999885332 245688775444 59999999988764
Q ss_pred ----CCEEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEE
Q 023430 187 ----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAA 257 (282)
Q Consensus 187 ----~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~ 257 (282)
...+.+|||.|+||.|+..+..++. |+|.++..|++||+.|+.|||+.+|.||||||+|+|.... ..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4578899999999999999987755 9999999999999999999999999999999999999754 569999
Q ss_pred ecCcccccc--cc----hhheeeccCccc
Q 023430 258 HSLNSHNQL--CC----FFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~--~~----~~~~~~~ape~~ 280 (282)
|||+++... .+ .+|+-|.|||++
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevl 235 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVL 235 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHh
Confidence 999998543 12 679999999987
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=202.91 Aligned_cols=161 Identities=24% Similarity=0.349 Sum_probs=138.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|...+.||+|++|.||++.+. ..+..+++|++.... ....+.+.+|+.+++.++|+||+++++++...+..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~ 91 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDEL 91 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC-----CCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeE
Confidence 4555679999999999999876 345679999875432 22345578899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
++++||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+.....
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 999999999999998876 5689999999999999999999999999999999999999999999999998753221
Q ss_pred ----chhheeeccCccc
Q 023430 268 ----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----~~~~~~~~ape~~ 280 (282)
..|+..|+|||.+
T Consensus 171 ~~~~~~~~~~y~aPE~~ 187 (285)
T cd06648 171 RRKSLVGTPYWMAPEVI 187 (285)
T ss_pred ccccccCCccccCHHHh
Confidence 2468899999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=214.52 Aligned_cols=165 Identities=25% Similarity=0.313 Sum_probs=138.4
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 185 (282)
+....|+++++||+|+.+.||++..- ....||+|.+.... .+...+..+.+|+.+|.+|+ |.+||+||++-.
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s------~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNS------DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecC------CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 34457999999999999999999743 34568888765443 34566778999999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.++.+||||||- ..+|..+|.+... ++...++.+..|++.++.++|..||||.||||.|+|+ -.|.+||+|||+|..
T Consensus 431 ~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 431 TDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANA 508 (677)
T ss_pred cCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcc
Confidence 999999999965 4589888877654 3335788999999999999999999999999999998 479999999999964
Q ss_pred cccc---------hhheeeccCccc
Q 023430 265 QLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~~---------~~~~~~~ape~~ 280 (282)
.-.| .||+-||+||+|
T Consensus 509 I~~DTTsI~kdsQvGT~NYMsPEAl 533 (677)
T KOG0596|consen 509 IQPDTTSIVKDSQVGTVNYMSPEAL 533 (677)
T ss_pred cCccccceeeccccCcccccCHHHH
Confidence 3222 899999999997
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=202.40 Aligned_cols=160 Identities=23% Similarity=0.426 Sum_probs=132.4
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC--C
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR--S 188 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~ 188 (282)
|++.+.||+|+||.||++..+ ..+..||+|++..... ..... ...+|+.+++++. |+||+++++++.+. +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-----KTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEc-----CCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 678899999999999999876 3567899998865432 11222 2346888888885 99999999999987 8
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
.+++||||+++ +|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||+++. +.++|+|||++.....
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 89999999975 77777765 356899999999999999999999999999999999999999 9999999999964321
Q ss_pred ------chhheeeccCccc
Q 023430 268 ------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ------~~~~~~~~ape~~ 280 (282)
..++..|+|||.+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~ 170 (282)
T cd07831 152 KPPYTEYISTRWYRAPECL 170 (282)
T ss_pred CCCcCCCCCCcccCChhHh
Confidence 1458899999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=209.13 Aligned_cols=165 Identities=21% Similarity=0.226 Sum_probs=137.5
Q ss_pred CCeE-EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhh-----------HHHHHHHHHHHHHhcCCCCe
Q 023430 110 GDFE-IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------HVDYMKAERDILTKVTHPFI 177 (282)
Q Consensus 110 ~~y~-~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~nI 177 (282)
++|. +.+.||+|+||.||+|.++ ..+..||+|++......... ....+.+|+.+++.++|+||
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDT-----LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEEC-----CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 3565 4577999999999999876 35678999998654322100 01236689999999999999
Q ss_pred eeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEE
Q 023430 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 178 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
+++++++...+..++||||+. ++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+
T Consensus 83 v~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 83 MGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred eeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEEC
Confidence 999999999999999999997 5898888877789999999999999999999999999999999999999999999999
Q ss_pred ecCcccccc---------------------cchhheeeccCccc
Q 023430 258 HSLNSHNQL---------------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~---------------------~~~~~~~~~ape~~ 280 (282)
|||++.... ...++..|+|||.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 205 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL 205 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhc
Confidence 999886433 11347789999976
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=210.52 Aligned_cols=164 Identities=22% Similarity=0.375 Sum_probs=136.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 187 (282)
.++|++.+.||+|+||.||+|.+. ..+..+|+|.+..... .......+.+|+.+++.+ +|+||+++++++...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR-----RTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc-----CCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 357999999999999999999876 3567899998854321 222334567899999999 999999999988653
Q ss_pred --CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
...|+||||+++ +|..++... .+.+..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 80 NDKDIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred CCceEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 368999999974 888888655 7888999999999999999999999999999999999999999999999988632
Q ss_pred ccc------------hhheeeccCccc
Q 023430 266 LCC------------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~------------~~~~~~~ape~~ 280 (282)
... .|+..|||||.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEIL 184 (337)
T ss_pred ccccccccCcchhcccccccccCceee
Confidence 211 457889999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=201.63 Aligned_cols=164 Identities=23% Similarity=0.352 Sum_probs=143.1
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..+.|+..+.||+|+||.||++.+. ..+..+++|++..... ..+.+.+|+++++.++|+||+++++.+...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDR-----ATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVG 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEc-----cCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC
Confidence 3456888999999999999999876 3466799999875432 345578899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
...|+++||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999999999998766 78999999999999999999999999999999999999999999999999875322
Q ss_pred c-------chhheeeccCccc
Q 023430 267 C-------CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~-------~~~~~~~~ape~~ 280 (282)
. -.++..|++||.+
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~ 188 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVI 188 (286)
T ss_pred cchhhhccccCCcccCCHhHh
Confidence 1 1467889999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=209.90 Aligned_cols=163 Identities=19% Similarity=0.313 Sum_probs=139.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-- 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 188 (282)
+|++.+.||+|+||.||+|++. ..+..||+|++..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-----RTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-----CCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5889999999999999999976 3467899998875431 2334456888999999999999999999987765
Q ss_pred ---EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+|++|||+++ +|..++.+...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 75 ~~~~~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 75 DFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cccceEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 78999999984 78888877778999999999999999999999999999999999999999999999999998642
Q ss_pred cc----------chhheeeccCccc
Q 023430 266 LC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~----------~~~~~~~~ape~~ 280 (282)
.. ..++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~ 178 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELL 178 (330)
T ss_pred cccccccccccccccccCcCCceee
Confidence 21 1458889999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=199.14 Aligned_cols=164 Identities=23% Similarity=0.382 Sum_probs=141.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+|++.+.||+|+||.||+++++ ..+..+++|.+...... ......+.+|+.+++.++|+||+++++.+......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-----SDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-----CCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence 4889999999999999999876 35678999998765432 23345677899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 191 YLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
|+||||+++++|..++.+ ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 999999999999988865 3458899999999999999999999999999999999999999999999999886332
Q ss_pred c-----chhheeeccCccc
Q 023430 267 C-----CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~-----~~~~~~~~ape~~ 280 (282)
. ..++..|++||.+
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~ 173 (256)
T cd08530 155 KNMAKTQIGTPHYMAPEVW 173 (256)
T ss_pred cCCcccccCCccccCHHHH
Confidence 2 3568899999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=207.08 Aligned_cols=165 Identities=19% Similarity=0.257 Sum_probs=134.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR-- 187 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-- 187 (282)
+|++.+.||+|+||.||++..... ..+..||+|++.... ......+.+.+|+.+++.+ +|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~---~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 76 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET---SEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG 76 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC---CcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence 488999999999999999997632 125679999886432 1222345577899999999 599999998865432
Q ss_pred --CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+|++|||+. ++|...+.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 77 NFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred cCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 45789999986 588888877778999999999999999999999999999999999999999999999999998632
Q ss_pred c----------c-chhheeeccCccc
Q 023430 266 L----------C-CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~----------~-~~~~~~~~ape~~ 280 (282)
. . -.|+..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~ 181 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIM 181 (332)
T ss_pred ccccccccccccCcccCccccCcHHH
Confidence 1 0 1468899999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=221.98 Aligned_cols=171 Identities=20% Similarity=0.276 Sum_probs=146.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
|..+...+.++||+|.||+|++|.|... +.....||||.++.+.... ....|.+|+.+|.+|+|+|+++|||...+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~p--sgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQP--SGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCC--CCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 4445677778999999999999999863 2345569999998765432 56779999999999999999999999987
Q ss_pred CCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..+.||||+++.|+|.+.|.+ +..|.......|+.||+.||.||..+++|||||..+|+||.....|||+|||+.+.
T Consensus 183 -qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 183 -QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred -chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceec
Confidence 568899999999999999987 34578888899999999999999999999999999999999999999999999985
Q ss_pred --cccchh--------heeeccCccccC
Q 023430 265 --QLCCFF--------FFLFLGGGVFNF 282 (282)
Q Consensus 265 --~~~~~~--------~~~~~ape~~~~ 282 (282)
+..|.| -+.|-|||.|+|
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhcc
Confidence 333433 568999999875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=206.48 Aligned_cols=164 Identities=21% Similarity=0.276 Sum_probs=137.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|+..+.||+|+||.||+++.+ ..+..+++|.+...........+.+.+|+.+++.++|+|++++++++......
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEc-----CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence 4777788999999999999976 34677999988654333333445677899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 191 YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
|+||||+. |++...+.. ...+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++....
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 99999997 477666643 4558999999999999999999999999999999999999999999999999886422
Q ss_pred cchhheeeccCccc
Q 023430 267 CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 170 ~~~~~~~y~aPE~~ 183 (308)
T cd06634 170 XFVGTPYWMAPEVI 183 (308)
T ss_pred cccCCccccCHHHH
Confidence 22568899999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=202.95 Aligned_cols=162 Identities=20% Similarity=0.303 Sum_probs=133.4
Q ss_pred eeCcCCCeEEEEEEEcCCCC-CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 117 VVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
.||+|+||.||+++++.... ...+..+|+|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 58999999999998764331 2233578999876432 12334567889999999999999999999999899999999
Q ss_pred ccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-----cEEEEecCccc
Q 023430 196 FINGGHLFFHLYRQ-------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HVMAAHSLNSH 263 (282)
Q Consensus 196 ~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-----~v~l~Dfg~s~ 263 (282)
|+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+|||++.++ .++++|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999988642 2367889999999999999999999999999999999999887 89999999986
Q ss_pred ccc---------cchhheeeccCccc
Q 023430 264 NQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~---------~~~~~~~~~ape~~ 280 (282)
... ...++..|+|||.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESL 185 (269)
T ss_pred ccccccccccCcccCCCccccCHHHH
Confidence 432 12446789999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=202.74 Aligned_cols=161 Identities=26% Similarity=0.449 Sum_probs=136.8
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 190 (282)
|++.+.||+|+||.||+|... ..++.|+||.+...... .......+|+..++.++ |+||+++++.+..++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNK-----ETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEEC-----CCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 678899999999999999976 34677999988654321 11223456889999999 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 191 YLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
++||||+ +++|.+++.... .+++..+..++.|++.+|.|||+++++|+||||+||+++.++.++|+|||++.....
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999999 778988887654 689999999999999999999999999999999999999999999999999864332
Q ss_pred -----chhheeeccCccc
Q 023430 268 -----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -----~~~~~~~~ape~~ 280 (282)
..++..|+|||++
T Consensus 153 ~~~~~~~~~~~~~aPE~~ 170 (283)
T cd07830 153 PPYTDYVSTRWYRAPEIL 170 (283)
T ss_pred CCcCCCCCcccccCceee
Confidence 2468889999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=201.24 Aligned_cols=166 Identities=20% Similarity=0.255 Sum_probs=134.2
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC---
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS--- 188 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 188 (282)
|.+.+.||+|+||.||+|.++.. ...+..+|||++..+.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG 77 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence 56778999999999999987642 23567899999876542 2233556788999999999999999999876432
Q ss_pred ---EEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 189 ---KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 189 ---~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
..++++||+.+|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++++||
T Consensus 78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcc
Confidence 347899999999998776432 24788899999999999999999999999999999999999999999999
Q ss_pred Ccccccccc---------hhheeeccCccc
Q 023430 260 LNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~~---------~~~~~~~ape~~ 280 (282)
|+++..... .+...|++||.+
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~ 187 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESL 187 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHH
Confidence 998743211 235789999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-27 Score=204.80 Aligned_cols=164 Identities=21% Similarity=0.294 Sum_probs=137.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe-C
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-R 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~ 187 (282)
.++|++.+.||+|+||.||++..+ ..+..||+|++.+... .....+.+.+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQ-----LTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEEC-----CCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 468999999999999999999876 4567899998865432 22334567789999999999999999998865 5
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
...+++|||+ +++|..++. ...+++..+..++.|++.||.|||+++|+||||||.|||++.++.++|+|||.+.....
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 5789999998 457877765 44578888999999999999999999999999999999999999999999999874322
Q ss_pred c----hhheeeccCccc
Q 023430 268 C----FFFFLFLGGGVF 280 (282)
Q Consensus 268 ~----~~~~~~~ape~~ 280 (282)
. .++..|+|||.+
T Consensus 161 ~~~~~~~~~~y~aPE~~ 177 (328)
T cd07856 161 QMTGYVSTRYYRAPEIM 177 (328)
T ss_pred CcCCCcccccccCceee
Confidence 2 457789999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=216.57 Aligned_cols=169 Identities=22% Similarity=0.284 Sum_probs=147.1
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
|.+...+.....+||-|.||.||.+.|+ +....||||.++.+.. .+++|..|+.+|+.++|||+|+|+|+|
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWK-----kyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeee-----ccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 4444456777789999999999999998 3456799999876543 456688899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..+..+|||+|||..|+|.+|+.+.. .++....+.++.||..||+||..+++|||||..+|+|+.++.-||++|||++
T Consensus 333 T~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 333 THEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred ccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchh
Confidence 99999999999999999999998743 3677777888999999999999999999999999999999999999999999
Q ss_pred cccccchh--------heeeccCccccC
Q 023430 263 HNQLCCFF--------FFLFLGGGVFNF 282 (282)
Q Consensus 263 ~~~~~~~~--------~~~~~ape~~~~ 282 (282)
+.-..|.| -..|.|||-|.|
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAy 440 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAY 440 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccc
Confidence 87777755 357999998866
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-27 Score=201.56 Aligned_cols=172 Identities=15% Similarity=0.138 Sum_probs=124.8
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhH--------HHHHHHHHHHHHhcCCCCee
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH--------VDYMKAERDILTKVTHPFIV 178 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~nIv 178 (282)
+...+|++.++||+|+||.||+|.+.... .....+|+|+........... ......+...+..+.|+||+
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~--~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDH--CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCc--ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34468999999999999999999976431 224456777543221100000 00111233445667899999
Q ss_pred eeeEEEEeCC----EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcE
Q 023430 179 QLRYSFQTRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254 (282)
Q Consensus 179 ~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v 254 (282)
++++++.... ..+++||++.. ++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9998765443 34778887744 566666555557888899999999999999999999999999999999999999
Q ss_pred EEEecCcccccc--------------cchhheeeccCcccc
Q 023430 255 MAAHSLNSHNQL--------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 255 ~l~Dfg~s~~~~--------------~~~~~~~~~ape~~~ 281 (282)
+|+|||+|+... ...||+.|||||.+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~ 206 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN 206 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence 999999986321 114799999999763
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=203.19 Aligned_cols=163 Identities=21% Similarity=0.309 Sum_probs=133.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
++|+..+.||+|+||.||++.+. ..+..+|+|.+...... .....+.+|+.++.++. |+||+++++++..++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK-----PSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC-----CCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 45667788999999999999976 35678999998754322 33456788999999986 999999999999999
Q ss_pred EEEEEEeccCCCchHH---HHH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 KLYLILDFINGGHLFF---HLY--RQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~---~l~--~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..+++|||+.. ++.. .+. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 77 DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 99999999865 4433 322 23568999999999999999999997 49999999999999999999999999998
Q ss_pred cccc------cchhheeeccCccc
Q 023430 263 HNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~------~~~~~~~~~ape~~ 280 (282)
.... ...|+..|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~ 179 (288)
T cd06616 156 GQLVDSIAKTRDAGCRPYMAPERI 179 (288)
T ss_pred HHhccCCccccccCccCccCHHHh
Confidence 5322 23568899999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=203.05 Aligned_cols=157 Identities=23% Similarity=0.336 Sum_probs=134.9
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 194 (282)
..+||+|+||.||++..+ .++..+|+|++.... ......+.+|+.+++.++|+||+++++.+...+..+++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK-----SSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96 (292)
T ss_pred HHHcCCCCCeEEEEEEEc-----CCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEE
Confidence 467999999999999876 356789999875432 223456888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 195 e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
||+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 97 e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 97 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence 9999999988764 45689999999999999999999999999999999999999999999999998753222
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
..++..|++||.+
T Consensus 176 ~~~~~~y~~pE~~ 188 (292)
T cd06657 176 LVGTPYWMAPELI 188 (292)
T ss_pred cccCccccCHHHh
Confidence 2457889999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=204.30 Aligned_cols=165 Identities=23% Similarity=0.324 Sum_probs=134.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++.+.||+|+||.||+|.++ ..+..+|+|++....... .....+.+|+++++.++|+||+++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI-----KTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC-----CCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 478999999999999999999976 356679999886543211 1223466799999999999999999877543
Q ss_pred -------CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 188 -------SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 188 -------~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
..+++||||+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+||
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence 357999999976 56666554 346899999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc------------------hhheeeccCccc
Q 023430 260 LNSHNQLCC------------------FFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~~------------------~~~~~~~ape~~ 280 (282)
|++...... .+++.|+|||.+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL 198 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHh
Confidence 988632211 346779999975
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=198.02 Aligned_cols=166 Identities=27% Similarity=0.454 Sum_probs=136.7
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-------hhhhHHHHHHHHHHHHHh-cCCCCeeeeeE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------IKKNHVDYMKAERDILTK-VTHPFIVQLRY 182 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~ 182 (282)
+|++.+.||+|+||.||++.++. ..+..+|+|.+..... ........+.+|+.++.+ ++|+||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC----CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 47888999999999999999763 2456899998764321 122334456678887765 78999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEE
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
.+...+..+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+ ++|+|+||||+|||++.++.++|+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence 99999999999999999999887743 3458899999999999999999996 789999999999999999999999
Q ss_pred ecCcccccc------cchhheeeccCccc
Q 023430 258 HSLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~------~~~~~~~~~ape~~ 280 (282)
|||++.... ...++..|++||.+
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~ 185 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIV 185 (269)
T ss_pred cccceeecccccccccccCcccCcChhhh
Confidence 999986322 22568899999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-27 Score=195.20 Aligned_cols=148 Identities=26% Similarity=0.366 Sum_probs=126.2
Q ss_pred CCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeccCCC
Q 023430 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG 200 (282)
Q Consensus 121 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 200 (282)
|.||.||+++++ .+++.||+|.+..... ..+|...+....||||+++++++......|++|||+++|
T Consensus 4 g~~~~v~~~~~~-----~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDT-----RTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEc-----cCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 889999999976 4567899999876431 233455555667999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc----hhheeecc
Q 023430 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC----FFFFLFLG 276 (282)
Q Consensus 201 ~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~----~~~~~~~a 276 (282)
+|.+++.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++...... .++..|||
T Consensus 71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a 150 (237)
T cd05576 71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150 (237)
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence 99999988777999999999999999999999999999999999999999999999999987532221 34677999
Q ss_pred Ccccc
Q 023430 277 GGVFN 281 (282)
Q Consensus 277 pe~~~ 281 (282)
||.++
T Consensus 151 PE~~~ 155 (237)
T cd05576 151 PEVGG 155 (237)
T ss_pred CcccC
Confidence 99864
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=200.42 Aligned_cols=169 Identities=27% Similarity=0.365 Sum_probs=137.1
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 183 (282)
+.+..++|++.+.||+|+||.||++.++ ..+..||||.+..... ......+.+|+.++.... |+||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~ 82 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGY 82 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEEC-----CCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence 4556788999999999999999999976 3467899999875432 122344556776666664 9999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+......|++|||+.+ .|..++.. ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+
T Consensus 83 ~~~~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~ 161 (296)
T cd06618 83 FITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGI 161 (296)
T ss_pred eecCCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcccc
Confidence 9999999999999854 66665544 4568899999999999999999997 6999999999999999999999999999
Q ss_pred cccc------ccchhheeeccCcccc
Q 023430 262 SHNQ------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~------~~~~~~~~~~ape~~~ 281 (282)
+... ....++..|+|||.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 187 (296)
T cd06618 162 SGRLVDSKAKTRSAGCAAYMAPERID 187 (296)
T ss_pred chhccCCCcccCCCCCccccCHhhcC
Confidence 8532 1224678999999873
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=202.68 Aligned_cols=159 Identities=21% Similarity=0.270 Sum_probs=129.9
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 193 (282)
+.+.+|.|+++.||++ + .++..||+|++..... .....+.+.+|+.+++.++|+||+++++++...+..+++
T Consensus 6 i~~~~~~~~~v~~~~~--~-----~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 77 (314)
T cd08216 6 IGKCFEDLMIVHLAKH--K-----PTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77 (314)
T ss_pred hhHhhcCCceEEEEEe--c-----CCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence 3444455555555444 3 3567899999876532 334556789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-----
Q 023430 194 LDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL----- 266 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~----- 266 (282)
|||+++++|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++++|||.+....
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999999999988753 458899999999999999999999999999999999999999999999999875321
Q ss_pred ---------cchhheeeccCccc
Q 023430 267 ---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ---------~~~~~~~~~ape~~ 280 (282)
...++..|+|||++
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~ 180 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVL 180 (314)
T ss_pred ccccccccccccccccccCHHHh
Confidence 11346789999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=204.16 Aligned_cols=163 Identities=20% Similarity=0.335 Sum_probs=134.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|.+.+.||+|+||.||+|.+. ..+..||+|++.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDK-----RTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeC-----CCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 358999999999999999999876 3567899999865432 222334577899999999999999999988654
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
...|+||||+.. +|..++ ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 256999999964 665544 345899999999999999999999999999999999999999999999999998
Q ss_pred cccccc----hhheeeccCccc
Q 023430 263 HNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~----~~~~~~~ape~~ 280 (282)
...... .++..|||||.+
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~ 186 (342)
T cd07879 165 RHADAEMTGYVVTRWYRAPEVI 186 (342)
T ss_pred cCCCCCCCCceeeecccChhhh
Confidence 743222 457889999975
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=199.61 Aligned_cols=162 Identities=25% Similarity=0.392 Sum_probs=138.6
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|++.+.||+|.||.||+|+.. ..+..+|+|++..... .....+.+..|+.+++.++|+||+++++++...+..+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeec-----CCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence 567789999999999999976 3567899999876531 2233355678999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc--
Q 023430 192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC-- 268 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~-- 268 (282)
+||||+++ +|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||++++++.++|+|||++......
T Consensus 75 ~v~e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 75 LVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred EEecCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 99999984 899998776 57899999999999999999999999999999999999999999999999998643221
Q ss_pred -----hhheeeccCccc
Q 023430 269 -----FFFFLFLGGGVF 280 (282)
Q Consensus 269 -----~~~~~~~ape~~ 280 (282)
.++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~aPE~~ 170 (282)
T cd07829 154 TYTHEVVTLWYRAPEIL 170 (282)
T ss_pred ccCccccCcCcCChHHh
Confidence 346779999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=196.21 Aligned_cols=162 Identities=25% Similarity=0.344 Sum_probs=133.3
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCCeeeeeEEEEeCC
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQTRS 188 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~ 188 (282)
|++.+.||+|+||.||+++++ ..+..||+|+++.... .......+.+|+.+++.+ +|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-----NTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-----CCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999986 3467899999875432 222233456688777665 5999999999998877
Q ss_pred E-----EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 189 K-----LYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 189 ~-----~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
. .+++|||+.+ +|..++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+
T Consensus 75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 6 9999999975 7888876643 489999999999999999999999999999999999999999999999998
Q ss_pred cccccc------chhheeeccCccc
Q 023430 262 SHNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~------~~~~~~~~ape~~ 280 (282)
+..... ..++..|+|||.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~PE~~ 178 (287)
T cd07838 154 ARIYSFEMALTSVVVTLWYRAPEVL 178 (287)
T ss_pred ceeccCCcccccccccccccChHHh
Confidence 864211 1357889999976
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=210.12 Aligned_cols=175 Identities=19% Similarity=0.243 Sum_probs=129.2
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCC-----------CCCCCcEEEEEEeechhhhhh-----------hHHHHHH
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVD-----------DGDSDGIYAMKVMRKDTIIKK-----------NHVDYMK 163 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~-----------~~~~~~~ 163 (282)
.+..++|++.++||+|+||.||+|...... ....++.||||.+........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999753221 123456799999864321110 0111233
Q ss_pred HHHHHHHhcCCCCe-----eeeeEEEEe--------CCEEEEEEeccCCCchHHHHHhc---------------------
Q 023430 164 AERDILTKVTHPFI-----VQLRYSFQT--------RSKLYLILDFINGGHLFFHLYRQ--------------------- 209 (282)
Q Consensus 164 ~E~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~--------------------- 209 (282)
.|+.++.+++|.++ ++++++|.. .+..|+||||+++++|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46677777776654 566666542 35689999999999998887632
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--------chhheeeccCc
Q 023430 210 ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--------CFFFFLFLGGG 278 (282)
Q Consensus 210 ---~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--------~~~~~~~~ape 278 (282)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||++..... ..+++.|+|||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1234567888999999999999999999999999999999999999999999853211 13378999999
Q ss_pred cc
Q 023430 279 VF 280 (282)
Q Consensus 279 ~~ 280 (282)
.+
T Consensus 381 ~l 382 (507)
T PLN03224 381 EL 382 (507)
T ss_pred hh
Confidence 86
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=205.37 Aligned_cols=164 Identities=21% Similarity=0.324 Sum_probs=138.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|++. ..+..||+|++..... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDT-----KTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEEC-----CCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 568999999999999999999976 3567899998865421 2233455778999999999999999988776554
Q ss_pred E------EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 K------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
. .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 4 89999998 5689888764 56899999999999999999999999999999999999999999999999999
Q ss_pred cccccc----hhheeeccCccc
Q 023430 263 HNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~----~~~~~~~ape~~ 280 (282)
...... .++..|+|||.+
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~ 187 (343)
T cd07851 166 RHTDDEMTGYVATRWYRAPEIM 187 (343)
T ss_pred ccccccccCCcccccccCHHHH
Confidence 753322 558889999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=204.18 Aligned_cols=161 Identities=20% Similarity=0.315 Sum_probs=133.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
++|++.+.||+|+||.||+|..+ .++..||+|++..... ...+.+.+|+.+++.++|+||+++++.+...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~-----~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS-----DCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC-----CCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 68999999999999999999876 4567899998865432 3345677899999999999999998776543
Q ss_pred ------------CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcE
Q 023430 188 ------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHV 254 (282)
Q Consensus 188 ------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v 254 (282)
...|+||||++ ++|..++. .+.+++..++.++.|++.||.|||++||+||||||+||+++. ++.+
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 35899999997 48877775 456899999999999999999999999999999999999985 5578
Q ss_pred EEEecCccccc----------ccchhheeeccCccc
Q 023430 255 MAAHSLNSHNQ----------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 255 ~l~Dfg~s~~~----------~~~~~~~~~~ape~~ 280 (282)
+++|||.+... ....++..|+|||.+
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 190 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHH
Confidence 99999998532 112467889999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=205.43 Aligned_cols=166 Identities=25% Similarity=0.330 Sum_probs=138.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechh--hh--hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--II--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
++|-++.+||+|+|+.||+|.+. ...+.||||+-..+. .. .....+...+|..|-+.|+||-||++|++|.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl-----~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDL-----TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred HHHHHHHHhccccHHHHHHhccc-----chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 46888899999999999999865 456789999864332 11 1233445668999999999999999999986
Q ss_pred -eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCEeeccCCCceEEcC---CCcEEEEec
Q 023430 186 -TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--GIVHRDLKPENILMDS---DGHVMAAHS 259 (282)
Q Consensus 186 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~--~iiHrDlKp~NILl~~---~~~v~l~Df 259 (282)
+.+.+|-|+|||+|.+|..++..++.+++.+++.|+-||+.||.||.+. .|||-||||.||||-+ .|.+||.||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 4567999999999999999999889999999999999999999999976 4999999999999953 488999999
Q ss_pred Ccccccccc--------------hhheeeccCccc
Q 023430 260 LNSHNQLCC--------------FFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~~~--------------~~~~~~~ape~~ 280 (282)
|+|+.--.+ .||.-|+.||-|
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF 652 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF 652 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCccee
Confidence 999632211 679999999987
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=197.44 Aligned_cols=162 Identities=23% Similarity=0.407 Sum_probs=137.5
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|++.+.||+|++|.||++... ..+..+++|.+...... ......+.+|+.+++.++|+||+++++.+..+...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-----LTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcC-----CCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence 567789999999999999865 35677999988654322 233456778999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 192 LILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
++|||+++ +|..++.. ...+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+.....
T Consensus 75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 99999976 77777765 35789999999999999999999999999999999999999999999999998853322
Q ss_pred ----chhheeeccCccc
Q 023430 268 ----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----~~~~~~~~ape~~ 280 (282)
..++..|++||.+
T Consensus 154 ~~~~~~~~~~~~~PE~~ 170 (283)
T cd05118 154 PYTHYVVTRWYRAPELL 170 (283)
T ss_pred cccCccCcccccCcHHH
Confidence 2468889999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=187.67 Aligned_cols=140 Identities=18% Similarity=0.266 Sum_probs=108.4
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhh-----------------------HHHHHHHHHHHHHhc
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN-----------------------HVDYMKAERDILTKV 172 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l 172 (282)
..||+|+||.||+|... +++.||||+++........ .......|+.++..+
T Consensus 3 ~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05147 3 GCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL 76 (190)
T ss_pred CccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999853 4678999999765321111 012334599999999
Q ss_pred CCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEeeccCCCceEEcCC
Q 023430 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 173 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~yl-H~~~iiHrDlKp~NILl~~~ 251 (282)
.++++......... ..+|||||++|+++.........+++..+..++.|++.+|.|+ |++||+||||||+|||++ +
T Consensus 77 ~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 77 VTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred HHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C
Confidence 88776443322222 2389999999987765544556789999999999999999999 799999999999999998 5
Q ss_pred CcEEEEecCcccc
Q 023430 252 GHVMAAHSLNSHN 264 (282)
Q Consensus 252 ~~v~l~Dfg~s~~ 264 (282)
+.++|+|||+|..
T Consensus 154 ~~v~LiDFG~a~~ 166 (190)
T cd05147 154 GKLYIIDVSQSVE 166 (190)
T ss_pred CcEEEEEcccccc
Confidence 8899999999963
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=195.64 Aligned_cols=165 Identities=23% Similarity=0.353 Sum_probs=131.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
+|.+.+.||+|+||.||++++... +..+++|+++.... ........+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA-----VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC-----CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence 488999999999999999987632 23344444432111 11122334667899999999999999999999889
Q ss_pred EEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..++||||+++++|..++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 99999999999999887753 345899999999999999999999999999999999999974 6799999998864
Q ss_pred cccc-------hhheeeccCcccc
Q 023430 265 QLCC-------FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~~-------~~~~~~~ape~~~ 281 (282)
.... .++..|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~pe~~~ 178 (260)
T cd08222 155 LMGSCDLATTFTGTPYYMSPEALK 178 (260)
T ss_pred cCCCcccccCCCCCcCccCHHHHc
Confidence 3221 4578899999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=212.32 Aligned_cols=168 Identities=18% Similarity=0.282 Sum_probs=118.5
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE-
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS- 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~- 183 (282)
..+..++|++.++||+|+||.||+|.+..+.. ..+..||+|++..... .+.+..| .++...+.++..+...
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence 44567899999999999999999999874321 2367899998754321 1111111 1112222222222211
Q ss_pred -----EEeCCEEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCEe
Q 023430 184 -----FQTRSKLYLILDFINGGHLFFHLYRQGI--------------------FREDQARFYTAEIVSAVSHLHKCGIVH 238 (282)
Q Consensus 184 -----~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~gL~ylH~~~iiH 238 (282)
.......|+||||+.+++|.+++..... ..+..+..++.|++.||.|||+++|||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2345679999999999999988864321 112345678999999999999999999
Q ss_pred eccCCCceEEcC-CCcEEEEecCcccccc--------cchhheeeccCccc
Q 023430 239 RDLKPENILMDS-DGHVMAAHSLNSHNQL--------CCFFFFLFLGGGVF 280 (282)
Q Consensus 239 rDlKp~NILl~~-~~~v~l~Dfg~s~~~~--------~~~~~~~~~ape~~ 280 (282)
|||||+|||++. ++.+||+|||+|+... ...+++.|||||.+
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 999999999986 5899999999996321 12568999999965
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-27 Score=195.74 Aligned_cols=159 Identities=21% Similarity=0.290 Sum_probs=132.6
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----E
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-----K 189 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~ 189 (282)
-+.||-|+||+||.+.+. ++++.||.|++..-. ..-...+++-+|+.+|..++|.|++..++...... .
T Consensus 58 DRPIGYGAFGVVWsVTDP-----RdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDP-----RSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred CCcccccceeEEEeccCC-----CCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 367999999999988744 678899999886432 22233456778999999999999999888775443 4
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
+|+++|+|.. +|...+.....++.+.+..++.||++||+|||+.+|+||||||.|+|++.+.-+||||||+++....|
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 7888898854 78777777788999999999999999999999999999999999999999999999999999976555
Q ss_pred -------hhheeeccCccc
Q 023430 269 -------FFFFLFLGGGVF 280 (282)
Q Consensus 269 -------~~~~~~~ape~~ 280 (282)
.-|--|-|||++
T Consensus 211 ~~hMTqEVVTQYYRAPEiL 229 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELL 229 (449)
T ss_pred hhhhHHHHHHHHhccHHHh
Confidence 337778899876
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=179.29 Aligned_cols=141 Identities=18% Similarity=0.217 Sum_probs=110.0
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-----------------------hhHHHHHHHHHHHHHh
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKAERDILTK 171 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~ 171 (282)
...||+|+||.||+|... ++..||||+++...... ......+.+|...+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 467999999999999853 46789999988652110 0012234678999999
Q ss_pred cCCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcC
Q 023430 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS 250 (282)
Q Consensus 172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~ 250 (282)
+.|++|.....+.... .||||||++|+++.........++..++..++.|++.+|.++|. +||+||||||+|||++
T Consensus 76 l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 76 LYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred HHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 9999875544333322 48999999988654443344567888999999999999999999 9999999999999998
Q ss_pred CCcEEEEecCcccc
Q 023430 251 DGHVMAAHSLNSHN 264 (282)
Q Consensus 251 ~~~v~l~Dfg~s~~ 264 (282)
++.++|+|||++..
T Consensus 153 ~~~~~liDFG~a~~ 166 (190)
T cd05145 153 DGKPYIIDVSQAVE 166 (190)
T ss_pred CCCEEEEEccccee
Confidence 89999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=201.16 Aligned_cols=160 Identities=28% Similarity=0.408 Sum_probs=135.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~ 187 (282)
.+.|++...+|.|+|+.|..+.+. .+...+++|++.+.... ..+|+.++.. -+|+||+++.+.+.+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~-----~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~ 388 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESS-----PTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDG 388 (612)
T ss_pred chhhccccccCCCCccceeeeecc-----ccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCC
Confidence 457888888999999999999877 45566899998765211 2346655544 4699999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE-cCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM-DSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl-~~~~~v~l~Dfg~s~~~~ 266 (282)
.+.|+|||++.|+.|.+.+.....+. .++..|+++|+.++.|||++|||||||||+|||+ ++.|+++|+|||.++..-
T Consensus 389 ~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 389 KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 99999999999999988887766555 7888899999999999999999999999999999 689999999999997544
Q ss_pred cc----hhheeeccCcccc
Q 023430 267 CC----FFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~~----~~~~~~~ape~~~ 281 (282)
.+ .+|..|.|||+++
T Consensus 468 ~~~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 468 RSCDTPALTLQYVAPEVLA 486 (612)
T ss_pred hhhcccchhhcccChhhhc
Confidence 44 6799999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=222.00 Aligned_cols=155 Identities=21% Similarity=0.269 Sum_probs=128.7
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|...++||+|+||.||+|+++ ..+..||||.+...... ...|++++++++|||||++++++...+..
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSI-----KNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hCCcccEEccCCCeeEEEEEEC-----CCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 3555678999999999999976 35678999988643211 12468889999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCEeeccCCCceEEcCCCcEEEEecCcccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH---KCGIVHRDLKPENILMDSDGHVMAAHSLNSHN--- 264 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~--- 264 (282)
|+||||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||....
T Consensus 759 ~lv~Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EEEEeCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999999999853 788999999999999999999 6699999999999999998887765 555432
Q ss_pred cccchhheeeccCcccc
Q 023430 265 QLCCFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~~~~~~~~~ape~~~ 281 (282)
.....+++.|||||++.
T Consensus 835 ~~~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 835 DTKCFISSAYVAPETRE 851 (968)
T ss_pred CCCccccccccCccccc
Confidence 22336789999999873
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=205.59 Aligned_cols=176 Identities=19% Similarity=0.311 Sum_probs=147.2
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCC--CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeee
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGD--SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQL 180 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l 180 (282)
.+.+...+..+.+.||+|.||.|++|...+..... ....||||.++.... ....+.+..|+++|+.+. |+||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 45555666677789999999999999866544322 256799999876643 255677899999999986 9999999
Q ss_pred eEEEEeCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCC
Q 023430 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~ 244 (282)
.|++...+.+++|+||+..|+|..++...+ .+...+...++.||+.|++||++..+|||||-.+
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999997655 3788899999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCcccccccc-hh---------heeeccCcccc
Q 023430 245 NILMDSDGHVMAAHSLNSHNQLCC-FF---------FFLFLGGGVFN 281 (282)
Q Consensus 245 NILl~~~~~v~l~Dfg~s~~~~~~-~~---------~~~~~ape~~~ 281 (282)
|||+..+..+||+|||+|+....+ .+ -..|||||.+.
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~ 494 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF 494 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc
Confidence 999999999999999999854333 11 23499999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-27 Score=192.21 Aligned_cols=164 Identities=23% Similarity=0.312 Sum_probs=128.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe---
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--- 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 186 (282)
+.|+-+.+||+|.||.||+|+.+ ..++.||+|++-.+... ...-..-.+|+.+|..++|+|++.+++.+..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~-----n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSK-----NTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhc-----CccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 45777789999999999999977 45566888865432211 1112224569999999999999998776643
Q ss_pred -----CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 187 -----RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 187 -----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
...+|+|+.+|+. +|.-++... ..++..++..++.+++.||.|+|+..|+|||+|++|+||+.+|.++|+|||
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 2359999999986 777777654 568999999999999999999999999999999999999999999999999
Q ss_pred ccccc-ccc----------hhheeeccCccc
Q 023430 261 NSHNQ-LCC----------FFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~-~~~----------~~~~~~~ape~~ 280 (282)
+++.- ..+ .-|.-|..||.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEll 200 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELL 200 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHh
Confidence 99531 111 227778888864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-24 Score=175.13 Aligned_cols=162 Identities=37% Similarity=0.571 Sum_probs=140.9
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|.+.+.||+|++|.||++... ..+..+++|.+...... ...+.+.+|+..++.++|+|++++++.+......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDK-----GTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEc-----CCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 567789999999999999876 24567999998765322 24567888999999999999999999999889999
Q ss_pred EEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc----
Q 023430 192 LILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL---- 266 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~---- 266 (282)
+++|++++++|..++..... +++..+..++.+++.+|.|||+++++|+||++.||+++.++.++|+|||.+....
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999999999987666 8999999999999999999999999999999999999999999999999886432
Q ss_pred ----cchhheeeccCccc
Q 023430 267 ----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ----~~~~~~~~~ape~~ 280 (282)
...+...|++||.+
T Consensus 154 ~~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVL 171 (225)
T ss_pred ccccceeccCCcCCHhHh
Confidence 23567889999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-25 Score=204.04 Aligned_cols=165 Identities=19% Similarity=0.156 Sum_probs=138.0
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
.+..++||+|+||+||+|.|...+ ..-...||||++..... ...-.++..|+-+|.+++|||+++|++++.... +.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Peg-e~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEG-ENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCC-ceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 444578999999999999998653 24556799999876543 333456888999999999999999999998765 88
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc--
Q 023430 192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC-- 268 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~-- 268 (282)
||++|+++|.|.++++.+ +.+.....+.|..||++||.|||++++|||||-.+|||+..-.+|||.|||+++-...|
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999764 56888899999999999999999999999999999999999999999999999754444
Q ss_pred -------hhheeeccCccc
Q 023430 269 -------FFFFLFLGGGVF 280 (282)
Q Consensus 269 -------~~~~~~~ape~~ 280 (282)
..-+.|||=|.+
T Consensus 854 ey~~~~gK~pikwmale~i 872 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESI 872 (1177)
T ss_pred cccccccccCcHHHHHHHh
Confidence 125667776654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=178.09 Aligned_cols=159 Identities=23% Similarity=0.370 Sum_probs=128.7
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEe
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT 186 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 186 (282)
..++|++.+++|+|.|+.||.|.+. .+...++||+++.-. .+.+.+|+.||..|. ||||+++++...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~-----~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINI-----TNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhccccc-----CCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 4578999999999999999999865 345668899986532 345889999999997 9999999999876
Q ss_pred CC--EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-CcEEEEecCccc
Q 023430 187 RS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMAAHSLNSH 263 (282)
Q Consensus 187 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-~~v~l~Dfg~s~ 263 (282)
.. ...+++||+.+.+...+. ..++..+++.++.+++.||+|||++||+|||+||.|++||.. ..++|+|+|++-
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 53 567999999886654333 457888999999999999999999999999999999999965 569999999993
Q ss_pred ------ccccchhheeeccCccc
Q 023430 264 ------NQLCCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ------~~~~~~~~~~~~ape~~ 280 (282)
.......+.-|-.||.|
T Consensus 182 FYHp~~eYnVRVASRyfKGPELL 204 (338)
T KOG0668|consen 182 FYHPGKEYNVRVASRYFKGPELL 204 (338)
T ss_pred hcCCCceeeeeeehhhcCCchhe
Confidence 12222445666777765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=171.69 Aligned_cols=137 Identities=16% Similarity=0.133 Sum_probs=105.7
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-----CCCCeeeeeEEEEeCC-
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THPFIVQLRYSFQTRS- 188 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~- 188 (282)
.+.||+|+||.||. +.. . ...+||++..... ...+.+.+|+.+++.+ .||||+++++++.++.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~-----~-~~k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE-----D-AQRCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred cceecCCCceEEEE--CCC-----C-cCeEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 46899999999995 432 2 2246898865421 2335688999999999 5799999999999873
Q ss_pred --E-EEEEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCCEeeccCCCceEEcCC----CcEEEEe
Q 023430 189 --K-LYLILDF--INGGHLFFHLYRQGIFREDQARFYTAEIVSAV-SHLHKCGIVHRDLKPENILMDSD----GHVMAAH 258 (282)
Q Consensus 189 --~-~~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL-~ylH~~~iiHrDlKp~NILl~~~----~~v~l~D 258 (282)
. +.+|||| +.+++|.+++.+. .+.+. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+|
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 4 3478999 5589999999653 46655 35677888887 99999999999999999999743 4799999
Q ss_pred cCccccc
Q 023430 259 SLNSHNQ 265 (282)
Q Consensus 259 fg~s~~~ 265 (282)
|+.+...
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 6655443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-23 Score=167.84 Aligned_cols=157 Identities=32% Similarity=0.494 Sum_probs=135.6
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEecc
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFI 197 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 197 (282)
||+|.+|.||++... ..+..+++|++....... ..+.+.+|+.+++.++|++|+++++++......+++||++
T Consensus 1 l~~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDK-----KTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEec-----CCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 689999999999865 246779999987654221 3456889999999999999999999999989999999999
Q ss_pred CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCccccccc-------c
Q 023430 198 NGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSHNQLC-------C 268 (282)
Q Consensus 198 ~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~~~~~-------~ 268 (282)
.+++|..++... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|||.+..... .
T Consensus 74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 999999998765 46889999999999999999999999999999999999999 89999999998863322 3
Q ss_pred hhheeeccCcccc
Q 023430 269 FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ~~~~~~~ape~~~ 281 (282)
.+...|++||.+.
T Consensus 154 ~~~~~~~~pe~~~ 166 (215)
T cd00180 154 VGTPAYMAPEVLL 166 (215)
T ss_pred cCCCCccChhHhc
Confidence 5689999999763
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=200.10 Aligned_cols=154 Identities=25% Similarity=0.271 Sum_probs=123.4
Q ss_pred EEeeeCcCCCeE-EEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Q 023430 114 IFRVVGQGAFGK-VFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 114 ~~~~lG~G~fg~-V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 191 (282)
-.+++|.|+.|+ ||+|... ++.||||.+... ......+||.+|+.-+ |||||++|+.-.+....|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-------~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y 579 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-------GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY 579 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-------CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence 346789999875 6888754 567999987443 3345678999999886 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-C--C-CHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---C--CcEEEEecCcc
Q 023430 192 LILDFINGGHLFFHLYRQG-I--F-REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---D--GHVMAAHSLNS 262 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~-~--~-~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~---~--~~v~l~Dfg~s 262 (282)
|..|.|.. +|.+++.... . . .....+.++.|++.||++||+.+||||||||.||||+. + ..++|+|||+|
T Consensus 580 IalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99999965 8999987631 1 1 11345778899999999999999999999999999976 3 46899999999
Q ss_pred cccccc----------hhheeeccCcccc
Q 023430 263 HNQLCC----------FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~~----------~~~~~~~ape~~~ 281 (282)
+..-.+ .||-+|+|||.+.
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~ 687 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLR 687 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHh
Confidence 643222 6799999999873
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=181.63 Aligned_cols=164 Identities=24% Similarity=0.366 Sum_probs=135.1
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--C----Ceeee
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--P----FIVQL 180 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----nIv~l 180 (282)
+...+|+++..+|+|+||.|..|..+ ..+..||+|+++.-. ...+.-.-|+++|.++.+ | -+|.+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~-----~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDR-----ETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeec-----CCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 33678999999999999999999876 346789999986532 233445569999999953 2 36778
Q ss_pred eEEEEeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-------
Q 023430 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------- 251 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~------- 251 (282)
.++|.-.++.|||+|.+ |-++++++..+. .++...++.++.|++.++.|||+.+++|-||||+|||+-+.
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 89999999999999988 568999997754 48899999999999999999999999999999999997532
Q ss_pred -------------CcEEEEecCcccccccc----hhheeeccCccc
Q 023430 252 -------------GHVMAAHSLNSHNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 252 -------------~~v~l~Dfg~s~~~~~~----~~~~~~~ape~~ 280 (282)
-.|+++|||.+...-.. .-|..|=|||++
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVI 281 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchhe
Confidence 23899999999865555 349999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=176.95 Aligned_cols=161 Identities=20% Similarity=0.248 Sum_probs=130.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeee-EEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLR-YSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~-~~~~~~ 187 (282)
+.|.+.+.||+|.||.+-+|+++ .+...+++|.+.+... ..+.|.+|...--.|. |.||+.-| ..|++.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr-----~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHR-----QSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred hhhhHHHHhcccceeeEEeeecc-----CCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 56899999999999999999998 4567799999876543 3345777876655555 89999866 457788
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC--CCcEEEEecCccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~--~~~v~l~Dfg~s~~~ 265 (282)
+.++++|||++.|+|..-+... .+.|.....++.|++.|++|+|++++||||||.+||||-. .-+||+||||+++..
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 8889999999999998877553 4688889999999999999999999999999999999953 357999999999743
Q ss_pred ccc----hhheeeccCccc
Q 023430 266 LCC----FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~----~~~~~~~ape~~ 280 (282)
-.. .+.-.|-+||.+
T Consensus 174 g~tV~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 174 GTTVKYLEYVNNYHAPELC 192 (378)
T ss_pred CceehhhhhhcccCCcHHH
Confidence 322 447777788765
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=171.75 Aligned_cols=152 Identities=41% Similarity=0.633 Sum_probs=132.6
Q ss_pred CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeccCCCc
Q 023430 122 AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201 (282)
Q Consensus 122 ~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 201 (282)
+||.||++.+.. .+..+++|++........ .+.+.+|++.++.++|+||+++++.+......++++||+++++
T Consensus 1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECC-----CCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 589999999763 467899999876543221 5678899999999999999999999999899999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc------chhheeec
Q 023430 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------CFFFFLFL 275 (282)
Q Consensus 202 L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------~~~~~~~~ 275 (282)
|..++.....+++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++++|||.+..... ..++..|+
T Consensus 74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 999987766689999999999999999999999999999999999999999999999999874333 36688999
Q ss_pred cCccc
Q 023430 276 GGGVF 280 (282)
Q Consensus 276 ape~~ 280 (282)
+||.+
T Consensus 154 ~pE~~ 158 (244)
T smart00220 154 APEVL 158 (244)
T ss_pred CHHHH
Confidence 99976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=165.70 Aligned_cols=143 Identities=15% Similarity=0.162 Sum_probs=115.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHH------HHHHHHHHHhcCCCCeeee
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY------MKAERDILTKVTHPFIVQL 180 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~nIv~l 180 (282)
+..++|.+.++||+|+||.||++.. ....+|+|++.......+...+. +.+|+..+.++.|++|..+
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 4467999999999999999998643 23459999997665444444333 5789999999999999999
Q ss_pred eEEEEeC--------CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 181 RYSFQTR--------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 181 ~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
.+++... +..+|+|||++|.+|.+... +++ ....+++.+|..+|+.|++|||+||+||+++.+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence 8876543 35899999999999977632 333 2456999999999999999999999999999988
Q ss_pred cEEEEecCccccc
Q 023430 253 HVMAAHSLNSHNQ 265 (282)
Q Consensus 253 ~v~l~Dfg~s~~~ 265 (282)
++++|||.....
T Consensus 173 -i~liDfg~~~~~ 184 (232)
T PRK10359 173 -LRIIDLSGKRCT 184 (232)
T ss_pred -EEEEECCCcccc
Confidence 999999988643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=161.97 Aligned_cols=162 Identities=17% Similarity=0.190 Sum_probs=129.9
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~ 184 (282)
.+..+.|.++++||.|+||.+|.+... ..+..||||+-....... .+..|..+.+.|++ ..|..+..++
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i-----~~ge~VAiK~Es~~a~hp-----qL~yEskvY~iL~~g~GiP~i~~y~ 80 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISI-----TSGEEVAIKLESSKAKHP-----QLLYESKVYRILQGGVGIPHIRHYG 80 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeec-----cCCceEEEEeecccCCCc-----chhHHHHHHHHhccCCCCchhhhhc
Confidence 355689999999999999999999977 467789999876554222 25668888888874 5777777777
Q ss_pred EeCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEEecC
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAAHSL 260 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~Dfg 260 (282)
.+...-.+||+++ |-+|.++..- ...++...++.++-|++.-++|+|.+++|||||||+|+|..-+ ..+.++|||
T Consensus 81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG 159 (341)
T KOG1163|consen 81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG 159 (341)
T ss_pred cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence 7888889999988 5677766643 3458899999999999999999999999999999999998643 568999999
Q ss_pred cccccc--------------cchhheeeccCc
Q 023430 261 NSHNQL--------------CCFFFFLFLGGG 278 (282)
Q Consensus 261 ~s~~~~--------------~~~~~~~~~ape 278 (282)
+|+.-. .-.||.+|++-.
T Consensus 160 LaKky~d~~t~~HIpyre~r~ltGTaRYASin 191 (341)
T KOG1163|consen 160 LAKKYRDIRTRQHIPYREDRNLTGTARYASIN 191 (341)
T ss_pred chhhhccccccccCccccCCccceeeeehhhh
Confidence 996322 127888887643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=170.02 Aligned_cols=143 Identities=22% Similarity=0.191 Sum_probs=110.3
Q ss_pred CeEEEeeeCcCCCeEEEEEE-EcCCCCCCCCcEEEEEEeechhhhh---------------------hhHHHHHHHHHHH
Q 023430 111 DFEIFRVVGQGAFGKVFQVK-KKGVDDGDSDGIYAMKVMRKDTIIK---------------------KNHVDYMKAERDI 168 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~-~~~~~~~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~ 168 (282)
.|.+.+.||+|+||.||+|. +. ..+..||+|+++...... ......+.+|+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~-----~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFD-----GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecC-----CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 47888999999999999997 33 356789999987542100 0012346789999
Q ss_pred HHhcCCCC--eeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CEeeccCCCc
Q 023430 169 LTKVTHPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG-IVHRDLKPEN 245 (282)
Q Consensus 169 l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~-iiHrDlKp~N 245 (282)
++.+.+.+ +.++++. ...++||||++|++|.........+....+..++.|++.+|.+||.+| |+||||||+|
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 99997533 3333332 235899999999888665534445666677899999999999999999 9999999999
Q ss_pred eEEcCCCcEEEEecCccc
Q 023430 246 ILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~ 263 (282)
||++ ++.++++|||.+.
T Consensus 180 Ili~-~~~i~LiDFg~a~ 196 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSV 196 (237)
T ss_pred EEEE-CCCEEEEEChhhh
Confidence 9999 8899999999886
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=170.25 Aligned_cols=134 Identities=24% Similarity=0.427 Sum_probs=111.8
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----C---CCeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----H---PFIVQ 179 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~ 179 (282)
..++|.+.++||.|.|++||+|.+. ...+.||+|+.+... ...+.-..||.+|++++ | .+||+
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDt-----q~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDT-----QNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred cCceEEEEEeccccccceeEEEeec-----cCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 3478999999999999999999865 567889999997653 34445667999999874 2 47999
Q ss_pred eeEEEEe----CCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH-HCCCEeeccCCCceEEcCC
Q 023430 180 LRYSFQT----RSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 180 l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH-~~~iiHrDlKp~NILl~~~ 251 (282)
|++.|.. +.++|||+|++ |.+|..+|.+ .+.++...++.|++||+.||+||| .+||||-||||+|||+..+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 9999974 34899999998 5577777765 355899999999999999999999 5699999999999999654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=158.34 Aligned_cols=132 Identities=17% Similarity=0.228 Sum_probs=101.0
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 191 (282)
+...|++|+||+||.+.. .+..++.+.+....... ......+.+|+++|++|. |++|++++++ +..+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred cceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 457899999999997652 34456655554332211 112235789999999996 5789988875 3479
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeecc-CCCceEEcCCCcEEEEecCccc
Q 023430 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDL-KPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDl-Kp~NILl~~~~~v~l~Dfg~s~ 263 (282)
++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++.
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~ 140 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAV 140 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence 99999999988654321 1 2356789999999999999999999 7999999999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=177.45 Aligned_cols=164 Identities=21% Similarity=0.350 Sum_probs=135.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC------CCeeee
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH------PFIVQL 180 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l 180 (282)
+..++|.+....|+|-|++|.+|... ..+..||||+++.+..+.+. =..|+++|++|+. -|+++|
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~-----~r~~~vAiKIIRnNE~M~Kt----Gl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQ-----ARGQEVAIKIIRNNEVMHKT----GLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred hhcceeEEEeccccceeeeeeecccc-----CCCCeeEEEEeecchHHhhh----hhHHHHHHHHhhccCchhhhHHHHH
Confidence 34567999999999999999999865 34558999999887655443 3459999999963 388999
Q ss_pred eEEEEeCCEEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEE
Q 023430 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMA 256 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l 256 (282)
+-.|...+++|||+|-+. .+|.+.+.+.+. +....++.|+.|+..||..|-.+||+|.||||+|||+++.. .+||
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence 999999999999999874 478888887543 77889999999999999999999999999999999999764 5799
Q ss_pred EecCcccccccc-----hhheeeccCccc
Q 023430 257 AHSLNSHNQLCC-----FFFFLFLGGGVF 280 (282)
Q Consensus 257 ~Dfg~s~~~~~~-----~~~~~~~ape~~ 280 (282)
||||.|...-.+ .-+..|-|||++
T Consensus 579 CDfGSA~~~~eneitPYLVSRFYRaPEIi 607 (752)
T KOG0670|consen 579 CDFGSASFASENEITPYLVSRFYRAPEII 607 (752)
T ss_pred ccCccccccccccccHHHHHHhccCccee
Confidence 999988643333 337889999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.9e-23 Score=170.65 Aligned_cols=162 Identities=20% Similarity=0.328 Sum_probs=132.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|.-++.+|.|.- .|..+.+. ..+..||+|++.... ......++..+|..++..++|+||++++.+|....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~-----v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQ-----VLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchh-----hccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 347888888999988 55555433 467789999887653 33444556778999999999999999999986543
Q ss_pred ------EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+|+|||+|.. +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||++
T Consensus 89 ~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred cHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 58999999965 6766665 34677889999999999999999999999999999999999999999999999
Q ss_pred cccccc------hhheeeccCccc
Q 023430 263 HNQLCC------FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~------~~~~~~~ape~~ 280 (282)
....-+ ..+.-|=|||++
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevi 189 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVI 189 (369)
T ss_pred cccCcccccCchhheeeccCchhe
Confidence 876666 338899999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=160.96 Aligned_cols=137 Identities=16% Similarity=0.229 Sum_probs=111.7
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----hhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
+.||+|++|.||+|.+. +..+++|+...... ........+.+|+.++..+.|++|.....++......
T Consensus 2 ~~l~~G~~~~vy~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEeeC-------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence 57999999999999863 34588887654321 1112234577899999999999988777677677788
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
+++|||++|++|.+.+..... ....++.+++.+|.++|..+++|+|++|.|||++ ++.++++|||.+..
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999999988865332 7788899999999999999999999999999999 88999999999864
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=164.69 Aligned_cols=157 Identities=17% Similarity=0.190 Sum_probs=129.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
-+|.++++||+|+||+++.|+.. -.+..||||.-...... -.+..|....+.|. .++|...|.+...+.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl-----~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNL-----YNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ccceeccccccCcceeeeccccc-----ccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 37999999999999999999866 46788999987654321 23666888888875 789999988888888
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-----cEEEEecCcc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-----HVMAAHSLNS 262 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-----~v~l~Dfg~s 262 (282)
+-.||||++ |-+|.++..-. ..|+...+..++.|++.-++|+|++.+|.|||||+|+||...+ .|.++|||++
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 888999988 56787776543 4599999999999999999999999999999999999998543 4899999999
Q ss_pred ccccc--------------chhheeeccC
Q 023430 263 HNQLC--------------CFFFFLFLGG 277 (282)
Q Consensus 263 ~~~~~--------------~~~~~~~~ap 277 (282)
+...+ ..||++||+-
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSI 205 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSI 205 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEe
Confidence 64332 2789999974
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-21 Score=164.77 Aligned_cols=161 Identities=35% Similarity=0.538 Sum_probs=138.8
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC-CeeeeeEEEEeCCEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP-FIVQLRYSFQTRSKL 190 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~ 190 (282)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+.|+ +|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence 788899999999999999865 56899998876544333566788999999999988 799999999877788
Q ss_pred EEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecCcccc--
Q 023430 191 YLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSLNSHN-- 264 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~-- 264 (282)
+++++++.++++..++.... .+.......++.|++.++.|+|..+++|||+||+||+++..+ .++++|||++..
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999999997776554 689999999999999999999999999999999999999998 799999998851
Q ss_pred -----------cccchhheeeccCccc
Q 023430 265 -----------QLCCFFFFLFLGGGVF 280 (282)
Q Consensus 265 -----------~~~~~~~~~~~ape~~ 280 (282)
.....|+..|++||.+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred CCCccccccccccccccccccCCHHHh
Confidence 1233779999999976
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=180.00 Aligned_cols=138 Identities=17% Similarity=0.159 Sum_probs=108.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeech-----hhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-----TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.|...+.||+|+||.||++.+.+. .+++|+.... ........+++.+|+.+++.++|++|+....++.
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~-------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR-------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc-------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 345578999999999999886521 2333332111 1111223456889999999999999988777777
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.....++||||++|++|.+++. ....++.|++.+|.|||++||+||||||+|||+ .++.++|+|||+++.
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7777899999999999988775 346788999999999999999999999999999 688999999999974
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=155.88 Aligned_cols=133 Identities=17% Similarity=0.154 Sum_probs=104.8
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
.||+|+||.||++.+. +..+++|........ ......++.+|+.++..+.|+++.....++......+
T Consensus 1 ~ig~G~~~~vy~~~~~-------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeecC-------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence 3899999999999843 345888875432211 1122356778999999999887655544555666779
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
++|||++|++|.+.+..... .++.+++.+|.+||+.|++|+|+||+|||++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999999887754321 7788999999999999999999999999999 89999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.5e-21 Score=166.29 Aligned_cols=145 Identities=23% Similarity=0.357 Sum_probs=119.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC----CCeeeeeEEE-E
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----PFIVQLRYSF-Q 185 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~ 185 (282)
+|.+.+.||+|+||.||.+...... ...+|+|+......... ..+..|+.++..+.. .++..+++.. .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~ 91 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRS 91 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccC
Confidence 7999999999999999999976321 45688998765432111 146778999988873 6888898888 4
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-----CcEEEEe
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-----GHVMAAH 258 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-----~~v~l~D 258 (282)
.....|+||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|+|||||||+|+++... ..+.+.|
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 777899999987 67898877543 569999999999999999999999999999999999999865 4599999
Q ss_pred cCccc
Q 023430 259 SLNSH 263 (282)
Q Consensus 259 fg~s~ 263 (282)
||+++
T Consensus 171 fGlar 175 (322)
T KOG1164|consen 171 FGLAR 175 (322)
T ss_pred cCCCc
Confidence 99998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=169.02 Aligned_cols=145 Identities=20% Similarity=0.387 Sum_probs=124.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 187 (282)
...|.+.++||+|+|+.||++..... ......||+|.+.... ...++.+|+++|..+. +.||+.+.+++..+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 45789999999999999999986642 2356779999886543 3345888999999986 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~ 263 (282)
++..+||||++.....++... ++..+++.+++.++.||.++|.+|||||||||.|+|.+. .++-.|.|||++-
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 999999999999877666643 678899999999999999999999999999999999985 4788999999984
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-21 Score=154.86 Aligned_cols=137 Identities=18% Similarity=0.160 Sum_probs=104.7
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh-------------------hHHHHHHHHHHHHHhc
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-------------------NHVDYMKAERDILTKV 172 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l 172 (282)
|.+.+.||+|+||.||++.+. ++..+|||+++....... .......+|..++..+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred hhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 777889999999999999753 467799998765321000 0112356788889888
Q ss_pred CCCC--eeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC
Q 023430 173 THPF--IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250 (282)
Q Consensus 173 ~h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~ 250 (282)
.|.+ +...++ ....++||||++|++|..... ......++.+++.++.++|..||+||||||+||+++.
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence 8774 344433 234689999999998865432 1345678889999999999999999999999999999
Q ss_pred CCcEEEEecCcccc
Q 023430 251 DGHVMAAHSLNSHN 264 (282)
Q Consensus 251 ~~~v~l~Dfg~s~~ 264 (282)
++.++|+|||.+..
T Consensus 161 ~~~~~liDfg~~~~ 174 (198)
T cd05144 161 DEKIYIIDWPQMVS 174 (198)
T ss_pred CCcEEEEECCcccc
Confidence 99999999999953
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=156.20 Aligned_cols=173 Identities=15% Similarity=0.207 Sum_probs=142.2
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+...++++..++-+|+||.||+|.|+..++-...+.|-+|.++... .+.++..+..|..++..+.|||+..+.+...
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 34456788888999999999999999876665566667778776543 4556677889999999999999999988765
Q ss_pred -eCCEEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEE
Q 023430 186 -TRSKLYLILDFINGGHLFFHLYRQ--------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMA 256 (282)
Q Consensus 186 -~~~~~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l 256 (282)
+....++++.++.-|+|..++... +.++..+...++.|++.|++|||++||||.||..+|.+||+.-.|||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 455788999999999999888621 23667788889999999999999999999999999999999999999
Q ss_pred EecCcccccccc----hh-----heeeccCccc
Q 023430 257 AHSLNSHNQLCC----FF-----FFLFLGGGVF 280 (282)
Q Consensus 257 ~Dfg~s~~~~~~----~~-----~~~~~ape~~ 280 (282)
+|-.+|+...-. .| -..||++|.+
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal 470 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL 470 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHH
Confidence 999999854333 22 6789999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3e-19 Score=144.26 Aligned_cols=138 Identities=20% Similarity=0.245 Sum_probs=96.1
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHH---------------------HHHHHHHHHHhcC
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD---------------------YMKAERDILTKVT 173 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~ 173 (282)
.+.||+|+||.||+|... .+..||||+++........... ....|...+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 467999999999999754 3567999998754321111111 1134556666665
Q ss_pred CCC--eeeeeEEEEeCCEEEEEEeccCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEc
Q 023430 174 HPF--IVQLRYSFQTRSKLYLILDFINGGHLFF-HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMD 249 (282)
Q Consensus 174 h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~ 249 (282)
+.. +.+.++. ...++||||++++.+.. .+... .. ..++..++.+++.++.++|. ++|+||||||+||+++
T Consensus 76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred HcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 433 3334432 23689999999954321 11111 11 16678899999999999999 9999999999999999
Q ss_pred CCCcEEEEecCccccc
Q 023430 250 SDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 250 ~~~~v~l~Dfg~s~~~ 265 (282)
++.++++|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 999999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.2e-19 Score=147.02 Aligned_cols=137 Identities=21% Similarity=0.278 Sum_probs=101.0
Q ss_pred eeC-cCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh----------hhhHHHHHHHHHHHHHhcCCCCe--eeeeEE
Q 023430 117 VVG-QGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----------KKNHVDYMKAERDILTKVTHPFI--VQLRYS 183 (282)
Q Consensus 117 ~lG-~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~nI--v~l~~~ 183 (282)
.|| .|+.|+||.+... +..+++|.+...... ......++.+|+.++..+.|++| ++.+++
T Consensus 38 ~lg~~~g~gtv~~v~~~-------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~ 110 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP-------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAA 110 (239)
T ss_pred eeecCCCCccEEEEEeC-------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEee
Confidence 466 6777778777642 456888887543210 11223457889999999998875 556655
Q ss_pred EEeC-C---EEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 184 FQTR-S---KLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 184 ~~~~-~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
.... . ..++|||+++| .+|.+++.. ..+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|
T Consensus 111 ~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 111 RVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred eeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence 4332 2 23599999997 688887754 3455433 56899999999999999999999999999999999999
Q ss_pred cCccccc
Q 023430 259 SLNSHNQ 265 (282)
Q Consensus 259 fg~s~~~ 265 (282)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.3e-20 Score=170.62 Aligned_cols=166 Identities=20% Similarity=0.237 Sum_probs=123.3
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 193 (282)
...++|.|++|.|+.+...........+.+.+| ... ..........+..|..+-..+.|+|++.....+.......-.
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~-~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKP-TESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cCC-cccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 457899999998877765533222222222222 111 111122222255677777889999998876666555555555
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc---------
Q 023430 194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN--------- 264 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~--------- 264 (282)
||||++ +|+.++.+.+.+...++..++.|++.|++|+|+.||.|||||++|+++...|.+||+|||.+..
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 999999 9999998887899999999999999999999999999999999999999999999999998842
Q ss_pred --cccchhheeeccCccccC
Q 023430 265 --QLCCFFFFLFLGGGVFNF 282 (282)
Q Consensus 265 --~~~~~~~~~~~ape~~~~ 282 (282)
...-.|...|+|||++.+
T Consensus 479 ~~~~g~~gS~pY~apE~~~~ 498 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTG 498 (601)
T ss_pred hhhcCcccCCcCcCcccccc
Confidence 111277999999999853
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.1e-21 Score=171.46 Aligned_cols=162 Identities=43% Similarity=0.670 Sum_probs=138.8
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEEEEe
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++|+|+||.|++++..+ ....+..||+|++++.....+... ....|..++..++ ||.+|++...++.+..++++++
T Consensus 1 vlg~g~~gkvfLvrk~~--g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAG--GADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCCcCCCcchHHHHHhc--cccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence 37999999999876443 224677899999887654433333 4556888888887 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc---hhhe
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC---FFFF 272 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~---~~~~ 272 (282)
+..||.|+..+.....+.+.....+...++.+++++|..+|+|||+|++||+++.+|++++.|||+++..+.. .|+.
T Consensus 78 ~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~ 157 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTY 157 (612)
T ss_pred hcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccch
Confidence 9999999999888888889999999999999999999999999999999999999999999999999754333 7799
Q ss_pred eeccCcccc
Q 023430 273 LFLGGGVFN 281 (282)
Q Consensus 273 ~~~ape~~~ 281 (282)
.|||||++|
T Consensus 158 eymApEI~~ 166 (612)
T KOG0603|consen 158 EYRAPEIIN 166 (612)
T ss_pred hhhhhHhhh
Confidence 999999986
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=134.82 Aligned_cols=132 Identities=20% Similarity=0.243 Sum_probs=109.1
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--CCeeeeeEEEEeCCEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~ 191 (282)
+.+.||+|.++.||++... +..+++|....... ...+..|+.+++.+.| .++++++.+....+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-------~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-------DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSY 69 (155)
T ss_pred cceecccccccceEEEEec-------CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence 3567999999999999864 24689998765432 3457789999999976 58889888888778899
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
++|||+.++.+..+ +......++.+++.+|.++|.. +++|+|+||+|||++..+.+++.|||.+..
T Consensus 70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999998876543 4556667788999999999985 699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.3e-19 Score=171.31 Aligned_cols=88 Identities=22% Similarity=0.192 Sum_probs=67.8
Q ss_pred cCC-CCeeeeeEEE-------EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccC
Q 023430 172 VTH-PFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242 (282)
Q Consensus 172 l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK 242 (282)
+.| .||++++++| .....++++||++ +++|.+++... ..+++.+++.++.||+.||.|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 4666677766 2234577888887 55999999653 458999999999999999999999999999999
Q ss_pred CCceEEcCCCcEEEEecC
Q 023430 243 PENILMDSDGHVMAAHSL 260 (282)
Q Consensus 243 p~NILl~~~~~v~l~Dfg 260 (282)
|+||||+..|.++++|||
T Consensus 108 P~NiLl~~~~~~k~~d~~ 125 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESA 125 (793)
T ss_pred chhEEEcccCcEEEeecc
Confidence 999999654444444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=6.5e-18 Score=161.85 Aligned_cols=145 Identities=21% Similarity=0.396 Sum_probs=115.3
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCCeeeeeE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRY 182 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~ 182 (282)
.+....|.|.+.||+|+||.||+|... .++.||+|+-+.... ++ |.--.+++.+|+ -+.|..+..
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~------~~~~~alK~e~P~~~--WE----fYI~~q~~~RLk~~~~~~~~~~~~ 761 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHS------NGKLVALKVEKPPNP--WE----FYICLQVMERLKPQMLPSIMHISS 761 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecC------CCcEEEEEeecCCCc--ee----eeehHHHHHhhchhhhcchHHHHH
Confidence 345567999999999999999999865 278899998765432 11 111223344444 245566666
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-------CcEE
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-------GHVM 255 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-------~~v~ 255 (282)
++.-.+.-+||+||.+.|+|.+++...+.+++..+..+..|++.-++.||.++|||+||||+|+||... -.++
T Consensus 762 a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 762 AHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred HHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 666677789999999999999999988889999999999999999999999999999999999999532 3489
Q ss_pred EEecCcc
Q 023430 256 AAHSLNS 262 (282)
Q Consensus 256 l~Dfg~s 262 (282)
|+|||-|
T Consensus 842 lIDfG~s 848 (974)
T KOG1166|consen 842 LIDFGRS 848 (974)
T ss_pred EEecccc
Confidence 9999977
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=143.06 Aligned_cols=175 Identities=24% Similarity=0.293 Sum_probs=118.7
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCC------------------------------CCCCcEEEEEEeechhh-
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD------------------------------GDSDGIYAMKVMRKDTI- 153 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~------------------------------~~~~~~vavK~~~~~~~- 153 (282)
.++.+++|++.+.||+|....||.+.....+. +...-..|||.+-.-..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 34667889999999999999999887554210 00112245565432111
Q ss_pred -hhhhHHHHHHHHHH------H-----------HH----h-cCCCCeeeeeEEEEeC-----------------------
Q 023430 154 -IKKNHVDYMKAERD------I-----------LT----K-VTHPFIVQLRYSFQTR----------------------- 187 (282)
Q Consensus 154 -~~~~~~~~~~~E~~------~-----------l~----~-l~h~nIv~l~~~~~~~----------------------- 187 (282)
.+...++.+.+|.. . ++ . -+|||||++..+|.+.
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 11222333333321 1 11 1 3599999998777432
Q ss_pred ----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc--CCC--cEEEEec
Q 023430 188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG--HVMAAHS 259 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~--~~~--~v~l~Df 259 (282)
..+|+||.-.+. +|..++..+. .+......++.|+++|+.|||.+||.|||+|.+|||+. +|+ .++++||
T Consensus 312 ~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred cCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 248999987754 8888887654 46667778889999999999999999999999999984 333 3789999
Q ss_pred Cccc-------------ccccchhheeeccCcccc
Q 023430 260 LNSH-------------NQLCCFFFFLFLGGGVFN 281 (282)
Q Consensus 260 g~s~-------------~~~~~~~~~~~~ape~~~ 281 (282)
|.|- ..+..-|...-||||+++
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9773 223335589999999975
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.8e-15 Score=136.04 Aligned_cols=140 Identities=16% Similarity=0.193 Sum_probs=93.6
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-------------------------------hhHHH----
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHVD---- 160 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~~---- 160 (282)
+.||.|++|.||+|+.+ +++.||||+.+...... .+..+
T Consensus 123 ~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred cceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 56999999999999865 46789999987542100 00000
Q ss_pred --HHHHHHHHHHhc----CCCCeeeeeEEE-EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHH
Q 023430 161 --YMKAERDILTKV----THPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVS-AVSHL 231 (282)
Q Consensus 161 --~~~~E~~~l~~l----~h~nIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~-gL~yl 231 (282)
.+.+|...+..+ +|.+-+.+...+ ......+|||||++|++|.+..... .... ...++.+++. .+..+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 133455555444 233223332222 2234579999999999997765432 1122 2345555555 47789
Q ss_pred HHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 232 HKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 232 H~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
|..|++|+|+||.||+++.+|.++++|||++..
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 999999999999999999999999999999853
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.5e-17 Score=132.75 Aligned_cols=167 Identities=16% Similarity=0.218 Sum_probs=135.9
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++..++.+|.+...|..|+++|.+. -+++|++.......+. -+.|..|.-.|+-+.||||+.+++.+..
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn-------divakil~vr~~t~ri-srdfneefp~lrifshpnilpvlgacns 258 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN-------DIVAKILNVREVTARI-SRDFNEEFPALRIFSHPNILPVLGACNS 258 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc-------chhhhhhhhhhcchhh-cchhhhhCcceeeecCCchhhhhhhccC
Confidence 3344566677899999999999998743 2566777654433322 2347778888999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcCCCcEEE--EecC
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMA--AHSL 260 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~~~~v~l--~Dfg 260 (282)
...+.++..||+.|+|+..++.+.. .+..++.+++.++++|+.|||+.. |----|....+++|++...+| +|--
T Consensus 259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence 9999999999999999999987654 577899999999999999999875 334468889999999876554 5888
Q ss_pred cccccccchhheeeccCcccc
Q 023430 261 NSHNQLCCFFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~~~~~~~~~~~ape~~~ 281 (282)
+|.+.....|.+.||+||.++
T Consensus 339 fsfqe~gr~y~pawmspealq 359 (448)
T KOG0195|consen 339 FSFQEVGRAYSPAWMSPEALQ 359 (448)
T ss_pred eeeeccccccCcccCCHHHHh
Confidence 888999999999999999874
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.2e-16 Score=141.82 Aligned_cols=141 Identities=16% Similarity=0.239 Sum_probs=91.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-------------------------------hhH
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNH 158 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~ 158 (282)
.+|+. +.||.|++|.||+|+.+. +++.||||+.++..... .+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~-----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKD-----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECC-----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 34665 789999999999999872 36789999998652100 011
Q ss_pred HHHHH------HHHHHHHhc----CCCCeeeeeEEEEe-CCEEEEEEeccCCCchHHH--HHhcCC----CCHHHHHHHH
Q 023430 159 VDYMK------AERDILTKV----THPFIVQLRYSFQT-RSKLYLILDFINGGHLFFH--LYRQGI----FREDQARFYT 221 (282)
Q Consensus 159 ~~~~~------~E~~~l~~l----~h~nIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~----~~~~~~~~i~ 221 (282)
.+.+. +|+..+.++ .+.+.+.+...+.+ ....+|||||+.|+.+.+. +...+. +.+..+..++
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 12222 333333333 23333433333322 3457899999999998764 333321 2333333444
Q ss_pred HHHHHHHHHHHHCCCEeeccCCCceEEcCCC----cEEEEecCccc
Q 023430 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMAAHSLNSH 263 (282)
Q Consensus 222 ~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~----~v~l~Dfg~s~ 263 (282)
.|+ ...|++|+|+||.||+++.+| .+++.|||+..
T Consensus 274 ~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg 312 (537)
T PRK04750 274 TQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVG 312 (537)
T ss_pred HHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEE
Confidence 444 468999999999999999988 99999999885
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.3e-16 Score=151.58 Aligned_cols=161 Identities=20% Similarity=0.305 Sum_probs=126.3
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechh--hhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
+|...+.||.+.|=+|.+|+++ .+.|+||++-+.. ..-....+++ .|++ ...+++||++.+..+.....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-------eG~vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-------EGLVVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDK 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-------CceEEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhH
Confidence 6888899999999999999865 3458999886653 1222333333 3555 56678999999987777777
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc-----
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH----- 263 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~----- 263 (282)
..|||-+|... +|++.+..+.-+...+.+.|+.|++.||.-+|..||+|+|||.+||||+.=+-+.|+||..=+
T Consensus 95 AAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 78888888855 899998777667788889999999999999999999999999999999999999999997432
Q ss_pred -ccccchh--------heeeccCcccc
Q 023430 264 -NQLCCFF--------FFLFLGGGVFN 281 (282)
Q Consensus 264 -~~~~~~~--------~~~~~ape~~~ 281 (282)
.+=.||+ =..|+|||.|.
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv 200 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFV 200 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhh
Confidence 3333422 24699999984
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=115.00 Aligned_cols=127 Identities=21% Similarity=0.241 Sum_probs=93.3
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCee-eeeEEEEeCCEEEEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSKLYLI 193 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv 193 (282)
.+.|+.|.++.||+++.. ++.|++|+...... ....+..|+.+++.+.+.+++ +++.... ...++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-------~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-------NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEEC-------CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEE
Confidence 357899999999998743 45699998754421 112256788888888655544 4544432 345899
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----EeeccCCCceEEcCCCcEEEEecCccc
Q 023430 194 LDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGI-----VHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 194 ~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~i-----iHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
|||++|.++... . .....++.+++++|..||..++ +|+|++|.||+++ ++.++++||+.+.
T Consensus 70 ~e~i~G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 999999877532 0 1113456789999999999885 9999999999999 6789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.1e-14 Score=112.10 Aligned_cols=142 Identities=18% Similarity=0.246 Sum_probs=98.0
Q ss_pred eeeCcCCCeEEEEEEEcCCC-CCCCCcEEEEEEeechhh--------h--h---------hhHHHHH----HHHHHHHHh
Q 023430 116 RVVGQGAFGKVFQVKKKGVD-DGDSDGIYAMKVMRKDTI--------I--K---------KNHVDYM----KAERDILTK 171 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~-~~~~~~~vavK~~~~~~~--------~--~---------~~~~~~~----~~E~~~l~~ 171 (282)
..||.|.-+.||.|...... ....+..+|||+.+.... . + ....+.+ .+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999743100 001346799998763210 0 0 1112223 379999988
Q ss_pred cCC--CCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEeeccCCCceEE
Q 023430 172 VTH--PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILM 248 (282)
Q Consensus 172 l~h--~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~yl-H~~~iiHrDlKp~NILl 248 (282)
+.. -++.+.+++ ..-+|||||+.+..+.....+...++..+...+..+++.+|..| |..||||+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 863 355556554 34689999998754432222333455666777889999999998 89999999999999999
Q ss_pred cCCCcEEEEecCcc
Q 023430 249 DSDGHVMAAHSLNS 262 (282)
Q Consensus 249 ~~~~~v~l~Dfg~s 262 (282)
+ ++.+.++|||-+
T Consensus 159 ~-~~~v~iIDF~qa 171 (197)
T cd05146 159 H-DGKVWFIDVSQS 171 (197)
T ss_pred E-CCcEEEEECCCc
Confidence 7 578999999976
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.9e-13 Score=113.53 Aligned_cols=164 Identities=23% Similarity=0.288 Sum_probs=100.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC----------CCeeee
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH----------PFIVQL 180 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~nIv~l 180 (282)
.+...+.||.|+|+.||.+++. .++..+|+|+............+.+++|.-....+.+ -.++--
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~-----~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDV-----ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEc-----cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 4566789999999999999977 4677899999876555555666777777644433222 111111
Q ss_pred eEEE---------EeCC--------EEEEEEeccCCCchHHHHH---hcCCC--C-HHHH-HHHHHHHHHHHHHHHHCCC
Q 023430 181 RYSF---------QTRS--------KLYLILDFINGGHLFFHLY---RQGIF--R-EDQA-RFYTAEIVSAVSHLHKCGI 236 (282)
Q Consensus 181 ~~~~---------~~~~--------~~~lv~e~~~~g~L~~~l~---~~~~~--~-~~~~-~~i~~qi~~gL~ylH~~~i 236 (282)
++.. .... ..+++|+-+. ++|.+++. ..... . ...+ ..+..|+++.+++||.+||
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 1211 1111 2366777764 47766543 22222 1 1222 3445799999999999999
Q ss_pred EeeccCCCceEEcCCCcEEEEecCcccc----cccchhheeeccCccc
Q 023430 237 VHRDLKPENILMDSDGHVMAAHSLNSHN----QLCCFFFFLFLGGGVF 280 (282)
Q Consensus 237 iHrDlKp~NILl~~~~~v~l~Dfg~s~~----~~~~~~~~~~~ape~~ 280 (282)
||+||||+|++++.+|.++|.||+.... ..+...+..|.+||..
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~ 214 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELE 214 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhh
Confidence 9999999999999999999999975532 1223446677777753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.5e-13 Score=104.15 Aligned_cols=133 Identities=20% Similarity=0.164 Sum_probs=97.5
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechh-----hhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT-----IIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
.+++|+-+.+|.+.+.+ ..+++|.-.+.. ...+-...+..+|+.++.++.--.|..-+-+..+.+...
T Consensus 3 ~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred hhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence 57889999999886642 235555433222 223333456678999998887555554444555667788
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
|+|||++|..|.+.+... ...++..+-.-+.-||..||||+||.++||++..++ +.++|||++..
T Consensus 76 I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998888888654 144566677778889999999999999999997655 99999999963
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.7e-13 Score=103.75 Aligned_cols=144 Identities=21% Similarity=0.173 Sum_probs=105.2
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEee-----chhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR-----KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.+..|-+|+-+.|+++.+. ++.+.||.-. ......+-..++..+|+.+|.++.--.|.--.-+|.+..
T Consensus 11 ~l~likQGAEArv~~~~~~-------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccC-------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 4567889999999998865 4455666432 223333445567888999999887555554444556666
Q ss_pred EEEEEEeccCCC-chHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc---EEEEecCcc
Q 023430 189 KLYLILDFINGG-HLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMAAHSLNS 262 (282)
Q Consensus 189 ~~~lv~e~~~~g-~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~---v~l~Dfg~s 262 (282)
.-.|+|||++|- ++.+++..... ........++.+|-+.+.-||..+|||+||.++||+|..+|. +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 678999999873 66777765422 222233678889999999999999999999999999977654 589999999
Q ss_pred cc
Q 023430 263 HN 264 (282)
Q Consensus 263 ~~ 264 (282)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.6e-14 Score=134.87 Aligned_cols=127 Identities=34% Similarity=0.517 Sum_probs=91.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..+|+.++.|..|+||.||.++++. +...+|+| ++++.... ++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~-----trqrfa~k-iNkq~lil-------Rn---ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE-----TRQRFAMK-INKQNLIL-------RN---ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc-----cccchhhc-ccccchhh-------hc---cccccCCccee----------
Confidence 4689999999999999999999883 45568885 33332111 11 23333344433
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc----
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN---- 264 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~---- 264 (282)
|+....+..-+.++. +++.+++|||+.||+|||+||+|+||..-|++|+.|||+++.
T Consensus 136 -----------gDc~tllk~~g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----------chhhhhcccCCCCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 455555554444443 337899999999999999999999999999999999998841
Q ss_pred ---------------cccc---hhheeeccCccc
Q 023430 265 ---------------QLCC---FFFFLFLGGGVF 280 (282)
Q Consensus 265 ---------------~~~~---~~~~~~~ape~~ 280 (282)
++.| .||+.|+|||++
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 1222 779999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.6e-15 Score=138.92 Aligned_cols=165 Identities=22% Similarity=0.288 Sum_probs=133.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 189 (282)
.|.+.+.||+|+|+.|-...... .....+|+|.+.... ........+..|..+-+.+. |.|++.+++.......
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~----~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSR----DPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcC----CCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcc
Confidence 57777889999999998765432 234456777665443 22334445566887777887 9999999999999999
Q ss_pred EEEEEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCCEeeccCCCceEEcCCC-cEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHL-YRQG-IFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDG-HVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l-~~~~-~~~~~~~~~i~~qi~~gL~ylH-~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~~ 265 (282)
.+++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ ..+++|||+|...
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999998888 4443 5777888999999999999999 99999999999999999999 9999999998532
Q ss_pred c----------cchh-heeeccCccc
Q 023430 266 L----------CCFF-FFLFLGGGVF 280 (282)
Q Consensus 266 ~----------~~~~-~~~~~ape~~ 280 (282)
- ...| ++.|+|||.+
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~ 201 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHL 201 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccc
Confidence 2 2277 9999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=9.3e-13 Score=105.00 Aligned_cols=73 Identities=19% Similarity=0.098 Sum_probs=64.0
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc--ccchhheeecc
Q 023430 200 GHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ--LCCFFFFLFLG 276 (282)
Q Consensus 200 g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~--~~~~~~~~~~a 276 (282)
|+|.+++... ..+++.++..++.|++.||.|||+++ ||+|||++.++.+++ ||++... ....|++.|||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~a 72 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFMA 72 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCcccccC
Confidence 6888888764 45999999999999999999999998 999999999999999 9998643 22367999999
Q ss_pred Cccc
Q 023430 277 GGVF 280 (282)
Q Consensus 277 pe~~ 280 (282)
||++
T Consensus 73 PE~~ 76 (176)
T smart00750 73 PEVI 76 (176)
T ss_pred hHHh
Confidence 9987
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.5e-12 Score=105.35 Aligned_cols=140 Identities=13% Similarity=0.182 Sum_probs=98.4
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--CeeeeeEEEEeC---CEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTR---SKL 190 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~---~~~ 190 (282)
+.|+.|.++.||++... .+..+++|+....... .....+.+|.++++.+.+. ++.+++.+.... +..
T Consensus 4 ~~l~~G~~n~~~~v~~~------~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG------GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred eecCCCccceEEEEEec------CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 56899999999998754 1356899987654321 1234577899999998753 356666665543 256
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------------- 233 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~------------------------------------- 233 (282)
++||||++|.++...+.. ..+++.+...++.++++.|..||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred eEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 899999999877554321 234555555666666666666663
Q ss_pred -------------------CCCEeeccCCCceEEcC--CCcEEEEecCcccc
Q 023430 234 -------------------CGIVHRDLKPENILMDS--DGHVMAAHSLNSHN 264 (282)
Q Consensus 234 -------------------~~iiHrDlKp~NILl~~--~~~v~l~Dfg~s~~ 264 (282)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.8e-14 Score=126.03 Aligned_cols=89 Identities=22% Similarity=0.220 Sum_probs=75.9
Q ss_pred EEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~- 265 (282)
+||.|++|...+|.+++.+.. ..+....+.++.|++.|++| ++.+|||+||.||+...++.+||.|||+...+
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 678999999999999997543 35667888999999999999 99999999999999999999999999987422
Q ss_pred ------------ccchhheeeccCcccc
Q 023430 266 ------------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ------------~~~~~~~~~~ape~~~ 281 (282)
..+.||..||+||.+.
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~ 435 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIR 435 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHh
Confidence 2337899999999873
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.2e-12 Score=114.29 Aligned_cols=166 Identities=20% Similarity=0.145 Sum_probs=127.0
Q ss_pred CeEEEeeeCc--CCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Q 023430 111 DFEIFRVVGQ--GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR 187 (282)
Q Consensus 111 ~y~~~~~lG~--G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 187 (282)
.+.+.+.+|. |.+|.||.+.... ......+|+|.-+...... .....=.+|+...++++ |+|.++.+..|...
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~---~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTN---SESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hcccccccccCCCCCceeecccCCc---ccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCcccccC
Confidence 4566778999 9999999987622 2455668888643222111 11111234666666675 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCCEeeccCCCceEEcCC-CcEEEEecCc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVS----AVSHLHKCGIVHRDLKPENILMDSD-GHVMAAHSLN 261 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~----gL~ylH~~~iiHrDlKp~NILl~~~-~~v~l~Dfg~ 261 (282)
+.+|+-+|+|. .+|..+...... ++...+...+.+... ||.++|..+++|-|+||+||++..+ ...++.|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999995 688787766544 788888888888888 9999999999999999999999999 7788889975
Q ss_pred cc------------ccccchhheeeccCcccc
Q 023430 262 SH------------NQLCCFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~------------~~~~~~~~~~~~ape~~~ 281 (282)
.. ..+...|...||+||..|
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~ 301 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN 301 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc
Confidence 42 334448899999999875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.4e-10 Score=96.20 Aligned_cols=102 Identities=13% Similarity=0.052 Sum_probs=77.6
Q ss_pred HHHHHHHHHhcCCCCee--eeeEEEEe-----CCEEEEEEeccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 023430 162 MKAERDILTKVTHPFIV--QLRYSFQT-----RSKLYLILDFINGG-HLFFHLYR--QGIFREDQARFYTAEIVSAVSHL 231 (282)
Q Consensus 162 ~~~E~~~l~~l~h~nIv--~l~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~yl 231 (282)
..+|...+..|..-+|. +..++... ....+||||++++- +|.+++.. ...........++.+++..+.-|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 56788888777533332 23334332 23578999999886 78888753 23455667788999999999999
Q ss_pred HHCCCEeeccCCCceEEcC-------CCcEEEEecCccc
Q 023430 232 HKCGIVHRDLKPENILMDS-------DGHVMAAHSLNSH 263 (282)
Q Consensus 232 H~~~iiHrDlKp~NILl~~-------~~~v~l~Dfg~s~ 263 (282)
|..||+|+|+++.|||++. +..+.++||+.+.
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999999999975 4679999999884
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.6e-12 Score=114.07 Aligned_cols=150 Identities=25% Similarity=0.305 Sum_probs=120.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 187 (282)
..+|..+..||.|.|+.|+.+..+. ..+.+|++|.+.+........+..+ .|+.+...+. |.+++.++..|...
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~----~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRP----EGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred cCCcceeEEccCCccccceeeeecC----CCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCcccc
Confidence 4578889999999999999877432 3567899998876554433333333 4666666665 99999998888888
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-CcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-~~v~l~Dfg~s~ 263 (282)
...|+-.|||+++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||.||++..+ +..++.|||...
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 8889999999999887666545567888999999999999999999999999999999999886 777888998774
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.7e-11 Score=109.50 Aligned_cols=112 Identities=16% Similarity=0.091 Sum_probs=97.4
Q ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCC-EeeccCCCce
Q 023430 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGI-VHRDLKPENI 246 (282)
Q Consensus 169 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~i-iHrDlKp~NI 246 (282)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ...+++.-...++++++.||.|||.-.| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4568899999999999999999999999999999999976 3457788888899999999999997765 9999999999
Q ss_pred EEcCCCcEEEEecCccccccc--c-------hhheeeccCccc
Q 023430 247 LMDSDGHVMAAHSLNSHNQLC--C-------FFFFLFLGGGVF 280 (282)
Q Consensus 247 Ll~~~~~v~l~Dfg~s~~~~~--~-------~~~~~~~ape~~ 280 (282)
++|....+|++|||+...... . .-...|.|||.+
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPell 123 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELL 123 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHh
Confidence 999999999999999875521 1 237789999976
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.9e-10 Score=90.63 Aligned_cols=97 Identities=23% Similarity=0.272 Sum_probs=64.3
Q ss_pred HHHHHHHHHHHhcCCC--CeeeeeEEEEeCCEEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHC
Q 023430 160 DYMKAERDILTKVTHP--FIVQLRYSFQTRSKLYLILDFIN--GGHLFFHLYRQGIFREDQARFYTAEIVSAVSH-LHKC 234 (282)
Q Consensus 160 ~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~y-lH~~ 234 (282)
.+.++|.+.|..+..- ++.+.+++. .-+|||||++ |..+..+.... +.......++.+++..+.. +|..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc
Confidence 3567899999999865 455665442 2379999998 65554433221 1134456677778885555 5799
Q ss_pred CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 235 GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
||||+||.+.|||++++ .+.++|||-+.
T Consensus 127 givHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp TEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred CceecCCChhhEEeecc-eEEEEecCcce
Confidence 99999999999999877 99999999774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.7e-10 Score=103.70 Aligned_cols=116 Identities=18% Similarity=0.279 Sum_probs=94.1
Q ss_pred CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHH
Q 023430 139 SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218 (282)
Q Consensus 139 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 218 (282)
.+..|.|........ ...+...+-++-|+.++||||++++..+...+.+|||+|-+. .|..++.+.+ ...+.
T Consensus 36 ~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HHHHH
Confidence 445566666654331 334556778889999999999999999999999999999876 4556665533 66677
Q ss_pred HHHHHHHHHHHHHH-HCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 219 FYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 219 ~i~~qi~~gL~ylH-~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..+.||+.||.||| +++++|++|.-..|+++..|+.||.+|-.+
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 77899999999998 678999999999999999999999998665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.7e-09 Score=87.56 Aligned_cols=104 Identities=25% Similarity=0.256 Sum_probs=80.9
Q ss_pred HHHHHHHHHHhcCCCCe--eeeeEEEEeC----CEEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 023430 161 YMKAERDILTKVTHPFI--VQLRYSFQTR----SKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233 (282)
Q Consensus 161 ~~~~E~~~l~~l~h~nI--v~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~ 233 (282)
...+|...+..|..-+| .+.+++.... ...++|+|++++. +|.+++......+......++.+++..+.-||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 46678877777654333 3344444432 2468999999884 788888764456777788899999999999999
Q ss_pred CCCEeeccCCCceEEcCCC---cEEEEecCcccc
Q 023430 234 CGIVHRDLKPENILMDSDG---HVMAAHSLNSHN 264 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~---~v~l~Dfg~s~~ 264 (282)
+||+|+|+++.|||++.++ .+.++||+.++.
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999887 899999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.4e-08 Score=82.36 Aligned_cols=142 Identities=10% Similarity=0.092 Sum_probs=98.3
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh---hhHHHHHHHHHHHHHhcCCCC--eeeeeEEEEe----CC
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPF--IVQLRYSFQT----RS 188 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~----~~ 188 (282)
-|+|+.+-|++.... +..+-+|.-....... +.-...|.+|...+..|..-+ +.+....-.. .-
T Consensus 26 ~~rgG~SgV~r~~~~-------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~ 98 (216)
T PRK09902 26 YRRNGMSGVQCVERN-------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW 98 (216)
T ss_pred cCCCCcceEEEEEeC-------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce
Confidence 367888889887643 2257777654211111 223456888999988886332 3343311111 12
Q ss_pred EEEEEEeccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc--EEEEecCccc
Q 023430 189 KLYLILDFING-GHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMAAHSLNSH 263 (282)
Q Consensus 189 ~~~lv~e~~~~-g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~--v~l~Dfg~s~ 263 (282)
.-+||+|-+.| .+|.+++... ...+......+..+++..+.-||+.|+.|+|+-+.|||++.+|. |+++||--++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 47899997765 4787777553 23467777889999999999999999999999999999987777 9999998776
Q ss_pred ccc
Q 023430 264 NQL 266 (282)
Q Consensus 264 ~~~ 266 (282)
..+
T Consensus 179 ~~l 181 (216)
T PRK09902 179 RRL 181 (216)
T ss_pred hhh
Confidence 443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-08 Score=84.00 Aligned_cols=135 Identities=19% Similarity=0.180 Sum_probs=93.7
Q ss_pred EEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----------------hhhhH--HHHHHHHHHHHHhcC
Q 023430 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----------------IKKNH--VDYMKAERDILTKVT 173 (282)
Q Consensus 113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~--~~~~~~E~~~l~~l~ 173 (282)
.+...||-|.-+.||.|... .+..+|||.-+.... ..+.. +...++|.++|.+|.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred hhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 35678999999999999843 567799996542210 00111 122457888998887
Q ss_pred CC--CeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC
Q 023430 174 HP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 174 h~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~ 251 (282)
.. .|.+.+++ +.-.+|||+++|-.|...- +.......++..|+.-+.-+-..||||+|+.+=|||++++
T Consensus 168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238 (304)
T ss_pred hcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC
Confidence 54 56655543 4568999999997664322 1233444455556665655558999999999999999999
Q ss_pred CcEEEEecCcc
Q 023430 252 GHVMAAHSLNS 262 (282)
Q Consensus 252 ~~v~l~Dfg~s 262 (282)
|.+.++||-=+
T Consensus 239 g~~~vIDwPQ~ 249 (304)
T COG0478 239 GDIVVIDWPQA 249 (304)
T ss_pred CCEEEEeCccc
Confidence 99999999633
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.7e-08 Score=78.82 Aligned_cols=142 Identities=19% Similarity=0.221 Sum_probs=91.3
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHH------HHHHHHHHhcC---CCC
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM------KAERDILTKVT---HPF 176 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~E~~~l~~l~---h~n 176 (282)
.+..++|.+.+++-......|.+-.. .++.+++|..+......+.....| .+++..+..+. --.
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~ 99 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE 99 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence 34567899999999988888887663 356789998765432222222211 22333333332 222
Q ss_pred eeeeeEEE-----EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC
Q 023430 177 IVQLRYSF-----QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 177 Iv~l~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~ 251 (282)
...++.+. .-....+++|||++|..|.+... +.+ .+...+.+++.-||..|+.|+|..|.|+++..
T Consensus 100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~- 170 (229)
T PF06176_consen 100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN- 170 (229)
T ss_pred cccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-
Confidence 22222222 12235678999999988755432 232 23456777899999999999999999999985
Q ss_pred CcEEEEecCccc
Q 023430 252 GHVMAAHSLNSH 263 (282)
Q Consensus 252 ~~v~l~Dfg~s~ 263 (282)
+.++++||+..+
T Consensus 171 ~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 NGIRIIDTQGKR 182 (229)
T ss_pred CcEEEEECcccc
Confidence 559999998764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.2e-07 Score=85.23 Aligned_cols=133 Identities=17% Similarity=0.217 Sum_probs=101.2
Q ss_pred CeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe----CCEEEEEEeccC
Q 023430 123 FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----RSKLYLILDFIN 198 (282)
Q Consensus 123 fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~ 198 (282)
-.+.|++... .++..|++|.+..++..... ....-++.++++.|.|||++.++|.+ ...+++|++|.+
T Consensus 289 ~~Ttyk~~s~-----~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP 360 (655)
T KOG3741|consen 289 SITTYKATSN-----VDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYP 360 (655)
T ss_pred cceeEeeeec-----cCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCC
Confidence 3567888765 46677999988544322221 12235678999999999999988873 347999999998
Q ss_pred CC-chHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 199 GG-HLFFHLYR---------------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 199 ~g-~L~~~l~~---------------~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+. +|.++-.. ....+|..++.++.|+..||.++|+.|+.-+-|.+.+||++.+.+++|...|+.
T Consensus 361 ~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 361 SSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred CCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 64 66654421 123578889999999999999999999999999999999999889988876655
Q ss_pred c
Q 023430 263 H 263 (282)
Q Consensus 263 ~ 263 (282)
.
T Consensus 441 D 441 (655)
T KOG3741|consen 441 D 441 (655)
T ss_pred e
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.9e-08 Score=88.14 Aligned_cols=139 Identities=17% Similarity=0.176 Sum_probs=89.1
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-------------------------------hhHHHH---
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-------------------------------KNHVDY--- 161 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~~~~--- 161 (282)
+.|+.++-|.||+|+.+ +++.||||+.+++.... .+..+.
T Consensus 131 ~PiAsASIaQVH~A~L~------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 131 EPIASASIAQVHRAVLK------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred CchhhhhHhhheeEEec------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 46899999999999986 47889999987643111 001111
Q ss_pred ---HHHHHHHHHhc----C-CCCeeeeeEEEEeCCEEEEEEeccCCCchHHHH--HhcCCCCHHHHHHHHHHHHHHHHHH
Q 023430 162 ---MKAERDILTKV----T-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL--YRQGIFREDQARFYTAEIVSAVSHL 231 (282)
Q Consensus 162 ---~~~E~~~l~~l----~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~i~~qi~~gL~yl 231 (282)
+.+|...+.++ . .++|.--.-++.-.+.-.|+|||++|-.+.+.. .. ..++...+.....++ -+.-+
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~ 281 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQL 281 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHH
Confidence 22344444433 2 344332223334455678999999998886663 33 334433332222221 13333
Q ss_pred HHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 232 HKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 232 H~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
-..|++|.|..|.||+++.+|++.+.|||+..
T Consensus 282 ~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g 313 (517)
T COG0661 282 LRDGFFHADPHPGNILVRSDGRIVLLDFGIVG 313 (517)
T ss_pred HhcCccccCCCccceEEecCCcEEEEcCccee
Confidence 45899999999999999999999999999874
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.1e-07 Score=75.67 Aligned_cols=133 Identities=16% Similarity=0.146 Sum_probs=80.4
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC--eeeeeEEEEeCCEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv 193 (282)
..||+|..+.||+.. +..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+|
T Consensus 7 ~~i~~G~t~~~y~~~---------~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---------TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEec---------CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence 568999999999731 2246788775432 1234678999998876433 35566776677778899
Q ss_pred EeccCCCc-hH--------------HHHHh-----c----CCCCHHH-HHHHHH----------HHHH-HHHHHHH----
Q 023430 194 LDFINGGH-LF--------------FHLYR-----Q----GIFREDQ-ARFYTA----------EIVS-AVSHLHK---- 233 (282)
Q Consensus 194 ~e~~~~g~-L~--------------~~l~~-----~----~~~~~~~-~~~i~~----------qi~~-gL~ylH~---- 233 (282)
||+++|.. +. ..+.+ + ....... ...+.. .+.. ...+|..
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99999963 11 11111 0 0111110 011100 1111 1222221
Q ss_pred CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..++|+|+.|.||++++++ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 2478999999999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.6e-07 Score=75.50 Aligned_cols=135 Identities=21% Similarity=0.219 Sum_probs=90.4
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhh---------------------HHHHHHHHHHHHHhcC-
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---------------------HVDYMKAERDILTKVT- 173 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~~~~~E~~~l~~l~- 173 (282)
..|..|.-+.||+|.. ..+..+|+|+.+.....-+. ...+...|...|+++.
T Consensus 54 g~istGKEA~Vy~a~~------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~e 127 (268)
T COG1718 54 GCISTGKEANVYLAET------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYE 127 (268)
T ss_pred eeecCCcceEEEeecc------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHH
Confidence 3688888999999874 24667999998754321111 1123345777777764
Q ss_pred -CCCeeeeeEEEEeCCEEEEEEeccCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcC
Q 023430 174 -HPFIVQLRYSFQTRSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDS 250 (282)
Q Consensus 174 -h~nIv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~ 250 (282)
+-.+.+-+.+. .-.|||||+....+ .-.|.. -.+...++..+..++++.+.-|-. .++||+||..=|||+.
T Consensus 128 AGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~- 201 (268)
T COG1718 128 AGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH- 201 (268)
T ss_pred cCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-
Confidence 33334444443 24799999865421 111211 122333677888899999988766 8999999999999999
Q ss_pred CCcEEEEecCcc
Q 023430 251 DGHVMAAHSLNS 262 (282)
Q Consensus 251 ~~~v~l~Dfg~s 262 (282)
++.+.|+|||=|
T Consensus 202 ~~~p~iID~~Qa 213 (268)
T COG1718 202 DGEPYIIDVSQA 213 (268)
T ss_pred CCeEEEEECccc
Confidence 899999999966
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.2e-06 Score=71.13 Aligned_cols=134 Identities=23% Similarity=0.242 Sum_probs=91.2
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-------------hhhhHHHHHHHHHHHHHhcC------CCC
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------------IKKNHVDYMKAERDILTKVT------HPF 176 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~~~~E~~~l~~l~------h~n 176 (282)
..||+|+.-.||.-- ......||++..... ......+...+|+.....+. +.+
T Consensus 7 ~~i~~G~~R~cy~HP--------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~ 78 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP--------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH 78 (199)
T ss_pred cccccCCCceEEECC--------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence 469999999999532 233468888876550 00112334556665555444 789
Q ss_pred eeeeeEEEEeCCEEEEEEeccCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC
Q 023430 177 IVQLRYSFQTRSKLYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250 (282)
Q Consensus 177 Iv~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~ 250 (282)
|.+++|+.+++-..-+|+|.+.. .+|.+++.. +.+++ ... ..+-+-.+||-+.+|+.+|++|.||++..
T Consensus 79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 99999999999999999998643 267777743 44555 322 33334467888999999999999999964
Q ss_pred C--C--cEEEEe-cCcc
Q 023430 251 D--G--HVMAAH-SLNS 262 (282)
Q Consensus 251 ~--~--~v~l~D-fg~s 262 (282)
. + .++|+| ||..
T Consensus 154 ~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEK 170 (199)
T ss_pred cCCCceEEEEEeCCCCc
Confidence 3 2 477887 5544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.1e-07 Score=74.88 Aligned_cols=137 Identities=23% Similarity=0.331 Sum_probs=78.4
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC--eeeeeEEEE---eCCE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQ---TRSK 189 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~---~~~~ 189 (282)
++.|+.|..+.||++... ++.+++|..... .....+.+|..+++.+.... +.+++.... ....
T Consensus 2 i~~l~~G~~n~~~~v~~~-------~~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-------DGRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEEESSSSEEEEEEET-------TSEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred CccCCCCCeeeEEEEEEC-------CcEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 467899999999998854 247899987543 23345677888888775332 445555332 2345
Q ss_pred EEEEEeccCCCchHH----------------HHH---hc--C--CCCHHH---------HHHH------------HHHHH
Q 023430 190 LYLILDFINGGHLFF----------------HLY---RQ--G--IFREDQ---------ARFY------------TAEIV 225 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~----------------~l~---~~--~--~~~~~~---------~~~i------------~~qi~ 225 (282)
.+++|++++|..+.. .+. .. . .+.... .... ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 799999999987665 111 11 0 011000 0000 01112
Q ss_pred H-HHHHHHH-------CCCEeeccCCCceEEc-CCCcEEEEecCccc
Q 023430 226 S-AVSHLHK-------CGIVHRDLKPENILMD-SDGHVMAAHSLNSH 263 (282)
Q Consensus 226 ~-gL~ylH~-------~~iiHrDlKp~NILl~-~~~~v~l~Dfg~s~ 263 (282)
. .+..++. ..++|+|+.+.|||++ .++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 2333332 3499999999999999 66667799998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.5e-08 Score=83.24 Aligned_cols=90 Identities=23% Similarity=0.459 Sum_probs=76.9
Q ss_pred HHHhcCCCCeeeeeEEEEeC-----CEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 023430 168 ILTKVTHPFIVQLRYSFQTR-----SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCG--I 236 (282)
Q Consensus 168 ~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~--i 236 (282)
-|-.+.|.|||+++.+|.+. ....++.|||..|+|.++|++ +..+......+|+.||+.||.|||++. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34456799999999888654 358899999999999998875 345777888899999999999999886 9
Q ss_pred EeeccCCCceEEcCCCcEEEE
Q 023430 237 VHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 237 iHrDlKp~NILl~~~~~v~l~ 257 (282)
+|+++..+-|++..+|-+|+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccCCcchhheeecCCceEEec
Confidence 999999999999999988876
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-06 Score=70.35 Aligned_cols=128 Identities=24% Similarity=0.349 Sum_probs=88.8
Q ss_pred CCeEEEeeeCcCCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhh---------h--h-------hHHHHHHHHHHHHH
Q 023430 110 GDFEIFRVVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---------K--K-------NHVDYMKAERDILT 170 (282)
Q Consensus 110 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~--~-------~~~~~~~~E~~~l~ 170 (282)
.+++.++.||.|.- |.||+++.. +..||+|+.+.-... . . ....-|..|.+...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 57999999999999 999999854 568999993321000 0 0 22334677877766
Q ss_pred hcC---CCCe--eeeeEEEEeC------------------CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHH
Q 023430 171 KVT---HPFI--VQLRYSFQTR------------------SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227 (282)
Q Consensus 171 ~l~---h~nI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~g 227 (282)
+|+ +.++ |+.+|++.-. ....||.||.+... .+... -+.+|++-
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~d 176 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRD 176 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHH
Confidence 654 5566 8888887432 12457888776543 12222 34577888
Q ss_pred HHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 228 VSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 228 L~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
|..+|..||+-+|+|+.|.. +| +|+|||.+
T Consensus 177 l~~~~k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 177 LKILHKLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HHHHHHCCeeeccCcccccc---CC--EEEecccC
Confidence 99999999999999999987 22 88999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.9e-09 Score=100.61 Aligned_cols=148 Identities=30% Similarity=0.390 Sum_probs=114.7
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
.++.+.+.+-+-+|.++.++.++..+ .+...++|+............+...++-.++-...+|-+++....+...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~-----sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAG-----SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccc-----cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCC
Confidence 45678888888999999999876553 3334555555444333333344455555555555678888766666677
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
...+|+|+|+.+++|...++.-+..++.-++.+...+..+++|||...++|||+||.|+|+..+|+.+++|||
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccc
Confidence 7899999999999999999887777777778888889999999999999999999999999999999999997
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-06 Score=72.67 Aligned_cols=134 Identities=12% Similarity=0.041 Sum_probs=79.0
Q ss_pred eeCcCCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEEEE
Q 023430 117 VVGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL 194 (282)
Q Consensus 117 ~lG~G~f-g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 194 (282)
.|-.|.. ..||+.... +..+.+|+..... ...+.+|+++++.+. +--+.+++++....+..++||
T Consensus 5 ~~~~g~~~~~v~~~~~~-------~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-------NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcCC-------CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 3445555 788987532 2357788765432 123567888888875 334556777776666789999
Q ss_pred eccCCCchHHHH----------------HhcCCC-------CHH--HHHHHHH--------------------HHHHHHH
Q 023430 195 DFINGGHLFFHL----------------YRQGIF-------RED--QARFYTA--------------------EIVSAVS 229 (282)
Q Consensus 195 e~~~~g~L~~~l----------------~~~~~~-------~~~--~~~~i~~--------------------qi~~gL~ 229 (282)
|+++|.+|.... .+-..+ ... ....... .+...+.
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 999987664321 000001 100 0000000 0111122
Q ss_pred HHH-------HCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 230 HLH-------KCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 230 ylH-------~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.|- ...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 221 1248999999999999997778899998874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.8e-06 Score=81.42 Aligned_cols=82 Identities=12% Similarity=0.250 Sum_probs=54.7
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCe--eeeeEEEEeC---C
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFI--VQLRYSFQTR---S 188 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~ 188 (282)
++.++.|.+..+|+...... .....+++|+........ ....+.+|..+|+.+. |.+| .+++.++.+. +
T Consensus 43 v~~l~gG~sn~ty~l~~~~~---~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G 117 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG---GSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG 117 (822)
T ss_pred EEEeCCCCcCceEEEEECCC---CcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC
Confidence 56789999999998875421 112357777664432111 1234778999999996 6665 6666666543 4
Q ss_pred EEEEEEeccCCCc
Q 023430 189 KLYLILDFINGGH 201 (282)
Q Consensus 189 ~~~lv~e~~~~g~ 201 (282)
..|+||||++|..
T Consensus 118 ~~flVME~v~G~~ 130 (822)
T PLN02876 118 TAFYIMEYLEGRI 130 (822)
T ss_pred CceEEEEecCCcc
Confidence 6789999999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.9e-06 Score=77.37 Aligned_cols=142 Identities=14% Similarity=0.163 Sum_probs=87.7
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh----------------------------hhHHHH------
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------------------------KNHVDY------ 161 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~~~------ 161 (282)
+.||.-+.|.||+|+.+ .+..||||+-++..... .+..+.
T Consensus 167 ~piaaASlaQVhrA~L~------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred chhhhcchhheEEEEec------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 56999999999999987 36779999876542110 011111
Q ss_pred HHHHHHH----HHhcCCCC------eeeeeEEEEeCCEEEEEEeccCCCchH--HHHHhcCCCCHHHHHHHHHHHHHHHH
Q 023430 162 MKAERDI----LTKVTHPF------IVQLRYSFQTRSKLYLILDFINGGHLF--FHLYRQGIFREDQARFYTAEIVSAVS 229 (282)
Q Consensus 162 ~~~E~~~----l~~l~h~n------Iv~l~~~~~~~~~~~lv~e~~~~g~L~--~~l~~~~~~~~~~~~~i~~qi~~gL~ 229 (282)
|.+|++. .+.+.|-+ |.++|..+ .....|+||||+|..+. +.+.+.+ ++...+...+.+.. +.
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~--~~ 315 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAY--LE 315 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHH--HH
Confidence 1223322 23344555 33333322 34578999999998664 4454444 44444433333322 22
Q ss_pred HHHHCCCEeeccCCCceEEcC----CCcEEEEecCcccccccc
Q 023430 230 HLHKCGIVHRDLKPENILMDS----DGHVMAAHSLNSHNQLCC 268 (282)
Q Consensus 230 ylH~~~iiHrDlKp~NILl~~----~~~v~l~Dfg~s~~~~~~ 268 (282)
-+-..|++|.|-.|.||++.. ++.+++-|||+.....+.
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 233568999999999999984 678999999998654433
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.7e-06 Score=66.03 Aligned_cols=129 Identities=18% Similarity=0.254 Sum_probs=88.5
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeee-eeEEEEeCCEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ-LRYSFQTRSKL 190 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~ 190 (282)
....+.|++|++|.||++.|++ ..+|+|+-+.+. .+..+..|+++|..++-.++.. +|.+- .-
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~-------~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~ 87 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRG-------GEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----ED 87 (201)
T ss_pred hhhhhhhhcccccEEEEeeccC-------ceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hh
Confidence 3445789999999999999873 368899865543 3345788999999888666543 44432 23
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccC-CCceEEcCCCcEEEEecCccc
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK-PENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK-p~NILl~~~~~v~l~Dfg~s~ 263 (282)
++.|||+.|-.|....... ...++ ..+++.---|-..||-|..|. |..++|..++.+.|+||--++
T Consensus 88 ~i~me~i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhcc---cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 5669999998886554321 22222 234444334556789999886 666666677799999998776
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.3e-05 Score=67.06 Aligned_cols=29 Identities=21% Similarity=0.133 Sum_probs=24.7
Q ss_pred CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 235 GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+++|+|+.+.|||++.++-..|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999866555799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.6e-05 Score=64.19 Aligned_cols=95 Identities=15% Similarity=0.145 Sum_probs=75.4
Q ss_pred HHHHHHHhcCC-CCeeeeeEEEEeCCEEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCC
Q 023430 164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH---LYRQGIFREDQARFYTAEIVSAVSHLHK---CGI 236 (282)
Q Consensus 164 ~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~i~~qi~~gL~ylH~---~~i 236 (282)
.|.-+|+.+.+ +++.+++|++- -+++.||...+++... +...-..++.....++.++++.+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 47788888886 69999999883 3678999987755321 1111235789999999999999999986 347
Q ss_pred EeeccCCCceEEcCCCcEEEEecCcc
Q 023430 237 VHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 237 iHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.-.|++++|+-++++|++|++|....
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhc
Confidence 77999999999999999999998644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00013 Score=63.18 Aligned_cols=78 Identities=9% Similarity=0.075 Sum_probs=52.3
Q ss_pred EEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC---CCeeeeeEEEEe---
Q 023430 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQT--- 186 (282)
Q Consensus 113 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~--- 186 (282)
.-.+.||.|..+.||+.... +..+.+|..+... ....+..|...|+.+.- -.+.++++.+..
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-------~~~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-------QGNPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred heeeecCCccceeEEEEEcC-------CCCEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34567999999999987522 2236667643210 11347789999988853 356677776643
Q ss_pred CCEEEEEEeccCCCch
Q 023430 187 RSKLYLILDFINGGHL 202 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L 202 (282)
.+..+||||+++|+++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 3668999999998654
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00024 Score=63.87 Aligned_cols=79 Identities=13% Similarity=0.168 Sum_probs=51.4
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh--h--hhHHHHHHHHHHHHHhcC---CCCeeeeeEEEEeC
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--K--KNHVDYMKAERDILTKVT---HPFIVQLRYSFQTR 187 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~ 187 (282)
.+.||.|.+..||++... ..++.++||.-...... . ....++...|.+.|+.+. ..++.+++.+ +.
T Consensus 31 ~~elggGn~N~VyrV~~~-----~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDT-----EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE 103 (401)
T ss_pred eeEcCCCceEEEEEEEeC-----CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence 467999999999999854 11236899975422110 1 123455677888887763 2456666655 34
Q ss_pred CEEEEEEeccCCC
Q 023430 188 SKLYLILDFINGG 200 (282)
Q Consensus 188 ~~~~lv~e~~~~g 200 (282)
...++||||+++.
T Consensus 104 ~~~~lVME~L~~~ 116 (401)
T PRK09550 104 ELAVTVMEDLSDH 116 (401)
T ss_pred CCCEEEEecCCCc
Confidence 5578999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=8.6e-07 Score=81.73 Aligned_cols=151 Identities=17% Similarity=0.129 Sum_probs=105.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~ 189 (282)
.+.....+++|+++++++.+.. ..+....+.+... ....-++++|.+++||| .+..++.+..+..
T Consensus 243 ws~~fh~fvK~altknpKkRpt------aeklL~h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~ 308 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPT------AEKLLQHPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY 308 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCC------hhhheeceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccc
Confidence 3555667899999999987633 1222335544322 22455889999999999 7778888888889
Q ss_pred EEEEEeccCCC-ch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 190 LYLILDFINGG-HL-FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 190 ~~lv~e~~~~g-~L-~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
.+++|+++.++ +- ...-...-.+.+.+...+.+.-+++|+|+|+---+||| |||..+ +.++..||+.....-
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc
Confidence 99999999887 22 11111111234445556677778899999988778998 777754 788999998775322
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...+++.|||||+.
T Consensus 384 ~~~~~t~~~~~~~~~pev~ 402 (829)
T KOG0576|consen 384 TMKPRTAIGTPEPLAPEVI 402 (829)
T ss_pred ccccccCCCCCCCCCchhh
Confidence 22679999999964
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.95 E-value=6.4e-05 Score=65.00 Aligned_cols=139 Identities=17% Similarity=0.181 Sum_probs=80.5
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC--eeeeeE------E
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRY------S 183 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~------~ 183 (282)
..-.+.|..|....+|+.... +..+++|+.... ....+..|+.++..+.+.+ +.+++. .
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~-------~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~ 82 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTD-------SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYL 82 (296)
T ss_pred hhheecccCccccceEEEEeC-------CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEe
Confidence 333567888888899987632 235888987531 1233556777777775322 334332 1
Q ss_pred EEeCCEEEEEEeccCCCchHH-----------HH---Hhc-CCCC--------HHHHH------------HHHHHHHHHH
Q 023430 184 FQTRSKLYLILDFINGGHLFF-----------HL---YRQ-GIFR--------EDQAR------------FYTAEIVSAV 228 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~-----------~l---~~~-~~~~--------~~~~~------------~i~~qi~~gL 228 (282)
....+..++|++|++|..+.. .+ +.. ..+. ..... .....+...+
T Consensus 83 ~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 162 (296)
T cd05153 83 SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADEL 162 (296)
T ss_pred eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHH
Confidence 233456789999999865411 11 100 0000 00000 0111123334
Q ss_pred HHHHH-------CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 229 SHLHK-------CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 229 ~ylH~-------~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.++-. .+++|+|+.|.|||+++++.+.|+||..+.
T Consensus 163 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 163 ARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 44443 369999999999999987777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00033 Score=58.41 Aligned_cols=76 Identities=25% Similarity=0.277 Sum_probs=45.2
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCCEEEEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv 193 (282)
++.|..|-...+|++.... ..++.|++|+....... . -...+|+.+++.+...+ ..++++.+. + .++
T Consensus 3 i~~l~gG~tN~~~~v~~~~----~~~~~~vlR~~~~~~~~---~-~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKE----DNQDAVLVRVYGNKTEL---I-IDRERELRIHKLLSKHGLAPKLYATFQ--N--GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCC----CCCCeEEEEEccCCccc---e-ecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEE
Confidence 3567888889999886321 02356888876543211 0 11246888888875333 344544332 2 479
Q ss_pred EeccCCCch
Q 023430 194 LDFINGGHL 202 (282)
Q Consensus 194 ~e~~~~g~L 202 (282)
|||++|.++
T Consensus 71 ~e~i~G~~l 79 (235)
T cd05157 71 YEFIPGRTL 79 (235)
T ss_pred EEeeCCCcC
Confidence 999998654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00028 Score=61.47 Aligned_cols=142 Identities=18% Similarity=0.225 Sum_probs=80.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC--eeeeeEE----
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYS---- 183 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~---- 183 (282)
+....++.++.|.-..+|++... ++.+++|+..... ..+.+..|.+++..|.... +.+++..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t~-------~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~ 89 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTTD-------VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGR 89 (307)
T ss_pred CCceeccccCCccccceEEEEeC-------CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCC
Confidence 34555677888888899987632 2347888765421 1123445666666664222 3333221
Q ss_pred --EEeCCEEEEEEeccCCCchH-----------HHH---Hhc-CCC--------CHH---HH--H----------HHHHH
Q 023430 184 --FQTRSKLYLILDFINGGHLF-----------FHL---YRQ-GIF--------RED---QA--R----------FYTAE 223 (282)
Q Consensus 184 --~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~-~~~--------~~~---~~--~----------~i~~q 223 (282)
....+..++++||++|..+. ..+ +.. ..+ ... .. . .....
T Consensus 90 ~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~ 169 (307)
T TIGR00938 90 QLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAE 169 (307)
T ss_pred eehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHH
Confidence 12245678999999885421 111 110 001 000 00 0 00112
Q ss_pred HHHHHHHHHH-------CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 224 IVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 224 i~~gL~ylH~-------~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+...++++.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 170 LDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3334555532 579999999999999988867899999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00014 Score=61.54 Aligned_cols=131 Identities=11% Similarity=0.151 Sum_probs=72.0
Q ss_pred eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEEeCCEEEEEEec
Q 023430 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLILDF 196 (282)
Q Consensus 118 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~ 196 (282)
+..|-.+.+|+... .+..+++|+.......- .. ...+|..+++.+....+ .+++... . -++||||
T Consensus 4 ~~~G~tn~~y~~~~-------~~~~~vlR~~~~~~~~~--~~-~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-------PGISFVWRPQSPVCKAL--GV-DRQREYQILQALSALGLAPKPILVN--E--HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEe-------CCccEEEeeCCcccccc--cC-cHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEe
Confidence 45677788888762 23457788754322110 01 13568888888764333 2333332 2 3689999
Q ss_pred cCCCchHH--------------HHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------CCCE
Q 023430 197 INGGHLFF--------------HLYR---QG----IFRE-DQARFYTAEI---------VSAVSHLHK--------CGIV 237 (282)
Q Consensus 197 ~~~g~L~~--------------~l~~---~~----~~~~-~~~~~i~~qi---------~~gL~ylH~--------~~ii 237 (282)
++|..+.. .+.+ .. .+.. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 99865421 1111 11 1111 1112221111 111222222 2489
Q ss_pred eeccCCCceEEcCCCcEEEEecCccc
Q 023430 238 HRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 238 HrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
|+|+.|.|||++.++ +.++||..+.
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccC
Confidence 999999999999877 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00045 Score=60.63 Aligned_cols=139 Identities=18% Similarity=0.298 Sum_probs=91.8
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh----------------------hhHH-HHHHHHHHHHHh
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------------------KNHV-DYMKAERDILTK 171 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------------------~~~~-~~~~~E~~~l~~ 171 (282)
-..|..|.-+.||.|.. ..+..+|||+.+-....- +..+ -+...|++.|++
T Consensus 149 nGCiSTGKEANVYHat~------~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkR 222 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATE------EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKR 222 (520)
T ss_pred ccccccCccceeEeeec------CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHH
Confidence 35688899999999863 356669999886322110 1111 123457778888
Q ss_pred cCCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCCEeeccCCCceEEcC
Q 023430 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL-HKCGIVHRDLKPENILMDS 250 (282)
Q Consensus 172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~yl-H~~~iiHrDlKp~NILl~~ 250 (282)
+....|..---.... .-.|||+|+.......-..+.-.++...+..+-.|++.-|.-| +.+++||.||.-=|+|+.
T Consensus 223 l~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 223 LNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH- 299 (520)
T ss_pred HHhcCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence 876554332211111 2478999997533322222334577778888888888888766 578999999999999984
Q ss_pred CCcEEEEecCcc
Q 023430 251 DGHVMAAHSLNS 262 (282)
Q Consensus 251 ~~~v~l~Dfg~s 262 (282)
+|.+.|+|-+=|
T Consensus 300 dG~lyiIDVSQS 311 (520)
T KOG2270|consen 300 DGKLYIIDVSQS 311 (520)
T ss_pred CCEEEEEEcccc
Confidence 789999998766
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0016 Score=56.99 Aligned_cols=30 Identities=23% Similarity=0.305 Sum_probs=25.7
Q ss_pred CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.++||+|+.+.|||++.+....|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999866555799999885
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0014 Score=56.83 Aligned_cols=79 Identities=15% Similarity=0.130 Sum_probs=44.8
Q ss_pred eeeCcCCCeEEEEEEEcCC-CCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEEeCCEEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYLI 193 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv 193 (282)
+.|..|-...+|++..... .....++.+++|+...... ......+|..+++.+....+ .++++.+. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 4566677778898764310 0011245688898654321 11124568888877753333 34555443 2 368
Q ss_pred EeccCCCch
Q 023430 194 LDFINGGHL 202 (282)
Q Consensus 194 ~e~~~~g~L 202 (282)
+||++|..+
T Consensus 76 ~e~i~G~~l 84 (302)
T cd05156 76 EEFIPSRTL 84 (302)
T ss_pred hheeCCCcC
Confidence 999988654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00049 Score=61.20 Aligned_cols=150 Identities=16% Similarity=0.174 Sum_probs=96.4
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH-hcCCCCeee--------eeEEEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQ--------LRYSFQ 185 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~--------l~~~~~ 185 (282)
.+.||+|+-+.+|-.-.. +. .+.|+.......... ..+..|. .-.||-+-. ++|. .
T Consensus 16 gr~LgqGgea~ly~l~e~-------~d-~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~ 80 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-------RD-QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGG-R 80 (637)
T ss_pred CccccCCccceeeecchh-------hc-hhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCC-C
Confidence 467999999999954311 11 345666543211111 1122222 234554332 1111 1
Q ss_pred eCCEEEEEEeccCCCc-hHHHHH---hc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 186 TRSKLYLILDFINGGH-LFFHLY---RQ---GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~-L~~~l~---~~---~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
.....-++|..+.|.. +..+.. +. ....+..+++.++.++.+..-||+.|-+-+|+.++|+|+.+++.|.|.|
T Consensus 81 ~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 81 RGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred ccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 1223667888877652 222221 12 3367889999999999999999999999999999999999999999995
Q ss_pred ---cCccc---ccccchhheeeccCcc
Q 023430 259 ---SLNSH---NQLCCFFFFLFLGGGV 279 (282)
Q Consensus 259 ---fg~s~---~~~~~~~~~~~~ape~ 279 (282)
|.++. .-.|-.|...|..||.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPEl 187 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPEL 187 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHH
Confidence 66553 3455588899999985
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0035 Score=55.40 Aligned_cols=76 Identities=16% Similarity=0.189 Sum_probs=46.9
Q ss_pred eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh----hhhHHHHHHHHHHHHHhcC--CC-CeeeeeEEEEeCCE
Q 023430 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII----KKNHVDYMKAERDILTKVT--HP-FIVQLRYSFQTRSK 189 (282)
Q Consensus 117 ~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~ 189 (282)
.||.|....||++... ..++.++||.-...... -+-..++...|...|+... -| .+.++|.+ +...
T Consensus 2 EigdGnlN~VfrV~~~-----~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQ-----EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcC-----CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccc
Confidence 5799999999999842 12246889875432211 1223445566888887664 34 34445433 4455
Q ss_pred EEEEEeccCC
Q 023430 190 LYLILDFING 199 (282)
Q Consensus 190 ~~lv~e~~~~ 199 (282)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 6799999865
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00022 Score=61.57 Aligned_cols=133 Identities=12% Similarity=0.162 Sum_probs=86.0
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----------------hhhhHHHH--HHHHHHHHHhc
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----------------IKKNHVDY--MKAERDILTKV 172 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~--~~~E~~~l~~l 172 (282)
+.++.+||-|.-+.||.+-.. .+...++|+-+.... ..+..+.+ ..+|...|+.|
T Consensus 94 ~svGnqIGVGKESDIY~v~d~------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL 167 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKAL 167 (465)
T ss_pred hhhccccccccccceEEEecC------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHH
Confidence 456778999999999988643 355677775432111 01112222 23577888877
Q ss_pred C-CCC-eeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC
Q 023430 173 T-HPF-IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250 (282)
Q Consensus 173 ~-h~n-Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~ 250 (282)
. |.. |.+.++ .+.-++|||++.|-.|.+.-.- ... ..+...+..-+.-|-.+|+||+|..-=||++++
T Consensus 168 ~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v---~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 168 YERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV---EDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred HHcCCCCCCccc----ccceeeHHHhhcccceeeeeec---CCh---HHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 5 322 223333 3467899999998776543211 122 223334444456677899999999999999999
Q ss_pred CCcEEEEecC
Q 023430 251 DGHVMAAHSL 260 (282)
Q Consensus 251 ~~~v~l~Dfg 260 (282)
++.++++||-
T Consensus 238 d~~i~vIDFP 247 (465)
T KOG2268|consen 238 DDKIVVIDFP 247 (465)
T ss_pred CCCEEEeech
Confidence 9999999995
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0031 Score=54.12 Aligned_cols=29 Identities=34% Similarity=0.492 Sum_probs=24.6
Q ss_pred CCEeeccCCCceEEcCCCcE-EEEecCccc
Q 023430 235 GIVHRDLKPENILMDSDGHV-MAAHSLNSH 263 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v-~l~Dfg~s~ 263 (282)
.++|+|+.+.|||++.++.+ -|.||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 48999999999999976664 699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0053 Score=53.45 Aligned_cols=29 Identities=21% Similarity=0.284 Sum_probs=27.0
Q ss_pred CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 235 GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.++|+|+.+.||+++.++.+-+.||+++.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 48999999999999999999999999885
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.007 Score=52.59 Aligned_cols=29 Identities=24% Similarity=0.293 Sum_probs=25.6
Q ss_pred CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.+++|+|+.+.|||++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 778999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0059 Score=54.93 Aligned_cols=77 Identities=12% Similarity=0.094 Sum_probs=48.3
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh----hHHHHHHHHHHHHHhcC---CCCeeeeeEEEEe
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----NHVDYMKAERDILTKVT---HPFIVQLRYSFQT 186 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 186 (282)
..+.||.|.-..||+.... ++.++||.-........ ....+-..|...|+.+. ...+.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~-------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence 3567899999999997742 23488887652221100 12333445666676654 246777777665
Q ss_pred CCEEEEEEeccCC
Q 023430 187 RSKLYLILDFING 199 (282)
Q Consensus 187 ~~~~~lv~e~~~~ 199 (282)
+..+++||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 446788999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.015 Score=51.46 Aligned_cols=143 Identities=17% Similarity=0.183 Sum_probs=79.4
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCee-eeeEEEEeCCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQTRSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~ 189 (282)
...+ +.|-.|-...+|++...... ....+.|++|+..... ....++ .+|..+++.+..-++. ++++.+.. +
T Consensus 38 ~~~i-~~l~gGlTN~~y~v~~~~~~-~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g- 109 (344)
T PLN02236 38 ALQV-IPLKGAMTNEVFQIKWPTKE-GNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G- 109 (344)
T ss_pred cEEE-EEcCCcccceeEEEEeCCCC-CCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECC-c-
Confidence 3444 45555888899998754211 1133568888775532 122222 4588888877644443 45565532 2
Q ss_pred EEEEEeccCCCchHH--------------HHH---hcC----C-C-CHHHHHHHHHHH-----------------HHHHH
Q 023430 190 LYLILDFINGGHLFF--------------HLY---RQG----I-F-REDQARFYTAEI-----------------VSAVS 229 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~--------------~l~---~~~----~-~-~~~~~~~i~~qi-----------------~~gL~ 229 (282)
.|+||+++.+|.. .+. ... . . ...++..+..++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 5789988766521 111 100 0 1 122233332211 11111
Q ss_pred HH----H----HCCCEeeccCCCceEEcC-CCcEEEEecCccc
Q 023430 230 HL----H----KCGIVHRDLKPENILMDS-DGHVMAAHSLNSH 263 (282)
Q Consensus 230 yl----H----~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~ 263 (282)
.| . ...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22 1 125899999999999986 4789999998775
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0076 Score=51.95 Aligned_cols=76 Identities=17% Similarity=0.291 Sum_probs=45.8
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCCeeeeeEEEEeCC
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS 188 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~ 188 (282)
.+-.+.|+-|....+|+.. ..++.+.||+-.... ...+..|.+-|+.|. --.+.+.+++....+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-------~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~ 85 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-------TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD 85 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-------TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred eeeeEecCCCChhheEEEE-------CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence 4445778989999999876 345679999875221 234677888888874 345667888877777
Q ss_pred EEEEEEeccCCC
Q 023430 189 KLYLILDFINGG 200 (282)
Q Consensus 189 ~~~lv~e~~~~g 200 (282)
.-||||||++.+
T Consensus 86 ~~fLlle~l~~~ 97 (288)
T PF03881_consen 86 DAFLLLEFLEMG 97 (288)
T ss_dssp CCEEEEE-----
T ss_pred CceEEEEeecCC
Confidence 779999998876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0009 Score=62.72 Aligned_cols=60 Identities=20% Similarity=0.309 Sum_probs=47.2
Q ss_pred HHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccccc------chh----------heeeccCccccC
Q 023430 223 EIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------CFF----------FFLFLGGGVFNF 282 (282)
Q Consensus 223 qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------~~~----------~~~~~ape~~~~ 282 (282)
+++.||.|+|. .++||+.|.|++|.++..|.+||+.|+.+-.... +.+ ..-|.|||++.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45599999995 4799999999999999999999999987743222 222 456888988754
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.017 Score=49.80 Aligned_cols=80 Identities=11% Similarity=0.137 Sum_probs=45.3
Q ss_pred CcCCCeEEEEEEEcC--C-CCCCCCcEEEEEEeechhhhh--hhHHHHHHHHHHHHHhcC---------C----CCeeee
Q 023430 119 GQGAFGKVFQVKKKG--V-DDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVT---------H----PFIVQL 180 (282)
Q Consensus 119 G~G~fg~V~~~~~~~--~-~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~---------h----~nIv~l 180 (282)
|.|-.|.+|++.... . ........++||......... -.....+.+|+.+.+.+- . ..+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 778889999887654 1 122334558899876322111 112345777876655431 1 233455
Q ss_pred eEEEEeCCEEEEEEeccC
Q 023430 181 RYSFQTRSKLYLILDFIN 198 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~~ 198 (282)
+..-......+||||-+.
T Consensus 82 ~~~~~~~~~~~lvlEDL~ 99 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDLS 99 (294)
T ss_pred EEeccCCCceeeehhhhh
Confidence 555544456789998753
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.0071 Score=60.21 Aligned_cols=122 Identities=15% Similarity=0.050 Sum_probs=86.2
Q ss_pred HHHHHHHHHHHhcCCCCeeeeeEEEEeCCE----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 023430 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235 (282)
Q Consensus 160 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~ 235 (282)
....-|...+.++.|+|++.++.+-..... ..+..|+|..-++...+..-+..+...++.+..++++||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 334456777888999999999877654332 2345577888888888888788899999999999999999999997
Q ss_pred CEeeccCCC---ceEEcCCCcEEEE--ecCcccccccchh------heeeccCcccc
Q 023430 236 IVHRDLKPE---NILMDSDGHVMAA--HSLNSHNQLCCFF------FFLFLGGGVFN 281 (282)
Q Consensus 236 iiHrDlKp~---NILl~~~~~v~l~--Dfg~s~~~~~~~~------~~~~~ape~~~ 281 (282)
..|.-+... +-..+.++.+.+. ||+.++..-...+ ...|.++|.++
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~ 363 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLK 363 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccc
Confidence 666666555 4445566677766 8877764332211 45555555543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.061 Score=46.84 Aligned_cols=29 Identities=17% Similarity=0.113 Sum_probs=26.7
Q ss_pred CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 235 GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+++|+|+.++|+|++.++.+.++||-.+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999997775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.025 Score=50.81 Aligned_cols=78 Identities=15% Similarity=0.229 Sum_probs=49.6
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh---hhHHHHHHHHHHHHHhcC--CC-CeeeeeEEEEeCC
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVT--HP-FIVQLRYSFQTRS 188 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~ 188 (282)
.+.||.|.-..||++.... .++.++||.-....... +-..++...|.+.|+.+. .| .+.++|.+ +..
T Consensus 34 ~~eigdGnlN~VfrV~~~~-----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e 106 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSV 106 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcH
Confidence 5678999999999998531 13458888654322111 223455667888888764 34 45555433 445
Q ss_pred EEEEEEeccCC
Q 023430 189 KLYLILDFING 199 (282)
Q Consensus 189 ~~~lv~e~~~~ 199 (282)
...+|||+++.
T Consensus 107 ~~~~vMEdL~~ 117 (409)
T PRK12396 107 MNCCVMEDLSD 117 (409)
T ss_pred HhhHHHHhCcc
Confidence 66789999865
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.033 Score=49.10 Aligned_cols=82 Identities=20% Similarity=0.280 Sum_probs=46.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~ 188 (282)
+..++.. |..|-...+|++...+.. .....|++|+...... ...+ ..+|..+++.+..-++ .++++++. .+
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~--~~~~~~v~Ri~g~~t~---~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEEN--GNEVSVTVRLFGPNTD---YVID-RERELQAIKYLSAAGFGAKLLGVFG-NG 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCC--CCCceEEEEEecCCcC---eEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc
Confidence 3455544 444777888988644211 1233688887754321 1111 2458888888765444 34555553 22
Q ss_pred EEEEEEeccCCCch
Q 023430 189 KLYLILDFINGGHL 202 (282)
Q Consensus 189 ~~~lv~e~~~~g~L 202 (282)
+|.+|++|..|
T Consensus 87 ---~i~~fi~g~~l 97 (330)
T PLN02421 87 ---MIQSFINARTL 97 (330)
T ss_pred ---EeehhhcCCCC
Confidence 48899877654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.01 Score=52.33 Aligned_cols=70 Identities=26% Similarity=0.266 Sum_probs=50.1
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..|++|++- |+.|. .+ ..-...++..++.+.+.-++-+..+ ..-|||+.-.||||+ +|+|-|+||-+|+-
T Consensus 300 y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 567777765 33442 11 1235677777777766655555433 588999999999999 99999999999973
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.032 Score=45.97 Aligned_cols=100 Identities=15% Similarity=0.159 Sum_probs=62.9
Q ss_pred EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHH
Q 023430 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221 (282)
Q Consensus 142 ~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~ 221 (282)
...+|+++.-... .....+..+..++.++. .|+++..- ..-.+-++.|.|-.... +.. .++
T Consensus 87 ~L~lKKi~slp~~--~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~~----N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCC--INDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NFS----NFI 147 (308)
T ss_pred hhhhhhccCCCcc--cchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------chh----HHH
Confidence 3455655443221 12233567788887765 57777632 33356788998854211 111 111
Q ss_pred HHHHHHHHHHHH--CCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 222 AEIVSAVSHLHK--CGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 222 ~qi~~gL~ylH~--~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
..=+..|.-.|+ .+.+|+|..|+||+-|..|.+||.|-+
T Consensus 148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 112456777883 469999999999999999999999965
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.076 Score=44.00 Aligned_cols=74 Identities=18% Similarity=0.340 Sum_probs=47.8
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC---CCeeeeeEEEEeCCEEEE
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH---PFIVQLRYSFQTRSKLYL 192 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~~~~l 192 (282)
+.+.-|---..|...+ ....+.+|+-. +..+..|..|+.-|..|.- -.|.+++.+-...+..|+
T Consensus 22 ~~v~gG~inea~~v~d-------g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl 88 (286)
T COG3001 22 EEVSGGDINEAWRLRD-------GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL 88 (286)
T ss_pred cccCCccccceeEeec-------CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence 3444455555555442 23457788642 3445567788877766653 456677777788889999
Q ss_pred EEeccCCCch
Q 023430 193 ILDFINGGHL 202 (282)
Q Consensus 193 v~e~~~~g~L 202 (282)
||||++-+.+
T Consensus 89 Vle~L~~~~~ 98 (286)
T COG3001 89 VLEYLPTGPL 98 (286)
T ss_pred EEeeccCCCC
Confidence 9999987544
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.36 Score=42.40 Aligned_cols=28 Identities=25% Similarity=0.190 Sum_probs=23.9
Q ss_pred CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.++||+|+.+.|||++ + .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999885
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.046 Score=49.01 Aligned_cols=60 Identities=23% Similarity=0.215 Sum_probs=40.2
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCEeeccCCCceEEcC
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS-HLHKCGIVHRDLKPENILMDS 250 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~-ylH~~~iiHrDlKp~NILl~~ 250 (282)
..|+-+|..|.++..++... ..++.....++.-.+.|+. -+--.+++|.|+.|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 45677788888887777543 3355455555544444443 334568999999999999853
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.13 Score=46.35 Aligned_cols=83 Identities=14% Similarity=0.153 Sum_probs=45.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCC-CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEEeCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDD-GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~ 188 (282)
..++ +.|..|-...+|++....... ....+.|.+++.... .....+ -.+|+.+++.+...++ .++++.+.
T Consensus 52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~--- 123 (383)
T PTZ00384 52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFG--- 123 (383)
T ss_pred cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEec-cHHHHHHHHHHHhCCCCCeEEEecC---
Confidence 3444 455558889999987532110 001122344432111 111111 2458889988875544 45666664
Q ss_pred EEEEEEeccCCCch
Q 023430 189 KLYLILDFINGGHL 202 (282)
Q Consensus 189 ~~~lv~e~~~~g~L 202 (282)
-+++.||++|..|
T Consensus 124 -~g~l~efIeGr~l 136 (383)
T PTZ00384 124 -DFTIQEWVEGNTM 136 (383)
T ss_pred -CEEEEEEeccccC
Confidence 2699999998765
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.04 Score=44.24 Aligned_cols=28 Identities=14% Similarity=0.226 Sum_probs=24.7
Q ss_pred CEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 236 IVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 236 iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+|+|+.|.||++.++| ++++||+-+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998777 89999987753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.069 Score=46.96 Aligned_cols=28 Identities=32% Similarity=0.493 Sum_probs=25.7
Q ss_pred CEeeccCCCceEEcCCCc-EEEEecCccc
Q 023430 236 IVHRDLKPENILMDSDGH-VMAAHSLNSH 263 (282)
Q Consensus 236 iiHrDlKp~NILl~~~~~-v~l~Dfg~s~ 263 (282)
+||.|+.+.|||++.+.. +.+.||+-|.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999886 8899999875
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.13 Score=41.63 Aligned_cols=30 Identities=30% Similarity=0.277 Sum_probs=25.4
Q ss_pred CCCEeeccCCCceEEcCCC-----cEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSDG-----HVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~-----~v~l~Dfg~s~ 263 (282)
..++|+|+.+.||++..++ .+.+.||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 3589999999999998554 68999998885
|
subfamily of choline kinases |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.76 E-value=1.5 Score=40.33 Aligned_cols=84 Identities=18% Similarity=0.190 Sum_probs=47.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCC---CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCee-eeeEEEE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDD---GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIV-QLRYSFQ 185 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~ 185 (282)
++. -++.|..|-.-.+|++....... ...++.|.+++..... ....+ ...|..+++.+...+|- ++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lId-R~~E~~v~~~ls~~gi~P~l~~~f~ 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYN-PISEFEVYKTMSKYRIAPQLLNTFS 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeC-HHHHHHHHHHHHHCCCCCceEEEeC
Confidence 345 45667778888899887542110 0124568888765432 11111 23477777776644443 3555543
Q ss_pred eCCEEEEEEeccCCCch
Q 023430 186 TRSKLYLILDFINGGHL 202 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L 202 (282)
-+.|.||++|..|
T Consensus 181 ----gg~I~efi~g~~l 193 (442)
T PTZ00296 181 ----GGRIEEWLYGDPL 193 (442)
T ss_pred ----CCEEEEeeCCccC
Confidence 2557899987643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 282 | ||||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-35 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-35 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-35 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-35 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-35 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-35 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-34 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-31 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-31 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-31 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-31 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-31 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-31 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-31 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-31 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-30 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-30 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-30 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-30 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-30 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-30 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-30 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-30 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-30 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-29 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-29 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-29 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-29 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-29 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-29 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-29 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-29 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-29 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-29 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-29 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-29 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-29 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-29 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-29 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-29 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-29 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-28 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-28 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-28 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-28 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-28 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-25 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-25 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 8e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-25 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-24 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-24 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-24 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-24 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-24 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-24 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-24 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-24 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-24 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-24 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-24 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-24 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-24 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-24 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-24 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-24 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-24 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-24 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-24 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-24 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-24 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-24 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-24 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-24 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-24 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-24 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-24 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-24 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-24 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-24 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-23 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-23 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-23 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-23 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-23 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-23 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-23 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-23 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-23 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-23 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-23 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-23 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-21 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-20 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-20 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-20 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-20 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-19 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-14 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-12 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-06 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-06 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-06 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-06 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-05 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-04 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-04 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-04 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-04 |
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 282 | |||
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-88 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-87 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-85 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-85 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-85 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-85 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 9e-85 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-84 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-84 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-83 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-83 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 2e-82 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-81 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 6e-81 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-79 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-79 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-78 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-77 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-77 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-77 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-76 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-74 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-59 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-57 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-49 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-46 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-44 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-44 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-44 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-43 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-42 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-40 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-39 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 4e-39 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 7e-38 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-37 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-37 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-37 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-37 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-37 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-37 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-37 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 5e-37 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 7e-37 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-36 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-36 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-36 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-36 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 3e-36 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-36 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-36 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-36 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-36 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-36 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 8e-36 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-35 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-35 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-35 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-35 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 7e-35 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 7e-35 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-35 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-35 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-34 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-34 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-34 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-34 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-34 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 3e-34 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-34 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-34 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-34 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 5e-34 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 6e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 6e-34 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 7e-34 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-34 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-34 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 8e-34 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 9e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-33 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-33 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-33 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-33 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-32 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-32 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 6e-32 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 9e-31 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-30 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-29 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-29 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-29 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-28 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 2e-27 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-27 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-26 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-26 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 6e-25 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-24 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-24 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-24 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-24 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-24 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 8e-23 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-22 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-22 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-22 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-21 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-21 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-21 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 8e-21 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-20 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-20 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-20 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 9e-20 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-19 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-19 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-19 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 9e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-18 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-18 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-18 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-18 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-18 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-18 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-18 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 4e-18 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 6e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-18 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-18 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-17 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-17 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-17 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-17 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 8e-17 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 9e-17 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-16 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-16 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-15 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-15 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-15 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-15 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-14 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-14 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-13 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-13 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 3e-13 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-13 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-13 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-13 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 6e-13 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-12 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-12 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-12 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-12 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-12 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-12 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 4e-12 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-12 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-12 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 9e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-11 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-11 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-11 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-11 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-11 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-11 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-11 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 4e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 5e-11 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 8e-11 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-10 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-10 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-10 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-10 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-10 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-10 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-10 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-10 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 2e-10 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-10 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-10 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-10 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 3e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 4e-10 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-10 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-10 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-09 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-09 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-09 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-09 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 3e-09 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-09 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 4e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 5e-09 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 7e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 8e-09 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-08 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-08 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-08 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-08 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-08 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-08 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 4e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-08 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 5e-08 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-07 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 3e-07 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 4e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-04 |
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 8e-88
Identities = 80/166 (48%), Positives = 109/166 (65%), Gaps = 3/166 (1%)
Query: 90 ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
++ E K P FE+ +V+GQG+FGKVF VKK D+ +YAMKV++
Sbjct: 4 SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKIS--GSDARQLYAMKVLK 61
Query: 150 KDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ 209
K T+ ++ V K ERDIL +V HPFIV+L Y+FQT KLYLILDF+ GG LF L ++
Sbjct: 62 KATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 120
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
+F E+ +FY AE+ A+ HLH GI++RDLKPENIL+D +GH+
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIK 166
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 262 bits (673), Expect = 2e-87
Identities = 80/155 (51%), Positives = 108/155 (69%), Gaps = 3/155 (1%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-NHVD 160
KI P FE+ RV+G+G +GKVFQV+K ++ I+AMKV++K I++
Sbjct: 9 RGPEKIRPECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTA 66
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
+ KAER+IL +V HPFIV L Y+FQT KLYLIL++++GG LF L R+GIF ED A FY
Sbjct: 67 HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
AEI A+ HLH+ GI++RDLKPENI+++ GHV
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-85
Identities = 77/171 (45%), Positives = 113/171 (66%), Gaps = 4/171 (2%)
Query: 87 QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
Q+ ++HE K+G +FE+ +V+G GA+GKVF V+K D+ +YAMK
Sbjct: 31 QLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMK 88
Query: 147 VMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
V++K TI+ K ++ + ER +L + PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 89 VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148
Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
HL ++ F E + + Y EIV A+ HLHK GI++RD+K ENIL+DS+GHV+
Sbjct: 149 HLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-85
Identities = 58/150 (38%), Positives = 96/150 (64%), Gaps = 5/150 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
K DF+I R +G G+FG+V ++ + + YAMKV++K+ +++ V++ E
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDE 56
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
R +L+ VTHPFI+++ +FQ ++++I+D+I GG LF L + F A+FY AE+
Sbjct: 57 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
A+ +LH I++RDLKPENIL+D +GH+
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIK 146
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 3e-85
Identities = 79/184 (42%), Positives = 107/184 (58%), Gaps = 6/184 (3%)
Query: 73 GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
G S L S P DF +V+G+G+FGKV + K
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLY 191
+ YA+KV++K I+KK ++ +ER++L K V HPF+V L +SFQT KLY
Sbjct: 61 -----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+LD+INGG LF+HL R+ F E +ARFY AEI SA+ +LH IV+RDLKPENIL+DS
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 175
Query: 252 GHVM 255
GH++
Sbjct: 176 GHIV 179
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 8e-85
Identities = 57/154 (37%), Positives = 91/154 (59%), Gaps = 5/154 (3%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
+ + FEI R +G+G+FGKV V+K D+ +YAMK M K +++N V
Sbjct: 7 DENEDVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRN 61
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
+ E I+ + HPF+V L YSFQ +++++D + GG L +HL + F+E+ + +
Sbjct: 62 VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFI 121
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
E+V A+ +L I+HRD+KP+NIL+D GHV
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVH 155
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 9e-85
Identities = 64/153 (41%), Positives = 96/153 (62%), Gaps = 5/153 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
RK P DF+ +++G+G+F V ++ + YA+K++ K IIK+N V Y+
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYV 77
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
ERD+++++ HPF V+L ++FQ KLY L + G L ++ + G F E RFYTA
Sbjct: 78 TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 137
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
EIVSA+ +LH GI+HRDLKPENIL++ D H+
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQ 170
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 5e-84
Identities = 65/150 (43%), Positives = 101/150 (67%), Gaps = 5/150 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
K+ DF+ +++G+G FGKV V++K + YAMK++RK+ II K+ V + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+L HPF+ L+Y+FQT +L ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
SA+ +LH +V+RD+K EN+++D DGH+
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIK 145
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 256 bits (655), Expect = 7e-84
Identities = 66/193 (34%), Positives = 120/193 (62%), Gaps = 7/193 (3%)
Query: 65 HNRSHSFVGPSP-RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
H+ H + P+ ++ I+E + + ++ +G DF++ RV+G+G++
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSY 65
Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRY 182
KV V+ K +D IYAM+V++K+ + +D+++ E+ + + + HPF+V L
Sbjct: 66 AKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120
Query: 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242
FQT S+L+ +++++NGG L FH+ RQ E+ ARFY+AEI A+++LH+ GI++RDLK
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180
Query: 243 PENILMDSDGHVM 255
+N+L+DS+GH+
Sbjct: 181 LDNVLLDSEGHIK 193
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 8e-83
Identities = 62/154 (40%), Positives = 106/154 (68%), Gaps = 6/154 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ +G DF++ RV+G+G++ KV V+ K +D IYAMKV++K+ + +D++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWV 56
Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
+ E+ + + + HPF+V L FQT S+L+ +++++NGG L FH+ RQ E+ ARFY+
Sbjct: 57 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
AEI A+++LH+ GI++RDLK +N+L+DS+GH+
Sbjct: 117 AEISLALNYLHERGIIYRDLKLDNVLLDSEGHIK 150
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 8e-83
Identities = 64/165 (38%), Positives = 103/165 (62%), Gaps = 6/165 (3%)
Query: 92 EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
+ + S ++G +FE RV+G+G+FGKV + K ++ +YA+KV++KD
Sbjct: 5 SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKD 59
Query: 152 TIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
I++ + V+ E+ IL+ HPF+ QL FQT +L+ +++F+NGG L FH+ +
Sbjct: 60 VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR 119
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
F E +ARFY AEI+SA+ LH GI++RDLK +N+L+D +GH
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 250 bits (642), Expect = 2e-82
Identities = 55/154 (35%), Positives = 95/154 (61%), Gaps = 6/154 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ ++ DF V+G+G+FGKV ++K +D +YA+K+++KD +I+ + V+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECT 67
Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
E+ +L PF+ QL FQT +LY +++++NGG L +H+ + G F+E A FY
Sbjct: 68 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 127
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
AEI + L GI++RDLK +N+++DS+GH+
Sbjct: 128 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 5e-81
Identities = 60/184 (32%), Positives = 104/184 (56%), Gaps = 5/184 (2%)
Query: 72 VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
+ + + S+ + + + + + E S+ F+ + +G G+FG+V VK
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 132 KGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191
K +S YAMK++ K ++K +++ E+ IL V PF+V+L +SF+ S LY
Sbjct: 63 K-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
++++++ GG +F HL R G F E ARFY A+IV +LH +++RDLKPEN+L+D
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 252 GHVM 255
G++
Sbjct: 178 GYIQ 181
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 6e-81
Identities = 62/154 (40%), Positives = 93/154 (60%), Gaps = 6/154 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
E ++ DFEI +V+G+GAF +V VK K + +YAMK+M K ++K+ V
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYT 221
+ ERD+L +I QL ++FQ + LYL++++ GG L L + G + ARFY
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
AEIV A+ +H+ G VHRD+KP+NIL+D GH+
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIR 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-79
Identities = 60/154 (38%), Positives = 95/154 (61%), Gaps = 6/154 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ ++ DFEI +V+G+GAFG+V VK K ++D ++AMK++ K ++K+
Sbjct: 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACF 121
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
+ ERD+L +I L Y+FQ + LYL++D+ GG L L + + E+ ARFY
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
AE+V A+ +H+ VHRD+KP+NILMD +GH+
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR 215
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 2e-79
Identities = 68/170 (40%), Positives = 106/170 (62%), Gaps = 6/170 (3%)
Query: 89 QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
E A+ + ++ +FE +++G+G FGKV VK+K + YAMK++
Sbjct: 127 DNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKIL 181
Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR 208
+K+ I+ K+ V + E +L HPF+ L+YSFQT +L ++++ NGG LFFHL R
Sbjct: 182 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR 241
Query: 209 QGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHVMAA 257
+ +F ED+ARFY AEIVSA+ +LH + +V+RDLK EN+++D DGH+
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKIT 291
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 1e-78
Identities = 56/153 (36%), Positives = 94/153 (61%), Gaps = 6/153 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ ++ D+E+ +V+G+GAFG+V V+ K + +YAMK++ K +IK++ +
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFF 116
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
ERDI+ P++VQL Y+FQ LY++++++ GG L + E ARFYTA
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTA 175
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
E+V A+ +H G +HRD+KP+N+L+D GH+
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-77
Identities = 53/153 (34%), Positives = 94/153 (61%), Gaps = 6/153 (3%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ K+ DF + +++G+G+FGKVF + K ++ +A+K ++KD ++ + V+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECT 64
Query: 163 KAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
E+ +L+ HPF+ + +FQT+ L+ +++++NGG L +H+ F +A FY
Sbjct: 65 MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
AEI+ + LH GIV+RDLK +NIL+D DGH+
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI 157
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-77
Identities = 62/155 (40%), Positives = 94/155 (60%), Gaps = 9/155 (5%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
+ +G F FRV+G+G FG+VF + K + +YA K + K + K+
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMV 234
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY----RQGIFREDQARFY 220
E+ IL KV FIV L Y+F+T++ L L++ +NGG + +H+Y F+E +A FY
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
TA+IVS + HLH+ I++RDLKPEN+L+D DG+V
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 7e-77
Identities = 64/157 (40%), Positives = 89/157 (56%), Gaps = 8/157 (5%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
E + DF + R++G+G FG+V+ +K D+ +YAMK + K I K
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETL 235
Query: 162 MKAERDILTKV---THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
ER +L+ V PFIV + Y+F T KL ILD +NGG L +HL + G+F E R
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR 295
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
FY AEI+ + H+H +V+RDLKP NIL+D GHV
Sbjct: 296 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 332
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 242 bits (618), Expect = 2e-76
Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 18/243 (7%)
Query: 15 TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
+ LT S + PD +T C + ++ H + V P
Sbjct: 100 ACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHE--YLSVAP 157
Query: 75 SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
Y S +Q E + + F +RV+G+G FG+V + +
Sbjct: 158 FADYLDSIYFNRFLQWKWLER---------QPVTKNTFRQYRVLGKGGFGEVCACQVR-- 206
Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLIL 194
+ +YA K + K I K+ E+ IL KV F+V L Y+++T+ L L+L
Sbjct: 207 ---ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263
Query: 195 DFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+NGG L FH+Y G F E +A FY AEI + LH+ IV+RDLKPENIL+D G
Sbjct: 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG 323
Query: 253 HVM 255
H+
Sbjct: 324 HIR 326
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 2e-74
Identities = 62/231 (26%), Positives = 111/231 (48%), Gaps = 7/231 (3%)
Query: 29 SPDFDFTEVFGPLTPCRHNNQSPASTSA-SLGDPQVIHNRSHSFVGPSPRYALSSSLPLQ 87
S F +E+ S ++ P + R +
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318
Query: 88 IQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
++ + + ++ DF V+G+G+FGKV ++K +D +YA+K+
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKI 373
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL 206
++KD +I+ + V+ E+ +L PF+ QL FQT +LY +++++NGG L +H+
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 207 YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ G F+E A FY AEI + L GI++RDLK +N+++DS+GH+ A
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 484
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 1e-59
Identities = 50/159 (31%), Positives = 88/159 (55%), Gaps = 5/159 (3%)
Query: 99 LEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH 158
L +RK DF+I R +G+G FG V+ ++K + I A+KV+ K + K+
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGV 57
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
++ E +I + + HP I+++ F R ++YL+L+F G L+ L + G F E ++
Sbjct: 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ E+ A+ + H+ ++HRD+KPEN+LM G + A
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIA 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-57
Identities = 49/151 (32%), Positives = 85/151 (56%), Gaps = 5/151 (3%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
+R+ DFEI R +G+G FG V+ ++K S I A+KV+ K + K ++
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLR 57
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
E +I + + HP I++L F +++YLIL++ G ++ L + F E + Y E
Sbjct: 58 REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +A+S+ H ++HRD+KPEN+L+ S G +
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLGSAGEL 148
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-49
Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 19/211 (9%)
Query: 46 HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
H++ + + S PR + + + E +
Sbjct: 3 HHHHHSSGVDLGTENLYF-----QSMHQLQPR-----RVSFRGEASETLQSPGYDPSRPE 52
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
F+ +G G++G+VF+V+ K +DG +YA+K K+ + E
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSK--EDGR---LYAVKRSMSPFRGPKDRARKLA-E 106
Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAE 223
KV HP V+L +++ LYL + G L H G E Q Y +
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRD 165
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ A++HLH G+VH D+KP NI + G
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFLGPRGRC 196
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 37/176 (21%), Positives = 68/176 (38%), Gaps = 30/176 (17%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK----- 156
E+ D+ I R + QG F K+ +K YA+K K + KK
Sbjct: 23 VKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-------KFYALKKYEKSLLEKKRDFTK 75
Query: 157 ---------NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
+ D K E I+T + + + + ++Y+I +++ +
Sbjct: 76 SNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135
Query: 208 RQGI--------FREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHV 254
+ + ++++ S++H + I HRD+KP NILMD +G V
Sbjct: 136 YFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 23/172 (13%), Positives = 68/172 (39%), Gaps = 8/172 (4%)
Query: 98 ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN 157
++ ++E ++G + ++G+GAF +V++ + ++D + + +KV + +
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112
Query: 158 HVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-----YRQGIF 212
+ L ++ + ++ L+ + + G L + + +
Sbjct: 113 I---GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264
+ + ++ + +H C I+H D+KP+N ++ + S
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 43/185 (23%), Positives = 81/185 (43%), Gaps = 8/185 (4%)
Query: 73 GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP---GDFEIFRVVGQGAFGKVFQV 129
GP+P + +P + E + P + R +G+G F K F++
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 130 KKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189
D D+ ++A K++ K ++K + + M E I + H +V F+
Sbjct: 61 S-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF 115
Query: 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
++++L+ L R+ E +AR+Y +IV +LH+ ++HRDLK N+ ++
Sbjct: 116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175
Query: 250 SDGHV 254
D V
Sbjct: 176 EDLEV 180
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-44
Identities = 41/164 (25%), Positives = 85/164 (51%), Gaps = 12/164 (7%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DF++ ++G+G+F V++ + + A+K++ K + K V ++ E I
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAV 228
++ HP I++L F+ + +YL+L+ + G + +L R F E++AR + +I++ +
Sbjct: 66 CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV------MAAHSLNSHNQL 266
+LH GI+HRDL N+L+ + ++ +A H +
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-43
Identities = 37/145 (25%), Positives = 70/145 (48%), Gaps = 5/145 (3%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+ R +G+G F K F++ D D+ ++A K++ K ++K + + M E I
Sbjct: 15 RRYVRGRFLGKGGFAKCFEIS-----DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
+ H +V F+ ++++L+ L R+ E +AR+Y +IV
Sbjct: 70 RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
+LH+ ++HRDLK N+ ++ D V
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEV 154
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-42
Identities = 41/160 (25%), Positives = 79/160 (49%), Gaps = 25/160 (15%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DFE V+GQGAFG+V + + D YA+K +R + + + +E +L
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNA------LDSRYYAIKKIRH----TEEKLSTILSEVMLL 56
Query: 170 TKVTHPFIVQLRYSFQ-------------TRSKLYLILDFINGGHLFFHLYRQGIF-RED 215
+ H ++V+ ++ +S L++ +++ G L+ ++ + + + D
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ +I+ A+S++H GI+HRDLKP NI +D +V
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ + + ++GQGA VF+ + K + ++A+KV + ++ VD
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54
Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
E ++L K+ H IV+L T LI++F G L+ L E +
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
++V ++HL + GIVHR++KP NI+
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIG 148
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 12/154 (7%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ + + ++GQGA VF+ + K + ++A+KV + ++ VD
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRP--VDVQ 54
Query: 163 KAERDILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQG---IFREDQA 217
E ++L K+ H IV+L T LI++F G L+ L E +
Sbjct: 55 MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
++V ++HL + GIVHR++KP NI+
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIG 148
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 10/169 (5%)
Query: 89 QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKV 147
H + +L E+ + + +G+G+FGK VK DG Y +K
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKST------EDGRQYVIKE 56
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
+ + K + + E +L + HP IVQ R SF+ LY+++D+ GG LF +
Sbjct: 57 INISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN 115
Query: 208 RQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
Q +F+EDQ + +I A+ H+H I+HRD+K +NI + DG V
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTV 164
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-38
Identities = 47/150 (31%), Positives = 84/150 (56%), Gaps = 11/150 (7%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
F V+G GAF +VF VK++ + ++A+K ++K + + + + E +L
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPAFRDSSL---ENEIAVLK 61
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
K+ H IV L +++ + YL++ ++GG LF + +G++ E A +++SAV +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVMAA 257
LH+ GIVHRDLKPEN+L + + +M
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMIT 151
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 47/188 (25%), Positives = 80/188 (42%), Gaps = 18/188 (9%)
Query: 73 GPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
GP + E + +++ +G+GAF V + K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDN---------YDVKEELGKGAFSVVRRCVHK 51
Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYL 192
+ +A K++ + ++ ++ E I K+ HP IV+L S Q S YL
Sbjct: 52 -----TTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHPNIVRLHDSIQEESFHYL 105
Query: 193 ILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-- 250
+ D + GG LF + + + E A +I+ ++++ H GIVHR+LKPEN+L+ S
Sbjct: 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165
Query: 251 -DGHVMAA 257
V A
Sbjct: 166 KGAAVKLA 173
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-37
Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+++ +G+GAF V + K + +A K++ + ++ ++ E I K
Sbjct: 8 YDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSARDFQK-LEREARICRK 61
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP IV+L S Q S YL+ D + GG LF + + + E A +I+ ++++
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 232 HKCGIVHRDLKPENILMDS---DGHVMAA 257
H GIVHR+LKPEN+L+ S V A
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLA 150
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 10/148 (6%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
+ + I + +G G KVFQV + IYA+K + + + Y E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 76
Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
L K+ I++L T +Y++++ L L ++ + + Y
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 135
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD 251
++ AV +H+ GIVH DLKP N L+
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLIVDG 163
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 47/202 (23%), Positives = 81/202 (40%), Gaps = 21/202 (10%)
Query: 65 HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERK----------IGPGDFEI 114
H+ H G PR + E +H + +L + + K + + I
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSI 60
Query: 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH 174
+ +G G KVFQV + IYA+K + + + Y E L K+
Sbjct: 61 LKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-EIAYLNKLQQ 113
Query: 175 P--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
I++L T +Y++++ L L ++ + + Y ++ AV +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 233 KCGIVHRDLKPENILMDSDGHV 254
+ GIVH DLKP N L+ DG +
Sbjct: 173 QHGIVHSDLKPANFLIV-DGML 193
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-37
Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 7/155 (4%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
+ + KIG + + +G G FGKV K G + A+K++ + I + V
Sbjct: 3 KHDGRVKIGH--YVLGDTLGVGTFGKV----KIGEHQLTGHKV-AVKILNRQKIRSLDVV 55
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
+K E L HP I++L T + ++++++++GG LF ++ + G E +AR
Sbjct: 56 GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I+SAV + H+ +VHRDLKPEN+L+D+ +
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA 150
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-37
Identities = 45/140 (32%), Positives = 79/140 (56%), Gaps = 6/140 (4%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ I ++G+G+FG+V + K + + YA+KV+ K + K+ + E ++L K
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKNKD-TSTILREVELLKK 77
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP I++L + S Y++ + GG LF + ++ F E A ++ S ++++
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 232 HKCGIVHRDLKPENILMDSD 251
HK IVHRDLKPENIL++S
Sbjct: 138 HKHNIVHRDLKPENILLESK 157
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-37
Identities = 45/141 (31%), Positives = 79/141 (56%), Gaps = 5/141 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++ RV+G+G+FG+V K K + A+KV+ K + +K + + E +L
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKI-----TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
++ HP I++L F+ + YL+ + GG LF + + F E A +++S +++
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 231 LHKCGIVHRDLKPENILMDSD 251
+HK IVHRDLKPEN+L++S
Sbjct: 142 MHKNKIVHRDLKPENLLLESK 162
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 11/150 (7%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDI 168
+F I + +G+G F +V++ DG A+K ++ ++ E D+
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACL------LDGVPVALKKVQIFDLMDAKARADCIKEIDL 85
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEI 224
L ++ HP +++ SF ++L ++L+ + G L + + E Y ++
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
SA+ H+H ++HRD+KP N+ + + G V
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGVV 175
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-37
Identities = 38/151 (25%), Positives = 65/151 (43%), Gaps = 11/151 (7%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
+ + I + +G G KVFQV + IYA+K + + + Y E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRN-E 57
Query: 166 RDILTKVTHP--FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
L K+ I++L T +Y++++ L L ++ + + Y
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN 116
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ AV +H+ GIVH DLKP N L+ DG +
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLIV-DGML 146
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 46 HNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESER 105
H++ + + S + +L + + +D
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD--------- 53
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
FE+ +G+GA V++ K+KG + YA+KV + K ++ E
Sbjct: 54 -----FFEVESELGRGATSIVYRCKQKG-----TQKPYALKV-----LKKTVDKKIVRTE 98
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+L +++HP I++L+ F+T +++ L+L+ + GG LF + +G + E A +I+
Sbjct: 99 IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 226 SAVSHLHKCGIVHRDLKPENILM---DSDGHVMAA 257
AV++LH+ GIVHRDLKPEN+L D + A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 8/142 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
+E+ +G G F V + ++K + YA K ++K + + ++ E +I
Sbjct: 7 YEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
L ++ HP I+ L F+ ++ + LIL+ ++GG LF L + ED+A + +I+ V
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 229 SHLHKCGIVHRDLKPENILMDS 250
+LH I H DLKPENI++
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLD 143
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 8/142 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
++I +G G F V + ++K + YA K ++K + ++ E I
Sbjct: 14 YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
L +V HP I+ L ++ R+ + LIL+ ++GG LF L ++ E++A + +I+ V
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 229 SHLHKCGIVHRDLKPENILMDS 250
++LH I H DLKPENI++
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLD 150
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-36
Identities = 36/152 (23%), Positives = 77/152 (50%), Gaps = 9/152 (5%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ + +++ + +G+GA+G+V + V+ ++ A+K++ + + +
Sbjct: 2 AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
K E I + H +V+ + + YL L++ +GG LF + E A+ +
Sbjct: 53 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++++ V +LH GI HRD+KPEN+L+D ++
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNL 144
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 9/150 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++++F +G+GAF V + K + YA ++ + ++H ++ E I
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVL-----AGQEYAAMIINTKKLSARDHQK-LEREARICR 65
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ HP IV+L S YLI D + GG LF + + + E A +I+ AV H
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 231 LHKCGIVHRDLKPENILMDS---DGHVMAA 257
H+ G+VHR+LKPEN+L+ S V A
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLA 155
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
++I +G G F V + ++K + YA K ++K + ++ E I
Sbjct: 14 YDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
L +V H ++ L ++ R+ + LIL+ ++GG LF L ++ E++A + +I+ V
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 229 SHLHKCGIVHRDLKPENILMDS 250
++LH I H DLKPENI++
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLD 150
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 45/141 (31%), Positives = 79/141 (56%), Gaps = 6/141 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ I ++G+G+FG+V + K + + YA+KV+ K + K+ + E ++L
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRI-----TQQEYAVKVINKASAKNKD-TSTILREVELLK 76
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
K+ HP I++L + S Y++ + GG LF + ++ F E A ++ S +++
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITY 136
Query: 231 LHKCGIVHRDLKPENILMDSD 251
+HK IVHRDLKPENIL++S
Sbjct: 137 MHKHNIVHRDLKPENILLESK 157
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-36
Identities = 44/140 (31%), Positives = 76/140 (54%), Gaps = 8/140 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ + +G+G++G+V +KG + A K + K VD K E +I+
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKG-----TRIRRAAKKIPKY---FVEDVDRFKQEIEIMKS 62
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP I++L +F+ + +YL+++ GG LF + + +FRE A +++SAV++
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 232 HKCGIVHRDLKPENILMDSD 251
HK + HRDLKPEN L +D
Sbjct: 123 HKLNVAHRDLKPENFLFLTD 142
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 38/142 (26%), Positives = 71/142 (50%), Gaps = 8/142 (5%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH---VDYMKAERDI 168
++ +G G F V + ++K + YA K ++K + ++ E I
Sbjct: 13 YDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
L ++ HP ++ L ++ ++ + LIL+ + GG LF L + E++A + +I++ V
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127
Query: 229 SHLHKCGIVHRDLKPENILMDS 250
+LH I H DLKPENI++
Sbjct: 128 YYLHSLQIAHFDLKPENIMLLD 149
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-36
Identities = 35/145 (24%), Positives = 72/145 (49%), Gaps = 11/145 (7%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DIL 169
+E+ V+G+G F V + + ++ +A+K++ + +R I
Sbjct: 26 YELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIV 225
+ HP IV+L ++ + LY++ +F++G L F + ++ ++ E A Y +I+
Sbjct: 81 HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 226 SAVSHLHKCGIVHRDLKPENILMDS 250
A+ + H I+HRD+KP +L+ S
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLAS 165
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-36
Identities = 43/141 (30%), Positives = 78/141 (55%), Gaps = 6/141 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++ + +G GA+G+V + K + A+K++RK ++ ++ + E +L
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKV-----THVERAIKIIRKTSVSTSSNSK-LLEEVAVLK 91
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ HP I++L F+ + YL+++ GG LF + + F E A +++S V++
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTY 151
Query: 231 LHKCGIVHRDLKPENILMDSD 251
LHK IVHRDLKPEN+L++S
Sbjct: 152 LHKHNIVHRDLKPENLLLESK 172
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 53/243 (21%), Positives = 91/243 (37%), Gaps = 18/243 (7%)
Query: 26 SASSPDFDFT-EVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSL 84
+S D F E RH + + + + +
Sbjct: 7 HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKK--LNDA 64
Query: 85 PLQIQELEHENDAELEAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
+ E + E E +F + V+G+G V + + +
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-----ATG 119
Query: 141 GIYAMKVMRKDTIIKKNHV-----DYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLIL 194
+A+K+M + + E IL +V HP I+ L S+++ S ++L+
Sbjct: 120 HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179
Query: 195 DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
D + G LF +L + E + R ++ AVS LH IVHRDLKPENIL+D + +
Sbjct: 180 DLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI 239
Query: 255 MAA 257
+
Sbjct: 240 RLS 242
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-35
Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---- 167
+E ++G+G V + K + YA+K++ + + +
Sbjct: 19 YEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 168 --ILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
IL KV+ HP I+QL+ +++T + +L+ D + G LF +L + E + R +
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ + LHK IVHRDLKPENIL+D D ++
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDDMNIKLT 166
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 45/137 (32%), Positives = 72/137 (52%), Gaps = 12/137 (8%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H 174
+ +G+G+F + K S+ +A+K II K + E L H
Sbjct: 17 KPLGEGSFSICRKCVHK-----KSNQAFAVK------IISKRMEANTQKEITALKLCEGH 65
Query: 175 PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC 234
P IV+L F + +L+++ +NGG LF + ++ F E +A + ++VSAVSH+H
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125
Query: 235 GIVHRDLKPENILMDSD 251
G+VHRDLKPEN+L +
Sbjct: 126 GVVHRDLKPENLLFTDE 142
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 36/152 (23%), Positives = 77/152 (50%), Gaps = 9/152 (5%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+ + +++ + +G+GA+G+V + V+ ++ A+K++ + + +
Sbjct: 2 AVPFVED--WDLVQTLGEGAYGEV----QLAVNR-VTEEAVAVKIVDMKRAVD--CPENI 52
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
K E I + H +V+ + + YL L++ +GG LF + E A+ +
Sbjct: 53 KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH 112
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++++ V +LH GI HRD+KPEN+L+D ++
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDERDNL 144
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-35
Identities = 41/155 (26%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER---- 166
++ + + +G GA G+V ++ + A+K++ K + + A
Sbjct: 11 EYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 167 -DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+IL K+ HP I++++ F Y++L+ + GG LF + +E + Y +++
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 226 SAVSHLHKCGIVHRDLKPENILMDS---DGHVMAA 257
AV +LH+ GI+HRDLKPEN+L+ S D +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-35
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 11/144 (7%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F R +G GAFG V V+++ S +K + KD + ++ ++AE ++L
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERS-----SGLERVIKTINKDRS--QVPMEQIEAEIEVLKS 76
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF----FHLYRQGIFREDQARFYTAEIVSA 227
+ HP I+++ F+ +Y++++ GG L R E ++++A
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 228 VSHLHKCGIVHRDLKPENILMDSD 251
+++ H +VH+DLKPENIL
Sbjct: 137 LAYFHSQHVVHKDLKPENILFQDT 160
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-35
Identities = 53/158 (33%), Positives = 85/158 (53%), Gaps = 16/158 (10%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG--VDDGDSDGIYAMKVMRKDTIIKKNH 158
A+ + IG + + + +G+G F KV K + G A+K++ K + N
Sbjct: 8 ADEQPHIGN--YRLLKTIGKGNFAKV----KLARHILTGRE---VAIKIIDKT---QLNP 55
Query: 159 VDYMKAER--DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQ 216
K R I+ + HP IV+L +T LYLI+++ +GG +F +L G +E +
Sbjct: 56 TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE 115
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
AR +IVSAV + H+ IVHRDLK EN+L+D+D ++
Sbjct: 116 ARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNI 153
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-35
Identities = 38/151 (25%), Positives = 73/151 (48%), Gaps = 11/151 (7%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--- 166
+ +G GAFG V VD + + +K ++K+ +++ ++ K +
Sbjct: 24 QKYSTMSPLGSGAFGFV----WTAVDKEKNKEV-VVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 167 --DILTKVTHPFIVQLRYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAE 223
IL++V H I+++ F+ + L+++ +G LF + R E A + +
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+VSAV +L I+HRD+K ENI++ D +
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTI 169
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 37/150 (24%), Positives = 82/150 (54%), Gaps = 11/150 (7%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-MKAERDI 168
G + + ++G+G++GKV K V D ++ A+K+++K + + + + +K E +
Sbjct: 5 GKYLMGDLLGEGSYGKV-----KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQL 59
Query: 169 LTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGH--LFFHLYRQGIFREDQARFYTAEI 224
L ++ H ++QL + + K+Y+++++ G + + + F QA Y ++
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQL 118
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + +LH GIVH+D+KP N+L+ + G +
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTL 148
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-34
Identities = 35/156 (22%), Positives = 74/156 (47%), Gaps = 19/156 (12%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
D+E+ +G G++G+ ++++K SDG I K + ++ + + +E ++L
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRK------SDGKILVWKELDYGSMTEAE-KQMLVSEVNLL 59
Query: 170 TKVTHPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAE 223
++ HP IV+ R+ LY+++++ GG L + + E+ +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 224 IVSAVSHLHKCG-----IVHRDLKPENILMDSDGHV 254
+ A+ H+ ++HRDLKP N+ +D +V
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 155
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-34
Identities = 45/155 (29%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV 159
+ + KIG + + +G G FGKV K G + + A+K++ + I + V
Sbjct: 8 KHDGRVKIGH--YILGDTLGVGTFGKV----KVGKHELTGHKV-AVKILNRQKIRSLDVV 60
Query: 160 DYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF 219
++ E L HP I++L T S +++++++++GG LF ++ + G E ++R
Sbjct: 61 GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I+S V + H+ +VHRDLKPEN+L+D+ +
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA 155
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-34
Identities = 37/141 (26%), Positives = 61/141 (43%), Gaps = 10/141 (7%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ I +G+G FG V + + S Y K ++ K +K E IL
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKV----KGTDQVLVKKEISILNI 57
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
H I+ L SF++ +L +I +FI+G +F E + Y ++ A+
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 231 LHKCGIVHRDLKPENILMDSD 251
LH I H D++PENI+ +
Sbjct: 118 LHSHNIGHFDIRPENIIYQTR 138
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-34
Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 100 EAESERKIGPGDF----EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
++ + P + + +G GA G+V ++ + A++++ K
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAI 175
Query: 156 KNHVDYMKAER-----DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
+ + A +IL K+ HP I++++ F Y++L+ + GG LF +
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK 234
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+E + Y +++ AV +LH+ GI+HRDLKPEN+L+ S
Sbjct: 235 RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 65 HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
H+ H G PR + + + +L E++ +++ ++G G FG
Sbjct: 5 HHHHHHSSGLVPRGSHMAPCN-------DLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 57
Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM---KAERDILTKVTH--PFIVQ 179
V+ + V D A+K + KD I + E +L KV+ +++
Sbjct: 58 SVYSGIR--VSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 180 LRYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVH 238
L F+ LIL+ LF + +G +E+ AR + +++ AV H H CG++H
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 172
Query: 239 RDLKPENILMDSD 251
RD+K ENIL+D +
Sbjct: 173 RDIKDENILIDLN 185
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 37/142 (26%), Positives = 72/142 (50%), Gaps = 9/142 (6%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
++I +G GAFG V +V ++ + +A K + ++ + ++ E ++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERA-----TGNNFAAKFVMTP---HESDKETVRKEIQTMSV 210
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
+ HP +V L +F+ +++ +I +F++GG LF ED+A Y ++ + H
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 270
Query: 231 LHKCGIVHRDLKPENILMDSDG 252
+H+ VH DLKPENI+ +
Sbjct: 271 MHENNYVHLDLKPENIMFTTKR 292
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-34
Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 9/143 (6%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
++ + +G G FG + + D + + A+K + + I +N ++ E
Sbjct: 20 DRYDFVKDIGSGNFGVA-----RLMRDKLTKELVAVKYIERGAAIDEN----VQREIINH 70
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
+ HP IV+ + T + L +I+++ +GG L+ + G F ED+ARF+ +++S VS
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 230 HLHKCGIVHRDLKPENILMDSDG 252
+ H I HRDLK EN L+D
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSP 153
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-34
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 33/178 (18%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
++ + + +G+G++G V K ++ D+ YAMKV+ K +I++
Sbjct: 7 GDCVQLNQ--YTLKDEIGKGSYGVV----KLAYNENDNT-YYAMKVLSKKKLIRQAGFPR 59
Query: 162 MKAERD-----------------------ILTKVTHPFIVQLR--YSFQTRSKLYLILDF 196
R IL K+ HP +V+L LY++ +
Sbjct: 60 RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119
Query: 197 INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+N G + + EDQARFY +++ + +LH I+HRD+KP N+L+ DGH+
Sbjct: 120 VNQGPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHI 176
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 39/142 (27%), Positives = 73/142 (51%), Gaps = 9/142 (6%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
++I +G GAFG V + +K + ++ K + + K V K E I+ +
Sbjct: 53 YDILEELGSGAFGVVHRCVEKA-----TGRVFVAKFINTPYPLDKYTV---KNEISIMNQ 104
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSH 230
+ HP ++ L +F+ + ++ LIL+F++GG LF + + E + Y + + H
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 231 LHKCGIVHRDLKPENILMDSDG 252
+H+ IVH D+KPENI+ ++
Sbjct: 165 MHEHSIVHLDIKPENIMCETKK 186
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-34
Identities = 37/157 (23%), Positives = 61/157 (38%), Gaps = 16/157 (10%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
I + + +G+G F V V+ YA+K + ++ + + E
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCH---EQQDREEAQRE 76
Query: 166 RDILTKVTHPFIVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ----GIFREDQA 217
D+ HP I++L + +L+L F G L+ + R EDQ
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ I + +H G HRDLKP NIL+ +G
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP 173
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-34
Identities = 47/154 (30%), Positives = 84/154 (54%), Gaps = 8/154 (5%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
A S+R IGP + I +G+G+FGKV K + A+K + + + K +
Sbjct: 2 AISKRHIGP--YIIRETLGEGSFGKV----KLATHYKTQQKV-ALKFISRQLLKKSDMHM 54
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
++ E L + HP I++L T + + +++++ GG LF ++ + ED+ R +
Sbjct: 55 RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I+ A+ + H+ IVHRDLKPEN+L+D + +V
Sbjct: 114 FQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNV 147
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-34
Identities = 41/183 (22%), Positives = 72/183 (39%), Gaps = 47/183 (25%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER--DI 168
+ + +GQG++G V + + I A+K+M K+ I + N D + + +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRL 81
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG------------------ 210
+ K+ HP I +L ++ + L+++ +GGHL L
Sbjct: 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 211 ----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248
+ RE +I SA+ +LH GI HRD+KPEN L
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF 201
Query: 249 DSD 251
++
Sbjct: 202 STN 204
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 7e-34
Identities = 39/139 (28%), Positives = 69/139 (49%), Gaps = 9/139 (6%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
V+G+GA +V + YA+K++ K + + E ++L + H
Sbjct: 20 VLGEGAHARVQTCINLI-----TSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHR 71
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
+++L F+ + YL+ + + GG + H++++ F E +A ++ SA+ LH G
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 236 IVHRDLKPENILMDSDGHV 254
I HRDLKPENIL + V
Sbjct: 132 IAHRDLKPENILCEHPNQV 150
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------KNHVD 160
+ R +G GA+G+V K+K A+KV++K K + +
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKN-----GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
+ E +L + HP I++L F+ + YL+ +F GG LF + + F E A
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI 151
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+I+S + +LHK IVHRD+KPENIL+++
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENK 182
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-34
Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 13/142 (9%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+E+ +G G++ + K ++ +A+K II K+ D E +IL
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVK------IIDKSKRD-PTEEIEILL 70
Query: 171 KVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
+ HP I+ L+ + +Y++ + + GG L + RQ F E +A I V
Sbjct: 71 RYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVE 130
Query: 230 HLHKCGIVHRDLKPENILMDSD 251
+LH G+VHRDLKP NIL +
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDE 152
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 36/163 (22%), Positives = 64/163 (39%), Gaps = 32/163 (19%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAERDIL 169
DF+ ++G G FG+VF+ K + DG Y +K ++ + + + E L
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHR------IDGKTYVIKRVKYNN-------EKAEREVKAL 58
Query: 170 TKVTHPFIVQLRYSFQ----------------TRSKLYLILDFINGGHLFFHL--YRQGI 211
K+ H IV + L++ ++F + G L + R
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ A +I V ++H +++RDLKP NI + V
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV 161
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
G +E+ +G G FG V + + D+ A+K R++ K + + E I+
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQELSPK--NRERWCLEIQIM 66
Query: 170 TKVTHPFIVQLRYSFQTRSKL------YLILDFINGGHLFFHLY---RQGIFREDQARFY 220
K+ HP +V R KL L +++ GG L +L +E R
Sbjct: 67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
++I SA+ +LH+ I+HRDLKPENI++
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-33
Identities = 45/179 (25%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 81 SSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSD 140
+ PLQ +R+ ++ + ++G+G FG VF + + D
Sbjct: 2 MLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHR--LTDRLQ- 58
Query: 141 GIYAMKVMRKDTIIKKNHVDYM---KAERDILTKV----THPFIVQLRYSFQTRSKLYLI 193
A+KV+ ++ ++ + + E +L KV HP +++L F+T+ L+
Sbjct: 59 --VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116
Query: 194 LDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
L+ + LF ++ +G E +R + ++V+A+ H H G+VHRD+K ENIL+D
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLR 175
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-33
Identities = 32/158 (20%), Positives = 64/158 (40%), Gaps = 9/158 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+F +G G FG VF+ K+ DG IYA+K +K + + ++
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKR--LDGC---IYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGG----HLFFHLYRQGIFREDQARFYTAEIVS 226
H +V+ ++ + + ++ NGG + + F+E + + ++
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 227 AVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264
+ ++H +VH D+KP NI + AA +
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 32/141 (22%), Positives = 71/141 (50%), Gaps = 9/141 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++G G FG+V + ++ + A K+++ + +K E ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETA-----TGLKLAAKIIKTR---GMKDKEEVKNEISVMN 141
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVS 229
++ H ++QL +F++++ + L++++++GG LF + + E + +I +
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 230 HLHKCGIVHRDLKPENILMDS 250
H+H+ I+H DLKPENIL +
Sbjct: 202 HMHQMYILHLDLKPENILCVN 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 17/177 (9%)
Query: 92 EHENDAELEAESERKIGPGDFEIF-----RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
H + +L E+ +F F + +G+G F V Q K + YA K
Sbjct: 6 HHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-----STGQEYAAK 60
Query: 147 VMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFH 205
++K + + + E +L P ++ L ++ S++ LIL++ GG +F
Sbjct: 61 FLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSL 119
Query: 206 LY--RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAA 257
+ E+ +I+ V +LH+ IVH DLKP+NIL+ G +
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 37/248 (14%), Positives = 71/248 (28%), Gaps = 43/248 (17%)
Query: 46 HNNQSPASTSASLGDP-----QVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELE 100
H++ S + P + + NR + + S+ +
Sbjct: 4 HHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFR 63
Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
ESE P V+GQ + + + G+ + + V N +
Sbjct: 64 VESELGERPRTLVRGTVLGQEDPYAYLEATDQ--ETGE---SFEVHVPYFTERPPSNAIK 118
Query: 161 YMKAER-------------------------DILTKVTHPFIVQLRYSFQTRSKLYLIL- 194
MK E D++ ++++R + L
Sbjct: 119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 195 -------DFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
G L H T +++ ++ LH G+VH L+P +I+
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238
Query: 248 MDSDGHVM 255
+D G V
Sbjct: 239 LDQRGGVF 246
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-31
Identities = 41/201 (20%), Positives = 81/201 (40%), Gaps = 14/201 (6%)
Query: 52 ASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD 111
S S S G + + + ++ S + E + + E +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETED-NEGVLLTEKLKPVDYEYREEVHW 59
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
VG+G+FG+V + D + A+K +R + + E
Sbjct: 60 MTHQPRVGRGSFGEVH----RMKD-KQTGFQCAVKKVRLEVFRVE--------ELVACAG 106
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
++ P IV L + + + + ++ + GG L + + G ED+A +Y + + + +L
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL 166
Query: 232 HKCGIVHRDLKPENILMDSDG 252
H I+H D+K +N+L+ SDG
Sbjct: 167 HTRRILHGDVKADNVLLSSDG 187
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 43/162 (26%), Positives = 64/162 (39%), Gaps = 28/162 (17%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-IYAMKVMRKDTIIKKNHVDYMKAER--D 167
DFE + +G+G FG VF+ K K D YA+K +R + + K R
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNK------VDDCNYAIKRIR----LPNRELAREKVMREVK 55
Query: 168 ILTKVTHPFIVQLRYSF------------QTRSKLYLILDFINGGHLFFHLYRQG---IF 212
L K+ HP IV+ ++ + LY+ + +L + +
Sbjct: 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 213 REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I AV LH G++HRDLKP NI D V
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 44/211 (20%), Positives = 90/211 (42%), Gaps = 25/211 (11%)
Query: 48 NQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKI 107
+ S + + + P P P Q + ++ +++ +
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID- 61
Query: 108 GPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
D+++ +V+G G GKV Q+ K + +A+K+++ ++ E
Sbjct: 62 ---DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EV 105
Query: 167 DILTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARF 219
++ + + P IV++ ++ R L ++++ ++GG LF + +G F E +A
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 165
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
I A+ +LH I HRD+KPEN+L S
Sbjct: 166 IMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 39/148 (26%), Positives = 74/148 (50%), Gaps = 21/148 (14%)
Query: 111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
D+++ +V+G G GKV Q+ K + +A+K+++ ++ E ++
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKR-----TQEKFALKMLQDCPKARR--------EVELH 64
Query: 170 TKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTA 222
+ + P IV++ ++ R L ++++ ++GG LF + +G F E +A
Sbjct: 65 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 124
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDS 250
I A+ +LH I HRD+KPEN+L S
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTS 152
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 38/161 (23%), Positives = 64/161 (39%), Gaps = 15/161 (9%)
Query: 94 ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
E D E S +G F V+G GA G + +G+ D A+K
Sbjct: 8 EQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIV---YRGMFDNRD---VAVK------R 55
Query: 154 IKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI- 211
I + E +L + HP +++ + + R Y+ ++ L ++ ++
Sbjct: 56 ILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+ + S ++HLH IVHRDLKP NIL+
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 37/141 (26%), Positives = 64/141 (45%), Gaps = 20/141 (14%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP 175
V+G G GKV + + + A+K++ ++ E D + + P
Sbjct: 36 VLGLGVNGKVLECFHRR-----TGQKCALKLLYDSPKARQ--------EVDHHWQASGGP 82
Query: 176 FIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVS 229
IV + ++ + L +I++ + GG LF + +G F E +A +I +A+
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 230 HLHKCGIVHRDLKPENILMDS 250
LH I HRD+KPEN+L S
Sbjct: 143 FLHSHNIAHRDVKPENLLYTS 163
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 21/161 (13%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+++G G+ G V +G G A+K + + D E +LT+
Sbjct: 17 VVSEKILGYGSSGTV---VFQGSFQGRP---VAVK------RMLIDFCDIALMEIKLLTE 64
Query: 172 VT-HPFIVQLRYSFQTRSKLYLILDFINGGHLF-------FHLYRQGIFREDQARFYTAE 223
HP +++ S T LY+ L+ N L + +E +
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCNLN-LQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264
I S V+HLH I+HRDLKP+NIL+ + A + N
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN 164
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 28/210 (13%), Positives = 62/210 (29%), Gaps = 42/210 (20%)
Query: 96 DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK 155
+AE +S G ++ + G VF V+ + +A+KV
Sbjct: 48 NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENS 102
Query: 156 KNHVDYMKAERDILTKVTHPFIVQLR--------------------------YSFQTRSK 189
++ ++ + ++ + R +
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 190 LYLILDFING------GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKP 243
L++ + L F +G TA+++ ++L G+VH P
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTP 222
Query: 244 ENILMDSDGHVM-----AAHSLNSHNQLCC 268
+N+ + DG +M A + +
Sbjct: 223 DNLFIMPDGRLMLGDVSALWKVGTRGPASS 252
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 40/162 (24%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
++G + RV+ +G F V++ + D S YA+K + + ++ + E
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQ-----DVGSGREYALKRLLSN---EEEKNRAIIQE 75
Query: 166 RDILTKVT-HPFIVQLRYSF-------QTRSKLYLILDFINGGHLFFHLYR---QGIFRE 214
+ K++ HP IVQ + T +L+L + G L L + +G
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 215 DQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHV 254
D + AV H+H+ I+HRDLK EN+L+ + G +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 34/225 (15%), Positives = 64/225 (28%), Gaps = 38/225 (16%)
Query: 64 IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAF 123
+ NR + + S+ + ESE P V+GQ
Sbjct: 32 LFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDP 91
Query: 124 GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER----------------- 166
+ D ++ + + V N + MK E
Sbjct: 92 YAYLEAT-----DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146
Query: 167 --------DILTKVTHPFIVQLRYSFQTRSKLYLILDFIN--------GGHLFFHLYRQG 210
D++ ++++R + L + G L H
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
T +++ ++ LH G+VH L+P +I++D G V
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVF 251
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 100 EAESERKIGPGDFEIFR-----VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
E + E + D+E V+G+G +G V+ G D + A+K + +
Sbjct: 7 EGDCESDLLEYDYEYDENGDRVVLGKGTYGIVY----AGRD-LSNQVRIAIKEIPER--- 58
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQGI 211
+ + E + + H IVQ SF + + ++ + GG L +
Sbjct: 59 DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK 118
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHV 254
E FYT +I+ + +LH IVHRD+K +N+L+++ G +
Sbjct: 119 DNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL 162
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 40/164 (24%), Positives = 81/164 (49%), Gaps = 9/164 (5%)
Query: 92 EHENDAELEAESERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
+ L K P + F +G+G+FG+VF KG+D+ + + A+K++
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVF----KGIDN-RTQKVVAIKIIDL 57
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
+ ++ ++ ++ E +L++ P++ + S+ +KL++I++++ GG L G
Sbjct: 58 EEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPG 114
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
E Q EI+ + +LH +HRD+K N+L+ G V
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV 158
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 46/201 (22%), Positives = 91/201 (45%), Gaps = 31/201 (15%)
Query: 64 IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGD----FEIFRVVG 119
+H+ H G + +L Q + HE + +A + GD + + +G
Sbjct: 1 MHHHHHHSSGVDLG---TENLYFQSGVVTHE---QFKAALRMVVDQGDPRLLLDSYVKIG 54
Query: 120 QGAFGKVFQVKKKGVDDGDSDGIYAMKVM------RKDTIIKKNHVDYMKAERDILTKVT 173
+G+ G V ++K S A+K+M R++ + E I+
Sbjct: 55 EGSTGIVCLAREK-----HSGRQVAVKMMDLRKQQRRELLFN---------EVVIMRDYQ 100
Query: 174 HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK 233
H +V++ S+ +L+++++F+ GG L + Q E+Q ++ A+++LH
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 234 CGIVHRDLKPENILMDSDGHV 254
G++HRD+K ++IL+ DG V
Sbjct: 160 QGVIHRDIKSDSILLTLDGRV 180
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 5/143 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F R +G G+FG V+ D + + A+K M + E L K
Sbjct: 56 FSDLREIGHGSFGAVY----FARDV-RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP +Q R + +L++++ G + +E + T + +++L
Sbjct: 111 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H ++HRD+K NIL+ G V
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLV 193
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-24
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY 161
+ D E +G G G+V++++ + + + A+K MR+ K
Sbjct: 17 GQRYQAEINDLENLGEMGSGTCGQVWKMRFRK-----TGHVIAVKQMRRS--GNKEENKR 69
Query: 162 MKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
+ + D++ K P+IVQ +F T + +++ ++ + QG E
Sbjct: 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKM 129
Query: 221 TAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHV 254
T IV A+ +L K G++HRD+KP NIL+D G +
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI 164
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 41/170 (24%), Positives = 75/170 (44%), Gaps = 25/170 (14%)
Query: 95 NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM-- 148
+D E+ + + GD + F +GQGA G V+ + A++ M
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55
Query: 149 ----RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
+K+ II E ++ + +P IV S+ +L+++++++ GG L
Sbjct: 56 QQQPKKELIIN---------EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT- 105
Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + E Q E + A+ LH ++HRD+K +NIL+ DG V
Sbjct: 106 DVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 155
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-24
Identities = 43/144 (29%), Positives = 75/144 (52%), Gaps = 9/144 (6%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+EI +G GAFGKV++ K K ++ + A KV+ + ++ E +IL
Sbjct: 21 WEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVI---ETKSEEELEDYIVEIEILAT 72
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIVSAVSH 230
HP+IV+L ++ KL+++++F GG + L E Q + +++ A++
Sbjct: 73 CDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LH I+HRDLK N+LM +G +
Sbjct: 133 LHSKRIIHRDLKAGNVLMTLEGDI 156
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-24
Identities = 41/166 (24%), Positives = 73/166 (43%), Gaps = 15/166 (9%)
Query: 97 AELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK 156
+E + I D+E+ V+G GA V A+K + + +
Sbjct: 2 SEDSSALPWSINRDDYELQEVIGSGATAVVQ----AAYCA-PKKEKVAIKRINLEKC--Q 54
Query: 157 NHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG---HLFFHLYRQ---- 209
+D + E +++ HP IV SF + +L+L++ ++GG + H+ +
Sbjct: 55 TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK 114
Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
G+ E E++ + +LHK G +HRD+K NIL+ DG V
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV 160
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 8e-23
Identities = 37/170 (21%), Positives = 73/170 (42%), Gaps = 13/170 (7%)
Query: 91 LEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
+E ++ E D + +G+GA+G V ++ K S I A+K +R
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRS 57
Query: 151 DTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF----H 205
+ + + + D++ + P+IVQ + ++ ++ ++ F +
Sbjct: 58 T--VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVY 115
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHV 254
+ E+ T V A++HL I+HRD+KP NIL+D G++
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNI 165
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 1e-22
Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 14/174 (8%)
Query: 89 QELEHENDAELEAESERKIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
+ + ++ ELE ++ G F F +G+G+F V+ KG+D + A
Sbjct: 4 RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVY----KGLDTETTV-EVAWCE 58
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF----QTRSKLYLILDFINGGHLF 203
+ +D + K+ K E ++L + HP IV+ S+ + + + L+ + + G L
Sbjct: 59 L-QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHV 254
+L R + + R + +I+ + LH I+HRDLK +NI + G V
Sbjct: 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV 171
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 44/176 (25%), Positives = 81/176 (46%), Gaps = 15/176 (8%)
Query: 87 QIQELEHENDAELEAESERKIG-------PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
+++ELE + E+ DFE +G G G VF+V K S
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP-----S 57
Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
+ A K++ + IK + + E +L + P+IV +F + ++ + ++ ++G
Sbjct: 58 GLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHV 254
G L L + G E + ++ +++L K I+HRD+KP NIL++S G +
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-22
Identities = 35/174 (20%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 82 SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
S +Q++ +L+ +S K F++ +G+G++G V++ K ++
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQ 55
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
I A+K + ++ +++ + E I+ + P +V+ S+ + L++++++ G
Sbjct: 56 IVAIKQVPVESDLQE-----IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110
Query: 202 LF-FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ R ED+ + + +LH +HRD+K NIL++++GH
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHA 164
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 8e-22
Identities = 41/195 (21%), Positives = 85/195 (43%), Gaps = 24/195 (12%)
Query: 65 HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
H+ H P Y + ++ L Q + +++ I D I +G G+FG
Sbjct: 3 HHHHHH---PMSDYDIPTTENLYFQGAM--DGDDMD------IPWCDLNIKEKIGAGSFG 51
Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184
V + + G D A+K++ + + ++++ E I+ ++ HP IV +
Sbjct: 52 TVHRAEWHGSD-------VAVKILMEQDFHAERVNEFLR-EVAIMKRLRHPNIVLFMGAV 103
Query: 185 QTRSKLYLILDFINGGHLFFHLYRQGIFRE---DQARFYTAEIVSAVSHLHKCG--IVHR 239
L ++ ++++ G L+ L++ G + + ++ +++LH IVHR
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 240 DLKPENILMDSDGHV 254
+LK N+L+D V
Sbjct: 164 NLKSPNLLVDKKYTV 178
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 33/166 (19%), Positives = 66/166 (39%), Gaps = 10/166 (6%)
Query: 93 HENDAELEAESERKIGPGDFEIFRVVGQGA--FGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
H + + S G +E+ V+G+G V + K + ++ +
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP-----TGEYVTVRRINL 62
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF--FHLYR 208
+ V +++ E + HP IV R +F ++L+++ F+ G +
Sbjct: 63 EAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121
Query: 209 QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
E + ++ A+ ++H G VHR +K +IL+ DG V
Sbjct: 122 MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKV 167
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-21
Identities = 36/154 (23%), Positives = 68/154 (44%), Gaps = 12/154 (7%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
++ D E +G+GA+G V +++ S I A+K +R + + +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRAT--VNSQEQKRLLMD 55
Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFF---HLYRQGIFREDQARFYT 221
DI + PF V + +++ ++ ++ F + + ED
Sbjct: 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIA 115
Query: 222 AEIVSAVSHLH-KCGIVHRDLKPENILMDSDGHV 254
IV A+ HLH K ++HRD+KP N+L+++ G V
Sbjct: 116 VSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV 149
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-21
Identities = 39/154 (25%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
G FE+ +VG G +G+V+ KG + + A+KVM + + + +K E ++L
Sbjct: 24 GIFELVELVGNGTYGQVY----KGRHV-KTGQLAAIKVMD----VTGDEEEEIKQEINML 74
Query: 170 TKV-THPFIVQLRYSF------QTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFY 220
K H I +F +L+L+++F G + + +E+ +
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI 134
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
EI+ +SHLH+ ++HRD+K +N+L+ + V
Sbjct: 135 CREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-21
Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
S I + E+ VVG+GAFG V + K + D A+K + ++ K ++
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKD-------VAIKQIESESERK----AFI 49
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
E L++V HP IV+L + + + L++++ GG L+ L+ A +
Sbjct: 50 V-ELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 223 ---EIVSAVSHLHKC---GIVHRDLKPENILMDSDGHV 254
+ V++LH ++HRDLKP N+L+ + G V
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-21
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 92 EHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD 151
H + +A + +I G + + +G G+FG V+ KG GD A+K++
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVY----KGKWHGD----VAVKMLNVT 57
Query: 152 TIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
+ + K E +L K H I+ + T +L ++ + G L+ HL+
Sbjct: 58 APTPQQLQAF-KNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASET 115
Query: 212 -FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
F + + + +LH I+HRDLK NI + D V
Sbjct: 116 KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTV 159
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-20
Identities = 33/153 (21%), Positives = 63/153 (41%), Gaps = 9/153 (5%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
R P D V+G+G FG+ +V + + + MK + + +
Sbjct: 3 PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRE-----TGEVMVMKELIRFD---EETQRTF 54
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYT 221
E ++ + HP +++ +L I ++I GG L + + Q +
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I S +++LH I+HRDL N L+ + +V
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNV 147
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-20
Identities = 35/197 (17%), Positives = 57/197 (28%), Gaps = 53/197 (26%)
Query: 111 DFEIFRVVGQGAFGKVFQVK----------KK---------------------------- 132
DFE + +G+G FG VF+ K K+
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 133 ------------GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
+ D I+ + + +D + + + V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIF---REDQARFYTAEIVSAVSHLHKCGIV 237
+ LY+ + +L + R+ +I AV LH G++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 238 HRDLKPENILMDSDGHV 254
HRDLKP NI D V
Sbjct: 187 HRDLKPSNIFFTMDDVV 203
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 9e-20
Identities = 35/172 (20%), Positives = 66/172 (38%), Gaps = 32/172 (18%)
Query: 100 EAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
A SE + + ++ ++G+G +G V++ G D A+KV +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYK--------GSLDERPVAVKVF------SFAN 48
Query: 159 VDYMKAERDI--LTKVTHPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGI 211
E++I + + H I + R + R + L++++ G L +L
Sbjct: 49 RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS 108
Query: 212 FREDQARFYTAEIVSAVSHLH---------KCGIVHRDLKPENILMDSDGHV 254
R + +++LH K I HRDL N+L+ +DG
Sbjct: 109 DWVSSCRL-AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 11/149 (7%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I EI ++G+G FG+V+ G G+ A++++ + + + K E
Sbjct: 30 IPFEQLEIGELIGKGRFGQVY----HGRWHGE----VAIRLIDIERDNEDQLKAF-KREV 80
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIV 225
+ H +V + + L +I G L+ + I ++ R EIV
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +LH GI+H+DLK +N+ D +G V
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFYD-NGKV 168
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 31/171 (18%), Positives = 63/171 (36%), Gaps = 28/171 (16%)
Query: 96 DAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-------AMKVM 148
+E + + E + +G+G FG V + G A+K +
Sbjct: 5 GSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHK------------GRLVKDKSVVAIKSL 52
Query: 149 RKDTIIKKNHVDYM----KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFF 204
+ + + E I++ + HP IV+L + ++++F+ G L+
Sbjct: 53 ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYH 110
Query: 205 HLYRQGIFREDQARFYTA-EIVSAVSHLHKCG--IVHRDLKPENILMDSDG 252
L + + + +I + ++ IVHRDL+ NI + S
Sbjct: 111 RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLD 161
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-19
Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 10/146 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
+E +G+G++G VF+ + + D+ I A+K + + + V A R+I
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLES---EDDPVIKKIALREIRM 55
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
L ++ HP +V L F+ + +L+L+ ++ + L Q E + T + + AV
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
+ HK +HRD+KPENIL+ +
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVI 141
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-19
Identities = 37/158 (23%), Positives = 63/158 (39%), Gaps = 28/158 (17%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
D + VG+G +G+V++ +G + A+K I E ++
Sbjct: 9 DITLLECVGKGRYGEVWRGSWQGEN-------VAVK------IFSSRDEKSWFRETELYN 55
Query: 169 LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
+ H I+ S + ++L+LI + G L+ +L + R I
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSI 114
Query: 225 VSAVSHLH--------KCGIVHRDLKPENILMDSDGHV 254
S ++HLH K I HRDLK +NIL+ +G
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC 152
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 9e-19
Identities = 33/158 (20%), Positives = 72/158 (45%), Gaps = 33/158 (20%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
+F+ +G+G +G V++ + + + + A+K +R + E +
Sbjct: 4 NFQKVEKIGEGTYGVVYKAR-----NKLTGEVVALKKIR------------LDTETEGVP 46
Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQ 216
+L ++ HP IV+L T +KLYL+ +F++ F
Sbjct: 47 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPL 104
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ Y +++ ++ H ++HRDLKP+N+L++++G +
Sbjct: 105 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI 142
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ +V+G G+FG V+Q K DS + A+K + +D + E I+ K
Sbjct: 56 YTDTKVIGNGSFGVVYQAK-----LCDSGELVAIKKVLQDK-------RFKNRELQIMRK 103
Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFINGG-HLFFHLYRQG--IFREDQARFYTA 222
+ H IV+LRY F + L L+LD++ + Y + + Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ +++++H GI HRD+KP+N+L+D D V
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-18
Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 26/161 (16%)
Query: 106 KIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
++ PGD +E+ + G G ++ +D + +K + +
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIY----LALDRNVNGRPVVLKGLVHS-----GDAE 121
Query: 161 YMK---AERDILTKVTHPFIVQLRYSF------QTRSKLYLILDFINGGHLFFHLYRQGI 211
AER L +V HP IVQ+ ++F Y++++++ G L +
Sbjct: 122 AQAMAMAERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQK 178
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+A Y EI+ A+S+LH G+V+ DLKPENI++ +
Sbjct: 179 LPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ 219
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 37/146 (25%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
+E +VG+G++G V + + K D+ I A+K + + + A R+I
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLES---DDDKMVKKIAMREIKL 77
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
L ++ H +V L + + + YL+ +F++ L + Y +I++ +
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
H I+HRD+KPENIL+ G V
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVV 163
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 30/158 (18%), Positives = 70/158 (44%), Gaps = 35/158 (22%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
+ +G+G +G V++ + +A+K +R ++ E +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIR------------LEKEDEGIP 44
Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
IL ++ H IV+L T+ +L L+ + ++ L +G
Sbjct: 45 STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC---EGGLESVT 101
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
A+ + ++++ +++ H ++HRDLKP+N+L++ +G +
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 31/184 (16%), Positives = 64/184 (34%), Gaps = 31/184 (16%)
Query: 88 IQELEHENDAELEAESER-KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMK 146
+ H + + ++ +E ++ V +G FG V++ + A+K
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-------VAVK 53
Query: 147 VMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGG 200
+ + E ++ L + H I+Q + L+LI F G
Sbjct: 54 IF------PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107
Query: 201 HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH----------KCGIVHRDLKPENILMDS 250
L L + + + +++LH K I HRD+K +N+L+ +
Sbjct: 108 SLSDFLKANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166
Query: 251 DGHV 254
+
Sbjct: 167 NLTA 170
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 3e-18
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 28/162 (17%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
++ + +G+G +G+V+ K +G A+K + E
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEK-------VAVK------VFFTTEEASWFRET 80
Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
+I + H I+ + ++LYLI D+ G L+ +L + + +
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKL- 139
Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHV 254
VS + HLH K I HRDLK +NIL+ +G
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-18
Identities = 39/162 (24%), Positives = 64/162 (39%), Gaps = 28/162 (17%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ +G+G FG+V++ K +G + A+K I E
Sbjct: 39 TIARTIVLQESIGKGRFGEVWRGKWRGEE-------VAVK------IFSSREERSWFREA 85
Query: 167 DI--LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
+I + H I+ T ++L+L+ D+ G LF +L R + E +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL- 144
Query: 221 TAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHV 254
S ++HLH K I HRDLK +NIL+ +G
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 36/152 (23%), Positives = 67/152 (44%), Gaps = 22/152 (14%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ +V+G G+FG VFQ K A+K + +D + E I+
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLV------ESDEVAIKKVLQDK-------RFKNRELQIMRI 88
Query: 172 VTHPFIVQLRYSFQTRS------KLYLILDFING---GHLFFHLYRQGIFREDQARFYTA 222
V HP +V L+ F + L L+L+++ + + + Y
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++ +++++H GI HRD+KP+N+L+D V
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV 180
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-18
Identities = 30/159 (18%), Positives = 69/159 (43%), Gaps = 26/159 (16%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
F+ +G G + V++ + + A+K ++ D T I+
Sbjct: 6 QFKQLEKLGNGTYATVYKGL-----NKTTGVYVALKEVKLDSEEGTPSTAIR-------- 52
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHL--FFHLYRQGIFREDQAR 218
E ++ ++ H IV+L T +KL L+ +F++ ++ + +
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
++ +++ ++ H+ I+HRDLKP+N+L++ G +
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLG 150
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 7e-18
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 35/158 (22%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
++ VG+G +G V++ K I A+K +R + AE +
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIR------------LDAEDEGIP 63
Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
+L ++ HP IV L + L L+ +F+ L + + ++ Q
Sbjct: 64 STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQ 120
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ Y +++ V+H H+ I+HRDLKP+N+L++SDG +
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGAL 158
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 8e-18
Identities = 31/158 (19%), Positives = 68/158 (43%), Gaps = 34/158 (21%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
+E +G+G +G VF+ K + ++ I A+K +R + + +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAK-----NRETHEIVALKRVR------------LDDDDEGVP 45
Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQ 216
+L ++ H IV+L + KL L+ +F + + G +
Sbjct: 46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEI 102
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + +++ + H ++HRDLKP+N+L++ +G +
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL 140
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-17
Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 22/157 (14%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
+E +G+GA+GKVF K D + A+K +R T + + + R++
Sbjct: 12 QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQT--GEEGMP-LSTIREVAV 64
Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
L HP +V+L +KL L+ + ++ + + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--QDLTTYLDKVPEPGVPTETI 122
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +++ + LH +VHRDLKP+NIL+ S G +
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 23/154 (14%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
+E +G+G F V++ + K +++ I A+K K IK H K A
Sbjct: 11 RYEKLDFLGEGQFATVYKARDK-----NTNQIVAIK---K---IKLGHRSEAKDGINRTA 59
Query: 165 ERDI--LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGI-FREDQARFY 220
R+I L +++HP I+ L +F +S + L+ DF+ L + + + Y
Sbjct: 60 LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME--TDLEVIIKDNSLVLTPSHIKAY 117
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + +LH+ I+HRDLKP N+L+D +G +
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVL 151
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 26/154 (16%), Positives = 57/154 (37%), Gaps = 14/154 (9%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I + + G++++ + +G D +KV++ + D+ + E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGND-------IVVKVLKVRDWSTRKSRDFNE-EC 58
Query: 167 DILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED--QARFYTA 222
L +HP ++ + LI ++ G L+ L+ F D QA +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 223 EIVSAVSHLHKCG--IVHRDLKPENILMDSDGHV 254
++ ++ LH I L ++++D D
Sbjct: 119 DMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTA 152
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 39/151 (25%), Positives = 65/151 (43%), Gaps = 12/151 (7%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAE 165
I + + ++G G FGKV++ G + A+K R D ++ ++ E
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDE-------VAVKAARHDPDEDISQTIENVRQE 56
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+ + HP I+ LR L L+++F GG L L + I D + +I
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-PPDILVNWAVQIA 115
Query: 226 SAVSHLHKCG---IVHRDLKPENILMDSDGH 253
+++LH I+HRDLK NIL+
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 20/157 (12%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-- 168
+E +G GA+G V++ + D S A+K +R + R++
Sbjct: 10 RYEPVAEIGVGAYGTVYKAR-----DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 169 ---LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGH---LFFHLYRQGIFREDQA 217
L HP +V+L K+ L+ + ++ + +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--QDLRTYLDKAPPPGLPAETI 122
Query: 218 RFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + + + LH IVHRDLKPENIL+ S G V
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-17
Identities = 26/154 (16%), Positives = 65/154 (42%), Gaps = 31/154 (20%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
+ +G+G +G+V++ ++ A+K +R ++ E +
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIR------------LEHEEEGVP 77
Query: 168 --------ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQAR 218
+L ++ H I++L+ +L+LI ++ + L ++ + +
Sbjct: 78 GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE--NDLKKYMDKNPDVSMRVIK 135
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+ ++++ V+ H +HRDLKP+N+L+
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD 169
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-17
Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 5/145 (3%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
++I +G G V+ + D + A+K + K+ + + E
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAE-----DTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
++++H IV + + YL++++I G L ++ G D A +T +I+ +
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
H H IVHRD+KP+NIL+DS+ +
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTL 150
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 9e-17
Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
G + + R+VG+G G V++ + D + I A+K+M + M+ E
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAE-----DTVRERIVALKLMSETLSSDPVFRTRMQREARTA 88
Query: 170 TKVTHPFIVQLRYSF-QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
++ P +V + + F + +LY+ + ING L L RQG +A +I SA+
Sbjct: 89 GRLQEPHVVPI-HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSAL 147
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
H G HRD+KPENIL+ +D
Sbjct: 148 DAAHAAGATHRDVKPENILVSADDFA 173
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 32/154 (20%), Positives = 68/154 (44%), Gaps = 27/154 (17%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKD-------TIIKKNHVDYMK 163
+ +G+G + V++ K K +D + A+K +R + T I+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEEGAPCTAIR-------- 49
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSKLYLILDFIN---GGHLFFHLYRQGIFREDQARFY 220
E +L + H IV L T L L+ ++++ +L I + +
Sbjct: 50 -EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYL---DDCGNIINMHNVKLF 105
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++ +++ H+ ++HRDLKP+N+L++ G +
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLINERGEL 139
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 6e-16
Identities = 39/147 (26%), Positives = 67/147 (45%), Gaps = 22/147 (14%)
Query: 118 VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHP 175
VG+G +G V++ K+K DG D YA+K + I M A R+I L ++ HP
Sbjct: 29 VGRGTYGHVYKAKRK---DGKDDKDYALKQIEGTGIS-------MSACREIALLRELKHP 78
Query: 176 FIVQLR--YSFQTRSKLYLILDF--------INGGHLFFHLYRQGIFREDQARFYTAEIV 225
++ L+ + K++L+ D+ I + + +I+
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDG 252
+ +LH ++HRDLKP NIL+ +G
Sbjct: 139 DGIHYLHANWVLHRDLKPANILVMGEG 165
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-16
Identities = 35/165 (21%), Positives = 67/165 (40%), Gaps = 40/165 (24%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD--- 167
+E +GQG FG+VF+ + + A+K + M+ E++
Sbjct: 18 KYEKLAKIGQGTFGEVFKAR-----HRKTGQKVALKKVL------------MENEKEGFP 60
Query: 168 --------ILTKVTHPFIVQLR--------YSFQTRSKLYLILDFINGGH-LFFHLYRQG 210
IL + H +V L + + +YL+ DF H L L
Sbjct: 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--HDLAGLLSNVL 118
Query: 211 I-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ F + + +++ + ++H+ I+HRD+K N+L+ DG +
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 163
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-15
Identities = 33/149 (22%), Positives = 65/149 (43%), Gaps = 9/149 (6%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+E+ ++G G +V + D A+KV+R D + + E
Sbjct: 12 DRYELGEILGFGGMSEVHLAR-----DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 170 TKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+ HP IV + Y+++++++G L ++ +G +A A+
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
A++ H+ GI+HRD+KP NI++ + V
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAV 155
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 40/172 (23%), Positives = 65/172 (37%), Gaps = 37/172 (21%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
+EI +G+GAFGKV + D A+K+++ N Y +A E +
Sbjct: 16 YEIVDTLGEGAFGKVVECI----DHKAGGRHVAVKIVK-------NVDRYCEAARSEIQV 64
Query: 169 LTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-------RQGIFR 213
L + VQ+ F+ + ++ + L Y FR
Sbjct: 65 LEHLNTTDPNSTFR--CVQMLEWFEHHGHICIVFEL-----LGLSTYDFIKENGFLP-FR 116
Query: 214 EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265
D R +I +V+ LH + H DLKPENIL + A + ++
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-15
Identities = 46/171 (26%), Positives = 71/171 (41%), Gaps = 37/171 (21%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
F + R +G G FG+V + D+ YA+KV+R N Y ++ E DI
Sbjct: 37 FLVIRKMGDGTFGRVLLCQ-----HIDNKKYYAVKVVR-------NIKKYTRSAKIEADI 84
Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-------RQGIFRE 214
L K+ + IV+ F + LI + L LY G F
Sbjct: 85 LKKIQNDDINNNN--IVKYHGKFMYYDHMCLIFEP-----LGPSLYEIITRNNYNG-FHI 136
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265
+ + Y EI+ A+++L K + H DLKPENIL+D + ++
Sbjct: 137 EDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 37/167 (22%), Positives = 59/167 (35%), Gaps = 49/167 (29%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
+EI +G+G FGKV + D A+K++R N Y +A E ++
Sbjct: 21 YEIVGNLGEGTFGKVVECL----DHARGKSQVALKIIR-------NVGKYREAARLEINV 69
Query: 169 LTKV--------THPFIVQLRYSFQTRSKLYLILDFINGGHLF----------FHLYRQG 210
L K+ V + F GH+ F ++
Sbjct: 70 LKKIKEKDKENKFL--CVLMSDWFNFH------------GHMCIAFELLGKNTFEFLKEN 115
Query: 211 IFR---EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
F+ R ++ A+ LH+ + H DLKPENIL +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 34/155 (21%), Positives = 67/155 (43%), Gaps = 21/155 (13%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F++ R+ GQG FG V K + + A+K + +D + + M+ L
Sbjct: 25 FQVERMAGQGTFGTVQLGK-----EKSTGMSVAIKKVIQDPRFRNRELQIMQ----DLAV 75
Query: 172 VTHPFIVQLRYSFQTRSK-------LYLILDFING---GHLFFHLYRQGIFREDQARFYT 221
+ HP IVQL+ F T + L ++++++ + RQ + +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 222 AEIVSAVSHLHKC--GIVHRDLKPENILMDSDGHV 254
+++ ++ LH + HRD+KP N+L++
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 28/155 (18%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
+E+ +V+G+G+FG+V + D A+K++R N + + E I
Sbjct: 99 YEVLKVIGKGSFGQVVKAY-----DHKVHQHVALKMVR-------NEKRFHRQAAEEIRI 146
Query: 169 LTKV-------THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR---EDQAR 218
L + T ++ + +F R+ + + F + L ++ F+ R
Sbjct: 147 LEHLRKQDKDNTM-NVIHMLENFTFRNHICMT--FELLSMNLYELIKKNKFQGFSLPLVR 203
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+ I+ + LHK I+H DLKPENIL+ G
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR 238
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 34/148 (22%), Positives = 67/148 (45%), Gaps = 21/148 (14%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
D+++ R +G+G + +VF+ + ++ +K+++ V K +R+I
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAI-----NITNNEKVVVKILKP--------VKKKKIKREI 81
Query: 169 --LTKVT-HPFIVQLRYSFQTRS--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
L + P I+ L + L+ + +N Q + RFY E
Sbjct: 82 KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF--KQLYQ-TLTDYDIRFYMYE 138
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSD 251
I+ A+ + H GI+HRD+KP N+++D +
Sbjct: 139 ILKALDYCHSMGIMHRDVKPHNVMIDHE 166
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-14
Identities = 23/148 (15%), Positives = 53/148 (35%), Gaps = 7/148 (4%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
G + + G + +Q D D A+ + ++ + + + L
Sbjct: 31 GRYRLLIFHGGVPPLQFWQAL-----DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
+++ P + ++ TR+ ++ ++I GG L + A + +A
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSP-SPVGAIRAMQSLAAAAD 143
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
H+ G+ P + + DG V+ A
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLA 171
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 7e-14
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
R + +F+ +V+G GAFG V+ KG+ +G+ I A+K +R+ T K + +
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
+ E ++ V +P + +L S + LI + G L ++ + +
Sbjct: 65 LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I +++L +VHRDL N+L+ + HV
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 26/156 (16%), Positives = 62/156 (39%), Gaps = 8/156 (5%)
Query: 101 AESERKIGPGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNH 158
E + + + +G G FG V KG A+K+++ +
Sbjct: 7 RPKEVYLDRKLLTLEDKELGSGNFGTVK----KGYYQMKKVVKTVAVKILKNEANDPALK 62
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQAR 218
+ + E +++ ++ +P+IV++ L+++ G L +L + ++
Sbjct: 63 DELLA-EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + +L + VHRDL N+L+ + +
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYA 156
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 38/190 (20%), Positives = 79/190 (41%), Gaps = 10/190 (5%)
Query: 68 SHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVF 127
++ G S + ++ E+ + + + +I E+ R +G+G FG V
Sbjct: 348 NNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVH 407
Query: 128 QVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185
+G+ + A+K + T +++ E + + HP IV+L
Sbjct: 408 ----QGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQ-EALTMRQFDHPHIVKL-IGVI 460
Query: 186 TRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
T + +++I++ G L L R+ Y ++ +A+++L VHRD+
Sbjct: 461 TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520
Query: 245 NILMDSDGHV 254
N+L+ S+ V
Sbjct: 521 NVLVSSNDCV 530
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 38/182 (20%), Positives = 81/182 (44%), Gaps = 9/182 (4%)
Query: 77 RYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD 136
+ + + + E + + + +G+G FG V + + D
Sbjct: 8 HHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67
Query: 137 GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLI 193
+ + A+K ++ T +++ D+ + E +IL + H IV+ + YS R+ L LI
Sbjct: 68 NTGEVV-AVKKLQHST--EEHLRDFER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLI 122
Query: 194 LDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
++++ G L +L + + + YT++I + +L +HRDL NIL++++
Sbjct: 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN 182
Query: 253 HV 254
V
Sbjct: 183 RV 184
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 34/154 (22%), Positives = 62/154 (40%), Gaps = 8/154 (5%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
IG D + +G G+FG V +G D S A+K ++ D + + +D
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVR----RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
E + + + H +++L Y + ++ + G L L QG F Y
Sbjct: 68 FIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + +L +HRDL N+L+ + V
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLV 160
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-13
Identities = 37/158 (23%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
+ + + +G+G FG V + + D + + A+K ++ T +++ D
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHST--EEHLRD 57
Query: 161 YMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQ 216
+ + E +IL + H IV+ + YS R+ L LI++++ G L +L + + +
Sbjct: 58 FER-EIEILKSLQHDNIVKYKGVCYSAGRRN-LKLIMEYLPYGSLRDYLQKHKERIDHIK 115
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
YT++I + +L +HRDL NIL++++ V
Sbjct: 116 LLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-13
Identities = 43/197 (21%), Positives = 75/197 (38%), Gaps = 13/197 (6%)
Query: 64 IHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEA--ESERKIGPGDFEIFRVVGQG 121
+H+ H G Y Q H + A R+I I +++G G
Sbjct: 1 MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60
Query: 122 AFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ 179
G+V G A+K ++ ++ D++ E I+ + HP I++
Sbjct: 61 DSGEVC----YGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLS-EASIMGQFDHPNIIR 114
Query: 180 LRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIV 237
L TR + ++ +++ G L L G F Q + + + +L G V
Sbjct: 115 L-EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 238 HRDLKPENILMDSDGHV 254
HRDL N+L+DS+
Sbjct: 174 HRDLAARNVLVDSNLVC 190
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-13
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
R + +F+ +V+G GAFG V+ KG+ +G+ I A+K +R+ T K + +
Sbjct: 10 RILKETEFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIKELREATS-PKANKEI 64
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
+ E ++ V +P + +L S + LI + G L ++ + +
Sbjct: 65 LD-EAYVMASVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I +++L +VHRDL N+L+ + HV
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHV 156
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-13
Identities = 35/170 (20%), Positives = 63/170 (37%), Gaps = 48/170 (28%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA---ERDI 168
+ + R +G G F V+ K D ++ AMK++R Y +A E +
Sbjct: 21 YILVRKLGWGHFSTVWLAK-----DMVNNTHVAMKIVR-------GDKVYTEAAEDEIKL 68
Query: 169 LTKVT-----------HPFIVQLRYSFQTRSKLYLILDFINGGHL-------------FF 204
L +V I++L F + NG H+
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLDHFNHKGP--------NGVHVVMVFEVLGENLLALI 120
Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGH 253
Y + + +++ + ++H+ CGI+H D+KPEN+LM+
Sbjct: 121 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 37/184 (20%), Positives = 68/184 (36%), Gaps = 53/184 (28%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ + + +G G+FG V +V D +S +A+K K + Y E DI+
Sbjct: 9 YSLGKTLGTGSFGIVCEVF-----DIESGKRFALK---KVLQDPR----YKNRELDIMKV 56
Query: 172 VTHPFIVQLRYSFQTRSK--------------------------------------LYLI 193
+ H I++L F T L +I
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 194 LDFINGG-HLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS 250
++++ H + + + Y ++ AV +H GI HRD+KP+N+L++S
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176
Query: 251 DGHV 254
+
Sbjct: 177 KDNT 180
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-12
Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDY 161
+ +I E+ R +G+G FG V +G+ + A+K + T +
Sbjct: 9 DYEIQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTS-DSVREKF 63
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
++ E + + HP IV+L T + +++I++ G L L R+ Y
Sbjct: 64 LQ-EALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ +A+++L VHRD+ N+L+ S+ V
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 155
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 12/149 (8%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
+ R +G+G FGKV D +DG A+K ++ D ++ + + E D
Sbjct: 32 YLKKIRDLGEGHFGKVS----LYCYDPTNDGTGEMVAVKALKADAG-PQHRSGWKQ-EID 85
Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
IL + H I++ + + L L+++++ G L +L R I F +I
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF-AQQIC 144
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++LH +HRDL N+L+D+D V
Sbjct: 145 EGMAYLHAQHYIHRDLAARNVLLDNDRLV 173
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 16/170 (9%)
Query: 93 HENDAELEAESERK-IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVM 148
H + A+L A + + +G+G FG V D D A+K +
Sbjct: 5 HHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVE----LCRYDPLGDNTGALVAVKQL 60
Query: 149 RKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR---YSFQTRSKLYLILDFINGGHLFFH 205
+ ++ D+ + E IL + FIV+ R Y +S L L+++++ G L
Sbjct: 61 QHSGPDQQR--DFQR-EIQILKALHSDFIVKYRGVSYGPGRQS-LRLVMEYLPSGCLRDF 116
Query: 206 LYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
L R + + Y+++I + +L VHRDL NIL++S+ HV
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIY-AMKVMRKDTIIKKNHVDY 161
R + +V+G G FG V KGV +G+S I +KV+ + +++
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVH----KGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAV 62
Query: 162 MKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFY 220
+ + H IV+L S L L+ ++ G L H+ +G +
Sbjct: 63 TD-HMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I + +L + G+VHR+L N+L+ S V
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQV 154
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 7/163 (4%)
Query: 94 ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
E+ + E +++ + I +VVG G FG+V + K + A+K ++
Sbjct: 29 EDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEIS--VAIKTLKVGYT 86
Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGI 211
+K D++ E I+ + HP I++L T+SK + ++ +++ G L L
Sbjct: 87 -EKQRRDFLG-EASIMGQFDHPNIIRL-EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ 143
Query: 212 FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
F Q I S + +L G VHRDL NIL++S+
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVC 186
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-12
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 12/150 (8%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY---AMKVMRKDTIIKKNHVDYMKAERD 167
+ R +G+G FGKV D + D A+K ++ ++ + D K E +
Sbjct: 22 FLKRIRDLGEGHFGKVE----LCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKK-EIE 75
Query: 168 ILTKVTHPFIVQLR--YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEI 224
IL + H IV+ + + + + LI++F+ G L +L + + Q Y +I
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +L VHRDL N+L++S+ V
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQV 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-12
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV---DDGDSDGIYAMKVMRKDTIIKKNH 158
+ +I P +V+G G FG+V+ KG+ G + A+K ++ +K
Sbjct: 36 KFTTEIHPSCVTRQKVIGAGEFGEVY----KGMLKTSSGKKEVPVAIKTLKAGYT-EKQR 90
Query: 159 VDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQ 216
VD++ E I+ + +H I++L ++ K + +I +++ G L L + G F Q
Sbjct: 91 VDFLG-EAGIMGQFSHHNIIRL-EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ 148
Query: 217 ARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
I + + +L VHRDL NIL++S+
Sbjct: 149 LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC 186
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-12
Identities = 40/182 (21%), Positives = 77/182 (42%), Gaps = 41/182 (22%)
Query: 95 NDAELEAESERKIGPGD-----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
ND + + + G+ +EI ++G+G+FG+V + D A+K+++
Sbjct: 34 NDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAY-----DRVEQEWVAIKIIK 88
Query: 150 KDTIIKKNHVDYMKA---ERDILTKVTHP------FIVQLRYSFQTRSKLYLILDFINGG 200
N ++ E +L + +IV L+ F R+ L L+ +
Sbjct: 89 -------NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----- 136
Query: 201 HLFFHLY-------RQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDSD 251
L ++LY +G + R + ++ +A+ L + I+H DLKPENIL+ +
Sbjct: 137 MLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195
Query: 252 GH 253
Sbjct: 196 KR 197
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 9e-12
Identities = 34/150 (22%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I P + + +G G FG V D A+K +R+ + ++ D+++ E
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDK------VAIKTIREGAMSEE---DFIE-EA 54
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
+++ K++HP +VQL Y + L+ +F+ G L +L ++G+F + ++
Sbjct: 55 EVMMKLSHPKLVQL-YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++L + ++HRDL N L+ + +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVI 143
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 1e-11
Identities = 32/200 (16%), Positives = 62/200 (31%), Gaps = 55/200 (27%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ +G+G FG+VFQ A+K++ + N + K +IL
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVN-GSHQKTFEEILP 72
Query: 171 KVT---------------HP--------FIVQLRY----------------------SFQ 185
++ VQ Y F
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPE 244
+L+++L+F GG R + A+ ++ ++++ HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQ-MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWG 191
Query: 245 NILMDSDGHVMAAHSLNSHN 264
N+L+ ++LN +
Sbjct: 192 NVLLKKTSLKKLHYTLNGKS 211
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-11
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKA 164
I D + R++G+G FG+V+ +GV A+K +KD N +M
Sbjct: 9 IAREDVVLNRILGEGFFGEVY----EGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMS- 62
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
E I+ + HP IV+L ++I++ G L +L + + Y+ +
Sbjct: 63 EAVIMKNLDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
I A+++L VHRD+ NIL+ S V
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECV 152
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 43/200 (21%), Positives = 73/200 (36%), Gaps = 50/200 (25%)
Query: 85 PLQIQELEHENDAELEAESERKIG------PGD-----FEIFRVVGQGAFGKVFQVKKKG 133
P Q +E+ +D E E ++ G GD + + R +G G F V+
Sbjct: 1 PEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSW--- 57
Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-----THP---FIVQLRYSFQ 185
D AMKV++ +++ + E +L V P +VQL F+
Sbjct: 58 --DIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111
Query: 186 TRSKLYLILDFINGGHL-------------FFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
NG H+ + + +++ + +LH
Sbjct: 112 ISGV--------NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163
Query: 233 -KCGIVHRDLKPENILMDSD 251
KC I+H D+KPENIL+ +
Sbjct: 164 TKCRIIHTDIKPENILLSVN 183
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 29/156 (18%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 101 AESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVD 160
+ +I ++ + +G G FG+V+ A+K M+ ++ +
Sbjct: 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK------VAVKTMKPGSMSVE---A 229
Query: 161 YMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQAR 218
++ E +++ + H +V+L ++ T+ +Y+I +F+ G L F +
Sbjct: 230 FLA-EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++A+I ++ + + +HRDL+ NIL+ +
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC 323
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-11
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 26/212 (12%)
Query: 50 SPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGP 109
S + +A + H S S R SS P + S+ +I
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTA---------SMPRPHSDWQIPD 53
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
+EI ++G G++G V + D + A+K K + ++ +D + R+I
Sbjct: 54 -RYEIRHLIGTGSYGHVCEAY-----DKLEKRVVAIK---KILRVFEDLIDCKRILREIA 104
Query: 169 -LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
L ++ H +V++ + +LY++L+ E +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLY 163
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ V ++H GI+HRDLKP N L++ D V
Sbjct: 164 NLLVGVKYVHSAGILHRDLKPANCLVNQDCSV 195
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 34/186 (18%), Positives = 74/186 (39%), Gaps = 20/186 (10%)
Query: 80 LSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
++S P + E E + + R +GQG+FG V++ KGV +
Sbjct: 1 MASVNPEYFSAADVYVPDEWE------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEP 54
Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFIN 198
+ A+K + + + ++++ E ++ + +V+L ++ + +I++ +
Sbjct: 55 ETRVAIKTVNEAA-SMRERIEFLN-EASVMKEFNCHHVVRL-LGVVSQGQPTLVIMELMT 111
Query: 199 GGHL--FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILM 248
G L + R + + EI +++L+ VHRDL N ++
Sbjct: 112 RGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171
Query: 249 DSDGHV 254
D V
Sbjct: 172 AEDFTV 177
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 44/242 (18%), Positives = 91/242 (37%), Gaps = 16/242 (6%)
Query: 15 TKLKKLTITPPSASSPDFDFTEVFGPLTPCRHNNQSPASTSASLGDPQVIHNRSHSFVGP 74
LK+ ++++ + + H + + ++ P+ S P
Sbjct: 248 YCLKEACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRP 307
Query: 75 SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
P + +S+ E + + D E+ G G FG V +GV
Sbjct: 308 MP---MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL----GCGNFGSVR----QGV 356
Query: 135 DDGDSDGIY-AMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLI 193
I A+KV+++ T K + + M+ E I+ ++ +P+IV+L L L+
Sbjct: 357 YRMRKKQIDVAIKVLKQGTE-KADTEEMMR-EAQIMHQLDNPYIVRL-IGVCQAEALMLV 413
Query: 194 LDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
++ GG L L ++ ++ + +L + VHR+L N+L+ +
Sbjct: 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH 473
Query: 253 HV 254
+
Sbjct: 474 YA 475
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 33/150 (22%), Positives = 63/150 (42%), Gaps = 10/150 (6%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ D + +G+G FG+VF G D+ + A+K R+ +++ E
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVF----SGRLRADNTLV-AVKSCRETLP-PDLKAKFLQ-EA 163
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
IL + +HP IV+L T+ + +Y++++ + GG L R +
Sbjct: 164 RILKQYSHPNIVRL-IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDA 222
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + +L +HRDL N L+ +
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 30/159 (18%), Positives = 64/159 (40%), Gaps = 8/159 (5%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMK 163
KI D +GQG F K+F+ ++ V D +KV+ K N+ +
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFF 60
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
+++K++H +V Y L+ +F+ G L +L + +
Sbjct: 61 EAASMMSKLSHKHLVLN-YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260
++ +A+ L + ++H ++ +NIL+ + +
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 34/161 (21%), Positives = 64/161 (39%), Gaps = 17/161 (10%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I F + R++G+G FG V + + K D A+K+++ D I + ++++ E
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK--VAVKMLKADIIASSDIEEFLR-EA 76
Query: 167 DILTKVTHPFIVQL------RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF- 219
+ + HP + +L + +IL F+ G L L E+
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLP 135
Query: 220 ------YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +I + +L +HRDL N ++ D V
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 36/150 (24%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I P D + +G G FG V K +G D A+K++++ ++ + ++++ E
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYD------VAIKMIKEGSMSED---EFIE-EA 70
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
++ ++H +VQL Y T+ + +++I +++ G L +L + F+ Q ++
Sbjct: 71 KVMMNLSHEKLVQL-YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
A+ +L +HRDL N L++ G V
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVV 159
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 35/151 (23%), Positives = 66/151 (43%), Gaps = 10/151 (6%)
Query: 107 IGPGDFEIFRVV-GQGAFGKVFQVKKKGVDDGDSDGIY-AMKVMRKDTIIKKNHVDYMKA 164
+ + I + G G FG V +GV I A+KV+++ T K + + M+
Sbjct: 6 LKRDNLLIADIELGCGNFGSVR----QGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMR- 59
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAE 223
E I+ ++ +P+IV+L L L+++ GG L L ++ +
Sbjct: 60 EAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + +L + VHRDL N+L+ + +
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYA 149
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-11
Identities = 40/202 (19%), Positives = 84/202 (41%), Gaps = 33/202 (16%)
Query: 61 PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
Q++ S G R L++ P + + E I + +GQ
Sbjct: 143 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 194
Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
G FG+V+ G A+K ++ T+ + +++ E ++ K+ H +VQL
Sbjct: 195 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 244
Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
Y+ + +Y++ ++++ G L L + + ++ A+I S ++++
Sbjct: 245 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 233 KCGIVHRDLKPENILMDSDGHV 254
+ VHRDL+ NIL+ +
Sbjct: 298 RMNYVHRDLRAANILVGENLVC 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 34/165 (20%), Positives = 64/165 (38%), Gaps = 31/165 (18%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG-------IYAMKVMRKDTIIKKNHVDY 161
+ + R + G++G V DS+G ++ + I +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGV-------DSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 162 MKAERDI--LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYR-----Q 209
+ R+I L HP I+ LR + KLYL+ + + L + +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQR 128
Query: 210 GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +++ I+ + LH+ G+VHRDL P NIL+ + +
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 24/157 (15%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
+ + +G G G VF D D D A+K K I+ + A R+I
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAV-----DNDCDKRVAIK---K--IVLTDPQSVKHALREI 59
Query: 169 --LTKVTHPFIVQL----RYSFQTRSKLYLILDFINGGHLFFHLY--------RQGIFRE 214
+ ++ H IV++ S + L +N ++ QG E
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE 119
Query: 215 DQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+ AR + +++ + ++H ++HRDLKP N+ ++++
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTE 156
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 39/191 (20%), Positives = 63/191 (32%), Gaps = 30/191 (15%)
Query: 85 PLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYA 144
+ I + D + E + +G GAFGKV + G+ D+ A
Sbjct: 4 YVYIDPTQLPYDHKWE------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA 57
Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
+K M K + M E +L+ + H IV L T +I ++ G L
Sbjct: 58 VK-MLKPSAHLTEREALMS-ELKVLSYLGNHMNIVNL-LGACTIGGPTLVITEYCCYGDL 114
Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
F ED ++ ++ L +HRDL
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174
Query: 245 NILMDSDGHVM 255
NIL+ + G +
Sbjct: 175 NILL-THGRIT 184
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 1e-10
Identities = 28/150 (18%), Positives = 66/150 (44%), Gaps = 13/150 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ ++ +G G FG+V+ G A+K +++ ++ ++ E
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTK------VAVKSLKQGSMSPD---AFLA-EA 59
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEI 224
+++ ++ H +V+L Y+ T+ +Y+I +++ G L F ++ A+I
Sbjct: 60 NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + + +HRDL+ NIL+
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSC 148
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 33/150 (22%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ + + + +G G FG V K KG D A+K++++ ++ + ++ + E
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYD------VAVKMIKEGSMSED---EFFQ-EA 54
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEI 224
+ K++HP +V+ Y ++ +Y++ ++I+ G L +L Q ++
Sbjct: 55 QTMMKLSHPKLVKF-YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ L +HRDL N L+D D V
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCV 143
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 38/213 (17%), Positives = 70/213 (32%), Gaps = 14/213 (6%)
Query: 49 QSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIG 108
P + G + + + +L N ++A IG
Sbjct: 26 LVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG 85
Query: 109 PGDFEI--FRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
P + V+G+G FG V+ G D+ A+K + ++
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLT- 139
Query: 165 ERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYT 221
E I+ +HP ++ L ++ ++L ++ G L F +D F
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF-G 198
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + L VHRDL N ++D V
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 231
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 34/158 (21%), Positives = 72/158 (45%), Gaps = 13/158 (8%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
+++ + + R +G GAFG+V++ + G+ + S A+K + + +++ +D++
Sbjct: 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLM 82
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT- 221
E I++K H IV+ +S +++++ + GG L L R+ R Q
Sbjct: 83 -EALIISKFNHQNIVRC-IGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAM 139
Query: 222 -------AEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252
+I +L + +HRD+ N L+ G
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG 177
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 40/202 (19%), Positives = 84/202 (41%), Gaps = 33/202 (16%)
Query: 61 PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
Q++ S G R L++ P + + E I + +GQ
Sbjct: 226 QQLVAYYSKHADGLCHR--LTTVCPTSKPQTQGLAKDAWE------IPRESLRLEVKLGQ 277
Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
G FG+V+ G A+K ++ T+ + +++ E ++ K+ H +VQL
Sbjct: 278 GCFGEVWMGTWNGTTR------VAIKTLKPGTMSPE---AFLQ-EAQVMKKLRHEKLVQL 327
Query: 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT--------AEIVSAVSHLH 232
Y+ + +Y++ ++++ G L L + + ++ A+I S ++++
Sbjct: 328 -YAVVSEEPIYIVTEYMSKGSLLDFL------KGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 233 KCGIVHRDLKPENILMDSDGHV 254
+ VHRDL+ NIL+ +
Sbjct: 381 RMNYVHRDLRAANILVGENLVC 402
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 42/196 (21%), Positives = 75/196 (38%), Gaps = 24/196 (12%)
Query: 75 SPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV 134
SP S L I E N I D + +G+GAFGKVF + +
Sbjct: 10 SPTEGKGSGLQGHIIE----NPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNL 65
Query: 135 DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLI 193
+ A+K +++ + + D+ + E ++LT + H IV+ + T + L ++
Sbjct: 66 LPEQDKMLVAVKALKEAS--ESARQDFQR-EAELLTMLQHQHIVRF-FGVCTEGRPLLMV 121
Query: 194 LDFINGGHLFFHLYRQGIFREDQARFYT---------------AEIVSAVSHLHKCGIVH 238
+++ G L L G + A +++ + + +L VH
Sbjct: 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVH 181
Query: 239 RDLKPENILMDSDGHV 254
RDL N L+ V
Sbjct: 182 RDLATRNCLVGQGLVV 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 35/169 (20%), Positives = 72/169 (42%), Gaps = 13/169 (7%)
Query: 94 ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
+++ + + R +G GAFG+V++ + G+ + S A+K + +
Sbjct: 55 FAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVC 113
Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIF 212
+++ +D++ E I++K H IV+ +S +++L+ + GG L L R+
Sbjct: 114 SEQDELDFLM-EALIISKFNHQNIVRC-IGVSLQSLPRFILLELMAGGDLKSFL-RETRP 170
Query: 213 REDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
R Q +I +L + +HRD+ N L+ G
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 42/216 (19%), Positives = 86/216 (39%), Gaps = 32/216 (14%)
Query: 61 PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
H+ H + P+ + + E E D E + + + +G+
Sbjct: 26 GYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWE------LPRDRLVLGKPLGE 79
Query: 121 GAFGKVFQVKKKGVDDGDSDGIY--AMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFI 177
GAFG+V + G+D + + A+K M K +K+ D + E +++ + H I
Sbjct: 80 GAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLIS-EMEMMKMIGKHKNI 137
Query: 178 VQLRYSFQTRSK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARF 219
+ L T+ LY+I+++ + G+L H + + +D
Sbjct: 138 INL-LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
++ + +L +HRDL N+L+ ++ +VM
Sbjct: 197 -AYQVARGMEYLASKKCIHRDLAARNVLV-TEDNVM 230
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 31/152 (20%), Positives = 66/152 (43%), Gaps = 17/152 (11%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ + ++ + +G+G FG V +G A+K ++ D + ++ E
Sbjct: 18 LNMKELKLLQTIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EA 65
Query: 167 DILTKVTHPFIVQLRYSFQTRSK--LYLILDFINGGHL--FFHLYRQGIFREDQARFYTA 222
++T++ H +VQL K LY++ +++ G L + + + D ++
Sbjct: 66 SVMTQLRHSNLVQL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ A+ +L VHRDL N+L+ D
Sbjct: 125 DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVA 156
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-10
Identities = 33/170 (19%), Positives = 60/170 (35%), Gaps = 17/170 (10%)
Query: 90 ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKV 147
EL + S + V+G+G FG V+ G D+ A+K
Sbjct: 10 ELVQAVQHVVIGPSSLIV-----HFNEVIGRGHFGCVY----HGTLLDNDGKKIHCAVKS 60
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHL--FF 204
+ ++ E I+ +HP ++ L ++ ++L ++ G L F
Sbjct: 61 L-NRITDIGEVSQFLT-EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 205 HLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+D F ++ + +L VHRDL N ++D V
Sbjct: 119 RNETHNPTVKDLIGF-GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTV 167
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-10
Identities = 38/151 (25%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ D + +G G +G+V+ +GV S + A+K +++DT+ + +++K E
Sbjct: 10 MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 60
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
++ ++ HP +VQL TR Y+I +F+ G+L + + + +
Sbjct: 61 AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
I SA+ +L K +HRDL N L+ + V
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 35/199 (17%), Positives = 80/199 (40%), Gaps = 25/199 (12%)
Query: 61 PQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQ 120
Q++ + + G R + + + + + + ++ + +G+
Sbjct: 150 MQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWA------LNMKELKLLQTIGK 203
Query: 121 GAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL 180
G FG V +G A+K ++ D + ++ E ++T++ H +VQL
Sbjct: 204 GEFGDVMLGDYRGNK-------VAVKCIKNDATAQ----AFLA-EASVMTQLRHSNLVQL 251
Query: 181 RY--SFQTRSKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCG 235
+ + LY++ +++ G L +L R + + +F + ++ A+ +L
Sbjct: 252 -LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNN 309
Query: 236 IVHRDLKPENILMDSDGHV 254
VHRDL N+L+ D
Sbjct: 310 FVHRDLAARNVLVSEDNVA 328
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 9e-10
Identities = 37/151 (24%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ D + +G G +G+V+ +GV S + A+K +++DT+ + +++K E
Sbjct: 217 MERTDITMKHKLGGGQYGEVY----EGVWKKYSLTV-AVKTLKEDTMEVE---EFLK-EA 267
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL--FFHLYRQGIFREDQARFYTAE 223
++ ++ HP +VQL TR Y+I +F+ G+L + + + +
Sbjct: 268 AVMKEIKHPNLVQL-LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
I SA+ +L K +HR+L N L+ + V
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 32/151 (21%), Positives = 60/151 (39%), Gaps = 16/151 (10%)
Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
+ +++G+G FG V + K D A+K M+ D ++ +++ E +
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLK--VAVKTMKLDNSSQREIEEFLS-EAACMKDF 93
Query: 173 THPFIVQL-----RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARF-------Y 220
+HP +++L S Q K +IL F+ G L +L +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKF 152
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+I + +L +HRDL N ++ D
Sbjct: 153 MVDIALGMEYLSNRNFLHRDLAARNCMLRDD 183
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-09
Identities = 38/168 (22%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
+ I D + R +G+GAFGKVF + + + A+K ++ T D+ +
Sbjct: 9 VQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQR 66
Query: 164 AERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------FFHLYRQGIFR 213
E ++LT + H IV+ Y L ++ +++ G L + G R
Sbjct: 67 -EAELLTNLQHEHIVKF-YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124
Query: 214 EDQARFYT-------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + ++I S + +L VHRDL N L+ ++ V
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 172
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 35/159 (22%), Positives = 68/159 (42%), Gaps = 30/159 (18%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
DF++ ++G+GA+G V + I A IKK + ++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSAT-----HKPTGEIVA---------IKKIEPFDKPLFALR 55
Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
R+I L H I+ + + S +Y+I + + H + + +D
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLH---RVISTQMLSDD 112
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++ + + AV LH ++HRDLKP N+L++S+ +
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDL 151
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 41/199 (20%), Positives = 76/199 (38%), Gaps = 22/199 (11%)
Query: 75 SPRYALSSSLPLQIQ--ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKK 132
P+Y + + + + +L + + + + + +G GAFGKV +
Sbjct: 9 KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 68
Query: 133 GVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-L 190
G+ D+ A+K M K T M E I++ + H IV L T +
Sbjct: 69 GLGKEDAVLKVAVK-MLKSTAHADEKEALMS-ELKIMSHLGQHENIVNL-LGACTHGGPV 125
Query: 191 YLILDFINGGHLFFHLYRQGIFREDQARFYT--------------AEIVSAVSHLHKCGI 236
+I ++ G L L R+ E F +++ ++ L
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC 185
Query: 237 VHRDLKPENILMDSDGHVM 255
+HRD+ N+L+ ++GHV
Sbjct: 186 IHRDVAARNVLL-TNGHVA 203
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-09
Identities = 34/151 (22%), Positives = 66/151 (43%), Gaps = 19/151 (12%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
++ + +G GA G V D D A+K K + +N +A R++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAY-----DAVLDRNVAIK---KLSRPFQNQTHAKRAYREL 112
Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
+ V H I+ L + + +YL+++ + + + + ++ +
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMEL-DHERMSYL 169
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+++ + HLH GI+HRDLKP NI++ SD
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 200
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-09
Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 34/196 (17%)
Query: 82 SSLPL--QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDS 139
LPL + L ++ + E ++ + +G+GAFG+V + G+D +
Sbjct: 4 DELPLDEHCERLPYDAS-KWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTAT 56
Query: 140 DGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY--SFQTRSKLYLILDF 196
A+K M K+ H M E IL + H +V L + L +I++F
Sbjct: 57 CRTVAVK-MLKEGATHSEHRALMS-ELKILIHIGHHLNVVNL-LGACTKPGGPLMVIVEF 113
Query: 197 INGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHR 239
G+L LY+ + E + + ++ + L +HR
Sbjct: 114 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY-SFQVAKGMEFLASRKCIHR 172
Query: 240 DLKPENILMDSDGHVM 255
DL NIL+ S+ +V+
Sbjct: 173 DLAARNILL-SEKNVV 187
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 34/155 (21%), Positives = 67/155 (43%), Gaps = 20/155 (12%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
+ + VG GA+G V DG + A+K K ++ + +A R++
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIK---KLYRPFQSELFAKRAYREL 75
Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARF 219
L + H ++ L + + YL++ F+ L + ED+ +F
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG---KLMKHEKLGEDRIQF 132
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++ + ++H GI+HRDLKP N+ ++ D +
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL 167
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 47/233 (20%), Positives = 91/233 (39%), Gaps = 41/233 (17%)
Query: 45 RHNNQSPASTSASLGDPQVIHNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESE 104
+ + +S+S + P V S +P A S E E D + E
Sbjct: 29 QVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVS-------EYELPEDPKWE---- 77
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV---MRKDTIIKKNHVDY 161
+ + +G+G FG+V + G+D A+ V M KD +K+ D
Sbjct: 78 --FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDL 133
Query: 162 MKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----------------- 202
+ E +++ + H I+ L T+ LY+I+++ + G+L
Sbjct: 134 VS-EMEMMKMIGKHKNIINL-LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 203 FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
+ + + +D T ++ + +L +HRDL N+L+ ++ +VM
Sbjct: 192 INRVPEEQMTFKDLVSC-TYQLARGMEYLASQKCIHRDLAARNVLV-TENNVM 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 42/205 (20%), Positives = 84/205 (40%), Gaps = 31/205 (15%)
Query: 72 VGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKK 131
+G S + S P+ E+E + + E R + + +G+GAFG+V +
Sbjct: 1 MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRD----KLTLGKPLGEGAFGQVVMAEA 56
Query: 132 KGVDDGDSDGIYAMKV---MRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187
G+D A+ V M KD +K+ D + E +++ + H I+ L T+
Sbjct: 57 VGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKNIINL-LGACTQ 112
Query: 188 SK-LYLILDFINGGHL-----------------FFHLYRQGIFREDQARFYTAEIVSAVS 229
LY+I+++ + G+L + + + +D T ++ +
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC-TYQLARGME 171
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
+L +HRDL N+L+ + +
Sbjct: 172 YLASQKCIHRDLAARNVLVTENNVM 196
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-09
Identities = 30/153 (19%), Positives = 61/153 (39%), Gaps = 16/153 (10%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
E ++G + + R +G G+FG ++ D + A+K+ T K +
Sbjct: 4 ELRVG-NRYRLGRKIGSGSFGDIYLGT-----DIAAGEEVAIKLECVKT--KHPQLHI-- 53
Query: 164 AERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
E I + I +R+ ++++ + + LF R+ F
Sbjct: 54 -ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLL 110
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+++S + ++H +HRD+KP+N LM
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 34/153 (22%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P ++ I ++G+G++G V+ D +++ A+K K + ++ +D + R+I
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAY-----DKNTEKNVAIK---KVNRMFEDLIDCKRILREI 76
Query: 169 --LTKVTHPFIVQLR-----YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
L ++ +I++L +LY++L+ L E+ +
Sbjct: 77 TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL 135
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + +H+ GI+HRDLKP N L++ D V
Sbjct: 136 YNLLLGENFIHESGIIHRDLKPANCLLNQDCSV 168
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-09
Identities = 36/154 (23%), Positives = 67/154 (43%), Gaps = 19/154 (12%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P + VG GA+G V D S A+K K + ++ + +A R++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAI-----DKRSGEKVAIK---KLSRPFQSEIFAKRAYREL 74
Query: 169 --LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFY 220
L + H ++ L F S YL++ F+ L F E++ ++
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL--QKIMGLKFSEEKIQYL 131
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++ + ++H G+VHRDLKP N+ ++ D +
Sbjct: 132 VYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCEL 165
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 27/149 (18%), Positives = 61/149 (40%), Gaps = 16/149 (10%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+G +++ R +G+G+FG +F+ + ++ A+K + + +
Sbjct: 4 QNNVVG-VHYKVGRRIGEGSFGVIFEGT-----NLLNNQQVAIKFEPRRS--DAPQLRD- 54
Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
E + I + Y Q L++D + + L R+ F
Sbjct: 55 --EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--FSVKTVAM 110
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILM 248
++++ V +H+ +V+RD+KP+N L+
Sbjct: 111 AAKQMLARVQSIHEKSLVYRDIKPDNFLI 139
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-09
Identities = 31/165 (18%), Positives = 62/165 (37%), Gaps = 20/165 (12%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I +G+ FGKV++ G G+ A+K ++ ++ E
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRH-EA 63
Query: 167 DILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHLFFHLYRQGIFREDQARFYT---- 221
+ ++ HP +V L T+ + L +I + + G L L + + +
Sbjct: 64 MLRARLQHPNVVCL-LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 222 ------------AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
A+I + + +L +VH+DL N+L+ +V
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 167
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-09
Identities = 29/159 (18%), Positives = 62/159 (38%), Gaps = 30/159 (18%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMK 163
+ +G+GA+G V D + A IKK + +
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAY-----DNLNKVRVA---------IKKISPFEHQTYCQR 71
Query: 164 AERDI--LTKVTHPFIVQLRYSFQTRSK-----LYLILDFINGG-HLFFHLYRQGIFRED 215
R+I L + H I+ + + + +Y++ D + + L + D
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLY---KLLKTQHLSND 128
Query: 216 QARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ +I+ + ++H ++HRDLKP N+L+++ +
Sbjct: 129 HICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDL 167
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 43/191 (22%), Positives = 73/191 (38%), Gaps = 29/191 (15%)
Query: 90 ELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR 149
E + + E E + + + + E +V+G GAFGKV G+ A+K M
Sbjct: 25 EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK-ML 83
Query: 150 KDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRSK-LYLILDFINGGHL----- 202
K+ M E ++T++ +H IV L T S +YLI ++ G L
Sbjct: 84 KEKADSSEREALMS-ELKMMTQLGSHENIVNL-LGACTLSGPIYLIFEYCCYGDLLNYLR 141
Query: 203 ----------FFHLYRQGIFREDQARFYT--------AEIVSAVSHLHKCGIVHRDLKPE 244
+ ++ + E+ T ++ + L VHRDL
Sbjct: 142 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201
Query: 245 NILMDSDGHVM 255
N+L + G V+
Sbjct: 202 NVL-VTHGKVV 211
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 29/154 (18%), Positives = 63/154 (40%), Gaps = 16/154 (10%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
+G +F + + +G G FG++ K + ++ A+K+ K+ +
Sbjct: 3 GVLMVG-PNFRVGKKIGCGNFGELRLGK-----NLYTNEYVAIKLEPM-----KSRAPQL 51
Query: 163 KAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARF 219
E ++ I Q+ Y ++L+ + + LF R F
Sbjct: 52 HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT--FSLKTVLM 109
Query: 220 YTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+++S + ++H +++RD+KPEN L+ G+
Sbjct: 110 IAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN 143
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 32/153 (20%), Positives = 62/153 (40%), Gaps = 16/153 (10%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
E ++G F + R +G G+FG+++ + ++ A+K+ T K + Y
Sbjct: 2 EPRVG-NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKT--KHPQLLY-- 51
Query: 164 AERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFI--NGGHLFFHLYRQGIFREDQARFY 220
E I + I +R+ L++D + + LF R+
Sbjct: 52 -ESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRK--LSLKTVLML 108
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
++++ V +H +HRD+KP+N LM
Sbjct: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 32/154 (20%), Positives = 67/154 (43%), Gaps = 18/154 (11%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P ++ VG GA+G V D + A+K K + ++ + + R++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAF-----DTKTGLRVAVK---KLSRPFQSIIHAKRTYREL 79
Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
L + H ++ L S + + +YL+ + G ++ + +D +F
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFL 137
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+I+ + ++H I+HRDLKP N+ ++ D +
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 31/154 (20%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYM------K 163
+F+ ++G G FGKV+ KGV DG KV +K+ + +
Sbjct: 40 NFDHKFLIGHGVFGKVY----KGVLRDG-------AKVA-----LKRRTPESSQGIEEFE 83
Query: 164 AERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARF 219
E + L+ HP +V L + + R+++ LI ++ G+L HLY + + R
Sbjct: 84 TEIETLSFCRHPHLVSLIGFCDE-RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 220 YTAEIVSA--VSHLHKCGIVHRDLKPENILMDSD 251
I +A + +LH I+HRD+K NIL+D +
Sbjct: 143 EIC-IGAARGLHYLHTRAIIHRDVKSINILLDEN 175
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 38/188 (20%), Positives = 75/188 (39%), Gaps = 31/188 (16%)
Query: 94 ENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI 153
+ ++ + + + + + + +G+G FGKV + + A+K M K+
Sbjct: 7 VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENA 65
Query: 154 IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYLILDFINGGHL---------- 202
D + E ++L +V HP +++L Y ++ L LI+++ G L
Sbjct: 66 SPSELRDLLS-EFNVLKQVNHPHVIKL-YGACSQDGPLLLIVEYAKYGSLRGFLRESRKV 123
Query: 203 ---------------FFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247
H + + D F +I + +L + +VHRDL NIL
Sbjct: 124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISF-AWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 248 MDSDGHVM 255
+ ++G M
Sbjct: 183 V-AEGRKM 189
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-08
Identities = 29/146 (19%), Positives = 60/146 (41%), Gaps = 10/146 (6%)
Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV 172
RV+G+G FG V+ + A+K + + T + +++ E ++ +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQ--CAIKSLSRITE-MQQVEAFLR-EGLLMRGL 79
Query: 173 THPFIVQLRY--SFQTRSKLYLILDFINGGHL--FFHLYRQGIFREDQARFYTAEIVSAV 228
HP ++ L +++L ++ G L F ++ +D F ++ +
Sbjct: 80 NHPNVLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF-GLQVARGM 137
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
+L + VHRDL N ++D V
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTV 163
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 38/151 (25%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
+E+ + +G+GA+G V++ D + + A+K K +N D + R+I
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSI-----DRRTGEVVAVK---KIFDAFQNSTDAQRTFREI 59
Query: 169 --LTK-VTHPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
LT+ H IV L + + +YL+ D++ + R I ++ +
Sbjct: 60 MILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQ 117
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + +LH G++HRD+KP NIL++++ HV
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHV 148
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 24/153 (15%), Positives = 53/153 (34%), Gaps = 14/153 (9%)
Query: 112 FEIFRVVGQGAFGKVF---QVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD- 167
+++ + G ++ D G +++K+ KD + + +A +
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 168 ------ILTKVTHPFIVQLRYSFQTRSKL-YLILDFINGGHL--FFHLYRQGIFREDQAR 218
L I + K +L+L + G L + + + E
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162
Query: 219 FYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
++ A+ LH+ VH ++ ENI +D +
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-08
Identities = 37/189 (19%), Positives = 70/189 (37%), Gaps = 17/189 (8%)
Query: 84 LPL--QIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
LPL + L ++ + E ++ + +G+GAFG+V + G+D +
Sbjct: 1 LPLDEHCERLPYDAS-KWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCR 53
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQ-LRYSFQTRSKLYLILDFING 199
A+K M K+ H M E IL + H +V L + L +I++F
Sbjct: 54 TVAVK-MLKEGATHSEHRALMS-ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF 111
Query: 200 GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259
G+L +L + ++ Y + G + DLK + S ++
Sbjct: 112 GNLSTYLRS----KRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167
Query: 260 LNSHNQLCC 268
+ +
Sbjct: 168 VEEKSLSDV 176
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 5e-08
Identities = 29/159 (18%), Positives = 60/159 (37%), Gaps = 26/159 (16%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDY 161
+++ +GQG FG ++ + SD +KV D ++
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 162 MKAERDILTKVTHPFIVQLRYS----FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA 217
+ K+ + + + S +S ++I+D G L Q I+ +
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDL------QKIYEANAK 147
Query: 218 RF-------YTAEIVSAVSHLHKCGIVHRDLKPENILMD 249
RF + I+ + ++H+ VH D+K N+L++
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLN 186
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 33/151 (21%), Positives = 66/151 (43%), Gaps = 19/151 (12%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
++ + +G GA G V D + A+K K + +N +A R++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAY-----DAILERNVAIK---KLSRPFQNQTHAKRAYREL 75
Query: 169 --LTKVTHPFIVQLR------YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFY 220
+ V H I+ L S + +Y++++ + + + + ++ +
Sbjct: 76 VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM--DANLCQVIQMEL-DHERMSYL 132
Query: 221 TAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251
+++ + HLH GI+HRDLKP NI++ SD
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 163
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 28/197 (14%), Positives = 70/197 (35%), Gaps = 29/197 (14%)
Query: 65 HNRSHSFVGPSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFG 124
H+ S +G Y S P E + + + + + +G G FG
Sbjct: 6 HHSSGVDLGTENLYFQSMPFP--------------EGKVLDDMEGNQWVLGKKIGSGGFG 51
Query: 125 KVFQVKKKGVDDGDSDGIYAMKVMRKDT--------IIKKNHVDYMKAERDILTKVTHPF 176
++ + + D + +KV ++ ++ + ++ +
Sbjct: 52 LIYLAFP--TNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109
Query: 177 IVQLRYS--FQTRSKLY--LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH 232
I S + + + Y ++++ + G L + G F++ ++ + ++H
Sbjct: 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIH 168
Query: 233 KCGIVHRDLKPENILMD 249
+ VH D+K N+L+
Sbjct: 169 ENEYVHGDIKAANLLLG 185
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 42/207 (20%), Positives = 78/207 (37%), Gaps = 42/207 (20%)
Query: 74 PSPRYALSSSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKG 133
P+P Y L L + L E + E R +G+GAFG+VFQ + G
Sbjct: 24 PNPMYQ-RMPLLLNPKLLSLE------------YPRNNIEYVRDIGEGAFGRVFQARAPG 70
Query: 134 VDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK-LYL 192
+ + + A+K M K+ D+ + E ++ + +P IV+L K + L
Sbjct: 71 LLPYEPFTMVAVK-MLKEEASADMQADFQR-EAALMAEFDNPNIVKL-LGVCAVGKPMCL 127
Query: 193 ILDFINGGHL----------------FFHLYRQGIFREDQARFYT--------AEIVSAV 228
+ +++ G L L + + ++ + +
Sbjct: 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVM 255
++L + VHRDL N L+ + V+
Sbjct: 188 AYLSERKFVHRDLATRNCLV-GENMVV 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 40/185 (21%), Positives = 74/185 (40%), Gaps = 28/185 (15%)
Query: 88 IQELEHENDAELEAESERK--IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIY-A 144
+++ H + + + + D + V+G+G FG+V K D + A
Sbjct: 1 MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVL----KARIKKDGLRMDAA 56
Query: 145 MKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSK-LYLILDFINGGHL 202
+K K+ K +H D+ E ++L K+ HP I+ L LYL +++ G+L
Sbjct: 57 IK-RMKEYASKDDHRDFAG-ELEVLCKLGHHPNIINL-LGACEHRGYLYLAIEYAPHGNL 113
Query: 203 FFHLYRQGIFREDQARFYT----------------AEIVSAVSHLHKCGIVHRDLKPENI 246
L + + D A A++ + +L + +HRDL NI
Sbjct: 114 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 173
Query: 247 LMDSD 251
L+ +
Sbjct: 174 LVGEN 178
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 3e-07
Identities = 32/145 (22%), Positives = 56/145 (38%), Gaps = 23/145 (15%)
Query: 117 VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--HVDYMKAERDILTKVTH 174
+G+G FG V+ KG + A+K + I + E ++ K H
Sbjct: 38 KMGEGGFGVVY----KGYVNN---TTVAVKKLAAMVDITTEELKQQF-DQEIKVMAKCQH 89
Query: 175 PFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQA------RFYTAE-IVS 226
+V+L +S L+ ++ G L L + R A+ +
Sbjct: 90 ENLVELLGFSSDGDDLC-LVYVYMPNGSLLDRLSC----LDGTPPLSWHMRCKIAQGAAN 144
Query: 227 AVSHLHKCGIVHRDLKPENILMDSD 251
++ LH+ +HRD+K NIL+D
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEA 169
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 4e-06
Identities = 38/151 (25%), Positives = 74/151 (49%), Gaps = 19/151 (12%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGV-DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
+F ++G+G FGKV+ KG DG + A+K + K+ + + + + E ++
Sbjct: 30 DNFSNKNILGRGGFGKVY----KGRLADGT---LVAVKRL-KEERTQGGELQF-QTEVEM 80
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFRED---QARFYTAEIV 225
++ H +++LR T ++ L+ ++ G + L + + R A +
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LG 139
Query: 226 SA--VSHLH-KCG--IVHRDLKPENILMDSD 251
SA +++LH C I+HRD+K NIL+D +
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEE 170
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 2e-04
Identities = 35/208 (16%), Positives = 65/208 (31%), Gaps = 47/208 (22%)
Query: 93 HENDAELEAESERKIGPGD-FEIFRVVGQGAFGKVFQVK------KKGVDDGDSDGIYAM 145
H D E E + D +F + AF F K K + + D I
Sbjct: 5 HHMDFET---GEHQYQYKDILSVF----EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMS 57
Query: 146 K--VMRK----DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFING 199
K V T++ K K ++L ++ + F++ + R + +I
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVL-RINYKFLMS-PIKTEQRQPSMMTRMYIE- 114
Query: 200 GHLFFHLYRQGIFREDQARF--YTAEIVSAVSHLHKCGIVHRDLKPENIL----MDSDG- 252
R ++ ++Q F Y + L + +L+P + + G
Sbjct: 115 -------QRDRLYNDNQ-VFAKYNVSRLQPYLKLRQA---LLELRPAKNVLIDGVLGSGK 163
Query: 253 HVMAAHSLNSHNQLCCFFFFLFLGGGVF 280
+A S+ C F +F
Sbjct: 164 TWVALDVCLSYKVQCKMDF------KIF 185
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 282 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.98 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.98 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.98 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.98 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.98 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.83 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.58 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.42 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.38 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.45 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.87 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.58 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.35 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.28 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.2 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.11 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.65 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.08 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 84.31 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 80.46 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.01 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=332.96 Aligned_cols=167 Identities=37% Similarity=0.644 Sum_probs=153.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
+++|+++++||+|+||+||+|+++ .+++.||||++.+.........+.+.+|+++|+.++|||||+++++|.+++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~-----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 457999999999999999999987 467889999998876666666788999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.+|||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999996321
Q ss_pred -----c--chhheeeccCccc
Q 023430 267 -----C--CFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~--~~~~~~~~ape~~ 280 (282)
. -.||+.|||||++
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl 206 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELL 206 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHH
T ss_pred CCcccccCcccCcccCCHHHH
Confidence 1 1689999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=327.84 Aligned_cols=167 Identities=28% Similarity=0.487 Sum_probs=143.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||+||+|+++ .+++.||||++.+.... ....+.+.+|+.+|+.++|||||+++++|.+++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 96 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKST-----EDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENG 96 (350)
T ss_dssp CCCEEEEEEC------CEEEEEET-----TTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccceEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC
Confidence 468999999999999999999987 46788999999876543 344677899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+|||||||+||+|.+++..++ .+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999999999997643 47899999999999999999999999999999999999999999999999997432
Q ss_pred c-------chhheeeccCcccc
Q 023430 267 C-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~-------~~~~~~~~ape~~~ 281 (282)
. ..||+.|||||++.
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~ 198 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICE 198 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHT
T ss_pred CCcccccccCCCccccCHHHHC
Confidence 2 15899999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=317.77 Aligned_cols=167 Identities=27% Similarity=0.420 Sum_probs=139.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||+||+|+++ .+++.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHT-----TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECT-----TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 468999999999999999999976 467889999998776555556677999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.+||||||| +|+|.+++.+++.+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999999999 679999999889999999999999999999999999999999999999999999999999999964221
Q ss_pred -----chhheeeccCcccc
Q 023430 268 -----CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 -----~~~~~~~~ape~~~ 281 (282)
..||+.|||||++.
T Consensus 166 ~~~~~~~GT~~Y~APE~~~ 184 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVIS 184 (275)
T ss_dssp ---------CTTSCHHHHS
T ss_pred CccCCeeECcccCChhhhc
Confidence 26899999999873
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=323.78 Aligned_cols=163 Identities=21% Similarity=0.321 Sum_probs=145.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
..|+++++||+|+||+||+|+++ .+++.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~-----~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 145 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVR-----SSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE 145 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HhcEEeEEeecCcCeEEEEEEEC-----CCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 46999999999999999999987 4678899999976542 223457889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 146 ~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 146 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp EEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 9999999999999998865 569999999999999999999999999999999999999999999999999996321
Q ss_pred ----cchhheeeccCcccc
Q 023430 267 ----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ----~~~~~~~~~ape~~~ 281 (282)
.-.||+.|||||++.
T Consensus 225 ~~~~~~~GTp~YmAPEvl~ 243 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELIS 243 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHT
T ss_pred CcccccccCcCcCCHHHHC
Confidence 126899999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=329.85 Aligned_cols=164 Identities=21% Similarity=0.312 Sum_probs=146.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
...|+++++||+|+||.||+|+++ .+++.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~-----~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVR-----SSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEEC-----CCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 356999999999999999999987 4678899999976542 22345789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.+|||||||+||+|.+++.. +.+++.++..|+.||+.||+|||++|||||||||+||||+.+|.|||+|||+|+....
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 99999999999999998864 5699999999999999999999999999999999999999999999999999963211
Q ss_pred ------chhheeeccCcccc
Q 023430 268 ------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ------~~~~~~~~ape~~~ 281 (282)
-.||+.|||||++.
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~ 320 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELIS 320 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHT
T ss_pred CccccccccCcCcCCHHHHC
Confidence 26899999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=322.66 Aligned_cols=173 Identities=47% Similarity=0.768 Sum_probs=145.8
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
+..+++|++++.||+|+||+||+|++... ..+++.||||++++...... ....+.+|+.+|+.++|||||++++++.
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~ 96 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISG--SDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQ 96 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSS--TTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccC--CCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 34457899999999999999999987532 24678899999976543222 2235778999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+++.+|||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999642
Q ss_pred cc-------chhheeeccCcccc
Q 023430 266 LC-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~-------~~~~~~~~ape~~~ 281 (282)
.. ..||+.|||||++.
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~ 199 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVN 199 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHH
T ss_pred cCCCccccccccCcccCCHHHhc
Confidence 21 26899999999873
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=310.94 Aligned_cols=166 Identities=22% Similarity=0.342 Sum_probs=145.2
Q ss_pred CCe-EEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Q 023430 110 GDF-EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-- 186 (282)
Q Consensus 110 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 186 (282)
++| ++.++||+|+||+||+|.++ .++..||+|++..... .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEEC-----CCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 455 77788999999999999987 4567899999976543 33456779999999999999999999999875
Q ss_pred --CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcC-CCcEEEEecCc
Q 023430 187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDS-DGHVMAAHSLN 261 (282)
Q Consensus 187 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~-~~~v~l~Dfg~ 261 (282)
+..+|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+||||+. +|.+||+|||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 3468999999999999999998889999999999999999999999998 999999999999985 79999999999
Q ss_pred ccccccc-----hhheeeccCcccc
Q 023430 262 SHNQLCC-----FFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~~~~-----~~~~~~~ape~~~ 281 (282)
|+..... .||+.|||||+++
T Consensus 179 a~~~~~~~~~~~~GTp~YmAPE~~~ 203 (290)
T 3fpq_A 179 ATLKRASFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp GGGCCTTSBEESCSSCCCCCGGGGG
T ss_pred CEeCCCCccCCcccCccccCHHHcC
Confidence 9632222 6899999999873
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=319.25 Aligned_cols=161 Identities=22% Similarity=0.265 Sum_probs=144.2
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..+.|++.++||+|+||+||+|+++ .+++.||||+++.+.. ..+|+.+|+.++|||||++++++.++
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~-----~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~ 122 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDK-----QTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREG 122 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEET
T ss_pred chhheEeCcEeccCCCeEEEEEEEC-----CCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 3467999999999999999999987 4677899999976532 23699999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~~~ 266 (282)
+.+|||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+...
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999999999888999999999999999999999999999999999999999998 69999999996422
Q ss_pred c------------chhheeeccCcccc
Q 023430 267 C------------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~------------~~~~~~~~ape~~~ 281 (282)
. -.||+.|||||++.
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~ 229 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVM 229 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHT
T ss_pred CCCcccceecCCccccCccccCHHHHC
Confidence 1 14899999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=315.41 Aligned_cols=173 Identities=20% Similarity=0.266 Sum_probs=147.4
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|.+.+.||+|+||+||+|+++......++..||||+++... ....+.|.+|+.+|++++|||||++++++.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 45567899999999999999999998866555677889999997542 344567899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ-------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
+++.+|||||||++|+|.+++... ..+++.+++.++.||+.||.|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3589999999999999999999999999999999999999999
Q ss_pred cEEEEecCccccccc---------chhheeeccCcccc
Q 023430 253 HVMAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
.+||+|||+|+.... ..||+.|||||++.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~ 203 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM 203 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHc
Confidence 999999999963211 14789999999873
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=317.39 Aligned_cols=174 Identities=20% Similarity=0.253 Sum_probs=146.4
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+...+|.+.++||+|+||+||+|++++.....++..||||+++... ....+.|.+|+.+|++++|||||++++++
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 345556899999999999999999998865555677889999997542 34456799999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ---------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~ 249 (282)
.+.+.+|||||||++|+|.+++... +.+++.+++.|+.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999998753 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCccccccc---------chhheeeccCcccc
Q 023430 250 SDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 250 ~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
.++.+||+|||+|+.... ..||+.|||||++.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~ 233 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL 233 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHT
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhc
Confidence 999999999999973211 15789999999874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=312.31 Aligned_cols=173 Identities=17% Similarity=0.259 Sum_probs=146.1
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..+++++.++||+|+||+||+|++.+..+...+..||||+++... .....+.|.+|+.+|++++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 45567899999999999999999998766555677889999997543 2334567999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~ 249 (282)
..+.++||||||++|+|.+++... ..+++.++..++.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999643 3588999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 250 SDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 250 ~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
+++.+||+|||+|+.... ..||+.|||||++
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 219 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI 219 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHH
Confidence 999999999999974221 1568999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=310.37 Aligned_cols=168 Identities=21% Similarity=0.252 Sum_probs=145.9
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY 182 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 182 (282)
..|.+..+++++.++||+|+||+||+|++++ .||||+++... ......+.|.+|+.+|++++|||||++++
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g 99 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMG 99 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3467888999999999999999999998652 48999987543 23445677999999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
++. ++.+|||||||+||+|.+++... ..+++.++..|+.||+.||.|||+++||||||||+||||++++.+||+|||+
T Consensus 100 ~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 100 YMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp EEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred EEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccC
Confidence 875 45689999999999999999764 5699999999999999999999999999999999999999999999999999
Q ss_pred ccccc---------cchhheeeccCccc
Q 023430 262 SHNQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~---------~~~~~~~~~ape~~ 280 (282)
|+... ...||+.|||||++
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l 206 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVI 206 (307)
T ss_dssp CBC------------CCCCTTSCCHHHH
T ss_pred ceecccCCcceeecccccCCCccCHHHh
Confidence 96321 11689999999987
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=307.19 Aligned_cols=165 Identities=26% Similarity=0.329 Sum_probs=137.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS- 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 188 (282)
++|++++.||+|+||+||+|+++ .+++.||||++.... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK-----VDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET-----TTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred hhCEEeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 36999999999999999999987 456789999997543 2334567889999999999999999999987654
Q ss_pred -----------EEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcE
Q 023430 189 -----------KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254 (282)
Q Consensus 189 -----------~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v 254 (282)
.+|||||||++|+|.+++..... ..+..++.++.||+.||+|||++|||||||||+||||+.+|.+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcE
Confidence 37999999999999999987654 3456788999999999999999999999999999999999999
Q ss_pred EEEecCccccccc-------------------chhheeeccCcccc
Q 023430 255 MAAHSLNSHNQLC-------------------CFFFFLFLGGGVFN 281 (282)
Q Consensus 255 ~l~Dfg~s~~~~~-------------------~~~~~~~~ape~~~ 281 (282)
||+|||+|+.... ..||+.|||||++.
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 203 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence 9999999964221 14899999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=325.84 Aligned_cols=171 Identities=36% Similarity=0.616 Sum_probs=150.6
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHH---HHHHHhcCCCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~nIv~l~ 181 (282)
..+..++|+++++||+|+||+||+|+++ .+++.||||++.+...........+.+| +.+++.++|||||+++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~-----~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~ 258 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence 3567789999999999999999999987 4678999999987665444444444444 5566778899999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
++|.+.+.+|||||||+||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+
T Consensus 259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 259 YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence 99999999999999999999999999989999999999999999999999999999999999999999999999999999
Q ss_pred ccccc-----cchhheeeccCccc
Q 023430 262 SHNQL-----CCFFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~-----~~~~~~~~~ape~~ 280 (282)
|+... ...||+.|||||++
T Consensus 339 A~~~~~~~~~t~~GTp~YmAPEvl 362 (689)
T 3v5w_A 339 ACDFSKKKPHASVGTHGYMAPEVL 362 (689)
T ss_dssp CEECSSCCCCSCCSCGGGCCHHHH
T ss_pred eeecCCCCCCCccCCcCccCHHHH
Confidence 96322 22789999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=308.27 Aligned_cols=176 Identities=19% Similarity=0.274 Sum_probs=151.9
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CCeeeee
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLR 181 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~ 181 (282)
..|.+..++|++.+.||+|+||+||+|+++++......+.||||++.... .....+.+.+|+.+|++++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34678888999999999999999999999887666677889999997653 23345678899999999975 8999999
Q ss_pred EEEEeC-CEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCC
Q 023430 182 YSFQTR-SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244 (282)
Q Consensus 182 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~ 244 (282)
+++... +.+|||||||++|+|.+++... ..+++.+++.++.||+.||.|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 998764 5789999999999999999753 34789999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 245 NILMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 245 NILl~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
|||+++++.+||+|||+|+....+ .||+.|||||++
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l 259 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 259 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence 999999999999999999742211 468899999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=306.40 Aligned_cols=164 Identities=17% Similarity=0.324 Sum_probs=144.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
++|++++.||+|+||+||+|+++ .+++.||||++++... .....+.+.+|+.+|+.++|||||++++++...
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~-----~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR-----LTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCeEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 57999999999999999999987 4678899999976542 233456688999999999999999999987643
Q ss_pred ----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+.+|||||||+ |+|.+++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 128 ~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 128 YGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceee
Confidence 57999999996 6799999888889999999999999999999999999999999999999999999999999996
Q ss_pred ccc-----------cchhheeeccCccc
Q 023430 264 NQL-----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~-----------~~~~~~~~~ape~~ 280 (282)
... .-.||+.|||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~ 234 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELM 234 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHH
T ss_pred ecccCccccccccccceeChHhcCHHHh
Confidence 321 12689999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=290.74 Aligned_cols=158 Identities=23% Similarity=0.265 Sum_probs=133.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-- 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 188 (282)
+|.+.++||+|+||+||+|+++ +..||||++..... .......|+..+..++|||||++++++...+
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-------g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-------TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 6899999999999999999864 46799999865431 1122345666677899999999999998654
Q ss_pred --EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEeeccCCCceEEcCCCcEEEEe
Q 023430 189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 189 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~--------~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
.+|||||||++|+|.+++... .+++..+..++.|++.||.|||++ +||||||||+||||+.++.+||+|
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 689999999999999999754 589999999999999999999987 899999999999999999999999
Q ss_pred cCccccccc-----------chhheeeccCccc
Q 023430 259 SLNSHNQLC-----------CFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~~-----------~~~~~~~~ape~~ 280 (282)
||+|+.... ..||+.|||||++
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l 184 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHH
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHh
Confidence 999863211 1589999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=290.71 Aligned_cols=145 Identities=21% Similarity=0.334 Sum_probs=128.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 187 (282)
.+.|++.++||+|+||+||+|+++.. ..+++.||+|++.+.. ....+.+|+++|+.+ +|||||+++++|.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred cCcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 35799999999999999999987531 1356789999886542 234577899999998 599999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-CcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-~~v~l~Dfg~s~ 263 (282)
+.+|||||||+||+|.+++. .+++.+++.++.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999999883 58999999999999999999999999999999999999877 899999999996
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.57 Aligned_cols=165 Identities=24% Similarity=0.389 Sum_probs=146.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||+||+|+++ .+++.||+|++..... ...+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~-----~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 368999999999999999999987 4677899999976532 23456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC--CcEEEEecCccccc
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~--~~v~l~Dfg~s~~~ 265 (282)
.+|||||||+||+|.+++.. .+.+++.+++.+++||+.||.|||++||+||||||+|||++.+ |.+||+|||+|+..
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999999999864 4579999999999999999999999999999999999999854 89999999999742
Q ss_pred cc------chhheeeccCcccc
Q 023430 266 LC------CFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~------~~~~~~~~ape~~~ 281 (282)
.. ..||+.|||||++.
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~ 329 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAE 329 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHT
T ss_pred cCCCceeeeEECccccCHHHhC
Confidence 21 26899999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=276.29 Aligned_cols=170 Identities=39% Similarity=0.705 Sum_probs=153.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++++.||+|+||.||+|+++ .+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 34578999999999999999999977 4577899999987765555566778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997422
Q ss_pred c-------chhheeeccCcccc
Q 023430 267 C-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~-------~~~~~~~~ape~~~ 281 (282)
. ..||+.|||||++.
T Consensus 157 ~~~~~~~~~~gt~~y~aPE~~~ 178 (337)
T 1o6l_A 157 SDGATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGS
T ss_pred cCCCcccccccChhhCChhhhc
Confidence 1 25799999999873
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=278.49 Aligned_cols=171 Identities=38% Similarity=0.724 Sum_probs=150.5
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
..+..++|+++++||+|+||.||+|+++ .+++.||||++.+.........+.+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 92 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCC 92 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEc-----CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEE
Confidence 3456789999999999999999999987 45778999999887655566667788899999988 69999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+.+.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 93 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 93 FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence 99999999999999999999999888889999999999999999999999999999999999999999999999999997
Q ss_pred ccccc-------hhheeeccCccc
Q 023430 264 NQLCC-------FFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~~-------~~~~~~~ape~~ 280 (282)
..... .||+.|||||++
T Consensus 173 ~~~~~~~~~~~~~gt~~y~aPE~~ 196 (353)
T 3txo_A 173 EGICNGVTTATFCGTPDYIAPEIL 196 (353)
T ss_dssp CSCC---------CCGGGCCHHHH
T ss_pred ecccCCccccccCCCcCeEChhhc
Confidence 53222 579999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=281.36 Aligned_cols=172 Identities=36% Similarity=0.707 Sum_probs=150.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
..+..++|+++++||+|+||.||+|+++ .+++.||+|++++.........+.+.+|+.+++.+ +||||++++++
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~ 121 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence 3456779999999999999999999987 45778999999877655555556688899999887 79999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+.+.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 122 FQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence 99999999999999999999999888889999999999999999999999999999999999999999999999999997
Q ss_pred cccc-------chhheeeccCcccc
Q 023430 264 NQLC-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~-------~~~~~~~~ape~~~ 281 (282)
.... ..||+.|||||++.
T Consensus 202 ~~~~~~~~~~~~~gt~~Y~aPE~l~ 226 (396)
T 4dc2_A 202 EGLRPGDTTSTFCGTPNYIAPEILR 226 (396)
T ss_dssp CCCCTTCCBCCCCBCGGGCCHHHHT
T ss_pred ecccCCCccccccCCcccCCchhhc
Confidence 4221 26799999999873
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.71 Aligned_cols=171 Identities=34% Similarity=0.616 Sum_probs=154.6
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++++.||+|+||.||+|+++ .+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455678999999999999999999987 457789999998776556666777889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+...+|+||||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999999632
Q ss_pred ------ccchhheeeccCcccc
Q 023430 266 ------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ------~~~~~~~~~~ape~~~ 281 (282)
....||+.|||||++.
T Consensus 166 ~~~~~~~~~~gt~~Y~aPE~~~ 187 (384)
T 4fr4_A 166 PRETQITTMAGTKPYMAPEMFS 187 (384)
T ss_dssp CTTCCBCCCCSCGGGCCGGGTC
T ss_pred cCCCceeccCCCccccCCeeec
Confidence 1226799999999873
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=271.99 Aligned_cols=170 Identities=37% Similarity=0.718 Sum_probs=152.8
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 184 (282)
.+..++|++++.||+|+||.||+|+++ .+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 345678999999999999999999987 45778999999877655556667788999999987 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+.+.+|+||||+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 80 ~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 80 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999974
Q ss_pred cc-------cchhheeeccCccc
Q 023430 265 QL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~-------~~~~~~~~~ape~~ 280 (282)
.. ...||+.|||||++
T Consensus 160 ~~~~~~~~~~~~gt~~y~aPE~~ 182 (345)
T 3a8x_A 160 GLRPGDTTSTFCGTPNYIAPEIL 182 (345)
T ss_dssp SCCTTCCBCCCCSCGGGCCHHHH
T ss_pred ccCCCCcccccCCCccccCcccc
Confidence 22 12679999999986
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=282.45 Aligned_cols=172 Identities=35% Similarity=0.623 Sum_probs=152.3
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
...+..++|+++++||+|+||+||+|+++ ..++.||+|++.+.........+.+.+|+.+++.++||||++++++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEc-----CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34566789999999999999999999987 4567899999987554444444557889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+.+.+.+|+|||||+||+|.+++.+ .+.+++..++.++.|++.||.|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 9999999999999999999999987 467999999999999999999999999999999999999999999999999999
Q ss_pred ccccc--------chhheeeccCccc
Q 023430 263 HNQLC--------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~--------~~~~~~~~ape~~ 280 (282)
+.... ..||+.|||||++
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l 248 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEIL 248 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHH
T ss_pred hhcccCCCcccccccCCcCeeChHHH
Confidence 53221 2689999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=272.09 Aligned_cols=170 Identities=32% Similarity=0.623 Sum_probs=150.4
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 184 (282)
.+..++|++.+.||+|+||.||+|+++ .+++.||||++++.........+.+..|..+++.+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 456789999999999999999999987 45778999999876554455566778899999876 899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999974
Q ss_pred cc-------cchhheeeccCccc
Q 023430 265 QL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~-------~~~~~~~~~ape~~ 280 (282)
.. ...||+.|||||++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~ 190 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEIL 190 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHH
T ss_pred cccCCCcccCCCCCcccCChhhh
Confidence 22 12679999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=269.91 Aligned_cols=169 Identities=34% Similarity=0.604 Sum_probs=152.1
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|+.+ .+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence 4568999999999999999999976 45778999999876554445567788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
..+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999999999988889999999999999999999999999999999999999999999999999996422
Q ss_pred ---cchhheeeccCcccc
Q 023430 267 ---CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ---~~~~~~~~~ape~~~ 281 (282)
...||+.|||||++.
T Consensus 159 ~~~~~~gt~~y~aPE~~~ 176 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVS 176 (318)
T ss_dssp CBCCCCSCTTTCCHHHHT
T ss_pred ccccccCCccccCHhHhc
Confidence 236799999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=269.02 Aligned_cols=167 Identities=30% Similarity=0.430 Sum_probs=149.8
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++++.||+|+||.||+|++. .+++.||||++.+... .....+.+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 86 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHI-----LTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE 86 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3578999999999999999999986 4567899999977543 334456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
+.+|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999999999999888889999999999999999999999999999999999999999999999999996321
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|++.|+|||.+
T Consensus 167 ~~~~~~~~gt~~y~aPE~~ 185 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELF 185 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHH
T ss_pred CCccccccCCcceeCcccc
Confidence 22679999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=272.07 Aligned_cols=171 Identities=34% Similarity=0.602 Sum_probs=154.0
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.....++|++++.||+|+||.||+|+++ .+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 110 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF 110 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEEC-----CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 3456679999999999999999999987 45678999999877655555667788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+...+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 111 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 111 KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccccee
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999964
Q ss_pred cc----cchhheeeccCccc
Q 023430 265 QL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~----~~~~~~~~~ape~~ 280 (282)
.. ...||+.|||||++
T Consensus 191 ~~~~~~~~~gt~~y~aPE~~ 210 (350)
T 1rdq_E 191 VKGRTWTLCGTPEALAPEII 210 (350)
T ss_dssp CSSCBCCCEECGGGCCHHHH
T ss_pred ccCCcccccCCccccCHHHh
Confidence 22 22679999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=277.91 Aligned_cols=173 Identities=36% Similarity=0.607 Sum_probs=153.0
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
...+..++|+++++||+|+||.||+|+++ .+++.||||++.+.........+.+.+|+.++..++||||++++++
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~-----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 44567789999999999999999999987 4677899999987654444455568889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+.+.+.+|+||||++||+|..++.+. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999999875 47999999999999999999999999999999999999999999999999999
Q ss_pred ccccc--------chhheeeccCcccc
Q 023430 263 HNQLC--------CFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~--------~~~~~~~~ape~~~ 281 (282)
+.... ..||+.|||||++.
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHh
Confidence 63221 26899999999863
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.36 Aligned_cols=171 Identities=33% Similarity=0.639 Sum_probs=151.7
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 184 (282)
.+..++|++++.||+|+||.||+|+++ .+++.||||++.+.........+.+..|..++..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 456789999999999999999999987 45778999999887655555667788899999887 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+.+.+|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999975
Q ss_pred cc-------cchhheeeccCcccc
Q 023430 265 QL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~-------~~~~~~~~~ape~~~ 281 (282)
.. ...||+.|||||++.
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~ 194 (353)
T 2i0e_A 171 NIWDGVTTKTFCGTPDYIAPEIIA 194 (353)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHT
T ss_pred cccCCcccccccCCccccChhhhc
Confidence 22 125799999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.09 Aligned_cols=173 Identities=34% Similarity=0.596 Sum_probs=151.8
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY 182 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 182 (282)
....+..++|+++++||+|+||.||+|+++ .+++.||+|++.+.........+.+.+|+.+++.++||||+++++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 136 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEE
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEEC-----CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 345567789999999999999999999987 456789999998755444444455788999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
++.+...+|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|
T Consensus 137 ~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence 99999999999999999999998865 46899999999999999999999999999999999999999999999999999
Q ss_pred cccc--------cchhheeeccCcccc
Q 023430 263 HNQL--------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~--------~~~~~~~~~ape~~~ 281 (282)
+... ...||+.|||||++.
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~ 242 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLK 242 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHH
T ss_pred EeeccCCcccccCCcCCccccCHHHhh
Confidence 5321 226899999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=273.47 Aligned_cols=169 Identities=45% Similarity=0.766 Sum_probs=141.0
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHH-HHhcCCCCeeeeeEEEEe
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI-LTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~ 186 (282)
..++|++++.||+|+||.||+|+++ .++..||||++.+.........+.+.+|..+ ++.++||||+++++++.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHK-----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEET-----TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEc-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence 3468999999999999999999987 4567899999987765444455556677776 577899999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997522
Q ss_pred c-------chhheeeccCcccc
Q 023430 267 C-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~-------~~~~~~~~ape~~~ 281 (282)
. ..||+.|||||++.
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~ 212 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLH 212 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHT
T ss_pred cCCCccccccCCccccCHHHhC
Confidence 1 26799999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=260.15 Aligned_cols=168 Identities=21% Similarity=0.260 Sum_probs=148.9
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|++. ..+..||+|++...........+.+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDT-----ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEET-----TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEEC-----CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 3468999999999999999999976 45678999998765544555667889999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
+..|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999963221
Q ss_pred --------chhheeeccCccc
Q 023430 268 --------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 --------~~~~~~~~ape~~ 280 (282)
..|++.|||||.+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~ 184 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQA 184 (294)
T ss_dssp -----------CCSSCCHHHH
T ss_pred ccccccCccccCccccCHhHh
Confidence 1579999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=265.30 Aligned_cols=167 Identities=27% Similarity=0.387 Sum_probs=149.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.+. .++..||+|++.+.........+.+.+|+.+++.++||||+++++++....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHY-----KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 478999999999999999999986 456789999998765444444567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc---
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ--- 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~--- 265 (282)
..++||||+ +|+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999999999 6899999988888999999999999999999999999999999999999999999999999998632
Q ss_pred ---ccchhheeeccCcccc
Q 023430 266 ---LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ---~~~~~~~~~~ape~~~ 281 (282)
....|++.|+|||.+.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~ 180 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVIN 180 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSC
T ss_pred cccccccCCcCcCCHHHHc
Confidence 2226799999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=265.61 Aligned_cols=168 Identities=28% Similarity=0.402 Sum_probs=148.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+.|++.+.||+|+||.||+|+++ .++..||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC-----CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 357999999999999999999987 4567899999986543221 13466889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC----cEEEEecCc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMAAHSLN 261 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~----~v~l~Dfg~ 261 (282)
....+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999999998888899999999999999999999999999999999999998877 799999999
Q ss_pred ccccc------cchhheeeccCcccc
Q 023430 262 SHNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~~------~~~~~~~~~ape~~~ 281 (282)
+.... ...|++.|||||++.
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~ 191 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVN 191 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred ceEcCCCCccccCCCCccEECchHHc
Confidence 96422 226899999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=277.52 Aligned_cols=172 Identities=35% Similarity=0.586 Sum_probs=152.8
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.++||+|+||.||+|+++ .+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 253 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY 253 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE
Confidence 3466788999999999999999999987 45778999999876655555566788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+.+.+|+||||++||+|..++...+. +++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||++
T Consensus 254 ~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla 333 (576)
T 2acx_A 254 ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333 (576)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccc
Confidence 999999999999999999999876543 899999999999999999999999999999999999999999999999999
Q ss_pred ccc------ccchhheeeccCcccc
Q 023430 263 HNQ------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~------~~~~~~~~~~ape~~~ 281 (282)
... ....||+.|||||++.
T Consensus 334 ~~~~~~~~~~~~~GT~~Y~APEvl~ 358 (576)
T 2acx_A 334 VHVPEGQTIKGRVGTVGYMAPEVVK 358 (576)
T ss_dssp EECCTTCCEECCCSCGGGCCHHHHT
T ss_pred eecccCccccccCCCccccCHHHHc
Confidence 642 1236799999999873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.42 Aligned_cols=170 Identities=40% Similarity=0.702 Sum_probs=142.8
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++++.||+|+||.||+|+++ ..+..||||++.............+.+|+.+++.++||||+++++++.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEc-----CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 445678999999999999999999977 457789999998765545555666788999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..+.+|+||||+++|+|..++...+.+++..+..++.||+.||.|||+ +|||||||||+|||++.++.+||+|||+|+.
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred eCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999999999999888889999999999999999999998 9999999999999999999999999999974
Q ss_pred ccc-------chhheeeccCccc
Q 023430 265 QLC-------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~-------~~~~~~~~ape~~ 280 (282)
... ..||+.|||||++
T Consensus 299 ~~~~~~~~~~~~gt~~y~aPE~~ 321 (446)
T 4ejn_A 299 GIKDGATMKTFCGTPEYLAPEVL 321 (446)
T ss_dssp TCC-----CCSSSCGGGCCHHHH
T ss_pred ccCCCcccccccCCccccCHhhc
Confidence 222 2579999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=261.43 Aligned_cols=173 Identities=46% Similarity=0.774 Sum_probs=142.4
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-hhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.+..++|++.+.||+|+||.||+|++... ...++.||+|++.+.... .......+.+|+.+|+.++||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTG--ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSS--TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEecc--CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 45567899999999999999999987521 246788999999765422 122345577899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
...+.+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999998888899999999999999999999999999999999999999999999999999864
Q ss_pred ccc-------chhheeeccCccc
Q 023430 265 QLC-------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~-------~~~~~~~~ape~~ 280 (282)
... ..|++.|||||.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~ 193 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEIL 193 (327)
T ss_dssp --------CTTSSCCTTSCHHHH
T ss_pred cccCCccccccCCCcCccCHhhC
Confidence 321 2579999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=255.88 Aligned_cols=167 Identities=20% Similarity=0.325 Sum_probs=147.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.++||+|+||.||+|.++ .++..||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHR-----ETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEEC-----CCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 34578999999999999999999987 45678999988543 23455678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999999999999999987 466899999999999999999999999999999999999999999999999999632
Q ss_pred c---------------------cchhheeeccCcccc
Q 023430 266 L---------------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~---------------------~~~~~~~~~ape~~~ 281 (282)
. ...|++.|||||.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHT
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhc
Confidence 1 225789999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-36 Score=264.62 Aligned_cols=174 Identities=17% Similarity=0.257 Sum_probs=148.0
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
+.+..++|++.+.||+|+||.||+|++.+... ...+..||||+++... .....+.+.+|+.+|+.+ +||||++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 44556789999999999999999999864322 2345679999997653 334456788999999999 899999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
+++...+.+|+||||+++|+|.+++.... .+++.++..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 47889999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCcccccc---------cchhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~---------~~~~~~~~~ape~~ 280 (282)
||++.++.+||+|||+++... ...+++.|||||++
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 277 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh
Confidence 999999999999999996321 12446789999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-36 Score=283.43 Aligned_cols=171 Identities=33% Similarity=0.638 Sum_probs=151.4
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 184 (282)
.+..++|+++++||+|+||.||+|+++ .+++.||||++++.........+.+..|..+|..+ +|++|+++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEES-----SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccceEEEEEEccCCCEEEEEEEEC-----CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 456789999999999999999999987 45678999999876555555566788899999887 699999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+.+.+||||||++||+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999974
Q ss_pred ccc-------chhheeeccCcccc
Q 023430 265 QLC-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~-------~~~~~~~~ape~~~ 281 (282)
... -.||+.|||||++.
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~ 515 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIA 515 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHT
T ss_pred cccCCcccccccCCCcccCHhhhc
Confidence 322 15799999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=274.31 Aligned_cols=172 Identities=37% Similarity=0.583 Sum_probs=152.8
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.++||+|+||.||+|+++ .+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4567789999999999999999999987 45778999999877655555567788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
.....+|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFG 334 (543)
T 3c4z_A 255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLG 334 (543)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecc
Confidence 9999999999999999999998764 358999999999999999999999999999999999999999999999999
Q ss_pred cccccc-------cchhheeeccCcccc
Q 023430 261 NSHNQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~~-------~~~~~~~~~ape~~~ 281 (282)
++.... ...||+.|||||++.
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~ 362 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLL 362 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHT
T ss_pred eeeeccCCCcccccccCCccccChhhhc
Confidence 996321 126899999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=273.68 Aligned_cols=171 Identities=26% Similarity=0.391 Sum_probs=152.8
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|.+.+.||+|+||.||+|+++ .++..||||++.+.........+.+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHE-----LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEET-----TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 344678999999999999999999977 456789999998765544455677899999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+.+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999999642
Q ss_pred c------cchhheeeccCcccc
Q 023430 266 L------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~------~~~~~~~~~ape~~~ 281 (282)
. ...|++.|+|||.+.
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~ 188 (476)
T 2y94_A 167 SDGEFLRTSCGSPNYAAPEVIS 188 (476)
T ss_dssp CTTCCBCCCCSCSTTCCHHHHT
T ss_pred cccccccccCCCcCeEChhhcc
Confidence 1 226799999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=268.78 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=145.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ .++..||+|++...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~-----~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKV-----LAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEET-----TTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred CCeEEEEEeccCCCeEEEEEEEC-----CCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 47999999999999999999977 46778999999765432 3345668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc---CCCcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~---~~~~v~l~Dfg~s~~~~ 266 (282)
.|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 999999999999999999888899999999999999999999999999999999999998 46889999999995322
Q ss_pred -------cchhheeeccCcccc
Q 023430 267 -------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -------~~~~~~~~~ape~~~ 281 (282)
...|++.|||||++.
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~ 186 (444)
T 3soa_A 165 GEQQAWFGFAGTPGYLSPEVLR 186 (444)
T ss_dssp TTCCBCCCSCSCGGGCCHHHHT
T ss_pred CCCceeecccCCcccCCHHHhc
Confidence 126799999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=262.41 Aligned_cols=166 Identities=28% Similarity=0.412 Sum_probs=146.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ .++..||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 102 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 102 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCeEEeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 46999999999999999999977 4567899999976543 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC---cEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~---~v~l~Dfg~s~~~~ 266 (282)
.|+||||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 999999999999999998888899999999999999999999999999999999999998654 59999999996422
Q ss_pred ------cchhheeeccCcccc
Q 023430 267 ------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ------~~~~~~~~~ape~~~ 281 (282)
...|++.|||||++.
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~ 203 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLK 203 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHT
T ss_pred CCcccccCCCCccccCHHHHc
Confidence 126799999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=261.18 Aligned_cols=163 Identities=26% Similarity=0.420 Sum_probs=140.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||.||+++++ .+++.||+|++...... .+.+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 89 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDK-----LTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPT 89 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEET-----TTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CCcEEEEEEeccCCCEEEEEEEEC-----CCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCC
Confidence 468999999999999999999987 45778999999764322 244778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc--EEEEecCcccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMAAHSLNSHNQL 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~--v~l~Dfg~s~~~~ 266 (282)
.+|+||||+.+|+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 99999999999999999988888999999999999999999999999999999999999987765 9999999986322
Q ss_pred ------cchhheeeccCccc
Q 023430 267 ------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ------~~~~~~~~~ape~~ 280 (282)
...|++.|||||++
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~ 189 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVL 189 (361)
T ss_dssp -----------CTTSCHHHH
T ss_pred ccCCCCCCcCCCCcCChhhh
Confidence 22679999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=254.78 Aligned_cols=163 Identities=21% Similarity=0.308 Sum_probs=144.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.+. ..++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBT-----TTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhceeeeeeeccCCCeEEEEEEEC-----CCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 457999999999999999999866 4577899999876542 23456788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc---
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ--- 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~--- 265 (282)
..|+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999999999998764 6899999999999999999999999999999999999999999999999998532
Q ss_pred ----ccchhheeeccCccc
Q 023430 266 ----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ----~~~~~~~~~~ape~~ 280 (282)
....|++.|||||.+
T Consensus 170 ~~~~~~~~gt~~y~aPE~~ 188 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVV 188 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHH
T ss_pred ccccCCccCCcCccChhhh
Confidence 122679999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=252.96 Aligned_cols=165 Identities=21% Similarity=0.359 Sum_probs=142.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++++.||+|+||.||+|+++ .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCceeeeEecCCCCeEEEEEEEC-----CCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence 58999999999999999999987 4567899999976542 33445667889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc----
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ---- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~---- 265 (282)
+++||||++++.+..+....+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9999999987444444444677999999999999999999999999999999999999999999999999999632
Q ss_pred ---ccchhheeeccCccc
Q 023430 266 ---LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ---~~~~~~~~~~ape~~ 280 (282)
....|++.|||||.+
T Consensus 156 ~~~~~~~~t~~y~aPE~~ 173 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVL 173 (292)
T ss_dssp SCCCSCCSCGGGCCHHHH
T ss_pred ccccCCccccCCcChHHH
Confidence 122669999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=261.53 Aligned_cols=168 Identities=20% Similarity=0.342 Sum_probs=148.4
Q ss_pred CCCCeEEEeeeCcC--CCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 108 GPGDFEIFRVVGQG--AFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 108 ~~~~y~~~~~lG~G--~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
..++|+++++||+| +||.||+|+++ .++..||||++..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYK-----PTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEc-----CCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 35689999999999 99999999987 4577899999987643 3345677889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 97 ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 999999999999999999999875 669999999999999999999999999999999999999999999999999874
Q ss_pred ccc--------------cchhheeeccCcccc
Q 023430 264 NQL--------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~--------------~~~~~~~~~ape~~~ 281 (282)
... ...|++.|||||++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 208 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHS
T ss_pred eeccccccccccccccccccccccccCHHHHh
Confidence 221 126788899999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=250.92 Aligned_cols=171 Identities=30% Similarity=0.442 Sum_probs=151.3
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|+++ ..+..||+|++...........+.+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 445678999999999999999999977 456789999997765544455667889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.....++||||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999988532
Q ss_pred c-----cchhheeeccCcccc
Q 023430 266 L-----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~-----~~~~~~~~~ape~~~ 281 (282)
. ...|++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~ 180 (279)
T 3fdn_A 160 PSSRRTDLCGTLDYLPPEMIE 180 (279)
T ss_dssp --------CCCCTTCCHHHHT
T ss_pred CcccccccCCCCCccCHhHhc
Confidence 2 226799999999863
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=254.93 Aligned_cols=164 Identities=23% Similarity=0.334 Sum_probs=144.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.++ .++..||+|++.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred hhceEeeeEEecCCCeEEEEEEEC-----CCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC
Confidence 468999999999999999999977 457789999986542 23355788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC--CCcEEEEecCccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~--~~~v~l~Dfg~s~~~ 265 (282)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 75 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999999999999765 36899999999999999999999999999999999999987 789999999999642
Q ss_pred c------cchhheeeccCcccc
Q 023430 266 L------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~------~~~~~~~~~ape~~~ 281 (282)
. ...|++.|||||.+.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~ 176 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQ 176 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHT
T ss_pred CCCCccccccCChhhcCcHHhc
Confidence 1 226799999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=259.19 Aligned_cols=167 Identities=20% Similarity=0.264 Sum_probs=144.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+++ ..++.||||++...........+.+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDL-----RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEEC-----CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 468999999999999999999976 457789999998765555556677889999999999999999999987643
Q ss_pred ----EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 189 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..|+||||+++++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3599999999999999998888899999999999999999999999999999999999999999999999999863
Q ss_pred ccc----------chhheeeccCccc
Q 023430 265 QLC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~----------~~~~~~~~ape~~ 280 (282)
... ..|++.|||||.+
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 191 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQA 191 (311)
T ss_dssp ----------------CCTTCCHHHH
T ss_pred ccccccccccccccCcCcccCCHHHh
Confidence 211 2479999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=259.43 Aligned_cols=165 Identities=22% Similarity=0.329 Sum_probs=143.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+++ ..++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhceeeeEEecCCCEEEEEEEEC-----CCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 468999999999999999999977 4567899999865432 222355788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+||||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999999999998777789999999999999999999999999999999999999999999999999996321
Q ss_pred -------cchhheeeccCccc
Q 023430 267 -------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -------~~~~~~~~~ape~~ 280 (282)
...|++.|||||.+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~ 179 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELL 179 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHH
T ss_pred CcccccCCCccCcCccCcHHh
Confidence 22679999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=258.40 Aligned_cols=167 Identities=23% Similarity=0.405 Sum_probs=143.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh--hHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK--NHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
+.|++.+.||+|+||.||+|.++ .+++.||||++........ ...+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cceEEeeEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 46999999999999999999977 4567899999976543221 2346688999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc---EEEEecC
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMAAHSL 260 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~---v~l~Dfg 260 (282)
+.+|+|||||++++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999999998877543 34899999999999999999999999999999999999987655 9999999
Q ss_pred cccccc-------cchhheeeccCcccc
Q 023430 261 NSHNQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~~-------~~~~~~~~~ape~~~ 281 (282)
++.... ...|++.|||||.+.
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVK 206 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHT
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHc
Confidence 996422 125799999999873
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=255.08 Aligned_cols=167 Identities=25% Similarity=0.378 Sum_probs=146.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh---hhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+.|++.+.||+|+||.||+|.++ .++..||+|++....... ....+.+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEeceEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46999999999999999999977 456789999997654221 1135668899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC----cEEEEecCcc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMAAHSLNS 262 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~----~v~l~Dfg~s 262 (282)
....++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998878899999999999999999999999999999999999999887 8999999999
Q ss_pred cccc------cchhheeeccCcccc
Q 023430 263 HNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~------~~~~~~~~~ape~~~ 281 (282)
.... ...|++.|||||.+.
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~ 190 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVN 190 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHT
T ss_pred eECCCCCccccccCCcCcCCceeec
Confidence 6421 226799999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=255.31 Aligned_cols=164 Identities=27% Similarity=0.330 Sum_probs=139.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS- 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 188 (282)
++|++.+.||+|+||.||+|+++ .+++.||||++.... .....+.+.+|+.+|+.++||||++++++|....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK-----VDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET-----TTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEc-----CCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 47999999999999999999987 456789999997543 2334567889999999999999999999986543
Q ss_pred --------------------------------------------------------EEEEEEeccCCCchHHHHHhcCC-
Q 023430 189 --------------------------------------------------------KLYLILDFINGGHLFFHLYRQGI- 211 (282)
Q Consensus 189 --------------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~- 211 (282)
.+++|||||++++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 38999999999999999987543
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------------------chh
Q 023430 212 --FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-------------------CFF 270 (282)
Q Consensus 212 --~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-------------------~~~ 270 (282)
..+..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 45667899999999999999999999999999999999999999999999864322 258
Q ss_pred heeeccCccc
Q 023430 271 FFLFLGGGVF 280 (282)
Q Consensus 271 ~~~~~ape~~ 280 (282)
++.|+|||.+
T Consensus 239 t~~y~aPE~~ 248 (332)
T 3qd2_B 239 TKLYMSPEQI 248 (332)
T ss_dssp CGGGSCHHHH
T ss_pred CcCccChHHh
Confidence 9999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=260.65 Aligned_cols=176 Identities=19% Similarity=0.273 Sum_probs=150.1
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
..+.+..++|++.+.||+|+||.||+|++.+......++.||||++.... .....+.+.+|+.+++.+ +||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 44566778999999999999999999998765555677899999997643 233456688999999999 789999999
Q ss_pred EEEEeCC-EEEEEEeccCCCchHHHHHhcCC-------------------------------------------------
Q 023430 182 YSFQTRS-KLYLILDFINGGHLFFHLYRQGI------------------------------------------------- 211 (282)
Q Consensus 182 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------- 211 (282)
+++...+ .+++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 49999999999999999976432
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-------
Q 023430 212 -----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC------- 267 (282)
Q Consensus 212 -----------------~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~------- 267 (282)
+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 88999999999999999999999999999999999999999999999999963211
Q ss_pred --chhheeeccCccc
Q 023430 268 --CFFFFLFLGGGVF 280 (282)
Q Consensus 268 --~~~~~~~~ape~~ 280 (282)
..|++.|||||.+
T Consensus 253 ~~~~~t~~y~aPE~~ 267 (359)
T 3vhe_A 253 GDARLPLKWMAPETI 267 (359)
T ss_dssp --CEECGGGCCHHHH
T ss_pred cccCCCceeEChhhh
Confidence 1457789999976
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=255.67 Aligned_cols=172 Identities=19% Similarity=0.202 Sum_probs=146.8
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|+++..+ ..+..||||++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPG--QRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTT--SCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCC--CCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 455678999999999999999999987432 345679999997543 2344567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..+..|+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999999999999754 5699999999999999999999999999999999999999999999999999964
Q ss_pred cccc----------hhheeeccCcccc
Q 023430 265 QLCC----------FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~~----------~~~~~~~ape~~~ 281 (282)
...+ .+++.|||||.+.
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~ 227 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIA 227 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHH
T ss_pred cccCccceeeccCCCCcccccCHhHhc
Confidence 3211 3356799999863
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=255.23 Aligned_cols=170 Identities=22% Similarity=0.314 Sum_probs=142.6
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
...+..++|++.+.||+|+||.||+|++. +..||||++..... .....+.+.+|+.+++.++||||++++++
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWH-------GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEEC-------CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34566779999999999999999999854 45699999876543 33445678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcCCCcEEEEe
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~~~~v~l~D 258 (282)
+...+..++||||+++|+|.+++...+. +++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 9999999999999999999999976543 899999999999999999999999 99999999999999999999999
Q ss_pred cCcccccc-------cchhheeeccCcccc
Q 023430 259 SLNSHNQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 259 fg~s~~~~-------~~~~~~~~~ape~~~ 281 (282)
||++.... ...|++.|+|||.+.
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212 (309)
T ss_dssp CC-----------------CCTTSCHHHHT
T ss_pred CCCCccccccccccccCCCCccccChhhhc
Confidence 99996322 236799999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=260.13 Aligned_cols=171 Identities=13% Similarity=0.262 Sum_probs=142.4
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~ 181 (282)
..+..++|.+.++||+|+||.||+|.++...+...++.||+|++.... .+.+.+|+.+++.++ |+||++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 345567899999999999999999975443344577889999986542 234677888888887 99999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC------
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS------ 250 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~------ 250 (282)
+++...+..|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred -----CCcEEEEecCccccc---------ccchhheeeccCcccc
Q 023430 251 -----DGHVMAAHSLNSHNQ---------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 251 -----~~~v~l~Dfg~s~~~---------~~~~~~~~~~ape~~~ 281 (282)
++.+||+|||+|... ....||+.|||||++.
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 258 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS 258 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc
Confidence 899999999999521 1225799999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=261.25 Aligned_cols=173 Identities=18% Similarity=0.255 Sum_probs=144.6
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|++.+......+..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 34557899999999999999999998765455577889999986532 2333456788999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC---cEE
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVM 255 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~---~v~ 255 (282)
.....|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999997643 488999999999999999999999999999999999999655 499
Q ss_pred EEecCcccc---------cccchhheeeccCccc
Q 023430 256 AAHSLNSHN---------QLCCFFFFLFLGGGVF 280 (282)
Q Consensus 256 l~Dfg~s~~---------~~~~~~~~~~~ape~~ 280 (282)
|+|||+++. ..+..+++.|||||.+
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 258 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF 258 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHh
Confidence 999999952 2223568899999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=256.27 Aligned_cols=174 Identities=20% Similarity=0.247 Sum_probs=150.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.+.||+|+||.||+|++.+......+..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 455667899999999999999999998765444566889999997643 234456788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeec
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ------------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRD 240 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrD 240 (282)
...+..|+||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999999763 4689999999999999999999999999999
Q ss_pred cCCCceEEcCCCcEEEEecCccccc---------ccchhheeeccCccc
Q 023430 241 LKPENILMDSDGHVMAAHSLNSHNQ---------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 241 lKp~NILl~~~~~v~l~Dfg~s~~~---------~~~~~~~~~~ape~~ 280 (282)
|||+|||++.++.+||+|||++... ....+++.|+|||.+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 248 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI 248 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhh
Confidence 9999999999999999999998532 122457889999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=244.89 Aligned_cols=171 Identities=27% Similarity=0.385 Sum_probs=146.9
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|+++ ..++.||+|++...........+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQ-----LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEEC-----CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 345678999999999999999999976 356789999998765444555677889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998643
Q ss_pred c------cchhheeeccCcccc
Q 023430 266 L------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~------~~~~~~~~~ape~~~ 281 (282)
. ...+++.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~ 183 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVIS 183 (276)
T ss_dssp CC-------------CCTGGGT
T ss_pred CCCcceecccCCccccCHHHHc
Confidence 2 236799999999873
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=251.22 Aligned_cols=168 Identities=27% Similarity=0.469 Sum_probs=139.3
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-----------------------hhHHHHHHH
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----------------------KNHVDYMKA 164 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~ 164 (282)
..++|++.+.||+|+||.||+|+++ ..+..||||++....... ....+.+.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 85 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNE-----NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ 85 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEET-----TTTEEEEEEEEECC-------------------------------CHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEEC-----CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence 3578999999999999999999876 457789999997653211 112355788
Q ss_pred HHHHHHhcCCCCeeeeeEEEEe--CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccC
Q 023430 165 ERDILTKVTHPFIVQLRYSFQT--RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242 (282)
Q Consensus 165 E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK 242 (282)
|+.+++.++||||+++++++.. ...+|+||||+++++|.+++ ..+.+++..+..++.|++.||.|||++||+|||||
T Consensus 86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 164 (298)
T 2zv2_A 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164 (298)
T ss_dssp HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 9999999999999999999986 56899999999999997754 34568999999999999999999999999999999
Q ss_pred CCceEEcCCCcEEEEecCcccccc-------cchhheeeccCcccc
Q 023430 243 PENILMDSDGHVMAAHSLNSHNQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 243 p~NILl~~~~~v~l~Dfg~s~~~~-------~~~~~~~~~ape~~~ 281 (282)
|+|||++.++.+||+|||++.... ...|++.|||||.+.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 210 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLS 210 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhc
Confidence 999999999999999999986321 226799999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=247.77 Aligned_cols=171 Identities=29% Similarity=0.485 Sum_probs=151.5
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|++. ..+..||+|++...........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEc-----CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 445678999999999999999999976 456789999997765444444567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+..|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999988532
Q ss_pred -----ccchhheeeccCcccc
Q 023430 266 -----LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 -----~~~~~~~~~~ape~~~ 281 (282)
....|++.|+|||.+.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~ 185 (284)
T 2vgo_A 165 PSLRRRTMCGTLDYLPPEMIE 185 (284)
T ss_dssp SSSCBCCCCSCGGGCCHHHHT
T ss_pred cccccccccCCCCcCCHHHhc
Confidence 2236799999999863
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=267.70 Aligned_cols=149 Identities=22% Similarity=0.346 Sum_probs=123.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++++.||+|+||.||+|+++ .+++.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-----LEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-----C--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-----CCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 478999999999999999999977 457789999986543 2334456788999999999999999999998543
Q ss_pred ----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+|+||||+. ++|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+
T Consensus 126 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 126 VEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp TTTCCCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred cccCceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccch
Confidence 57999999985 6899999888889999999999999999999999999999999999999999999999999996
Q ss_pred c
Q 023430 264 N 264 (282)
Q Consensus 264 ~ 264 (282)
.
T Consensus 205 ~ 205 (458)
T 3rp9_A 205 T 205 (458)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=253.21 Aligned_cols=167 Identities=22% Similarity=0.350 Sum_probs=150.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||.||++++. ..++.||+|++...........+.+.+|+.+++.++|+||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDA-----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 357999999999999999999976 456789999998765545556677889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+||||+.+++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999986422
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|++.|+|||.+
T Consensus 195 ~~~~~~~~gt~~y~aPE~~ 213 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVL 213 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHH
T ss_pred cccccccCCCccccCHHHh
Confidence 22579999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=247.33 Aligned_cols=168 Identities=22% Similarity=0.350 Sum_probs=150.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||.||++.++ ..++.||+|++...........+.+.+|+.+++.++|+||+++++++...+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDA-----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEEC-----CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 468999999999999999999976 456789999998765545556677889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999986422
Q ss_pred -----cchhheeeccCcccc
Q 023430 267 -----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -----~~~~~~~~~ape~~~ 281 (282)
...|++.|+|||.+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~ 188 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLS 188 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHT
T ss_pred ccccccccCCCCcCCcchhc
Confidence 225799999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=251.92 Aligned_cols=175 Identities=18% Similarity=0.251 Sum_probs=150.1
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++.+.||+|+||.||+|.+........+..||+|++.... .....+.+.+|+.+++.++||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 4456667899999999999999999998654434456789999997543 33445678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCCEee
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGI------------------------FREDQARFYTAEIVSAVSHLHKCGIVHR 239 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~gL~ylH~~~iiHr 239 (282)
+...+..++||||+++++|.+++..... +++.++..++.|++.||.|||++||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 9999999999999999999999986543 7899999999999999999999999999
Q ss_pred ccCCCceEEcCCCcEEEEecCcccccc---------cchhheeeccCccc
Q 023430 240 DLKPENILMDSDGHVMAAHSLNSHNQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 240 DlKp~NILl~~~~~v~l~Dfg~s~~~~---------~~~~~~~~~ape~~ 280 (282)
||||+|||++.++.++|+|||++.... ...+++.|+|||.+
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 224 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESL 224 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHH
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhh
Confidence 999999999999999999999986321 12446789999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=257.68 Aligned_cols=174 Identities=17% Similarity=0.264 Sum_probs=148.8
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
+.+..++|++.+.||+|+||.||+|++.++.. ...+..||+|++.... .....+.+.+|+++++.+ +||||++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 34556789999999999999999999875432 1344679999997653 334456788999999999 899999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
+++...+..|+||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998753 48999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCcccccc---------cchhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~---------~~~~~~~~~ape~~ 280 (282)
||++.++.+||+|||++.... ...+++.|+|||.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~ 265 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh
Confidence 999999999999999996321 12457889999976
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=244.14 Aligned_cols=168 Identities=23% Similarity=0.371 Sum_probs=137.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|++. ..+..||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred cccceeeeeecCCCceEEEEEEEc-----cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 357999999999999999999976 356789999998765444455677889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999998765 568999999999999999999999999999999999999999999999999986422
Q ss_pred ------cchhheeeccCcccc
Q 023430 267 ------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ------~~~~~~~~~ape~~~ 281 (282)
...|++.|+|||.+.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~ 185 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIAT 185 (278)
T ss_dssp ---------------------
T ss_pred CCCcceeccCCCCcCCcchhc
Confidence 236799999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=247.61 Aligned_cols=168 Identities=25% Similarity=0.353 Sum_probs=147.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|++. ..++.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDT-----VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEc-----CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 578999999999999999999976 456789999998765545555677889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999985322
Q ss_pred ------cchhheeeccCcccc
Q 023430 267 ------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ------~~~~~~~~~ape~~~ 281 (282)
...|++.|+|||.+.
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~ 208 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFS 208 (309)
T ss_dssp ---------CCGGGCCGGGTC
T ss_pred ccccccccCCCcCccCHHHHc
Confidence 125789999999873
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=251.68 Aligned_cols=165 Identities=25% Similarity=0.384 Sum_probs=140.2
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++++.||+|+||.||+|++. .++.||+|++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 3578999999999999999999874 367899999976532 333456688899999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc-
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ- 265 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~- 265 (282)
..+++||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999999985 777777654 45899999999999999999999999999999999999999999999999999632
Q ss_pred ------ccchhheeeccCccc
Q 023430 266 ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ------~~~~~~~~~~ape~~ 280 (282)
....+++.|||||.+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~ 191 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVL 191 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHH
T ss_pred CCcccccCCcccCCcCCHHHh
Confidence 122669999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=266.85 Aligned_cols=165 Identities=17% Similarity=0.234 Sum_probs=135.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhcC---------C
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVT---------H 174 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h 174 (282)
.++|++.+.||+|+||.||+|++. ++.||||++...... .....+.+.+|+.+|+.++ |
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h 91 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD-------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRT 91 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET-------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBC
T ss_pred cccchheeeecccCceEEEEEEeC-------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccC
Confidence 357888999999999999999863 478999999865321 2233466888999998886 7
Q ss_pred CCeeeeeEEEE-----------------e-------------CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHH
Q 023430 175 PFIVQLRYSFQ-----------------T-------------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224 (282)
Q Consensus 175 ~nIv~l~~~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi 224 (282)
+||+++.+.+. . ...+|||||||++|++.+.+.+ +.+++..++.++.||
T Consensus 92 ~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 92 EGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQL 170 (336)
T ss_dssp CCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHH
T ss_pred CchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHH
Confidence 77777666543 2 6789999999999977666633 568999999999999
Q ss_pred HHHHHHHH-HCCCEeeccCCCceEEcCCC--------------------cEEEEecCcccccc--cchhheeeccCcccc
Q 023430 225 VSAVSHLH-KCGIVHRDLKPENILMDSDG--------------------HVMAAHSLNSHNQL--CCFFFFLFLGGGVFN 281 (282)
Q Consensus 225 ~~gL~ylH-~~~iiHrDlKp~NILl~~~~--------------------~v~l~Dfg~s~~~~--~~~~~~~~~ape~~~ 281 (282)
+.||.||| ++|||||||||+|||++.++ .+||+|||+|+... ...||+.|||||.|.
T Consensus 171 ~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 171 TASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGC
T ss_pred HHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhc
Confidence 99999999 99999999999999999987 89999999997533 337899999999983
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=248.54 Aligned_cols=165 Identities=24% Similarity=0.300 Sum_probs=136.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH-hcCCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~ 188 (282)
++|++.++||+|+||+||+|+++ ..++.||||++...........+ ...|+..+. ..+|+||+++++++...+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~-~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-----EDGRLYAVKRSMSPFRGPKDRAR-KLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTSCEEEEEEESSSCCSHHHHHH-HHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hheeeeheeccCCCeEEEEEEEC-----CCCeEEEEEEecccccChHHHHH-HHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 46999999999999999999977 45778999998654333333333 334554444 458999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
.+|+||||+ +++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999999999 66888887664 459999999999999999999999999999999999999999999999999985322
Q ss_pred -----cchhheeeccCcccc
Q 023430 267 -----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -----~~~~~~~~~ape~~~ 281 (282)
...|++.|||||++.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~ 229 (311)
T 3p1a_A 210 AGAGEVQEGDPRYMAPELLQ 229 (311)
T ss_dssp -----CCCCCGGGCCGGGGG
T ss_pred CCCCcccCCCccccCHhHhc
Confidence 225799999999873
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=253.13 Aligned_cols=164 Identities=21% Similarity=0.281 Sum_probs=143.9
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++++.||+|+||.||+|++. ..+..||||++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred heeeeeEEccCCCEEEEEEEEc-----cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence 5999999999999999999976 45778999999765444445556788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 191 YLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
|+||||+. |+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~ 208 (348)
T 1u5q_A 130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 208 (348)
T ss_dssp EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence 99999998 57777765 35679999999999999999999999999999999999999999999999999996432
Q ss_pred cchhheeeccCccc
Q 023430 267 CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~~~~~~~~~ape~~ 280 (282)
...|++.|||||.+
T Consensus 209 ~~~gt~~y~aPE~~ 222 (348)
T 1u5q_A 209 SFVGTPYWMAPEVI 222 (348)
T ss_dssp CCCSCGGGCCHHHH
T ss_pred cccCCcceeCHhhh
Confidence 23679999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=253.79 Aligned_cols=175 Identities=19% Similarity=0.294 Sum_probs=147.0
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
.+.+..++|++.+.||+|+||.||+|++........+..||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4566778999999999999999999998654444566789999997543 223346688999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEee
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQG-----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHR 239 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHr 239 (282)
++...+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 27899999999999999999999999999
Q ss_pred ccCCCceEEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 240 DLKPENILMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 240 DlKp~NILl~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
||||+|||++.++.++|+|||++.....+ .+++.|+|||.+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 246 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence 99999999999999999999999633211 346689999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=261.17 Aligned_cols=165 Identities=19% Similarity=0.321 Sum_probs=144.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++.+.||+|+||.||+|+++ .+++.||||++.... ......+.+.+|+.+|+.++|+||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK-----NTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC-----CCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 568999999999999999999977 457789999997543 2334456788999999999999999999999766
Q ss_pred ----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 57999999987 5999999887789999999999999999999999999999999999999999999999999996
Q ss_pred ccc-----------------------------cchhheeeccCccc
Q 023430 264 NQL-----------------------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~-----------------------------~~~~~~~~~ape~~ 280 (282)
... ...||+.|+|||.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 223 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHH
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence 421 22569999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=257.01 Aligned_cols=164 Identities=24% Similarity=0.405 Sum_probs=143.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ .++..||+|++..... .....+.+|+.+|+.++||||+++++++.....
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCEEEEEEEEC-----CCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 57999999999999999999977 4567899999876432 223468899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC--CCcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~--~~~v~l~Dfg~s~~~~ 266 (282)
+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 999999999999999887543 6899999999999999999999999999999999999974 4779999999996422
Q ss_pred ------cchhheeeccCcccc
Q 023430 267 ------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ------~~~~~~~~~ape~~~ 281 (282)
...||+.|||||++.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~ 223 (387)
T 1kob_A 203 PDEIVKVTTATAEFAAPEIVD 223 (387)
T ss_dssp TTSCEEEECSSGGGCCHHHHT
T ss_pred CCcceeeeccCCCccCchhcc
Confidence 226799999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=249.96 Aligned_cols=166 Identities=24% Similarity=0.342 Sum_probs=143.3
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.++||+|+||.||+|+++ .+++.||||++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEEC-----CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 3468999999999999999999987 3567899999976542 23345677899999999999999999998875
Q ss_pred C--EEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE----cCCCcEEEEe
Q 023430 188 S--KLYLILDFINGGHLFFHLYRQGI---FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMAAH 258 (282)
Q Consensus 188 ~--~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl----~~~~~v~l~D 258 (282)
. ..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 5 78999999999999999976433 8999999999999999999999999999999999999 7888899999
Q ss_pred cCcccccc------cchhheeeccCccc
Q 023430 259 SLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~------~~~~~~~~~ape~~ 280 (282)
||++.... ...|++.|+|||.+
T Consensus 160 fg~a~~~~~~~~~~~~~gt~~y~aPE~~ 187 (319)
T 4euu_A 160 FGAARELEDDEQFVSLYGTEEYLHPDMY 187 (319)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHH
T ss_pred CCCceecCCCCceeecccCCCccCHHHh
Confidence 99996422 22579999999976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=246.94 Aligned_cols=172 Identities=18% Similarity=0.180 Sum_probs=147.0
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+..++|++.+.||+|+||.||+|+++.+++ ......||+|++.... ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 3456789999999999999999998774321 0112569999986543 3445668899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc--------E
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--------V 254 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~--------v 254 (282)
+...+..++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 899999999999999999999999999999999999998887 9
Q ss_pred EEEecCcccccccc---hhheeeccCccc
Q 023430 255 MAAHSLNSHNQLCC---FFFFLFLGGGVF 280 (282)
Q Consensus 255 ~l~Dfg~s~~~~~~---~~~~~~~ape~~ 280 (282)
+|+|||++...... .+++.|+|||.+
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~ 189 (289)
T 4fvq_A 161 KLSDPGISITVLPKDILQERIPWVPPECI 189 (289)
T ss_dssp EECCCCSCTTTSCHHHHHHTTTTSCHHHH
T ss_pred eeccCcccccccCccccCCcCcccCHHHh
Confidence 99999999654332 568999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=264.38 Aligned_cols=168 Identities=29% Similarity=0.435 Sum_probs=143.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh----------hhHHHHHHHHHHHHHhcCCCCee
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----------KNHVDYMKAERDILTKVTHPFIV 178 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~nIv 178 (282)
.++|+++++||+|+||.||+|+++ ..+..||+|++.+..... ....+.+.+|+.+|+.++||||+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEK-----NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEET-----TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEEC-----CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 357999999999999999999987 456789999997654321 13356688999999999999999
Q ss_pred eeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC---cEE
Q 023430 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVM 255 (282)
Q Consensus 179 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~---~v~ 255 (282)
++++++.....+|+|||||++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence 99999999999999999999999999998888899999999999999999999999999999999999999876 699
Q ss_pred EEecCccccc------ccchhheeeccCcccc
Q 023430 256 AAHSLNSHNQ------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 256 l~Dfg~s~~~------~~~~~~~~~~ape~~~ 281 (282)
|+|||++... ....|++.|+|||++.
T Consensus 190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 221 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK 221 (504)
T ss_dssp ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT
T ss_pred EEECCCCEEcCCCCccccccCCcCCCCHHHhc
Confidence 9999999632 2236899999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=261.62 Aligned_cols=166 Identities=28% Similarity=0.446 Sum_probs=146.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.++||+|+||.||+|+++ .++..||||++.+.... ....+.+.+|+.+|+.++||||+++++++.....
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR-----ITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET-----TTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cceEEeEEEeecCCEEEEEEEEC-----CCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 46999999999999999999977 45678999999765432 2335668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc---CCCcEEEEecCccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMAAHSLNSHNQ- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~---~~~~v~l~Dfg~s~~~- 265 (282)
+|+|||||.+++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999998888899999999999999999999999999999999999995 4567999999999632
Q ss_pred -----ccchhheeeccCcccc
Q 023430 266 -----LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 -----~~~~~~~~~~ape~~~ 281 (282)
....|++.|||||++.
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~ 196 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLR 196 (486)
T ss_dssp CC----CCTTGGGGCCGGGGG
T ss_pred CCCccCCCcCCCCCCCHHHhC
Confidence 1226899999999873
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=247.09 Aligned_cols=166 Identities=22% Similarity=0.272 Sum_probs=143.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||.||+|++. .++..||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cccceEeeEEeecCCeEEEEEEeC-----CCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence 368999999999999999999976 456789999886543 23334566788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..++||||+++++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 76 RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999999999999888877889999999999999999999999999999999999999999999999999996322
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|++.|+|||.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~ 174 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELL 174 (311)
T ss_dssp ----------GGGCCHHHH
T ss_pred ccccCCCcCCccccChHHH
Confidence 22679999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=259.65 Aligned_cols=171 Identities=19% Similarity=0.298 Sum_probs=146.8
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++.+.||+|+||.||+|+++ ..+..||||+++... .....+.+.+|+.+|+.++||||++++++
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLR-----ADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEe-----cCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 34556678999999999999999999987 356789999987542 23334557889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+...+..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 999899999999999999999987653 5899999999999999999999999999999999999999999999999999
Q ss_pred cccccc---------hhheeeccCcccc
Q 023430 263 HNQLCC---------FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~~---------~~~~~~~ape~~~ 281 (282)
+..... .++..|||||.++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 288 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALN 288 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHH
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhc
Confidence 743221 2356799999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=256.16 Aligned_cols=166 Identities=23% Similarity=0.340 Sum_probs=145.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh-----hHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK-----NHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
++|++.+.||+|+||.||+|+++ ..+..||||++........ ...+.+.+|+.+++.++||||+++++++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDK-----EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEET-----TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEEC-----CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 47999999999999999999976 4577899999986542221 1233466799999999999999999999
Q ss_pred EeCCEEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...+.+++||||+.+| +|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999999776 999999888889999999999999999999999999999999999999999999999999996
Q ss_pred ccc------cchhheeeccCccc
Q 023430 264 NQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~------~~~~~~~~~ape~~ 280 (282)
... ...|++.|||||.+
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~ 201 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVL 201 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHH
T ss_pred ECCCCCceeccCCCccccChhhh
Confidence 322 22579999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=256.90 Aligned_cols=174 Identities=43% Similarity=0.729 Sum_probs=147.8
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-hhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
.+..++|++.+.||+|+||.||+|++... ...++.||||++++.... .....+.+.+|+.+|+.+ +|+||++++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 127 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 127 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEccc--CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence 34557899999999999999999987531 236788999998754321 112223466799999999 69999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+.....+++||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999999999888889999999999999999999999999999999999999999999999999986
Q ss_pred cccc--------chhheeeccCcccc
Q 023430 264 NQLC--------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~--------~~~~~~~~ape~~~ 281 (282)
.... ..|++.|||||.+.
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 233 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVR 233 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred ecccCCCCcccCcccCcCccChhhhc
Confidence 3211 25799999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=243.90 Aligned_cols=167 Identities=22% Similarity=0.322 Sum_probs=144.7
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++.+.||+|+||.||+|++. .+..||+|++..... ..+.+.+|+.+++.++||||++++++
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~ 73 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGV 73 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec------CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 35566789999999999999999999875 345699999976532 22458889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 74 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred EecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999999999999654 45899999999999999999999999999999999999999999999999999
Q ss_pred cccccc--------hhheeeccCccc
Q 023430 263 HNQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~--------~~~~~~~ape~~ 280 (282)
...... .+++.|+|||.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 179 (269)
T 4hcu_A 154 RFVLDDQYTSSTGTKFPVKWASPEVF 179 (269)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHH
T ss_pred ccccccccccccCcccccccCCHHHh
Confidence 643222 346679999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=253.72 Aligned_cols=163 Identities=31% Similarity=0.476 Sum_probs=133.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.+.|++.+.||+|+||.||+|+++ ..++.||||++.... ..+.+.+|+.+++.++||||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 121 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQK-----GTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT 121 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred cCcEEEeeEEeeCCCEEEEEEEEC-----CCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence 357999999999999999999987 356789999987543 2345778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---CCcEEEEecCccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~---~~~v~l~Dfg~s~~~ 265 (282)
..++||||+++++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++...
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999999999988888999999999999999999999999999999999999975 899999999998642
Q ss_pred c------cchhheeeccCcccc
Q 023430 266 L------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~------~~~~~~~~~ape~~~ 281 (282)
. ...|++.|+|||.+.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~ 223 (349)
T 2w4o_A 202 EHQVLMKTVCGTPGYCAPEILR 223 (349)
T ss_dssp -----------CGGGSCHHHHT
T ss_pred CcccccccccCCCCccCHHHhc
Confidence 2 225799999999863
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=264.23 Aligned_cols=166 Identities=28% Similarity=0.421 Sum_probs=148.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.++||+|+||.||+|+++ .++..||||++.+.........+.+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDK-----ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CceEEeeEEecCCCEEEEEEEEC-----CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 47999999999999999999977 4567899999977654444556778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE---cCCCcEEEEecCccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAAHSLNSHNQ- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl---~~~~~v~l~Dfg~s~~~- 265 (282)
.|+||||+.+|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 99999999999999999888889999999999999999999999999999999999999 56789999999988532
Q ss_pred -----ccchhheeeccCccc
Q 023430 266 -----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 -----~~~~~~~~~~ape~~ 280 (282)
....|++.|||||++
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~ 200 (484)
T 3nyv_A 181 ASKKMKDKIGTAYYIAPEVL 200 (484)
T ss_dssp CCCSHHHHTTGGGTCCHHHH
T ss_pred cccccccCCCCccccCceee
Confidence 122689999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=242.24 Aligned_cols=166 Identities=28% Similarity=0.414 Sum_probs=147.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.++ ..+..||+|++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEES 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc-----CCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC
Confidence 478999999999999999999977 4567899999976543 3344567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc---EEEEecCccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~---v~l~Dfg~s~~~ 265 (282)
..++||||+++++|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 79 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 79 FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999999999999988888999999999999999999999999999999999999987665 999999998532
Q ss_pred c------cchhheeeccCccc
Q 023430 266 L------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~------~~~~~~~~~ape~~ 280 (282)
. ...|++.|+|||.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~ 179 (284)
T 3kk8_A 159 NDSEAWHGFAGTPGYLSPEVL 179 (284)
T ss_dssp CSSCBCCCSCSCGGGCCHHHH
T ss_pred ccCccccCCCCCcCCcCchhh
Confidence 1 23679999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=248.58 Aligned_cols=175 Identities=17% Similarity=0.226 Sum_probs=150.2
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
.+.+..++|++.+.||+|+||.||+|++........+..||+|++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3556677999999999999999999997654444667889999997653 223456788999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCC
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~ 244 (282)
++...+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999997653 3899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 245 NILMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 245 NILl~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
|||++.++.+||+|||++...... .+++.|+|||.+
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 219 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHh
Confidence 999999999999999998642211 346789999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=244.92 Aligned_cols=167 Identities=22% Similarity=0.307 Sum_probs=142.5
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++++.||+|+||.||++.++ .+..||+|++...... .+.+.+|+.+++.++|+||++++++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 34566779999999999999999999875 3456999999765322 2457889999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+...+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence 9999999999999999999999976 456999999999999999999999999999999999999999999999999999
Q ss_pred ccccc--------chhheeeccCccc
Q 023430 263 HNQLC--------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~--------~~~~~~~~ape~~ 280 (282)
..... ..+++.|+|||.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVL 193 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHH
T ss_pred ccccccccccccCCccCcccCCHHHh
Confidence 64322 2446789999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=255.63 Aligned_cols=160 Identities=25% Similarity=0.424 Sum_probs=133.1
Q ss_pred CCCeEEE-eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH-HhcCCCCeeeeeEEEEe
Q 023430 109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 109 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~ 186 (282)
.++|.+. ++||+|+||+||+|.++ .++..||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEEC-----CCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 3578887 78999999999999977 45778999998642 2356788876 45589999999999875
Q ss_pred ----CCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---CCcEEEE
Q 023430 187 ----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMAA 257 (282)
Q Consensus 187 ----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~---~~~v~l~ 257 (282)
...+|||||||+||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence 567999999999999999997653 4899999999999999999999999999999999999998 7899999
Q ss_pred ecCcccccc------cchhheeeccCcccc
Q 023430 258 HSLNSHNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 258 Dfg~s~~~~------~~~~~~~~~ape~~~ 281 (282)
|||+++... ...||+.|||||++.
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 236 (400)
T 1nxk_A 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236 (400)
T ss_dssp CCTTCEECC-----------CTTCCGGGSC
T ss_pred ecccccccCCCCccccCCCCCCccCHhhcC
Confidence 999996422 226699999999873
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=250.98 Aligned_cols=164 Identities=19% Similarity=0.335 Sum_probs=128.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||.||+|.++ .++..||+|++.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK-----TTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECS-----SSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEEC-----CCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 357999999999999999999866 456789999987653 2223355778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+|+||||++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999999998 5898888653 35899999999999999999999999999999999999999999999999998
Q ss_pred cccc-------cchhheeeccCccc
Q 023430 263 HNQL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~-------~~~~~~~~~ape~~ 280 (282)
.... ...|++.|||||++
T Consensus 156 ~~~~~~~~~~~~~~~t~~y~aPE~~ 180 (317)
T 2pmi_A 156 RAFGIPVNTFSSEVVTLWYRAPDVL 180 (317)
T ss_dssp EETTSCCCCCCCCCSCCTTCCHHHH
T ss_pred eecCCCcccCCCCcccccccCchHh
Confidence 6421 22679999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=246.62 Aligned_cols=171 Identities=19% Similarity=0.272 Sum_probs=143.7
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++++.||+|+||.||+|++.... ...+..||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTC-SSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEeccc-CCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345578999999999999999999865432 2467889999987542 344567889999999999999999999986
Q ss_pred eC--CEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 186 TR--SKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 186 ~~--~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.. ..+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 43 56899999999999999997754 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccc----------chhheeeccCccc
Q 023430 263 HNQLC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~----------~~~~~~~~ape~~ 280 (282)
..... ..++..|+|||.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESL 189 (295)
T ss_dssp C-------------CTTCGGGGCCHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHh
Confidence 64221 1346679999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=247.89 Aligned_cols=160 Identities=28% Similarity=0.503 Sum_probs=127.7
Q ss_pred CeEEE---eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEe
Q 023430 111 DFEIF---RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT 186 (282)
Q Consensus 111 ~y~~~---~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 186 (282)
+|++. +.||+|+||.||+|.++ .++..||||++.+.. ...+.+|+.+++.+. ||||+++++++.+
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~ 77 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHK-----KSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHD 77 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEET-----TTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEEC-----CCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 46664 68999999999999987 456789999986542 244678999999997 9999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC---cEEEEecCccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMAAHSLNSH 263 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~---~v~l~Dfg~s~ 263 (282)
....|+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 78 QLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999999999999888899999999999999999999999999999999999998766 89999999996
Q ss_pred ccc-------cchhheeeccCcccc
Q 023430 264 NQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~-------~~~~~~~~~ape~~~ 281 (282)
... ...|++.|||||.+.
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~ 182 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLN 182 (325)
T ss_dssp ECCC---------------------
T ss_pred ecCCCCCcccccCCCcCccCHHHhc
Confidence 321 225699999999873
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=246.80 Aligned_cols=163 Identities=20% Similarity=0.345 Sum_probs=140.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++++.||+|+||.||+|++. .++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 58999999999999999999863 456799999876542 22233557789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ--- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~--- 265 (282)
.++||||+++ +|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9999999986 888888754 56899999999999999999999999999999999999999999999999998632
Q ss_pred ----ccchhheeeccCccc
Q 023430 266 ----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ----~~~~~~~~~~ape~~ 280 (282)
....+++.|||||.+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~ 172 (288)
T 1ob3_A 154 VRKYTHEIVTLWYRAPDVL 172 (288)
T ss_dssp --------CCCTTCCHHHH
T ss_pred ccccccccccccccCchhe
Confidence 122569999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=251.52 Aligned_cols=159 Identities=25% Similarity=0.396 Sum_probs=138.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 188 (282)
++|++.+.||+|+||.||+|.++ .+++.||+|++.+.... ..+|++++..+ +||||+++++++.+..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~ 89 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGK 89 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred ccEEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence 47999999999999999999987 45778999999765321 34588888887 7999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC----CcEEEEecCcccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD----GHVMAAHSLNSHN 264 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~----~~v~l~Dfg~s~~ 264 (282)
.+|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999999999999888889999999999999999999999999999999999998543 3599999999963
Q ss_pred cc-------cchhheeeccCccc
Q 023430 265 QL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~-------~~~~~~~~~ape~~ 280 (282)
.. ...|++.|||||++
T Consensus 170 ~~~~~~~~~~~~gt~~y~aPE~~ 192 (342)
T 2qr7_A 170 LRAENGLLMTPCYTANFVAPEVL 192 (342)
T ss_dssp CBCTTCCBCCSSCCSSCCCHHHH
T ss_pred CcCCCCceeccCCCccccCHHHh
Confidence 22 22569999999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=242.33 Aligned_cols=163 Identities=27% Similarity=0.419 Sum_probs=145.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ ..+..+|+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQK-----GTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhEEeeeEEeecCCEEEEEEEeC-----CCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 46999999999999999999977 3566799999876532 234568899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE---cCCCcEEEEecCccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAAHSLNSHNQ- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl---~~~~~v~l~Dfg~s~~~- 265 (282)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999888889999999999999999999999999999999999999 78899999999998532
Q ss_pred -----ccchhheeeccCccc
Q 023430 266 -----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 -----~~~~~~~~~~ape~~ 280 (282)
....|++.|+|||.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~ 180 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVL 180 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHH
T ss_pred CccchhccCCCCCccChHHh
Confidence 222679999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=245.27 Aligned_cols=172 Identities=20% Similarity=0.235 Sum_probs=138.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.+.||+|+||.||+|.+.... ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 4456678999999999999999999986432 345679999886542 234456788999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
. .+..|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 4 567899999999999999997654 58999999999999999999999999999999999999999999999999996
Q ss_pred cccc--------chhheeeccCcccc
Q 023430 264 NQLC--------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~--------~~~~~~~~ape~~~ 281 (282)
.... ..+++.|+|||.++
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESIN 190 (281)
T ss_dssp --------------CCGGGCCHHHHH
T ss_pred ccCcccccccccCCCcccccChhhcc
Confidence 4221 24467899999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=256.95 Aligned_cols=166 Identities=25% Similarity=0.423 Sum_probs=138.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-----hhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-----KNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.++|.+.+.||+|+||.||+|.++ .+++.||||++.+..... ......+.+|+.+|+.++||||++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 358999999999999999999977 456789999997654221 1122347789999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC---cEEEEecC
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG---HVMAAHSL 260 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~---~v~l~Dfg 260 (282)
+. .+..|+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 209 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 209 FD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp EE-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 75 456899999999999999888788899999999999999999999999999999999999997654 49999999
Q ss_pred ccccccc------chhheeeccCccc
Q 023430 261 NSHNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~------~~~~~~~~ape~~ 280 (282)
++..... ..|++.|||||++
T Consensus 288 ~a~~~~~~~~~~~~~gt~~y~aPE~~ 313 (419)
T 3i6u_A 288 HSKILGETSLMRTLCGTPTYLAPEVL 313 (419)
T ss_dssp TTTSCC-----------CTTCCTTTT
T ss_pred cceecCCCccccccCCCCCccCceee
Confidence 9964221 2579999999987
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=248.74 Aligned_cols=167 Identities=27% Similarity=0.388 Sum_probs=146.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
++|++.+.||+|+||.||+|+++ .++..||+|++........ ...+.+.+|+.+++.++||||+++++++..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccEEEeeEeeecCCEEEEEEEEC-----CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46999999999999999999977 4567899999976542221 135668899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC----cEEEEecCcc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMAAHSLNS 262 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~----~v~l~Dfg~s 262 (282)
....++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999999998888899999999999999999999999999999999999999888 7999999999
Q ss_pred cccc------cchhheeeccCcccc
Q 023430 263 HNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~------~~~~~~~~~ape~~~ 281 (282)
.... ...|++.|+|||.+.
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~ 191 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVN 191 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred eecCccccccccCCCCCccCccccc
Confidence 6422 225799999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=243.09 Aligned_cols=164 Identities=24% Similarity=0.377 Sum_probs=142.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|.+.+.||+|+||.||+|+++ ..+..+|+|++..... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 94 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER-----SSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN 94 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeccCCCeEEEEEEEc-----cCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence 47999999999999999999976 4567899999876542 3335668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE---cCCCcEEEEecCcc
Q 023430 190 LYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAAHSLNS 262 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl---~~~~~v~l~Dfg~s 262 (282)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999999888854 3679999999999999999999999999999999999999 45688999999999
Q ss_pred ccc------ccchhheeeccCccc
Q 023430 263 HNQ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~------~~~~~~~~~~ape~~ 280 (282)
... ....|++.|+|||.+
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~ 198 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVF 198 (285)
T ss_dssp CC----------CTTGGGCCHHHH
T ss_pred eecCCcccCcCcccccCcCChHHh
Confidence 632 222679999999976
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=241.43 Aligned_cols=165 Identities=22% Similarity=0.300 Sum_probs=143.1
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|+++ .+..||+|++..... ..+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK------GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCS 73 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EechhheeeeeeeccCCCceEEEEEec------CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 345678999999999999999999875 345699999976542 2245788999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.....++||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred cCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 9999999999999999999987654 489999999999999999999999999999999999999999999999999863
Q ss_pred cccc--------hhheeeccCccc
Q 023430 265 QLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~~--------~~~~~~~ape~~ 280 (282)
.... .+++.|+|||.+
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~ 177 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVF 177 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHH
T ss_pred cchhhhhcccCCCcCcccCCHHHH
Confidence 2221 335679999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=245.92 Aligned_cols=164 Identities=24% Similarity=0.364 Sum_probs=141.9
Q ss_pred CCCeEEE-eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEe
Q 023430 109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT 186 (282)
Q Consensus 109 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 186 (282)
.+.|++. +.||+|+||.||+|+++ .+++.||||++.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINL-----ITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECS-----SSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEc-----CCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3579885 78999999999999866 456789999997643 23345688899999885 79999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc---EEEEecCccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMAAHSLNSH 263 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~---v~l~Dfg~s~ 263 (282)
.+.+|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 83 EDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 9999999999999999999988888999999999999999999999999999999999999998776 9999999986
Q ss_pred ccc--------------cchhheeeccCccc
Q 023430 264 NQL--------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~--------------~~~~~~~~~ape~~ 280 (282)
... ...|++.|+|||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 193 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193 (316)
T ss_dssp -------------------CCSGGGCCHHHH
T ss_pred ccccCCccccccccccccccCCcCccChHHh
Confidence 321 11489999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=249.21 Aligned_cols=174 Identities=16% Similarity=0.259 Sum_probs=149.8
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
+.+..++|++.+.||+|+||.||+|.+..++.......||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 456678999999999999999999998876555556789999987643 233456688999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ--------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD 249 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~--------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~ 249 (282)
+...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999988653 3578999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 250 SDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 250 ~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
.++.++|+|||++.....+ .+++.|||||.+
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHh
Confidence 9999999999999743221 346689999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=262.12 Aligned_cols=165 Identities=27% Similarity=0.418 Sum_probs=140.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++++.||+|+||.||+|+++ ..+..||+|++.+..... ...+.+.+|+.+++.++||||+++++++.....+
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDK-----VTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp HEEEEEEEECC---EEEEEEET-----TTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CeEEeeEEecCCCEEEEEEEEC-----CCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 6999999999999999999987 456789999998654322 2345688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEEecCccccc--
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAAHSLNSHNQ-- 265 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~Dfg~s~~~-- 265 (282)
|+|||||.+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.. +.+||+|||++...
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999999999888889999999999999999999999999999999999999764 45999999998532
Q ss_pred ----ccchhheeeccCcccc
Q 023430 266 ----LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ----~~~~~~~~~~ape~~~ 281 (282)
....|++.|||||++.
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~ 211 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLR 211 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHT
T ss_pred CccccccCCCcCeeCHHHHc
Confidence 2226899999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=249.98 Aligned_cols=177 Identities=17% Similarity=0.264 Sum_probs=148.2
Q ss_pred hhhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCee
Q 023430 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIV 178 (282)
Q Consensus 102 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv 178 (282)
...+.+..++|++.+.||+|+||.||+|++.+... ...+..||+|++.... .....+.+.+|+.+++.+ +||||+
T Consensus 27 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 27 DPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 34455667899999999999999999999864322 2356679999997543 234456788999999999 899999
Q ss_pred eeeEEEEeCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccC
Q 023430 179 QLRYSFQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLK 242 (282)
Q Consensus 179 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlK 242 (282)
++++++...+.+|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+|||||
T Consensus 105 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp CEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 99999999999999999999999999997643 38899999999999999999999999999999
Q ss_pred CCceEEcCCCcEEEEecCcccccc---------cchhheeeccCccc
Q 023430 243 PENILMDSDGHVMAAHSLNSHNQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 243 p~NILl~~~~~v~l~Dfg~s~~~~---------~~~~~~~~~ape~~ 280 (282)
|+|||++.++.+||+|||++.... ...+++.|+|||.+
T Consensus 185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 231 (334)
T 2pvf_A 185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231 (334)
T ss_dssp GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH
T ss_pred cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh
Confidence 999999999999999999986321 12446789999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=251.15 Aligned_cols=171 Identities=23% Similarity=0.320 Sum_probs=150.4
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
...+..++|++.+.||+|+||.||+|.++ ..+..||+|++.... .....+.+.+|+.+++.++||||++++++
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 99 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGA 99 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEEC-----CCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEE
Confidence 34566789999999999999999999977 456789999987653 23445678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
+...+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.++|+|||++
T Consensus 100 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999999999999999999999998888899999999999999999999986 9999999999999999999999999998
Q ss_pred ccc-----ccchhheeeccCcccc
Q 023430 263 HNQ-----LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~-----~~~~~~~~~~ape~~~ 281 (282)
... ....|++.|+|||.+.
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~ 203 (360)
T 3eqc_A 180 GQLIDSMANSFVGTRSYMSPERLQ 203 (360)
T ss_dssp HHHHHHC----CCCCTTCCHHHHT
T ss_pred cccccccccCCCCCCCeECHHHHc
Confidence 532 2226799999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=241.30 Aligned_cols=165 Identities=20% Similarity=0.261 Sum_probs=142.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 188 (282)
++|++.+.||+|+||.||+|.++ .+++.||+|++...... ......+.+|+..+..+ +||||+++++++...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred chhhhhhhhcCCCceEEEEEEEc-----CCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 47999999999999999999976 45678999998765332 23345577899999998 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-------------
Q 023430 189 KLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD------------- 251 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~------------- 251 (282)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999998764 668999999999999999999999999999999999999844
Q ss_pred ------CcEEEEecCcccccc---cchhheeeccCccc
Q 023430 252 ------GHVMAAHSLNSHNQL---CCFFFFLFLGGGVF 280 (282)
Q Consensus 252 ------~~v~l~Dfg~s~~~~---~~~~~~~~~ape~~ 280 (282)
..++|+|||.+.... ...|++.|+|||.+
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~ 202 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVL 202 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHH
T ss_pred cccCCceEEEEcccccccccCCccccCCCccccChhHh
Confidence 479999999986422 23579999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=246.17 Aligned_cols=162 Identities=22% Similarity=0.325 Sum_probs=142.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|+..+.||+|+||.||+|+.+ ..++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~-----~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK-----HSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL 117 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hhhccEEeccCCCeEEEEEEEC-----CCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 3888899999999999999976 356789999987543 23345688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc----
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL---- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~---- 266 (282)
|+||||+++++|.+++. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 118 ~lv~e~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp EEEECCCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEecCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc
Confidence 99999999999998875 4568999999999999999999999999999999999999999999999999985322
Q ss_pred ---cchhheeeccCcccc
Q 023430 267 ---CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ---~~~~~~~~~ape~~~ 281 (282)
...|++.|||||.+.
T Consensus 197 ~~~~~~gt~~y~aPE~~~ 214 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVIS 214 (321)
T ss_dssp CBCCCCSCGGGCCHHHHT
T ss_pred ccccccCCccccCHhhhc
Confidence 226799999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=252.57 Aligned_cols=173 Identities=17% Similarity=0.109 Sum_probs=139.8
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHH--------HHHHHHHHHHHhcCCCCeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHV--------DYMKAERDILTKVTHPFIVQ 179 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~h~nIv~ 179 (282)
..++|++.+.||+|+||.||+|.++.......++.||||++........... ..+..|+..++.++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999999999999987654444567899999876532111111 11334566777889999999
Q ss_pred eeEEEEeC----CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc--CCC
Q 023430 180 LRYSFQTR----SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDG 252 (282)
Q Consensus 180 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~--~~~ 252 (282)
+++++... ...||||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 99998764 4589999999 99999999775 5799999999999999999999999999999999999999 889
Q ss_pred cEEEEecCccccccc--------------chhheeeccCcccc
Q 023430 253 HVMAAHSLNSHNQLC--------------CFFFFLFLGGGVFN 281 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~--------------~~~~~~~~ape~~~ 281 (282)
.+||+|||+++.... ..||+.|||||.+.
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 234 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHN 234 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHT
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhC
Confidence 999999999953211 13899999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=248.27 Aligned_cols=165 Identities=23% Similarity=0.315 Sum_probs=143.3
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--CCeeeeeEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH--PFIVQLRYSF 184 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~ 184 (282)
+..+.|++.+.||+|+||.||++.+. .+..||||++..... .....+.+.+|+.+|+.++| +||+++++++
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 34567999999999999999999853 467899999976542 33445678899999999986 9999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.....+|+||| +.+++|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 79 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 79 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred eeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99999999999 56789999999888899999999999999999999999999999999999997 68899999999964
Q ss_pred cc---------cchhheeeccCccc
Q 023430 265 QL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~---------~~~~~~~~~ape~~ 280 (282)
.. ...|++.|||||.+
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~ 181 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAI 181 (343)
T ss_dssp C------------CCCCSSCCHHHH
T ss_pred cCcccccccCCCCcCCcCcCCHHHH
Confidence 21 22579999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=248.69 Aligned_cols=165 Identities=18% Similarity=0.183 Sum_probs=140.7
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.++||+|+||.||+|++. ++.||||++.... .......+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~ 87 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAE 87 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred cccchhhchhhheecccCceEEEEEEEC-------CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhccee
Confidence 3455678999999999999999999864 4679999996543 2223455689999999999999999999
Q ss_pred EeCC----EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CCEeeccCCCceEEcC
Q 023430 185 QTRS----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC----------GIVHRDLKPENILMDS 250 (282)
Q Consensus 185 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~----------~iiHrDlKp~NILl~~ 250 (282)
.... .+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.
T Consensus 88 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~ 166 (322)
T 3soc_A 88 KRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166 (322)
T ss_dssp EEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred ccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC
Confidence 8744 47999999999999999965 4589999999999999999999999 9999999999999999
Q ss_pred CCcEEEEecCcccccc---------cchhheeeccCcccc
Q 023430 251 DGHVMAAHSLNSHNQL---------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 251 ~~~v~l~Dfg~s~~~~---------~~~~~~~~~ape~~~ 281 (282)
++.+||+|||++.... ...|++.|+|||.+.
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 206 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLE 206 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHT
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcc
Confidence 9999999999995311 125799999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=259.77 Aligned_cols=163 Identities=21% Similarity=0.321 Sum_probs=136.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++++.||+|+||.||+|.++ .+++.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEEC-----CCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 468999999999999999999977 457789999997653 2334456788999999999999999999999654
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..+|+||||++++ |...+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 135 ~~~~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccccCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 4689999999875 555553 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccc------chhheeeccCccc
Q 023430 263 HNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~------~~~~~~~~ape~~ 280 (282)
+.... ..||+.|+|||++
T Consensus 212 ~~~~~~~~~~~~~gt~~y~aPE~~ 235 (464)
T 3ttj_A 212 RTAGTSFMMTPYVVTRYYRAPEVI 235 (464)
T ss_dssp -----CCCC----CCCTTCCHHHH
T ss_pred eecCCCcccCCCcccccccCHHHH
Confidence 64322 2679999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-34 Score=248.13 Aligned_cols=162 Identities=16% Similarity=0.174 Sum_probs=141.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 187 (282)
.++|++.+.||+|+||.||+|++. .+++.||||++..... .+.+.+|+.+++.+ +|+||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 77 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL-----YTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG 77 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET-----TTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET
T ss_pred cCCeEEEEEeeccCCceEEEEEEC-----CCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC
Confidence 468999999999999999999976 4577899999875432 12377899999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc-----EEEEecCc
Q 023430 188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMAAHSLN 261 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~-----v~l~Dfg~ 261 (282)
...++||||+ +++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred CccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9999999999 9999999976 367999999999999999999999999999999999999999887 99999999
Q ss_pred cccc--------------ccchhheeeccCcccc
Q 023430 262 SHNQ--------------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~--------------~~~~~~~~~~ape~~~ 281 (282)
+... ....||+.|||||.+.
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 190 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHL 190 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHc
Confidence 9632 1236799999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=252.64 Aligned_cols=164 Identities=22% Similarity=0.385 Sum_probs=132.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 187 (282)
.++|++++.||+|+||.||+|.++ .+++.||||++.... ......+.+.+|+.+++.+. ||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDR-----RTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEET-----TTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEEC-----CCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 358999999999999999999977 457789999986543 22344556778999999997 99999999999765
Q ss_pred C--EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 S--KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+ .+|+|||||+ ++|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred CCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 4 7999999998 588888865 57899999999999999999999999999999999999999999999999999642
Q ss_pred cc----------------------------chhheeeccCccc
Q 023430 266 LC----------------------------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~----------------------------~~~~~~~~ape~~ 280 (282)
.. ..||+.|||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 11 1579999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=258.19 Aligned_cols=167 Identities=20% Similarity=0.316 Sum_probs=144.6
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY 182 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 182 (282)
..+.+..++|++.+.||+|+||.||++.+. +..||||+++... ..+.+.+|+.+|+.++||||+++++
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~ 253 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLG 253 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEE
Confidence 456677889999999999999999999865 4579999997543 2356888999999999999999999
Q ss_pred EEEeCC-EEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 183 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
++.... .+|+||||+++|+|.+++...+. +++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus 254 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~Df 333 (450)
T 1k9a_A 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF 333 (450)
T ss_dssp EEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeC
Confidence 987655 79999999999999999987543 789999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc----hhheeeccCcccc
Q 023430 260 LNSHNQLCC----FFFFLFLGGGVFN 281 (282)
Q Consensus 260 g~s~~~~~~----~~~~~~~ape~~~ 281 (282)
|+++..... .++..|||||.+.
T Consensus 334 G~a~~~~~~~~~~~~~~~y~aPE~~~ 359 (450)
T 1k9a_A 334 GLTKEASSTQDTGKLPVKWTAPEALR 359 (450)
T ss_dssp TTCEECC------CCCTTTSCHHHHH
T ss_pred CCcccccccccCCCCCcceeCHHHhc
Confidence 999743222 4478899999863
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=248.90 Aligned_cols=164 Identities=27% Similarity=0.394 Sum_probs=142.4
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----CCCeeeee
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----HPFIVQLR 181 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv~l~ 181 (282)
+..++|++.++||+|+||.||+|++. ..++.||||++.... ...+.+..|+.+++.+. ||||++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHI-----DNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEEC-----CCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 44578999999999999999999986 356789999986432 23345677999999986 99999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---------
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------- 250 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~--------- 250 (282)
+++...+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 889999998754 4899999999999999999999999999999999999975
Q ss_pred ----------------CCcEEEEecCcccccc----cchhheeeccCccc
Q 023430 251 ----------------DGHVMAAHSLNSHNQL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 251 ----------------~~~v~l~Dfg~s~~~~----~~~~~~~~~ape~~ 280 (282)
++.+||+|||++.... ...|++.|||||.+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~ 231 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVI 231 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHH
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHH
Confidence 7899999999996322 22679999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=255.41 Aligned_cols=171 Identities=20% Similarity=0.230 Sum_probs=139.3
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|+++.. ...+..||||+++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 116 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLP--SKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVT 116 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCT--TSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecC--CCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 44556899999999999999999986532 2346679999987543 2344567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..+..++||||+++|+|.+++...+ .+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 117 KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999999997654 589999999999999999999999999999999999999999999999999964
Q ss_pred cccc----------hhheeeccCccc
Q 023430 265 QLCC----------FFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~~----------~~~~~~~ape~~ 280 (282)
...+ .++..|||||.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 222 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAI 222 (373)
T ss_dssp -----------------CTTSCHHHH
T ss_pred cccCCccceeccCCCcCCCccChhhh
Confidence 3221 235679999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=249.67 Aligned_cols=165 Identities=16% Similarity=0.263 Sum_probs=137.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||.||+|++. ..++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred hhhEEEEEEEEecCCeEEEEEEEC-----CCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 468999999999999999999876 4677899999976532 2333455778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc-----CCCcEEEEecCccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-----SDGHVMAAHSLNSH 263 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~-----~~~~v~l~Dfg~s~ 263 (282)
.+++||||+++ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999999985 9999998888899999999999999999999999999999999999994 45569999999985
Q ss_pred cc-------ccchhheeeccCccc
Q 023430 264 NQ-------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~-------~~~~~~~~~~ape~~ 280 (282)
.. ....|++.|+|||.+
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~ 209 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEIL 209 (329)
T ss_dssp HHC-----------CCTTCCHHHH
T ss_pred ccCCcccccCCCcCCccccCHHHh
Confidence 32 222569999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-34 Score=247.55 Aligned_cols=174 Identities=17% Similarity=0.208 Sum_probs=147.0
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+.+..++|++.+.||+|+||.||+|.++.......+..||+|++.... .......+.+|+.+++.++|+||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344557899999999999999999987743333456789999987543 223445688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcE
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v 254 (282)
...+..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999988652 346899999999999999999999999999999999999999999
Q ss_pred EEEecCccccccc---------chhheeeccCccc
Q 023430 255 MAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 255 ~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
||+|||++..... ..+++.|+|||.+
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 212 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 212 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhh
Confidence 9999999963221 1346789999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=247.08 Aligned_cols=175 Identities=18% Similarity=0.271 Sum_probs=148.8
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
.+.+..++|++.+.||+|+||.||+|++.+......++.||||++.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 4456678999999999999999999998765555677889999997653 233445688999999999 6999999999
Q ss_pred EEEeCC-EEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 183 SFQTRS-KLYLILDFINGGHLFFHLYRQGI----------------FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 183 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
++...+ .+++||||+++++|.+++..... +++..+..++.|++.||.|||++||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 59999999999999999986543 7899999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
||++.++.+||+|||++..... ..+++.|+|||.+
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 222 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh
Confidence 9999999999999999963221 1446789999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=240.42 Aligned_cols=167 Identities=28% Similarity=0.424 Sum_probs=146.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
++|++.+.||+|+||.||+|+++ .+++.||+|++........ ...+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhHHhhcccCceEEEEEEEc-----CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 46999999999999999999977 3567899999876543221 135678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC----cEEEEecCcc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMAAHSLNS 262 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~----~v~l~Dfg~s 262 (282)
....++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999999998888899999999999999999999999999999999999999887 8999999998
Q ss_pred cccc------cchhheeeccCcccc
Q 023430 263 HNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~------~~~~~~~~~ape~~~ 281 (282)
.... ...+++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVN 184 (283)
T ss_dssp EECC--------CCCGGGCCHHHHT
T ss_pred eeccCCCcccccCCCcCccCcceec
Confidence 6422 225799999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=248.59 Aligned_cols=166 Identities=27% Similarity=0.369 Sum_probs=145.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----hhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
++|++.+.||+|+||.||+|+++ .++..||||++..... ......+.+.+|+.+++.+ +||||++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHR-----ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhcccceEEecCCCEEEEEEEEC-----CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 46999999999999999999976 3567899999875431 1123345678999999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+......|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 99999999999999999999999888889999999999999999999999999999999999999999999999999885
Q ss_pred cc------ccchhheeeccCccc
Q 023430 264 NQ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~------~~~~~~~~~~ape~~ 280 (282)
.. ....|++.|+|||++
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~ 271 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEIL 271 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHH
T ss_pred ccCCCcccccCCCCCCccChhhc
Confidence 32 122679999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=241.89 Aligned_cols=169 Identities=22% Similarity=0.263 Sum_probs=141.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
...|++.+.||+|+||.||+|++.... ...++.||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEG-DNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTS-SSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhccCCCCceEEEEEEEcccc-CccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 356999999999999999999865322 2467889999997653 233456788999999999999999999999876
Q ss_pred -CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 188 -SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 188 -~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 678999999999999999954 456999999999999999999999999999999999999999999999999998532
Q ss_pred c----------cchhheeeccCccc
Q 023430 266 L----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~----------~~~~~~~~~ape~~ 280 (282)
. ...++..|+|||.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~ 201 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECL 201 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeee
Confidence 1 12457779999976
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=258.69 Aligned_cols=167 Identities=14% Similarity=0.111 Sum_probs=136.9
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHH---HHHhcCCCCeeeee---
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD---ILTKVTHPFIVQLR--- 181 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~nIv~l~--- 181 (282)
..++|++.+.||+|+||.||+|+++ .+++.||||++...........+.+.+|+. +|+.++||||++++
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQ-----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred CCceEEEcceeecCCCEEEEEEEEC-----CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 3567999999999999999999975 356789999998654445556677889994 55566799999998
Q ss_pred ----EEEEeCC-----------------EEEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHH
Q 023430 182 ----YSFQTRS-----------------KLYLILDFINGGHLFFHLYRQGIFRE-------DQARFYTAEIVSAVSHLHK 233 (282)
Q Consensus 182 ----~~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~i~~qi~~gL~ylH~ 233 (282)
+++...+ ..|+||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 6666553 289999999 6799999987554555 7777899999999999999
Q ss_pred CCCEeeccCCCceEEcCCCcEEEEecCccccccc----chhheeeccCcccc
Q 023430 234 CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC----CFFFFLFLGGGVFN 281 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~----~~~~~~~~ape~~~ 281 (282)
+||+||||||+|||++.+|.+||+|||++..... ..| +.|||||.+.
T Consensus 225 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~ 275 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEA 275 (377)
T ss_dssp TTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhc
Confidence 9999999999999999999999999999974221 255 9999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-33 Score=238.21 Aligned_cols=167 Identities=20% Similarity=0.303 Sum_probs=145.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 186 (282)
...|++.+.||+|+||.||+|.+. ..+..||+|++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred ceeEEeeeeccCCCCeEEEEeEec-----CCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 345899999999999999999876 4567899999876543 33456778899999999999999999998875
Q ss_pred --CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEc-CCCcEEEEecCc
Q 023430 187 --RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMAAHSLN 261 (282)
Q Consensus 187 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~-~~~~v~l~Dfg~ 261 (282)
...+++||||+++++|.+++...+.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||+
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 3568999999999999999988888999999999999999999999999 99999999999998 789999999999
Q ss_pred cccccc-----chhheeeccCcccc
Q 023430 262 SHNQLC-----CFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~~~-----~~~~~~~~ape~~~ 281 (282)
+..... ..|++.|+|||.+.
T Consensus 179 ~~~~~~~~~~~~~~t~~y~aPE~~~ 203 (290)
T 1t4h_A 179 ATLKRASFAKAVIGTPEFMAPEMYE 203 (290)
T ss_dssp GGGCCTTSBEESCSSCCCCCGGGGG
T ss_pred cccccccccccccCCcCcCCHHHHh
Confidence 953222 25799999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=239.70 Aligned_cols=168 Identities=28% Similarity=0.357 Sum_probs=147.2
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh------hhhhHHHHHHHHHHHHHhcC-CCCeeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI------IKKNHVDYMKAERDILTKVT-HPFIVQL 180 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~-h~nIv~l 180 (282)
..++|++.+.||+|+||.||+|.++ .+++.||||++..... ......+.+.+|+.+++.+. ||||+++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL 89 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred hhhccceeeeecCCCceEEEEEEEc-----CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 3578999999999999999999986 4567899999875431 11233456788999999996 9999999
Q ss_pred eEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
++++......++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 90 KDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999999999999999888889999999999999999999999999999999999999999999999999
Q ss_pred ccccc------ccchhheeeccCccc
Q 023430 261 NSHNQ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~------~~~~~~~~~~ape~~ 280 (282)
++... ....|++.|+|||.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 195 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEII 195 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHH
T ss_pred chhhcCCCcccccccCCccccCHHHh
Confidence 98532 122679999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=246.99 Aligned_cols=166 Identities=22% Similarity=0.300 Sum_probs=144.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||.||+|++. ..++.||+|++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEET-----TTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hhhheeeeEEeecCCEEEEEEEEC-----CCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC
Confidence 468999999999999999999976 456789999986543 23334456788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
..|+||||+++++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999999999998887777789999999999999999999999999999999999999999999999999996322
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|++.|+|||.+
T Consensus 178 ~~~~~~~~~t~~y~aPE~~ 196 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELL 196 (331)
T ss_dssp ------CCCCCTTCCHHHH
T ss_pred ccccCCCcCCccccCcccc
Confidence 22679999999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=262.54 Aligned_cols=168 Identities=22% Similarity=0.267 Sum_probs=145.9
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+.+...+|++.+.||+|+||.||+|.++ ..+..||||++.... ...+.+.+|+.+|+.++||||+++++++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~ 285 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC 285 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEG-----GGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEc-----CCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 4455678999999999999999999987 346789999997543 2345688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.....+||||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccc
Confidence 9999999999999999999999764 45899999999999999999999999999999999999999999999999999
Q ss_pred cccccc--------hhheeeccCcccc
Q 023430 263 HNQLCC--------FFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~~~--------~~~~~~~ape~~~ 281 (282)
+....+ .++..|||||.+.
T Consensus 366 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 392 (495)
T 1opk_A 366 RLMTGDTYTAHAGAKFPIKWTAPESLA 392 (495)
T ss_dssp ECCTTCCEECCTTCCCCGGGCCHHHHH
T ss_pred eeccCCceeecCCCcCCcceeCHhHHh
Confidence 743222 2356899999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=246.32 Aligned_cols=173 Identities=21% Similarity=0.260 Sum_probs=132.2
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.+.||+|+||.||+|+++... .....||||++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQED--GSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccC--CcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 4456778999999999999999999876422 1223799999976542 233456788999999999999999999999
Q ss_pred EeCCEE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC
Q 023430 185 QTRSKL------YLILDFINGGHLFFHLYRQG------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 185 ~~~~~~------~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~ 252 (282)
...... ++||||+.+|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 877655 99999999999999886532 589999999999999999999999999999999999999999
Q ss_pred cEEEEecCccccccc---------chhheeeccCccc
Q 023430 253 HVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
.+||+|||++..... ..+++.|+|||.+
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 211 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESL 211 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhh
Confidence 999999999963211 1346689999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=239.83 Aligned_cols=164 Identities=30% Similarity=0.521 Sum_probs=143.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|.+.+.||+|+||.||+|+++ ..++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccceeeeeccCCCCceEEEEEEC-----CCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 47999999999999999999976 3567899999976432 223457889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE---cCCCcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl---~~~~~v~l~Dfg~s~~~~ 266 (282)
.|+||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999999999888889999999999999999999999999999999999999 788999999999986432
Q ss_pred c-----chhheeeccCcccc
Q 023430 267 C-----CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~-----~~~~~~~~ape~~~ 281 (282)
. ..|++.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~ 180 (304)
T 2jam_A 161 NGIMSTACGTPGYVAPEVLA 180 (304)
T ss_dssp CBTTHHHHSCCCBCCTTTBS
T ss_pred CCccccccCCCCccChHHhc
Confidence 2 25799999999873
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=250.39 Aligned_cols=166 Identities=27% Similarity=0.405 Sum_probs=140.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
++|++.+.||+|+||.||+|.++ ..+..||+|++...... .....+.+.+|+.+++.++||||+++++++...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hheeecceeeecCCeEEEEEEEC-----CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 36999999999999999999976 45778999999765432 234567788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHH
Q 023430 188 SKLYLILDFINGGHLFFHLYR----------------------------------------QGIFREDQARFYTAEIVSA 227 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~g 227 (282)
+..++||||+++|+|.+++.. ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999988741 0113567788999999999
Q ss_pred HHHHHHCCCEeeccCCCceEEcCCC--cEEEEecCccccc-----------ccchhheeeccCccc
Q 023430 228 VSHLHKCGIVHRDLKPENILMDSDG--HVMAAHSLNSHNQ-----------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 228 L~ylH~~~iiHrDlKp~NILl~~~~--~v~l~Dfg~s~~~-----------~~~~~~~~~~ape~~ 280 (282)
|.|||++||+||||||+|||++.++ .+||+|||++... ....|++.|+|||.+
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence 9999999999999999999998776 8999999999632 223679999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=250.36 Aligned_cols=162 Identities=23% Similarity=0.404 Sum_probs=135.0
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
|...+.||+|+||.||+|++. ..+..||+|++..... ...+.+.+|+.+|+.++||||+++++++...+.++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~-----~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 162 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEET-----ATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162 (373)
T ss_dssp EEEEEECC-----CEEEEEET-----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecceEEecCcCEEEEEEEEc-----CCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 334678999999999999976 4567899999976532 23456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE--cCCCcEEEEecCcccccc--
Q 023430 192 LILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM--DSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl--~~~~~v~l~Dfg~s~~~~-- 266 (282)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 163 lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 999999999999888654 458999999999999999999999999999999999999 567899999999996321
Q ss_pred ----cchhheeeccCcccc
Q 023430 267 ----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ----~~~~~~~~~ape~~~ 281 (282)
...|++.|||||.++
T Consensus 243 ~~~~~~~gt~~y~aPE~~~ 261 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVN 261 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHT
T ss_pred cccccccCCCcEeChhhcc
Confidence 225899999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=253.95 Aligned_cols=165 Identities=24% Similarity=0.340 Sum_probs=142.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.++||+|+||.||+|+++ .+++.||||++..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCceEEEEEEEcCCCeEEEEEEEC-----CCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 468999999999999999999987 4567899999976542 233456778999999999999999999998755
Q ss_pred --EEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE----cCCCcEEEEec
Q 023430 189 --KLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGHVMAAHS 259 (282)
Q Consensus 189 --~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl----~~~~~v~l~Df 259 (282)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DF 160 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDF 160 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred CCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecC
Confidence 7899999999999999987543 28999999999999999999999999999999999999 77888999999
Q ss_pred Ccccccc------cchhheeeccCccc
Q 023430 260 LNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~------~~~~~~~~~ape~~ 280 (282)
|++.... ...|++.|+|||.+
T Consensus 161 G~a~~~~~~~~~~~~~gt~~y~aPE~~ 187 (396)
T 4eut_A 161 GAARELEDDEQFVSLYGTEEYLHPDMY 187 (396)
T ss_dssp GGCEECCCGGGSSCSSSCCTTCCHHHH
T ss_pred CCceEccCCCccccccCCccccCHHHh
Confidence 9996422 22579999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=250.21 Aligned_cols=164 Identities=20% Similarity=0.304 Sum_probs=136.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||.||+|.++ .+++.||||++.... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG-----RTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET-----TTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEEC-----CCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 468999999999999999999976 457789999986543 23344567889999999999999999999997653
Q ss_pred ------EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 7899888865 56899999999999999999999999999999999999999999999999999
Q ss_pred cccc----cchhheeeccCccc
Q 023430 263 HNQL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~----~~~~~~~~~ape~~ 280 (282)
+... ...+++.|+|||.+
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~ 197 (367)
T 1cm8_A 176 RQADSEMTGYVVTRWYRAPEVI 197 (367)
T ss_dssp EECCSSCCSSCSCGGGCCTHHH
T ss_pred cccccccCcCcCCCCcCCHHHH
Confidence 7432 22669999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=239.19 Aligned_cols=165 Identities=22% Similarity=0.332 Sum_probs=145.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|.++ ..+..||+|++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEEC-----CCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 47999999999999999999976 3567899999875532 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc----
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ---- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~---- 265 (282)
.|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999999999998877677999999999999999999999999999999999999999999999999998632
Q ss_pred -----ccchhheeeccCcccc
Q 023430 266 -----LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 -----~~~~~~~~~~ape~~~ 281 (282)
....|++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~ 180 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLK 180 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGT
T ss_pred chhcccCCccccCccChHHHh
Confidence 1225799999999873
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=251.02 Aligned_cols=163 Identities=23% Similarity=0.312 Sum_probs=142.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC--CCCeeeeeEEEEe
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQT 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~ 186 (282)
..+|++.+.||+|+||.||+|.+. .+..||||++..... .....+.+.+|+.+|+.++ |+||+++++++..
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred CCceEEEEEEccCCCeEEEEEEcC------CCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 456999999999999999999854 367899999976543 3445567889999999997 5999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+.+|+||| +.+++|.+++.....+++.++..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus 128 ~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 128 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999999999 66889999999888899999999999999999999999999999999999995 6899999999996421
Q ss_pred ---------cchhheeeccCccc
Q 023430 267 ---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ---------~~~~~~~~~ape~~ 280 (282)
...|++.|||||++
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~ 228 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAI 228 (390)
T ss_dssp --------CCSCCCGGGCCHHHH
T ss_pred CCCccccCCCCCcCCCccChHHh
Confidence 12589999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=258.08 Aligned_cols=167 Identities=20% Similarity=0.283 Sum_probs=143.6
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++.+.||+|+||.||+|.++ .+..||||+++... ...+.+.+|+.+|+.++||||++++++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET------TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC------CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 45666788999999999999999999875 34569999997643 234668899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+. ...+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 86 56799999999999999999753 3688999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--------hhheeeccCcccc
Q 023430 262 SHNQLCC--------FFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~~~~--------~~~~~~~ape~~~ 281 (282)
++....+ .++..|||||.++
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~ 358 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAIN 358 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHH
T ss_pred ceEcCCCceeccCCCcccccccCHHHhc
Confidence 9753222 2356899999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=241.03 Aligned_cols=167 Identities=20% Similarity=0.306 Sum_probs=139.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.+. ..+..||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACL-----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEET-----TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccceEEEEeecCCCCceEEEEEEc-----CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 357999999999999999999976 356789999997654444555677889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 189 KLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999988864 45689999999999999999999999999999999999999999999999999863
Q ss_pred cc-------cchhheeeccCccc
Q 023430 265 QL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~-------~~~~~~~~~ape~~ 280 (282)
.. ...|++.|+|||.+
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~ 208 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERI 208 (310)
T ss_dssp -------------CCSSCCHHHH
T ss_pred ecCCCccccccCCCeeEeChHHh
Confidence 22 12578999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=244.96 Aligned_cols=174 Identities=21% Similarity=0.226 Sum_probs=144.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+...+|++.+.||+|+||.||+|.++... ...+..||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 115 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI 115 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 4566789999999999999999999877432 1234569999987543 233445688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999999999999764 568999999999999999999999999999999999999999999999999996
Q ss_pred ccccc----------hhheeeccCcccc
Q 023430 264 NQLCC----------FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~~----------~~~~~~~ape~~~ 281 (282)
....+ .++..|+|||.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAIS 223 (333)
T ss_dssp ---------------CCCGGGSCHHHHH
T ss_pred hhccccccccccCCCCccccccCchhcc
Confidence 43221 2356799999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=246.28 Aligned_cols=170 Identities=19% Similarity=0.206 Sum_probs=137.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||+|++...+. .....||+|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCc-eEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 445689999999999999999999874322 122346888876432 23344668899999999999999999999987
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.. .++|+||+.+|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 54 78999999999999998774 56899999999999999999999999999999999999999999999999998532
Q ss_pred c---------cchhheeeccCccc
Q 023430 266 L---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~---------~~~~~~~~~ape~~ 280 (282)
. ...++..|||||.+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHH
T ss_pred cCCcccccccCCCccccccChHHh
Confidence 1 11346789999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=242.18 Aligned_cols=167 Identities=24% Similarity=0.300 Sum_probs=136.3
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcC---CCCeeeeeE
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII--KKNHVDYMKAERDILTKVT---HPFIVQLRY 182 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~---h~nIv~l~~ 182 (282)
..++|++.+.||+|+||.||+|+++ .+++.||+|++...... .......+.+|+.+++.++ ||||+++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDP-----HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECT-----TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 3568999999999999999999966 45778999998753311 1111234556777776664 999999999
Q ss_pred EEEeCC-----EEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEE
Q 023430 183 SFQTRS-----KLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 183 ~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~ 255 (282)
++.... .+++||||+. ++|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence 998765 5899999997 599999887644 89999999999999999999999999999999999999999999
Q ss_pred EEecCccccc------ccchhheeeccCccc
Q 023430 256 AAHSLNSHNQ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 256 l~Dfg~s~~~------~~~~~~~~~~ape~~ 280 (282)
|+|||++... ....|++.|||||.+
T Consensus 161 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 191 (308)
T 3g33_A 161 LADFGLARIYSYQMALTPVVVTLWYRAPEVL 191 (308)
T ss_dssp ECSCSCTTTSTTCCCSGGGGCCCSSCCHHHH
T ss_pred EeeCccccccCCCcccCCccccccccCchHH
Confidence 9999999632 122679999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=241.12 Aligned_cols=168 Identities=23% Similarity=0.350 Sum_probs=142.2
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+++++ ..++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEET-----TTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEec-----CCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 345678999999999999999999976 456789999886532 344566889999999999999999999986
Q ss_pred e----CCEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEE
Q 023430 186 T----RSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 186 ~----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~ 257 (282)
. ....|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence 3 3478999999999999998875 3568999999999999999999999999999999999999999999999
Q ss_pred ecCcccccc----------------cchhheeeccCcccc
Q 023430 258 HSLNSHNQL----------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 258 Dfg~s~~~~----------------~~~~~~~~~ape~~~ 281 (282)
|||++.... ...|++.|+|||.+.
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 216 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFS 216 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSS
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhc
Confidence 999875421 114589999999873
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=238.10 Aligned_cols=168 Identities=19% Similarity=0.295 Sum_probs=143.1
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhH----HHHHHHHHHHHHhcCCCCeeeee
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH----VDYMKAERDILTKVTHPFIVQLR 181 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~nIv~l~ 181 (282)
.+..++|++.+.||+|+||.||+|++. ..++.||+|++.......... .+.+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLV-----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEET-----TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhhhccceehhccccCCceeEEEEEEc-----CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 355679999999999999999999986 456789999986544322211 25688999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcCCCc-----
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGH----- 253 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~~~~----- 253 (282)
+++.... ++||||+++++|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 9987665 7999999999998888654 46899999999999999999999999 999999999999998887
Q ss_pred EEEEecCcccccccc----hhheeeccCccc
Q 023430 254 VMAAHSLNSHNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 254 v~l~Dfg~s~~~~~~----~~~~~~~ape~~ 280 (282)
+||+|||++...... .|++.|+|||.+
T Consensus 168 ~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~ 198 (287)
T 4f0f_A 168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETI 198 (287)
T ss_dssp EEECCCTTCBCCSSCEECCCCCCTTSCGGGS
T ss_pred EEeCCCCccccccccccccCCCccccCchhh
Confidence 999999999743332 679999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=245.77 Aligned_cols=165 Identities=26% Similarity=0.442 Sum_probs=138.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-----KKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
++|++.+.||+|+||.||+|.++ .+++.||||++...... .......+.+|+.+++.++||||+++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEc-----CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 46999999999999999999976 45678999998764321 112234577899999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc---EEEEecCc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMAAHSLN 261 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~---v~l~Dfg~ 261 (282)
.... .|+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 7655 8999999999999999988788999999999999999999999999999999999999987665 99999999
Q ss_pred cccccc------chhheeeccCccc
Q 023430 262 SHNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~------~~~~~~~~ape~~ 280 (282)
+..... ..|++.|+|||.+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~ 188 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVL 188 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHH
T ss_pred ceecccccccccccCCcCccCchhh
Confidence 964322 2579999999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=265.37 Aligned_cols=157 Identities=15% Similarity=0.068 Sum_probs=125.3
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-------hhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeC
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-------IKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTR 187 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 187 (282)
...+.|++|.+..++.. ..+..|++|++.+... ......+.+.+|+++|+++ .|+||++++++++++
T Consensus 240 ~~~~~~~~~~h~~~rr~-----~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~ 314 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRY-----FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA 314 (569)
T ss_dssp CC-C--------CCEEE-----EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred hccccCCcccccccccc-----cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence 34667777766665544 2456799999976431 1234456799999999999 599999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
+.+||||||++|++|.+++.+.+.+++. .|+.||+.||+|+|++|||||||||+||||+.+|.|||+|||+|+....
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999999999988888765 4789999999999999999999999999999999999999999974322
Q ss_pred -------chhheeeccCccc
Q 023430 268 -------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -------~~~~~~~~ape~~ 280 (282)
..||+.|||||.+
T Consensus 392 ~~~~~~t~vGTp~YmAPE~l 411 (569)
T 4azs_A 392 DCSWPTNLVQSFFVFVNELF 411 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC
T ss_pred CCccccCceechhhccHHHh
Confidence 2789999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=241.77 Aligned_cols=168 Identities=23% Similarity=0.274 Sum_probs=146.4
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++.+.||+|+||.||+|.++ ..+..||+|++.... ...+.+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEG-----GGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEec-----CCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34556778999999999999999999987 356789999987543 344668899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+...+..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 99999999999999999999999864 3489999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--------hhheeeccCccc
Q 023430 262 SHNQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~~--------~~~~~~~ape~~ 280 (282)
+.....+ .+++.|+|||.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 184 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESL 184 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHH
T ss_pred ceeccCCccccccCCccccCcCChhhh
Confidence 8642221 346679999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=243.11 Aligned_cols=170 Identities=21% Similarity=0.296 Sum_probs=145.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE-
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ- 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~- 185 (282)
+..++|++.+.||+|+||.||+|++.... ...+..||||++.... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLG-DNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTS-SSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCC-CCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 45578999999999999999999865432 2467889999987643 334466889999999999999999999886
Q ss_pred -eCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 -TRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 -~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
....+++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 45679999999999999999976 3569999999999999999999999999999999999999999999999999996
Q ss_pred ccc----------cchhheeeccCccc
Q 023430 264 NQL----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~----------~~~~~~~~~ape~~ 280 (282)
... ...++..|+|||.+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESL 202 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHh
Confidence 321 11457779999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-33 Score=238.82 Aligned_cols=170 Identities=15% Similarity=0.180 Sum_probs=143.2
Q ss_pred CcCCCCeEEEe-eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.+...+|++.+ .||+|+||.||+|.+... ..+..||||++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eecchhhhhccCccccccCeeeEeeeecCC---CceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 44556899998 999999999999976522 3567899999976532 334456788999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..+..++||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 5667899999999999999998888899999999999999999999999999999999999999999999999999863
Q ss_pred ccc----------chhheeeccCccc
Q 023430 265 QLC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~----------~~~~~~~~ape~~ 280 (282)
... ..+++.|+|||.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 192 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECI 192 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHH
T ss_pred eccCCCcccccccCCCCceeeChHHh
Confidence 221 1335789999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=238.83 Aligned_cols=169 Identities=13% Similarity=0.188 Sum_probs=146.2
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.+.||+|+||.||+|++. +..||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 3456678999999999999999999864 45699999976542 234456688999999999999999999999
Q ss_pred EeC--CEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcCCCcEEEEe
Q 023430 185 QTR--SKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 185 ~~~--~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~~~~v~l~D 258 (282)
... ...++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++++|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEe
Confidence 877 78899999999999999998765 4899999999999999999999999 99999999999999999999997
Q ss_pred cCccc--ccccchhheeeccCcccc
Q 023430 259 SLNSH--NQLCCFFFFLFLGGGVFN 281 (282)
Q Consensus 259 fg~s~--~~~~~~~~~~~~ape~~~ 281 (282)
||++. ......|++.|||||.+.
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~ 181 (271)
T 3kmu_A 157 ADVKFSFQSPGRMYAPAWVAPEALQ 181 (271)
T ss_dssp GGSCCTTSCTTCBSCGGGSCHHHHH
T ss_pred ccceeeecccCccCCccccChhhhc
Confidence 76654 344457899999999863
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=235.72 Aligned_cols=166 Identities=22% Similarity=0.320 Sum_probs=144.8
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+.+..++|++.+.||+|+||.||+|.+. .+..||+|++..... ..+.+.+|+.+++.++||||+++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~ 72 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVC 72 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4456678999999999999999999875 345799999976542 224588899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred ccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence 9999999999999999999999765 458999999999999999999999999999999999999999999999999986
Q ss_pred cccc--------chhheeeccCccc
Q 023430 264 NQLC--------CFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~--------~~~~~~~~ape~~ 280 (282)
.... ..++..|+|||.+
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~ 177 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVF 177 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHH
T ss_pred ccccccccccccccccccccChhhh
Confidence 4322 2446789999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=239.20 Aligned_cols=160 Identities=23% Similarity=0.283 Sum_probs=134.5
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCCeeeeeEEEE
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQ 185 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~ 185 (282)
..++|++.+.||+|+||.||+|++. +..||||++.... .+.+.+|.+++.. ++||||+++++++.
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ-------GENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET-------TEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC-------CEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 4568999999999999999999863 5679999986542 2334556777666 78999999999865
Q ss_pred e----CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEeeccCCCceEEcCCCc
Q 023430 186 T----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGH 253 (282)
Q Consensus 186 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH--------~~~iiHrDlKp~NILl~~~~~ 253 (282)
. ...+|+||||+++|+|.+++. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred cccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC
Confidence 4 246899999999999999994 456899999999999999999999 999999999999999999999
Q ss_pred EEEEecCccccccc-----------chhheeeccCcccc
Q 023430 254 VMAAHSLNSHNQLC-----------CFFFFLFLGGGVFN 281 (282)
Q Consensus 254 v~l~Dfg~s~~~~~-----------~~~~~~~~ape~~~ 281 (282)
+||+|||++..... ..|++.|+|||.+.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 190 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHT
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhc
Confidence 99999999852111 16799999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=239.63 Aligned_cols=166 Identities=23% Similarity=0.291 Sum_probs=141.6
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--RS 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~ 188 (282)
.|++++.||+|+||.||++.++.... ..++.||||++.... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTND-GTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHhhhheecCCCCeEEEEEEEccCCC-CCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 35999999999999999998764432 467889999997653 23445678899999999999999999999987 46
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.+++||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 899999999999999998654 48999999999999999999999999999999999999999999999999996321
Q ss_pred --------cchhheeeccCccc
Q 023430 267 --------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 --------~~~~~~~~~ape~~ 280 (282)
...++..|+|||.+
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~ 209 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECL 209 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHH
T ss_pred ccccccccCCCCCceeeChHHh
Confidence 11457779999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=245.59 Aligned_cols=171 Identities=18% Similarity=0.219 Sum_probs=139.3
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|++...+. .....||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGE-SIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTC-SCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCc-eEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 3456789999999999999999999874322 122347888775432 1222234667999999999999999999886
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
....++||||+.+|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45699999999999999998764 4689999999999999999999999999999999999999999999999999964
Q ss_pred ccc---------chhheeeccCccc
Q 023430 265 QLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~---------~~~~~~~~ape~~ 280 (282)
... ..++..|||||.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~ 189 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESI 189 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHH
T ss_pred cCcccccccccCCCCcccccChHHh
Confidence 211 1346689999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=246.95 Aligned_cols=163 Identities=20% Similarity=0.320 Sum_probs=136.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++++.||+|+||.||+|+++ .++..||+|++...... .....+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEEC-----CCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence 58999999999999999999977 45678999998654321 111124469999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.++||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred EEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9999999985 888888764 458999999999999999999999999999999999999999999999999986322
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|++.|+|||.+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~ 172 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDIL 172 (324)
T ss_dssp ---------CGGGCCHHHH
T ss_pred ccccccccCcccccChhhh
Confidence 12569999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=243.90 Aligned_cols=167 Identities=23% Similarity=0.327 Sum_probs=140.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCc--EEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
+..++|++.+.||+|+||.||+|+++. .+. .+|+|.+.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 445789999999999999999999773 333 35899886532 233445688899999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceE
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQG----------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NIL 247 (282)
+...+..|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 174 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence 999999999999999999999997654 6899999999999999999999999999999999999
Q ss_pred EcCCCcEEEEecCcccccc------cchhheeeccCccc
Q 023430 248 MDSDGHVMAAHSLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 248 l~~~~~v~l~Dfg~s~~~~------~~~~~~~~~ape~~ 280 (282)
++.++.+||+|||++.... ...+++.|+|||.+
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 213 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 213 (327)
T ss_dssp ECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH
T ss_pred EcCCCeEEEcccCcCccccccccccCCCCCccccChhhh
Confidence 9999999999999986322 22457789999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=235.49 Aligned_cols=166 Identities=23% Similarity=0.335 Sum_probs=134.3
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
+..++|++.+.||+|+||.||+|.+. +..||+|++....... ....+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 45679999999999999999999864 4579999987643222 233466889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CEeeccCCCceEEcC--------CCcE
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG---IVHRDLKPENILMDS--------DGHV 254 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~NILl~~--------~~~v 254 (282)
..+..++||||+++++|.+++. .+.+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred cCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 9999999999999999988874 557899999999999999999999999 999999999999986 7789
Q ss_pred EEEecCccccc-----ccchhheeeccCccc
Q 023430 255 MAAHSLNSHNQ-----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 255 ~l~Dfg~s~~~-----~~~~~~~~~~ape~~ 280 (282)
+|+|||++... ....|++.|+|||.+
T Consensus 156 kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~ 186 (271)
T 3dtc_A 156 KITDFGLAREWHRTTKMSAAGAYAWMAPEVI 186 (271)
T ss_dssp EECCCCC-------------CCGGGSCHHHH
T ss_pred EEccCCcccccccccccCCCCccceeCHHHh
Confidence 99999999632 223679999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-33 Score=237.59 Aligned_cols=168 Identities=21% Similarity=0.278 Sum_probs=134.7
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|+++ ..++.||+|++..... .....+.+.++...++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEec-----CCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 345678999999999999999999976 4577899999976532 2233344555666688899999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecC
Q 023430 186 TRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
..+..++||||+++ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999985 77666543 46799999999999999999999998 99999999999999999999999999
Q ss_pred ccccccc------chhheeeccCccc
Q 023430 261 NSHNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~------~~~~~~~~ape~~ 280 (282)
++..... ..|++.|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 156 ISGYLVDDVAKDIDAGCKPYMAPERI 181 (290)
T ss_dssp --------------CCCCCCSCHHHH
T ss_pred CcccccccccccccCCCccccChhhc
Confidence 9863221 2679999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=244.59 Aligned_cols=164 Identities=20% Similarity=0.299 Sum_probs=135.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|.+. ..++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA-----ILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEEC-----CCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 468999999999999999999876 456789999997643 23344566888999999999999999999997654
Q ss_pred ------EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 78999999975 6777774 45899999999999999999999999999999999999999999999999999
Q ss_pred cccc------cchhheeeccCcccc
Q 023430 263 HNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~------~~~~~~~~~ape~~~ 281 (282)
.... ...|++.|||||.+.
T Consensus 175 ~~~~~~~~~~~~~gt~~y~aPE~~~ 199 (371)
T 2xrw_A 175 RTAGTSFMMTPYVVTRYYRAPEVIL 199 (371)
T ss_dssp ---------------CTTCCHHHHT
T ss_pred cccccccccCCceecCCccCHHHhc
Confidence 6432 226799999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=246.34 Aligned_cols=164 Identities=23% Similarity=0.310 Sum_probs=142.8
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|+++ .+..||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3568999999999999999999853 36689999886542 23456788999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999998886542 48899999999999999999999999999999999999999999999999986
Q ss_pred ccc---------cchhheeeccCccc
Q 023430 264 NQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~---------~~~~~~~~~ape~~ 280 (282)
... ...|++.|+|||.+
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYF 213 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHH
T ss_pred ccccccccccccccCCCccccCHHHh
Confidence 321 11479999999976
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=246.11 Aligned_cols=165 Identities=21% Similarity=0.290 Sum_probs=138.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 186 (282)
.++|++++.||+|+||.||+|+++ .+++.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEET-----TTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEEC-----CCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 368999999999999999999986 45678999998665422 2223456789999999999999999999887
Q ss_pred ------CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 187 ------RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 187 ------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
.+.+|+||||+++ +|...+... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999986 666666543 56999999999999999999999999999999999999999999999999
Q ss_pred Cccccc-----------ccchhheeeccCccc
Q 023430 260 LNSHNQ-----------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~-----------~~~~~~~~~~ape~~ 280 (282)
|++... ....|++.|||||.+
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 200 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhh
Confidence 998531 112569999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-33 Score=236.28 Aligned_cols=170 Identities=22% Similarity=0.269 Sum_probs=143.2
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|++.... ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHK--GEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTT--CCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCC--CCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 445678999999999999999999876422 345569999987653 2334567889999999999999999999986
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
. +..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 5 4578999999999999999765 4589999999999999999999999999999999999999999999999999864
Q ss_pred ccc--------chhheeeccCccc
Q 023430 265 QLC--------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~--------~~~~~~~~ape~~ 280 (282)
... ..+++.|+|||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~ 186 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESI 186 (281)
T ss_dssp C---------CCCCCGGGCCHHHH
T ss_pred cccccccccccCCCCcceeCchhh
Confidence 221 2446789999976
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=243.40 Aligned_cols=172 Identities=17% Similarity=0.238 Sum_probs=139.5
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||+|++.+......+..||||++.... .......+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 4456899999999999999999996654344567789999986432 23344568889999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEE
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG-------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMA 256 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l 256 (282)
....|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+ +.++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999998653 48899999999999999999999999999999999999954 45999
Q ss_pred EecCcccc---------cccchhheeeccCccc
Q 023430 257 AHSLNSHN---------QLCCFFFFLFLGGGVF 280 (282)
Q Consensus 257 ~Dfg~s~~---------~~~~~~~~~~~ape~~ 280 (282)
+|||++.. ..+..+++.|+|||.+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 217 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 217 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHh
Confidence 99998852 1223568899999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=240.58 Aligned_cols=170 Identities=19% Similarity=0.211 Sum_probs=138.5
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.++||+|+||.||+|.+...+. .....||+|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTC-SCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCc-eEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 456789999999999999999999875432 122336777775432 23345668899999999999999999999987
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.. .++|+||+.+|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 65 88999999999999998764 56899999999999999999999999999999999999999999999999999632
Q ss_pred cc---------chhheeeccCccc
Q 023430 266 LC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~---------~~~~~~~~ape~~ 280 (282)
.. ..+++.|||||.+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~ 191 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESI 191 (327)
T ss_dssp ------------CCCGGGSCHHHH
T ss_pred cCccccccccCCCccccccCHHHH
Confidence 11 1346689999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-33 Score=238.44 Aligned_cols=170 Identities=22% Similarity=0.311 Sum_probs=137.8
Q ss_pred hhhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeee
Q 023430 102 ESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLR 181 (282)
Q Consensus 102 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 181 (282)
.....+..++|++.+.||+|+||.||+|++. ..+|+|+++.... .....+.+.+|+.+++.++|+||++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFM 86 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 3445677889999999999999999999854 2499999875532 344556788999999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
++. .....++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp EEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred eec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccce
Confidence 955 55678999999999999998854 3458999999999999999999999999999999999999999999999999
Q ss_pred cccccc---------cchhheeeccCcccc
Q 023430 261 NSHNQL---------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~~---------~~~~~~~~~ape~~~ 281 (282)
++.... ...|++.|+|||.+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp ------------------CCCTTCCHHHHC
T ss_pred eccccccccccccccccCCCccccCchhhc
Confidence 986322 125799999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=239.27 Aligned_cols=164 Identities=27% Similarity=0.438 Sum_probs=140.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+++ ..+..||+|++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEET-----TTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-
T ss_pred ccceeecceeccCCCeEEEEEEEc-----CCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC
Confidence 357999999999999999999987 356789999986543 234566888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ-- 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~-- 265 (282)
..++||||+++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999999988865 456999999999999999999999999999999999999999999999999987532
Q ss_pred -----ccchhheeeccCccc
Q 023430 266 -----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 -----~~~~~~~~~~ape~~ 280 (282)
....|++.|+|||.+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~ 189 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVV 189 (302)
T ss_dssp HHHC-----CCGGGCCHHHH
T ss_pred cccccccccCChhhcCCeee
Confidence 222679999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=236.71 Aligned_cols=164 Identities=22% Similarity=0.399 Sum_probs=144.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
+.|++.+.||+|+||.||+|.+. ..++.||+|++..... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 94 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDN-----RTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK 94 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred HHHHHhhhhcccCCeEEEEEEEC-----CCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence 46999999999999999999876 4567899999976542 3345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--- 266 (282)
.|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 95 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred EEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999999998854 568999999999999999999999999999999999999999999999999985321
Q ss_pred ----cchhheeeccCcccc
Q 023430 267 ----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ----~~~~~~~~~ape~~~ 281 (282)
...|++.|+|||.+.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~ 192 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIK 192 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHT
T ss_pred cccCccCCCcCccCHHHHh
Confidence 225789999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=237.04 Aligned_cols=163 Identities=26% Similarity=0.448 Sum_probs=138.4
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe---
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--- 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 186 (282)
++|++.+.||+|+||.||+|++. ..++.||||++... ....+.+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA-----LDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEc-----CCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 46999999999999999999976 45678999998653 2344668899999999999999999998865
Q ss_pred ----------CCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEE
Q 023430 187 ----------RSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 187 ----------~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~ 255 (282)
....|+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence 357899999999999999997644 478899999999999999999999999999999999999999999
Q ss_pred EEecCcccccc---------------------cchhheeeccCcccc
Q 023430 256 AAHSLNSHNQL---------------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 256 l~Dfg~s~~~~---------------------~~~~~~~~~ape~~~ 281 (282)
|+|||++.... ...|++.|+|||.+.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 203 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHT
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCccccc
Confidence 99999986421 225789999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=261.46 Aligned_cols=166 Identities=16% Similarity=0.204 Sum_probs=139.6
Q ss_pred CeEEE-eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 111 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
.+.+. +.||+|+||.||+|.+... ..++.||||+++... ......+.+.+|+.+|+.++|||||++++++.. +.
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECS---SCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred hccccCCEeccCCCEEEEEEEEcCC---CcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 44443 4799999999999976532 356789999997654 233445678999999999999999999999864 56
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc-
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC- 268 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~- 268 (282)
+++||||+++|+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....+
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 8999999999999999988888999999999999999999999999999999999999999999999999998632211
Q ss_pred ---------hhheeeccCcccc
Q 023430 269 ---------FFFFLFLGGGVFN 281 (282)
Q Consensus 269 ---------~~~~~~~ape~~~ 281 (282)
.+++.|||||+++
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~ 545 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECIN 545 (635)
T ss_dssp -----------CGGGSCHHHHH
T ss_pred cccccccCCCCceeeeChhhhc
Confidence 3457899999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=236.73 Aligned_cols=165 Identities=19% Similarity=0.356 Sum_probs=139.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
...++|++.+.||+|+||.||+|.++ .++..||+|++.... ..+.+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET-----TTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC-----CCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 34568999999999999999999976 456789999987542 23457889999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+..|+||||+++++|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999999999999986 3567999999999999999999999999999999999999999999999999998532
Q ss_pred c-------cchhheeeccCcccc
Q 023430 266 L-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~-------~~~~~~~~~ape~~~ 281 (282)
. ...|++.|+|||.+.
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~ 198 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQ 198 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHS
T ss_pred hhhccccCccCCCCCccChhhcC
Confidence 2 226799999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=247.44 Aligned_cols=166 Identities=14% Similarity=0.199 Sum_probs=125.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc--CCCCeeeee------
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV--THPFIVQLR------ 181 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~------ 181 (282)
.+|++.+.||+|+||.||+|+++ .+++.||||++...........+.+.+|+.+++.+ +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEEC-----CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 45999999999999999999987 45678999999886554555566788886555444 699988754
Q ss_pred -EEEEeC-----------------CEEEEEEeccCCCchHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCC
Q 023430 182 -YSFQTR-----------------SKLYLILDFINGGHLFFHLYRQ-GIFREDQA------RFYTAEIVSAVSHLHKCGI 236 (282)
Q Consensus 182 -~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~------~~i~~qi~~gL~ylH~~~i 236 (282)
+++... ..+|+||||++ |+|.+++... ..+.+... ..++.||+.||.|||++||
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 454433 34899999999 8999999764 23444444 5667999999999999999
Q ss_pred EeeccCCCceEEcCCCcEEEEecCcccccc----cchhheeeccCcccc
Q 023430 237 VHRDLKPENILMDSDGHVMAAHSLNSHNQL----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 237 iHrDlKp~NILl~~~~~v~l~Dfg~s~~~~----~~~~~~~~~ape~~~ 281 (282)
|||||||+|||++.+|.+||+|||+++... ...+++.|||||.+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~ 264 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLN 264 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHT
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhcc
Confidence 999999999999999999999999996322 336689999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=242.38 Aligned_cols=162 Identities=17% Similarity=0.270 Sum_probs=140.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
++|++++.||+|+||.||+|.+. ..+..||||++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDN-----LNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred ccEEEEEEeecCCCeEEEEEEEC-----CCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 58999999999999999999976 456789999987532 233446688999999999999999999999765
Q ss_pred ---CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 188 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
...|+||||+.+ +|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 100 EQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 368999999975 89888865 4689999999999999999999999999999999999999999999999999963
Q ss_pred ccc----------chhheeeccCccc
Q 023430 265 QLC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~~----------~~~~~~~~ape~~ 280 (282)
... ..|++.|+|||.+
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~ 203 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIM 203 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHh
Confidence 221 1679999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=239.48 Aligned_cols=173 Identities=20% Similarity=0.226 Sum_probs=138.5
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|.+.+.||+|+||.||+|.+... ...+..||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECT--TSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEecc--CCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 345567899999999999999999987642 23456899999876532 234456688999999999999999999998
Q ss_pred EeCC-----EEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc
Q 023430 185 QTRS-----KLYLILDFINGGHLFFHLYR------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253 (282)
Q Consensus 185 ~~~~-----~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~ 253 (282)
.... ..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7654 35999999999999999853 345899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccc---------chhheeeccCccc
Q 023430 254 VMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 254 v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
+||+|||++..... ..+++.|+|||.+
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 221 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL 221 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHH
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhh
Confidence 99999999964221 2447789999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=235.45 Aligned_cols=169 Identities=20% Similarity=0.224 Sum_probs=142.0
Q ss_pred CcCCCCeEEEe-eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.+..++|.+.+ .||+|+||.||+|.++.. ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 79 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC 79 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccC---CCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence 34556788887 999999999999987532 346779999997642 334556788999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 80 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 80 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158 (287)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred -cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECccccee
Confidence 456799999999999999988654 458999999999999999999999999999999999999999999999999986
Q ss_pred ccc----------cchhheeeccCccc
Q 023430 264 NQL----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~----------~~~~~~~~~ape~~ 280 (282)
... ...+++.|+|||.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECI 185 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred eeccCcceeeccccccccccccCHHHh
Confidence 321 11346889999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=241.59 Aligned_cols=169 Identities=25% Similarity=0.355 Sum_probs=128.9
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+.+..++|++.+.||+|+||.||+|.+. ..+..||||++..... ....+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCA-----PKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC------------------CCCCCCCTTBCCEEEEE
T ss_pred cccchhhhhhhheeccccceEEEEEEEC-----CCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 4566789999999999999999999865 3567899999865432 23345678899999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEE
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYR--------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMA 256 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l 256 (282)
...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 999999999999999999998864 345899999999999999999999999999999999999999999999
Q ss_pred EecCcccccc------------cchhheeeccCccc
Q 023430 257 AHSLNSHNQL------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 257 ~Dfg~s~~~~------------~~~~~~~~~ape~~ 280 (282)
+|||++.... ...|++.|+|||.+
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 198 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHH
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHh
Confidence 9999885321 12578999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=253.18 Aligned_cols=166 Identities=22% Similarity=0.266 Sum_probs=140.6
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++.+.||+|+||.||+|.++. ...||||+++.... ..+.+.+|+.+|+.++||||++++++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 355667789999999999999999999762 34699999976432 23458899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+.. +..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 866 678999999999999999864 35689999999999999999999999999999999999999999999999999
Q ss_pred ccccccc--------hhheeeccCccc
Q 023430 262 SHNQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~~--------~~~~~~~ape~~ 280 (282)
++....+ .++..|||||.+
T Consensus 327 a~~~~~~~~~~~~~~~~~~~y~aPE~~ 353 (452)
T 1fmk_A 327 ARLIEDNEYTARQGAKFPIKWTAPEAA 353 (452)
T ss_dssp TC--------------CCGGGSCHHHH
T ss_pred ceecCCCceecccCCcccccccCHhHH
Confidence 9743221 345789999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=246.69 Aligned_cols=164 Identities=20% Similarity=0.300 Sum_probs=127.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++++.||+|+||.||+|.+. .++..||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEET-----TTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCceEEeeEEeecCCeEEEEEEEC-----CCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 368999999999999999999876 467789999986543 2233456678899999999999999999998654
Q ss_pred -----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 188 -----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 188 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..+|+|||++ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 5689999999 6789888765 56899999999999999999999999999999999999999999999999999
Q ss_pred ccccc----chhheeeccCccc
Q 023430 263 HNQLC----CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~----~~~~~~~~ape~~ 280 (282)
+.... ..|++.|+|||.+
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~ 201 (367)
T 2fst_X 180 RHTADEMTGYVATRWYRAPEIM 201 (367)
T ss_dssp -----------CCCTTCCHHHH
T ss_pred ccccccCCCcCcCcCccChHHH
Confidence 74322 2679999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=236.86 Aligned_cols=166 Identities=19% Similarity=0.367 Sum_probs=142.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 186 (282)
.++|++.+.||+|+||.||+++++ .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEEC-----CCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 358999999999999999999976 4567899999976543 23445678899999999999999999998754
Q ss_pred CCEEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----CEeeccCCCceEEcCCCcEEEE
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ----GIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMAA 257 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~gL~ylH~~~-----iiHrDlKp~NILl~~~~~v~l~ 257 (282)
....|+||||+++++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 57899999999999999998753 34899999999999999999999999 9999999999999999999999
Q ss_pred ecCcccccc-------cchhheeeccCccc
Q 023430 258 HSLNSHNQL-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 258 Dfg~s~~~~-------~~~~~~~~~ape~~ 280 (282)
|||++.... ...|++.|+|||.+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~ 188 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQM 188 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHH
T ss_pred cCchheeeccccccccccCCCccccChHHh
Confidence 999986322 22578999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=243.97 Aligned_cols=166 Identities=17% Similarity=0.233 Sum_probs=141.1
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
...++|++.+.||+|+||.||+|++. .+..||||++........ ...+.+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred HHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEec
Confidence 34578999999999999999999743 466799999876542221 2247889999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEeeccCCCceEEcCCCcEEEEec
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG----IFREDQARFYTAEIVSAVSHLHKC---GIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
....++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 999999999999999999997643 389999999999999999999999 9999999999999999999999999
Q ss_pred Ccccccc--------cchhheeeccCccc
Q 023430 260 LNSHNQL--------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~--------~~~~~~~~~ape~~ 280 (282)
|++.... ...|++.|+|||.+
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYL 207 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHH
T ss_pred ccccccCcccccccccccCCcCccCHHHh
Confidence 9996321 11479999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-33 Score=236.61 Aligned_cols=167 Identities=19% Similarity=0.279 Sum_probs=142.1
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
++.+..++|++.+.||+|+||.||+|.+. .+..||+|++..... ..+.+.+|+.+++.++||||++++++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~ 76 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAV 76 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEE
Confidence 45667789999999999999999999865 345799999875432 23568889999999999999999998
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+.. +..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 77 ~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 864 56899999999999999886432 689999999999999999999999999999999999999999999999999
Q ss_pred cccccc--------chhheeeccCcccc
Q 023430 262 SHNQLC--------CFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~~~--------~~~~~~~~ape~~~ 281 (282)
+..... ..++..|+|||.++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 183 (279)
T 1qpc_A 156 ARLIEDNEYTAREGAKFPIKWTAPEAIN 183 (279)
T ss_dssp CEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred cccccCcccccccCCCCccCccChhhhc
Confidence 864221 13466899999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=234.45 Aligned_cols=166 Identities=28% Similarity=0.443 Sum_probs=145.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++.+.||+|+||.||+|+++ ..++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDR-----ITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hcceeeEEEcCCCCEEEEEEEEc-----CCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 47999999999999999999976 35678999999765432 3345668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~Dfg~s~~~~ 266 (282)
.++||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999999998888889999999999999999999999999999999999999764 469999999986322
Q ss_pred ------cchhheeeccCcccc
Q 023430 267 ------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ------~~~~~~~~~ape~~~ 281 (282)
...+++.|+|||.+.
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~ 196 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLR 196 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHT
T ss_pred CCCccccccCcccccChHHhc
Confidence 225799999999763
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-32 Score=234.07 Aligned_cols=163 Identities=17% Similarity=0.186 Sum_probs=141.3
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 185 (282)
+..++|++.+.||+|+||.||+|++. ..++.||+|++..... .+.+.+|+.+++.+ +|+||+++++++.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEEC-----CCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 34568999999999999999999976 4577899999865432 12367899999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc-----EEEEec
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH-----VMAAHS 259 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~-----v~l~Df 259 (282)
.....++||||+ +++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+||
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df 155 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 155 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence 999999999999 999999998754 5999999999999999999999999999999999999988776 999999
Q ss_pred Ccccccc--------------cchhheeeccCccc
Q 023430 260 LNSHNQL--------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~--------------~~~~~~~~~ape~~ 280 (282)
|++.... ...|++.|+|||.+
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 190 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 190 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhh
Confidence 9996321 12579999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=236.57 Aligned_cols=167 Identities=17% Similarity=0.171 Sum_probs=138.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~ 188 (282)
..|++.++||+|+||.||+|.+.... .....+|+|.+.... .....+.+.+|+.+++.++||||+++++++. .++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred eehhhcceeeecCCceEEEEEEecCC--CceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 46999999999999999999876322 234568999886532 3344567889999999999999999999854 556
Q ss_pred EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~ 267 (282)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 889999999999999999763 4588999999999999999999999999999999999999999999999999963211
Q ss_pred -----------chhheeeccCccc
Q 023430 268 -----------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -----------~~~~~~~~ape~~ 280 (282)
..+++.|+|||.+
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~ 204 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESL 204 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHH
T ss_pred cchhccccccCCCCCccccChHHh
Confidence 1346789999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=235.43 Aligned_cols=159 Identities=21% Similarity=0.306 Sum_probs=138.8
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe---
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--- 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 186 (282)
++|++.+.||+|+||.||+|++. ..++.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHR-----IDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEET-----TTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cccceeeeeccCCceEEEEEEEc-----CCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 36999999999999999999976 356789999987543 235679999999999999999998854
Q ss_pred -------------CCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC
Q 023430 187 -------------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 187 -------------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~ 251 (282)
...+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 44689999999999999999754 568999999999999999999999999999999999999999
Q ss_pred CcEEEEecCccccc------ccchhheeeccCccc
Q 023430 252 GHVMAAHSLNSHNQ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 252 ~~v~l~Dfg~s~~~------~~~~~~~~~~ape~~ 280 (282)
+.++|+|||++... ....|++.|+|||.+
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 193 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQI 193 (284)
T ss_dssp TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHH
T ss_pred CCEEECcchhheeccccccccccCCcccccChhhh
Confidence 99999999998632 223679999999976
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=236.76 Aligned_cols=165 Identities=22% Similarity=0.377 Sum_probs=139.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+++ ..++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN 75 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred cchhhhhhhhccCCCeeEEEEEEc-----CCCceEEEEEeecCcc-chhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCC
Confidence 468999999999999999999976 3567899999876532 2222355778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ- 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~- 265 (282)
..|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 76 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 154 (299)
T 2r3i_A 76 KLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154 (299)
T ss_dssp EEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred ceEEEEEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhcc
Confidence 9999999998 5898888765 45899999999999999999999999999999999999999999999999988532
Q ss_pred ------ccchhheeeccCccc
Q 023430 266 ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ------~~~~~~~~~~ape~~ 280 (282)
....+++.|+|||.+
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~ 175 (299)
T 2r3i_A 155 VPVRTYTHEVVTLWYRAPEIL 175 (299)
T ss_dssp CCSBCTTSCBCCCTTCCHHHH
T ss_pred CCccccCcccccccccCcHHh
Confidence 222568999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=239.10 Aligned_cols=158 Identities=22% Similarity=0.350 Sum_probs=137.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEe-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQT- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~- 186 (282)
.++|++.+.||+|+||.||+|++. ..++.||+|++.... .+.+.+|+.+++.++ ||||+++++++..
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~ 103 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP 103 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CCceEEEEEecccCCeEEEEEEEC-----CCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence 468999999999999999999976 456789999986432 345788999999997 9999999999987
Q ss_pred -CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecCcccc
Q 023430 187 -RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSLNSHN 264 (282)
Q Consensus 187 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~ 264 (282)
....++||||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 104 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~ 180 (330)
T 3nsz_A 104 VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180 (330)
T ss_dssp TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence 668999999999999988774 389999999999999999999999999999999999999777 899999999963
Q ss_pred c------ccchhheeeccCccc
Q 023430 265 Q------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~------~~~~~~~~~~ape~~ 280 (282)
. ....++..|+|||.+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~ 202 (330)
T 3nsz_A 181 YHPGQEYNVRVASRYFKGPELL 202 (330)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHH
T ss_pred cCCCCccccccccccccChhhh
Confidence 2 122678999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-33 Score=257.97 Aligned_cols=165 Identities=22% Similarity=0.267 Sum_probs=141.3
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
+.+..++|++.+.||+|+||.||+|.++. ...||||+++.... ..+.+.+|+.+|+.++|+||+++++++
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~ 331 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVV 331 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34556679999999999999999999762 35699999976432 234588899999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.. ..+||||||+.+|+|.+++.. ...+++.++..++.||+.||.|||+++||||||||+|||++.++.+||+|||++
T Consensus 332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 66 678999999999999999864 356899999999999999999999999999999999999999999999999999
Q ss_pred cccccc--------hhheeeccCccc
Q 023430 263 HNQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~--------~~~~~~~ape~~ 280 (282)
+....+ .++..|||||.+
T Consensus 411 ~~~~~~~~~~~~~~~~~~~y~aPE~~ 436 (535)
T 2h8h_A 411 RLIEDNEYTARQGAKFPIKWTAPEAA 436 (535)
T ss_dssp TTCCCHHHHTTCSTTSCGGGSCHHHH
T ss_pred eecCCCceecccCCcCcccccCHHHh
Confidence 743222 345789999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.22 Aligned_cols=160 Identities=23% Similarity=0.362 Sum_probs=133.1
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
..++|++.+.||+|+||.||+|++. .+++.||||++..+... ..+|+.+|+.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDI-----ESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEET-----TTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEEC-----CCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeec
Confidence 3568999999999999999999976 45778999998654321 23699999999999999999998543
Q ss_pred --------------------------------------CEEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHH
Q 023430 188 --------------------------------------SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIV 225 (282)
Q Consensus 188 --------------------------------------~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~ 225 (282)
..+++||||+++ +|.+.+. ....+++..++.++.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 348999999985 7666554 356799999999999999
Q ss_pred HHHHHHHHCCCEeeccCCCceEEc-CCCcEEEEecCccccc------ccchhheeeccCccc
Q 023430 226 SAVSHLHKCGIVHRDLKPENILMD-SDGHVMAAHSLNSHNQ------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 226 ~gL~ylH~~~iiHrDlKp~NILl~-~~~~v~l~Dfg~s~~~------~~~~~~~~~~ape~~ 280 (282)
.||.|||++||+||||||+|||++ .++.+||+|||+++.. ....+++.|+|||.+
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELM 213 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHh
Confidence 999999999999999999999998 6899999999999632 222668899999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=235.19 Aligned_cols=166 Identities=19% Similarity=0.195 Sum_probs=140.5
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++.++||+|+||.||+|.+.... .....+|+|++.... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred EEccCceeccCCCceEEEEEEecCC--Cceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCC
Confidence 4677899999999999999876432 344579999986532 334456788999999999999999999999876655
Q ss_pred -EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 191 -YLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 191 -~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 999999999999999976 35688999999999999999999999999999999999999999999999999963211
Q ss_pred ----------chhheeeccCccc
Q 023430 268 ----------CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ----------~~~~~~~~ape~~ 280 (282)
..+++.|+|||.+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~ 200 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESL 200 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHH
T ss_pred cccccccCcCCCCCccccChhhh
Confidence 2457899999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=245.80 Aligned_cols=166 Identities=22% Similarity=0.353 Sum_probs=135.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh--hhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
.++|++.+.||+|+||.||+|+++ .++..||||++....... ....+.+.+|+.+++.++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECS-----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hcccEEEeEEeecCCEEEEEEEEC-----CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 468999999999999999999976 356789999987543211 1112357789999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+..++||||+++ +|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999999986 787777654 35889999999999999999999999999999999999999999999999998642
Q ss_pred c-------cchhheeeccCccc
Q 023430 266 L-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~-------~~~~~~~~~ape~~ 280 (282)
. ...|++.|+|||.+
T Consensus 163 ~~~~~~~~~~~~t~~y~aPE~~ 184 (346)
T 1ua2_A 163 GSPNRAYTHQVVTRWYRAPELL 184 (346)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHH
T ss_pred cCCcccCCcccccccccCchHh
Confidence 1 22679999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=259.45 Aligned_cols=170 Identities=21% Similarity=0.231 Sum_probs=141.7
Q ss_pred CcCCCCeEEEe-eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.+..+++.+.+ .||+|+||.||+|.++.. ..+..||||+++... .....+.+.+|+.+|+.++||||+++++++
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECS---SCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecC---CCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 34556777776 899999999999987643 245679999997652 233456788999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.. +.+++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+++
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 76 5699999999999999998654 458999999999999999999999999999999999999999999999999997
Q ss_pred ccccc----------hhheeeccCcccc
Q 023430 264 NQLCC----------FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~~----------~~~~~~~ape~~~ 281 (282)
....+ .+++.|||||+++
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~ 512 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECIN 512 (613)
T ss_dssp TCC--------------CCTTSCHHHHH
T ss_pred cccCCCceeeeccCCCCccceeCHhhhc
Confidence 43211 2347899999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-33 Score=236.79 Aligned_cols=171 Identities=18% Similarity=0.250 Sum_probs=135.3
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||+|++.... .....||+|++...........+.+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCC--CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 34568999999999999999999875321 2334689999876654445566778999999999999999999999987
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.. .++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 65 89999999999999988764 56899999999999999999999999999999999999999999999999998642
Q ss_pred cc----------chhheeeccCccc
Q 023430 266 LC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~----------~~~~~~~~ape~~ 280 (282)
.. ..++..|+|||.+
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESL 196 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHH
T ss_pred cccccchhhhccCCCCceeeCchhh
Confidence 11 1346689999976
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-33 Score=243.74 Aligned_cols=170 Identities=16% Similarity=0.094 Sum_probs=136.5
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhh--------HHHHHHHHHHHHHhcCCCCeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN--------HVDYMKAERDILTKVTHPFIVQ 179 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~ 179 (282)
..++|++.+.||+|+||.||+|.+... ...+..+|+|++......... ....+.+|+.+++.++||||++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNK--PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSS--CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCC--CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 356899999999999999999998742 135678999998764311111 1123557888999999999999
Q ss_pred eeEEEEe----CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC--c
Q 023430 180 LRYSFQT----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG--H 253 (282)
Q Consensus 180 l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~--~ 253 (282)
+++++.. ....|+||||+ +++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 9999987 67899999999 999999998777899999999999999999999999999999999999999887 9
Q ss_pred EEEEecCccccc--------------ccchhheeeccCccc
Q 023430 254 VMAAHSLNSHNQ--------------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 254 v~l~Dfg~s~~~--------------~~~~~~~~~~ape~~ 280 (282)
+||+|||+++.. ....|++.|||||.+
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH 232 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence 999999999532 222679999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=246.90 Aligned_cols=166 Identities=17% Similarity=0.188 Sum_probs=134.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCCE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ-TRSK 189 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~ 189 (282)
.|++.+.||+|+||.||+|++.... .....||+|.+.... .....+.+.+|+.+++.++||||+++++++. ..+.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETT--TEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCC--CcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence 5888999999999999999876321 234568999886532 3345567889999999999999999999865 4568
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 89999999999999999764 458899999999999999999999999999999999999999999999999996321
Q ss_pred ---------cchhheeeccCccc
Q 023430 267 ---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 ---------~~~~~~~~~ape~~ 280 (282)
...+++.|||||.+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~ 268 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESL 268 (373)
T ss_dssp ------------CCGGGSCHHHH
T ss_pred ccccccccCCCCCcccccChHHh
Confidence 11346789999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=238.05 Aligned_cols=163 Identities=18% Similarity=0.268 Sum_probs=133.1
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHH--HHhcCCCCeeeeeE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI--LTKVTHPFIVQLRY 182 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~ 182 (282)
..+..++|++.+.||+|+||.||+|++. +..||||++..... +.+..|.++ +..++|+||+++++
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLD-------ERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEET-------TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEEC-------CeEEEEEEeeccch------hhHHHHHHHHHHHhccCcchhhhee
Confidence 4566789999999999999999999753 56899999865431 223334444 45689999999987
Q ss_pred EEEe-----CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CCEeeccCCCceEE
Q 023430 183 SFQT-----RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC---------GIVHRDLKPENILM 248 (282)
Q Consensus 183 ~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~---------~iiHrDlKp~NILl 248 (282)
.+.. ...+++||||+++|+|.+++.... .++..+..++.|++.||.|||++ ||+||||||+|||+
T Consensus 75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred cccccccCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE
Confidence 6542 236799999999999999996654 58899999999999999999999 99999999999999
Q ss_pred cCCCcEEEEecCcccccc---------------cchhheeeccCcccc
Q 023430 249 DSDGHVMAAHSLNSHNQL---------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 249 ~~~~~v~l~Dfg~s~~~~---------------~~~~~~~~~ape~~~ 281 (282)
+.++.+||+|||++.... ...|++.|+|||.+.
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 201 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHT
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhc
Confidence 999999999999995321 125899999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=236.44 Aligned_cols=167 Identities=23% Similarity=0.354 Sum_probs=139.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcCCCCeeeeeEEEE--
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK-KNHVDYMKAERDILTKVTHPFIVQLRYSFQ-- 185 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-- 185 (282)
.++|++.+.||+|+||.||+|.+. .++..||+|++....... ....+.+.+|+.+++.++|+||+++++++.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDS-----ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE 78 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBT-----TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC
T ss_pred ccceeEeeEEecCCCeEEEEEEEC-----CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 468999999999999999999865 456789999997654322 334567889999999999999999999984
Q ss_pred eCCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.....|+||||+.++ |.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 79 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 79 EKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp ---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 455799999999887 6666655 3568999999999999999999999999999999999999999999999999986
Q ss_pred ccc---------cchhheeeccCcccc
Q 023430 264 NQL---------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~---------~~~~~~~~~ape~~~ 281 (282)
... ...|++.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~ 184 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIAN 184 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHT
T ss_pred ccCccccccccccCCCCCCCcChhhcc
Confidence 321 225799999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=245.46 Aligned_cols=162 Identities=22% Similarity=0.366 Sum_probs=138.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc------CCCCeeeeeE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV------THPFIVQLRY 182 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~ 182 (282)
..+|+++++||+|+||.||+|.+. ..+..||||++.... ...+.+.+|+.+++.+ +|+||+++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDH-----KVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEET-----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEEC-----CCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 457999999999999999999876 457789999997543 2334566788888776 5779999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc--EEEEe
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH--VMAAH 258 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~--v~l~D 258 (282)
++.....+++||||+. ++|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999999999996 58988887653 4899999999999999999999999999999999999999987 99999
Q ss_pred cCccccccc----chhheeeccCccc
Q 023430 259 SLNSHNQLC----CFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~~----~~~~~~~~ape~~ 280 (282)
||++..... ..|++.|||||++
T Consensus 246 FG~a~~~~~~~~~~~gt~~y~aPE~~ 271 (429)
T 3kvw_A 246 FGSSCYEHQRVYTYIQSRFYRAPEVI 271 (429)
T ss_dssp CTTCEETTCCCCSSCSCGGGCCHHHH
T ss_pred cccceecCCcccccCCCCCccChHHH
Confidence 999953222 2679999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=236.12 Aligned_cols=165 Identities=24% Similarity=0.394 Sum_probs=141.2
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEe
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQT 186 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 186 (282)
..++|++.+.||+|+||.||+|++. ..+..||+|++.... ...+.+.+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEEC-----CCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 4578999999999999999999976 356789999987543 2234578899999998 79999999999987
Q ss_pred ------CCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEe
Q 023430 187 ------RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 187 ------~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
...+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence 46899999999999999999764 4689999999999999999999999999999999999999999999999
Q ss_pred cCcccccc-------cchhheeeccCcccc
Q 023430 259 SLNSHNQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 259 fg~s~~~~-------~~~~~~~~~ape~~~ 281 (282)
||++.... ...|++.|+|||.+.
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC
T ss_pred CcCceecCcCccccccccCCccccChhhhc
Confidence 99986421 225799999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=242.17 Aligned_cols=168 Identities=24% Similarity=0.382 Sum_probs=145.8
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhH--------------HHHHHHHHHHHHhc
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNH--------------VDYMKAERDILTKV 172 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~~~~E~~~l~~l 172 (282)
+..++|++.+.||+|+||.||+|.+ .+..||+|++.......... .+.+.+|+.+++.+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 100 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC
Confidence 3457899999999999999999986 36789999998664332211 26688999999999
Q ss_pred CCCCeeeeeEEEEeCCEEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCC
Q 023430 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFH------LYR--QGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKP 243 (282)
Q Consensus 173 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp 243 (282)
+||||+++++++...+..++||||+++++|.++ +.. ...+++..+..++.|++.||.|||+ +||+||||||
T Consensus 101 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p 180 (348)
T 2pml_X 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKP 180 (348)
T ss_dssp CCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCG
T ss_pred CCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCCh
Confidence 999999999999999999999999999999887 554 4668999999999999999999999 9999999999
Q ss_pred CceEEcCCCcEEEEecCccccc-----ccchhheeeccCcccc
Q 023430 244 ENILMDSDGHVMAAHSLNSHNQ-----LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 244 ~NILl~~~~~v~l~Dfg~s~~~-----~~~~~~~~~~ape~~~ 281 (282)
+|||++.++.++|+|||++... ....|+..|+|||.+.
T Consensus 181 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~ 223 (348)
T 2pml_X 181 SNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFS 223 (348)
T ss_dssp GGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGS
T ss_pred HhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhc
Confidence 9999999999999999999642 2236799999999874
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=236.57 Aligned_cols=171 Identities=19% Similarity=0.269 Sum_probs=143.7
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
.+..++|++.+.||+|+||.||+|++.... ...+..||+|++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTS-SSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEecccc-CCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 344568999999999999999999865322 246788999998754 2344567889999999999999999999886
Q ss_pred eCC--EEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 186 TRS--KLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 186 ~~~--~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..+ .+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 544 789999999999999999875 45899999999999999999999999999999999999999999999999998
Q ss_pred ccccc----------chhheeeccCccc
Q 023430 263 HNQLC----------CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~----------~~~~~~~~ape~~ 280 (282)
..... ..++..|+|||.+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 220 (326)
T 2w1i_A 193 KVLPQDKEYYKVKEPGESPIFWYAPESL 220 (326)
T ss_dssp EECCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred hhccccccccccccCCCCceeEECchhh
Confidence 63211 1346679999976
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=239.51 Aligned_cols=170 Identities=24% Similarity=0.313 Sum_probs=145.0
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcC--CCCeeee
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKVT--HPFIVQL 180 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~nIv~l 180 (282)
....++|++.+.||+|+||.||+|+++ ..+..||||++........ ...+.+.+|+.+++.++ |+||+++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEET-----TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 345678999999999999999999876 4567899999976543221 11233567999999996 5999999
Q ss_pred eEEEEeCCEEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc-CCCcEEEEe
Q 023430 181 RYSFQTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMAAH 258 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~-~~~~v~l~D 258 (282)
++++...+..++|||++.+ ++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999999986 89999998888899999999999999999999999999999999999999 789999999
Q ss_pred cCcccccc-----cchhheeeccCccc
Q 023430 259 SLNSHNQL-----CCFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~-----~~~~~~~~~ape~~ 280 (282)
||++.... ...|++.|+|||.+
T Consensus 194 fg~~~~~~~~~~~~~~gt~~y~aPE~~ 220 (320)
T 3a99_A 194 FGSGALLKDTVYTDFDGTRVYSPPEWI 220 (320)
T ss_dssp CTTCEECCSSCBCCCCSCGGGSCHHHH
T ss_pred CccccccccccccCCCCCccCCChHHh
Confidence 99986322 22579999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.8e-32 Score=236.51 Aligned_cols=165 Identities=22% Similarity=0.335 Sum_probs=129.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 185 (282)
+...+|++.++||+|+||.||+|++. ..++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~ 96 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDV-----GSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS 96 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred ccCceEEEEEEEccCCceEEEEEEEC-----CCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence 44568999999999999999999986 356789999886543 334456788999999996 999999999984
Q ss_pred --------eCCEEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEcCCC
Q 023430 186 --------TRSKLYLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMDSDG 252 (282)
Q Consensus 186 --------~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~~~~ 252 (282)
....+++||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 3446899999996 688888764 456999999999999999999999999 99999999999999999
Q ss_pred cEEEEecCcccccc-------------------cchhheeeccCccc
Q 023430 253 HVMAAHSLNSHNQL-------------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 253 ~v~l~Dfg~s~~~~-------------------~~~~~~~~~ape~~ 280 (282)
.+||+|||++.... ...|++.|+|||.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp CEEBCCCTTCBCCSSCC------------------------------
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 99999999996422 22479999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=238.79 Aligned_cols=165 Identities=25% Similarity=0.339 Sum_probs=141.8
Q ss_pred CeEEE-eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 111 DFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 111 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
.|.+. +.||+|+||.||+|.++ ..++.||+|++..... .......+.+|+.+++.+. ||||+++++++....
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISK-----STGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred EEeeccceeCCCCCeEEEEEEEC-----CCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 57777 89999999999999977 4567899999976543 2333556888999999995 699999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---CCcEEEEecCccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMAAHSLNSH 263 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~---~~~v~l~Dfg~s~ 263 (282)
..++||||+.+|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~ 182 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence 999999999999999888543 56899999999999999999999999999999999999998 7899999999996
Q ss_pred cccc------chhheeeccCcccc
Q 023430 264 NQLC------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~------~~~~~~~~ape~~~ 281 (282)
.... ..|++.|+|||.+.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~ 206 (327)
T 3lm5_A 183 KIGHACELREIMGTPEYLAPEILN 206 (327)
T ss_dssp EC---------CCCGGGCCHHHHT
T ss_pred ccCCccccccccCCcCccCCeeec
Confidence 4222 25799999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=234.92 Aligned_cols=165 Identities=19% Similarity=0.313 Sum_probs=137.2
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.+.+..++|++.+.||+|+||.||++++. +..||+|++.... ..+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc-------CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 34566789999999999999999999864 4679999986542 34568889999999999999999998
Q ss_pred EEeC-CEEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 184 FQTR-SKLYLILDFINGGHLFFHLYRQGI--FREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 184 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
+... +..++||||+++++|.+++...+. +++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence 7554 478999999999999999876543 8899999999999999999999999999999999999999999999999
Q ss_pred ccccccc----chhheeeccCccc
Q 023430 261 NSHNQLC----CFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~----~~~~~~~~ape~~ 280 (282)
++..... ..++..|+|||.+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~ 186 (278)
T 1byg_A 163 LTKEASSTQDTGKLPVKWTAPEAL 186 (278)
T ss_dssp C------------CCTTTSCHHHH
T ss_pred ccccccccccCCCccccccCHHHh
Confidence 9864322 2457889999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=236.88 Aligned_cols=158 Identities=23% Similarity=0.297 Sum_probs=134.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~ 187 (282)
++|++.+.||+|+||.||+|++. +..||||++..... ..+.+|.+++.. ++||||+++++++...
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR-------GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cceEEEeEeecCCCeEEEEEEEC-------CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 57999999999999999999864 56799999865421 223445555554 4899999999999887
Q ss_pred ----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CCEeeccCCCceEEcCCCcEE
Q 023430 188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKC--------GIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~--------~iiHrDlKp~NILl~~~~~v~ 255 (282)
..+|+||||+++|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 7899999999999999999654 689999999999999999999999 999999999999999999999
Q ss_pred EEecCcccccc-----------cchhheeeccCcccc
Q 023430 256 AAHSLNSHNQL-----------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 256 l~Dfg~s~~~~-----------~~~~~~~~~ape~~~ 281 (282)
|+|||++.... ...|++.|||||.+.
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 219 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcc
Confidence 99999995321 125799999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-32 Score=237.54 Aligned_cols=163 Identities=21% Similarity=0.321 Sum_probs=139.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|++.+.||+|+||.||+|.++ .++..||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 82 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK-----PTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDS 82 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC-----CCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence 468999999999999999999976 456789999986432 233445677899999999999999999987654
Q ss_pred ----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...|+||||+. ++|..++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 83 FENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp STTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 67999999997 588888865 568999999999999999999999999999999999999999999999999986
Q ss_pred ccc-----------------cchhheeeccCccc
Q 023430 264 NQL-----------------CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~-----------------~~~~~~~~~ape~~ 280 (282)
... ...|++.|+|||.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 194 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeee
Confidence 321 11568899999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.3e-32 Score=257.24 Aligned_cols=172 Identities=20% Similarity=0.237 Sum_probs=144.6
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.+.||+|+||.||+|.++... ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSS--SCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCC--CccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 4455678999999999999999999987432 345679999886542 234456788999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
. .+..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 5 456899999999999999997654 58999999999999999999999999999999999999999999999999997
Q ss_pred cccc--------chhheeeccCcccc
Q 023430 264 NQLC--------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~--------~~~~~~~~ape~~~ 281 (282)
.... ..+++.|||||.++
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~ 565 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESIN 565 (656)
T ss_dssp SCCC----------CCGGGCCHHHHH
T ss_pred ecCCCcceeccCCCCCcceeCHHHhc
Confidence 4322 13467899999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-32 Score=241.86 Aligned_cols=163 Identities=22% Similarity=0.312 Sum_probs=138.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||.||+|.++ .+++.||||++.... ......+.+.+|+.+++.++||||+++++++...+
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK-----RSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccEEEEeEEecCCCeEEEEEEEC-----CCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 368999999999999999999977 467789999997643 23344567889999999999999999999998766
Q ss_pred EE------EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 KL------YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ~~------~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.. |+||||+. ++|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred CcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 54 99999997 57877663 45899999999999999999999999999999999999999999999999999
Q ss_pred ccccc----chhheeeccCccc
Q 023430 263 HNQLC----CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~----~~~~~~~~ape~~ 280 (282)
..... ..|++.|+|||.+
T Consensus 192 ~~~~~~~~~~~~t~~y~aPE~~ 213 (371)
T 4exu_A 192 RHADAEMTGYVVTRWYRAPEVI 213 (371)
T ss_dssp --------CTTCCCTTSCHHHH
T ss_pred cccccCcCCcccCccccCHHHh
Confidence 64322 2569999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=236.29 Aligned_cols=160 Identities=26% Similarity=0.364 Sum_probs=134.0
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++.+.||+|+||.||++++. ++.||+|++... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 44568999999999999999999864 456999998643 234568889999999999999999998763
Q ss_pred CCEEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCEeeccCCCceEEcCCCc-EEEEec
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHK---CGIVHRDLKPENILMDSDGH-VMAAHS 259 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~NILl~~~~~-v~l~Df 259 (282)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+||
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 4799999999999999997654 36889999999999999999999 89999999999999998887 799999
Q ss_pred Cccccc----ccchhheeeccCccc
Q 023430 260 LNSHNQ----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~----~~~~~~~~~~ape~~ 280 (282)
|++... ....|++.|||||.+
T Consensus 151 g~~~~~~~~~~~~~gt~~y~aPE~~ 175 (307)
T 2eva_A 151 GTACDIQTHMTNNKGSAAWMAPEVF 175 (307)
T ss_dssp CC------------CCTTSSCHHHH
T ss_pred ccccccccccccCCCCCceEChhhh
Confidence 998632 223679999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=234.26 Aligned_cols=162 Identities=17% Similarity=0.146 Sum_probs=139.0
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-hhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
|...+.||+|+||.||+|.+ .+..||+|++..... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccCCccccCCCeEEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence 44458899999999999984 356799999875432 2234456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc-
Q 023430 191 YLILDFINGGHLFFHLYR---QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL- 266 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~- 266 (282)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 185 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccc
Confidence 999999999999999874 3458999999999999999999999999999999999999999999999999985321
Q ss_pred --------cchhheeeccCccc
Q 023430 267 --------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 --------~~~~~~~~~ape~~ 280 (282)
...|++.|+|||.+
T Consensus 186 ~~~~~~~~~~~g~~~y~aPE~~ 207 (307)
T 2nru_A 186 FAQTVMTSRIVGTTAYMAPEAL 207 (307)
T ss_dssp CSSCEECSSCCSCGGGCCHHHH
T ss_pred ccccccccccCCCcCcCChHHh
Confidence 12579999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.5e-32 Score=239.70 Aligned_cols=166 Identities=20% Similarity=0.300 Sum_probs=135.2
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh--------hhhhHHHHHHHHHHHHHhcCCCCeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI--------IKKNHVDYMKAERDILTKVTHPFIVQ 179 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~nIv~ 179 (282)
..++|++.+.||+|+||.||+|.+. .+..||||++..... ......+.+.+|+.+++.++||||++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4578999999999999999999854 367899999865322 12233467889999999999999999
Q ss_pred eeEEEEe-----CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc
Q 023430 180 LRYSFQT-----RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253 (282)
Q Consensus 180 l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~ 253 (282)
+++++.. ...+|+||||+. |+|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~ 172 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND 172 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC
Confidence 9999854 337899999998 5777777654 36899999999999999999999999999999999999999999
Q ss_pred EEEEecCccccccc------chhheeeccCccc
Q 023430 254 VMAAHSLNSHNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 254 v~l~Dfg~s~~~~~------~~~~~~~~ape~~ 280 (282)
+||+|||++..... ..+++.|+|||.+
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~ 205 (362)
T 3pg1_A 173 ITICDFNLAREDTADANKTHYVTHRWYRAPELV 205 (362)
T ss_dssp EEECCTTC---------------CGGGCCHHHH
T ss_pred EEEEecCcccccccccccceecccceecCcHHh
Confidence 99999999963222 2568899999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-32 Score=242.94 Aligned_cols=162 Identities=22% Similarity=0.314 Sum_probs=136.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC--------CCCeeee
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--------HPFIVQL 180 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l 180 (282)
.++|++.++||+|+||.||+|++. ..++.||||++.... ...+.+.+|+.+++.++ |+||+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDI-----QGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred CCeEEEEEEeeecCCeeEEEEEec-----CCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 478999999999999999999876 457789999997542 33456788999999885 7889999
Q ss_pred eEEEE----eCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCC-
Q 023430 181 RYSFQ----TRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDG- 252 (282)
Q Consensus 181 ~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~- 252 (282)
++++. ....+|+||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99987 456899999999 55666666544 4589999999999999999999998 999999999999999776
Q ss_pred ------------------------------------------------cEEEEecCccccc----ccchhheeeccCccc
Q 023430 253 ------------------------------------------------HVMAAHSLNSHNQ----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 253 ------------------------------------------------~v~l~Dfg~s~~~----~~~~~~~~~~ape~~ 280 (282)
.+||+|||++... ....||+.|||||.+
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhh
Confidence 7999999999632 223679999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=234.23 Aligned_cols=170 Identities=21% Similarity=0.292 Sum_probs=129.7
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHH-HHHhcCCCCeeeee
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERD-ILTKVTHPFIVQLR 181 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~ 181 (282)
..+.+..++|++.+.||+|+||.||+|.++ .+++.||||++..... ......+..|+. +++.++||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~ 87 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFY 87 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEET-----TTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEc-----CCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeee
Confidence 345667789999999999999999999976 4577899999976432 222233444555 77788999999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEE
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYR-----QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~ 255 (282)
+++...+..++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~k 166 (327)
T 3aln_A 88 GALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIK 166 (327)
T ss_dssp EEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEE
T ss_pred eEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEE
Confidence 999999999999999986 77766653 46789999999999999999999998 999999999999999999999
Q ss_pred EEecCccccccc------chhheeeccCccc
Q 023430 256 AAHSLNSHNQLC------CFFFFLFLGGGVF 280 (282)
Q Consensus 256 l~Dfg~s~~~~~------~~~~~~~~ape~~ 280 (282)
|+|||++..... ..|++.|+|||.+
T Consensus 167 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~ 197 (327)
T 3aln_A 167 LCDFGISGQLVDSIAKTRDAGCRPYMAPERI 197 (327)
T ss_dssp ECCCSSSCC----------------------
T ss_pred EccCCCceecccccccccCCCCccccCceee
Confidence 999999964322 2679999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=244.91 Aligned_cols=158 Identities=25% Similarity=0.424 Sum_probs=130.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC--
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR-- 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-- 187 (282)
.+|++.++||+|+||.||+|+++ .++..||||++..... ...+|+++|+.++|+||+++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~ 121 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGE 121 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEET
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC-----CCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCC
Confidence 36999999999999999999987 3567899999865431 134699999999999999999988542
Q ss_pred ----CEEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC-CcEEEEe
Q 023430 188 ----SKLYLILDFINGGHLFFHLY----RQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD-GHVMAAH 258 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~-~~v~l~D 258 (282)
..+++||||+++ +|...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|
T Consensus 122 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp TTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEecc
Confidence 247799999986 5555443 24679999999999999999999999999999999999999965 5689999
Q ss_pred cCcccccc------cchhheeeccCccc
Q 023430 259 SLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~------~~~~~~~~~ape~~ 280 (282)
||+++... ...|++.|||||++
T Consensus 201 FG~a~~~~~~~~~~~~~~t~~y~aPE~~ 228 (420)
T 1j1b_A 201 FGSAKQLVRGEPNVSYICSRYYRAPELI 228 (420)
T ss_dssp CTTCEECCTTCCCCSCCSCTTSCCHHHH
T ss_pred chhhhhcccCCCceeeeeCCCcCCHHHH
Confidence 99996422 22669999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=240.87 Aligned_cols=163 Identities=15% Similarity=0.163 Sum_probs=136.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCC---CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeee------
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDG---DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQ------ 179 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~------ 179 (282)
.++|++.+.||+|+||.||+|+++.+... ..+..||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 46899999999999999999998743211 13678999998754 23678999999999999987
Q ss_pred ---------eeEEEEe-CCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceE
Q 023430 180 ---------LRYSFQT-RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENIL 247 (282)
Q Consensus 180 ---------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NIL 247 (282)
+++++.. ....|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5667665 67899999999 99999999875 67999999999999999999999999999999999999
Q ss_pred EcCCC--cEEEEecCccccccc--------------chhheeeccCccc
Q 023430 248 MDSDG--HVMAAHSLNSHNQLC--------------CFFFFLFLGGGVF 280 (282)
Q Consensus 248 l~~~~--~v~l~Dfg~s~~~~~--------------~~~~~~~~ape~~ 280 (282)
++.++ .+||+|||++..... ..|++.|+|||.+
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 240 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH 240 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence 99998 899999999953211 1679999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=233.94 Aligned_cols=164 Identities=22% Similarity=0.330 Sum_probs=140.2
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC------Ceeeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP------FIVQLR 181 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------nIv~l~ 181 (282)
..++|++.+.||+|+||.||+|.+.. ..+..||+|++.... ...+.+.+|+.+++.++|+ +|++++
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHK----AGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecC----CCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 35689999999999999999998742 356789999986532 3345678899999888765 499999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---------
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--------- 250 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~--------- 250 (282)
+++...+..++||||+ +++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999987765 5889999999999999999999999999999999999987
Q ss_pred ----------CCcEEEEecCcccccc----cchhheeeccCccc
Q 023430 251 ----------DGHVMAAHSLNSHNQL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 251 ----------~~~v~l~Dfg~s~~~~----~~~~~~~~~ape~~ 280 (282)
++.++|+|||++.... ...|++.|+|||.+
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~ 206 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVI 206 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHH
T ss_pred ccccccccccCCCceEeeCcccccCccccccccCCccccChHHh
Confidence 6689999999986422 22679999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=238.62 Aligned_cols=168 Identities=24% Similarity=0.330 Sum_probs=135.9
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhc----CCCCeeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---NHVDYMKAERDILTKV----THPFIVQL 180 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~nIv~l 180 (282)
..++|++.+.||+|+||.||+|+++ ..++.||+|++........ .....+.+|+.+++.+ +|+||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRL-----TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECT-----TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEc-----cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 3568999999999999999999865 4567899999976543221 1122355789999888 89999999
Q ss_pred eEEEEeCCEEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc-CCCcEEEEe
Q 023430 181 RYSFQTRSKLYLILDF-INGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMAAH 258 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~-~~~~v~l~D 258 (282)
++++...+..++|||+ +.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++ .++.++|+|
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999998999999999 78999999998888899999999999999999999999999999999999999 889999999
Q ss_pred cCcccccc-----cchhheeeccCccc
Q 023430 259 SLNSHNQL-----CCFFFFLFLGGGVF 280 (282)
Q Consensus 259 fg~s~~~~-----~~~~~~~~~ape~~ 280 (282)
||++.... ...|+..|+|||.+
T Consensus 184 fg~~~~~~~~~~~~~~~~~~y~aPE~~ 210 (312)
T 2iwi_A 184 FGSGALLHDEPYTDFDGTRVYSPPEWI 210 (312)
T ss_dssp CSSCEECCSSCBCCCCSCTTTSCHHHH
T ss_pred cchhhhcccCcccccCCcccccCceee
Confidence 99986322 22579999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=259.32 Aligned_cols=163 Identities=22% Similarity=0.317 Sum_probs=137.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||++.++. ..++.||||++.... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGG----GTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcC----CCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 4789999999999999999999763 146789999886532 2344556889999999999999999999998765
Q ss_pred E-----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 189 K-----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 189 ~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
. .||||||++|++|.+++.. .+++.+++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 5 7999999999999887754 68999999999999999999999999999999999999875 99999999997
Q ss_pred ccc---cchhheeeccCccc
Q 023430 264 NQL---CCFFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~---~~~~~~~~~ape~~ 280 (282)
... ...||+.|||||.+
T Consensus 230 ~~~~~~~~~gt~~y~aPE~~ 249 (681)
T 2pzi_A 230 RINSFGYLYGTPGFQAPEIV 249 (681)
T ss_dssp ETTCCSCCCCCTTTSCTTHH
T ss_pred hcccCCccCCCccccCHHHH
Confidence 432 22579999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=230.52 Aligned_cols=163 Identities=21% Similarity=0.289 Sum_probs=138.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|....+||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDL-----SNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEET-----TTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cCCCCcEEEeecCcEEEEEEEEC-----CCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 34555568999999999999976 356789999987543 2344668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNSHNQ 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s~~~ 265 (282)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.++|+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 999999999999999987652 4568889999999999999999999999999999999987 899999999998642
Q ss_pred c-------cchhheeeccCccc
Q 023430 266 L-------CCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~-------~~~~~~~~~ape~~ 280 (282)
. ...|++.|+|||.+
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~ 195 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEII 195 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHH
T ss_pred CCCCCcccccCCCccccChhhh
Confidence 1 22578999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=237.87 Aligned_cols=163 Identities=21% Similarity=0.307 Sum_probs=138.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|.+.+.||+|+||.||+|.++ .+++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDK-----RSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEEC-----CCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 468999999999999999999976 457789999987643 23344566889999999999999999999998765
Q ss_pred E------EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 K------LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
. .|+||||+. ++|..++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred ccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 3 599999997 58876663 35899999999999999999999999999999999999999999999999999
Q ss_pred ccccc----chhheeeccCccc
Q 023430 263 HNQLC----CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~----~~~~~~~~ape~~ 280 (282)
..... ..+++.|+|||.+
T Consensus 174 ~~~~~~~~~~~~t~~y~aPE~~ 195 (353)
T 3coi_A 174 RHADAEMTGYVVTRWYRAPEVI 195 (353)
T ss_dssp TC--------CCSBCCSCHHHH
T ss_pred cCCCCCccccccCcCcCCHHHH
Confidence 74322 2669999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=240.95 Aligned_cols=158 Identities=23% Similarity=0.350 Sum_probs=129.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS- 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 188 (282)
.+|++.++||+|+||.||+|++.. ...+|+|++...... ..+|+.+|+.++||||+++++++...+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~------~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVE------SDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT------TEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECC------CCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 479999999999999999999762 234888887654321 236999999999999999999986543
Q ss_pred -----EEEEEEeccCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc-CCCcEEEEec
Q 023430 189 -----KLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGHVMAAHS 259 (282)
Q Consensus 189 -----~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~-~~~~v~l~Df 259 (282)
.+++||||++++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 388999999875443322 2256799999999999999999999999999999999999999 7999999999
Q ss_pred Ccccccc------cchhheeeccCccc
Q 023430 260 LNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~------~~~~~~~~~ape~~ 280 (282)
|+++... ...+++.|+|||.+
T Consensus 187 G~a~~~~~~~~~~~~~~t~~y~aPE~~ 213 (394)
T 4e7w_A 187 GSAKILIAGEPNVSYICSRYYRAPELI 213 (394)
T ss_dssp TTCEECCTTCCCCSSCSCGGGCCHHHH
T ss_pred CCcccccCCCCCcccccCcCccCHHHH
Confidence 9996422 22668999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=230.37 Aligned_cols=162 Identities=20% Similarity=0.292 Sum_probs=133.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE---
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ--- 185 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--- 185 (282)
.++|++++.||+|+||.||+|.+. ..++.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN-----DCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET-----TTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred CCceeEEEEeccCCCeEEEEEEEC-----CCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 468999999999999999999976 456789999986542 344566889999999999999999998873
Q ss_pred -----------eCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc-CCCc
Q 023430 186 -----------TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD-SDGH 253 (282)
Q Consensus 186 -----------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~-~~~~ 253 (282)
.....|+||||+. |+|.+++. .+.+++..++.++.|++.||.|||++||+||||||+|||++ .++.
T Consensus 82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred cccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 3468999999998 58988885 45689999999999999999999999999999999999997 5679
Q ss_pred EEEEecCcccccc----------cchhheeeccCccc
Q 023430 254 VMAAHSLNSHNQL----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 254 v~l~Dfg~s~~~~----------~~~~~~~~~ape~~ 280 (282)
+||+|||++.... ...++..|+|||.+
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 196 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLL 196 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHh
Confidence 9999999986421 22458889999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=231.42 Aligned_cols=166 Identities=23% Similarity=0.312 Sum_probs=141.8
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC--CCCeeeeeEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSF 184 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~ 184 (282)
+..++|++.+.||+|+||.||++.+. .+..||+|++..... .....+.+.+|+.+++.++ |+||+++++++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34567999999999999999999854 366799999876432 3345567889999999997 59999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
...+..++||| +.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||++..
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccc
Confidence 99999999999 66789999998888899999999999999999999999999999999999996 58999999999964
Q ss_pred cc---------cchhheeeccCcccc
Q 023430 265 QL---------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~---------~~~~~~~~~ape~~~ 281 (282)
.. ...|++.|+|||.+.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 201 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIK 201 (313)
T ss_dssp --------------CCGGGCCHHHHT
T ss_pred ccCccccccccCCCCCCCcCCHHHHh
Confidence 21 125799999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=243.33 Aligned_cols=162 Identities=25% Similarity=0.362 Sum_probs=126.4
Q ss_pred CCeEE-EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Q 023430 110 GDFEI-FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-- 186 (282)
Q Consensus 110 ~~y~~-~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 186 (282)
+.|++ .++||+|+||.||+|+++.. ..+..||||++..... ...+.+|+.+|+.++||||+++++++..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG---KDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS---SCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC---CCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 35666 45799999999999997732 3567799999875432 1346789999999999999999999954
Q ss_pred CCEEEEEEeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE----cCCCc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ---------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----DSDGH 253 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl----~~~~~ 253 (282)
...+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 6789999999975 777766532 248999999999999999999999999999999999999 67899
Q ss_pred EEEEecCcccccc----------cchhheeeccCccc
Q 023430 254 VMAAHSLNSHNQL----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 254 v~l~Dfg~s~~~~----------~~~~~~~~~ape~~ 280 (282)
+||+|||++.... ...||+.|||||++
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 207 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 207 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHH
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhh
Confidence 9999999996321 12569999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=231.89 Aligned_cols=161 Identities=23% Similarity=0.374 Sum_probs=120.6
Q ss_pred CCCeEEEe-eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe-
Q 023430 109 PGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT- 186 (282)
Q Consensus 109 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~- 186 (282)
.++|.+.+ +||+|+||.||+|.++ .+++.||||++..... ...+....++.++|+||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHR-----RTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEEC-----CCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 46899965 6999999999999987 4567899999865321 12223334667899999999999876
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC---CcEEEEe
Q 023430 187 ---RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---GHVMAAH 258 (282)
Q Consensus 187 ---~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---~~v~l~D 258 (282)
...+++||||+++|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 456899999999999999998753 58999999999999999999999999999999999999864 5599999
Q ss_pred cCcccccc-----cchhheeeccCcccc
Q 023430 259 SLNSHNQL-----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 259 fg~s~~~~-----~~~~~~~~~ape~~~ 281 (282)
||++.... ...|++.|||||.+.
T Consensus 175 fg~~~~~~~~~~~~~~~t~~y~aPE~~~ 202 (336)
T 3fhr_A 175 FGFAKETTQNALQTPCYTPYYVAPEVLG 202 (336)
T ss_dssp CTTCEEC---------------------
T ss_pred cccceeccccccccCCCCcCccChhhhC
Confidence 99996432 226699999999873
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=227.05 Aligned_cols=162 Identities=15% Similarity=0.141 Sum_probs=133.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE-EEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS-FQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~-~~~~ 187 (282)
.++|++.+.||+|+||.||+|++. ..++.||||++...... +.+.+|+.+++.++|++++..+.. +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred CCceEEeeeecCCCCeEEEEEEEc-----CCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence 368999999999999999999976 45678999987654322 236779999999998877765554 4677
Q ss_pred CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE---cCCCcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl---~~~~~v~l~Dfg~s~ 263 (282)
...++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 8899999999 8999999875 4569999999999999999999999999999999999999 789999999999996
Q ss_pred ccc--------------cchhheeeccCcccc
Q 023430 264 NQL--------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~--------------~~~~~~~~~ape~~~ 281 (282)
... ...|++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHT
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhc
Confidence 321 226799999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=232.06 Aligned_cols=165 Identities=24% Similarity=0.328 Sum_probs=136.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCCeeeeeEEEE-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQ- 185 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~- 185 (282)
++|++.+.||+|+||.||+|++.. ..+..||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 589999999999999999999742 346789999987543211 1112355677777665 8999999999987
Q ss_pred ----eCCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEec
Q 023430 186 ----TRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHS 259 (282)
Q Consensus 186 ----~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Df 259 (282)
.....++||||+. |+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecC
Confidence 4567999999998 59999987653 4899999999999999999999999999999999999999999999999
Q ss_pred Ccccccc------cchhheeeccCccc
Q 023430 260 LNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 260 g~s~~~~------~~~~~~~~~ape~~ 280 (282)
|++.... ...|++.|+|||.+
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~ 191 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVL 191 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHH
T ss_pred cccccccCCCCccccccccceeCHHHH
Confidence 9986422 22569999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=225.11 Aligned_cols=147 Identities=15% Similarity=0.175 Sum_probs=130.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|++. ..++.||||++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDT-----ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEET-----TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEec-----CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC
Confidence 468999999999999999999976 457789999998765444555677889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
..|+||||++|++|.+++.. + ....++..++.|++.||.|||++||+||||||+|||++.+|.+||+++|..
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 99999999999999999843 3 466678899999999999999999999999999999999999999977654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=232.13 Aligned_cols=157 Identities=24% Similarity=0.284 Sum_probs=136.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCCeeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK--VTHPFIVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~ 187 (282)
++|++.+.||+|+||.||+|++. ++.||||++.... .+.+.+|+++++. ++||||+++++++...
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc-------CccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 47999999999999999999863 5679999986432 2446678888887 7899999999999877
Q ss_pred C----EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCCEeeccCCCceEEcCCCcEE
Q 023430 188 S----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH--------KCGIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 188 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH--------~~~iiHrDlKp~NILl~~~~~v~ 255 (282)
. .+++||||+++|+|.+++.+ ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence 6 89999999999999999975 46899999999999999999999 89999999999999999999999
Q ss_pred EEecCcccccc-----------cchhheeeccCccc
Q 023430 256 AAHSLNSHNQL-----------CCFFFFLFLGGGVF 280 (282)
Q Consensus 256 l~Dfg~s~~~~-----------~~~~~~~~~ape~~ 280 (282)
|+|||++.... ...|++.|+|||.+
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 223 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHH
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhh
Confidence 99999985321 12579999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=235.87 Aligned_cols=162 Identities=23% Similarity=0.328 Sum_probs=123.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||.||+|+++ .++..||||++....... +...+|+..++.++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEK-----STGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HTTEEEC----------CEEEEET-----TTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 368999999999999999999987 356789999886543221 23456788888999999999999987643
Q ss_pred E-------EEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCCEeeccCCCceEEcC-CCcE
Q 023430 189 K-------LYLILDFINGGHLFFHL----YRQGIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMDS-DGHV 254 (282)
Q Consensus 189 ~-------~~lv~e~~~~g~L~~~l----~~~~~~~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~NILl~~-~~~v 254 (282)
. +++||||++++ |...+ .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 3 89999999875 43333 24566899999999999999999999 999999999999999997 8999
Q ss_pred EEEecCcccccc------cchhheeeccCccc
Q 023430 255 MAAHSLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 255 ~l~Dfg~s~~~~------~~~~~~~~~ape~~ 280 (282)
||+|||++.... ...|++.|+|||.+
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 203 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPNVAYICSRYYRAPELI 203 (360)
T ss_dssp EECCCTTCBCCCTTSCCCSTTSCGGGCCHHHH
T ss_pred EEeeCCCceecCCCCCcccccCCcceeCHHHH
Confidence 999999996322 23679999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=225.42 Aligned_cols=162 Identities=15% Similarity=0.142 Sum_probs=136.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE-EEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS-FQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~-~~~~ 187 (282)
.++|++.+.||+|+||.||+|++. ..++.||+|++..... .+.+.+|+.+++.++|++++..+.. +...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~ 77 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 77 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc-----CCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCC
Confidence 468999999999999999999976 4577899999865432 1247789999999998876665544 4667
Q ss_pred CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE---cCCCcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl---~~~~~v~l~Dfg~s~ 263 (282)
...++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 78 DYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 7899999999 8999999874 4569999999999999999999999999999999999999 588999999999986
Q ss_pred cc--------------ccchhheeeccCcccc
Q 023430 264 NQ--------------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~--------------~~~~~~~~~~ape~~~ 281 (282)
.. ....|++.|+|||.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHL 188 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHT
T ss_pred cccccccccccccccccccccccccCChhhhc
Confidence 32 1226799999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=238.48 Aligned_cols=169 Identities=21% Similarity=0.314 Sum_probs=141.6
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY 182 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 182 (282)
..+.+..++|++.+.||+|+||.||+|++.+ .+|+|++..... .....+.+.+|+.+++.++|+||+++++
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 96 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMG 96 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 4566778899999999999999999998752 389999875432 2222344677999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
++...+..++||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++ ++.++|+|||+
T Consensus 97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp EEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred EEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999999999987654 589999999999999999999999999999999999998 78999999998
Q ss_pred cccc------------ccchhheeeccCcccc
Q 023430 262 SHNQ------------LCCFFFFLFLGGGVFN 281 (282)
Q Consensus 262 s~~~------------~~~~~~~~~~ape~~~ 281 (282)
+... ....|++.|+|||.+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 207 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHS
T ss_pred ccccccccccccccccccCCCcccccChHHhh
Confidence 7521 1125789999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=231.19 Aligned_cols=164 Identities=21% Similarity=0.290 Sum_probs=137.7
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC------eeeee
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF------IVQLR 181 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~ 181 (282)
..++|++.+.||+|+||.||+|.+... .+..||+|++.... ...+.+.+|+.+++.++|++ ++.++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHAR----GKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCC----CceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 356899999999999999999997632 23679999987532 23455778999999887665 89999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE-----------
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM----------- 248 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl----------- 248 (282)
+++...+..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 56676776654 368999999999999999999999999999999999999
Q ss_pred --------cCCCcEEEEecCcccccc----cchhheeeccCccc
Q 023430 249 --------DSDGHVMAAHSLNSHNQL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 249 --------~~~~~v~l~Dfg~s~~~~----~~~~~~~~~ape~~ 280 (282)
+.++.+||+|||++.... ...|++.|||||.+
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~ 211 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVI 211 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHH
T ss_pred cccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeee
Confidence 668899999999996422 22679999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.8e-31 Score=228.12 Aligned_cols=167 Identities=24% Similarity=0.329 Sum_probs=129.3
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
...++|++++.||+|+||.||+|+++ .+++.||||++..... .....+.+.++..+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFR-----KTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEET-----TTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhccccccceeeecCCeeEEEEEEe-----cCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 34568999999999999999999986 3567899999976542 22233445556667888999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+..++||||+ ++.+..+... ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999999999 4455554443 46799999999999999999999995 999999999999999999999999999853
Q ss_pred cc------cchhheeeccCccc
Q 023430 265 QL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~------~~~~~~~~~ape~~ 280 (282)
.. ...|++.|+|||.+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~ 196 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERI 196 (318)
T ss_dssp ------------CCTTCCHHHH
T ss_pred ccCCccccccCCCccccChhhc
Confidence 22 22679999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=240.72 Aligned_cols=162 Identities=17% Similarity=0.185 Sum_probs=137.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~ 187 (282)
.++|++.++||+|+||.||+|++. ..+..||||++...... +.+.+|+.+++.++| ++|..+..++...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~ 75 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEG 75 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET-----TTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEET
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC-----CCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeC
Confidence 468999999999999999999976 45678999988654321 236779999999986 5566666677788
Q ss_pred CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE---cCCCcEEEEecCccc
Q 023430 188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM---DSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl---~~~~~v~l~Dfg~s~ 263 (282)
...+|||||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred CEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 8999999999 8999999975 4579999999999999999999999999999999999999 688999999999996
Q ss_pred ccc--------------cchhheeeccCcccc
Q 023430 264 NQL--------------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~--------------~~~~~~~~~ape~~~ 281 (282)
... ...|++.|||||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 186 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred eccCCccccccccccccccCCCccccCHHHhc
Confidence 321 235799999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=232.69 Aligned_cols=163 Identities=20% Similarity=0.301 Sum_probs=137.7
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----------CCC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPF 176 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~n 176 (282)
..++|++.+.||+|+||.||+|++. ..++.||||++.... ...+.+.+|+.+++.++ |+|
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 87 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 87 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cCCeEEEEEeeeecCCeEEEEEEec-----CCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccch
Confidence 4568999999999999999999976 457789999997543 23345778999988876 899
Q ss_pred eeeeeEEEEeCC----EEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCEeeccCCCceEEc
Q 023430 177 IVQLRYSFQTRS----KLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKC-GIVHRDLKPENILMD 249 (282)
Q Consensus 177 Iv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~NILl~ 249 (282)
|+++++++...+ .+++||||+ +++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~ 166 (373)
T 1q8y_A 88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166 (373)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEe
Confidence 999999988654 789999999 88999998763 4589999999999999999999998 999999999999995
Q ss_pred ------CCCcEEEEecCccccc----ccchhheeeccCccc
Q 023430 250 ------SDGHVMAAHSLNSHNQ----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 250 ------~~~~v~l~Dfg~s~~~----~~~~~~~~~~ape~~ 280 (282)
..+.+||+|||++... ....|++.|||||.+
T Consensus 167 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 167 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVL 207 (373)
T ss_dssp EEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHH
T ss_pred ccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHH
Confidence 3447999999999632 223679999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=231.20 Aligned_cols=162 Identities=22% Similarity=0.361 Sum_probs=137.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CC-----CeeeeeE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HP-----FIVQLRY 182 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~ 182 (282)
.++|++.+.||+|+||.||+|+++ ..++.||||++.... ...+.+.+|+.+++.++ |+ +|+++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDR-----VEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEc-----CCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 578999999999999999999976 456789999997542 23455677888888875 55 4999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCCEeeccCCCceEEc--CCCcEEE
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLH--KCGIVHRDLKPENILMD--SDGHVMA 256 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH--~~~iiHrDlKp~NILl~--~~~~v~l 256 (282)
++...+..|+||||+.+ +|.+++... ..+++..++.++.|++.||.||| ++|||||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999965 999988765 45899999999999999999999 57999999999999995 4788999
Q ss_pred EecCccccc----ccchhheeeccCccc
Q 023430 257 AHSLNSHNQ----LCCFFFFLFLGGGVF 280 (282)
Q Consensus 257 ~Dfg~s~~~----~~~~~~~~~~ape~~ 280 (282)
+|||++... ....|++.|||||++
T Consensus 203 ~DFG~a~~~~~~~~~~~~t~~y~aPE~~ 230 (382)
T 2vx3_A 203 VDFGSSCQLGQRIYQYIQSRFYRSPEVL 230 (382)
T ss_dssp CCCTTCEETTCCCCSSCSCGGGCCHHHH
T ss_pred EeccCceecccccccccCCccccChHHH
Confidence 999999643 223679999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=236.33 Aligned_cols=164 Identities=20% Similarity=0.206 Sum_probs=131.9
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYS 183 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 183 (282)
..++..+|.+.++||+|+||+||.... ..++.||||++...... .+.+|+.+|+.+ +||||++++++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~------~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~ 86 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGM------FDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCT 86 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEE------SSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEE------eCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEE
Confidence 345556799999999999999654322 24678999998654321 245799999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-----CCcEEEE
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMAA 257 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-----~~~v~l~ 257 (282)
+......|+|||||. |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++. ...+||+
T Consensus 87 ~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 87 EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp EEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred EecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 999999999999997 59999887653 3555667889999999999999999999999999999953 2358899
Q ss_pred ecCccccccc----------chhheeeccCcccc
Q 023430 258 HSLNSHNQLC----------CFFFFLFLGGGVFN 281 (282)
Q Consensus 258 Dfg~s~~~~~----------~~~~~~~~ape~~~ 281 (282)
|||+|..... ..||+.|||||++.
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~ 199 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTS
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhh
Confidence 9999864221 25799999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-30 Score=234.16 Aligned_cols=158 Identities=24% Similarity=0.219 Sum_probs=125.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 188 (282)
+.|.+.+.||+|+||+||.+.. ..++.||||++..+. .+.+.+|+.+|+.+ +||||+++++++....
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~------~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS------FQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE------SSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred heeeccCeEeeCCCeEEEEEEE------ECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 4567778999999999986532 246789999986542 23467899999876 8999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC----------
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIF-------REDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD---------- 251 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~---------- 251 (282)
.+|+|||||. |+|.+++...... .+..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 5999999765432 223456799999999999999999999999999999754
Q ss_pred ---CcEEEEecCccccccc-----------chhheeeccCccc
Q 023430 252 ---GHVMAAHSLNSHNQLC-----------CFFFFLFLGGGVF 280 (282)
Q Consensus 252 ---~~v~l~Dfg~s~~~~~-----------~~~~~~~~ape~~ 280 (282)
+.+||+|||++..... ..|++.|||||++
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 204 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL 204 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHH
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence 4899999999963211 2579999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=215.80 Aligned_cols=143 Identities=27% Similarity=0.464 Sum_probs=125.2
Q ss_pred CCCeEEE-eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH-HhcCCCCeeeeeEEEEe
Q 023430 109 PGDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL-TKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 109 ~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~ 186 (282)
.++|.+. +.||+|+||.||+|.++ ..++.||+|++... ..+.+|+.++ +.++||||+++++++..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEc-----CCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 3578887 78999999999999976 45678999998643 2356688887 66689999999999887
Q ss_pred ----CCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---CCcEEEE
Q 023430 187 ----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMAA 257 (282)
Q Consensus 187 ----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~---~~~v~l~ 257 (282)
...+++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++. ++.++|+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 678999999999999999998754 5899999999999999999999999999999999999998 7889999
Q ss_pred ecCcccc
Q 023430 258 HSLNSHN 264 (282)
Q Consensus 258 Dfg~s~~ 264 (282)
|||++..
T Consensus 163 Dfg~a~~ 169 (299)
T 3m2w_A 163 DFGFAKE 169 (299)
T ss_dssp CCTTCEE
T ss_pred ccccccc
Confidence 9999953
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-31 Score=247.33 Aligned_cols=166 Identities=25% Similarity=0.324 Sum_probs=139.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 186 (282)
.++|++.+.||+|+||.||+|.++ ..+..||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~-----~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCT-----TTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 368999999999999999998865 456789999987542 23445678899999999999999999988755
Q ss_pred ----CCEEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc---EEE
Q 023430 187 ----RSKLYLILDFINGGHLFFHLYRQG---IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH---VMA 256 (282)
Q Consensus 187 ----~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~---v~l 256 (282)
.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence 667899999999999999998644 5889999999999999999999999999999999999997775 999
Q ss_pred EecCcccccc------cchhheeeccCcccc
Q 023430 257 AHSLNSHNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 257 ~Dfg~s~~~~------~~~~~~~~~ape~~~ 281 (282)
+|||++.... ...|++.|+|||.+.
T Consensus 166 ~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~ 196 (676)
T 3qa8_A 166 IDLGYAKELDQGELCTEFVGTLQYLAPELLE 196 (676)
T ss_dssp CSCCCCCBTTSCCCCCCCCSCCTTCSSCSSC
T ss_pred cccccccccccccccccccCCcccCChHHhc
Confidence 9999996422 126799999999874
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=237.32 Aligned_cols=151 Identities=15% Similarity=0.025 Sum_probs=117.3
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-----hhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-----IKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
..++||+|+||.||++.+ .+..+++|+...... ......+.+.+|+.+|+.++||||+++..++...+
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp --------CCEEEEEEEC-------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred CCCEEeeCCCEEEEEEEE-------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 356899999999999953 345688887644322 12223456889999999999999996655556777
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
..||||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. .+||+|||+|+....
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 78999999999999998864 5688999999999999999999999999999998 999999999974222
Q ss_pred -------------chhheeeccCcccc
Q 023430 268 -------------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 -------------~~~~~~~~ape~~~ 281 (282)
-.||+.|||||+|+
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~ 509 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWE 509 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHH
Confidence 26799999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-29 Score=224.43 Aligned_cols=165 Identities=15% Similarity=0.070 Sum_probs=123.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CCee---------
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIV--------- 178 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv--------- 178 (282)
...|.+.++||+|+||.||+|++. .+++.||||++...........+.+.+|+.+++.+.| .|+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~ 151 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQ-----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred ceeEEEecccccCCCEEEEEEEec-----CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence 345888999999999999999977 4567899999875443333445678899999999987 2211
Q ss_pred ------ee------eEEEEe-----CCEEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC
Q 023430 179 ------QL------RYSFQT-----RSKLYLILDFINGGHLFFHLYR-------QGIFREDQARFYTAEIVSAVSHLHKC 234 (282)
Q Consensus 179 ------~l------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~gL~ylH~~ 234 (282)
.+ ...+.. ....+++|+++ +++|.+++.. ...+++..+..++.|++.||.|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 230 (413)
T 3dzo_A 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 230 (413)
T ss_dssp CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 11 111111 12467777765 5788887742 22366778888999999999999999
Q ss_pred CCEeeccCCCceEEcCCCcEEEEecCcccccccc----hhheeeccCccc
Q 023430 235 GIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~----~~~~~~~ape~~ 280 (282)
|||||||||+|||++.++.+||+|||+++..... .| +.|||||.+
T Consensus 231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETT 279 (413)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHH
T ss_pred CcccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhh
Confidence 9999999999999999999999999998643222 56 999999987
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-28 Score=208.21 Aligned_cols=146 Identities=16% Similarity=0.142 Sum_probs=113.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhh---------------hHHHHHHHHHHHHHhcCCC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKK---------------NHVDYMKAERDILTKVTHP 175 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~ 175 (282)
.|.+.+.||+|+||.||+|.+. ++..||+|+++....... .....+.+|+.+|+.++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~~------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred EEEecCEeccCCCceEEEEEeC------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3455599999999999999862 467899999865331111 13456889999999999
Q ss_pred CeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEE
Q 023430 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255 (282)
Q Consensus 176 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~ 255 (282)
| +++++++.. +..|+||||++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ +|.++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEE
Confidence 5 666665544 45699999999999976 31 133557999999999999999999999999999999 99999
Q ss_pred EEecCcccccccchhheeeccCccc
Q 023430 256 AAHSLNSHNQLCCFFFFLFLGGGVF 280 (282)
Q Consensus 256 l~Dfg~s~~~~~~~~~~~~~ape~~ 280 (282)
|+|||+|.. +..++|||.|
T Consensus 233 l~DFG~a~~------~~~~~a~e~l 251 (282)
T 1zar_A 233 IIDFPQSVE------VGEEGWREIL 251 (282)
T ss_dssp ECCCTTCEE------TTSTTHHHHH
T ss_pred EEECCCCeE------CCCCCHHHHH
Confidence 999999963 3446677665
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-24 Score=181.39 Aligned_cols=140 Identities=19% Similarity=0.124 Sum_probs=105.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcE--EEEEEeechhhhh---------------------hhHHHHHHHHHH
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGI--YAMKVMRKDTIIK---------------------KNHVDYMKAERD 167 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~ 167 (282)
-|++.+.||+|+||.||+|.+. ..+.. ||||+++...... ......+.+|+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~-----~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 122 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGV-----FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR 122 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEE-----ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEc-----CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence 3788999999999999999874 24567 9999875432110 011235788999
Q ss_pred HHHhcCCCCe--eeeeEEEEeCCEEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCEee
Q 023430 168 ILTKVTHPFI--VQLRYSFQTRSKLYLILDFING-G----HLFFHLYRQGIFREDQARFYTAEIVSAVSHLH-KCGIVHR 239 (282)
Q Consensus 168 ~l~~l~h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH-~~~iiHr 239 (282)
+|+.+.|++| ..+++. ...+|||||+.+ | .|.+.... .++..+..++.|++.||.||| ++|||||
T Consensus 123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHr 195 (258)
T 1zth_A 123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHA 195 (258)
T ss_dssp HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 9999988764 333332 246899999942 3 56554322 234567889999999999999 9999999
Q ss_pred ccCCCceEEcCCCcEEEEecCcccc
Q 023430 240 DLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 240 DlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
||||+|||++. .++|+|||+|..
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCHHHEEEcC--cEEEEECccccc
Confidence 99999999988 999999999953
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=1.3e-20 Score=166.16 Aligned_cols=138 Identities=13% Similarity=0.138 Sum_probs=97.8
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh------------hh---hHH----HHHHHHHHHHHh
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII------------KK---NHV----DYMKAERDILTK 171 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~------------~~---~~~----~~~~~E~~~l~~ 171 (282)
-|.+...||+|+||.||+|... .++.||||+++..... .. ..+ -+..+|...|.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 3899999999999999999853 4678999987643210 00 000 112356777777
Q ss_pred cCCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC
Q 023430 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~ 251 (282)
+.+.++....-+.... .+|||||++|+.|..+. ....+..++.|++.+|.|||++|||||||||.|||++++
T Consensus 170 L~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp HHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEE
T ss_pred HHhcCCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCC
Confidence 7555443221111222 37999999998875432 223456778999999999999999999999999999988
Q ss_pred C----------cEEEEecCcc
Q 023430 252 G----------HVMAAHSLNS 262 (282)
Q Consensus 252 ~----------~v~l~Dfg~s 262 (282)
| .+.|+||+=+
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQM 262 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTC
T ss_pred CCcccccccccceEEEEeCCc
Confidence 7 3899999854
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-14 Score=120.66 Aligned_cols=139 Identities=11% Similarity=0.012 Sum_probs=108.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
+.|++...++.|+++.||++.. .++.+++|+........ ...+.+|+.+++.+. +..+.++++++...+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~-------~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC-------SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred ccceeEeeccCCCCCeEEEEEC-------CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 4688999999999999999862 24579999986532111 124778999999885 677888999988889
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK----------------------------------- 233 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~----------------------------------- 233 (282)
..|+||||++|.+|...+ .+......++.+++.+|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEEECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred ceEEEEEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 999999999999886642 1222334677899999999998
Q ss_pred ------------------------CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 ------------------------CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ------------------------~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..++|+|+++.|||+++++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999875556699999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.42 E-value=6.4e-13 Score=111.06 Aligned_cols=134 Identities=12% Similarity=0.095 Sum_probs=95.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC--eeeeeEEEEeC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRYSFQTR 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~ 187 (282)
..|.+..+.+.|..+.||++... .+..+++|+..... ...+.+|+.+++.+.+.+ +.+++++....
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCCceEecccCCCCceEEEEecC------CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 35666555456777999998632 34568999875431 123677999998886444 45688888777
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG-------------------------------- 235 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~-------------------------------- 235 (282)
+..|+||||++|.+|. . .... ...++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 7899999999998873 1 1112 1245566777777777543
Q ss_pred --------------------------CEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 236 --------------------------IVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 236 --------------------------iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876656799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=114.49 Aligned_cols=141 Identities=13% Similarity=0.212 Sum_probs=102.8
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEee--chhhhhhhHHHHHHHHHHHHHhcC--CCCeeeeeEEEEeC
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMR--KDTIIKKNHVDYMKAERDILTKVT--HPFIVQLRYSFQTR 187 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~ 187 (282)
....+.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+. +..+.+++.++.+.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-------~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~ 110 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-------GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDE 110 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-------SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred CceEEEcCCcccceEEEEEEC-------CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence 334677899999999998742 3468888775 32211 11234778999999987 34577788877665
Q ss_pred ---CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------
Q 023430 188 ---SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------- 233 (282)
Q Consensus 188 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~------------------------------- 233 (282)
+..|+||||++|..+.+.. ...++..+...++.+++..|..||.
T Consensus 111 ~~~g~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 111 SVIGRAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp TTTSSCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred CccCCeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 4589999999998764311 2236778888889999999999997
Q ss_pred ---------------------------CCCEeeccCCCceEEcCCCc--EEEEecCccc
Q 023430 234 ---------------------------CGIVHRDLKPENILMDSDGH--VMAAHSLNSH 263 (282)
Q Consensus 234 ---------------------------~~iiHrDlKp~NILl~~~~~--v~l~Dfg~s~ 263 (282)
..++|+|+++.|||++.++. +.|+||+.+.
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999998764 5899999886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.9e-09 Score=92.37 Aligned_cols=131 Identities=15% Similarity=0.196 Sum_probs=92.6
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCC--eeeeeEEEEeCC---E
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPF--IVQLRYSFQTRS---K 189 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~ 189 (282)
+.++.|....||++. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... .
T Consensus 26 ~~~~~G~~n~v~~v~----------~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~ 90 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----------RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM 90 (304)
T ss_dssp CEEEECSSEEEEEST----------TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred EecCCCCcceEEEEC----------CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence 458999999999742 24888886433 23355888999998874 333 333443332222 3
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------------ 233 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~------------------------------------ 233 (282)
.|+|||+++|..|..... ..++..+...++.+++..|..||+
T Consensus 91 ~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp SCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred ceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 589999999988865332 235677777778888888888875
Q ss_pred ----------------------CCCEeeccCCCceEEcC--CCcEEEEecCccc
Q 023430 234 ----------------------CGIVHRDLKPENILMDS--DGHVMAAHSLNSH 263 (282)
Q Consensus 234 ----------------------~~iiHrDlKp~NILl~~--~~~v~l~Dfg~s~ 263 (282)
..++|+|+++.|||++. .+.+.++||+.+.
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 13799999999999998 4557899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1.4e-07 Score=80.97 Aligned_cols=132 Identities=14% Similarity=0.187 Sum_probs=85.1
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC---CeeeeeEEEE-eCCEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQ-TRSKL 190 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~ 190 (282)
.+.++.|....||+. +..+++|+-... .....+.+|..+|+.+.+. .|.+.+.+.. ..+..
T Consensus 24 v~~l~~G~~n~v~~v----------g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~ 88 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----------NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP 88 (306)
T ss_dssp EEEEEECSSEEEEEE----------TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred eeecCCCcceeEEEE----------CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence 355788999999976 123788874321 2345688999999998752 2445555553 34567
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------------- 233 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~------------------------------------- 233 (282)
|+|||+++|..+..... ..++..+...++.++...|..||+
T Consensus 89 ~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~ 166 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE 166 (306)
T ss_dssp EEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred EEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence 89999999987755221 112333333333333333333332
Q ss_pred -----------------------CCCEeeccCCCceEEcC---CCcE-EEEecCccc
Q 023430 234 -----------------------CGIVHRDLKPENILMDS---DGHV-MAAHSLNSH 263 (282)
Q Consensus 234 -----------------------~~iiHrDlKp~NILl~~---~~~v-~l~Dfg~s~ 263 (282)
..++|+|+++.|||++. ++.+ .|+||+.+.
T Consensus 167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 14699999999999987 4665 799999775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=2.1e-07 Score=77.95 Aligned_cols=131 Identities=15% Similarity=0.142 Sum_probs=87.1
Q ss_pred eCcCCC-eEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEEEEe
Q 023430 118 VGQGAF-GKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 118 lG~G~f-g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e 195 (282)
+..|.. ..||+.... ..+..+++|+-.... ...+.+|..+|+.+. +--|.+++.++...+..|+|||
T Consensus 32 ~~~G~S~~~v~rl~~~-----~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK-----PNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp EECSSSSCEEEEEECC-----TTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccCCCcCCeEEEEEec-----CCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 344544 468876533 234568889765432 334778999998875 3335677888888899999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK------------------------------------------ 233 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~------------------------------------------ 233 (282)
+++|.++.+..... ......+..++...|.-||.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99998776544321 11122334444444444442
Q ss_pred ---------C-------CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 ---------C-------GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ---------~-------~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
. .++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 27999999999999987767799998885
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=2.3e-07 Score=82.39 Aligned_cols=80 Identities=15% Similarity=0.249 Sum_probs=48.6
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhh-hh---hhHHHHHHHHHHHHHhcCC--CC-eeeeeEEEEe
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTI-IK---KNHVDYMKAERDILTKVTH--PF-IVQLRYSFQT 186 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~h--~n-Iv~l~~~~~~ 186 (282)
..+.||.|.++.||++... ..++.+++|....... .. ....+++..|.++|+.+.. +. +.+++.+ +
T Consensus 34 ~~~~lg~G~~n~vyrv~~~-----~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQ-----EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred EEEECCCCceEEEEEEEEC-----CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence 3567999999999998643 1345689997653221 00 0122346678888887742 33 3345543 3
Q ss_pred CCEEEEEEeccCCC
Q 023430 187 RSKLYLILDFINGG 200 (282)
Q Consensus 187 ~~~~~lv~e~~~~g 200 (282)
....++|||++++.
T Consensus 107 ~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 107 TEMAVTVMEDLSHL 120 (397)
T ss_dssp TTTTEEEECCCTTS
T ss_pred CCccEEEEEeCCCc
Confidence 44568999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.45 E-value=2.8e-06 Score=73.31 Aligned_cols=30 Identities=13% Similarity=0.206 Sum_probs=27.4
Q ss_pred CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
..++|+|+++.|||++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.2e-07 Score=82.78 Aligned_cols=91 Identities=11% Similarity=0.135 Sum_probs=53.6
Q ss_pred eEEEeee-CcCCCeEEEEEEEcCCCCCC-CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-C--CCeeeeeEEEEe
Q 023430 112 FEIFRVV-GQGAFGKVFQVKKKGVDDGD-SDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-H--PFIVQLRYSFQT 186 (282)
Q Consensus 112 y~~~~~l-G~G~fg~V~~~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~ 186 (282)
....+.| +.|....+|+.......++. .+..+++|+..............+.+|..+++.+. + -.+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 88999999987642000000 14568888765432000000123667888888775 2 245667766654
Q ss_pred C---CEEEEEEeccCCCch
Q 023430 187 R---SKLYLILDFINGGHL 202 (282)
Q Consensus 187 ~---~~~~lv~e~~~~g~L 202 (282)
. +..|+||||++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 4 356899999988653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.26 E-value=6.5e-06 Score=73.59 Aligned_cols=30 Identities=17% Similarity=0.293 Sum_probs=26.7
Q ss_pred HCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 233 KCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 233 ~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...++|+|+++.|||++.++ ++++||+.+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 45799999999999998776 9999998885
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.17 E-value=2.8e-05 Score=66.71 Aligned_cols=78 Identities=12% Similarity=0.143 Sum_probs=58.0
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCCeeeeeEEEEeCC
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT---HPFIVQLRYSFQTRS 188 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~ 188 (282)
..-.+.|+.|....+|+... .+..+++|+.... ....+.+|...|+.+. ...+.+++.+....+
T Consensus 38 i~~~~~l~gG~~n~~y~v~~-------~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g 104 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLIND-------EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG 104 (312)
T ss_dssp CCEEEEECCSSSSEEEEEES-------SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS
T ss_pred eeeeEEeCCccceeeeEEEE-------CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC
Confidence 34457789999999998762 2456888986543 2345778988888874 245777888777778
Q ss_pred EEEEEEeccCCCch
Q 023430 189 KLYLILDFINGGHL 202 (282)
Q Consensus 189 ~~~lv~e~~~~g~L 202 (282)
..|+||||++|..+
T Consensus 105 ~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 HSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEEECCCCCCC
T ss_pred ceEEEEEeccCCCC
Confidence 89999999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.87 E-value=4.3e-05 Score=65.41 Aligned_cols=143 Identities=13% Similarity=0.135 Sum_probs=78.4
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC--eeeeeE----
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF--IVQLRY---- 182 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~---- 182 (282)
.+...-++.|+.|....+|++... +..+++|+..... .. +.+..|..+++.+...+ +.+++.
T Consensus 21 ~~~~~~~~~i~~G~~n~~~~v~~~-------~g~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g 88 (322)
T 2ppq_A 21 VGSLTSYKGIAEGVENSNFLLHTT-------KDPLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDG 88 (322)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-------SCCEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTC
T ss_pred CCcceEeeccCCCcccceEEEEeC-------CccEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCC
Confidence 344555677888999999988743 2258899876521 11 22455777766654212 223321
Q ss_pred --EEEeCCEEEEEEeccCCCchH-----------H---HHHhc-CCC--------CHHHHHH---------------HHH
Q 023430 183 --SFQTRSKLYLILDFINGGHLF-----------F---HLYRQ-GIF--------REDQARF---------------YTA 222 (282)
Q Consensus 183 --~~~~~~~~~lv~e~~~~g~L~-----------~---~l~~~-~~~--------~~~~~~~---------------i~~ 222 (282)
+....+..+++|+|++|..+. . .++.. ..+ ....-.. +..
T Consensus 89 ~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~ 168 (322)
T 2ppq_A 89 ELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLRE 168 (322)
T ss_dssp CSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHH
T ss_pred CEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHH
Confidence 112346789999999985431 1 11111 001 1000000 001
Q ss_pred HHHHHHHHHHH-------CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 223 EIVSAVSHLHK-------CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 223 qi~~gL~ylH~-------~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.+...++++.. .+++|+|+.+.|||++.++.+.++||+.+.
T Consensus 169 ~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 169 EIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13344555552 358999999999999876656799998775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.84 E-value=6e-05 Score=64.07 Aligned_cols=28 Identities=25% Similarity=0.154 Sum_probs=24.2
Q ss_pred CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 235 GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.++|+|+.+.||| ..++.+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 3899999999999 667789999998774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00021 Score=60.19 Aligned_cols=78 Identities=12% Similarity=0.072 Sum_probs=52.1
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC---CeeeeeEEEEeC
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP---FIVQLRYSFQTR 187 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~ 187 (282)
...-.+.+|.|..+.||+.+.. +++.|++|+...... .....+.+|...|+.+.-. -+.++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~------DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~ 84 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA------DGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD 84 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET------TSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET
T ss_pred CeEEEEecCCCCCeEEEEEEEC------CCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC
Confidence 4566788999999999998753 456799997654321 1123477899999888522 23344443 22
Q ss_pred CEEEEEEeccCCCc
Q 023430 188 SKLYLILDFINGGH 201 (282)
Q Consensus 188 ~~~~lv~e~~~~g~ 201 (282)
-++||||++++.
T Consensus 85 --~~lv~e~l~~~~ 96 (288)
T 3f7w_A 85 --RTLAMEWVDERP 96 (288)
T ss_dssp --TEEEEECCCCCC
T ss_pred --ceEEEEeecccC
Confidence 378999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00018 Score=61.96 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=26.2
Q ss_pred CCCEeeccCCCceEEcCC----CcEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSD----GHVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~----~~v~l~Dfg~s~ 263 (282)
..++|+|+.+.|||++.+ +.+.++||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 469999999999999875 679999999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0003 Score=60.24 Aligned_cols=75 Identities=9% Similarity=0.184 Sum_probs=44.5
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--CeeeeeEE-----EEeCC
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYS-----FQTRS 188 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~-----~~~~~ 188 (282)
..|+ |....||++... .++.+++|+...... ....+..|..+++.+... .+.+++.. ....+
T Consensus 32 ~~l~-g~~n~~y~v~~~------~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g 100 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG 100 (328)
T ss_dssp EEEC-CSSSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred Eeec-CcccceEEEEcC------CCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence 3466 788899986532 234589998864321 123456677777766421 23333332 22356
Q ss_pred EEEEEEeccCCCc
Q 023430 189 KLYLILDFINGGH 201 (282)
Q Consensus 189 ~~~lv~e~~~~g~ 201 (282)
..+++|++++|..
T Consensus 101 ~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 101 FYFAVFPSVGGRQ 113 (328)
T ss_dssp EEEEEEECCCCEE
T ss_pred EEEEEEEecCCCC
Confidence 7789999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00081 Score=60.18 Aligned_cols=79 Identities=14% Similarity=0.119 Sum_probs=47.7
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEEeCCEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKL 190 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~ 190 (282)
-++.|+.|....||++....... ...+..+++|+..... . .+.+.+|..+++.+...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 34678889899999987542100 0123568888874311 1 1234468888887753333 45666543 2
Q ss_pred EEEEeccCCCc
Q 023430 191 YLILDFINGGH 201 (282)
Q Consensus 191 ~lv~e~~~~g~ 201 (282)
.+||||++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38999998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00049 Score=60.11 Aligned_cols=79 Identities=14% Similarity=0.119 Sum_probs=42.0
Q ss_pred EeeeCcCCCeEEEEEEEcCCC---CCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCCEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVD---DGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSKL 190 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~ 190 (282)
.+.|+.|....+|++...... ....+..+++|+....... ......|..+++.+...+ +.++++.+ .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 456788888999998754200 0001246888876543211 001346777777775333 34565544 22
Q ss_pred EEEEeccCCCc
Q 023430 191 YLILDFINGGH 201 (282)
Q Consensus 191 ~lv~e~~~~g~ 201 (282)
++||||++|..
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 78999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0021 Score=55.56 Aligned_cols=29 Identities=14% Similarity=0.260 Sum_probs=26.1
Q ss_pred CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 235 GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 235 ~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.++|+|+.+.|||++.++.+.++||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 58999999999999988889999997664
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00072 Score=59.46 Aligned_cols=145 Identities=16% Similarity=0.118 Sum_probs=80.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCC--CCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC-eeeeeEEEEe
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGV--DDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQT 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~ 186 (282)
+.+++ +.|..|-...+|++..... .....+..+++|+..... .....+.+|..+++.+.-.+ ..++++.+..
T Consensus 51 ~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 34443 4577788888999875310 001123568888753311 11233557888888775222 3456655543
Q ss_pred CCEEEEEEeccCCCchH--------------HHHH---hcC-----CC--CHHHHHHHHHHHHH----------------
Q 023430 187 RSKLYLILDFINGGHLF--------------FHLY---RQG-----IF--REDQARFYTAEIVS---------------- 226 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~--------------~~l~---~~~-----~~--~~~~~~~i~~qi~~---------------- 226 (282)
.+||||++|..|. ..+. ... .. -+.++..+..++..
T Consensus 126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2899999985431 1111 111 11 13455555544422
Q ss_pred ---HHHHHH----HC----CCEeeccCCCceEEcCC----CcEEEEecCccc
Q 023430 227 ---AVSHLH----KC----GIVHRDLKPENILMDSD----GHVMAAHSLNSH 263 (282)
Q Consensus 227 ---gL~ylH----~~----~iiHrDlKp~NILl~~~----~~v~l~Dfg~s~ 263 (282)
.+.+|. .. .++|+|+.+.|||++.+ +.+.++||..+.
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 22 48999999999999876 789999998875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.012 Score=52.88 Aligned_cols=75 Identities=17% Similarity=0.290 Sum_probs=45.6
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEEeCCEEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRSKLYL 192 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~l 192 (282)
-++.|+.|-...+|++.... .+..+++|+..... ....+ ..+|..+++.|...++ .++++.+. + .+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~---~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~ 178 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKT---DEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GR 178 (458)
T ss_dssp EEEEECC--CEEEEEEEETT-----TTEEEEEEEECC-C---CSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred EEEEcCCCeEeEEEEEEECC-----CCceEEEEECCCCh---hhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence 34568889899999987541 23568888764321 11111 2468888888875545 45666652 3 25
Q ss_pred EEeccCCCc
Q 023430 193 ILDFINGGH 201 (282)
Q Consensus 193 v~e~~~~g~ 201 (282)
||||++|..
T Consensus 179 v~e~I~G~~ 187 (458)
T 2qg7_A 179 IEEFMDGYA 187 (458)
T ss_dssp EEECCCSEE
T ss_pred EEEeeCCcc
Confidence 999998744
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.11 E-value=0.013 Score=52.27 Aligned_cols=79 Identities=16% Similarity=0.170 Sum_probs=45.2
Q ss_pred EeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCCEEE
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPF-IVQLRYSFQTRSKLY 191 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~ 191 (282)
++.|..|-...+|++....... ...+..+++|+..... ....+ ..+|..+++.+...+ ..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~id-R~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYD-SKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCC-HHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcC-HHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 4567778889999987642100 0014568888864421 11111 245888877775222 34455433 22 7
Q ss_pred EEEeccCCCc
Q 023430 192 LILDFINGGH 201 (282)
Q Consensus 192 lv~e~~~~g~ 201 (282)
+||||++|..
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 8999999865
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.65 E-value=0.034 Score=50.13 Aligned_cols=63 Identities=8% Similarity=0.057 Sum_probs=16.1
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEE------EEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM------KVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
+.+.|| ||.||++.++. ....||+ |..+... ...+....+.+|..+++.++|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~-----~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYK-----KHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC--------------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccc-----cCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceEE
Confidence 345666 99999998763 1234677 6554322 23344456778899999999999999877654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.42 E-value=1.4 Score=35.10 Aligned_cols=83 Identities=14% Similarity=0.040 Sum_probs=57.7
Q ss_pred CCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCEeeccCCCceEEcCC
Q 023430 173 THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS-HLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 173 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~-ylH~~~iiHrDlKp~NILl~~~ 251 (282)
.||++ -...-.+++.+.+.++.-+++.-+..+. .++....++++..|+.... ++ ..-+|--|.|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 57777 2334467778888887665543344443 3677777777777666544 33 445777788999999999
Q ss_pred CcEEEEecCcc
Q 023430 252 GHVMAAHSLNS 262 (282)
Q Consensus 252 ~~v~l~Dfg~s 262 (282)
+.+++...|+-
T Consensus 121 ~~p~i~hRGi~ 131 (219)
T 4ano_A 121 LEPFFLHVGVK 131 (219)
T ss_dssp CCEEESCCEET
T ss_pred CcEEEEEcCCc
Confidence 99999988863
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.08 E-value=0.34 Score=42.55 Aligned_cols=28 Identities=25% Similarity=0.306 Sum_probs=24.2
Q ss_pred CEeeccCCCceEE------cCCCcEEEEecCccc
Q 023430 236 IVHRDLKPENILM------DSDGHVMAAHSLNSH 263 (282)
Q Consensus 236 iiHrDlKp~NILl------~~~~~v~l~Dfg~s~ 263 (282)
++|.|+.+.|||+ ++++.+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 456779999998885
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=84.31 E-value=15 Score=34.01 Aligned_cols=81 Identities=14% Similarity=0.147 Sum_probs=46.5
Q ss_pred eeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCC-----------------CCHHHHHHHHHHHHH--HHHHHHHCCCEe
Q 023430 178 VQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-----------------FREDQARFYTAEIVS--AVSHLHKCGIVH 238 (282)
Q Consensus 178 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~i~~qi~~--gL~ylH~~~iiH 238 (282)
++.|.+.......- +.|++++.++.+.+.+.+. ..+.....+++.++. -+.|+-. |
T Consensus 402 i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YILG--i-- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILG--V-- 476 (614)
T ss_dssp CCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHHHT--C--
T ss_pred eeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhheeee--c--
Confidence 34455555544444 3467776555544432211 012223344444433 3445443 3
Q ss_pred eccCCCceEEcCCCcEEEEecCccc
Q 023430 239 RDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 239 rDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+|=.++||||+.+|++.=+|||..-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 4777999999999999999999874
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=80.46 E-value=21 Score=33.58 Aligned_cols=25 Identities=16% Similarity=0.224 Sum_probs=22.8
Q ss_pred eccCCCceEEcCCCcEEEEecCccc
Q 023430 239 RDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 239 rDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+|=.++||||+.+|++.=+|||.+.
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred CCCCCcceEEeCCCCEEEEeehhhh
Confidence 5778999999999999999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.01 E-value=2 Score=34.14 Aligned_cols=85 Identities=14% Similarity=0.155 Sum_probs=59.1
Q ss_pred cCCCCeeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC
Q 023430 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD 251 (282)
Q Consensus 172 l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~ 251 (282)
..||+.+.. ..-.+.+.+.+.++.-+.+.=+..+ ..++....++++.+|+....++ ..-+|--|.|+||+++.+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence 358888866 4556667777777765433212223 2367778888888887766444 334677788999999999
Q ss_pred CcEEEEecCcc
Q 023430 252 GHVMAAHSLNS 262 (282)
Q Consensus 252 ~~v~l~Dfg~s 262 (282)
+.+++..-|+-
T Consensus 116 ~~p~i~~RGik 126 (215)
T 4ann_A 116 GLPIAKTRGLQ 126 (215)
T ss_dssp SCEEESCCEET
T ss_pred CCEEEEEccCc
Confidence 99999988763
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 282 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-47 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-39 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-36 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-35 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-35 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-31 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-29 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-13 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-47
Identities = 64/151 (42%), Positives = 96/151 (63%), Gaps = 5/151 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
RK P DF+ +++G+G+F V ++ + YA+K++ K IIK+N V Y+
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTR 57
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
ERD+++++ HPF V+L ++FQ KLY L + G L ++ + G F E RFYTAEI
Sbjct: 58 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 117
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
VSA+ +LH GI+HRDLKPENIL++ D H+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQ 148
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-43
Identities = 48/144 (33%), Positives = 82/144 (56%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFEI R +G+G FG V+ ++K S I A+KV+ K + K ++ E +I +
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ HP I++L F +++YLIL++ G ++ L + F E + Y E+ +A+S+
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
H ++HRD+KPEN+L+ S G +
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGEL 145
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-41
Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DFE +G G G VF+V K S + A K++ + IK + + E +L
Sbjct: 7 DFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLE--IKPAIRNQIIRELQVLH 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+ P+IV +F + ++ + ++ ++GG L L + G E + ++ +++
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 231 LH-KCGIVHRDLKPENILMDSDGHV 254
L K I+HRD+KP NIL++S G +
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEI 144
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (358), Expect = 5e-41
Identities = 32/143 (22%), Positives = 59/143 (41%), Gaps = 5/143 (3%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
F R +G G+FG V+ + + + A+K M + E L K
Sbjct: 17 FSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 172 VTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHL 231
+ HP +Q R + +L++++ G + +E + T + +++L
Sbjct: 72 LRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 232 HKCGIVHRDLKPENILMDSDGHV 254
H ++HRD+K NIL+ G V
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGLV 154
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-41
Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 10/153 (6%)
Query: 104 ERKIGPGD-FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
R + P D +EI +G GAFGKV++ + K ++ + A KV+ + ++
Sbjct: 5 TRDLNPEDFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTK---SEEELEDY 56
Query: 163 KAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYT 221
E DIL HP IV+L +F + L+++++F GG + + + E Q +
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + A+++LH I+HRDLK NIL DG +
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDI 149
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (355), Expect = 3e-40
Identities = 63/147 (42%), Positives = 88/147 (59%), Gaps = 8/147 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF + R++G+G FG+V+ +K D+ +YAMK + K I K ER +L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59
Query: 171 KVT---HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
V+ PFIV + Y+F T KL ILD +NGG L +HL + G+F E RFY AEI+
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 119
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
+ H+H +V+RDLKP NIL+D GHV
Sbjct: 120 LEHMHNRFVVYRDLKPANILLDEHGHV 146
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 7e-40
Identities = 36/145 (24%), Positives = 74/145 (51%), Gaps = 7/145 (4%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
D+++ + +G+GA+G+V + ++ A+K++ + + +K E I
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDC--PENIKKEICIN 57
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
+ H +V+ + + YL L++ +GG LF + E A+ + ++++ V
Sbjct: 58 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHV 254
+LH GI HRD+KPEN+L+D ++
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNL 142
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-39
Identities = 65/149 (43%), Positives = 101/149 (67%), Gaps = 5/149 (3%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
K+ DF+ +++G+G FGKV V++K + YAMK++RK+ II K+ V + E
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTE 55
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+L HPF+ L+Y+FQT +L ++++ NGG LFFHL R+ +F E++ARFY AEIV
Sbjct: 56 SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV 115
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
SA+ +LH +V+RD+K EN+++D DGH+
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHI 144
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 137 bits (345), Expect = 8e-39
Identities = 60/174 (34%), Positives = 101/174 (58%), Gaps = 5/174 (2%)
Query: 82 SSLPLQIQELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG 141
S+ + + + + + E S+ F+ + +G G+FG+V VK K +S
Sbjct: 13 ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGN 67
Query: 142 IYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH 201
YAMK++ K ++K +++ E+ IL V PF+V+L +SF+ S LY++++++ GG
Sbjct: 68 HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127
Query: 202 LFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
+F HL R G F E ARFY A+IV +LH +++RDLKPEN+L+D G++
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-38
Identities = 40/164 (24%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 95 NDAELEAESERKIGPGD----FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRK 150
+D E+ + + GD + F +GQGA G V+ + A++ M
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNL 55
Query: 151 DTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG 210
KK + E ++ + +P IV S+ +L+++++++ GG L +
Sbjct: 56 QQQPKKELI---INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112
Query: 211 IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
E Q E + A+ LH ++HRD+K +NIL+ DG V
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV 155
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 134 bits (338), Expect = 4e-38
Identities = 57/144 (39%), Positives = 95/144 (65%), Gaps = 5/144 (3%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF+I R +G G+FG+V ++ + + YAMKV++K+ +++ V++ ER +L+
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 59
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
VTHPFI+++ +FQ ++++I+D+I GG LF L + F A+FY AE+ A+ +
Sbjct: 60 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LH I++RDLKPENIL+D +GH+
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHI 143
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 134 bits (339), Expect = 5e-38
Identities = 37/143 (25%), Positives = 74/143 (51%), Gaps = 9/143 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++I +G GAFG V +V ++ + +A K + ++ + ++ E ++
Sbjct: 27 HYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTP---HESDKETVRKEIQTMS 78
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVS 229
+ HP +V L +F+ +++ +I +F++GG LF + + ED+A Y ++ +
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 230 HLHKCGIVHRDLKPENILMDSDG 252
H+H+ VH DLKPENI+ +
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKR 161
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-38
Identities = 80/180 (44%), Positives = 120/180 (66%), Gaps = 6/180 (3%)
Query: 87 QIQELEHE-NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAM 145
Q+ ++HE A L +E+ +G +FE+ +V+G GA+GKVF V+K + D+ +YAM
Sbjct: 1 QLLTVKHELRTANLTGHAEK-VGIENFELLKVLGTGAYGKVFLVRK--ISGHDTGKLYAM 57
Query: 146 KVMRKDTIIKK-NHVDYMKAERDILTKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLF 203
KV++K TI++K ++ + ER +L + PF+V L Y+FQT +KL+LILD+INGG LF
Sbjct: 58 KVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF 117
Query: 204 FHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263
HL ++ F E + + Y EIV A+ HLHK GI++RD+K ENIL+DS+GHV+ S
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 177
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-37
Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 11/149 (7%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I G + + +G G+FG V++ K G A+K++ + + K E
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQ-QLQAFKNEV 55
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
+L K H I+ + T +L ++ + G L+ HL+ + F + +
Sbjct: 56 GVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ +LH I+HRDLK NI + D V
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTV 143
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-37
Identities = 52/146 (35%), Positives = 91/146 (62%), Gaps = 6/146 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
DF + +++G+G+FGKVF + K ++ +A+K ++KD ++ + V+ E+ +L+
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 57
Query: 171 KV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
HPF+ + +FQT+ L+ +++++NGG L +H+ F +A FY AEI+ +
Sbjct: 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 117
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVM 255
LH GIV+RDLK +NIL+D DGH+
Sbjct: 118 FLHSKGIVYRDLKLDNILLDKDGHIK 143
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (328), Expect = 4e-37
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 12/151 (7%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK------A 164
++E ++G+G V + K + YA+K++ + + +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58
Query: 165 ERDILTKV-THPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAE 223
E DIL KV HP I+QL+ +++T + +L+ D + G LF +L + E + R
Sbjct: 59 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
++ + LHK IVHRDLKPENIL+D D ++
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNI 149
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 131 bits (331), Expect = 1e-36
Identities = 39/145 (26%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
++I +G GAFG V + +K + ++ K + + K V K E I+
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYPLDKYTV---KNEISIM 80
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAV 228
++ HP ++ L +F+ + ++ LIL+F++GG LF + + E + Y + +
Sbjct: 81 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGL 140
Query: 229 SHLHKCGIVHRDLKPENILMDSDGH 253
H+H+ IVH D+KPENI+ ++
Sbjct: 141 KHMHEHSIVHLDIKPENIMCETKKA 165
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 1e-36
Identities = 33/160 (20%), Positives = 70/160 (43%), Gaps = 15/160 (9%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ + ++ + +G+G FG V +G A+K ++ D + AE
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATAQA-----FLAEA 51
Query: 167 DILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAE 223
++T++ H +VQL + + LY++ +++ G L +L +G + D ++ +
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263
+ A+ +L VHRDL N+L+ D + +
Sbjct: 112 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 127 bits (321), Expect = 4e-36
Identities = 32/150 (21%), Positives = 67/150 (44%), Gaps = 9/150 (6%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+E+ ++G G +V + A+KV+R D + + E
Sbjct: 7 DRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 170 TKVTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+ HP IV + + + + Y+++++++G L ++ +G +A A+
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
A++ H+ GI+HRD+KP NI++ + V
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVK 151
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-35
Identities = 31/152 (20%), Positives = 60/152 (39%), Gaps = 4/152 (2%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
IG D + +G G+FG V + + A+K ++ D + + +D E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 62
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
+ + + H +++L Y + ++ + G L L QG F Y ++
Sbjct: 63 NAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+ +L +HRDL N+L+ + V
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIG 153
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (320), Expect = 1e-35
Identities = 36/151 (23%), Positives = 63/151 (41%), Gaps = 5/151 (3%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
++I +I +V+G G FG+V K G + A+K ++ + +
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKSGYT--EKQRRDFLS 76
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAE 223
E I+ + HP ++ L + + +I +F+ G L F G F Q
Sbjct: 77 EASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
I + + +L VHRDL NIL++S+
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVC 167
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 3e-35
Identities = 34/150 (22%), Positives = 64/150 (42%), Gaps = 11/150 (7%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ D + +G G +G+V++ K A+K +++DT+ + E
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTMEVEE----FLKEA 64
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
++ ++ HP +VQL Y+I +F+ G+L +L + +I
Sbjct: 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
SA+ +L K +HRDL N L+ + V
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLV 154
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-35
Identities = 36/191 (18%), Positives = 72/191 (37%), Gaps = 26/191 (13%)
Query: 89 QELEHENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVM 148
E + + E E + + + + E +V+G GAFGKV G+ A+K++
Sbjct: 16 NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 75
Query: 149 RKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY 207
++ + + + +E ++T++ H IV L + +YLI ++ G L +L
Sbjct: 76 KEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 208 RQ-----------------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244
+ + + + ++ + L VHRDL
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 193
Query: 245 NILMDSDGHVM 255
N+L+ V
Sbjct: 194 NVLVTHGKVVK 204
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-35
Identities = 31/184 (16%), Positives = 67/184 (36%), Gaps = 21/184 (11%)
Query: 93 HENDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDT 152
+ + +L + + + + +G GAFGKV + G+ D+ A+K+++
Sbjct: 6 YIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 153 IIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYR--- 208
+ + + +E +L+ + H IV L + +I ++ G L L R
Sbjct: 66 HLT--EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 209 ---------------QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+ + ++ ++ ++ L +HRDL NIL+
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI 183
Query: 254 VMAA 257
Sbjct: 184 TKIC 187
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-35
Identities = 32/155 (20%), Positives = 73/155 (47%), Gaps = 17/155 (10%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D+E+ +G G++G+ ++++K I K + ++ + + +E ++L
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSMTEAE-KQMLVSEVNLLR 58
Query: 171 KVTHPFIVQLRYSF--QTRSKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEI 224
++ HP IV+ +T + LY+++++ GG L + + + E+ ++
Sbjct: 59 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118
Query: 225 VSAVSHLHKCG-----IVHRDLKPENILMDSDGHV 254
A+ H+ ++HRDLKP N+ +D +V
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV 153
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 7e-35
Identities = 33/153 (21%), Positives = 67/153 (43%), Gaps = 11/153 (7%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I P D + +G G FG V K +G A+K++++ ++ + E
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSMSEDE----FIEEA 50
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
++ ++H +VQL + +++I +++ G L +L + F+ Q ++
Sbjct: 51 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258
A+ +L +HRDL N L++ G V +
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSD 143
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (315), Expect = 9e-35
Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
++ V+G GAF +V + K + + A+K + K + + M+ E +L
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKAL--EGKEGSMENEIAVLH 62
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
K+ HP IV L +++ LYLI+ ++GG LF + +G + E A +++ AV +
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 231 LHKCGIVHRDLKPENIL---MDSDGHVM 255
LH GIVHRDLKPEN+L +D D +M
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIM 150
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-34
Identities = 30/149 (20%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I P + + +G G FG V + A+K +R+ + +++ E
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMSEED----FIEEA 51
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLF-FHLYRQGIFREDQARFYTAEIV 225
+++ K++HP +VQL ++ + L+ +F+ G L + ++G+F + ++
Sbjct: 52 EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++L + ++HRDL N L+ + +
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVI 140
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-33
Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 10/144 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ I +G+G FG V + + S Y K ++ K +K E IL
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKV----KGTDQVLVKKEISILN 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGI-FREDQARFYTAEIVSAVS 229
H I+ L SF++ +L +I +FI+G +F + E + Y ++ A+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 230 HLHKCGIVHRDLKPENILMDSDGH 253
LH I H D++PENI+ +
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRS 140
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-32
Identities = 35/144 (24%), Positives = 68/144 (47%), Gaps = 7/144 (4%)
Query: 113 EIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA--ERDILT 170
E +G+G F V++ + K +++ I A+K ++ + A E +L
Sbjct: 1 EKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
+++HP I+ L +F +S + L+ DF+ + + Y + + +
Sbjct: 56 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 231 LHKCGIVHRDLKPENILMDSDGHV 254
LH+ I+HRDLKP N+L+D +G +
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVL 139
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-32
Identities = 29/149 (19%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
+ ++ +G G FG+V+ G A+K +++ ++ AE
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGSMSPDA----FLAEA 59
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR--EDQARFYTAEI 224
+++ ++ H +V+L Y+ T+ +Y+I +++ G L L + ++ A+I
Sbjct: 60 NLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH 253
++ + + +HRDL+ NIL+
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLS 147
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 3e-32
Identities = 31/168 (18%), Positives = 67/168 (39%), Gaps = 26/168 (15%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ E R +G+GAFG+VFQ + G+ + + A+K+++++ + + E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG-------------------- 210
+ +P IV+L + L+ +++ G L L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 211 ----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ ++ + +++L + VHRDL N L+ + V
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 5e-32
Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERD 167
++ +G G F V + ++K + YA K ++K + ++ E
Sbjct: 11 YYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 168 ILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
IL ++ HP ++ L ++ ++ + LIL+ + GG LF L + E++A + +I++
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 125
Query: 228 VSHLHKCGIVHRDLKPENILMDSDG 252
V +LH I H DLKPENI++
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRN 150
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-32
Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 21/152 (13%)
Query: 110 GDFEIF-RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
D+++ +V+G G GKV Q+ K + +A+K+++ ++ E ++
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDCPKARR--------EVEL 57
Query: 169 LTKVT-HPFIVQLRYSFQT----RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYT 221
+ + P IV++ ++ R L ++++ ++GG LF + +G F E +A
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
I A+ +LH I HRD+KPEN+L S
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 149
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 6e-32
Identities = 33/149 (22%), Positives = 63/149 (42%), Gaps = 6/149 (4%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I E+ R +G+G FG V +G+ + A+ + + + E
Sbjct: 4 IQRERIELGRCIGEGQFGDVH----QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLY-RQGIFREDQARFYTAEIV 225
+ + HP IV+L T + +++I++ G L L R+ Y ++
Sbjct: 60 LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+A+++L VHRD+ N+L+ S+ V
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCV 147
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-31
Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAER 166
I + +GQG FG+V+ G A+K ++ T+ + E
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMSPEA----FLQEA 63
Query: 167 DILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEI 224
++ K+ H +VQL Y+ + +Y++ ++++ G L L + R Q A+I
Sbjct: 64 QVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
S ++++ + VHRDL+ NIL+ +
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVC 152
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 1e-31
Identities = 35/149 (23%), Positives = 63/149 (42%), Gaps = 11/149 (7%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
D E+ G G FG V Q + A+KV+++ T +K + M E I+
Sbjct: 13 ADIEL----GCGNFGSVRQGVYRMRKKQI---DVAIKVLKQGT--EKADTEEMMREAQIM 63
Query: 170 TKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAV 228
++ +P+IV+L Q L L+++ GG L L + ++ +
Sbjct: 64 HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMAA 257
+L + VHRDL N+L+ + + +
Sbjct: 123 KYLEEKNFVHRDLAARNVLLVNRHYAKIS 151
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 2e-31
Identities = 25/140 (17%), Positives = 60/140 (42%), Gaps = 5/140 (3%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP 175
+ +G G FG V + + A+K+++ + D + AE +++ ++ +P
Sbjct: 13 KELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNP 68
Query: 176 FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG 235
+IV++ L+++ G L +L + ++ ++ + +L +
Sbjct: 69 YIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 236 IVHRDLKPENILMDSDGHVM 255
VHRDL N+L+ + +
Sbjct: 128 FVHRDLAARNVLLVTQHYAK 147
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-31
Identities = 33/150 (22%), Positives = 63/150 (42%), Gaps = 3/150 (2%)
Query: 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKA 164
R + +F+ +V+G GAFG V++ + A+K +R+ T K N +
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKAN--KEILD 60
Query: 165 ERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
E ++ V +P + +L T + + G L + + + +I
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++L +VHRDL N+L+ + HV
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVLVKTPQHV 150
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 3e-31
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK---AER 166
+++ ++G G FG V+ + + A+K + KD I + E
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 167 DILTKVT--HPFIVQLRYSFQTRSKLYLILDFINGGH-LFFHLYRQGIFREDQARFYTAE 223
+L KV+ +++L F+ LIL+ LF + +G +E+ AR + +
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 224 IVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
++ AV H H CG++HRD+K ENIL+D + +
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGEL 150
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 4e-31
Identities = 34/150 (22%), Positives = 67/150 (44%), Gaps = 13/150 (8%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ +G+G+F V++ ++ A ++ + K + K E ++L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKG 64
Query: 172 VTHPFIVQLRYSFQTRSK----LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
+ HP IV+ S+++ K + L+ + + G L +L R + + R + +I+
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 228 VSHLHKCG--IVHRDLKPENILMDS-DGHV 254
+ LH I+HRDLK +NI + G V
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSV 154
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-31
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ +V+G G+FG V+Q K DS + A+K + +D K E I+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRFKNR-------ELQIMR 68
Query: 171 KVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLY---RQGIFREDQARFYT 221
K+ H IV+LRY F + + L L+LD++ + + + Y
Sbjct: 69 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVM 255
++ +++++H GI HRD+KP+N+L+D D V+
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 7e-31
Identities = 34/150 (22%), Positives = 62/150 (41%), Gaps = 4/150 (2%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
+I P +V+G G FG+V++ K G + A+K ++ + E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKT-SSGKKEVPVAIKTLKAG--YTEKQRVDFLGE 59
Query: 166 RDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGG-HLFFHLYRQGIFREDQARFYTAEI 224
I+ + +H I++L + +I +++ G F + G F Q I
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 119
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + +L VHRDL NIL++S+
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVC 149
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 7e-31
Identities = 32/153 (20%), Positives = 67/153 (43%), Gaps = 14/153 (9%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+E +GQG FG+VF+ + + + A+K + + + + ++ E IL
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEKEGFPITALR-EIKIL 63
Query: 170 TKVTHPFIVQLRYSFQTRS--------KLYLILDFINGGHLFFHLYRQGIFREDQARFYT 221
+ H +V L +T++ +YL+ DF F + +
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 222 AEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+++ + ++H+ I+HRD+K N+L+ DG +
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 156
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-30
Identities = 32/170 (18%), Positives = 66/170 (38%), Gaps = 12/170 (7%)
Query: 95 NDAELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII 154
+ A++ E ++ + R +GQG+FG V++ KGV + + A+K + + +
Sbjct: 5 SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64
Query: 155 KKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR- 213
+ E ++ + +V+L +I++ + G L +L
Sbjct: 65 R--ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 214 ---------EDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ EI +++L+ VHRDL N ++ D V
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 2e-30
Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+E +G+G +G VF+ K + ++ I A+K +R D + E +L
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDD-DEGVPSSALREICLLK 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
++ H IV+L + KL L+ +F + + G + + + +++ +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 231 LHKCGIVHRDLKPENILMDSDGH 253
H ++HRDLKP+N+L++ +G
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGE 139
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (282), Expect = 3e-30
Identities = 29/145 (20%), Positives = 68/145 (46%), Gaps = 7/145 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+ +G+G +G V++ + +A+K +R + + E IL
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILK 55
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSH 230
++ H IV+L T+ +L L+ + ++ +G A+ + ++++ +++
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 231 LHKCGIVHRDLKPENILMDSDGHVM 255
H ++HRDLKP+N+L++ +G +
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELK 140
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 4e-30
Identities = 34/166 (20%), Positives = 63/166 (37%), Gaps = 22/166 (13%)
Query: 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE 165
+ D + V+G+G FG+V + + K + R K+ E
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIK-----KDGLRMDAAIKRMKEYASKDDHRDFAGE 60
Query: 166 RDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQ--------------- 209
++L K+ HP I+ L + + R LYL +++ G+L L +
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 210 -GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
Q + A++ + +L + +HRDL NIL+ +
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 5e-30
Identities = 31/175 (17%), Positives = 71/175 (40%), Gaps = 21/175 (12%)
Query: 98 ELEAESERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDG--IYAMKVMRKDTIIK 155
EL + ++ + + +G+GAFG+V + G+D + A+K+++ D
Sbjct: 1 ELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-- 58
Query: 156 KNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQG---- 210
+ + + +E +++ + H I+ L + LY+I+++ + G+L +L +
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 211 ------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
++ + +L +HRDL N+L+ D
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV 173
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 7e-30
Identities = 37/148 (25%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
+F+ +G+G +G V++ + K + + A+K +R DT + ++ E +L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIR-EISLLK 56
Query: 171 KVTHPFIVQLRYSFQTRSKLYLILDFIN-GGHLFFHLYRQGIFREDQARFYTAEIVSAVS 229
++ HP IV+L T +KLYL+ +F++ F + Y +++ ++
Sbjct: 57 ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 230 HLHKCGIVHRDLKPENILMDSDGHVMAA 257
H ++HRDLKP+N+L++++G + A
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLA 144
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 5e-29
Identities = 32/169 (18%), Positives = 66/169 (39%), Gaps = 18/169 (10%)
Query: 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYM 162
S+ + ++ + +G+GAFG+V + G+D + A+K++++ H M
Sbjct: 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALM 64
Query: 163 KAERDILTKVTHPFIVQLR-YSFQTRSKLYLILDFINGGHLFFHLYRQG----------- 210
+ ++ H +V L + L +I++F G+L +L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 211 -----IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ Y+ ++ + L +HRDL NIL+ V
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 173
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (273), Expect = 7e-29
Identities = 25/156 (16%), Positives = 56/156 (35%), Gaps = 12/156 (7%)
Query: 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK 163
E ++G + + R +G G+FG ++ + A+K+ K +
Sbjct: 2 ELRVG-NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECV-----KTKHPQLH 50
Query: 164 AERDILTKVTHP-FIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
E I + I +R+ ++++ + + F
Sbjct: 51 IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD 110
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAH 258
+++S + ++H +HRD+KP+N LM +
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVY 146
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 9e-29
Identities = 38/174 (21%), Positives = 70/174 (40%), Gaps = 12/174 (6%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMK--AERDI 168
+E +G+GA+GKVF K D + A+K +R T + + ++ A
Sbjct: 8 QYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 169 LTKVTHPFIVQLRYSFQT-----RSKLYLILDFINGGHL-FFHLYRQGIFREDQARFYTA 222
L HP +V+L +KL L+ + ++ + + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCCFFFFLFLG 276
+++ + LH +VHRDLKP+NIL+ S G + A + +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 177
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-28
Identities = 26/146 (17%), Positives = 57/146 (39%), Gaps = 10/146 (6%)
Query: 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK 171
+ +G+GA+G V + A+K + + + E IL +
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLR 62
Query: 172 VTHPFIVQLRYSFQTRS---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
H I+ + + + + L G + L + D ++ +I+ +
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 122
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHV 254
++H ++HRDLKP N+L+++ +
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDL 148
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-28
Identities = 34/149 (22%), Positives = 59/149 (39%), Gaps = 10/149 (6%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
+ + VG GA+G V DG + A+K + + + E +
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAV-----DGRTGAKVAIKKLYRP-FQSELFAKRAYRELRL 70
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFI----NGGHLFFHLYRQGIFREDQARFYTAEI 224
L + H ++ L F L DF G L + ED+ +F ++
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+ + ++H GI+HRDLKP N+ ++ D
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCE 159
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 3e-27
Identities = 34/147 (23%), Positives = 63/147 (42%), Gaps = 17/147 (11%)
Query: 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT 170
D+++ R +G+G + +VF+ ++ +K I+K +K E IL
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVK------ILKPVKKKKIKREIKILE 84
Query: 171 KV-THPFIVQLRYSFQTRSK--LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSA 227
+ P I+ L + L+ + +N + RFY EI+ A
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 141
Query: 228 VSHLHKCGIVHRDLKPENILMDSDGHV 254
+ + H GI+HRD+KP N+++D +
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRK 168
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 3e-27
Identities = 31/149 (20%), Positives = 57/149 (38%), Gaps = 10/149 (6%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
P ++ VG GA+G V + A+K + + H E +
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 70
Query: 169 LTKVTHPFIVQLRYSFQTRSKL----YLILDFINGGHLFFHLYRQGIFREDQARFYTAEI 224
L + H ++ L F L + L G ++ + +D +F +I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 225 VSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+ + ++H I+HRDLKP N+ ++ D
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCE 159
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 102 bits (254), Expect = 3e-26
Identities = 26/162 (16%), Positives = 60/162 (37%), Gaps = 11/162 (6%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+++ R +G+G+FG +F+ ++ A+K + + + ++ E
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSDAPQ-----LRDEYRTY 54
Query: 170 TKVTH-PFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAV 228
+ I + Y Q L++D + F ++++ V
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 229 SHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCCFF 270
+H+ +V+RD+KP+N L+ A + F+
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 4e-26
Identities = 35/169 (20%), Positives = 63/169 (37%), Gaps = 8/169 (4%)
Query: 90 ELEHENDAELEAESERKIGPGDFEIF--RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKV 147
+L N ++A IGP + V+G+G FG V+ +D+ A+K
Sbjct: 5 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVY--HGTLLDNDGKKIHCAVKS 62
Query: 148 MRKDTIIKKNHVDYMKAERDILTKVTHPFIVQL-RYSFQTRSKLYLILDFINGGHLF-FH 205
+ + T V E I+ +HP ++ L ++ ++L ++ G L F
Sbjct: 63 LNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 206 LYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHV 254
+ ++ + L VHRDL N ++D V
Sbjct: 121 RNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 169
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-26
Identities = 38/157 (24%), Positives = 67/157 (42%), Gaps = 24/157 (15%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDIL 169
+ +G+G FG+V++ K +G A+K+ ++ + +AE
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGE-------EVAVKIFSS----REERSWFREAEIYQT 51
Query: 170 TKVTHPFIVQLRYSFQ----TRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIV 225
+ H I+ + T ++L+L+ D+ G LF +L R + E +
Sbjct: 52 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTA 110
Query: 226 SAVSHLH--------KCGIVHRDLKPENILMDSDGHV 254
S ++HLH K I HRDLK +NIL+ +G
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 5e-26
Identities = 32/151 (21%), Positives = 60/151 (39%), Gaps = 15/151 (9%)
Query: 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI 168
++ + +G GA G V D A+K + + + H E +
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRP-FQNQTHAKRAYRELVL 69
Query: 169 LTKVTHPFIVQLRYSFQTRSK------LYLILDFINGGHLFFHLYRQGIFREDQARFYTA 222
+ V H I+ L F + +YL+++ ++ ++ +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLY 126
Query: 223 EIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253
+++ + HLH GI+HRDLKP NI++ SD
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 157
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 88.9 bits (219), Expect = 6e-21
Identities = 29/157 (18%), Positives = 62/157 (39%), Gaps = 18/157 (11%)
Query: 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDI- 168
+ + R +G G F V+ K ++ AMK++R D + + D +K + +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 169 ------LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGH-----LFFHLYRQGIFREDQA 217
+ I++L F + + + + Y
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 218 RFYTAEIVSAVSHLH-KCGIVHRDLKPENILMDSDGH 253
+ + +++ + ++H +CGI+H D+KPEN+LM+
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.2 bits (158), Expect = 2e-13
Identities = 21/151 (13%), Positives = 44/151 (29%), Gaps = 22/151 (14%)
Query: 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDY-------MKAERDI 168
+++G+G VF + G +K + K +
Sbjct: 6 KLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59
Query: 169 LTKVTHPFIVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFR---EDQARFYTAEIV 225
+ + +L+ + + G + L + I+
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMIL 113
Query: 226 SAVSHLHKCGIVHRDLKPENILMDSDGHVMA 256
V+ + GIVH DL N+L+ +G +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSEEGIWII 144
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 282 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.01 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=309.96 Aligned_cols=170 Identities=30% Similarity=0.451 Sum_probs=154.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++++.||+|+||+||+|+++ .+++.||+|++.+.........+.+.+|+.+|+.++|||||++++++.+
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 77 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD 77 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cchhHeEEEEEEecCCCcEEEEEEEC-----CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE
Confidence 34578999999999999999999987 4567899999987765555666778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
++.+|+|||||++|+|.+++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|....
T Consensus 78 ~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 78 ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred CCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999996432
Q ss_pred cc-----hhheeeccCcccc
Q 023430 267 CC-----FFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~~-----~~~~~~~ape~~~ 281 (282)
.. .||+.|||||++.
T Consensus 158 ~~~~~~~~Gt~~Y~APE~~~ 177 (263)
T d2j4za1 158 SSRRTTLCGTLDYLPPEMIE 177 (263)
T ss_dssp CCCCEETTEEGGGCCHHHHT
T ss_pred CCcccccCCCCcccCHHHHc
Confidence 22 6899999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=309.14 Aligned_cols=170 Identities=36% Similarity=0.627 Sum_probs=153.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
..+++|++++.||+|+||+||+|+++ .+++.||||++.+.........+.+.+|+++|+.++||||+++++++.+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 34578999999999999999999987 4567899999987765556667789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
++.+|+|||||+||+|.+++...+.+++.+++.++.|++.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999996321
Q ss_pred ---------cchhheeeccCcccc
Q 023430 267 ---------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ---------~~~~~~~~~ape~~~ 281 (282)
...||+.|||||+++
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~ 183 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLT 183 (288)
T ss_dssp ----------CCCCGGGCCHHHHH
T ss_pred cCCcccccccccCCccccCceeec
Confidence 115899999999873
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-45 Score=308.33 Aligned_cols=165 Identities=22% Similarity=0.329 Sum_probs=145.2
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|+++++||+|+||+||+|+++ .+++.||||++..... ....+.+.+|+.+|++++|||||++++++.+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 468999999999999999999987 4567899999976532 223456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.+|||||||++|+|.+++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 999999999999999999877889999999999999999999999999999999999999999999999999996321
Q ss_pred -------cchhheeeccCccc
Q 023430 267 -------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -------~~~~~~~~~ape~~ 280 (282)
...||+.|||||++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~ 177 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELL 177 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHH
T ss_pred CccccccceeeCcCccCHhHh
Confidence 11589999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=311.92 Aligned_cols=170 Identities=39% Similarity=0.705 Sum_probs=155.3
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|++++.||+|+||.||+|+++ .+++.||||++.+.........+.+.+|+.+|+.++||||++++++|.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 45678999999999999999999987 4678899999988766566667788899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
.+.+|+|||||+||+|..++.+.+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred ccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999997432
Q ss_pred c-------chhheeeccCcccc
Q 023430 267 C-------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~-------~~~~~~~~ape~~~ 281 (282)
. ..||+.|||||++.
T Consensus 157 ~~~~~~~~~~GT~~Y~aPE~~~ 178 (337)
T d1o6la_ 157 SDGATMKTFCGTPEYLAPEVLE 178 (337)
T ss_dssp CTTCCBCCCEECGGGCCGGGGS
T ss_pred cCCcccccceeCHHHhhhhhcc
Confidence 2 16799999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.4e-44 Score=307.19 Aligned_cols=165 Identities=20% Similarity=0.270 Sum_probs=150.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKL 190 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 190 (282)
.|++++.||+|+||+||+|+++ .++..||||++...........+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEEC-----CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence 4999999999999999999987 45778999999876655556667789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc---
Q 023430 191 YLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC--- 267 (282)
Q Consensus 191 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~--- 267 (282)
|+|||||.+|+|..++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|.....
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 99999999999987777778899999999999999999999999999999999999999999999999999974332
Q ss_pred chhheeeccCccc
Q 023430 268 CFFFFLFLGGGVF 280 (282)
Q Consensus 268 ~~~~~~~~ape~~ 280 (282)
..||+.|||||++
T Consensus 171 ~~GT~~Y~APE~~ 183 (309)
T d1u5ra_ 171 FVGTPYWMAPEVI 183 (309)
T ss_dssp CCSCGGGCCHHHH
T ss_pred cccCccccCHHHH
Confidence 2789999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-43 Score=305.33 Aligned_cols=168 Identities=35% Similarity=0.601 Sum_probs=153.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||+||+|+++ .+++.||||++++.........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEEC-----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 468999999999999999999987 457789999998776555666778999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.+|+|||||+||+|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+....
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999999999999888899999999999999999999999999999999999999999999999999964222
Q ss_pred ---chhheeeccCcccc
Q 023430 268 ---CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ---~~~~~~~~ape~~~ 281 (282)
..||+.|||||++.
T Consensus 158 ~~~~~Gt~~Y~APE~l~ 174 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVS 174 (316)
T ss_dssp BCCCCSCTTTCCHHHHT
T ss_pred cccccCcccccCHHHHc
Confidence 26899999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=309.62 Aligned_cols=167 Identities=23% Similarity=0.338 Sum_probs=149.5
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+..++|+++++||+|+||+||+|+++ .++..||+|+++... .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEET-----TTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred CCccCCEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34578999999999999999999987 467889999997653 23445678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
.+.+|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +|||||||||+|||++.+|.+||+|||+|...
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 99999999999999999999988889999999999999999999997 59999999999999999999999999999732
Q ss_pred cc-----chhheeeccCccc
Q 023430 266 LC-----CFFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~-----~~~~~~~~ape~~ 280 (282)
.. -.||+.|||||++
T Consensus 156 ~~~~~~~~~GT~~Y~APEvl 175 (322)
T d1s9ja_ 156 IDSMANSFVGTRSYMSPERL 175 (322)
T ss_dssp HHHTC---CCSSCCCCHHHH
T ss_pred CCCccccccCCccccCchHH
Confidence 21 2689999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=300.99 Aligned_cols=164 Identities=21% Similarity=0.307 Sum_probs=145.6
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||+||+|+++ .+++.||||++..... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 90 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBT-----TTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccccEEEEEEecCcCcEEEEEEEC-----CCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence 357999999999999999999976 4577899999976542 23466889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
.+|||||||+||+|..++.+ +.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 99999999999999987765 569999999999999999999999999999999999999999999999999996321
Q ss_pred -----cchhheeeccCcccc
Q 023430 267 -----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -----~~~~~~~~~ape~~~ 281 (282)
...||+.|||||++.
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~ 189 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVT 189 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHS
T ss_pred cccccccccCCCccChhhhc
Confidence 125899999999874
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-43 Score=306.08 Aligned_cols=170 Identities=34% Similarity=0.599 Sum_probs=154.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
...++|++++.||+|+||.||+|+++ .+++.||||++.+.........+.+.+|+.+|+.++|||||++++++..
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~-----~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHK-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccCeEEEEEeecCcCcEEEEEEEC-----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 34578999999999999999999987 4577899999987765555667778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
...+++||||+.+|+|..++.+.+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999996422
Q ss_pred ----cchhheeeccCcccc
Q 023430 267 ----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ----~~~~~~~~~ape~~~ 281 (282)
...||+.|||||++.
T Consensus 193 ~~~~~~~Gt~~Y~APE~~~ 211 (350)
T d1rdqe_ 193 GRTWTLCGTPEALAPEIIL 211 (350)
T ss_dssp SCBCCCEECGGGCCHHHHT
T ss_pred cccccccCccccCCHHHHc
Confidence 226899999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=300.39 Aligned_cols=163 Identities=28% Similarity=0.431 Sum_probs=145.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
+.|++++.||+|+||.||+|+++ .++..||||++.... ....+.+.+|+++|+.++|||||++++++.+.+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC-----CCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 46999999999999999999987 456789999997643 2334567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
+|+|||||++|+|.+++.+ .+.+++.+++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999999999998765 4569999999999999999999999999999999999999999999999999996322
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...||+.|||||++
T Consensus 164 ~~~~~~~~Gt~~y~APE~l 182 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVV 182 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHH
T ss_pred cccccccccccccCCHHHH
Confidence 22679999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=290.81 Aligned_cols=164 Identities=21% Similarity=0.324 Sum_probs=143.1
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe----C
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT----R 187 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~ 187 (282)
|++.++||+|+||+||+|+++ .++..||+|++..... .....+.+.+|+++|++++|||||++++++.. .
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~-----~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEeeeEEecCcCcEEEEEEEC-----CCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 467788999999999999987 3567899999876543 33456678999999999999999999999875 3
Q ss_pred CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CEeeccCCCceEEc-CCCcEEEEecCcccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCG--IVHRDLKPENILMD-SDGHVMAAHSLNSHN 264 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~NILl~-~~~~v~l~Dfg~s~~ 264 (282)
..+|+|||||++|+|.+++.+.+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred CEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 468999999999999999998888999999999999999999999998 99999999999996 578999999999964
Q ss_pred cccc-----hhheeeccCcccc
Q 023430 265 QLCC-----FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~~-----~~~~~~~ape~~~ 281 (282)
...+ .||+.|||||.++
T Consensus 165 ~~~~~~~~~~GT~~Y~aPE~~~ 186 (270)
T d1t4ha_ 165 KRASFAKAVIGTPEFMAPEMYE 186 (270)
T ss_dssp CCTTSBEESCSSCCCCCGGGGG
T ss_pred ccCCccCCcccCccccCHHHhC
Confidence 2222 6899999999874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.1e-43 Score=297.52 Aligned_cols=167 Identities=23% Similarity=0.274 Sum_probs=147.5
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
|++..++|++.+.||+|+||+||+|+++ .++..||||+++.+. ...+.+.+|+.+|+.++|||||++++++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEG-----GGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEEC-----CCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 5566779999999999999999999987 356789999987643 2345688999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+.+.+|+|||||++|+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence 9999999999999999999998764 45899999999999999999999999999999999999999999999999999
Q ss_pred cccccc--------hhheeeccCccc
Q 023430 263 HNQLCC--------FFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~~--------~~~~~~~ape~~ 280 (282)
+....+ .|++.|||||++
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~ 188 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESL 188 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHH
T ss_pred eecCCCCceeeccccccccccChHHH
Confidence 642211 457889999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-42 Score=298.71 Aligned_cols=165 Identities=30% Similarity=0.471 Sum_probs=135.0
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
+.|++.++||+|+||+||+|+++ .+++.||||++.+.... ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 81 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH 81 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEET-----TTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 56999999999999999999987 45678999999865432 223557889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc---CCCcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD---SDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~---~~~~v~l~Dfg~s~~~~ 266 (282)
+|||||||+||+|.+++...+.+++.++..++.||+.||.|||++|||||||||+|||+. .++.+||+|||+|+...
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred EEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999999999999888899999999999999999999999999999999999995 57899999999996322
Q ss_pred c------chhheeeccCcccc
Q 023430 267 C------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~------~~~~~~~~ape~~~ 281 (282)
. ..||+.|||||++.
T Consensus 162 ~~~~~~~~~GT~~y~APE~~~ 182 (307)
T d1a06a_ 162 PGSVLSTACGTPGYVAPEVLA 182 (307)
T ss_dssp -----------CTTSCHHHHT
T ss_pred CCCeeeeeeeCccccCcHHHc
Confidence 1 16899999999873
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=293.77 Aligned_cols=166 Identities=19% Similarity=0.381 Sum_probs=137.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--C
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--R 187 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~ 187 (282)
++|++++.||+|+||+||+|+++ .+++.||||++..... .+...+.+.+|+++|+.++|||||++++++.+ .
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred hhCEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 57999999999999999999987 4567899999977653 34456778899999999999999999999864 4
Q ss_pred CEEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----CEeeccCCCceEEcCCCcEEEEe
Q 023430 188 SKLYLILDFINGGHLFFHLYR----QGIFREDQARFYTAEIVSAVSHLHKCG-----IVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~gL~ylH~~~-----iiHrDlKp~NILl~~~~~v~l~D 258 (282)
+.+|||||||++|+|.+++.+ .+.+++..++.++.|++.||.|||+++ ||||||||+|||++.+|.+||+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 568999999999999998864 356999999999999999999999876 99999999999999999999999
Q ss_pred cCcccccc-------cchhheeeccCcccc
Q 023430 259 SLNSHNQL-------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 259 fg~s~~~~-------~~~~~~~~~ape~~~ 281 (282)
||+|+... ...||+.|||||+++
T Consensus 158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~ 187 (269)
T d2java1 158 FGLARILNHDTSFAKAFVGTPYYMSPEQMN 187 (269)
T ss_dssp HHHHHHC-----------CCCSCCCHHHHT
T ss_pred ccceeecccCCCccccCCCCcccCCHHHHc
Confidence 99996321 126799999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.1e-42 Score=301.64 Aligned_cols=169 Identities=36% Similarity=0.623 Sum_probs=147.1
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHH---HHHHHhcCCCCeeeeeEEE
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAE---RDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~ 184 (282)
..++|+++++||+|+||.||+|+++ .+++.||||++.+...........+.+| +.+++.++|||||++++++
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~-----~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 3578999999999999999999987 4577899999987654433333334444 6677778899999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+.+.+|+|||||+||+|..++.+...+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999963
Q ss_pred cc-----cchhheeeccCcccc
Q 023430 265 QL-----CCFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~-----~~~~~~~~~ape~~~ 281 (282)
.. ...||+.|||||++.
T Consensus 157 ~~~~~~~~~~GT~~y~APE~~~ 178 (364)
T d1omwa3 157 FSKKKPHASVGTHGYMAPEVLQ 178 (364)
T ss_dssp CSSSCCCSCCSCGGGCCHHHHS
T ss_pred cCCCcccccccccccchhHHhh
Confidence 22 226899999999873
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=293.47 Aligned_cols=167 Identities=22% Similarity=0.272 Sum_probs=144.5
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
|++..++|++.++||+|+||+||+|+++ ..||||+++.... .....+.+.+|+.+|++++|||||++++++
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 5677889999999999999999999854 2499999976543 345567899999999999999999999986
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
. .+.+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+
T Consensus 74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp C-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred e-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence 5 45689999999999999999764 559999999999999999999999999999999999999999999999999995
Q ss_pred cccc---------chhheeeccCcccc
Q 023430 264 NQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~---------~~~~~~~~ape~~~ 281 (282)
.... ..||+.|||||+|.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~ 179 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIR 179 (276)
T ss_dssp C------------CCCCGGGCCHHHHT
T ss_pred eccccCCcccccccccCcccCCHHHHh
Confidence 3211 15799999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=291.70 Aligned_cols=167 Identities=25% Similarity=0.378 Sum_probs=147.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh---hhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK---KNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+.|++++.||+|+||+||+|+++ .+++.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCEEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 47999999999999999999987 457789999997654322 2235678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC----cEEEEecCcc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG----HVMAAHSLNS 262 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~----~v~l~Dfg~s 262 (282)
.+.+|||||||++|+|.+++...+.+++..++.++.|++.||.|||+++||||||||+|||++.++ .+|++|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999999998888899999999999999999999999999999999999998876 4999999998
Q ss_pred cccc------cchhheeeccCcccc
Q 023430 263 HNQL------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 263 ~~~~------~~~~~~~~~ape~~~ 281 (282)
.... ...|++.|||||+++
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~ 189 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVN 189 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHT
T ss_pred hhcCCCccccccCCCCcccCHHHHc
Confidence 5321 226799999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=296.62 Aligned_cols=175 Identities=19% Similarity=0.294 Sum_probs=147.4
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
.|.+..++|++.++||+|+||+||+|++++.........||+|++.... .....+.+.+|+.+|+++ +|||||++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4567778999999999999999999998876544455679999886543 223345688899999998 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEee
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQG-----------------------IFREDQARFYTAEIVSAVSHLHKCGIVHR 239 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHr 239 (282)
++.+.+.+|+|||||++|+|.+++.... .+++..++.++.|++.||.|||+++||||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997542 47889999999999999999999999999
Q ss_pred ccCCCceEEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 240 DLKPENILMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 240 DlKp~NILl~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
||||+|||++.++.+||+|||+|+..... .||+.|||||++
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l 238 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence 99999999999999999999999642221 458899999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=292.48 Aligned_cols=167 Identities=32% Similarity=0.619 Sum_probs=148.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH-hcCCCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILT-KVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~ 188 (282)
++|+++++||+|+||+||+|+++ .+++.||||++++.........+.+..|+.++. .++|||||++++++.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-----~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-----CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 68999999999999999999987 467889999998766545555566666777665 689999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc-
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC- 267 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~- 267 (282)
.+|||||||++|+|.+++.....+++.+++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+++....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999963221
Q ss_pred ------chhheeeccCcccc
Q 023430 268 ------CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ------~~~~~~~~ape~~~ 281 (282)
..||+.|||||++.
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~ 176 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILL 176 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHT
T ss_pred cccccccCCCCCcCCHHHHc
Confidence 26799999999873
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-41 Score=297.23 Aligned_cols=165 Identities=24% Similarity=0.395 Sum_probs=145.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||.||+|+++ .++..||||++..... ...+.+.+|+.+|+.++|||||++++++.+++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~-----~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 358999999999999999999987 4678899999976532 33466889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC--CCcEEEEecCccccc
Q 023430 189 KLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS--DGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~--~~~v~l~Dfg~s~~~ 265 (282)
.+|||||||+||+|.+++.+ .+.+++.+++.++.||+.||.|||++|||||||||+|||++. +|.+||+|||+|+..
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 99999999999999998854 456999999999999999999999999999999999999964 588999999999632
Q ss_pred c------cchhheeeccCcccc
Q 023430 266 L------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~------~~~~~~~~~ape~~~ 281 (282)
- ...||+.|||||++.
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~ 198 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAE 198 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHH
T ss_pred ccccccceecCcccccCHHHHc
Confidence 1 136799999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-41 Score=297.37 Aligned_cols=164 Identities=24% Similarity=0.396 Sum_probs=144.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|++++.||+|+||.||+|+++ .+++.||||++..... ...+.+.+|+.+|+.++|||||+++++|.+++.
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 100 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 100 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred cceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 57999999999999999999987 4577899999876542 223567889999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEc--CCCcEEEEecCcccccc
Q 023430 190 LYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMD--SDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~--~~~~v~l~Dfg~s~~~~ 266 (282)
+|||||||+||+|.+++...+ .+++.+++.++.||+.||.|||++|||||||||+||||+ .++.+||+|||+|....
T Consensus 101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence 999999999999988876544 599999999999999999999999999999999999998 57899999999996422
Q ss_pred c------chhheeeccCcccc
Q 023430 267 C------CFFFFLFLGGGVFN 281 (282)
Q Consensus 267 ~------~~~~~~~~ape~~~ 281 (282)
. ..|++.|||||++.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~ 201 (352)
T d1koba_ 181 PDEIVKVTTATAEFAAPEIVD 201 (352)
T ss_dssp TTSCEEEECSSGGGCCHHHHT
T ss_pred CCCceeeccCcccccCHHHHc
Confidence 1 26799999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-41 Score=291.90 Aligned_cols=173 Identities=21% Similarity=0.228 Sum_probs=141.8
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
..+..++|++.++||+|+||+||+|+++.++ .....||||.+.... .....+.+.+|+.+|++++|||||++++++
T Consensus 21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~ 96 (299)
T d1jpaa_ 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPG--KREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVV 96 (299)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhChhhcEEeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 3466778999999999999999999987432 234568999886543 234456789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...+.+|+|||||++|+|.+++... +.+++.+++.++.||+.||.|||+++||||||||+||||+.++.+||+|||+|+
T Consensus 97 ~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 97 TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred eeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccce
Confidence 9999999999999999999988764 468999999999999999999999999999999999999999999999999996
Q ss_pred cccc------------chhheeeccCcccc
Q 023430 264 NQLC------------CFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~------------~~~~~~~~ape~~~ 281 (282)
.... ..|++.|||||.+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 206 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 206 (299)
T ss_dssp -------------------CGGGSCHHHHH
T ss_pred EccCCCCcceeeecccccCCccccCHHHHh
Confidence 3211 13578899999863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=286.92 Aligned_cols=165 Identities=22% Similarity=0.340 Sum_probs=139.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+.+++|++++.||+|+||.||+|+++ ++..||||+++.... ..+.+.+|+.++++++|||||++++++..
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET------TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC------CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceecc
Confidence 35678999999999999999999876 345799999976432 23458899999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
++.+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 99999999999999999988765 45889999999999999999999999999999999999999999999999999632
Q ss_pred c--------cchhheeeccCcccc
Q 023430 266 L--------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~--------~~~~~~~~~ape~~~ 281 (282)
. ...|++.|||||++.
T Consensus 152 ~~~~~~~~~~~~gt~~y~aPE~l~ 175 (263)
T d1sm2a_ 152 LDDQYTSSTGTKFPVKWASPEVFS 175 (263)
T ss_dssp -------------CTTSCCHHHHT
T ss_pred cCCCceeecceecCcccCChHHhc
Confidence 2 125688999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.6e-41 Score=284.50 Aligned_cols=167 Identities=28% Similarity=0.366 Sum_probs=148.3
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh------hhHHHHHHHHHHHHHhcC-CCCeeeee
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK------KNHVDYMKAERDILTKVT-HPFIVQLR 181 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~nIv~l~ 181 (282)
.++|++.+.||+|+||+||+|+++ .+++.||||++.+..... +...+.+.+|+.+|++++ ||||++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~-----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEEC-----CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 368999999999999999999976 467889999997654221 223456788999999997 99999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+++.+++.+|||||||++|+|.+++..++.+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999999999999888999999999999999999999999999999999999999999999999999
Q ss_pred ccccc------cchhheeeccCccc
Q 023430 262 SHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~------~~~~~~~~~ape~~ 280 (282)
+.... ...||+.|+|||.+
T Consensus 157 a~~~~~~~~~~~~~gt~~y~~PE~~ 181 (277)
T d1phka_ 157 SCQLDPGEKLREVCGTPSYLAPEII 181 (277)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHH
T ss_pred eeEccCCCceeeeeccCCCCCHHHh
Confidence 96321 12679999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-41 Score=285.49 Aligned_cols=168 Identities=20% Similarity=0.258 Sum_probs=146.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++.+.||+|+||+||+|+++ .+++.||||++++....+....+.+.+|+.+|+.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 357999999999999999999987 467889999998776555666778999999999999999999999987654
Q ss_pred ----EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 189 ----KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 189 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+|||||||+|++|..++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.++.++++|||.+..
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred CCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhh
Confidence 4899999999999999998888999999999999999999999999999999999999999999999999998753
Q ss_pred cccc----------hhheeeccCcccc
Q 023430 265 QLCC----------FFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~~----------~~~~~~~ape~~~ 281 (282)
.... .||+.|||||++.
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~ 187 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQAR 187 (277)
T ss_dssp CC----------------TTCCHHHHT
T ss_pred hccccccccccccccCcccccCHHHHc
Confidence 2111 5799999999873
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-41 Score=284.50 Aligned_cols=173 Identities=20% Similarity=0.218 Sum_probs=144.2
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
++.++.|++.++||+|+||.||+|.++.... .....||||++.... .......+.+|+.+|+.++|||||++++++.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG-KKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 79 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCC-EEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence 4567789999999999999999999875432 234579999986543 2334456889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
..+.+++|||||.++++.+++... ..+++.++..++.|++.||.|||+++||||||||+||||+.++.+||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 999999999999999998877654 5699999999999999999999999999999999999999999999999999963
Q ss_pred ccc----------chhheeeccCcccc
Q 023430 265 QLC----------CFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~----------~~~~~~~~ape~~~ 281 (282)
... ..||+.|||||.++
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~ 186 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAIS 186 (283)
T ss_dssp --------------CCCGGGSCHHHHH
T ss_pred ccCCCccceEeccCCCCccccCHHHHc
Confidence 211 13588999999873
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=283.88 Aligned_cols=161 Identities=17% Similarity=0.215 Sum_probs=137.1
Q ss_pred eeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Q 023430 116 RVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLYLILD 195 (282)
Q Consensus 116 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 195 (282)
++||+|+||.||+|.++.. ..++.||||+++... ......+.+.+|+.+|++++|||||++++++.. +..+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK---KVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECS---SSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccC---CcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence 4699999999999987632 356789999997654 234455678999999999999999999999865 45789999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc---------
Q 023430 196 FINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL--------- 266 (282)
Q Consensus 196 ~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~--------- 266 (282)
||++|+|.+++.....+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 88 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 88 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred cCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999996321
Q ss_pred -cchhheeeccCcccc
Q 023430 267 -CCFFFFLFLGGGVFN 281 (282)
Q Consensus 267 -~~~~~~~~~ape~~~ 281 (282)
...|++.|||||.+.
T Consensus 168 ~~~~gt~~y~APE~l~ 183 (277)
T d1xbba_ 168 THGKWPVKWYAPECIN 183 (277)
T ss_dssp ---CCCGGGCCHHHHH
T ss_pred cccCCCceecCchhhc
Confidence 114688999999873
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-41 Score=285.85 Aligned_cols=168 Identities=18% Similarity=0.271 Sum_probs=143.0
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeE
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRY 182 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 182 (282)
..|.+..++|++.+.||+|+||.||+|+++ .+..||||+++.... ..+.+.+|+.+|++++|||||++++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g 75 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYA 75 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEe
Confidence 345677789999999999999999999975 346799999975432 2356889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 183 SFQTRSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 183 ~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
++.. +.+|+|||||++|+|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+||||+.++.+||+|||
T Consensus 76 ~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFG 154 (272)
T d1qpca_ 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFG 154 (272)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeecccc
Confidence 8754 5689999999999998876433 358999999999999999999999999999999999999999999999999
Q ss_pred cccccc--------cchhheeeccCcccc
Q 023430 261 NSHNQL--------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~~--------~~~~~~~~~ape~~~ 281 (282)
+|+... ...|++.|||||.+.
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~ 183 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAIN 183 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHH
T ss_pred ceEEccCCccccccccCCcccccChHHHh
Confidence 996321 125688999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=286.10 Aligned_cols=164 Identities=23% Similarity=0.337 Sum_probs=144.5
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||+||+|.++ .+++.||||+++.... ....+.+|+.+|+.++|||||+++++|.+.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-----~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 74 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESME 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETT
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 468999999999999999999987 4577899999976532 2345788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCC--CcEEEEecCccccc
Q 023430 189 KLYLILDFINGGHLFFHLYRQG-IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSD--GHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~--~~v~l~Dfg~s~~~ 265 (282)
.+|||||||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++...
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999999999997654 69999999999999999999999999999999999999854 58999999999643
Q ss_pred ccc------hhheeeccCcccc
Q 023430 266 LCC------FFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~~~------~~~~~~~ape~~~ 281 (282)
... .+++.|||||.+.
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~ 176 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQ 176 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHT
T ss_pred ccCCcccccccccccccchhcc
Confidence 222 6799999999863
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=282.84 Aligned_cols=169 Identities=21% Similarity=0.256 Sum_probs=141.8
Q ss_pred cCCCCeEEEee-eCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEE
Q 023430 107 IGPGDFEIFRV-VGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQ 185 (282)
Q Consensus 107 ~~~~~y~~~~~-lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 185 (282)
+..++|.+.+. ||+|+||.||+|.++.. ..+..||||+++... .....+.+.+|+.+|++++|||||++++++.
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecC---CCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 34467888885 99999999999987643 234579999997543 3445667899999999999999999999986
Q ss_pred eCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 186 TRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
. +.+|||||||++|+|.+++... +.+++.++..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred c-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 5 4689999999999999987653 5699999999999999999999999999999999999999999999999999963
Q ss_pred cc----------cchhheeeccCcccc
Q 023430 265 QL----------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~----------~~~~~~~~~ape~~~ 281 (282)
.. ...|++.|||||++.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECIN 185 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred ccccccccccccccccCccccChHHHh
Confidence 21 114688999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=282.42 Aligned_cols=175 Identities=18% Similarity=0.278 Sum_probs=139.1
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRY 182 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~ 182 (282)
.|.+..++|++.++||+|+||.||+|+++......+++.||||+++.... ....+.+.+|..++.++ +|+||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 45566789999999999999999999998776666778899999875432 23345566777777776 5899999998
Q ss_pred EEEeC-CEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCc
Q 023430 183 SFQTR-SKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPEN 245 (282)
Q Consensus 183 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 245 (282)
++... ..+++|||||++|+|.+++... ..+++.+++.++.||+.||.|||+++||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 87654 4689999999999999998653 247899999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCcccccc---------cchhheeeccCccc
Q 023430 246 ILMDSDGHVMAAHSLNSHNQL---------CCFFFFLFLGGGVF 280 (282)
Q Consensus 246 ILl~~~~~v~l~Dfg~s~~~~---------~~~~~~~~~ape~~ 280 (282)
|||+.++.+||+|||+|+... ...||+.|||||++
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l 208 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 208 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence 999999999999999996311 11578999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-40 Score=281.85 Aligned_cols=175 Identities=19% Similarity=0.255 Sum_probs=151.5
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
.++..++|++.+.||+|+||+||+|++++.....++..||||++.... .....+.+.+|+.+|+.++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 455667899999999999999999999876666677889999987543 334456789999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeec
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQG------------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRD 240 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrD 240 (282)
...+..+++|||+++|+|.+++.... .+++..++.++.|++.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999986432 378889999999999999999999999999
Q ss_pred cCCCceEEcCCCcEEEEecCccccccc---------chhheeeccCcccc
Q 023430 241 LKPENILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVFN 281 (282)
Q Consensus 241 lKp~NILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~~ 281 (282)
|||+|||++.++.+||+|||+|+.... ..|++.|||||.++
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc
Confidence 999999999999999999999963211 14578899999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-40 Score=276.02 Aligned_cols=163 Identities=22% Similarity=0.309 Sum_probs=143.5
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
.+++|+++++||+|+||+||+|+++ .+..||||++++.... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~ 71 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeC
Confidence 4678999999999999999999975 3567999999865432 34588999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
+.+++||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 72 ~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~ 151 (258)
T d1k2pa_ 72 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 151 (258)
T ss_dssp SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheecc
Confidence 999999999999999888765 4568999999999999999999999999999999999999999999999999995311
Q ss_pred --------cchhheeeccCccc
Q 023430 267 --------CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 --------~~~~~~~~~ape~~ 280 (282)
...|++.|||||.+
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~ 173 (258)
T d1k2pa_ 152 DDEYTSSVGSKFPVRWSPPEVL 173 (258)
T ss_dssp SSSCCCCCCSCCCGGGCCHHHH
T ss_pred CCCceeecccCCCCCcCCcHHh
Confidence 12568899999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=284.72 Aligned_cols=163 Identities=21% Similarity=0.321 Sum_probs=136.7
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh--hhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK--KNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSKLY 191 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 191 (282)
.+++||+|+||+||+|+++ .+++.||||+++...... ....+.+.+|+.+|+.++|||||++++++..++.+|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEEC-----CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence 4689999999999999976 457789999997654321 112345789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc----
Q 023430 192 LILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC---- 267 (282)
Q Consensus 192 lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~---- 267 (282)
|||||+.++.+..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 9999999988776666567799999999999999999999999999999999999999999999999999964222
Q ss_pred ---chhheeeccCcccc
Q 023430 268 ---CFFFFLFLGGGVFN 281 (282)
Q Consensus 268 ---~~~~~~~~ape~~~ 281 (282)
..||+.|||||++.
T Consensus 157 ~~~~~gt~~y~aPE~~~ 173 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLF 173 (299)
T ss_dssp CCCSCCCCTTCCHHHHT
T ss_pred ccceecChhhccHHHHc
Confidence 15799999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-40 Score=276.70 Aligned_cols=172 Identities=20% Similarity=0.231 Sum_probs=139.1
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
|++..++|++.+.||+|+||.||+|++.... ..+..||||.++... .....+.+.+|+.+|+.++|||||++++++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4566789999999999999999999987432 345568899886432 344456788999999999999999999998
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
. .+.+|+||||+++|+|..++... ..+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+
T Consensus 78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 78 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred e-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhe
Confidence 5 56789999999999999887654 568999999999999999999999999999999999999999999999999996
Q ss_pred ccc--------cchhheeeccCcccc
Q 023430 264 NQL--------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~--------~~~~~~~~~ape~~~ 281 (282)
... ...|++.|||||.++
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~ 182 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESIN 182 (273)
T ss_dssp --------------CCGGGCCHHHHH
T ss_pred eccCCcceeccceecCcccchhhHhc
Confidence 321 114588999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=279.69 Aligned_cols=165 Identities=22% Similarity=0.362 Sum_probs=138.7
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|+++++||+|+||+||+|+++ .+++.||||+++.... .....+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence 68999999999999999999987 4567899999976542 23334668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc--
Q 023430 190 LYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL-- 266 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~-- 266 (282)
+|+||||+.++.+...... ...+++.+++.++.|++.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9999999986544433333 3569999999999999999999999999999999999999999999999999995321
Q ss_pred -----cchhheeeccCccc
Q 023430 267 -----CCFFFFLFLGGGVF 280 (282)
Q Consensus 267 -----~~~~~~~~~ape~~ 280 (282)
...|++.|+|||.+
T Consensus 156 ~~~~~~~~gt~~y~apE~~ 174 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEIL 174 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHH
T ss_pred cccceeecccceeeehhhh
Confidence 12679999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=277.35 Aligned_cols=166 Identities=25% Similarity=0.329 Sum_probs=142.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhh---HHHHHHHHHHHHHhcC--CCCeeeeeEEE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKN---HVDYMKAERDILTKVT--HPFIVQLRYSF 184 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~E~~~l~~l~--h~nIv~l~~~~ 184 (282)
++|++.++||+|+||+||+|+++ .++..||||++.+....... ...++.+|+.+|+.++ |||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 58999999999999999999987 45678999999865432211 1223567999999987 89999999999
Q ss_pred EeCCEEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-CCcEEEEecCcc
Q 023430 185 QTRSKLYLILDFING-GHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-DGHVMAAHSLNS 262 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-~~~v~l~Dfg~s 262 (282)
.+.+..|+||||+.+ +++.+++.....+++.+++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccc
Confidence 999999999999976 578888888888999999999999999999999999999999999999985 479999999999
Q ss_pred ccccc-----chhheeeccCccc
Q 023430 263 HNQLC-----CFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~~-----~~~~~~~~ape~~ 280 (282)
..... ..||+.|||||.+
T Consensus 159 ~~~~~~~~~~~~GT~~y~aPE~~ 181 (273)
T d1xwsa_ 159 ALLKDTVYTDFDGTRVYSPPEWI 181 (273)
T ss_dssp EECCSSCBCCCCSCGGGSCHHHH
T ss_pred eecccccccccccCCCcCCHHHH
Confidence 63221 2679999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=280.98 Aligned_cols=160 Identities=24% Similarity=0.406 Sum_probs=136.4
Q ss_pred CCCeEEEe-eeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCCeeeeeEEEEe
Q 023430 109 PGDFEIFR-VVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTK-VTHPFIVQLRYSFQT 186 (282)
Q Consensus 109 ~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 186 (282)
.++|+++. .||+|+||+||+|+++ .+++.||||+++.. ..+.+|+.++.+ .+|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEEC-----CCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 46899875 5999999999999987 45678999998643 236679988655 589999999999875
Q ss_pred ----CCEEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---CCcEEEE
Q 023430 187 ----RSKLYLILDFINGGHLFFHLYRQ--GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMAA 257 (282)
Q Consensus 187 ----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~---~~~v~l~ 257 (282)
...+|||||||+||+|.+++.+. ..+++.+++.++.||+.||.|||++||+||||||+|||++. .+.+||+
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence 45799999999999999999764 35899999999999999999999999999999999999985 4679999
Q ss_pred ecCccccccc------chhheeeccCcccc
Q 023430 258 HSLNSHNQLC------CFFFFLFLGGGVFN 281 (282)
Q Consensus 258 Dfg~s~~~~~------~~~~~~~~ape~~~ 281 (282)
|||+|+.... ..||+.|||||++.
T Consensus 157 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (335)
T d2ozaa1 157 DFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186 (335)
T ss_dssp CCTTCEECCCCCCCCCCSCCCSSCCCCCCC
T ss_pred ccceeeeccCCCccccccCCcccCCcHHHc
Confidence 9999963222 26899999999873
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=277.02 Aligned_cols=166 Identities=22% Similarity=0.276 Sum_probs=140.7
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.|.+..++|++.+.||+|+||.||+|+++. ...||||++..... ..+.+.+|+.+|++++|+|||+++++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~------~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECC------CCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEE
Confidence 345667899999999999999999999762 34699999975532 23568899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYR--QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
+. .+..|+|||||++|+|..++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 81 ~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred Ee-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 85 4568999999999999887754 35699999999999999999999999999999999999999999999999999
Q ss_pred cccc--------ccchhheeeccCccc
Q 023430 262 SHNQ--------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~--------~~~~~~~~~~ape~~ 280 (282)
|+.. ....|++.|||||++
T Consensus 160 a~~~~~~~~~~~~~~~gt~~y~aPE~~ 186 (285)
T d1fmka3 160 ARLIEDNEYTARQGAKFPIKWTAPEAA 186 (285)
T ss_dssp TC--------------CCGGGSCHHHH
T ss_pred hhhccCCCceeeccccccccccChHHH
Confidence 9632 112568999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=278.69 Aligned_cols=176 Identities=17% Similarity=0.231 Sum_probs=153.0
Q ss_pred hhcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeee
Q 023430 103 SERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLR 181 (282)
Q Consensus 103 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~ 181 (282)
..|.+..++|++.++||+|+||.||+|++++......++.||||+++... .......+.+|+.+++.+ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 45667778999999999999999999998876555678899999997654 233445688999999999 699999999
Q ss_pred EEEEeCCEEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCC
Q 023430 182 YSFQTRSKLYLILDFINGGHLFFHLYRQG------------------IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKP 243 (282)
Q Consensus 182 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp 243 (282)
+++.....+|+|||||++|+|..++.+.. .+++..++.++.||+.||.|||+++||||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999999999999987543 488999999999999999999999999999999
Q ss_pred CceEEcCCCcEEEEecCccccccc---------chhheeeccCccc
Q 023430 244 ENILMDSDGHVMAAHSLNSHNQLC---------CFFFFLFLGGGVF 280 (282)
Q Consensus 244 ~NILl~~~~~v~l~Dfg~s~~~~~---------~~~~~~~~ape~~ 280 (282)
+|||++.++.++++|||+++.... ..|++.|||||.+
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 219 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI 219 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh
Confidence 999999999999999999963221 1558999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-39 Score=276.27 Aligned_cols=169 Identities=19% Similarity=0.204 Sum_probs=138.6
Q ss_pred CCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC
Q 023430 108 GPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR 187 (282)
Q Consensus 108 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 187 (282)
...+|+++++||+|+||+||+|+++.++. .....||+|.++... .....+.+.+|+.+|++++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCC-EEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 44689999999999999999999875432 223358999886543 234456789999999999999999999999765
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQL 266 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~ 266 (282)
..+++||++.+|+|.+++... ..+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 578889999999998887664 568999999999999999999999999999999999999999999999999986321
Q ss_pred c---------chhheeeccCccc
Q 023430 267 C---------CFFFFLFLGGGVF 280 (282)
Q Consensus 267 ~---------~~~~~~~~ape~~ 280 (282)
. ..||+.|||||.+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l 185 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESI 185 (317)
T ss_dssp TTCC--------CCTTTSCHHHH
T ss_pred cccccccccccccCccccChHHH
Confidence 1 1468999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-39 Score=273.40 Aligned_cols=171 Identities=19% Similarity=0.255 Sum_probs=136.2
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT 186 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 186 (282)
+...+|++++.||+|+||.||+|+++... .....||||++.+.........+.+.+|+.+|+.++||||+++++++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~--~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPS--GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTT--SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCC--CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44568999999999999999999876432 2344699999987765556666789999999999999999999999975
Q ss_pred CCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 187 RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 187 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
+..++|||||++|++.+++.. .+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 467899999999999887765 456999999999999999999999999999999999999999999999999999742
Q ss_pred ccc----------hhheeeccCccc
Q 023430 266 LCC----------FFFFLFLGGGVF 280 (282)
Q Consensus 266 ~~~----------~~~~~~~ape~~ 280 (282)
..+ .|+..|||||.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~ 186 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESL 186 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHH
T ss_pred ccCCCcceecCccccCcccCCHHHH
Confidence 111 357789999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-39 Score=275.46 Aligned_cols=175 Identities=18% Similarity=0.217 Sum_probs=150.7
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEE
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYS 183 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 183 (282)
.|.+..++|++.+.||+|+||.||+|.+++......+..||||+++... .......+.+|+.++++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 4677789999999999999999999998765444456789999997543 23344568899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCc
Q 023430 184 FQTRSKLYLILDFINGGHLFFHLYRQ----------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGH 253 (282)
Q Consensus 184 ~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~ 253 (282)
+......++|||||++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999988642 23688899999999999999999999999999999999999999
Q ss_pred EEEEecCcccccccc---------hhheeeccCccc
Q 023430 254 VMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 254 v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
+||+|||+|+..... .|++.|||||.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l 207 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL 207 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHH
Confidence 999999999633221 568999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-39 Score=272.79 Aligned_cols=164 Identities=19% Similarity=0.332 Sum_probs=143.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|+++++||+|+||+||+|+++ .++.||||++..... .....+.+.+|+.+|+.++|||||++++++...+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 68999999999999999999875 457899999976543 33345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc----
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ---- 265 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~---- 265 (282)
.+++||++.++.+..+....+.+++..++.++.||+.||+|||+++||||||||+|||++.++.+|++|||+|...
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9999999998877777766788999999999999999999999999999999999999999999999999998531
Q ss_pred ---ccchhheeeccCccc
Q 023430 266 ---LCCFFFFLFLGGGVF 280 (282)
Q Consensus 266 ---~~~~~~~~~~ape~~ 280 (282)
....+++.|+|||.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~ 172 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVL 172 (286)
T ss_dssp -------CCCTTCCHHHH
T ss_pred cccceecccchhhhHHHH
Confidence 111568999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=274.41 Aligned_cols=170 Identities=23% Similarity=0.311 Sum_probs=141.9
Q ss_pred CcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeeeeEEE
Q 023430 106 KIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQLRYSF 184 (282)
Q Consensus 106 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 184 (282)
.+..++|++.++||+|+||.||+|+++.++ ....||||.+.... .....+.+.+|+++|+++ +|||||++++++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~ 80 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGAC 80 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCC---eEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence 355679999999999999999999987431 22347788775432 233455688999999998 699999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEE
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILM 248 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl 248 (282)
..++.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||+
T Consensus 81 ~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 81 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 160 (309)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE
Confidence 9999999999999999999998653 468999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCcccccc------cchhheeeccCccc
Q 023430 249 DSDGHVMAAHSLNSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 249 ~~~~~v~l~Dfg~s~~~~------~~~~~~~~~ape~~ 280 (282)
+.++.+||+|||+|+... ...|+..|||||.+
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l 198 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESL 198 (309)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHH
T ss_pred cCCCceEEccccccccccccccccceecCCcccchHHh
Confidence 999999999999996322 22578999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=271.74 Aligned_cols=175 Identities=17% Similarity=0.269 Sum_probs=143.0
Q ss_pred hcCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCC--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCCeeee
Q 023430 104 ERKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDG--DSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV-THPFIVQL 180 (282)
Q Consensus 104 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l 180 (282)
.|.+..++|++++.||+|+||.||+|+...+... ..+..||||+++++. .......+.+|...+.++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 3667778999999999999999999998765432 234579999997654 233445677888888887 79999999
Q ss_pred eEEEEeCCEEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCC
Q 023430 181 RYSFQTRSKLYLILDFINGGHLFFHLYRQ----------------GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPE 244 (282)
Q Consensus 181 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~ 244 (282)
++++.+++.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||+++||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999754 24899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCcccccccc---------hhheeeccCccc
Q 023430 245 NILMDSDGHVMAAHSLNSHNQLCC---------FFFFLFLGGGVF 280 (282)
Q Consensus 245 NILl~~~~~v~l~Dfg~s~~~~~~---------~~~~~~~ape~~ 280 (282)
|||++.++.+||+|||++...... .|++.|||||.+
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l 209 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence 999999999999999999632221 568899999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=267.71 Aligned_cols=164 Identities=20% Similarity=0.335 Sum_probs=137.7
Q ss_pred cCcCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEE
Q 023430 105 RKIGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSF 184 (282)
Q Consensus 105 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 184 (282)
|.+..++|++.+.||+|+||.||+|+++ +..||||+++.+. ..+.+.+|+.++++++||||+++++++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 5677789999999999999999999975 3569999996542 335688999999999999999999988
Q ss_pred Ee-CCEEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCc
Q 023430 185 QT-RSKLYLILDFINGGHLFFHLYRQG--IFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLN 261 (282)
Q Consensus 185 ~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~ 261 (282)
.. .+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||+++||||||||+|||++.+|.+|++|||+
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence 54 456899999999999999986543 489999999999999999999999999999999999999999999999999
Q ss_pred ccccccc----hhheeeccCccc
Q 023430 262 SHNQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~~----~~~~~~~ape~~ 280 (282)
++..-.. .++..|||||++
T Consensus 150 s~~~~~~~~~~~~~~~y~aPE~l 172 (262)
T d1byga_ 150 TKEASSTQDTGKLPVKWTAPEAL 172 (262)
T ss_dssp ------------CCTTTSCHHHH
T ss_pred ceecCCCCccccccccCCChHHH
Confidence 9753222 558899999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-37 Score=268.57 Aligned_cols=164 Identities=16% Similarity=0.239 Sum_probs=135.3
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS- 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 188 (282)
++|++++.||+|+||+||+|+++ .++..||||++.+.. .....+.+.+|+.+|+.++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~ 80 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 80 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEET-----TTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred CCeEEEEEEeeccCeEEEEEEEC-----CCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc
Confidence 46999999999999999999976 457789999997543 2344566889999999999999999999987643
Q ss_pred ---EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccc
Q 023430 189 ---KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQ 265 (282)
Q Consensus 189 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~ 265 (282)
..+++++++.+|+|.+++.. +.+++.+++.++.|++.||+|||++|||||||||+|||++.+|.+||+|||+|...
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 23444556678999999865 46899999999999999999999999999999999999999999999999998532
Q ss_pred c----------cchhheeeccCcccc
Q 023430 266 L----------CCFFFFLFLGGGVFN 281 (282)
Q Consensus 266 ~----------~~~~~~~~~ape~~~ 281 (282)
. ...|++.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~ 185 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIML 185 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTT
T ss_pred cCCCccceeeccccccceechHHHhh
Confidence 1 115799999999873
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-37 Score=270.78 Aligned_cols=164 Identities=20% Similarity=0.315 Sum_probs=136.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS 188 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 188 (282)
.++|++++.||+|+||+||+|.++ .+++.||||++++... .....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG-----RTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET-----TTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 468999999999999999999987 4578899999976542 3445667889999999999999999999997654
Q ss_pred ------EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcc
Q 023430 189 ------KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNS 262 (282)
Q Consensus 189 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s 262 (282)
.+|+||||| +.+|..++ +.+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+|++|||+|
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred cccccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccce
Confidence 579999999 55666655 4567999999999999999999999999999999999999999999999999999
Q ss_pred cccc----cchhheeeccCccc
Q 023430 263 HNQL----CCFFFFLFLGGGVF 280 (282)
Q Consensus 263 ~~~~----~~~~~~~~~ape~~ 280 (282)
...- ...|++.|||||++
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~ 190 (346)
T d1cm8a_ 169 RQADSEMTGYVVTRWYRAPEVI 190 (346)
T ss_dssp EECCSSCCSSCSCGGGCCTHHH
T ss_pred eccCCccccccccccccCHHHH
Confidence 6422 23779999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-37 Score=261.82 Aligned_cols=165 Identities=21% Similarity=0.351 Sum_probs=147.1
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRSK 189 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 189 (282)
++|+++++||+|+||+||+|+++ .+++.||||+++... ......+.+.+|+.+|+.++||||+++++++.....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEEC-----CCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence 58999999999999999999987 467789999997654 234556778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccccccc--
Q 023430 190 LYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLC-- 267 (282)
Q Consensus 190 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~-- 267 (282)
.++|||++.+++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||.|.....
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999999999988888888899999999999999999999999999999999999999999999999999964221
Q ss_pred -----chhheeeccCccc
Q 023430 268 -----CFFFFLFLGGGVF 280 (282)
Q Consensus 268 -----~~~~~~~~ape~~ 280 (282)
..+++.|+|||.+
T Consensus 156 ~~~~~~~~~~~~~~pe~~ 173 (292)
T d1unla_ 156 RCYSAEVVTLWYRPPDVL 173 (292)
T ss_dssp SCCCSCCSCGGGCCHHHH
T ss_pred ccceeeccccchhhhhHh
Confidence 1447888888876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-37 Score=263.65 Aligned_cols=159 Identities=23% Similarity=0.268 Sum_probs=133.0
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC--
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTRS-- 188 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-- 188 (282)
+|.+.++||+|+||.||+|++. +..||||++..... .......|+..++.++|||||++++++...+
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-------g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~ 72 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-------TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc
Confidence 6889999999999999999864 56799999865431 1122334555666789999999999987654
Q ss_pred --EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCCEeeccCCCceEEcCCCcEEEEe
Q 023430 189 --KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHK--------CGIVHRDLKPENILMDSDGHVMAAH 258 (282)
Q Consensus 189 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~--------~~iiHrDlKp~NILl~~~~~v~l~D 258 (282)
.+|+|||||++|+|.+++.+. .+++.+...++.|++.||.|||. +|||||||||+||||+.++.+||+|
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 73 WTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 689999999999999999764 58899999999999999999996 5899999999999999999999999
Q ss_pred cCccccccc-----------chhheeeccCcccc
Q 023430 259 SLNSHNQLC-----------CFFFFLFLGGGVFN 281 (282)
Q Consensus 259 fg~s~~~~~-----------~~~~~~~~ape~~~ 281 (282)
||+++.... ..||+.|||||.++
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 185 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhcc
Confidence 999963221 15799999999874
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=268.62 Aligned_cols=172 Identities=43% Similarity=0.725 Sum_probs=148.6
Q ss_pred cCCCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh-hhhHHHHHHHHHHHHHhcCC-CCeeeeeEEE
Q 023430 107 IGPGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII-KKNHVDYMKAERDILTKVTH-PFIVQLRYSF 184 (282)
Q Consensus 107 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~ 184 (282)
++.++|++++.||+|+||+||+|++... ..+++.||||++++.... +....+.+.+|+.+|++++| |||+++++++
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 4567899999999999999999987532 246788999998765422 12233457789999999976 8999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccc
Q 023430 185 QTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHN 264 (282)
Q Consensus 185 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~ 264 (282)
.+...++++|||+.+|+|..++...+.+++..+..++.||+.||.|||+++||||||||+|||++.+|.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999853
Q ss_pred cc--------cchhheeeccCccc
Q 023430 265 QL--------CCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~~--------~~~~~~~~~ape~~ 280 (282)
.. ...|++.||+||.+
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~ 202 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIV 202 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred hcccccccccccccccccchhHHh
Confidence 21 12679999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-37 Score=265.79 Aligned_cols=167 Identities=22% Similarity=0.295 Sum_probs=135.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCCeeeeeEEEEe
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKV---THPFIVQLRYSFQT 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~ 186 (282)
++|+++++||+|+||+||+|+++. ..++.||||+++...... .....+.+|+.+|+.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEEC----CCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 589999999999999999999763 235679999997654222 1122355677776665 79999999999853
Q ss_pred -----CCEEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 187 -----RSKLYLILDFINGGHLFFHLYR-QGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 187 -----~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
...++++|||+.++.+...... ...+++..++.++.|++.||+|||+++||||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 3478999999998876544433 3558999999999999999999999999999999999999999999999999
Q ss_pred cccccccc------hhheeeccCcccc
Q 023430 261 NSHNQLCC------FFFFLFLGGGVFN 281 (282)
Q Consensus 261 ~s~~~~~~------~~~~~~~ape~~~ 281 (282)
+++..... .||+.|||||++.
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~ 188 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLL 188 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHT
T ss_pred hhhhhcccccCCCcccChhhcCcchhc
Confidence 98643222 6799999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-37 Score=267.00 Aligned_cols=158 Identities=22% Similarity=0.350 Sum_probs=136.0
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 187 (282)
.++|+++++||+|+||+||+|+++ .+++.||||+++... .+.+.+|+.+|+.+. ||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 467999999999999999999987 467889999986432 345788999999996 99999999999754
Q ss_pred --CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecCcccc
Q 023430 188 --SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSLNSHN 264 (282)
Q Consensus 188 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg~s~~ 264 (282)
..+++|||||.+++|..+. +.+++.+++.++.||+.||.|||++|||||||||+|||++.++ .++|+|||+|..
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 5699999999999986643 4699999999999999999999999999999999999999765 589999999963
Q ss_pred c------ccchhheeeccCccc
Q 023430 265 Q------LCCFFFFLFLGGGVF 280 (282)
Q Consensus 265 ~------~~~~~~~~~~ape~~ 280 (282)
. ....+|+.|+|||.+
T Consensus 180 ~~~~~~~~~~~~t~~y~aPE~~ 201 (328)
T d3bqca1 180 YHPGQEYNVRVASRYFKGPELL 201 (328)
T ss_dssp CCTTCCCCSCCSCGGGCCHHHH
T ss_pred ccCCCcccccccCccccCcccc
Confidence 2 122569999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=260.91 Aligned_cols=163 Identities=18% Similarity=0.185 Sum_probs=136.3
Q ss_pred EEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEE
Q 023430 114 IFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-RSKLYL 192 (282)
Q Consensus 114 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~l 192 (282)
..++||+|+||+||+|++.... .....||||++++.. .....+.+.+|+++|++++||||+++++++.. ++..++
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC------CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred cceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence 3678999999999999987432 234468999986532 34456779999999999999999999999765 568999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCcccccccc---
Q 023430 193 ILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSHNQLCC--- 268 (282)
Q Consensus 193 v~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~~~~~~--- 268 (282)
|||||++|+|.+++... ..+++..++.++.|++.||.|||+++|+||||||+|||+++++.+||+|||+++.....
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999999988754 34778889999999999999999999999999999999999999999999999632111
Q ss_pred --------hhheeeccCccc
Q 023430 269 --------FFFFLFLGGGVF 280 (282)
Q Consensus 269 --------~~~~~~~ape~~ 280 (282)
.|++.|||||.+
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~ 206 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESL 206 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHH
T ss_pred cceecccccccccccChHHH
Confidence 468899999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-37 Score=266.21 Aligned_cols=166 Identities=20% Similarity=0.276 Sum_probs=138.1
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe--
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT-- 186 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-- 186 (282)
.++|++++.||+|+||+||+|+++ .+++.||||++..... .....+.+.+|+.+|+.++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 468999999999999999999987 4677899999876543 23344567889999999999999999998754
Q ss_pred ------CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecC
Q 023430 187 ------RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSL 260 (282)
Q Consensus 187 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg 260 (282)
.+.+|+||||+.++.+.........+++..++.++.|++.||.|||++|||||||||+|||++.++.+|++|||
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 34689999999888776555556679999999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----------chhheeeccCccc
Q 023430 261 NSHNQLC-----------CFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~~-----------~~~~~~~~ape~~ 280 (282)
++...-. ..||+.|||||++
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~ 193 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHH
Confidence 9952111 1479999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-37 Score=268.35 Aligned_cols=158 Identities=25% Similarity=0.399 Sum_probs=132.2
Q ss_pred CeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC---
Q 023430 111 DFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR--- 187 (282)
Q Consensus 111 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--- 187 (282)
+|+.+++||+|+||+||+|+++ .+++.||||++..+... ..+|+.+|+.++|+||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEEC-----CCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 6999999999999999999987 46788999999765321 34699999999999999999998543
Q ss_pred ---CEEEEEEeccCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCC-cEEEEecC
Q 023430 188 ---SKLYLILDFINGGHLFFHL---YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDG-HVMAAHSL 260 (282)
Q Consensus 188 ---~~~~lv~e~~~~g~L~~~l---~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~-~v~l~Dfg 260 (282)
..+|||||||+++.+..+. .....+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEeccc
Confidence 3589999999876443332 3355699999999999999999999999999999999999999775 89999999
Q ss_pred cccccc------cchhheeeccCccc
Q 023430 261 NSHNQL------CCFFFFLFLGGGVF 280 (282)
Q Consensus 261 ~s~~~~------~~~~~~~~~ape~~ 280 (282)
++.... ...|++.|+|||.+
T Consensus 169 ~a~~~~~~~~~~~~~gt~~y~aPE~~ 194 (350)
T d1q5ka_ 169 SAKQLVRGEPNVSYICSRYYRAPELI 194 (350)
T ss_dssp TCEECCTTSCCCSCCSCTTSCCHHHH
T ss_pred chhhccCCcccccccccccccChHHh
Confidence 986322 22679999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=264.35 Aligned_cols=165 Identities=18% Similarity=0.240 Sum_probs=137.8
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQTR- 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~- 187 (282)
.++|+++++||+|+||+||+|+++ .+++.||||++.+... .....+.+.+|+.+|+.++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET-----TTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 468999999999999999999977 4678899999976542 334455688999999999999999999998643
Q ss_pred ----CEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 188 ----SKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 188 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...+++|+++.+|+|.+++. .+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+|++|||+|.
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred ccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence 34466677888999998885 4569999999999999999999999999999999999999999999999999986
Q ss_pred ccccc----hhheeeccCccc
Q 023430 264 NQLCC----FFFFLFLGGGVF 280 (282)
Q Consensus 264 ~~~~~----~~~~~~~ape~~ 280 (282)
..... .|++.|||||.+
T Consensus 170 ~~~~~~~~~~g~~~y~apE~~ 190 (348)
T d2gfsa1 170 HTDDEMTGYVATRWYRAPEIM 190 (348)
T ss_dssp CCTGGGSSSCHHHHTSCHHHH
T ss_pred ccCcccccccccccccCchhh
Confidence 43222 679999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-35 Score=253.90 Aligned_cols=161 Identities=17% Similarity=0.170 Sum_probs=137.9
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CCeeeeeEEEEeC
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTH-PFIVQLRYSFQTR 187 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~ 187 (282)
.++|++.++||+|+||+||+|+++ .+++.||||++...... ..+.+|+++++.++| +||+.+++++...
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~ 73 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG 73 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred CCceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecC
Confidence 368999999999999999999987 45778999998654321 236678999999975 8999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC-----CCcEEEEecCc
Q 023430 188 SKLYLILDFINGGHLFFHLYRQ-GIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS-----DGHVMAAHSLN 261 (282)
Q Consensus 188 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~-----~~~v~l~Dfg~ 261 (282)
...++||||+ +++|.+++... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++.++|+|||+
T Consensus 74 ~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 74 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred CccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccce
Confidence 9999999999 67898888765 46999999999999999999999999999999999999974 57899999999
Q ss_pred cccccc--------------chhheeeccCccc
Q 023430 262 SHNQLC--------------CFFFFLFLGGGVF 280 (282)
Q Consensus 262 s~~~~~--------------~~~~~~~~ape~~ 280 (282)
|+.... -.||+.|||||.+
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~ 185 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHh
Confidence 964211 1589999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-36 Score=262.68 Aligned_cols=163 Identities=21% Similarity=0.307 Sum_probs=133.9
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCeeeeeEEEEe---
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFIVQLRYSFQT--- 186 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--- 186 (282)
++|+++++||+|+||+||+|+++ .++..||||++++... .....+.+.+|+.+|+.++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~-----~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET-----TTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEEC-----CCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 57999999999999999999987 4678899999986543 34455678899999999999999999999964
Q ss_pred ---CCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 187 ---RSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 187 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
...+|+|||||.++.+ ..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TTTCCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cccCceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 3689999999976544 444 4568999999999999999999999999999999999999999999999999886
Q ss_pred ccccc------hhheeeccCcccc
Q 023430 264 NQLCC------FFFFLFLGGGVFN 281 (282)
Q Consensus 264 ~~~~~------~~~~~~~ape~~~ 281 (282)
..... .+|+.|+|||++.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~ 191 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVIL 191 (355)
T ss_dssp -------------CCTTCCHHHHT
T ss_pred ccccccccccccccccccChhhhc
Confidence 43332 6799999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-35 Score=252.03 Aligned_cols=161 Identities=15% Similarity=0.172 Sum_probs=131.5
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~ 188 (282)
++|++.+.||+|+||.||+|+++ .+++.||||++...... +.+.+|+++++.++|+|+ +.+.+++...+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~ 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGD 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETT
T ss_pred CEEEEeEEEeeCCCcEEEEEEEC-----CCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCC
Confidence 47999999999999999999987 45678999998764321 236789999999987665 55566677888
Q ss_pred EEEEEEeccCCCchHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcC---CCcEEEEecCcccc
Q 023430 189 KLYLILDFINGGHLFFHL-YRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDS---DGHVMAAHSLNSHN 264 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l-~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~---~~~v~l~Dfg~s~~ 264 (282)
..++||||+.+ +|...+ ...+.+++..+..++.|++.||+|||++|||||||||+|||++. +..++++|||+|+.
T Consensus 77 ~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 77 YNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999999955 555544 44567999999999999999999999999999999999999864 45799999999964
Q ss_pred ccc--------------chhheeeccCcccc
Q 023430 265 QLC--------------CFFFFLFLGGGVFN 281 (282)
Q Consensus 265 ~~~--------------~~~~~~~~ape~~~ 281 (282)
... -.||+.|||||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHL 186 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT
T ss_pred ccccccccceeccccCCcCCCccccCHHHHh
Confidence 211 15899999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=6.9e-30 Score=223.77 Aligned_cols=163 Identities=21% Similarity=0.296 Sum_probs=129.2
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----------CCCee
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-----------HPFIV 178 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv 178 (282)
++|+++++||+|+||+||+|+++ .+++.||||+++++.. ..+.+.+|+.+++.++ |+||+
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~-----~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv 83 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHIL 83 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred CcEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceE
Confidence 56999999999999999999977 4678899999976532 2345677888887765 57899
Q ss_pred eeeEEEEe--CCEEEEEEeccCCCchHHHH-H--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCEeeccCCCceEEcCCC
Q 023430 179 QLRYSFQT--RSKLYLILDFINGGHLFFHL-Y--RQGIFREDQARFYTAEIVSAVSHLHK-CGIVHRDLKPENILMDSDG 252 (282)
Q Consensus 179 ~l~~~~~~--~~~~~lv~e~~~~g~L~~~l-~--~~~~~~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~NILl~~~~ 252 (282)
++++++.. ....+++|+++..+...... . ....+++..++.++.||+.||.|||+ +||+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~ 163 (362)
T d1q8ya_ 84 KLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163 (362)
T ss_dssp CCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred EEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccC
Confidence 99988754 45677777776655433222 2 23568999999999999999999997 8999999999999998765
Q ss_pred c------EEEEecCcccccccc----hhheeeccCcccc
Q 023430 253 H------VMAAHSLNSHNQLCC----FFFFLFLGGGVFN 281 (282)
Q Consensus 253 ~------v~l~Dfg~s~~~~~~----~~~~~~~ape~~~ 281 (282)
. ++++|||.|...... .|++.|||||++.
T Consensus 164 ~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~ 202 (362)
T d1q8ya_ 164 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL 202 (362)
T ss_dssp TTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHH
T ss_pred cccccceeeEeecccccccccccccccccccccChhhcc
Confidence 4 999999998643222 6799999999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.4e-26 Score=185.01 Aligned_cols=135 Identities=18% Similarity=0.192 Sum_probs=104.2
Q ss_pred eEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhh---------------hhhHHHHHHHHHHHHHhcCCCC
Q 023430 112 FEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTII---------------KKNHVDYMKAERDILTKVTHPF 176 (282)
Q Consensus 112 y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~n 176 (282)
+.+.++||+|+||+||+|+.. .++.||||+++..... ..........|...+..+.|.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred chhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence 467899999999999999864 4678999987642211 0111233456888999999999
Q ss_pred eeeeeEEEEeCCEEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCEeeccCCCceEEcCCCcEEE
Q 023430 177 IVQLRYSFQTRSKLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLHKCGIVHRDLKPENILMDSDGHVMA 256 (282)
Q Consensus 177 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~NILl~~~~~v~l 256 (282)
++..+++.. .+++|||+++..+.. +++..+..++.|++.+|.|||++||+||||||+|||++++ .++|
T Consensus 76 v~~~~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 76 VPKVYAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp SCCEEEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEE
T ss_pred cceEEEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEE
Confidence 998876532 379999999865532 4555667889999999999999999999999999999864 5899
Q ss_pred EecCcccc
Q 023430 257 AHSLNSHN 264 (282)
Q Consensus 257 ~Dfg~s~~ 264 (282)
+|||.|..
T Consensus 144 iDFG~a~~ 151 (191)
T d1zara2 144 IDFPQSVE 151 (191)
T ss_dssp CCCTTCEE
T ss_pred EECCCccc
Confidence 99998853
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.79 E-value=3.1e-08 Score=80.65 Aligned_cols=139 Identities=10% Similarity=-0.003 Sum_probs=87.6
Q ss_pred CCeEEEeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCC
Q 023430 110 GDFEIFRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVT-HPFIVQLRYSFQTRS 188 (282)
Q Consensus 110 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 188 (282)
..|++.+..+-++.+.||+... .+..+++|+......... ..+.+|...+..+. +--+.+++.+...++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~-------~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC-------SSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred hceEEEEcCCCCCCCcEEEEEe-------CCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 3577777655555678998762 344578888765432221 23567888887764 333566777778888
Q ss_pred EEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH------------------------------------
Q 023430 189 KLYLILDFINGGHLFFHLYRQGIFREDQARFYTAEIVSAVSHLH------------------------------------ 232 (282)
Q Consensus 189 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~gL~ylH------------------------------------ 232 (282)
..|+||++++|..+....... .. ...++.++.+.+..||
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred ceEEEEEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999999987764322110 00 1112222222233333
Q ss_pred -----------------HC------CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 233 -----------------KC------GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 233 -----------------~~------~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.. .++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11 27999999999999876666799998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.32 E-value=1.1e-06 Score=75.96 Aligned_cols=80 Identities=15% Similarity=0.247 Sum_probs=47.6
Q ss_pred EeeeCcCCCeEEEEEEEcCCCCCCCCcEEEEEEeechhhhh----hhHHHHHHHHHHHHHhcC-C--CCeeeeeEEEEeC
Q 023430 115 FRVVGQGAFGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIK----KNHVDYMKAERDILTKVT-H--PFIVQLRYSFQTR 187 (282)
Q Consensus 115 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~ 187 (282)
.+.||.|....||++... ..++.+++|.-....... ....++...|.+.|+.+. + ..+.+++.+ +.
T Consensus 31 ~~eig~G~~N~vfrV~~~-----~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ-----EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred EEEeCCCceEeEEEEEeC-----CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence 456899999999998743 234568888654321110 112234556888777663 2 344555543 44
Q ss_pred CEEEEEEeccCCCc
Q 023430 188 SKLYLILDFINGGH 201 (282)
Q Consensus 188 ~~~~lv~e~~~~g~ 201 (282)
...++|||++.+..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 55688999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.26 E-value=1.7e-06 Score=69.65 Aligned_cols=135 Identities=13% Similarity=0.096 Sum_probs=78.9
Q ss_pred eeCcCC-CeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--CeeeeeEEEEeCCEEEEE
Q 023430 117 VVGQGA-FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHP--FIVQLRYSFQTRSKLYLI 193 (282)
Q Consensus 117 ~lG~G~-fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~lv 193 (282)
.+..|. -+.||+.... .+..+++|....... ..+..|...|+.+... .+.+++.+....+..++|
T Consensus 17 ~~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp ECSCTTSSCEEEEEECT------TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred EcCCcccCCeEEEEEeC------CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 345554 4688987633 344578887654321 2256688877776532 355677777788889999
Q ss_pred EeccCCCchHH--------------HHHhcC-------CC--CHHHHHH-----HH---------------HHHHHHHHH
Q 023430 194 LDFINGGHLFF--------------HLYRQG-------IF--REDQARF-----YT---------------AEIVSAVSH 230 (282)
Q Consensus 194 ~e~~~~g~L~~--------------~l~~~~-------~~--~~~~~~~-----i~---------------~qi~~gL~y 230 (282)
|++++|.++.. .+.+-. .+ ....... +. ......+..
T Consensus 85 ~~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 85 LGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp EECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred EEeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 99998865421 111100 00 0000000 00 001222333
Q ss_pred HHHC-------CCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 231 LHKC-------GIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 231 lH~~-------~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
+... .++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 4332 27999999999999877667799998774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.54 E-value=0.0001 Score=61.42 Aligned_cols=68 Identities=12% Similarity=0.263 Sum_probs=41.7
Q ss_pred CeEEEEEEEcCCCCCCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-----eee--eEEEEeCCEEEEEEe
Q 023430 123 FGKVFQVKKKGVDDGDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-----VQL--RYSFQTRSKLYLILD 195 (282)
Q Consensus 123 fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l--~~~~~~~~~~~lv~e 195 (282)
--.||+++.. .+..|++|+.+.... ..+.+..|...+..|...+| +.. -..+...+..+.+++
T Consensus 35 EN~vy~v~~~------dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 35 ENRVYQFQDE------DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SSEEEEECCT------TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred cceeEEEEcC------CCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 4689987642 456699999865432 12346678877776642222 111 122345677899999
Q ss_pred ccCCC
Q 023430 196 FINGG 200 (282)
Q Consensus 196 ~~~~g 200 (282)
+++|.
T Consensus 105 ~~~G~ 109 (325)
T d1zyla1 105 SVGGR 109 (325)
T ss_dssp CCCCE
T ss_pred ecCCc
Confidence 99874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.11 E-value=0.0011 Score=56.39 Aligned_cols=84 Identities=15% Similarity=0.152 Sum_probs=50.7
Q ss_pred CCCeEEEeeeCcCCCeEEEEEEEcCCCC--CCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCCe-eeeeEEEE
Q 023430 109 PGDFEIFRVVGQGAFGKVFQVKKKGVDD--GDSDGIYAMKVMRKDTIIKKNHVDYMKAERDILTKVTHPFI-VQLRYSFQ 185 (282)
Q Consensus 109 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~ 185 (282)
.+++++ +.|+-|-.-.+|++....... ......|.+++.... .... ...+|..+++.+.-.++ .++++++.
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~i-dr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETES-HLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHH-HHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhh-HHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 345555 568889999999988653211 122345667765421 1112 24568888888763344 46777664
Q ss_pred eCCEEEEEEeccCCCch
Q 023430 186 TRSKLYLILDFINGGHL 202 (282)
Q Consensus 186 ~~~~~~lv~e~~~~g~L 202 (282)
. ++||||++|..|
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 2 689999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.01 E-value=0.0011 Score=54.35 Aligned_cols=30 Identities=20% Similarity=0.261 Sum_probs=26.6
Q ss_pred CCCEeeccCCCceEEcCCCcEEEEecCccc
Q 023430 234 CGIVHRDLKPENILMDSDGHVMAAHSLNSH 263 (282)
Q Consensus 234 ~~iiHrDlKp~NILl~~~~~v~l~Dfg~s~ 263 (282)
.|+||+|+.++|||++.++..-+.||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 369999999999999988777899999885
|